Psyllid ID: psy2306
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 335 | 2.2.26 [Sep-21-2011] | |||||||
| O60285 | 661 | NUAK family SNF1-like kin | yes | N/A | 0.797 | 0.403 | 0.591 | 4e-96 | |
| Q641K5 | 658 | NUAK family SNF1-like kin | yes | N/A | 0.797 | 0.405 | 0.588 | 9e-96 | |
| Q5R7G9 | 628 | NUAK family SNF1-like kin | no | N/A | 0.791 | 0.421 | 0.590 | 8e-93 | |
| Q9H093 | 628 | NUAK family SNF1-like kin | no | N/A | 0.791 | 0.421 | 0.590 | 9e-93 | |
| Q8BZN4 | 639 | NUAK family SNF1-like kin | no | N/A | 0.820 | 0.430 | 0.552 | 1e-89 | |
| Q66HE5 | 630 | NUAK family SNF1-like kin | no | N/A | 0.820 | 0.436 | 0.565 | 2e-89 | |
| O08679 | 722 | Serine/threonine-protein | no | N/A | 0.838 | 0.389 | 0.452 | 3e-66 | |
| Q00372 | 612 | Carbon catabolite-derepre | yes | N/A | 0.755 | 0.413 | 0.498 | 3e-66 | |
| Q7KZI7 | 788 | Serine/threonine-protein | no | N/A | 0.838 | 0.356 | 0.452 | 4e-66 | |
| P06782 | 633 | Carbon catabolite-derepre | yes | N/A | 0.755 | 0.399 | 0.494 | 8e-66 |
| >sp|O60285|NUAK1_HUMAN NUAK family SNF1-like kinase 1 OS=Homo sapiens GN=NUAK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 351 bits (901), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 158/267 (59%), Positives = 208/267 (77%)
Query: 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRI 83
GV+ H+H+ LK R+++ LG+G YGKV+ + +G+ VAIK+I+K KI+ E D++ I
Sbjct: 41 GVKRHHHKHNLKHRYELQETLGKGTYGKVKRATERFSGRVVAIKSIRKDKIKDEQDMVHI 100
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RREI+IMSS+ HP+II IYEVFEN++K+V++MEYA+ GELYD++ +++ L+E E R FR
Sbjct: 101 RREIEIMSSLNHPHIISIYEVFENKDKIVIIMEYASKGELYDYISERRRLSERETRHFFR 160
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
QI +AV+YCHK+ + HRDLKLENILLD+N N KIADFGLSN++ + +FL TFCGSPLYAS
Sbjct: 161 QIVSAVHYCHKNGVVHRDLKLENILLDDNCNIKIADFGLSNLYQKDKFLQTFCGSPLYAS 220
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIV G PY GPEVD W+LGVLLYTLVYG MPFDG + K L++QIS+G+Y EP S A
Sbjct: 221 PEIVNGRPYRGPEVDSWALGVLLYTLVYGTMPFDGFDHKNLIRQISSGEYREPTQPSDAR 280
Query: 264 PLIAEMLNINPSSRADISVICSHWWID 290
LI ML +NP RA I I +HWW++
Sbjct: 281 GLIRWMLMVNPDRRATIEDIANHWWVN 307
|
Serine/threonine-protein kinase involved in various processes such as cell adhesion, regulation of cell ploidy and senescence, cell proliferation and tumor progression. Phosphorylates ATM, CASP6, LATS1, PPP1R12A and p53/TP53. Acts as a regulator of cellular senescence and cellular ploidy by mediating phosphorylation of 'Ser-464' of LATS1, thereby controlling its stability. Controls cell adhesion by regulating activity of the myosin protein phosphatase 1 (PP1) complex. Acts by mediating phosphorylation of PPP1R12A subunit of myosin PP1: phosphorylated PPP1R12A then interacts with 14-3-3, leading to reduced dephosphorylation of myosin MLC2 by myosin PP1. May be involved in DNA damage response: phosphorylates p53/TP53 at 'Ser-15' and 'Ser-392' and is recruited to the CDKN1A/WAF1 promoter to participate to transcription activation by p53/TP53. May also act as a tumor malignancy-associated factor by promoting tumor invasion and metastasis under regulation and phosphorylation by AKT1. Suppresses Fas-induced apoptosis by mediating phosphorylation of CASP6, thereby suppressing the activation of the caspase and the subsequent cleavage of CFLAR. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q641K5|NUAK1_MOUSE NUAK family SNF1-like kinase 1 OS=Mus musculus GN=Nuak1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (898), Expect = 9e-96, Method: Compositional matrix adjust.
Identities = 157/267 (58%), Positives = 208/267 (77%)
Query: 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRI 83
GV+ H+H+ LK R+++ LG+G YGKV+ + +G+ VAIK+I+K KI+ E D++ I
Sbjct: 42 GVKRHHHKHNLKHRYELQETLGKGTYGKVKRATERFSGRVVAIKSIRKDKIKDELDMVHI 101
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RREI+IMSS+ HP+II IYEVFEN++K+V++MEYA+ GELYD++ +++ L+E E R FR
Sbjct: 102 RREIEIMSSLNHPHIISIYEVFENKDKIVIIMEYASKGELYDYISERRRLSERETRHFFR 161
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
QI +AV+YCHK+ + HRDLKLENILLD+N N KIADFGLSN++ + +FL TFCGSPLYAS
Sbjct: 162 QIVSAVHYCHKNGVVHRDLKLENILLDDNCNIKIADFGLSNLYQKDKFLQTFCGSPLYAS 221
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIV G PY GPEVD W+LGVLLYTL+YG MPFDG + K L++QIS+G+Y EP S A
Sbjct: 222 PEIVNGRPYRGPEVDSWALGVLLYTLIYGTMPFDGFDHKNLIRQISSGEYREPTQPSDAR 281
Query: 264 PLIAEMLNINPSSRADISVICSHWWID 290
LI ML +NP RA I I +HWW++
Sbjct: 282 GLIRWMLMVNPDRRATIEDIANHWWVN 308
|
Serine/threonine-protein kinase involved in various processes such as cell adhesion, regulation of cell ploidy and senescence, cell proliferation and tumor progression. Phosphorylates ATM, CASP6, LATS1, PPP1R12A and p53/TP53. Acts as a regulator of cellular senescence and cellular ploidy by mediating phosphorylation of 'Ser-464' of LATS1, thereby controlling its stability. Controls cell adhesion by regulating activity of the myosin protein phosphatase 1 (PP1) complex. Acts by mediating phosphorylation of PPP1R12A subunit of myosin PP1: phosphorylated PPP1R12A then interacts with 14-3-3, leading to reduced dephosphorylation of myosin MLC2 by myosin PP1. May be involved in DNA damage response: phosphorylates p53/TP53 at 'Ser-15' and 'Ser-392' and is recruited to the CDKN1A/WAF1 promoter to participate to transcription activation by p53/TP53. May also act as a tumor malignancy-associated factor by promoting tumor invasion and metastasis under regulation and phosphorylation by AKT1. Suppresses Fas-induced apoptosis by mediating phosphorylation of CASP6, thereby suppressing the activation of the caspase and the subsequent cleavage of CFLAR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R7G9|NUAK2_PONAB NUAK family SNF1-like kinase 2 OS=Pongo abelii GN=NUAK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (872), Expect = 8e-93, Method: Compositional matrix adjust.
Identities = 157/266 (59%), Positives = 206/266 (77%), Gaps = 1/266 (0%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
V+ H+H+ L+ R++ + LG+G YGKV+ + +G+ VAIK+I+K KI+ E DL+ IR
Sbjct: 40 VKRHHHKHNLRHRYEFLETLGKGTYGKVKKA-RESSGRLVAIKSIRKDKIKDEQDLMHIR 98
Query: 85 REIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQ 144
REI+IMSS+ HP+II I+EVFEN K+V+VMEYA+ G+LYD++ +++ L+E EAR FRQ
Sbjct: 99 REIEIMSSLNHPHIIAIHEVFENSSKIVIVMEYASRGDLYDYISERQQLSEREARHFFRQ 158
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
I +AV+YCH++++ HRDLKLENILLD NGN KIADFGLSN++ + +FL TFCGSPLYASP
Sbjct: 159 IVSAVHYCHQNRVVHRDLKLENILLDANGNIKIADFGLSNLYHQGKFLQTFCGSPLYASP 218
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264
EIV G PY GPEVD WSLGVLLY LV+G MPFDG + K LVKQISNG Y EP S A
Sbjct: 219 EIVNGKPYTGPEVDSWSLGVLLYILVHGTMPFDGHDHKILVKQISNGAYREPPKPSDACG 278
Query: 265 LIAEMLNINPSSRADISVICSHWWID 290
LI +L +NP+ RA + + SHWW++
Sbjct: 279 LIRWLLMVNPTRRATLEDVASHWWVN 304
|
Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95-activated tumor cells. Able to phosphorylate 'Ser-464' of LATS1. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9H093|NUAK2_HUMAN NUAK family SNF1-like kinase 2 OS=Homo sapiens GN=NUAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (872), Expect = 9e-93, Method: Compositional matrix adjust.
Identities = 157/266 (59%), Positives = 206/266 (77%), Gaps = 1/266 (0%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
V+ H+H+ L+ R++ + LG+G YGKV+ + +G+ VAIK+I+K KI+ E DL+ IR
Sbjct: 40 VKRHHHKHNLRHRYEFLETLGKGTYGKVKKA-RESSGRLVAIKSIRKDKIKDEQDLMHIR 98
Query: 85 REIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQ 144
REI+IMSS+ HP+II I+EVFEN K+V+VMEYA+ G+LYD++ +++ L+E EAR FRQ
Sbjct: 99 REIEIMSSLNHPHIIAIHEVFENSSKIVIVMEYASRGDLYDYISERQQLSEREARHFFRQ 158
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
I +AV+YCH++++ HRDLKLENILLD NGN KIADFGLSN++ + +FL TFCGSPLYASP
Sbjct: 159 IVSAVHYCHQNRVVHRDLKLENILLDANGNIKIADFGLSNLYHQGKFLQTFCGSPLYASP 218
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264
EIV G PY GPEVD WSLGVLLY LV+G MPFDG + K LVKQISNG Y EP S A
Sbjct: 219 EIVNGKPYTGPEVDSWSLGVLLYILVHGTMPFDGHDHKILVKQISNGAYREPPKPSDACG 278
Query: 265 LIAEMLNINPSSRADISVICSHWWID 290
LI +L +NP+ RA + + SHWW++
Sbjct: 279 LIRWLLMVNPTRRATLEDVASHWWVN 304
|
Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95-activated tumor cells. Able to phosphorylate 'Ser-464' of LATS1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BZN4|NUAK2_MOUSE NUAK family SNF1-like kinase 2 OS=Mus musculus GN=Nuak2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 330 bits (846), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 157/284 (55%), Positives = 208/284 (73%), Gaps = 9/284 (3%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
V+ H+H+ L+ R++ + LG+G YGKV+ + +G+ VAIK+I+K KI+ E DL+ IR
Sbjct: 44 VKRHHHKHNLRHRYEFLETLGKGTYGKVKKA-RESSGRLVAIKSIRKDKIKDEQDLLHIR 102
Query: 85 REIQIMSSVRHPNIIHIYEV--------FENREKMVLVMEYAAGGELYDFLDQKKVLTEE 136
REI+IMSS+ HP+II I+EV FEN K+V+VMEYA+ G+LYD++ ++ L+E
Sbjct: 103 REIEIMSSLNHPHIIAIHEVGRSRLVTVFENSSKIVIVMEYASRGDLYDYISERPRLSER 162
Query: 137 EARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFC 196
+AR FRQI +A++YCH++ I HRDLKLENILLD NGN KIADFGLSN++ + +FL TFC
Sbjct: 163 DARHFFRQIVSALHYCHQNGIVHRDLKLENILLDANGNIKIADFGLSNLYHKGKFLQTFC 222
Query: 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP 256
GSPLYASPEIV G PY GPEVD WSLGVLLY LV+G MPFDG + K LVKQISNG Y EP
Sbjct: 223 GSPLYASPEIVNGKPYVGPEVDSWSLGVLLYILVHGTMPFDGQDHKTLVKQISNGAYREP 282
Query: 257 KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEE 300
S A LI +L +NP+ RA + + SHWW++ ++ E+
Sbjct: 283 PKPSDACGLIRWLLMVNPTRRATLEDVASHWWVNWGYTTGVGEQ 326
|
Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95-activated tumor cells. Able to phosphorylate 'Ser-464' of LATS1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66HE5|NUAK2_RAT NUAK family SNF1-like kinase 2 OS=Rattus norvegicus GN=Nuak2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 156/276 (56%), Positives = 206/276 (74%), Gaps = 1/276 (0%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
V+ H+H+ L+ R++ + LG+G YGKV+ + +G+ VAIK+I+K KI+ E DL+ IR
Sbjct: 44 VKRHHHKHNLRHRYEFLETLGKGTYGKVKKA-RESSGRLVAIKSIRKDKIKDEQDLLHIR 102
Query: 85 REIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQ 144
REI+IMSS+ HP+II I+EVFEN K+V+VMEYA+ G+LYD++ ++ L E +AR FRQ
Sbjct: 103 REIEIMSSLNHPHIIAIHEVFENSSKIVIVMEYASRGDLYDYISERPRLNERDARHFFRQ 162
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
I +A++YCH++ I HRDLKLENILLD +GN KIADFGLSN++ + +FL TFCGSPLYASP
Sbjct: 163 IVSALHYCHQNGIVHRDLKLENILLDASGNIKIADFGLSNLYHKGKFLQTFCGSPLYASP 222
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264
EIV G PY GPEVD WSLGVLLY LV+G MPFDG + K LVKQIS+G Y EP S A
Sbjct: 223 EIVNGKPYVGPEVDSWSLGVLLYILVHGTMPFDGQDHKTLVKQISSGAYREPCKPSDACG 282
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVACLEE 300
LI +L +NP RA + + SHWW++ +S E+
Sbjct: 283 LIRWLLMVNPIRRATLEDVASHWWVNWGYSTRIGEQ 318
|
Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95-activated tumor cells. Able to phosphorylate 'Ser-464' of LATS1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O08679|MARK2_RAT Serine/threonine-protein kinase MARK2 OS=Rattus norvegicus GN=Mark2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (643), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 129/285 (45%), Positives = 186/285 (65%), Gaps = 4/285 (1%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
+ +++ +G+GN+ KV+L + TG+EVA+K I K ++ + + L ++ RE++IM + HPN
Sbjct: 53 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVLNHPN 111
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
I+ ++EV E + + LVMEYA+GGE++D+L + E+EAR FRQI +AV YCH+ I
Sbjct: 112 IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFI 171
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEV 217
HRDLK EN+LLD + N KIADFG SN FT L TFCGSP YA+PE+ +G Y GPEV
Sbjct: 172 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEV 231
Query: 218 DCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPSS 276
D WSLGV+LYTLV G++PFDG N K L +++ G Y P ST L+ + L +NPS
Sbjct: 232 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSK 291
Query: 277 RADISVICSHWWIDKDHSVACLEE-AEELAN-QTPVRLDLLLSLA 319
R + I W++ H L+ E L + + P R +L++S+
Sbjct: 292 RGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMG 336
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4, MAPT/TAU and RAB11FIP2. Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q00372|SNF1_CANGA Carbon catabolite-derepressing protein kinase OS=Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) GN=SNF1 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 252 bits (643), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 128/257 (49%), Positives = 179/257 (69%), Gaps = 4/257 (1%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI-RIRREIQIMSSVRHP 96
+ IV+ LG+G++GKV+L + TGQ+VA+K I K K+ ++D+ RI REI + +RHP
Sbjct: 39 YQIVKTLGEGSFGKVKLAYHVTTGQKVALKIINK-KVLAKSDMQGRIEREISYLRLLRHP 97
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
+II +Y+V ++++++++V+EYA G EL+D++ Q+ ++E+EARR F+QI +AV YCH+HK
Sbjct: 98 HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRNKMSEQEARRFFQQIISAVEYCHRHK 156
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
I HRDLK EN+LLDE+ N KIADFGLSN+ T+ FL T CGSP YA+PE++ G Y GPE
Sbjct: 157 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 216
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPS 275
VD WS GV+LY ++ +PFD + L K ISNG Y PK S AS LI ML +NP
Sbjct: 217 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGASDLIKRMLIVNPL 276
Query: 276 SRADISVICSHWWIDKD 292
+R I I W D
Sbjct: 277 NRISIHEIMQDEWFKVD 293
|
Essential for release from glucose repression. It interacts and has functional relationship to the regulatory protein SNF4. Could phosphorylates CAT8. Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (taxid: 284593) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7KZI7|MARK2_HUMAN Serine/threonine-protein kinase MARK2 OS=Homo sapiens GN=MARK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 251 bits (642), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 129/285 (45%), Positives = 186/285 (65%), Gaps = 4/285 (1%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
+ +++ +G+GN+ KV+L + TG+EVA+K I K ++ + + L ++ RE++IM + HPN
Sbjct: 53 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVLNHPN 111
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
I+ ++EV E + + LVMEYA+GGE++D+L + E+EAR FRQI +AV YCH+ I
Sbjct: 112 IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFI 171
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEV 217
HRDLK EN+LLD + N KIADFG SN FT L TFCGSP YA+PE+ +G Y GPEV
Sbjct: 172 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEV 231
Query: 218 DCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPSS 276
D WSLGV+LYTLV G++PFDG N K L +++ G Y P ST L+ + L +NPS
Sbjct: 232 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPSK 291
Query: 277 RADISVICSHWWIDKDHSVACLEE-AEELAN-QTPVRLDLLLSLA 319
R + I W++ H L+ E L + + P R +L++S+
Sbjct: 292 RGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMG 336
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4, MAPT/TAU, and RAB11FIP2. Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P06782|SNF1_YEAST Carbon catabolite-derepressing protein kinase OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=SNF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (640), Expect = 8e-66, Method: Compositional matrix adjust.
Identities = 127/257 (49%), Positives = 179/257 (69%), Gaps = 4/257 (1%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI-RIRREIQIMSSVRHP 96
+ IV+ LG+G++GKV+L + TGQ+VA+K I K K+ ++D+ RI REI + +RHP
Sbjct: 55 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLRLLRHP 113
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
+II +Y+V ++++++++V+EYA G EL+D++ Q+ ++E+EARR F+QI +AV YCH+HK
Sbjct: 114 HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 172
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
I HRDLK EN+LLDE+ N KIADFGLSN+ T+ FL T CGSP YA+PE++ G Y GPE
Sbjct: 173 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 232
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPS 275
VD WS GV+LY ++ +PFD + L K ISNG Y PK S A+ LI ML +NP
Sbjct: 233 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 292
Query: 276 SRADISVICSHWWIDKD 292
+R I I W D
Sbjct: 293 NRISIHEIMQDDWFKVD 309
|
Essential for release from glucose repression. It interacts and has functional relationship to the regulatory protein SNF4. Could phosphorylate CAT8. Phosphorylates histone H3 to form H3S10ph, which promotes H3K14ac formation, and which is required for transcriptional activation through TBP recruitment to the promoters. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 335 | ||||||
| 332024514 | 2704 | NUAK family SNF1-like kinase 1 [Acromyrm | 0.988 | 0.122 | 0.828 | 1e-166 | |
| 307177175 | 2617 | NUAK family SNF1-like kinase 1 [Camponot | 0.973 | 0.124 | 0.831 | 1e-165 | |
| 340723267 | 2648 | PREDICTED: hypothetical protein LOC10064 | 0.973 | 0.123 | 0.828 | 1e-165 | |
| 307199055 | 2771 | NUAK family SNF1-like kinase 1 [Harpegna | 0.973 | 0.117 | 0.828 | 1e-165 | |
| 328776417 | 2586 | PREDICTED: hypothetical protein LOC40995 | 0.973 | 0.126 | 0.828 | 1e-165 | |
| 383849695 | 2753 | PREDICTED: uncharacterized protein LOC10 | 0.973 | 0.118 | 0.813 | 1e-163 | |
| 242007420 | 1185 | serine/threonine protein kinase, putativ | 0.979 | 0.276 | 0.793 | 1e-160 | |
| 347969406 | 1355 | AGAP003174-PA [Anopheles gambiae str. PE | 0.961 | 0.237 | 0.801 | 1e-160 | |
| 312385886 | 3414 | hypothetical protein AND_00217 [Anophele | 0.961 | 0.094 | 0.798 | 1e-159 | |
| 386765465 | 2537 | CG43143, isoform E [Drosophila melanogas | 0.964 | 0.127 | 0.780 | 1e-157 |
| >gi|332024514|gb|EGI64712.1| NUAK family SNF1-like kinase 1 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1520), Expect = e-166, Method: Compositional matrix adjust.
Identities = 275/332 (82%), Positives = 299/332 (90%), Gaps = 1/332 (0%)
Query: 5 MVVPQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEV 64
MVV +ASI+NIMGG+ESTGGVRLHNH+RKLKQRFDI++KLGQG YGKVQLGINKETGQEV
Sbjct: 1 MVVGEASIHNIMGGMESTGGVRLHNHKRKLKQRFDIIKKLGQGTYGKVQLGINKETGQEV 60
Query: 65 AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELY 124
AIKTIKKCKIETEADLIRIRREIQIMSSV+HPNIIHIYEVFENREKMVLVMEYAAGGELY
Sbjct: 61 AIKTIKKCKIETEADLIRIRREIQIMSSVQHPNIIHIYEVFENREKMVLVMEYAAGGELY 120
Query: 125 DFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184
D+L ++KVL+E EARRIFRQIATAV+YCHKHKICHRDLKLENILLD+ GNAKIADFGLSN
Sbjct: 121 DYLSERKVLSEHEARRIFRQIATAVFYCHKHKICHRDLKLENILLDQVGNAKIADFGLSN 180
Query: 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
VF E R L+TFCGSPLYASPEIVKG PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL
Sbjct: 181 VFDEQRLLNTFCGSPLYASPEIVKGTPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 240
Query: 245 VKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEEL 304
VKQIS DYFEPK S ASPLI EML + PS RADI IC+HWW+++ + CL+ AE+L
Sbjct: 241 VKQISQSDYFEPKKPSPASPLIKEMLTVCPSRRADIERICTHWWVNEGYEQNCLDIAEDL 300
Query: 305 ANQTPVRLDLLLSLAP-SPSTDKILVGADAIA 335
A QTPVRLDLLLSL P S S +K+LVG D A
Sbjct: 301 AAQTPVRLDLLLSLVPQSASAEKLLVGGDQQA 332
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307177175|gb|EFN66408.1| NUAK family SNF1-like kinase 1 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 272/327 (83%), Positives = 296/327 (90%), Gaps = 1/327 (0%)
Query: 5 MVVPQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEV 64
MVV +ASI+NIMGG+ESTGGVRLHNH+RKLKQRFDI++KLGQG YGKVQLGINKETGQEV
Sbjct: 2 MVVGEASIHNIMGGMESTGGVRLHNHKRKLKQRFDIIKKLGQGTYGKVQLGINKETGQEV 61
Query: 65 AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELY 124
AIKTIKKCKIETEADLIRIRREIQIMSSV+HPNIIHIYEVFENREKMVLVMEYAAGGELY
Sbjct: 62 AIKTIKKCKIETEADLIRIRREIQIMSSVQHPNIIHIYEVFENREKMVLVMEYAAGGELY 121
Query: 125 DFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184
D+L ++KVL+E EARRIFRQIATAV+YCHKHKICHRDLKLENILLD+ GNAKIADFGLSN
Sbjct: 122 DYLSERKVLSEHEARRIFRQIATAVFYCHKHKICHRDLKLENILLDQVGNAKIADFGLSN 181
Query: 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
VF E R L+TFCGSPLYASPEIVKG PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL
Sbjct: 182 VFDEQRLLNTFCGSPLYASPEIVKGTPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 241
Query: 245 VKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEEL 304
VKQIS DYFEPK S ASPLI EML + P RADI IC+HWW+++ + CL+ AE+L
Sbjct: 242 VKQISQSDYFEPKKPSPASPLIKEMLTVCPGRRADIEKICTHWWVNEGYEQNCLDIAEDL 301
Query: 305 ANQTPVRLDLLLSLAP-SPSTDKILVG 330
A QTPVRLDLLLSL P S S +K+LVG
Sbjct: 302 AAQTPVRLDLLLSLVPQSASAEKLLVG 328
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340723267|ref|XP_003400013.1| PREDICTED: hypothetical protein LOC100642972 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 271/327 (82%), Positives = 297/327 (90%), Gaps = 1/327 (0%)
Query: 5 MVVPQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEV 64
MVV +ASI+NIMGG+ESTGGVRLHNH+RKLKQRFDI++KLGQG YGKVQLGINKETGQEV
Sbjct: 1 MVVGEASIHNIMGGMESTGGVRLHNHKRKLKQRFDIIKKLGQGTYGKVQLGINKETGQEV 60
Query: 65 AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELY 124
AIKTIKKCKIETEADLIRIRREIQIMSSV+HPNIIHIYEVFENREKMVLVMEYAAGGELY
Sbjct: 61 AIKTIKKCKIETEADLIRIRREIQIMSSVQHPNIIHIYEVFENREKMVLVMEYAAGGELY 120
Query: 125 DFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184
D+L ++KVLTE EARRIFRQIATAV+YCHKHKICHRDLKLENILLD+ GNAKIADFGLSN
Sbjct: 121 DYLSERKVLTEHEARRIFRQIATAVFYCHKHKICHRDLKLENILLDQVGNAKIADFGLSN 180
Query: 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
VF E R L+TFCGSPLYASPEIVKG PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL
Sbjct: 181 VFDEQRLLNTFCGSPLYASPEIVKGTPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 240
Query: 245 VKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEEL 304
VKQIS DYFEPK S ASPLI +ML + P+ RADI IC+HWW+++ + CL+ AE+L
Sbjct: 241 VKQISQSDYFEPKKPSPASPLIKDMLTVCPARRADIERICTHWWVNEGYEQNCLDIAEDL 300
Query: 305 ANQTPVRLDLLLSLAP-SPSTDKILVG 330
A QTPVRLDLLLSL P S S +K++VG
Sbjct: 301 AAQTPVRLDLLLSLVPQSASAEKLVVG 327
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307199055|gb|EFN79779.1| NUAK family SNF1-like kinase 1 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1513), Expect = e-165, Method: Compositional matrix adjust.
Identities = 271/327 (82%), Positives = 295/327 (90%), Gaps = 1/327 (0%)
Query: 5 MVVPQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEV 64
MVV + SI+NIMGG+ESTGGVRLHNH+RKLKQRFDI++KLGQG YGKVQLGINKETGQEV
Sbjct: 1 MVVGEPSIHNIMGGMESTGGVRLHNHKRKLKQRFDIIKKLGQGTYGKVQLGINKETGQEV 60
Query: 65 AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELY 124
AIKTIKKCKIETEADLIRIRREIQIMSSV+HPNIIHIYEVFENREKMVLVMEYAAGGELY
Sbjct: 61 AIKTIKKCKIETEADLIRIRREIQIMSSVQHPNIIHIYEVFENREKMVLVMEYAAGGELY 120
Query: 125 DFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184
D+L ++KVL+E EARRIFRQIATAV+YCHKHKICHRDLKLENILLD+ GNAKIADFGLSN
Sbjct: 121 DYLSERKVLSEHEARRIFRQIATAVFYCHKHKICHRDLKLENILLDQVGNAKIADFGLSN 180
Query: 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
VF E R LSTFCGSPLYASPEIVKG PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL
Sbjct: 181 VFGEQRLLSTFCGSPLYASPEIVKGTPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 240
Query: 245 VKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEEL 304
VKQIS DYFEPK S ASPLI EML + P RAD+ IC+HWW+++ + CL+ AE+L
Sbjct: 241 VKQISQSDYFEPKKPSPASPLIKEMLTVCPGRRADVERICTHWWVNEGYEQNCLDIAEDL 300
Query: 305 ANQTPVRLDLLLSLAP-SPSTDKILVG 330
A QTPVRLDLLLSL P S S +K+LVG
Sbjct: 301 AAQTPVRLDLLLSLVPQSASAEKLLVG 327
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328776417|ref|XP_393444.4| PREDICTED: hypothetical protein LOC409952 isoform 1 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1511), Expect = e-165, Method: Compositional matrix adjust.
Identities = 271/327 (82%), Positives = 296/327 (90%), Gaps = 1/327 (0%)
Query: 5 MVVPQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEV 64
MVV +ASI+NIMGG+ESTGGVRLHNH+RKLKQRFDI++KLGQG YGKVQLGINKETGQEV
Sbjct: 1 MVVGEASIHNIMGGMESTGGVRLHNHKRKLKQRFDIIKKLGQGTYGKVQLGINKETGQEV 60
Query: 65 AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELY 124
AIKTIKKCKIETEADLIRIRREIQIMSSV+HPNIIHIYEVFENREKMVLVMEYAAGGELY
Sbjct: 61 AIKTIKKCKIETEADLIRIRREIQIMSSVQHPNIIHIYEVFENREKMVLVMEYAAGGELY 120
Query: 125 DFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184
D+L ++KVLTE EARRIFRQIATAV+YCHKHKICHRDLKLENILLD+ GNAKIADFGLSN
Sbjct: 121 DYLSERKVLTEHEARRIFRQIATAVFYCHKHKICHRDLKLENILLDQVGNAKIADFGLSN 180
Query: 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
VF E R L+TFCGSPLYASPEIVKG PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL
Sbjct: 181 VFDEQRLLNTFCGSPLYASPEIVKGTPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 240
Query: 245 VKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEEL 304
VKQIS DYFEPK S ASPLI +ML + P RADI IC+HWW+++ + CL+ AEEL
Sbjct: 241 VKQISQSDYFEPKKPSPASPLIKDMLTVCPGRRADIERICTHWWVNEGYEQNCLDIAEEL 300
Query: 305 ANQTPVRLDLLLSLAP-SPSTDKILVG 330
A QTPVRLDLLLSL P S S +K+++G
Sbjct: 301 AAQTPVRLDLLLSLVPQSASAEKLVIG 327
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383849695|ref|XP_003700480.1| PREDICTED: uncharacterized protein LOC100882281 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1494), Expect = e-163, Method: Compositional matrix adjust.
Identities = 266/327 (81%), Positives = 294/327 (89%), Gaps = 1/327 (0%)
Query: 5 MVVPQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEV 64
MVV +ASI+NIMGG+ESTGGVRLHNH+RKLKQRFDI++KLGQG YGKVQLG+NKETGQ V
Sbjct: 1 MVVGEASIHNIMGGMESTGGVRLHNHKRKLKQRFDIIKKLGQGTYGKVQLGLNKETGQAV 60
Query: 65 AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELY 124
AIKTIKKCKIETEADLIRIRREIQIMSSV+HPNIIHIYEVFENREKMVLVMEYAAGGELY
Sbjct: 61 AIKTIKKCKIETEADLIRIRREIQIMSSVQHPNIIHIYEVFENREKMVLVMEYAAGGELY 120
Query: 125 DFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184
D+L ++K LTE+EARRIFRQIA AV+YCHKHKICHRDLKLENILLD+ GNAKIADFGLSN
Sbjct: 121 DYLSERKKLTEQEARRIFRQIAIAVFYCHKHKICHRDLKLENILLDQVGNAKIADFGLSN 180
Query: 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
VF E R L+TFCGSPLYASPEIVKG PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL
Sbjct: 181 VFDEQRLLNTFCGSPLYASPEIVKGTPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 240
Query: 245 VKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEEL 304
VKQIS DY+EPK S ASPLI +ML + P RADI IC+HWW+++ + CL+ AE+L
Sbjct: 241 VKQISQSDYYEPKKPSPASPLIKDMLTVCPGRRADIERICTHWWVNEGYEQNCLDIAEDL 300
Query: 305 ANQTPVRLDLLLSLAP-SPSTDKILVG 330
A QTPVRLDLLLSL P S S +K++VG
Sbjct: 301 AAQTPVRLDLLLSLVPQSASAEKLVVG 327
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242007420|ref|XP_002424538.1| serine/threonine protein kinase, putative [Pediculus humanus corporis] gi|212507971|gb|EEB11800.1| serine/threonine protein kinase, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 571 bits (1471), Expect = e-160, Method: Compositional matrix adjust.
Identities = 261/329 (79%), Positives = 298/329 (90%), Gaps = 1/329 (0%)
Query: 5 MVVPQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEV 64
MVV ++++++IM G++ST GVRLHNHR+KL+QRFDI++KLGQG YGKVQLGINKETGQEV
Sbjct: 1 MVVDRSNVDHIMRGLQSTEGVRLHNHRKKLRQRFDIIKKLGQGTYGKVQLGINKETGQEV 60
Query: 65 AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELY 124
AIKTIKKCKIET+ADL+RIRREIQIMSSVRHPNIIHIYEVFENREK+VLVMEYAAGGELY
Sbjct: 61 AIKTIKKCKIETDADLVRIRREIQIMSSVRHPNIIHIYEVFENREKIVLVMEYAAGGELY 120
Query: 125 DFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184
D+L ++KVL E EARRIFRQI+TA+YYCHKHKICHRDLKLENILLDE+G+AKIADFGLSN
Sbjct: 121 DYLSERKVLEETEARRIFRQISTAIYYCHKHKICHRDLKLENILLDEHGSAKIADFGLSN 180
Query: 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
VF R L+T+CGSPLYASPEIVKG PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL
Sbjct: 181 VFDGQRLLNTYCGSPLYASPEIVKGTPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 240
Query: 245 VKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEEL 304
VKQIS GDYFEPK S AS LI +ML +N RA+I ICSHWW+++ +V+CL+ AE+L
Sbjct: 241 VKQISQGDYFEPKKASPASSLIRDMLTVNSPDRANIEQICSHWWVNQGFNVSCLDIAEDL 300
Query: 305 ANQTPVRLDLLLSLAPSP-STDKILVGAD 332
ANQTPVRLDLLLSLAP P +T+KI+V D
Sbjct: 301 ANQTPVRLDLLLSLAPPPENTEKIVVTDD 329
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347969406|ref|XP_312866.5| AGAP003174-PA [Anopheles gambiae str. PEST] gi|333468510|gb|EAA08346.5| AGAP003174-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 569 bits (1467), Expect = e-160, Method: Compositional matrix adjust.
Identities = 259/323 (80%), Positives = 294/323 (91%), Gaps = 1/323 (0%)
Query: 9 QASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKT 68
+A+I NIM GIE+TG V+++NHR+KL+QRFDI++KLGQG YGKVQLGINKETGQEVAIKT
Sbjct: 24 KATIENIMSGIENTGAVKMNNHRKKLRQRFDIIKKLGQGTYGKVQLGINKETGQEVAIKT 83
Query: 69 IKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLD 128
IKK KIETEADLIRIRRE+QIMSSV+HPNIIHIYEVFENREKMVLVME+AAGGELYD+L
Sbjct: 84 IKKSKIETEADLIRIRREVQIMSSVQHPNIIHIYEVFENREKMVLVMEFAAGGELYDYLS 143
Query: 129 QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188
++KVL EEEARRIFRQ++TA+YYCHKHKICHRDLKLENILLDE+GNAKIADFGLSNVF E
Sbjct: 144 ERKVLAEEEARRIFRQVSTAIYYCHKHKICHRDLKLENILLDEHGNAKIADFGLSNVFDE 203
Query: 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
R L+TFCGSPLYASPEIVKG PY GPEVDCWSLGVLLYTLVYGAMPFDG+NFKRLVKQI
Sbjct: 204 QRLLATFCGSPLYASPEIVKGTPYQGPEVDCWSLGVLLYTLVYGAMPFDGANFKRLVKQI 263
Query: 249 SNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQT 308
S GDYFEPK S ASPLI EML + PS RA+I IC+HWW+++ + +CL+ AEELANQT
Sbjct: 264 SQGDYFEPKKPSRASPLIREMLTVCPSHRANIEQICNHWWVNEGYEESCLDLAEELANQT 323
Query: 309 PVRLDLLLSLA-PSPSTDKILVG 330
PVRLD+LLSLA PS + D++LVG
Sbjct: 324 PVRLDVLLSLAPPSVTADQLLVG 346
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|312385886|gb|EFR30278.1| hypothetical protein AND_00217 [Anopheles darlingi] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1461), Expect = e-159, Method: Compositional matrix adjust.
Identities = 258/323 (79%), Positives = 291/323 (90%), Gaps = 1/323 (0%)
Query: 9 QASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKT 68
+A+I NIM GIE+TG V+++NHR+KL+QRFDI++KLGQG YGKVQLGINKETGQEVAIKT
Sbjct: 24 KATIENIMSGIENTGAVKMNNHRKKLRQRFDIIKKLGQGTYGKVQLGINKETGQEVAIKT 83
Query: 69 IKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLD 128
IKK KIETEADLIRIRRE+QIMSSV+HPNIIHIYEVFENREKMVLVME+AAGGELYD+L
Sbjct: 84 IKKSKIETEADLIRIRREVQIMSSVQHPNIIHIYEVFENREKMVLVMEFAAGGELYDYLS 143
Query: 129 QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188
++KVL EEEARRIFRQ++T +YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF E
Sbjct: 144 ERKVLAEEEARRIFRQVSTDIYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFDE 203
Query: 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
R L+TFCGSPLYASPEIVKG PY GPEVDCWSLGVLLYTLVYGAMPFDG+NFKRLVKQI
Sbjct: 204 QRLLATFCGSPLYASPEIVKGTPYQGPEVDCWSLGVLLYTLVYGAMPFDGANFKRLVKQI 263
Query: 249 SNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQT 308
S GDYFEPK S ASPLI EML + P RA I IC+HWW+++ + +CL+ AEELANQT
Sbjct: 264 SAGDYFEPKKPSRASPLIREMLTVCPRQRASIEQICNHWWVNEGYDESCLDLAEELANQT 323
Query: 309 PVRLDLLLSLA-PSPSTDKILVG 330
PVRLD+LLSLA PS + D++LVG
Sbjct: 324 PVRLDVLLSLAPPSVTADQLLVG 346
|
Source: Anopheles darlingi Species: Anopheles darlingi Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|386765465|ref|NP_649993.2| CG43143, isoform E [Drosophila melanogaster] gi|383292609|gb|AAF54518.2| CG43143, isoform E [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1446), Expect = e-157, Method: Compositional matrix adjust.
Identities = 252/323 (78%), Positives = 286/323 (88%)
Query: 7 VPQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAI 66
+PQ I+NIM GI +TG V+++NHR+KL+QRFDI++KLGQG YGKVQLGINKETGQEVAI
Sbjct: 39 IPQDQIDNIMSGIANTGNVKMNNHRKKLRQRFDIIKKLGQGTYGKVQLGINKETGQEVAI 98
Query: 67 KTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDF 126
KTIKKCKIE EADL+RIRRE+QIMSSV HPNIIHIYEVFENREKMVLVME+AAGGELYD+
Sbjct: 99 KTIKKCKIEAEADLVRIRREVQIMSSVHHPNIIHIYEVFENREKMVLVMEFAAGGELYDY 158
Query: 127 LDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186
L ++KVLTEEEARRIFRQ+ATAVYYCHKHKICHRDLKLENILLDE GNAKIADFGLSNVF
Sbjct: 159 LSERKVLTEEEARRIFRQVATAVYYCHKHKICHRDLKLENILLDEKGNAKIADFGLSNVF 218
Query: 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVK 246
+ R L TFCGSPLYASPEIV+G PY GPEVDCWSLGVLLYTLVYG+MPFDGSNFKRLVK
Sbjct: 219 DDQRLLGTFCGSPLYASPEIVEGTPYQGPEVDCWSLGVLLYTLVYGSMPFDGSNFKRLVK 278
Query: 247 QISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELAN 306
QIS GDY+EP+ S AS LI +ML + P RA I ICSHWW++++ +V+CL+ AE+LAN
Sbjct: 279 QISQGDYYEPRKPSRASTLIRDMLTVCPRKRASIEQICSHWWVNENDNVSCLDLAEDLAN 338
Query: 307 QTPVRLDLLLSLAPSPSTDKILV 329
QTPVRLD+LLSL P+ T LV
Sbjct: 339 QTPVRLDVLLSLTPATITADQLV 361
|
Source: Drosophila melanogaster Species: Drosophila melanogaster Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 335 | ||||||
| WB|WBGene00006814 | 1793 | unc-82 [Caenorhabditis elegans | 0.868 | 0.162 | 0.580 | 9.6e-90 | |
| ZFIN|ZDB-GENE-041210-122 | 617 | si:dkey-261e22.1 "si:dkey-261e | 0.814 | 0.442 | 0.571 | 2.6e-86 | |
| UNIPROTKB|F1P356 | 654 | NUAK1 "Uncharacterized protein | 0.797 | 0.408 | 0.569 | 5e-83 | |
| UNIPROTKB|E1B9B6 | 662 | NUAK1 "Uncharacterized protein | 0.797 | 0.403 | 0.565 | 8.2e-83 | |
| UNIPROTKB|J9P812 | 666 | NUAK1 "Uncharacterized protein | 0.797 | 0.400 | 0.565 | 8.2e-83 | |
| UNIPROTKB|O60285 | 661 | NUAK1 "NUAK family SNF1-like k | 0.797 | 0.403 | 0.565 | 8.2e-83 | |
| UNIPROTKB|F1SPP7 | 666 | NUAK1 "Uncharacterized protein | 0.797 | 0.400 | 0.565 | 1e-82 | |
| MGI|MGI:1925226 | 658 | Nuak1 "NUAK family, SNF1-like | 0.797 | 0.405 | 0.561 | 1e-82 | |
| RGD|1309956 | 661 | Nuak1 "NUAK family, SNF1-like | 0.797 | 0.403 | 0.561 | 1e-82 | |
| UNIPROTKB|F1NRW2 | 656 | Gga.12811 "Uncharacterized pro | 0.820 | 0.419 | 0.561 | 3.6e-82 |
| WB|WBGene00006814 unc-82 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 907 (324.3 bits), Expect = 9.6e-90, P = 9.6e-90
Identities = 169/291 (58%), Positives = 211/291 (72%)
Query: 13 NNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXX 72
N+ G G + +K K RF+I +KLG G YGKV L + + +EVA
Sbjct: 272 NSYGPGTHPMSGAEPCSPTKKEKHRFEITKKLGSGTYGKVSLAYDHKFDREVAVKLIKKS 331
Query: 73 XXXXXADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV 132
ADL+RIRREI+IMS++ HPNII IYEVFEN++K++LVMEY++GGELYD++ +
Sbjct: 332 AIESKADLVRIRREIRIMSALNHPNIIQIYEVFENKDKIILVMEYSSGGELYDYVSRCGS 391
Query: 133 LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192
L E EARRIFRQI +AV YCHKH++ HRDLKLENILLD+N NAKIADFGLSN F + L
Sbjct: 392 LPEAEARRIFRQITSAVLYCHKHRVAHRDLKLENILLDQNNNAKIADFGLSNYFADKNLL 451
Query: 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD 252
+TFCGSPLYASPEI+ G PY GPEVDCWSLG+LLYTLVYG+MPFDG +F R+V+QI G
Sbjct: 452 TTFCGSPLYASPEIINGTPYKGPEVDCWSLGILLYTLVYGSMPFDGRDFNRMVRQIKRGA 511
Query: 253 YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEE 303
YFEP+ STAS LI ML +NP RA I I SHWW++ + ++ ++E E
Sbjct: 512 YFEPETPSTASMLIRNMLRVNPERRATIFDIASHWWLNLEENMPVIQELPE 562
|
|
| ZFIN|ZDB-GENE-041210-122 si:dkey-261e22.1 "si:dkey-261e22.1" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
Identities = 156/273 (57%), Positives = 202/273 (73%)
Query: 18 GIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXXXXXXX 77
G+ V+ H+H+ LK R++++ LG+G YGKV+ I + TG+ VA
Sbjct: 33 GVRRGSSVKKHHHKHNLKHRYELLETLGRGTYGKVKKAIERHTGRVVAIKSIRKEKIKDE 92
Query: 78 ADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEE 137
D++ IRREI+IMSS+RHP+II IYEVFEN++K+V+VMEYA+ GELYD++ +++ LTE E
Sbjct: 93 QDMVHIRREIEIMSSLRHPHIISIYEVFENKDKIVIVMEYASKGELYDYISERRRLTERE 152
Query: 138 ARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCG 197
R FRQI +AV+YCHK + HRDLKLENILLD+NGN KIADFGLSN++ + + L TFCG
Sbjct: 153 TRHFFRQIVSAVHYCHKKGVVHRDLKLENILLDDNGNIKIADFGLSNLYHKDKLLQTFCG 212
Query: 198 SPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPK 257
SPLYASPEIV G PY GPEVD W+LGVLLYTLVYG MPFDG + +RL++QISNG+Y EP
Sbjct: 213 SPLYASPEIVNGRPYRGPEVDSWALGVLLYTLVYGTMPFDGGDHQRLIRQISNGEYREPP 272
Query: 258 NQSTASPLIAEMLNINPSSRADISVICSHWWID 290
S A LI ML +NP RA + I +HWW++
Sbjct: 273 QSSDARGLIRWMLMVNPDRRATVEDIANHWWVN 305
|
|
| UNIPROTKB|F1P356 NUAK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 5.0e-83, P = 5.0e-83
Identities = 152/267 (56%), Positives = 199/267 (74%)
Query: 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXXXXXXXADLIRI 83
GV+ H+H+ LK R+++ LG+G YGKV+ I + +G+ VA D++ I
Sbjct: 34 GVKRHHHKHNLKHRYELQETLGKGTYGKVKRAIERFSGRVVAIKSIRKDKIKDEQDMVHI 93
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RREI+IMSS+ HP+II IYEVFEN++K+V++MEYA+ GELYD++ +++ L+E E R FR
Sbjct: 94 RREIEIMSSLSHPHIITIYEVFENKDKIVIIMEYASKGELYDYISERRRLSERETRHFFR 153
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
QI +AV+YCHK+ + HRDLKLENILLD+N N KIADFGLSN++ + +FL TFCGSPLYAS
Sbjct: 154 QIVSAVHYCHKNGVVHRDLKLENILLDDNFNIKIADFGLSNLYHKDKFLQTFCGSPLYAS 213
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIV G PY GPEVD W+LGVLLYTLVYG MPFDG + K L++QIS+G+Y EP S A
Sbjct: 214 PEIVNGRPYRGPEVDSWALGVLLYTLVYGTMPFDGFDHKNLIRQISSGEYREPTQTSDAR 273
Query: 264 PLIAEMLNINPSSRADISVICSHWWID 290
LI ML +NP RA I I +HWW++
Sbjct: 274 GLIRWMLMVNPERRATIEDIANHWWVN 300
|
|
| UNIPROTKB|E1B9B6 NUAK1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 151/267 (56%), Positives = 198/267 (74%)
Query: 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXXXXXXXADLIRI 83
GV+ H+H+ LK R+++ LG+G YGKV+ + +G+ VA D++ I
Sbjct: 42 GVKRHHHKHNLKHRYELQETLGKGTYGKVKRATERFSGRVVAIKSIRKDKIKDEQDMVHI 101
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RREI+IMSS+ HP+II IYEVFEN++K+V++MEYA+ GELYD++ +++ L+E E R FR
Sbjct: 102 RREIEIMSSLNHPHIISIYEVFENKDKIVIIMEYASKGELYDYISERRRLSERETRHFFR 161
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
QI +AV+YCHK+ + HRDLKLENILLD+N N KIADFGLSN++ + +FL TFCGSPLYAS
Sbjct: 162 QIVSAVHYCHKNGVVHRDLKLENILLDDNCNIKIADFGLSNLYQKDKFLQTFCGSPLYAS 221
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIV G PY GPEVD W+LGVLLYTLVYG MPFDG + K L++QIS+G+Y EP S A
Sbjct: 222 PEIVNGRPYRGPEVDSWALGVLLYTLVYGTMPFDGFDHKNLIRQISSGEYREPTQPSDAR 281
Query: 264 PLIAEMLNINPSSRADISVICSHWWID 290
LI ML +NP RA I I +HWW++
Sbjct: 282 GLIRWMLMVNPDRRATIEDIANHWWVN 308
|
|
| UNIPROTKB|J9P812 NUAK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 151/267 (56%), Positives = 198/267 (74%)
Query: 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXXXXXXXADLIRI 83
GV+ H+H+ LK R+++ LG+G YGKV+ + +G+ VA D++ I
Sbjct: 46 GVKRHHHKHNLKHRYELQETLGKGTYGKVKRATERFSGRVVAIKSIRKDKIKDEQDMVHI 105
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RREI+IMSS+ HP+II IYEVFEN++K+V++MEYA+ GELYD++ +++ L+E E R FR
Sbjct: 106 RREIEIMSSLNHPHIISIYEVFENKDKIVIIMEYASKGELYDYISERRRLSERETRHFFR 165
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
QI +AV+YCHK+ + HRDLKLENILLD+N N KIADFGLSN++ + +FL TFCGSPLYAS
Sbjct: 166 QIVSAVHYCHKNGVVHRDLKLENILLDDNCNIKIADFGLSNLYQKDKFLQTFCGSPLYAS 225
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIV G PY GPEVD W+LGVLLYTLVYG MPFDG + K L++QIS+G+Y EP S A
Sbjct: 226 PEIVNGRPYRGPEVDSWALGVLLYTLVYGTMPFDGFDHKNLIRQISSGEYREPTQPSDAR 285
Query: 264 PLIAEMLNINPSSRADISVICSHWWID 290
LI ML +NP RA I I +HWW++
Sbjct: 286 GLIRWMLMVNPDRRATIEDIANHWWVN 312
|
|
| UNIPROTKB|O60285 NUAK1 "NUAK family SNF1-like kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 151/267 (56%), Positives = 198/267 (74%)
Query: 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXXXXXXXADLIRI 83
GV+ H+H+ LK R+++ LG+G YGKV+ + +G+ VA D++ I
Sbjct: 41 GVKRHHHKHNLKHRYELQETLGKGTYGKVKRATERFSGRVVAIKSIRKDKIKDEQDMVHI 100
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RREI+IMSS+ HP+II IYEVFEN++K+V++MEYA+ GELYD++ +++ L+E E R FR
Sbjct: 101 RREIEIMSSLNHPHIISIYEVFENKDKIVIIMEYASKGELYDYISERRRLSERETRHFFR 160
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
QI +AV+YCHK+ + HRDLKLENILLD+N N KIADFGLSN++ + +FL TFCGSPLYAS
Sbjct: 161 QIVSAVHYCHKNGVVHRDLKLENILLDDNCNIKIADFGLSNLYQKDKFLQTFCGSPLYAS 220
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIV G PY GPEVD W+LGVLLYTLVYG MPFDG + K L++QIS+G+Y EP S A
Sbjct: 221 PEIVNGRPYRGPEVDSWALGVLLYTLVYGTMPFDGFDHKNLIRQISSGEYREPTQPSDAR 280
Query: 264 PLIAEMLNINPSSRADISVICSHWWID 290
LI ML +NP RA I I +HWW++
Sbjct: 281 GLIRWMLMVNPDRRATIEDIANHWWVN 307
|
|
| UNIPROTKB|F1SPP7 NUAK1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 1.0e-82, P = 1.0e-82
Identities = 151/267 (56%), Positives = 198/267 (74%)
Query: 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXXXXXXXADLIRI 83
GV+ H+H+ LK R+++ LG+G YGKV+ + +G+ VA D++ I
Sbjct: 46 GVKRHHHKHNLKHRYELQETLGKGTYGKVKRATERFSGRVVAIKSIRKDKIKDEQDMVHI 105
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RREI+IMSS+ HP+II IYEVFEN++K+V++MEYA+ GELYD++ +++ L+E E R FR
Sbjct: 106 RREIEIMSSLSHPHIISIYEVFENKDKIVIIMEYASKGELYDYISERRRLSERETRHFFR 165
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
QI +AV+YCHK+ + HRDLKLENILLD+N N KIADFGLSN++ + +FL TFCGSPLYAS
Sbjct: 166 QIVSAVHYCHKNGVVHRDLKLENILLDDNCNIKIADFGLSNLYQKDKFLQTFCGSPLYAS 225
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIV G PY GPEVD W+LGVLLYTLVYG MPFDG + K L++QIS+G+Y EP S A
Sbjct: 226 PEIVNGRPYRGPEVDSWALGVLLYTLVYGTMPFDGFDHKNLIRQISSGEYREPTQPSDAR 285
Query: 264 PLIAEMLNINPSSRADISVICSHWWID 290
LI ML +NP RA I I +HWW++
Sbjct: 286 GLIRWMLMVNPDRRATIEDIANHWWVN 312
|
|
| MGI|MGI:1925226 Nuak1 "NUAK family, SNF1-like kinase, 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 1.0e-82, P = 1.0e-82
Identities = 150/267 (56%), Positives = 198/267 (74%)
Query: 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXXXXXXXADLIRI 83
GV+ H+H+ LK R+++ LG+G YGKV+ + +G+ VA D++ I
Sbjct: 42 GVKRHHHKHNLKHRYELQETLGKGTYGKVKRATERFSGRVVAIKSIRKDKIKDELDMVHI 101
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RREI+IMSS+ HP+II IYEVFEN++K+V++MEYA+ GELYD++ +++ L+E E R FR
Sbjct: 102 RREIEIMSSLNHPHIISIYEVFENKDKIVIIMEYASKGELYDYISERRRLSERETRHFFR 161
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
QI +AV+YCHK+ + HRDLKLENILLD+N N KIADFGLSN++ + +FL TFCGSPLYAS
Sbjct: 162 QIVSAVHYCHKNGVVHRDLKLENILLDDNCNIKIADFGLSNLYQKDKFLQTFCGSPLYAS 221
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIV G PY GPEVD W+LGVLLYTL+YG MPFDG + K L++QIS+G+Y EP S A
Sbjct: 222 PEIVNGRPYRGPEVDSWALGVLLYTLIYGTMPFDGFDHKNLIRQISSGEYREPTQPSDAR 281
Query: 264 PLIAEMLNINPSSRADISVICSHWWID 290
LI ML +NP RA I I +HWW++
Sbjct: 282 GLIRWMLMVNPDRRATIEDIANHWWVN 308
|
|
| RGD|1309956 Nuak1 "NUAK family, SNF1-like kinase, 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 1.0e-82, P = 1.0e-82
Identities = 150/267 (56%), Positives = 198/267 (74%)
Query: 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXXXXXXXADLIRI 83
GV+ H+H+ LK R+++ LG+G YGKV+ + +G+ VA D++ I
Sbjct: 42 GVKRHHHKHNLKHRYELQETLGKGTYGKVKRATERFSGRVVAIKSIRKDKIKDELDMVHI 101
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RREI+IMSS+ HP+II IYEVFEN++K+V++MEYA+ GELYD++ +++ L+E E R FR
Sbjct: 102 RREIEIMSSLNHPHIISIYEVFENKDKIVIIMEYASKGELYDYISERRRLSERETRHFFR 161
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
QI +AV+YCHK+ + HRDLKLENILLD+N N KIADFGLSN++ + +FL TFCGSPLYAS
Sbjct: 162 QIVSAVHYCHKNGVVHRDLKLENILLDDNCNIKIADFGLSNLYQKDKFLQTFCGSPLYAS 221
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIV G PY GPEVD W+LGVLLYTL+YG MPFDG + K L++QIS+G+Y EP S A
Sbjct: 222 PEIVNGRPYRGPEVDSWALGVLLYTLIYGTMPFDGFDHKNLIRQISSGEYREPTQPSDAR 281
Query: 264 PLIAEMLNINPSSRADISVICSHWWID 290
LI ML +NP RA I I +HWW++
Sbjct: 282 GLIRWMLMVNPDRRATIEDIANHWWVN 308
|
|
| UNIPROTKB|F1NRW2 Gga.12811 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 824 (295.1 bits), Expect = 3.6e-82, P = 3.6e-82
Identities = 155/276 (56%), Positives = 201/276 (72%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAXXXXXXXXXXXXADLIRIR 84
V+ H+H+ LK R++ + LG+G YGKV+ + +G+ VA DLI IR
Sbjct: 43 VKRHHHKHNLKHRYEFLETLGKGTYGKVKKA-RERSGKLVAIKSIRKDRIKDEQDLIHIR 101
Query: 85 REIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQ 144
REI+IMSS+ HP+II ++EVFEN K+V+VMEYA+ G+LYD++ +++ L+E+EAR FRQ
Sbjct: 102 REIEIMSSLNHPHIIAVHEVFENSSKIVIVMEYASKGDLYDYISERQRLSEQEARHFFRQ 161
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
+ +AVYYCHK+ I HRDLKLENILLD NGN KIADFGLSNV+ + +FL T+CGSPLYASP
Sbjct: 162 VVSAVYYCHKNGIVHRDLKLENILLDANGNIKIADFGLSNVYQQDKFLQTYCGSPLYASP 221
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264
EI+ G PY GPEVD WSLGVLLY LV+G MPFDG ++K LVKQI++GDY EP S A
Sbjct: 222 EIINGRPYKGPEVDSWSLGVLLYILVHGTMPFDGHDYKTLVKQITSGDYREPTKLSDACG 281
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVACLEE 300
LI ML +NP RA I I +HWW++ + V E+
Sbjct: 282 LIRWMLMVNPERRATIEDIATHWWVNWGYRVPVGEQ 317
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q641K5 | NUAK1_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5880 | 0.7970 | 0.4057 | yes | N/A |
| O60285 | NUAK1_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5917 | 0.7970 | 0.4039 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 335 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-105 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-94 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-78 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-75 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-72 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-61 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-60 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-58 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-55 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-53 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-53 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-52 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-51 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-50 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-50 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-50 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-49 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-49 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-48 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-48 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-47 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-47 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-46 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-46 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-45 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-45 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-45 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-45 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-44 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-44 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-44 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-44 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-44 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-44 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-44 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-43 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-43 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-43 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-42 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-42 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-42 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-42 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-41 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-41 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-41 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-41 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-41 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-41 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-40 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-40 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-40 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-40 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-40 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-39 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-39 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-39 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-39 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-39 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-39 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-38 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-38 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-38 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-38 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-38 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-37 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-37 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-37 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-37 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-37 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-36 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-36 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-36 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-36 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-35 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-35 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-35 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-35 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-34 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-34 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-33 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-33 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-33 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-33 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-33 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-33 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-32 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-32 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-32 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-32 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-31 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-31 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-31 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-31 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-31 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-31 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-31 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-30 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-30 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-30 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-30 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-30 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-30 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-30 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-30 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-29 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-29 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-29 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-29 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-29 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-28 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-28 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-28 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-28 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-27 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-26 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-26 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-26 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-25 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-25 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-25 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-25 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-25 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-25 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-24 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-24 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-24 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-24 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-24 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-23 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-23 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-23 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-22 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-22 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-22 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-22 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-21 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-20 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-18 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-17 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-17 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-10 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 6e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| pfam06293 | 206 | pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/Waa | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| PRK01723 | 239 | PRK01723, PRK01723, 3-deoxy-D-manno-octulosonic-ac | 7e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.001 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 307 bits (790), Expect = e-105
Identities = 113/257 (43%), Positives = 159/257 (61%), Gaps = 8/257 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++I+ KLG+G++GKV L +K+TG+ VAIK IKK + + D RI REI+I+ ++HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKK--KKIKKDRERILREIKILKKLKHPN 58
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
I+ +Y+VFE+ +K+ LVMEY GG+L+D L ++ L+E+EAR RQI +A+ Y H I
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEV 217
HRDLK ENILLDE+G+ K+ADFGL+ L+TF G+P Y +PE++ G Y G V
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY-GKAV 177
Query: 218 DCWSLGVLLYTLVYGAMPFDGS-NFKRLVKQISNGDYFEPKNQSTASP----LIAEMLNI 272
D WSLGV+LY L+ G PF G L K+I P + SP LI ++L
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237
Query: 273 NPSSRADISVICSHWWI 289
+P R H +
Sbjct: 238 DPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 1e-94
Identities = 107/261 (40%), Positives = 161/261 (61%), Gaps = 10/261 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++++RKLG G++G V +K TG+ VA+K +KK +++ D RREI+I+ + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKD-QTARREIRILRRLSHPN 59
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
I+ + + FE+++ + LVMEY GG+L+D+L + L+E+EA++I QI + Y H + I
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLSTFCGSPLYASPEIVKGIPYHGPE 216
HRDLK ENILLDENG KIADFGL+ +S L+TF G+P Y +PE++ G +GP+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNF---KRLVKQISNGDYFEPKNQSTASP-----LIAE 268
VD WSLGV+LY L+ G PF G N +L+++I + + ++ LI +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 269 MLNINPSSRADISVICSHWWI 289
LN +PS R I H W
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 1e-78
Identities = 90/257 (35%), Positives = 138/257 (53%), Gaps = 11/257 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+++I++++G+G++GKV L K G+ +K I + +E + E++I+ + HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV----LTEEEARRIFRQIATAVYYC 152
NII YE FE + K+ +VMEYA GG+L + ++K EE+ F Q+ A+ Y
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTFCGSPLYASPEIVKGIP 211
H KI HRD+K +NI L NG K+ DFG+S V + + T G+P Y SPE+ + P
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPL---IAE 268
Y + D WSLG +LY L PF+G N L +I G Y P +S L ++
Sbjct: 180 Y-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY-PPIPSQYSSELRNLVSS 237
Query: 269 MLNINPSSRADISVICS 285
+L +P R I+ I
Sbjct: 238 LLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 3e-75
Identities = 95/246 (38%), Positives = 129/246 (52%), Gaps = 35/246 (14%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G +G V L +K+TG++VAIK IKK + + + REI+I+ + HPNI+ +Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE--ELLREIEILKKLNHPNIVKLYG 58
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
VFE+ + LVMEY GG L D L + L+E+E RI QI + Y H + I HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 163 KLENILLDE-NGNAKIADFGLSNVFTE-SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCW 220
K ENILLD NG K+ADFGLS + T L T G+P Y +PE++ G Y+ + D W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 221 SLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADI 280
SLGV+LY L K L+++ ML +P R
Sbjct: 179 SLGVILYEL---------PELKDLIRK---------------------MLQKDPEKRPSA 208
Query: 281 SVICSH 286
I H
Sbjct: 209 KEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 223 bits (572), Expect = 3e-72
Identities = 95/236 (40%), Positives = 140/236 (59%), Gaps = 3/236 (1%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G++GKV L K+TG+ A+K +KK KI ++ E I+S + HP I+ ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLK 163
F+ EK+ LV+EYA GGEL+ L ++ +EE AR +I A+ Y H I +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 164 LENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSL 222
ENILLD +G+ K+ DFGL+ +E +TFCG+P Y +PE++ G Y G VD WSL
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSL 179
Query: 223 GVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS-TASPLIAEMLNINPSSR 277
GVLLY ++ G PF + K + ++I P+ S A LI+ +L +P+ R
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 2e-61
Identities = 81/254 (31%), Positives = 135/254 (53%), Gaps = 9/254 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+I+ K+G+G +G+V +K TG+EVAIK IK +E++ +I EIQI+ +HPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHPN 58
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHK 156
I+ Y + ++++ +VME+ +GG L D L + LTE + + +++ + Y H +
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
I HRD+K NILL +G K+ DFGLS ++++ +T G+P + +PE++ G PY +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY-DYK 177
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNI---- 272
D WSLG+ L G P+ + + +I+ +N S + L
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237
Query: 273 NPSSRADISVICSH 286
NP R + H
Sbjct: 238 NPEKRPTAEQLLKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 193 bits (494), Expect = 4e-60
Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 24/263 (9%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHP 96
F + +G+G++ V L KET +E AIK + K ++ E + ++ E ++++ + HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
II +Y F++ E + V+EYA GEL ++ + L E+ R +I A+ Y H
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTES---------------------RFLSTF 195
I HRDLK ENILLD++ + KI DFG + V + R ++F
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-F 254
G+ Y SPE++ P G D W+LG ++Y ++ G PF GSN ++I +Y F
Sbjct: 183 VGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 255 EPKNQSTASPLIAEMLNINPSSR 277
P A LI ++L ++P R
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDR 264
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 2e-58
Identities = 89/262 (33%), Positives = 132/262 (50%), Gaps = 18/262 (6%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
+ +G YG+V L K TG AIK IKK + + + ++ E I+S + P ++ +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLK 163
F+ ++ + LVMEY GG+L L+ L E+ AR +I A+ Y H + I HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 164 LENILLDENGNAKIADFGLSNVFTESRFL---------STFCGSPLYASPEIVKGIPYHG 214
+NIL+D NG+ K+ DFGLS V R + G+P Y +PE++ G H
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HS 179
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP----LIAEML 270
VD WSLG +LY + G PF G + + + I NG E S LI+++L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLL 238
Query: 271 NINPSSRAD---ISVICSHWWI 289
+P R I I +H +
Sbjct: 239 VPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 3e-58
Identities = 82/260 (31%), Positives = 134/260 (51%), Gaps = 16/260 (6%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++++ +G+G++G V+ K G+ + K I + TE + ++ E+ I+ ++HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPN 60
Query: 98 IIHIYEVFENREK--MVLVMEYAAGGELYDFL----DQKKVLTEEEARRIFRQIATAVYY 151
I+ Y+ +R + +VMEY GG+L + ++K + EE RI Q+ A+Y
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 152 CH-----KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTFCGSPLYASPE 205
CH + + HRDLK NI LD N N K+ DFGL+ + F T+ G+P Y SPE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTA-S 263
+ + Y + D WSLG L+Y L + PF N +L +I G + P S+ +
Sbjct: 181 QLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239
Query: 264 PLIAEMLNINPSSRADISVI 283
+I MLN++P R +
Sbjct: 240 EVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 2e-55
Identities = 68/192 (35%), Positives = 110/192 (57%), Gaps = 7/192 (3%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ LG+G++G V L ++K+TG+ +A+K+++ ++E +L + REI+I+SS++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVEL-SGDSEEELEALEREIRILSSLQHP 59
Query: 97 NIIHIYEVFENREKMVL--VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
NI+ Y + EK L +EY +GG L L + L E R+ RQI + Y H
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTE---SRFLSTFCGSPLYASPEIVKGIP 211
+ I HRD+K NIL+D +G K+ADFG + + + G+P + +PE+++G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 212 YHGPEVDCWSLG 223
Y G D WSLG
Sbjct: 180 Y-GRAADIWSLG 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 179 bits (453), Expect = 4e-53
Identities = 97/281 (34%), Positives = 145/281 (51%), Gaps = 31/281 (11%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP- 96
+ I+RKLG+G++G+V L ++ + VA+K + K ++ R REIQI++S+ HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLD---QKKVLTEEEARRIFRQIATAVYYCH 153
NI+ +Y+ F++ + LVMEY GG L D L +K L+E EA I QI +A+ Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 154 KHKICHRDLKLENILLDENGN-AKIADFGLSNVFTES-------RFLSTFCGSPLYASPE 205
I HRD+K ENILLD +G K+ DFGL+ + + ST G+P Y +PE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 206 IVKGI--PYHGPEVDCWSLGVLLYTLVYGAMPFDG----SNFKRLVKQISNGDY------ 253
++ G+ Y D WSLG+ LY L+ G PF+G S + +K I
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 254 ----FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290
AS L+ ++L +P +R S SH +
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 8e-53
Identities = 84/239 (35%), Positives = 131/239 (54%), Gaps = 4/239 (1%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIH 100
+ LG+G++GKV L K T + A+K +KK I + D+ E ++++ +HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
++ F+ ++++ VMEY GG+L + + E AR +I + + H+ I +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 161 DLKLENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDC 219
DLKL+N+LLD G+ KIADFG+ STFCG+P Y +PEI+ PY GP VD
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 220 WSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPSSR 277
W+LGVLLY ++ G PF+G + L + I + P+ S A ++ L NP R
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 9e-52
Identities = 86/251 (34%), Positives = 136/251 (54%), Gaps = 20/251 (7%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR------IRREIQI 89
F+ ++ LG G++G+V L +K +G+ A+K + K KI ++ + E +I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI------VKLKQVEHVLNEKRI 54
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
+ S+RHP ++++Y F++ + LVMEY GGEL+ L + E AR Q+ A+
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL 114
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV-- 207
Y H I +RDLK EN+LLD +G KI DFG + + T CG+P Y +PEI+
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILS 172
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS-TASPLI 266
KG +G VD W+LG+L+Y ++ G PF N ++ ++I G P S A LI
Sbjct: 173 KG---YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLI 229
Query: 267 AEMLNINPSSR 277
+L ++ + R
Sbjct: 230 RNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (432), Expect = 7e-51
Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 58/284 (20%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSVRH 95
++ + KLG+G YG V +K+TG+ VA+K I+ ++ E + I REI ++ ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR---LDNEEEGIPSTALREISLLKELKH 57
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCHK 154
PNI+ + +V K+ LV EY +L +LD++ L+ + I Q+ + YCH
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------YAS 203
H+I HRDLK +NIL++ +G K+ADFGL+ F G PL Y +
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAF----------GIPLRTYTHEVVTLWYRA 166
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS----------------------NF 241
PEI+ G ++ VD WS+G + ++ G F G
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226
Query: 242 KRLVKQISNGDYFEPKNQSTASP--------LIAEMLNINPSSR 277
+L F PK+ P L+++ML NP+ R
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKR 270
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 8e-50
Identities = 88/256 (34%), Positives = 127/256 (49%), Gaps = 9/256 (3%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
F +++KLG+G+YG V Q A+K + ++ + EI+I++SV HP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD-LGSMSQKEREDAVNEIRILASVNHP 59
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYC 152
NII E F + K+ +VMEYA G+L + + +K++ E+E RIF Q+ +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
H+ KI HRDLK NILL N KI D G+S V T G+P Y +PE+ KG PY
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEML 270
D WSLG LLY + A PF+ + + L ++ G Y P I ML
Sbjct: 179 SYKS-DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237
Query: 271 NINPSSRADISVICSH 286
+ P R + I +
Sbjct: 238 QVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 9e-50
Identities = 90/277 (32%), Positives = 140/277 (50%), Gaps = 36/277 (12%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ F ++ LG+G+ G+V L K TG+ A+K + K ++ + R+ E +I++++ H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCH 153
P + +Y F+ + LVM+Y GGEL+ L + K L+EE AR ++ A+ Y H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLS---NVFT-------------------ESRF 191
I +RDLK ENILL E+G+ ++DF LS +V S
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 192 LS--------TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR 243
S +F G+ Y +PE++ G HG VD W+LG+LLY ++YG PF GSN
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239
Query: 244 LVKQISNGDYFEPKNQ---STASPLIAEMLNINPSSR 277
I + P + S+A LI ++L +PS R
Sbjct: 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 9e-50
Identities = 74/261 (28%), Positives = 132/261 (50%), Gaps = 10/261 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+++R +G+G +GKV + ++T + A+K + K K + + + E +I+ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+++++ F++ E M LV++ GG+L L QK +EE+ + +I A+ Y H I
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEV 217
HRD+K +NILLDE G+ I DF ++ T ++ G+P Y +PE++ + V
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-QGYSVAV 180
Query: 218 DCWSLGVLLYTLVYGAMPFDGSNFKR----LVKQISNGDYFEPKNQSTASPLIAEMLNIN 273
D WSLGV Y + G P+ G + KQ + + + A I ++L +
Sbjct: 181 DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD 240
Query: 274 PSSRADISVICSHWWIDKDHS 294
P R + + + K+H
Sbjct: 241 PQKR----LGDNLKDL-KNHP 256
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 1e-49
Identities = 88/255 (34%), Positives = 129/255 (50%), Gaps = 12/255 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
FDI+ KLG+G+YG V I+KETGQ VAIK + E DL I +EI I+ P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK-----VVPVEEDLQEIIKEISILKQCDSPY 59
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHK 156
I+ Y + + +VMEY G + D + K LTEEE I Q + Y H +K
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS-TFCGSPLYASPEIVKGIPYHGP 215
HRD+K NILL+E G AK+ADFG+S T++ T G+P + +PE+++ I Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN- 178
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---DYFEPKNQSTA-SPLIAEMLN 271
+ D WSLG+ + G P+ + R + I N +P+ S + + + L
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238
Query: 272 INPSSRADISVICSH 286
+P R + H
Sbjct: 239 KDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-49
Identities = 84/266 (31%), Positives = 124/266 (46%), Gaps = 19/266 (7%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR--IRREIQIMSSVRH 95
+ V+ LGQG+ G V +K TG+ A+K I + R + RE++ + S
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH----VDGDEEFRKQLLRELKTLRSCES 58
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH-K 154
P ++ Y F ++ +V+EY GG L D L + + E I RQI + Y H K
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-STFCGSPLYASPEIVKGIPYH 213
I HRD+K N+L++ G KIADFG+S V + +TF G+ Y SPE ++G Y
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY- 177
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSN---FKRLVKQISNGD-YFEPKNQSTASP----L 265
D WSLG+ L G PF F L++ I +G P + SP
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEE--FSPEFRDF 235
Query: 266 IAEMLNINPSSRADISVICSHWWIDK 291
I+ L +P R + + H +I K
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-48
Identities = 85/236 (36%), Positives = 140/236 (59%), Gaps = 3/236 (1%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G +GKV L K TG+ A+K ++K I + ++ E +++ + RHP + +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLK 163
F+ +++ VMEYA GGEL+ L +++V TEE AR +I +A+ Y H + +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 164 LENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSL 222
LEN++LD++G+ KI DFGL ++ + TFCG+P Y +PE+++ Y G VD W L
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGL 181
Query: 223 GVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPSSR 277
GV++Y ++ G +PF + +RL + I + P+ S A L+A +L +P R
Sbjct: 182 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 4e-48
Identities = 89/256 (34%), Positives = 143/256 (55%), Gaps = 9/256 (3%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+++ +R +G+G +G V L K + V IK I ++ T+ + + + E Q++ + HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHP 59
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHK 154
NII YE F + +++VMEYA GG L +++ ++ +L E+ F QI A+++ H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 155 HKICHRDLKLENILLDENGN-AKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
I HRDLK +NILLD++ KI DFG+S + + T G+P Y SPE+ +G PY+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP---LIAEML 270
+ D W+LG +LY L F+ +N LV +I +G F P + + LI ML
Sbjct: 180 -QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-FAPISDRYSPDLRQLILSML 237
Query: 271 NINPSSRADISVICSH 286
N++PS R +S I +
Sbjct: 238 NLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-47
Identities = 77/248 (31%), Positives = 129/248 (52%), Gaps = 11/248 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
+ + K+G+G G+V ++ TG+EVAIK K ++ + I EI IM +HPN
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIK---KMRLRKQNKE-LIINEILIMKDCKHPN 76
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCHKHK 156
I+ Y+ + +++ +VMEY GG L D + Q V + E + + R++ + Y H
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-STFCGSPLYASPEIVKGIPYHGP 215
+ HRD+K +NILL ++G+ K+ADFG + T+ + ++ G+P + +PE++K Y GP
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY-GP 195
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAE----MLN 271
+VD WSLG++ + G P+ R + I+ KN SP + L
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 272 INPSSRAD 279
+P R
Sbjct: 256 KDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 2e-47
Identities = 87/250 (34%), Positives = 143/250 (57%), Gaps = 8/250 (3%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G +GKV L K TG+ A+K +KK I + ++ E +++ + RHP + +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLK 163
F+ +++ VMEYA GGEL+ L +++V +E+ AR +I +A+ Y H + +RDLK
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK 122
Query: 164 LENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSL 222
LEN++LD++G+ KI DFGL ++ + TFCG+P Y +PE+++ Y G VD W L
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGL 181
Query: 223 GVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS-TASPLIAEMLNINPSSR---- 277
GV++Y ++ G +PF + ++L + I + P+ S A L+A +L +P R
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGG 241
Query: 278 -ADISVICSH 286
D I H
Sbjct: 242 PEDAKEIMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 90/255 (35%), Positives = 137/255 (53%), Gaps = 17/255 (6%)
Query: 38 FDIVRKLGQGNYGKV----QLGINKETGQEVAIKTIKKCKIETEAD-LIRIRREIQIMSS 92
F+++R LG G YGKV ++G + G+ A+K +KK I +A R E Q++ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVG-GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 93 VRH-PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYY 151
VR P ++ ++ F+ K+ L+++Y GGEL+ L Q++ TE E R +I A+ +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT---ESRFLSTFCGSPLYASPEIVK 208
H+ I +RD+KLENILLD G+ + DFGLS F E R S FCG+ Y +PE+++
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIR 179
Query: 209 -GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS-----NGDYFEPKNQSTA 262
G H VD WSLGVL + L+ GA PF + +IS + F + A
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 263 SPLIAEMLNINPSSR 277
I ++L +P R
Sbjct: 240 RDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-46
Identities = 75/258 (29%), Positives = 125/258 (48%), Gaps = 17/258 (6%)
Query: 40 IVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ +KLG+G +G+V G + EVA+KT+K+ +E + RE +IM + H
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLDH 60
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHK 154
PN++ + V E + +VMEY GG+L +L + L+ + QIA + Y
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGSPL-YASPE-IVKGIP 211
HRDL N L+ EN KI+DFGLS +++ + + P+ + +PE + +G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK- 179
Query: 212 YHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEML 270
+ D WS GVLL+ + G P+ G + + +++ + NG Y P+ + L ML
Sbjct: 180 -FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLPQPPNCPPELYDLML 237
Query: 271 ---NINPSSRADISVICS 285
+P R S +
Sbjct: 238 QCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-46
Identities = 90/263 (34%), Positives = 129/263 (49%), Gaps = 21/263 (7%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR-IRREIQIMSSVRHPNIIHIY 102
LG G +G+V+L K + A+K +KK I E I E +I+ HP I+ +Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
F++++ + ++MEY GGEL+ L + + E AR + A Y H I +RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 163 KLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV--KGIPYHGPEVDCW 220
K EN+LLD NG K+ DFG + + TFCG+P Y +PEI+ KG + VD W
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG---YDFSVDYW 176
Query: 221 SLGVLLYTLVYGAMPFDGSN------FKRLVKQISNGDYFEPKNQS-TASPLIAEMLNIN 273
SLG+LLY L+ G PF + + ++K NG P A LI ++L N
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILK--GNGKLEFPNYIDKAAKDLIKQLLRRN 234
Query: 274 PSSR-----ADISVICSHWWIDK 291
P R I I H W +
Sbjct: 235 PEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 4e-46
Identities = 78/261 (29%), Positives = 127/261 (48%), Gaps = 18/261 (6%)
Query: 40 IVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ +KLG+G +G+V G EVA+KT+K+ +E + RE +IM + H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKLDH 60
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYCH 153
PNI+ + V E +++VMEY GG+L D+L ++ K L+ + QIA + Y
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGSPL-YASPE-IVKGI 210
HRDL N L+ EN KI+DFGLS +++ + + P+ + +PE + +G
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 211 PYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEM 269
+ + D WS GVLL+ + G P+ G + +++ + G Y PK + L M
Sbjct: 181 -F-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG-YRLPKPPNCPPELYKLM 237
Query: 270 L---NINPSSRADISVICSHW 287
L +P R S +
Sbjct: 238 LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 84/236 (35%), Positives = 142/236 (60%), Gaps = 3/236 (1%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G +GKV L K +G+ A+K +KK I + ++ E +++ + RHP + +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLK 163
F+ ++++ VMEY GGEL+ L +++V +E+ R +I +A+ Y H KI +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 164 LENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSL 222
LEN++LD++G+ KI DFGL T++ + TFCG+P Y +PE+++ Y G VD W L
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGL 181
Query: 223 GVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPSSR 277
GV++Y ++ G +PF + ++L + I D P+ S A L++ +L +P+ R
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 4e-45
Identities = 70/211 (33%), Positives = 116/211 (54%), Gaps = 13/211 (6%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTI----KKCKIETEADLIRIRREIQIMSS 92
R+ I+ ++G+G +G V ++ETG+ VA+K + + I +A REI+ + +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA-----LREIKALQA 55
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYY 151
+HP ++ + +VF + VLVMEY L + L D+++ L E + + R + V Y
Sbjct: 56 CQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT--ESRFLSTFCGSPLYASPEIVKG 209
H + I HRDLK N+L+ +G KIADFGL+ +F+ E R S + Y +PE++ G
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+ P VD W++G + L+ G+ F G N
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-45
Identities = 87/257 (33%), Positives = 151/257 (58%), Gaps = 16/257 (6%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQIMSSV 93
R++I++K+G+G++GK+ L K + IK I K+ E EA ++E+ +++ +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS----KKEVILLAKM 56
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYY 151
+HPNI+ + F+ ++ +VMEY GG+L +++++ + +E++ F QI+ + +
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 152 CHKHKICHRDLKLENILLDENGN-AKIADFGLSNVFTESRFLSTFC-GSPLYASPEIVKG 209
H KI HRD+K +NI L +NG AK+ DFG++ +S L+ C G+P Y SPEI +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTA---SPLI 266
PY+ + D WSLG +LY L PF+G+N +LV +I G YF P + + + LI
Sbjct: 177 RPYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG-YFAPISPNFSRDLRSLI 234
Query: 267 AEMLNINPSSRADISVI 283
+++ ++P R I+ I
Sbjct: 235 SQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-45
Identities = 86/239 (35%), Positives = 132/239 (55%), Gaps = 8/239 (3%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKK--CKIETEADLIRIRREIQIMSSVRHPNIIHI 101
LG+G++GKV L K T + AIK +KK + + + + R + ++ HP + H+
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHL 61
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRD 161
+ F+ +E + VMEY GG+L + E AR +I + + HK I +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 162 LKLENILLDENGNAKIADFGL--SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDC 219
LKL+N+LLD++G+ KIADFG+ N+ E + STFCG+P Y +PEI+KG Y+ VD
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKENMNGEGK-ASTFCGTPDYIAPEILKGQKYNE-SVDW 179
Query: 220 WSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPSSR 277
WS GVLLY ++ G PF G + L I N P+ S A ++++ +P+ R
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 9e-45
Identities = 85/254 (33%), Positives = 143/254 (56%), Gaps = 11/254 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
++ V+K+G+G++GK L +KE G++ IK I K+ + + R+E+ ++S+++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHP 59
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHK 154
NI+ E FE + +VM+Y GG+LY ++ ++ + E++ F QI A+ + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFC-GSPLYASPEIVKGIPYH 213
KI HRD+K +NI L ++G K+ DFG++ V + L+ C G+P Y SPEI + PY+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP----LIAEM 269
+ D W+LG +LY + F+ N K LV +I G Y P S S L++++
Sbjct: 180 N-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY--PPVSSHYSYDLRNLVSQL 236
Query: 270 LNINPSSRADISVI 283
NP R ++ I
Sbjct: 237 FKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-44
Identities = 72/219 (32%), Positives = 118/219 (53%), Gaps = 29/219 (13%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEAD--LIRIRREIQIMSSVRH 95
++ + ++G+G YG+V NK+TG+ VA+K K ++E E + I REI+++ +RH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 96 PNIIHIYEVFENREK--MVLVMEYAAGGELYDF---LDQKKV-LTEEEARRIFRQIATAV 149
PNI+ + E+ ++ K + +V EY +D LD +V TE + + +Q+ +
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGL 113
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL--------Y 201
Y H + I HRD+K NIL++ +G K+ADFGL+ +T+ + Y
Sbjct: 114 QYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN------SADYTNRVITLWY 167
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
PE++ G +GPEVD WS+G +L L G F GS
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 73/203 (35%), Positives = 115/203 (56%), Gaps = 3/203 (1%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F I+ ++GQG YG+V L K+TG+ VA+K +KK + ++ + E I+++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ + F++ E + L MEY GG+ L+ VL+E+ AR ++ AV H+
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEV 217
HRDLK EN L+D +G+ K+ DFGLS + ++ GSP Y +PE+++G Y V
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGY-DFTV 179
Query: 218 DCWSLGVLLYTLVYGAMPFDGSN 240
D WSLG +LY + G PF GS
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-44
Identities = 77/215 (35%), Positives = 126/215 (58%), Gaps = 3/215 (1%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SVRHPNIIHIY 102
LG+G++GKV L K T + AIK +KK I + D+ E +I++ + +HP + ++
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
F+ ++++ VMEY GG+L + + + E +R ++ A+ + H+H + +RDL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 163 KLENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWS 221
KL+NILLD G+ K+ADFG+ +TFCG+P Y +PEI++ + Y GP VD W+
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDWWA 181
Query: 222 LGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP 256
LGVL+Y ++ G PF+ N L + I + D P
Sbjct: 182 LGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 86/239 (35%), Positives = 135/239 (56%), Gaps = 4/239 (1%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIH 100
R LG+G++GKV L KE+G+ A+K +KK I + D+ E +I+S R HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
+Y F+ +++ VME+ GG+L + + + E AR +I +A+ + H I +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 161 DLKLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDC 219
DLKL+N+LLD G+ K+ADFG+ + STFCG+P Y +PEI++ + Y GP VD
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179
Query: 220 WSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPK-NQSTASPLIAEMLNINPSSR 277
W++GVLLY ++ G PF+ N L + I N + P A ++ + NP+ R
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 90/247 (36%), Positives = 136/247 (55%), Gaps = 11/247 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI----ETEADLIRIRREIQIMSSV 93
F + LG+G++GKV L K+TG+ AIK +KK I E E+ L+ +R + +S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVES-LMCEKRIFETANSE 59
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
RHP +++++ F+ + + VMEYAAGG+L + V +E A + + Y H
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGL--SNVFTESRFLSTFCGSPLYASPEIVKGIP 211
++KI +RDLKL+N+LLD G KIADFGL + R STFCG+P + +PE++
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTFCGTPEFLAPEVLTETS 177
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAE-ML 270
Y VD W LGVL+Y ++ G PF G + + + I N + P+ S + I +L
Sbjct: 178 Y-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236
Query: 271 NINPSSR 277
NP R
Sbjct: 237 RRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 5e-44
Identities = 68/205 (33%), Positives = 112/205 (54%), Gaps = 4/205 (1%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
+ + K+G+G YG V +K TG+ VAIK IK + E+E REI+++ + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKL-RFESEGIPKTALREIKLLKELNHPN 59
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHK 156
II + +VF ++ + LV E+ +LY + +++ L E + Q+ + +CH H
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPYHGP 215
I HRDLK EN+L++ G K+ADFGL+ F + R + + + Y +PE++ G +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSN 240
VD WS+G + L+ F G +
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 7e-44
Identities = 71/224 (31%), Positives = 114/224 (50%), Gaps = 18/224 (8%)
Query: 40 IVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ +KLG+G +G+V G + T +VA+KT+K+ +E + E IM + H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA--SEEEREEFLEEASIMKKLSH 60
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHK 154
PNI+ + V E + +V EY GG+L DFL + LT ++ ++ QIA + Y
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGSPL---YASPE-IVKG 209
HRDL N L+ EN KI+DFGLS +++ + + G L + +PE + G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR-GGGKLPIKWMAPESLKDG 179
Query: 210 IPYHGPEVDCWSLGVLLYTLV-YGAMPFDG-SNFKRLVKQISNG 251
+ D WS GVLL+ + G P+ G SN +++ + +G
Sbjct: 180 KFTS--KSDVWSFGVLLWEIFTLGEQPYPGMSNE-EVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 9e-44
Identities = 66/194 (34%), Positives = 108/194 (55%), Gaps = 5/194 (2%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSVR 94
R++ +KLG+G Y V +KETG+ VAIK IK + + D I REI+++ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCH 153
HPNII + +VF ++ + LV E+ +L + K VLT + + + Y H
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPY 212
+ I HRDLK N+L+ +G K+ADFGL+ F + +R ++ + Y +PE++ G +
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH 179
Query: 213 HGPEVDCWSLGVLL 226
+G VD WS+G +
Sbjct: 180 YGVGVDMWSVGCIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 75/202 (37%), Positives = 109/202 (53%), Gaps = 7/202 (3%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ F ++ +G+G++G+V I+K T Q VAIK I E E ++ I++EIQ +S R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL--EEAEDEIEDIQQEIQFLSQCRS 58
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
P I Y F K+ ++MEY GG D L K L E I R++ + Y H+
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEE 117
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSN--VFTESRFLSTFCGSPLYASPEIVKGIPYH 213
HRD+K NILL E G+ K+ADFG+S T S+ +TF G+P + +PE++K Y
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNTFVGTPFWMAPEVIKQSGYD 176
Query: 214 GPEVDCWSLGVLLYTLVYGAMP 235
+ D WSLG+ L G P
Sbjct: 177 E-KADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-43
Identities = 91/246 (36%), Positives = 136/246 (55%), Gaps = 13/246 (5%)
Query: 41 VRKLGQGNYGKVQLGINKETGQE----VAIKTIKKCKIETEA-DLIRIRREIQIMSSVRH 95
++ LG+G YGKV + K TG + A+K +KK I D + E I+ +V+H
Sbjct: 1 LKVLGKGGYGKV-FQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH 59
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
P I+ + F+ K+ L++EY +GGEL+ L+++ + E+ A +I+ A+ + H+
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 156 KICHRDLKLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIV--KGIPY 212
I +RDLK ENILLD G+ K+ DFGL E TFCG+ Y +PEI+ G
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG--- 176
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLN 271
HG VD WSLG L+Y ++ GA PF N K+ + +I G P + A L+ ++L
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLK 236
Query: 272 INPSSR 277
NPSSR
Sbjct: 237 RNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 5e-43
Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 29/267 (10%)
Query: 42 RKLGQGNYGKVQLGI---NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
+KLG+G +G+V G EVA+KT+K+ +E + +E ++M + HPN+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPNV 58
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL---------DQKKVLTEEEARRIFRQIATAV 149
+ + V E + LV+EY GG+L D+L +K L+ ++ QIA +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCG-SPL-YASPE- 205
Y K HRDL N L+ E+ KI+DFGLS +V+ + + G P+ + +PE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTAS 263
+ GI + D WS GVLL+ + GA P+ G + + +++ + G P+
Sbjct: 179 LKDGI--FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEY---CP 233
Query: 264 PLIAEML----NINPSSRADISVICSH 286
+ E++ ++P R S +
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 7e-43
Identities = 84/237 (35%), Positives = 140/237 (59%), Gaps = 4/237 (1%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G +GKV L K TG+ A+K +KK I + ++ E +++ + RHP + +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK-ICHRDL 162
F+ +++ VMEYA GGEL+ L +++V +E+ AR +I +A+ Y H K + +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 163 KLENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWS 221
KLEN++LD++G+ KI DFGL + + TFCG+P Y +PE+++ Y G VD W
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWG 181
Query: 222 LGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS-TASPLIAEMLNINPSSR 277
LGV++Y ++ G +PF + ++L + I + P+ S A L++ +L +P R
Sbjct: 182 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 77/245 (31%), Positives = 130/245 (53%), Gaps = 8/245 (3%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
F++ LG G++G+V++ +K TG+ AIK +KK +I + + +E I+ + H
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
P I+++ F++ ++ ++E+ GGEL+ L + + A+ ++ A Y H
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV--KGIPYH 213
I +RDLK EN+LLD G+ K+ DFG + + F T CG+P Y +PE++ KG H
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--TLCGTPEYLAPEVIQSKG---H 192
Query: 214 GPEVDCWSLGVLLYTLVYGAMPF-DGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNI 272
G VD W++GVLLY + G PF D + F+ K ++ F A L+ +L
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT 252
Query: 273 NPSSR 277
+ + R
Sbjct: 253 DHTKR 257
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 2e-42
Identities = 80/254 (31%), Positives = 141/254 (55%), Gaps = 8/254 (3%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+++++R +G+G++G+ L + + Q+ A+K I+ K + + + R+E +++ ++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHK 154
NI+ E FE + +VMEY GG+L + + K+ E+ + F Q+ V + H+
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLSTFCGSPLYASPEIVKGIPYH 213
++ HRD+K +NI L +NG K+ DFG + + T + T+ G+P Y PEI + +PY+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQS-TASPLIAEMLN 271
+ D WSLG +LY L PF +++K L+ ++ G Y P + S LI +M
Sbjct: 179 N-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237
Query: 272 INPSSRADISVICS 285
NP SR + I S
Sbjct: 238 RNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-42
Identities = 81/248 (32%), Positives = 131/248 (52%), Gaps = 9/248 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+I+ K+G+G++G V + K + A+K I K+ + E ++++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSY 60
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLD--QKKVLTEEEARRIFRQIATAVYYCHKH 155
II YE F ++ K+ +VMEYA G+L+ L + + L E++ R F QI + + H
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPYHG 214
KI HRD+K N+ LD N KI D G++ + + F +T G+P Y SPE+ + PY+
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN- 179
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTA---SPLIAEMLN 271
+ D W+LGV+LY G PFD +N L+ +I G F P +Q + + LI + L
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-VFPPVSQMYSQQLAQLIDQCLT 238
Query: 272 INPSSRAD 279
+ R D
Sbjct: 239 KDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-42
Identities = 73/258 (28%), Positives = 124/258 (48%), Gaps = 9/258 (3%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ + +G+G +G V G+N ETG VAIK I KI+ E L I +EI ++ +++HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHP 59
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
NI+ E + + +++EYA G L + + E Q+ + Y H+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 157 ICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
+ HRD+K NIL ++G K+ADFG++ + S+ ++ G+P + +PE+++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-AST 178
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEML----N 271
D WSLG + L+ G P+ N + +I D P SP + + L
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--HPPLPEGISPELKDFLMQCFQ 236
Query: 272 INPSSRADISVICSHWWI 289
+P+ R + H WI
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 66/210 (31%), Positives = 112/210 (53%), Gaps = 9/210 (4%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR--IRREIQIMSSV 93
+++++ +G+G YG V NK TG+ VAIK K K + + ++ RE++++ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK---KFKESEDDEDVKKTALREVKVLRQL 57
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYC 152
RH NI+++ E F + ++ LV EY L + L+ L + R Q+ A+ YC
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES--RFLSTFCGSPLYASPEIVKGI 210
H H I HRD+K ENIL+ E+G K+ DFG + L+ + + Y +PE++ G
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 211 PYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+G VD W++G ++ L+ G F G +
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-41
Identities = 83/238 (34%), Positives = 133/238 (55%), Gaps = 6/238 (2%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKI--ETEADLIRIRREIQIMSSVRHPNIIHI 101
+G+G++GKV L +K G+ A+K ++K I + E I R + ++ +V+HP ++ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRD 161
+ F+ +K+ V++Y GGEL+ L +++ E AR +IA+A+ Y H I +RD
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 162 LKLENILLDENGNAKIADFGLSNVFTE-SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCW 220
LK ENILLD G+ + DFGL E S+ STFCG+P Y +PE+++ PY VD W
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWW 180
Query: 221 SLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS-TASPLIAEMLNINPSSR 277
LG +LY ++YG PF + + I N N S +A L+ +L + + R
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 65/202 (32%), Positives = 108/202 (53%), Gaps = 8/202 (3%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHI 101
K+G G +GKV +N +TG+ +A+K I+ + + + I E++++ ++HPN++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKY 64
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRD 161
Y V +REK+ + MEY +GG L + L+ ++L E R Q+ + Y H H I HRD
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 162 LKLENILLDENGNAKIADFGLSNVFTES-----RFLSTFCGSPLYASPEIVKGIPYHGPE 216
+K NI LD NG K+ DFG + + + + G+P Y +PE++ G G
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 217 --VDCWSLGVLLYTLVYGAMPF 236
D WSLG ++ + G P+
Sbjct: 185 RAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-41
Identities = 85/244 (34%), Positives = 134/244 (54%), Gaps = 6/244 (2%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SVRHP 96
F+ + LG+G++GKV L K T + AIK +KK I + D+ E ++++ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
+ ++ F+ +++ VMEY GG+L + Q E A +IA +++ H
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 157 ICHRDLKLENILLDENGNAKIADFGL--SNVFTESRFLSTFCGSPLYASPEIVKGIPYHG 214
I +RDLKL+N++LD G+ KIADFG+ N+F + TFCG+P Y +PEI+ PY G
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-GGKTTRTFCGTPDYIAPEIIAYQPY-G 179
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS-TASPLIAEMLNIN 273
VD W+ GVLLY ++ G PFDG + L + I + PK+ S A + +L +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239
Query: 274 PSSR 277
P+ R
Sbjct: 240 PAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-41
Identities = 84/245 (34%), Positives = 139/245 (56%), Gaps = 13/245 (5%)
Query: 41 VRKLGQGNYGKVQLG---INKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++ LGQG++GKV L + GQ A+K +KK ++ D +R + E I++ V HP
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPF 59
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
I+ ++ F+ K+ L++++ GG+L+ L ++ + TEE+ + ++A A+ + H I
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 158 CHRDLKLENILLDENGNAKIADFGLSN--VFTESRFLSTFCGSPLYASPEIV--KGIPYH 213
+RDLK ENILLDE G+ K+ DFGLS + E + S FCG+ Y +PE+V +G H
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRG---H 175
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNI 272
D WS GVL++ ++ G++PF G + K + I P+ S A L+ +
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235
Query: 273 NPSSR 277
NP++R
Sbjct: 236 NPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-41
Identities = 78/207 (37%), Positives = 122/207 (58%), Gaps = 9/207 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEV----AIKTIKKCKIETEADLIR-IRREIQIMSS 92
F++++ LG G YGKV L + K TG + A+K ++K + +A + R E ++
Sbjct: 2 FELLKVLGTGAYGKVFL-VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 93 VRH-PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYY 151
VR P ++ ++ F+ K+ L+++Y +GGE++ L Q+ +E+E R +I A+ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST--FCGSPLYASPEIVKG 209
HK I +RD+KLENILLD G+ + DFGLS F T FCG+ Y +PEI++G
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPF 236
HG VD WSLG+L++ L+ GA PF
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-41
Identities = 81/250 (32%), Positives = 127/250 (50%), Gaps = 43/250 (17%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR------IRREIQIM 90
F++++ +G+G +G+V L +K+TGQ A+K ++K D+I+ +R E I+
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS------DMIKRNQIAHVRAERDIL 55
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
+ P I+ +Y F++ E + LVMEY GG+L + L +K V EE AR ++ A+
Sbjct: 56 ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLS---------NVFTESRFLSTFC----- 196
HK HRD+K +NIL+D +G+ K+ADFGL + F
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 197 ----------------GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
G+P Y +PE+++G PY G E D WSLGV+LY ++YG PF
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 241 FKRLVKQISN 250
+ +I N
Sbjct: 235 LQETYNKIIN 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 8e-41
Identities = 88/264 (33%), Positives = 142/264 (53%), Gaps = 17/264 (6%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++I+ +LG G +GKV +KETG A K I+ IE+E +L EI I+S +HPN
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMVEIDILSECKHPN 63
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHK 156
I+ +YE + K+ +++E+ GG L + + ++ LTE + R + RQ+ A+ + H HK
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 157 ICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASPEIV-----KG 209
+ HRDLK NILL +G+ K+ADFG+S N T + TF G+P + +PE+V K
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-RDTFIGTPYWMAPEVVACETFKD 182
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD---YFEPKNQSTA-SPL 265
PY + D WSLG+ L L P N R++ +I + +P S++ +
Sbjct: 183 NPYDY-KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241
Query: 266 IAEMLNINPSSRADISVICSHWWI 289
+ L +P R + + H ++
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-40
Identities = 65/186 (34%), Positives = 100/186 (53%), Gaps = 7/186 (3%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEA--DLIRIRREIQIMSSVRHPNIIHI 101
LGQG +G+V L + +TG+E+A+K + E ++ + EIQ++ +++H I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRD 161
Y + E + + MEY GG + D L LTE R+ RQI V Y H + I HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 162 LKLENILLDENGNAKIADFG----LSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEV 217
+K NIL D GN K+ DFG L + + + + G+P + SPE++ G Y G +
Sbjct: 130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKA 188
Query: 218 DCWSLG 223
D WS+G
Sbjct: 189 DVWSVG 194
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-40
Identities = 83/257 (32%), Positives = 128/257 (49%), Gaps = 9/257 (3%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI-ETEADLIRIRREIQIMSSVRH 95
+ +R LG+G +G+ L E V K + ++ E E EI I+S ++H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL--NEIVILSLLQH 58
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYCH 153
PNII Y F + +++ MEYA GG LYD + + ++ EE QI +AV Y H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPY 212
K I HRD+K NI L + G K+ DFG+S + +E T G+P Y SPE+ +G+ Y
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKY 178
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS--PLIAEML 270
+ + D W+LG +LY L+ FD +N LV +I G+Y + ++ L+ +L
Sbjct: 179 NF-KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237
Query: 271 NINPSSRADISVICSHW 287
+P R +
Sbjct: 238 QQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 4e-40
Identities = 92/293 (31%), Positives = 136/293 (46%), Gaps = 57/293 (19%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ-IMSSVRHP 96
+ ++++LG G +G V L NKETG+ VAIK +KK K + + + +R E++ + HP
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK-KFYSWEECMNLR-EVKSLRKLNEHP 58
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYCHK 154
NI+ + EVF +++ V EY G LY + + K +E R I QI + + HK
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 155 HKICHRDLKLENILLDENGNAKIADFGL------SNVFTESRFLSTFCGSPLYASPEIVK 208
H HRDLK EN+L+ KIADFGL +T+ ++ST Y +PEI+
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVST----RWYRAPEILL 171
Query: 209 GIPYHGPEVDCWSLGVL---LYTLVYGAMP-FDGSN-----FK----------------- 242
+ VD W+LG + LYTL P F GS+ +K
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTL----RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227
Query: 243 RLVKQIS-NGDYFEPKNQST----ASP----LIAEMLNINPSSRADISVICSH 286
+L ++ F P + ASP LI +ML +P R S H
Sbjct: 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 5e-40
Identities = 82/266 (30%), Positives = 138/266 (51%), Gaps = 21/266 (7%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ +++++++G G YG V + TG+ VAIK IK +E D I++EI ++ R
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECR 58
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCH 153
HPNI+ + + R+K+ +VMEY GG L D + L+E + + R+ + Y H
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 154 -KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS---TFCGSPLYASPEIV-- 207
KI HRD+K NILL E+G+ K+ADFG+S T + ++ +F G+P + +PE+
Sbjct: 119 ETGKI-HRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAKRKSFIGTPYWMAPEVAAV 175
Query: 208 -KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP--KNQSTASP 264
+ Y G + D W+LG+ L P + R + IS ++ P K++ SP
Sbjct: 176 ERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234
Query: 265 L----IAEMLNINPSSRADISVICSH 286
+ I + L +P R + + H
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 9e-40
Identities = 75/256 (29%), Positives = 125/256 (48%), Gaps = 11/256 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F I +K+G+G + V I G+ VA+K ++ ++ +EI ++ + HPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELY----DFLDQKKVLTEEEARRIFRQIATAVYYCH 153
+I F ++ +V+E A G+L F QK+++ E + F Q+ +A+ + H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPY 212
+I HRD+K N+ + G K+ D GL F+ ++ + G+P Y SPE + Y
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPF--DGSNFKRLVKQISNGDYFE-PKNQSTAS--PLIA 267
+ + D WSLG LLY + PF D N L K+I DY P + + L++
Sbjct: 184 NF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242
Query: 268 EMLNINPSSRADISVI 283
+N +P R DIS +
Sbjct: 243 RCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 80/219 (36%), Positives = 121/219 (55%), Gaps = 5/219 (2%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SVRHPNIIH 100
+ LG+G++GKV L K T Q AIK +KK + + D+ E +++S + HP + H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
+Y F+ +E + VMEY GG+L + A +I + + H I +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 161 DLKLENILLDENGNAKIADFGL--SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVD 218
DLKL+NILLD +G+ KIADFG+ N+ +++ TFCG+P Y +PEI+ G Y VD
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY-NTSVD 178
Query: 219 CWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPK 257
WS GVLLY ++ G PF G + + L + I + P+
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 88/254 (34%), Positives = 142/254 (55%), Gaps = 15/254 (5%)
Query: 38 FDIVRKLGQGNYGKVQLGINK----ETGQEVAIKTIKKCKIETEADLIR-IRREIQIMSS 92
F++++ LG G YGKV L + K ++G+ A+K +KK I +A R E Q++
Sbjct: 2 FELLKVLGTGAYGKVFL-VRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 93 VRH-PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYY 151
+R P ++ ++ F+ K+ L+++Y GGEL+ L Q++ E+E + +I A+ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVF--TESRFLSTFCGSPLYASPEIVKG 209
HK I +RD+KLENILLD NG+ + DFGLS F E +FCG+ Y +P+IV+G
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 210 IPY-HGPEVDCWSLGVLLYTLVYGAMPF----DGSNFKRLVKQISNGDYFEPKNQST-AS 263
H VD WS+GVL+Y L+ GA PF + ++ + ++I + P+ S A
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240
Query: 264 PLIAEMLNINPSSR 277
+I +L +P R
Sbjct: 241 DIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-39
Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 10/243 (4%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH-PNII 99
++ + +G +G V L + TG AIK +KK + + + ++ E IM P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
+Y F++++ + LVMEY GG+ + L E+ A++ ++ V H+ I H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDC 219
RD+K EN+L+D+ G+ K+ DFGLS E++ F G+P Y +PE + G+ D
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENK---KFVGTPDYLAPETILGVG-DDKMSDW 176
Query: 220 WSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTA-SP----LIAEMLNINP 274
WSLG +++ ++G PF + I + P+ SP LI +L ++P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 275 SSR 277
+ R
Sbjct: 237 AKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 77/216 (35%), Positives = 123/216 (56%), Gaps = 9/216 (4%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKI--ETEADLIRIRREIQIMSSVRHPNIIHI 101
+G+G++GKV L K G A+K ++K I + E + I R + ++ +++HP ++ +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRD 161
+ F+ EK+ V++Y GGEL+ L +++ E AR ++A+A+ Y H I +RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 162 LKLENILLDENGNAKIADFGLSNVFTESR-FLSTFCGSPLYASPEIVKGIPYHGPEVDCW 220
LK ENILLD G+ + DFGL E STFCG+P Y +PE+++ PY VD W
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWW 180
Query: 221 SLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP 256
LG +LY ++YG PF + R V Q+ + +P
Sbjct: 181 CLGAVLYEMLYGLPPF----YSRDVSQMYDNILHKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 5e-39
Identities = 81/243 (33%), Positives = 134/243 (55%), Gaps = 4/243 (1%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHP 96
F+ + LG+G++GKV L K T + AIK +KK + + D+ E ++++ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
+ ++ F+ +++ VMEY GG+L + Q E +A +I+ +++ H+
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 157 ICHRDLKLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
I +RDLKL+N++LD G+ KIADFG+ + TFCG+P Y +PEI+ PY G
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GK 180
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAE-MLNINP 274
VD W+ GVLLY ++ G PFDG + L + I + PK+ S + I + ++ +P
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 240
Query: 275 SSR 277
S R
Sbjct: 241 SKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-39
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 14/209 (6%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTI--KKCKIETEADLIRIRREIQIMSSVRH 95
++++ +G G V I ++VAIK I +KC+ + +R+E+Q MS H
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD----ELRKEVQAMSQCNH 58
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK---KVLTEEEARRIFRQIATAVYYC 152
PN++ Y F +++ LVM Y +GG L D + L E + +++ + Y
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-----SRFLSTFCGSPLYASPEIV 207
H + HRD+K NILL E+G+ KIADFG+S + + TF G+P + +PE++
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
+ + + + D WS G+ L GA P+
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 77/208 (37%), Positives = 121/208 (58%), Gaps = 5/208 (2%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SVRHPNIIHIY 102
LG+G++GKV L K G+ A+K +KK + + D+ E ++++ + +P + H+Y
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
F+ +E + VME+ GG+L + K A +I + + H I +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 163 KLENILLDENGNAKIADFGL--SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCW 220
KL+N++LD +G+ KIADFG+ NVF ++R STFCG+P Y +PEI++G+ Y VD W
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNR-ASTFCGTPDYIAPEILQGLKYTF-SVDWW 180
Query: 221 SLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
S GVLLY ++ G PF G + L + I
Sbjct: 181 SFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 78/262 (29%), Positives = 132/262 (50%), Gaps = 14/262 (5%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
FD+ +G+G++G+VQ+ K TG A+K +KK + + + E I+S P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHK 156
I + F++++ + LVMEY GG+L L++ + E+ A+ ++ A++ H+
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF--CGSPLYASPEIVKGIP--- 211
HRD+K EN+L+D G+ K+ADFG + T ++ +++ G+P Y +PE++ +
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 212 --YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-----EPKNQSTASP 264
+G E D WSLGV+ Y ++YG PF + I N F +PK S
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLD 242
Query: 265 LIAEMLNINPSSRADISVICSH 286
LI +L R +C H
Sbjct: 243 LIQSLL-CGQKERLGYEGLCCH 263
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 82/244 (33%), Positives = 135/244 (55%), Gaps = 6/244 (2%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SVRHP 96
F+ + LG+G++GKV L K T + AIK +KK + + D+ E ++++ S + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
+ ++ F+ +++ VMEY GG+L + Q E A +IA +++ H
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 157 ICHRDLKLENILLDENGNAKIADFGL--SNVFTESRFLSTFCGSPLYASPEIVKGIPYHG 214
I +RDLKL+N++LD G+ KIADFG+ N++ + TFCG+P Y +PEI+ PY G
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-DGVTTKTFCGTPDYIAPEIIAYQPY-G 179
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAE-MLNIN 273
VD W+ GVLLY ++ G PF+G + L + I + PK+ S + I + ++ +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239
Query: 274 PSSR 277
P R
Sbjct: 240 PGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-38
Identities = 82/271 (30%), Positives = 125/271 (46%), Gaps = 24/271 (8%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-TEADLIRIRREIQIMSSVR 94
+ + +LG GN G V +++ TG+ +A+KTI+ +E EA +I RE+ I+
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR---LEINEAIQKQILRELDILHKCN 57
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCH 153
P I+ Y F N + + MEY GG L L + + + E +I + + Y H
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 154 -KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
KHKI HRD+K NIL++ G K+ DFG+S S TF G+ Y +PE ++G Y
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGNDY 176
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-----RLVKQISNGDYFEPKNQSTASPLIA 267
+ D WSLG+ L L G P+ N L++ I N EP + +
Sbjct: 177 -SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN----EPPPRLPSGKFSP 231
Query: 268 EM-------LNINPSSRADISVICSHWWIDK 291
+ L +P R + H +I K
Sbjct: 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-38
Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 13/243 (5%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIK--KCKIETEADLIRIRREIQIMSSVRHPNIIHI 101
LG G++G V G+N + G A+K + + + ++ +EI ++S ++HPNI+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRD 161
+ + + +E GG L L + E R RQI + Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 162 LKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWS 221
+K NIL+D NG K+ADFG++ E F +F GSP + +PE++ +G D WS
Sbjct: 128 IKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWS 187
Query: 222 LGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------DYFEPKNQSTASPLIAEMLNINP 274
LG + + G P+ V +I D+ + A I + L +P
Sbjct: 188 LGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDE----AKDFILKCLQRDP 243
Query: 275 SSR 277
S R
Sbjct: 244 SLR 246
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 8e-38
Identities = 79/238 (33%), Positives = 129/238 (54%), Gaps = 6/238 (2%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKI--ETEADLIRIRREIQIMSSVRHPNIIHI 101
+G+G++GKV L K G+ A+K ++K + E I R + ++ +V+HP ++ +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRD 161
+ F+ EK+ V+++ GGEL+ L +++ E AR +IA+A+ Y H I +RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 162 LKLENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCW 220
LK ENILLD G+ + DFGL +S +TFCG+P Y +PE+++ PY VD W
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TVDWW 180
Query: 221 SLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSR 277
LG +LY ++YG PF + + I + P TA ++ E+L + R
Sbjct: 181 CLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 82/286 (28%), Positives = 140/286 (48%), Gaps = 24/286 (8%)
Query: 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR-IRREIQIMSS 92
L QR +++ G+G YG V G + TG+ VA+K I ++T D + I+RE+ ++S
Sbjct: 2 LYQRLELI---GRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQ 55
Query: 93 VRH---PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
+R PNI Y + ++ ++MEYA GG + + + E+ I R++ A+
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVAL 114
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFLSTFCGSPLYASPEIVK 208
Y HK + HRD+K NIL+ GN K+ DFG++ + + S STF G+P + +PE++
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174
Query: 209 GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS-------NGDYFEPKNQST 261
Y+ + D WSLG+ +Y + G P+ + R + I + + +
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE- 233
Query: 262 ASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQ 307
+A L+ P R + WI K HS + +EL ++
Sbjct: 234 ---FVAACLDEEPKERLSAEELLKSKWI-KAHSKTPVSILKELISR 275
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 72/251 (28%), Positives = 130/251 (51%), Gaps = 20/251 (7%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRR------EIQI 89
+ ++ +G G +G+V L ++ + A+K + ++IR+++ E ++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI------PEVIRLKQEQHVHNEKRV 54
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
+ V HP II ++ ++ + ++MEY GGEL+ +L + +I A+
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV-- 207
Y H +I +RDLK ENILLD+ G+ K+ DFG + + + T CG+P Y +PE++
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLAPEVIQS 172
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLI 266
KG H VD W+LG+L+Y ++ G PF N + ++I G P++ A LI
Sbjct: 173 KG---HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLI 229
Query: 267 AEMLNINPSSR 277
++L ++ + R
Sbjct: 230 KKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 4e-37
Identities = 70/198 (35%), Positives = 119/198 (60%), Gaps = 3/198 (1%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIH 100
R +G+G+Y KV L K+T + A+K IKK + + D+ ++ E + + HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
++ F+ ++ V+E+ +GG+L + +++ L EE AR +I+ A+ + H+ I +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 161 DLKLENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDC 219
DLKL+N+LLD G+ K+ D+G+ STFCG+P Y +PEI++G Y G VD
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179
Query: 220 WSLGVLLYTLVYGAMPFD 237
W+LGVL++ ++ G PFD
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-37
Identities = 76/236 (32%), Positives = 127/236 (53%), Gaps = 3/236 (1%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
+G+G++GKV ++T + A+KTI+K I + +++ E +++ V P I+ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLK 163
F++ EK+ LV+ + GGEL+ L ++ AR ++ A+ HK + +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 164 LENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSL 222
ENILLD G+ + DFGL + + +TFCG+P Y +PE++ G Y VD W+L
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY-TKAVDWWTL 179
Query: 223 GVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKN-QSTASPLIAEMLNINPSSR 277
GVLLY ++ G PF N + ++I P A L+ +L+ +P+ R
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 7e-37
Identities = 87/261 (33%), Positives = 129/261 (49%), Gaps = 20/261 (7%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQE-VAIKTI-------KKCKIETEADLIRIRREIQI 89
+ ++ LG G +G V K GQ +A+K I K K E + + I E+ I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 90 M-SSVRHPNIIHIYEVFENREKMVLVMEYAAG---GELYDFLDQKK-VLTEEEARRIFRQ 144
+ +RHPNI+ Y+ F +++ +VM+ G GE ++ L +KK TEE IF Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 145 IATAVYYCHKHK-ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
+ A+ Y HK K I HRDL NI+L E+ I DFGL+ L++ G+ LY+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
PEIVK PY G + D W+ G +LY + PF +N L +I Y EP + S
Sbjct: 182 PEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY-EPLPEGMYS 239
Query: 264 PLIAEM----LNINPSSRADI 280
+ ++ L + +R DI
Sbjct: 240 EDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 79/276 (28%), Positives = 144/276 (52%), Gaps = 24/276 (8%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRR------EIQ 88
+ D K+G+G+ G V + +K TG++VA+K + DL + +R E+
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---------DLRKQQRRELLFNEVV 68
Query: 89 IMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATA 148
IM +HPNI+ +Y + +++ +VME+ GG L D + + + EE+ + + A
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKA 127
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIV 207
+ + H + HRD+K ++ILL +G K++DFG + V E + G+P + +PE++
Sbjct: 128 LSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMP-FDGSNFKRLVKQISNGDYFEPKNQSTASP-- 264
+PY G EVD WSLG+++ +V G P F+ + + K+I + + KN SP
Sbjct: 188 SRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-KRIRDNLPPKLKNLHKVSPRL 245
Query: 265 --LIAEMLNINPSSRADISVICSHWWIDKDHSVACL 298
+ ML +P+ RA + + +H ++ K + +
Sbjct: 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-36
Identities = 71/198 (35%), Positives = 117/198 (59%), Gaps = 3/198 (1%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIH 100
R +G+G+Y KV L K+T + A+K +KK + + D+ ++ E + HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
++ F+ ++ V+EY GG+L + +++ L EE AR +I+ A+ Y H+ I +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 161 DLKLENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDC 219
DLKL+N+LLD G+ K+ D+G+ STFCG+P Y +PEI++G Y G VD
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179
Query: 220 WSLGVLLYTLVYGAMPFD 237
W+LGVL++ ++ G PFD
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 7e-36
Identities = 75/231 (32%), Positives = 123/231 (53%), Gaps = 5/231 (2%)
Query: 29 NHRRKLK-QRFDIVRKLGQGNYGKVQLGINK-ETGQEVAIKTIKKCKIETEADLIRIRRE 86
+ K+K + F+ +R LG G++G+V L K E VAIK +K KI + + + E
Sbjct: 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 87 IQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
+I++ + HP +++Y F++ + LV+E+ GGE + FL + K + QI
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206
Y I +RDLK EN+LLD++G K+ DFG + V + T CG+P Y +PEI
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEI 199
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPK 257
+ + HG D W+LG+ +Y ++ G PF + + ++I G + PK
Sbjct: 200 LLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK 249
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 9e-36
Identities = 80/237 (33%), Positives = 130/237 (54%), Gaps = 4/237 (1%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM-SSVRHPNIIHIY 102
+G+G++GKV L +K + A+K ++K I + + I E ++ +V+HP ++ ++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
F+ +K+ V++Y GGEL+ L +++ E AR +IA+A+ Y H I +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 163 KLENILLDENGNAKIADFGLSNVFTE-SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWS 221
K ENILLD G+ + DFGL E + STFCG+P Y +PE++ PY VD W
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWC 181
Query: 222 LGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSR 277
LG +LY ++YG PF N + I N +P ++A L+ +L + + R
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-35
Identities = 70/198 (35%), Positives = 117/198 (59%), Gaps = 3/198 (1%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIH 100
R +G+G+Y KV L K+ Q A+K +KK + + D+ ++ E + +P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
++ F+ ++ LV+EY GG+L + +++ L EE AR +I A+ + H+ I +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 161 DLKLENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDC 219
DLKL+N+LLD +G+ K+ D+G+ STFCG+P Y +PEI++G Y G VD
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179
Query: 220 WSLGVLLYTLVYGAMPFD 237
W+LGVL++ ++ G PFD
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-35
Identities = 80/238 (33%), Positives = 130/238 (54%), Gaps = 6/238 (2%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
K+++ K+GQG G V I+ TGQEVAIK + + + + +LI EI +M +
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELII--NEILVMRENK 74
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
HPNI++ + + +++ +VMEY AGG L D + + + E + + R+ A+ + H
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS 133
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPYH 213
+++ HRD+K +NILL +G+ K+ DFG T E ST G+P + +PE+V Y
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLN 271
GP+VD WSLG++ +V G P+ N R + I+ E +N S + + LN
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 69/202 (34%), Positives = 116/202 (57%), Gaps = 10/202 (4%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR----REIQIMS 91
++++ + K+G+G+YG V N+ETGQ VAIK +E+E D + I+ REI+++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPV-IKKIALREIRMLK 55
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYY 151
++HPN++++ EVF + K+ LV EY L + + + E ++I Q AV +
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGI 210
CHKH HRD+K ENIL+ + G K+ DFG + + T + + + Y +PE++ G
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 211 PYHGPEVDCWSLGVLLYTLVYG 232
+GP VD W++G + L+ G
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 9e-35
Identities = 74/240 (30%), Positives = 129/240 (53%), Gaps = 6/240 (2%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRI--RREIQIMSSVRH-PNIIH 100
+G+G +G+V K+T + A+K + K +I + ++ R I + + + P I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
+ F+ + LV +Y +GGEL+ L ++ +E+ A+ ++ A+ + HK+ I +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 161 DLKLENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDC 219
DLK ENILLD G+ + DFGLS T+++ +TFCG+ Y +PE++ + VD
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 220 WSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKN--QSTASPLIAEMLNINPSSR 277
WSLGVL++ + G PF + +++ + I+ G PKN + +LN NP R
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-35
Identities = 80/260 (30%), Positives = 128/260 (49%), Gaps = 21/260 (8%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+ ++ + G YG V L +KET Q A+K I K + + ++ E I++ +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ ++ FE + + +VMEY GG+ L L + AR F + A+ Y H + I
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESR---------------FL-STFCGSPLY 201
HRDLK +N+L+ G+ K+ DFGLS + S FL CG+P Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKN--- 258
+PE++ Y G VD W++G++LY + G +PF G + L Q+ + D P+
Sbjct: 183 IAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241
Query: 259 -QSTASPLIAEMLNINPSSR 277
+ A LI+ +L NP R
Sbjct: 242 LPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-34
Identities = 80/238 (33%), Positives = 131/238 (55%), Gaps = 6/238 (2%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
K+++ K+GQG G V I+ TGQEVAIK I K + +I EI +M ++
Sbjct: 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN---EILVMKELK 74
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
+PNI++ + F +++ +VMEY AGG L D + + + E + + R+ A+ + H
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHA 133
Query: 155 HKICHRDLKLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
+++ HRD+K +N+LL +G+ K+ DFG + + E ST G+P + +PE+V Y
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLN 271
GP+VD WSLG++ +V G P+ N R + I+ E +N SP+ + LN
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-34
Identities = 84/261 (32%), Positives = 131/261 (50%), Gaps = 20/261 (7%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRR----EIQIMSSVRHP 96
VR +G+G+YG+V L ++ G++ IK K+ R R+ E Q++S ++HP
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIK-----KLNLRNASRRERKAAEQEAQLLSQLKHP 59
Query: 97 NIIHIYEVFENREKMV-LVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCH 153
NI+ E +E + ++ +VM + GG+LY L ++K +L E + F QIA A+ Y H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPY 212
+ I HRDLK +N+ L K+ D G++ V + ST G+P Y SPE+ PY
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP----LIAE 268
+ + D W+LG +Y + F+ + LV +I G P SP LIA
Sbjct: 180 N-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--PPMPKDYSPELGELIAT 236
Query: 269 MLNINPSSRADISVICSHWWI 289
ML+ P R + I +I
Sbjct: 237 MLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 72/220 (32%), Positives = 106/220 (48%), Gaps = 28/220 (12%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKT--IKKCKIETEADLIRIRREIQIM---S 91
F++V +G+G YGKV +K+TGQ VAIK I + + E I+ E I+ S
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE------EIKEEYNILRKYS 60
Query: 92 SVRHPNIIHIYEVFENREKMV------LVMEYAAGGELYD----FLDQKKVLTEEEARRI 141
+ HPNI Y F + LVME GG + D + K L EE I
Sbjct: 61 N--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 142 FRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSPL 200
R+ + Y H++K+ HRD+K +NILL +N K+ DFG+S + +TF G+P
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 201 YASPEIV----KGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
+ +PE++ + + D WSLG+ L G P
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R+++++ +G G YG V ++K TG++VAIK I + D RI REI+++ +RH
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHE 59
Query: 97 NIIHIYEVF-----ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYY 151
NII + ++ E+ + +V E +L+ + + LT++ + QI + Y
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNV----FTESRFLSTFCGSPLYASPEIV 207
H + HRDLK NIL++ N + KI DFGL+ E FL+ + + Y +PE++
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL 178
Query: 208 KGIPYHGPEVDCWSLGVLL 226
+ +D WS+G +
Sbjct: 179 LSSSRYTKAIDIWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 31/199 (15%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI---RIRREIQIMSSVRHPN 97
V K+G+G YG V +K TG+ VA+K I+ +ETE + + IR EI ++ + HPN
Sbjct: 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIR-EISLLKELNHPN 59
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV--LTEEEARRIFRQIATAVYYCHKH 155
I+ + +V + K+ LV E+ +L ++D + L + Q+ + YCH H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------YASP 204
++ HRDLK +N+L+D G K+ADFGL+ F G P+ Y +P
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF----------GVPVRTYTHEVVTLWYRAP 168
Query: 205 EIVKGIPYHGPEVDCWSLG 223
EI+ G + VD WS+G
Sbjct: 169 EILLGSRQYSTPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 81/251 (32%), Positives = 120/251 (47%), Gaps = 32/251 (12%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGI-NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93
++ + RKLG G +G+V +G N T +VA+KT+K + EA L +E QIM +
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFL----QEAQIMKKL 58
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYY 151
RH ++ +Y V E + +V EY + G L DFL + K L + + QIA + Y
Sbjct: 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK-GI 210
HRDL NIL+ EN KIADFGL+ + + Y + E K I
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE----------YTAREGAKFPI 168
Query: 211 PYHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQ 259
+ PE D WS G+LL +V YG +P+ G + +++Q+ G Y P+
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPP 227
Query: 260 STASPLIAEML 270
+ L ML
Sbjct: 228 NCPEELYDLML 238
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 81/296 (27%), Positives = 125/296 (42%), Gaps = 39/296 (13%)
Query: 29 NHRRKLKQRFDIVRK-LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR----- 82
N + +R+ LG+G YGKV+ + TG+ VAIK +K +I + R
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60
Query: 83 ------IRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEE 136
RE++IM+ ++H NI+ + +V+ + + LVM+ A +L +D+K LTE
Sbjct: 61 CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTES 119
Query: 137 EARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFC 196
+ + I QI + HK HRDL NI ++ G KIADFGL+ + + T
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 197 GSPL---------------YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF 241
Y +PE++ G + VD WS+G + L+ G F G N
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239
Query: 242 KRLVKQISNGDYF-----EPKN--QSTASPLIAEMLNINPSSRADISVICSHWWID 290
+ +I + N Q+ PL E P I S ID
Sbjct: 240 IDQLGRI----FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAID 291
|
Length = 335 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 77/238 (32%), Positives = 129/238 (54%), Gaps = 6/238 (2%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
K+++ K+GQG G V I+ TGQEVAIK + ++ + I EI +M +
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENK 74
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
+PNI++ + + +++ +VMEY AGG L D + + + E + + R+ A+ + H
Sbjct: 75 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHS 133
Query: 155 HKICHRDLKLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
+++ HRD+K +NILL +G+ K+ DFG + + E ST G+P + +PE+V Y
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLN 271
GP+VD WSLG++ +V G P+ N R + I+ E +N S + + LN
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 30/202 (14%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSVRH 95
++ + ++ +G YG V +K+TG+ VA+K +K +E E + I REI I+ ++H
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQH 63
Query: 96 PNIIHIYEVF--ENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYC 152
PNI+ + EV N +K+ +VMEY +L ++ K + E + + Q+ + V +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------Y 201
H + I HRDLK N+LL+ G KI DFGL+ + GSPL Y
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGILKICDFGLAREY----------GSPLKPYTQLVVTLWY 172
Query: 202 ASPEIVKGIPYHGPEVDCWSLG 223
+PE++ G + +D WS+G
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-33
Identities = 84/250 (33%), Positives = 133/250 (53%), Gaps = 11/250 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE--TEADLIRIRREIQIMSSVR 94
R+ + ++LG+G++G V L +K+ E +K +K+ + + ++ +E Q++S +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVY 150
HP I+ + F R+ ++ EY G +L L++ K L+E + F Q+ V+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-STFCGSPLYASPEIVKG 209
Y H+ +I HRDLK +NI L N KI DFG+S + S L +TF G+P Y SPE +K
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTASPLIAE 268
Y + D WSLG +LY + A F+G NF +V +I G P+ S I +
Sbjct: 180 QGYDS-KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238
Query: 269 -MLNINPSSR 277
MLN +PS R
Sbjct: 239 SMLNKDPSLR 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 93/291 (31%), Positives = 147/291 (50%), Gaps = 26/291 (8%)
Query: 28 HNH-RRKL--KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
+ H RR L + ++I+ +LG G +GKV NKETG A K I+ ++E +L
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET---KSEEELEDYM 57
Query: 85 REIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGEL-YDFLDQKKVLTEEEARRIFR 143
EI+I+++ HP I+ + F K+ +++E+ GG + L+ + LTE + + I R
Sbjct: 58 VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR 117
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLY 201
Q+ A+ Y H KI HRDLK N+LL +G+ K+ADFG+S NV T R +F G+P +
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-RDSFIGTPYW 176
Query: 202 ASPEIV-----KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP 256
+PE+V K PY + D WSLG+ L + P N R++ +I+ + P
Sbjct: 177 MAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---P 232
Query: 257 KNQSTASPLIAEM-------LNINPSSRADISVICSHWWIDKDHSVACLEE 300
S S E L+ +P +R + + H ++ S L E
Sbjct: 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRE 283
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 40/238 (16%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+ ++ +G+G +G+V+L K+TG A+K ++K ++ + + +R E I++ +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ +Y F++ + L+MEY GG++ L +K TEEE R + A+ HK
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESR---------------FLSTFC------ 196
HRD+K +N+LLD G+ K++DFGL +S FL
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 197 ------------------GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
G+P Y +PE+ Y E D WSLGV++Y ++ G PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-33
Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F V K+G+G YG V NK TG+ VA+K I+ ETE REI ++ + HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLD--QKKVLTEEEARRIFRQIATAVYYCHKH 155
I+ + +V K+ LV E+ +L F+D + + Q+ + +CH H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------YASP 204
++ HRDLK +N+L++ G K+ADFGL+ F G P+ Y +P
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAF----------GVPVRTYTHEVVTLWYRAP 169
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLV 230
EI+ G Y+ VD WSLG + +V
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 79/256 (30%), Positives = 117/256 (45%), Gaps = 35/256 (13%)
Query: 40 IVRKLGQGNYGKVQLGI-NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
++RKLG G +G+V G+ N T VA+KT+K ++ + L E QIM +RHP +
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFL----AEAQIMKKLRHPKL 63
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYCHKHK 156
I +Y V E + +V E G L ++L + L + + Q+A+ + Y
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK-GIPYHGP 215
HRDL N+L+ EN K+ADFGL+ V E +Y + E K I + P
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKED----------IYEAREGAKFPIKWTAP 173
Query: 216 EV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264
E D WS G+LL +V YG MP+ G +++Q+ G Y P
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKE 232
Query: 265 LIAEML---NINPSSR 277
L ML +P R
Sbjct: 233 LYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 74/261 (28%), Positives = 137/261 (52%), Gaps = 10/261 (3%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY 102
K+G+G+ G V + K +G++VA+K + K + L E+ IM +H N++ +Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMY 84
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
+ + E++ ++ME+ GG L D + Q + L EE+ + + A+ Y H + HRD+
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 163 KLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWS 221
K ++ILL +G K++DFG + + + + G+P + +PE++ PY G EVD WS
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWS 202
Query: 222 LGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAE----MLNINPSSR 277
LG+++ +V G P+ + + +K++ + + KN SP++ + ML P R
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER 262
Query: 278 ADISVICSHWWIDKDHSVACL 298
A + H ++ + CL
Sbjct: 263 ATAQELLDHPFLLQTGLPECL 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 16/195 (8%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY 102
K+GQG +G+V +K+T Q VA+K + E E I REI+I+ ++H N++++
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLI 77
Query: 103 EV------FENREK--MVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCH 153
E+ NR K LV E+ +L L K V T E +++ + + +YY H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP-----LYASPEIVK 208
++KI HRD+K NIL+ ++G K+ADFGL+ F+ S+ + Y PE++
Sbjct: 137 RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196
Query: 209 GIPYHGPEVDCWSLG 223
G +GP +D W G
Sbjct: 197 GERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 74/238 (31%), Positives = 129/238 (54%), Gaps = 6/238 (2%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
K+++ K+GQG G V ++ TGQEVAI+ + ++ + I EI +M +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENK 75
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
+PNI++ + + +++ +VMEY AGG L D + + + E + + R+ A+ + H
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS 134
Query: 155 HKICHRDLKLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
+++ HRD+K +NILL +G+ K+ DFG + + E ST G+P + +PE+V Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLN 271
GP+VD WSLG++ ++ G P+ N R + I+ E +N S + + LN
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 64/197 (32%), Positives = 107/197 (54%), Gaps = 6/197 (3%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM 90
RR ++ F++++++G G YG V N TG+ AIK IK +E D +++EI +M
Sbjct: 4 RRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMM 60
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
+H NI+ + + R+K+ + ME+ GG L D L+E + + R+ +Y
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLSTFCGSPLYASPEI--V 207
Y H HRD+K NILL +NG+ K+ADFG+S T + +F G+P + +PE+ V
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 208 KGIPYHGPEVDCWSLGV 224
+ + D W++G+
Sbjct: 181 ERKGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 30/202 (14%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI--RIRREIQIMSSVRH 95
+ + K+G+G YG V G NK+TGQ VA+K I+ +E+E + + REI ++ ++H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQH 58
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ---KKVLTEEEARRIFRQIATAVYYC 152
PNI+ + +V ++ L+ E+ + +L +LD + + E + QI + +C
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------Y 201
H ++ HRDLK +N+L+D G K+ADFGL+ F G P+ Y
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF----------GIPVRVYTHEVVTLWY 167
Query: 202 ASPEIVKGIPYHGPEVDCWSLG 223
+PE++ G P + VD WS+G
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-31
Identities = 74/261 (28%), Positives = 135/261 (51%), Gaps = 10/261 (3%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY 102
K+G+G+ G V + K +G+ VA+K + K + L E+ IM +H N++ +Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMY 83
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
+ +++ +VME+ GG L D + + + EE+ + + A+ H + HRD+
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 163 KLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWS 221
K ++ILL +G K++DFG + V E + G+P + +PE++ +PY GPEVD WS
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 222 LGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIA----EMLNINPSSR 277
LG+++ +V G P+ + +K I + + KN SP + +L +P+ R
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 278 ADISVICSHWWIDKDHSVACL 298
A + + H ++ K +C+
Sbjct: 262 ATAAELLKHPFLAKAGPPSCI 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-31
Identities = 67/204 (32%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI--RIRREIQIMSSVRHPNI 98
+ +LG+G G V K TG A+KTI + +I RE++I S + P I
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 99 IHIYEVF-ENREKMV-LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY----YC 152
+ Y F + + + MEY GG L + K ++ +IA +V Y
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
H KI HRD+K NILL G K+ DFG+S S TF G+ Y +PE ++G PY
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-LAGTFTGTSFYMAPERIQGKPY 180
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPF 236
D WSLG+ L + PF
Sbjct: 181 -SITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 78/223 (34%), Positives = 123/223 (55%), Gaps = 13/223 (5%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++I+ +LG G +GKV NKETG A K I ++E +L EI I++S HPN
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT---KSEEELEDYMVEIDILASCDHPN 63
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYD-FLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
I+ + + F + +++E+ AGG + L+ ++ LTE + R + +Q A+ Y H++K
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 157 ICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASPEIV-----KG 209
I HRDLK NIL +G+ K+ADFG+S N T R +F G+P + +PE+V K
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKD 182
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD 252
PY + D WSLG+ L + P N R++ +I+ +
Sbjct: 183 RPYDY-KADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE 224
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 4e-31
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEAD------LIRIRREIQIMSSVRHPN 97
+G G++G V LG+N +G+ +A+K ++ + + L + REI ++ ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
I+ + + + + +EY GG + L+ E R RQI + Y H I
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST--------FCGSPLYASPEIVKG 209
HRD+K NIL+D G KI+DFG+S E+ LST GS + +PE+VK
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPF 236
Y + D WSLG L+ ++ G PF
Sbjct: 187 TSY-TRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 4e-31
Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 17/263 (6%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ F + K+G+G++G+V GI+ T + VAIK I + E E + I++EI ++S
Sbjct: 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE--DIQQEITVLSQCD 60
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
P + Y + K+ ++MEY GG D L+ L E + I R+I + Y H
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHS 119
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSPLYASPEIVKGIPYH 213
K HRD+K N+LL E+G K+ADFG++ T+++ +TF G+P + +PE++K Y
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN-------GDYFEPKNQSTASPLI 266
+ D WSLG+ L G P + +++ I G+Y +P + +
Sbjct: 180 S-KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE-----FV 233
Query: 267 AEMLNINPSSRADISVICSHWWI 289
LN PS R + H +I
Sbjct: 234 EACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 70/232 (30%), Positives = 110/232 (47%), Gaps = 31/232 (13%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ F + RKLG G +G+V G+ K + VAIK +K + ++E+Q + +R
Sbjct: 5 REEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKS---DDLLKQQDFQKEVQALKRLR 60
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLD--QKKVLTEEEARRIFRQIATAVYYC 152
H ++I ++ V E + ++ E G L FL + +VL + Q+A + Y
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
+ HRDL NIL+ E+ K+ADFGL+ + E +Y S + K IPY
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE----------DVYLSSD--KKIPY 168
Query: 213 H--GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
PE D WS G+LLY + YG +P+ G N + QI+ G
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 76/244 (31%), Positives = 130/244 (53%), Gaps = 17/244 (6%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEAD--LIRIR-REIQIMSS 92
++++ + +G+G+YG V +KETGQ VAIK +E+E D + +I REI+++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQ 56
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
+RH N++++ EVF ++++ LV E+ L D L E R+ QI + +C
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST-FCGSPLYASPEIVKGIP 211
H H I HRD+K ENIL+ ++G K+ DFG + + T + + Y +PE++ G
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSN----FKRLVKQISNGDYFEPKNQS--TASPL 265
+G VD W++G L+ ++ G F G + ++K + N P++Q +PL
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN---LIPRHQEIFQKNPL 233
Query: 266 IAEM 269
A M
Sbjct: 234 FAGM 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 83/267 (31%), Positives = 134/267 (50%), Gaps = 27/267 (10%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE--TEADLIRIRREIQI 89
++ +++ I R LG G G V G+ A+K + +E +EAD R + E+
Sbjct: 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD---MEGMSEADKNRAQAEVCC 84
Query: 90 MSSVRHPNIIHIYEVF--------ENREKMVLVMEYAAGGELYDFLDQK----KVLTEEE 137
+ + +I+ +E F EN + LV++YA G+L + + + E E
Sbjct: 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144
Query: 138 ARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES---RFLST 194
A +F Q+ AV++ H + HRD+K NILL NG K+ DFG S ++ + T
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204
Query: 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF 254
FCG+P Y +PEI + PY + D +SLGVLLY L+ PFDG N + ++ + G +
Sbjct: 205 FCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-Y 262
Query: 255 EPKNQSTASP----LIAEMLNINPSSR 277
+P S SP ++ +L+ +P R
Sbjct: 263 DPLPPSI-SPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-31
Identities = 69/213 (32%), Positives = 122/213 (57%), Gaps = 9/213 (4%)
Query: 32 RKLKQR---FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ 88
RKL+ + +D+V+ +G+G +G+VQL +K + + A+K + K ++ +D E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 89 IMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATA 148
IM+ P ++ ++ F++ + + +VMEY GG+L + + V E+ A+ ++ A
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVVLA 154
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL--STFCGSPLYASPEI 206
+ H + HRD+K +N+LLD++G+ K+ADFG E+ + T G+P Y SPE+
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 207 VK---GIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
+K G Y+G E D WS+GV L+ ++ G PF
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 65/213 (30%), Positives = 116/213 (54%), Gaps = 13/213 (6%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-TEADLIRIRREIQIMSSVRHPNIIHI 101
KLG+G Y V G N+ TG+ VA+K I E T + IR EI +M ++H NI+ +
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVRL 63
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLD---QKKVLTEEEARRIFRQIATAVYYCHKHKIC 158
++V K++LV EY +L ++D + L + Q+ + +CH++++
Sbjct: 64 HDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 159 HRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL---YASPEIVKGIPYHGP 215
HRDLK +N+L+++ G K+ADFGL+ F ++TF + Y +P+++ G +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
+D WS+G ++ ++ G F G+N + + +I
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-30
Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 9/201 (4%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIK--KCKIETEADLIRIRREIQIMSSVRHPNIIHI 101
LGQG +G+V L + +TG+E+A K ++ ET ++ + EIQ++ +++H I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 102 YEVFENR--EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
Y +R + + + MEY GG + D L LTE R+ RQI + Y H + I H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 160 RDLKLENILLDENGNAKIADFG----LSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
RD+K NIL D GN K+ DFG L + + + G+P + SPE++ G Y G
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-GR 188
Query: 216 EVDCWSLGVLLYTLVYGAMPF 236
+ D WSLG + ++ P+
Sbjct: 189 KADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 64/204 (31%), Positives = 109/204 (53%), Gaps = 17/204 (8%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSVR- 94
++ + ++G+G YG V + TG+ VA+K ++ + + I + REI ++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 95 --HPNIIHIYEVFEN----RE-KMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQI 145
HPNI+ + +V RE K+ LV E+ +L +L + K L E + + RQ+
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 146 ATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
V + H H+I HRDLK +NIL+ +G KIADFGL+ +++ L++ + Y +PE
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTL 229
++ Y P VD WS+G + L
Sbjct: 177 VLLQSSYATP-VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 5/200 (2%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F + ++G+G++G+V GI+ T + VAIK I + E E + I++EI ++S P
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE--DIQQEITVLSQCDSPY 63
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
I Y + K+ ++MEY GG D L + L E I R+I + Y H +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSPLYASPEIVKGIPYHGPE 216
HRD+K N+LL E G+ K+ADFG++ T+++ +TF G+P + +PE++K Y +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF-K 181
Query: 217 VDCWSLGVLLYTLVYGAMPF 236
D WSLG+ L G P
Sbjct: 182 ADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 70/216 (32%), Positives = 119/216 (55%), Gaps = 9/216 (4%)
Query: 29 NHRRKLKQR---FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRR 85
N R L+ + +++V+ +G+G +G+VQL +K T + A+K + K ++ +D
Sbjct: 33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 86 EIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQI 145
E IM+ P ++ ++ F++ + +VMEY GG+L + + V E+ AR ++
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEV 151
Query: 146 ATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL--STFCGSPLYAS 203
A+ H HRD+K +N+LLD++G+ K+ADFG + + T G+P Y S
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 204 PEIVK---GIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
PE++K G Y+G E D WS+GV LY ++ G PF
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 66/189 (34%), Positives = 101/189 (53%), Gaps = 11/189 (5%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIK---KCKIETEADLIRIRREIQIMSSVRHPNIIH 100
LG+G +G+V L + +TG+E+A+K + + ET ++ + EIQ++ ++RH I+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ-ETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 101 IYEVFENRE--KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKIC 158
Y + E K+ + +EY GG + D L LTE RR RQI V Y H + I
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 159 HRDLKLENILLDENGNAKIADFGLS----NVFTESRFLSTFCGSPLYASPEIVKGIPYHG 214
HRD+K NIL D GN K+ DFG S + + + G+P + SPE++ G Y G
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-G 187
Query: 215 PEVDCWSLG 223
+ D WS+
Sbjct: 188 RKADVWSVA 196
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 69/203 (33%), Positives = 111/203 (54%), Gaps = 10/203 (4%)
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV----LTEEEAR 139
R E+ +++ H I+ ++ F++ +K++L+MEY +GG+L + Q+ E E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL---STFC 196
+F QI A+ H K+ HRDLK NI L G K+ DFG S +++S L S+FC
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--F 254
G+P Y +PE+ + Y + D WSLGV+LY L+ PF G + + +++Q+ G Y F
Sbjct: 233 GTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 255 EPKNQSTASPLIAEMLNINPSSR 277
S L+ +L+ NP+ R
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-30
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSVR 94
++I+ KLG+G +G+V +TG+ VA+K I + E D I REI+I+ ++
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILKKLK 65
Query: 95 HPNIIHIYEVFENREK--------MVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQI 145
HPN++ + ++ R + +V Y +L L+ V LTE + + Q+
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQL 124
Query: 146 ATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL----- 200
+ Y H++ I HRD+K NIL+D G KIADFGL+ + G
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 201 -------YASPEIVKGIPYHGPEVDCWSLGVLL 226
Y PE++ G + VD W +G +
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 72/231 (31%), Positives = 125/231 (54%), Gaps = 8/231 (3%)
Query: 11 SINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIK 70
+I+N + E ++ R K + FD+++ +G+G +G+VQL +K + Q A+K +
Sbjct: 20 NIDNFLSRYEKAAE-KITKLRMKAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS 77
Query: 71 KCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK 130
K ++ +D E IM+ I+ ++ F++ + + +VMEY GG+L + +
Sbjct: 78 KFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY 137
Query: 131 KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190
+ E+ AR ++ A+ H HRD+K +N+LLD++G+ K+ADFG +
Sbjct: 138 DI-PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196
Query: 191 FL--STFCGSPLYASPEIVK---GIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
+ T G+P Y SPE++K G Y+G E D WS+GV LY ++ G PF
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 79/268 (29%), Positives = 131/268 (48%), Gaps = 21/268 (7%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ F + ++G+G++G+V GI+ T Q VAIK I + E E + I++EI ++S
Sbjct: 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE--DIQQEITVLSQCD 60
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
P + Y + K+ ++MEY GG D L + E + + ++I + Y H
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSPLYASPEIVKGIPYH 213
K HRD+K N+LL E G+ K+ADFG++ T+++ +TF G+P + +PE+++ Y
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTA---------SP 264
+ D WSLG+ L G P + R++ I PKN
Sbjct: 180 S-KADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKNNPPTLTGEFSKPFKE 231
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKD 292
I LN +PS R + H +I K+
Sbjct: 232 FIDACLNKDPSFRPTAKELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-30
Identities = 68/205 (33%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI-----QIMSSVRHPN 97
KL G +GKV + +K T + K IK + I Q+M +PN
Sbjct: 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKA----------KNFNAIEPMVHQLMKD--NPN 70
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
I +Y + VL+M+Y G+L+D L ++ L+E E ++I RQ+ A+ HKH I
Sbjct: 71 FIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNI 130
Query: 158 CHRDLKLENILLDEN-GNAKIADFGLS-NVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
H D+KLEN+L D + D+GL + T S + G+ Y SPE +KG Y
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNY-DV 185
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSN 240
D W++GVL Y L+ G PF
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-30
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
FDI+ ++G+G YG+V +K+TG+ VA+K ++ E E I REI+I+ + H N
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKILRQLNHRN 67
Query: 98 IIHIYEVF----------ENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIA 146
I+++ E+ +++ LV EY +L L+ V +E+ + +Q+
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT--ESRFLSTFCGSPLYASP 204
+ YCHK HRD+K NILL+ G K+ADFGL+ ++ ESR + + Y P
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 205 EIVKGIPYHGPEVDCWSLGVLL 226
E++ G +GP +D WS G +L
Sbjct: 187 ELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-30
Identities = 68/194 (35%), Positives = 100/194 (51%), Gaps = 21/194 (10%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIK--KCKIETEADLIRIRREIQIMSSVRHPNIIHI 101
LGQG +G+V L + +TG+E+A+K ++ ET ++ + EIQ++ ++ H I+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 102 YEVFENREKMVL--VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
Y + + L ME+ GG + D L LTE R+ RQI V Y H + I H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFC----------GSPLYASPEIVKG 209
RD+K NIL D GN K+ DFG S+ L T C G+P + SPE++ G
Sbjct: 130 RDIKGANILRDSVGNVKLGDFG------ASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 210 IPYHGPEVDCWSLG 223
Y G + D WS+G
Sbjct: 184 EGY-GRKADIWSVG 196
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 10/208 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSVRH 95
F+ + ++G+G YG V + +G+ VA+K K +++ E D I I REI ++ ++RH
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALK---KVRMDNERDGIPISSLREITLLLNLRH 65
Query: 96 PNIIHIYEVFENR--EKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYC 152
PNI+ + EV + + + LVMEY +L LD +E + + + Q+ + Y
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-YASPEIVKGIP 211
H++ I HRDLK+ N+LL + G KIADFGL+ + T L Y +PE++ G
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGS 239
+ +D W++G +L L+ G
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGK 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 69/220 (31%), Positives = 119/220 (54%), Gaps = 7/220 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+I++ +G+G +G+V + K T + A+K + K ++ A+ R E ++ +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHK 156
I ++ F++ + LVM+Y GG+L L + + L E+ AR ++ A++ H+
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL--STFCGSPLYASPEIVK----GI 210
HRD+K +N+LLD NG+ ++ADFG + + S G+P Y SPEI++ G+
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 211 PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN 250
+GPE D WSLGV +Y ++YG PF + +I N
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 64/217 (29%), Positives = 116/217 (53%), Gaps = 9/217 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI--RIRREIQIMSSVR 94
+++ + K+G+G YG V N+ET + VA+K ++ ++ + + + REI ++ ++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELK 57
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR-QIATAVYYCH 153
H NI+ +Y+V + +K+ LV EY +L + D + E + F Q+ + +CH
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPY 212
H + HRDLK +N+L+++NG K+ADFGL+ F R S + Y P+++ G
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 213 HGPEVDCWSLGVLLYTLVYGAMP-FDGSNFKRLVKQI 248
+ +D WS G + L P F G++ +K+I
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-29
Identities = 72/269 (26%), Positives = 136/269 (50%), Gaps = 10/269 (3%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ D K+G+G+ G V + K TG++VA+K + K + L E+ IM
Sbjct: 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYH 77
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
H N++ +Y + +++ +VME+ GG L D + + + EE+ + + A+ Y H
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHN 136
Query: 155 HKICHRDLKLENILLDENGNAKIADFGL-SNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
+ HRD+K ++ILL +G K++DFG + V E + G+P + +PE++ +PY
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY- 195
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNI- 272
G EVD WSLG+++ ++ G P+ + +++I + K+ S ++ L++
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255
Query: 273 ---NPSSRADISVICSHWWIDKDHSVACL 298
PS RA + H ++ +C+
Sbjct: 256 LVREPSQRATAQELLQHPFLKLAGPPSCI 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 69/235 (29%), Positives = 114/235 (48%), Gaps = 12/235 (5%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G +G+V K TG+ A K + K +++ E +I+ V I+ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF--RQIATAVYYCHKHKICHRD 161
FE ++ + LVM GG+L + EAR IF QI + + H+ +I +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 162 LKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWS 221
LK EN+LLD++GN +I+D GL+ + + G+P Y +PE+++G Y VD ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-VDWFA 179
Query: 222 LGVLLYTLVYGAMPF-------DGSNFKRLVKQ--ISNGDYFEPKNQSTASPLIA 267
LG LY ++ G PF + KR + + D F P+ + L+
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 69/222 (31%), Positives = 118/222 (53%), Gaps = 7/222 (3%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ F+I++ +G+G +G+V + K + A+K + K ++ A+ R E ++ + +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHK 154
I ++ F++ + LVM+Y GG+L L + + L E+ AR ++ A+ H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL--STFCGSPLYASPEIVK---- 208
HRD+K +NIL+D NG+ ++ADFG E + S G+P Y SPEI++
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 209 GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN 250
G +GPE D WSLGV +Y ++YG PF + +I N
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 70/209 (33%), Positives = 119/209 (56%), Gaps = 13/209 (6%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+I++ +G+G +G+V + K TGQ A+K + K ++ A+ R E ++ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHK 156
I +++ F++ + LVM+Y GG+L L + + L E+ AR ++ A+ H+
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 157 ICHRDLKLENILLDENGNAKIADFG-----LSNVFTESRFLSTFCGSPLYASPEIVK--- 208
HRD+K +N+LLD+NG+ ++ADFG L++ +S + G+P Y SPEI++
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS---NVAVGTPDYISPEILQAME 179
Query: 209 -GIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
G +GPE D WSLGV +Y ++YG PF
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 42 RKLGQGNYGKVQLGINKETGQ---EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
++LG GN+G V G+ EVA+KT+K+ I RE +M+ + HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKIC 158
+ + V + E ++LVME A G L +L +++ + + + + Q+A + Y
Sbjct: 59 VRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 159 HRDLKLENILLDENGNAKIADFGLSNV--FTESRFLSTFCGS-PL--YASPEIVKGIPYH 213
HRDL N+LL AKI+DFG+S + +T G PL YA PE I Y
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA-PE---CINYG 173
Query: 214 --GPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ D WS GV L+ YGA P+ ++ + +G
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 78/280 (27%), Positives = 118/280 (42%), Gaps = 50/280 (17%)
Query: 44 LGQGNYGKVQLG-----INKETGQEVAIKTIKKCKIETEADLIR-IRREIQIMSSVRHPN 97
LG+G +GKV G + + VAIKT+K+ E + + R+E ++MS ++HPN
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKE---NAEPKVQQEFRQEAELMSDLQHPN 69
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFL----------------DQKKVLTEEEARRI 141
I+ + V + ++ EY A G+L++FL K L + I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 142 FRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL- 200
QIA + Y H HRDL N L+ E KI+DFGLS + + S L
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 201 --YASPEIVKGIPYH--GPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE 255
+ PE I Y E D WS GV+L+ + YG P+ G + + +++ I
Sbjct: 190 VRWMPPE---AILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR------ 240
Query: 256 PKNQSTASP---------LIAEMLNINPSSRADISVICSH 286
Q P L+ E N P+ R I +
Sbjct: 241 -SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 68/250 (27%), Positives = 122/250 (48%), Gaps = 26/250 (10%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKT--IKKCKIETEADLIR-----IRREIQIMSSVRHP 96
+G+G YG+V L +N TG+ +A+K + + +R EI+ + + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 97 NIIHIYEVFENREKMV-LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
NI+ Y FE E+ + + +EY GG + L E+ R Q+ + Y H
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 156 KICHRDLKLENILLDENGNAKIADFGLS----NVFTESRFLSTFCGSPLYASPEIV--KG 209
I HRDLK +N+L+D +G KI+DFG+S +++ + +S GS + +PE++
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWMAPEVIHSYS 186
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEM 269
Y +VD WSLG ++ + G P+ S+ + + F+ N+ +A P+ ++
Sbjct: 187 QGYSA-KVDIWSLGCVVLEMFAGRRPW--SDEEAI------AAMFKLGNKRSAPPIPPDV 237
Query: 270 L-NINPSSRA 278
N++P +
Sbjct: 238 SMNLSPVALD 247
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 5e-28
Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 4/206 (1%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+F+++ +G+G YG V +KET + VAIK K + E +R E++++ +++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQE 60
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
NI+ + E F R K+ LV EY L + + E+ R Q+ A+++CHK+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESR--FLSTFCGSPLYASPEIVKGIPYHG 214
I HRD+K EN+L+ N K+ DFG + +E + + + Y SPE++ G PY G
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY-G 179
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSN 240
VD WS+G +L L G F G +
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 12/265 (4%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM 90
RR + +++++++G G YG V N TG+ A+K IK +E D I++EI ++
Sbjct: 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMV 60
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
+H NI+ + + +REK+ + MEY GG L D L+E + + R+ +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLSTFCGSPLYASPEI--V 207
Y H HRD+K NILL +NG+ K+ADFG++ T + +F G+P + +PE+ V
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP--KNQSTASPL 265
+ + D W++G+ L P + R + +S ++ P K+++ S
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240
Query: 266 IAEMLNI----NPSSRADISVICSH 286
+ I NP R + +H
Sbjct: 241 FHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 70/211 (33%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR-IRREIQIMSSVR 94
+ + + LG GN G V + TG +A K + I ++ + + I RE+QIM R
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECR 61
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV----- 149
P I+ Y F N + + ME+ G L + + E I +IA AV
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE----ILGKIAVAVVEGLT 117
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
Y + H+I HRD+K NIL++ G K+ DFG+S S TF G+ Y SPE ++G
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQG 176
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
Y + D WSLG+ + L G PF SN
Sbjct: 177 GKY-TVKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 17/261 (6%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQIMSSVR 94
F I +K+G+G + +V G VA+K ++ + + AD I+ EI ++ +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLN 60
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYD----FLDQKKVLTEEEARRIFRQIATAVY 150
HPN+I Y F ++ +V+E A G+L F QK+++ E+ + F Q+ +A+
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKG 209
+ H ++ HRD+K N+ + G K+ D GL F +++ + G+P Y SPE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPF--DGSNFKRLVKQISNGDYFE-PKNQSTAS--P 264
Y+ + D WSLG LLY + PF D N L K+I DY P + +
Sbjct: 181 NGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 265 LIAEMLNINPSSRADISVICS 285
L+ +N +P R DI+ +
Sbjct: 240 LVNMCINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 66/197 (33%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIK---KCKIETEADLIRIRREIQIMS 91
++ F +R++G G++G V + T + VAIK + K E D+I+ E++ +
Sbjct: 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK---EVRFLQ 70
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVY 150
+RHPN I + LVMEY G D L+ KK L E E I +
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSA-SDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI 210
Y H H+ HRD+K NILL E G K+ADFG +++ + + ++F G+P + +PE++ +
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAM 186
Query: 211 ---PYHGPEVDCWSLGV 224
Y G +VD WSLG+
Sbjct: 187 DEGQYDG-KVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLG----INKETGQEVAIKTIKK-CKIETEADLIRIR 84
+R LK +++LG+G++GKV+L + TG++VA+K++ + + +D
Sbjct: 2 EKRHLKF----IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF---E 54
Query: 85 REIQIMSSVRHPNIIHIYEVFE--NREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRI 141
REI+I+ ++ H NI+ V E + L+MEY G L D+L + + +
Sbjct: 55 REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF 114
Query: 142 FRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR---FLSTFCGS 198
QI + Y + HRDL NIL++ KI+DFGL+ V E + ++ S
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 199 PL--YASPEIVKGIPYHGPEVDCWSLGVLLYTL 229
P+ YA PE ++ + D WS GV LY L
Sbjct: 175 PIFWYA-PECLRTSKFSS-ASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-27
Identities = 70/256 (27%), Positives = 122/256 (47%), Gaps = 11/256 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F I +K+G+G + +V + VA+K ++ ++ +EI ++ + HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYD----FLDQKKVLTEEEARRIFRQIATAVYYCH 153
+I + F ++ +V+E A G+L F QK+++ E + F Q+ +AV + H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPY 212
++ HRD+K N+ + G K+ D GL F +++ + G+P Y SPE + Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPF--DGSNFKRLVKQISNGDYFE-PKNQSTAS--PLIA 267
+ + D WSLG LLY + PF D N L ++I DY P + L++
Sbjct: 184 NF-KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242
Query: 268 EMLNINPSSRADISVI 283
+ +P R DI +
Sbjct: 243 MCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 72/223 (32%), Positives = 115/223 (51%), Gaps = 30/223 (13%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI------ETEADLIRIRREIQI 89
++++I++KLG+G YG V I++ T + VA+K KI T+A R REI
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQ--RTFREIMF 59
Query: 90 MSSVR-HPNIIHIYEVF--ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
+ + HPNI+ + V EN + + LV EY +L+ + + +L + R I Q+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLL 117
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL------ 200
A+ Y H + HRDLK NILL+ + K+ADFGL+ +E L +P+
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE---LEENPENPVLTDYVA 174
Query: 201 ---YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
Y +PEI+ G + VD WS+G +L ++ G F G++
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 21 STGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL 80
S+ K + V ++G G G V I++ TG+ A+K I +
Sbjct: 59 SSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVR 116
Query: 81 IRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARR 140
+I REI+I+ V HPN++ +++F++ ++ +++E+ GG L + + E+
Sbjct: 117 RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLAD 172
Query: 141 IFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSP 199
+ RQI + + Y H+ I HRD+K N+L++ N KIADFG+S + ++ ++ G+
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232
Query: 200 LYASPEIV-----KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---NFKRLVKQISNG 251
Y SPE + G Y G D WSLGV + G PF ++ L+ I
Sbjct: 233 AYMSPERINTDLNHGA-YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS 291
Query: 252 DYFEPKNQSTASP----LIAEMLNINPSSR 277
P+ +TAS I+ L P+ R
Sbjct: 292 Q--PPEAPATASREFRHFISCCLQREPAKR 319
|
Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 65/215 (30%), Positives = 118/215 (54%), Gaps = 24/215 (11%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKC--KIETEADLIRIRREIQIMSSVR- 94
+ I+ K+G+G + +V +++TG+ AIK +KK +E +L REIQ + +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----REIQALRRLSP 56
Query: 95 HPNIIHIYEVFENRE--KMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYY 151
HPNI+ + EV +R+ ++ LV E LY+ + +K+ L E+ + Q+ ++ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNV------FTESRFLSTFCGSPLYASPE 205
H++ I HRD+K ENIL+ ++ K+ADFG +TE ++ST Y +PE
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE--YIST----RWYRAPE 168
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+ Y+GP++D W++G + + ++ F G+N
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 80/254 (31%), Positives = 123/254 (48%), Gaps = 21/254 (8%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL-IRIRREIQIMSSVRHPNIIH 100
K+G+GN+G V G+ K EVA+KT C+ DL + +E +I+ HPNI+
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKT---CRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCHKHKICH 159
+ V ++ + +VME GG L FL +KK LT ++ ++ A + Y H
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 160 RDLKLENILLDENGNAKIADFGLS-----NVFTESRFLSTFCGSPL-YASPEIVKGIPYH 213
RDL N L+ EN KI+DFG+S ++T S L P+ + +PE + Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI---PIKWTAPEALNYGRY- 172
Query: 214 GPEVDCWSLGVLLY-TLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNI 272
E D WS G+LL+ T G P+ G + ++ ++I +G Y P Q + ML
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQLCPEEIYRLMLQC 231
Query: 273 ---NPSSRADISVI 283
+P +R S I
Sbjct: 232 WAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 5/202 (2%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY 102
KLG+G Y V G +K T VA+K I+ + E A IR E+ ++ +++H NI+ ++
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIR-LEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR-QIATAVYYCHKHKICHRD 161
++ + LV EY +L +LD L +IF Q+ + YCHK KI HRD
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128
Query: 162 LKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCW 220
LK +N+L++E G K+ADFGL+ + ++ S + Y P+++ G + +D W
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMW 188
Query: 221 SLGVLLYTLVYGAMPFDGSNFK 242
+G +LY + G F GS K
Sbjct: 189 GVGCILYEMATGRPMFPGSTVK 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 64/221 (28%), Positives = 117/221 (52%), Gaps = 11/221 (4%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
R+ + +G G YG+V + +TG++VAIK + + ++ R RE++++ + H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDH 73
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
N+I + +VF E+ + + LV G +L + + +K L+++ + + QI +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK-LSDDHIQFLVYQILRGL 131
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
Y H I HRDLK NI ++E+ KI DFGL+ T+ ++ + + Y +PEI+
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDE-MTGYVATRWYRAPEIMLN 189
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN 250
++ VD WS+G ++ L+ G F GS+ +K+I N
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 85/291 (29%), Positives = 140/291 (48%), Gaps = 48/291 (16%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+++ V K+G+G YG V ++ T + +A+K I+ + E E REI ++ ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQH 60
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVL--TEEEAR--RIFR----QIAT 147
NI+ + +V + +++ LV EY LD KK + + + A+ R+ + QI
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNA-KIADFGLSNVF-TESRFLSTFCGSPLYASPE 205
+ YCH H++ HRDLK +N+L+D NA K+ADFGL+ F R + + Y +PE
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE 173
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVK--QI-------------S 249
I+ G ++ VD WS+G + +V F G S L K +I S
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233
Query: 250 NGDY------FEPKNQSTASP--------LIAEMLNINPSSRADISVICSH 286
DY + PK+ +T P L+++ML ++PS R H
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284
|
Length = 294 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 5/199 (2%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY 102
KLG+G Y V G +K T VA+K I+ + E A IR E+ ++ ++H NI+ ++
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIR-LEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRD 161
++ + + LV EY +L +LD + + Q+ + YCH+ K+ HRD
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129
Query: 162 LKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCW 220
LK +N+L++E G K+ADFGL+ + ++ S + Y P+I+ G + ++D W
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMW 189
Query: 221 SLGVLLYTLVYGAMPFDGS 239
+G + Y + G F GS
Sbjct: 190 GVGCIFYEMSTGRPLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 5/206 (2%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G +G+V K TG+ A K + K +++ ++ E +I+ V P I+++
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF--RQIATAVYYCHKHKICHRD 161
FE++ + LVM GG+L + E R I QI + + H I +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 162 LKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWS 221
+K EN+LLD+ GN +++D GL+ + + ++ G+ Y +PEI+K PY P VD ++
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VDWFA 179
Query: 222 LGVLLYTLVYGAMPFDGSNFKRLVKQ 247
+G +Y +V G PF + K V +
Sbjct: 180 MGCSIYEMVAGRTPF--KDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 71/306 (23%), Positives = 131/306 (42%), Gaps = 45/306 (14%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI-RIRREIQIMS 91
+ R+ + +G G YG V I+ +G++VAIK I L R RE++I+
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILR 59
Query: 92 SVRHPNIIHIYEVFENREK----MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
+H NII I ++ + +VM+ +L+ + + LTEE R Q+
Sbjct: 60 HFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGL-----SNVFTESRFLSTFCGSPLYA 202
+ Y H + HRDLK N+L++E+ +I DFG+ S+ F++ + + Y
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF---------------KRLVKQ 247
+PE++ +P + +D WS+G + ++ F G N+ + ++ +
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 248 ISNG---DYFE--------------PKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290
I + Y + PK A L+++ML +P R + H ++
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298
Query: 291 KDHSVA 296
+ H
Sbjct: 299 QYHDPD 304
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 79/266 (29%), Positives = 121/266 (45%), Gaps = 21/266 (7%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-TEADLIRIRREIQIMSSVRHPNIIHI 101
+LG+GNYG V +++ TG +A+K I+ +E E+ +I E+ I+ P I+
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIR---LELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-----HK 156
Y F + + MEY G L D L V TE + R+I AV K H
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG-----IP 211
I HRD+K N+L++ NG K+ DFG+S S T G Y +PE +K P
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS---NGD--YFEPKNQSTASPLI 266
+ + D WSLG+ + + G P+ + + Q+S +GD A +
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFV 242
Query: 267 AEMLNINPSSRADISVICSHWWIDKD 292
A+ LN P+ R + + H W+ K
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHPWLVKY 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 20/214 (9%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHP 96
F++V +G G YG+V G + +TGQ AIK + E E I++EI ++ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE----EIKQEINMLKKYSHHR 63
Query: 97 NIIHIYEVFENR------EKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATA 148
NI Y F + +++ LVME+ G + D + K L EE I R+I
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF--TESRFLSTFCGSPLYASPEI 206
+ + H+HK+ HRD+K +N+LL EN K+ DFG+S T R +TF G+P + +PE+
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEV 182
Query: 207 V----KGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
+ + + D WSLG+ + GA P
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-25
Identities = 70/237 (29%), Positives = 123/237 (51%), Gaps = 14/237 (5%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGI-NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93
++ +V+KLG G +G+V +G N T +VA+KT+K + +A L E +M ++
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGYYNNST--KVAVKTLKPGTMSVQAFL----EEANLMKTL 58
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYY 151
+H ++ +Y V E + ++ EY A G L DFL D+ + + QIA + Y
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 118
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS-PL-YASPEIVKG 209
+ HRDL+ N+L+ E+ KIADFGL+ V ++ + + P+ + +PE +
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 210 IPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPL 265
+ + D WS G+LLY +V YG +P+ G + ++ + G Y P+ ++ L
Sbjct: 179 GSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDEL 233
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-25
Identities = 75/252 (29%), Positives = 122/252 (48%), Gaps = 18/252 (7%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F R LG+G +G+V + TG+ A K ++K +I+ E QI+ V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF--RQIATAVYYCHKH 155
++ + +E ++ + LV+ GG+L + EE R +F +I + H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY-HG 214
+I +RDLK ENILLD++G+ +I+D GL+ E + + G+ Y +PE+VK Y
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFK-------RLVKQISN--GDYFEPKNQSTASPL 265
P D W+LG LLY ++ G PF K RLVK++ + F P +S L
Sbjct: 182 P--DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239
Query: 266 IAEMLNINPSSR 277
+ + +P R
Sbjct: 240 LCK----DPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 66/217 (30%), Positives = 117/217 (53%), Gaps = 14/217 (6%)
Query: 41 VRKLGQGNYGKVQLGINKETGQ-EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
+++LG G +G V LG K G+ +VAIK I++ + +E D I E ++M + HPN++
Sbjct: 9 LKELGSGQFGVVHLG--KWRGKIDVAIKMIREGAM-SEDDFIE---EAKVMMKLSHPNLV 62
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKIC 158
+Y V + + +V EY A G L ++L ++K L E + + A+ Y +
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 159 HRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS--PL-YASPEIVKGIPYHGP 215
HRDL N L+ E+ K++DFGL+ + ++ S+ G+ P+ +A PE+ +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVKWAPPEVFDYSRF-SS 180
Query: 216 EVDCWSLGVLLYTL-VYGAMPFDGSNFKRLVKQISNG 251
+ D WS GVL++ + G MP++ + +V+ +S G
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 30/231 (12%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ +V+KLG G +G+V +G +VAIK++K+ + EA L E +M ++
Sbjct: 5 RETLKLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSMSPEAFL----AEANLMKQLQ 59
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYC 152
HP ++ +Y V +E + ++ EY G L DFL + LT + + QIA + +
Sbjct: 60 HPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK-GIP 211
+ HRDL+ NIL+ E KIADFGL+ + ++ Y + E K I
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE----------YTAREGAKFPIK 168
Query: 212 YHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ PE D WS G+LL +V YG +P+ G +++ + G
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG 219
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 35/276 (12%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
QR+DI+R +G+G G+V L + + VA+K I++ E R RE +I + + H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLD---QKKVLTEEEAR--------RIFRQ 144
P I+ +Y + + + + M Y G L L QK+ L++E A IF +
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-------------------NV 185
I + Y H + HRDLK +NILL G I D+G +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV 245
++ G+P Y +PE + G+P D ++LGV+LY ++ + P+ +++
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240
Query: 246 --KQISNGDYFEPKNQ--STASPLIAEMLNINPSSR 277
I + P + S + + L ++P+ R
Sbjct: 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
R+ + +G+G YG V +K TG +VAIK I + +T R REI+I+ +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC--QRTLREIKILRRFKH 62
Query: 96 PNIIHIYEV-----FENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
NII I ++ FE+ + +V E +LY + + + L+ + + QI +
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLK 120
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE----SRFLSTFCGSPLYASPEI 206
Y H + HRDLK N+LL+ N + KI DFGL+ + + FL+ + + Y +PEI
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 207 VKGIPYHGPEVDCWSLGVLL 226
+ + +D WS+G +L
Sbjct: 181 MLNSKGYTKAIDIWSVGCIL 200
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 59/239 (24%), Positives = 111/239 (46%), Gaps = 23/239 (9%)
Query: 40 IVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++R+LGQG++G V G+ K E VAIKT+ + + + I E +M
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFN 67
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK----------VLTEEEARRIFRQ 144
+++ + V + ++VME A G+L +L ++ T ++ ++ +
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL---Y 201
IA + Y K HRDL N ++ E+ KI DFG++ E+ + L +
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKN 258
+PE +K + D WS GV+L+ + P+ G + + ++K + +G + + P+N
Sbjct: 188 MAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPEN 245
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 82/294 (27%), Positives = 133/294 (45%), Gaps = 48/294 (16%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI--RIRREIQIMSSVRH-PN 97
+ K+G+G YGKV +K TG+ VA+K K ++E + + I REI ++ +
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 98 IIHIYEVFENREK-----MVLVMEYAAGGELYDFLD-----QKKVLTEEEARRIFRQIAT 147
I+ + +V EK + LV EY +L F+D + L + + Q+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNA-KIADFGLSNVFTESRFLSTFCGSPL-YASPE 205
V +CHKH + HRDLK +N+L+D+ KIAD GL F+ T L Y +PE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVK----------QISNG--- 251
++ G ++ VD WS+G + + F G S ++L+ Q+ G
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241
Query: 252 --DYFE-----PKNQSTASP--------LIAEMLNINPSSRADISVICSHWWID 290
D+ E P++ S A P L+ +ML +P+ R +H + D
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 11/228 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F +R++G G++G V + T + VAIK + ++ I +E++ + ++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHK 156
I + LVMEY G D L+ KK L E E I + Y H H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI---PYH 213
+ HRD+K NILL E G K+ADFG +++ + + ++F G+P + +PE++ + Y
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYD 202
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST 261
G +VD WSLG+ L P N + I+ + P QS
Sbjct: 203 G-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPTLQSN 247
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 69/224 (30%), Positives = 106/224 (47%), Gaps = 11/224 (4%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
+ ++G G++G V N T + VA+K + +T I +E++ + ++HPN I
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
+ LVMEY G D L+ KK L E E I + Y H H + H
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI---PYHGPE 216
RD+K NILL E G K+ADFG ++ + + ++F G+P + +PE++ + Y G +
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPA---NSFVGTPYWMAPEVILAMDEGQYDG-K 200
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS 260
VD WSLG+ L P N + I+ D P QS
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLQS 242
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHP 96
F++V +G G YG+V G + +TGQ AIK + + E E I+ EI ++ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE----EIKLEINMLKKYSHHR 73
Query: 97 NIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATA 148
NI Y F + +++ LVME+ G + D + K L E+ I R+I
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF--TESRFLSTFCGSPLYASPEI 206
+ + H HK+ HRD+K +N+LL EN K+ DFG+S T R +TF G+P + +PE+
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEV 192
Query: 207 VKGIPYHGPEV------DCWSLGVLLYTLVYGAMPF 236
+ P+ D WSLG+ + GA P
Sbjct: 193 IAC--DENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 60/242 (24%), Positives = 110/242 (45%), Gaps = 43/242 (17%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F ++ +G G +G+V L +T A+KT++K + ++ E I++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ +Y F++++ + VM+Y GG++ L + + E+ AR ++ A+ HK
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFT---ESRFLS--------TFCGSPLYASPEI 206
HRD+K +NIL+D +G+ K+ DFGL F +S++ + S ++ +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 207 VK---------------------GIP-YHGPEV----------DCWSLGVLLYTLVYGAM 234
+ G P Y PEV D WS+GV+LY ++ G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 235 PF 236
PF
Sbjct: 243 PF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 76/245 (31%), Positives = 116/245 (47%), Gaps = 22/245 (8%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
I + +G G +G+V G K G++ VAIKT+K ++ + E IM HP
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHP 65
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL---DQKKVLTEEEARRIFRQIATAVYYCH 153
NII + V ++++ EY G L FL D K T + + R IA+ + Y
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLS 123
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCG--SPL-YASPEIVKGI 210
+ HRDL NIL++ N K++DFGLS +S T G P+ + +PE I
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE---AI 180
Query: 211 PYH--GPEVDCWSLGVLLY-TLVYGAMPF-DGSNFKRLVKQISNGDYFEPKNQSTASPLI 266
Y D WS G++++ + YG P+ D SN + ++K + +G Y P S L
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG-YRLPPPMDCPSALY 238
Query: 267 AEMLN 271
ML+
Sbjct: 239 QLMLD 243
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-24
Identities = 59/201 (29%), Positives = 107/201 (53%), Gaps = 5/201 (2%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
+ KLG+G Y V G +K T VA+K I+ + E A IR E+ ++ ++H NI+
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIR-LEHEEGAPCTAIR-EVSLLKDLKHANIVT 68
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICH 159
++++ + + LV EY +L ++D +++ + QI + YCH+ K+ H
Sbjct: 69 LHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPYHGPEVD 218
RDLK +N+L++E G K+ADFGL+ + ++ S + Y P+++ G + ++D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 219 CWSLGVLLYTLVYGAMPFDGS 239
W +G + + + G F GS
Sbjct: 188 MWGVGCIFFEMASGRPLFPGS 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-24
Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 16/219 (7%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQ-EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
+++LG G +G V+ G K GQ +VAIK IK+ + +E + I E ++M + H +
Sbjct: 8 FLKELGTGQFGVVKYG--KWRGQYDVAIKMIKEGSM-SEDEFIE---EAKVMMKLSHEKL 61
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+ +Y V + + +V EY + G L ++L + K + + + + + Y +
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS--PLYASPEIVKGIPYHGP 215
HRDL N L+D+ G K++DFGLS + + S+ GS P+ SP V
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLLYSKFSS 180
Query: 216 EVDCWSLGVLL---YTLVYGAMPFDGSNFKRLVKQISNG 251
+ D W+ GVL+ Y+L G MP++ N V+++S G
Sbjct: 181 KSDVWAFGVLMWEVYSL--GKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-24
Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 18/226 (7%)
Query: 36 QRFDIV--RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93
+R DI KLG G YG+V G+ K+ VA+KT+K+ +E E L +E +M +
Sbjct: 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEI 59
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYY 151
+HPN++ + V ++ E+ G L D+L + ++ + + QI++A+ Y
Sbjct: 60 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS--PL-YASPEIVK 208
K HRDL N L+ EN K+ADFGLS + T + + G+ P+ + +PE
Sbjct: 120 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPE--- 175
Query: 209 GIPYH--GPEVDCWSLGVLLYTL-VYGAMPFDGSNFKRLVKQISNG 251
+ Y+ + D W+ GVLL+ + YG P+ G + ++ + + G
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-24
Identities = 68/253 (26%), Positives = 120/253 (47%), Gaps = 25/253 (9%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKC---KIETEADLIRIRREIQIMSSVRHPNIIH 100
LG G + + +TG +A+K + E E + +R+EI++M+ + HP+II
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
+ L +E+ AGG + L + E Q+ + Y H+++I HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 161 DLKLENILLDENGN-AKIADFG----LSNVFTES-RFLSTFCGSPLYASPEIVKGIPYHG 214
D+K N+L+D G +IADFG L+ T + F G+ + +PE+++G Y G
Sbjct: 128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-G 186
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDG---SNFKRLVKQISNGDYFEPKNQSTASPLIAEMLN 271
D WS+G ++ + P++ SN L+ +I++ +T +P I E L
Sbjct: 187 RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS---------ATTAPSIPEHL- 236
Query: 272 INPSSRADISVIC 284
+P R D+++ C
Sbjct: 237 -SPGLR-DVTLRC 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 5e-24
Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 15/229 (6%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
V+++G G +G V LG E ++VAIKTI++ + +E D I E Q+M + HP ++
Sbjct: 9 VQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAM-SEEDFIE---EAQVMMKLSHPKLVQ 63
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
+Y V R + LV E+ G L D+L Q+ ++E + + + Y + H
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL---YASPEIVKGIPYHGPE 216
RDL N L+ EN K++DFG++ + ++ S+ G+ ++SPE+ Y +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKY-SSK 181
Query: 217 VDCWSLGVLLYTLVY--GAMPFDGSNFKRLVKQISNG-DYFEPKNQSTA 262
D WS GVL++ V+ G P++ + +V+ I+ G ++P+ S +
Sbjct: 182 SDVWSFGVLMWE-VFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 60/249 (24%), Positives = 116/249 (46%), Gaps = 37/249 (14%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+ ++ +G+G +G+V+L K+TG A+K ++K + + + IR E I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ ++ F+++ + L+ME+ GG++ L +K L+EE + + A+ H+
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTES---------------------------- 189
HRD+K +N+LLD G+ K++DFGL ++
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 190 --------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF 241
+ + G+P Y +PE+ Y+ D WSLGV++Y ++ G PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 242 KRLVKQISN 250
+ +++ N
Sbjct: 242 QETYRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 6e-24
Identities = 65/251 (25%), Positives = 119/251 (47%), Gaps = 37/251 (14%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ F+ ++ +G+G +G+V+L K+TG A+K ++K + + + IR E I+
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
++ ++ F+++ + L+ME+ GG++ L +K LTEEE + + A+ H+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 156 KICHRDLKLENILLDENGNAKIADFGL--------------------------------- 182
HRD+K +N+LLD G+ K++DFGL
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 183 -SNVFTESRFLSTF--CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS 239
+ + +R F G+P Y +PE+ Y+ D WSLGV++Y ++ G PF
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 240 NFKRLVKQISN 250
+ K++ N
Sbjct: 240 TPQETYKKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-24
Identities = 71/262 (27%), Positives = 112/262 (42%), Gaps = 33/262 (12%)
Query: 36 QRFDIV--RKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLI-RIRREIQI 89
QR DI R +G+G +G V G+ E VA+KT CK T + + +E I
Sbjct: 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT---CKNCTSPSVREKFLQEAYI 60
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF-RQIATA 148
M HP+I+ + V + +VME A GEL +L K + + ++ Q++TA
Sbjct: 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK 208
+ Y + HRD+ N+L+ K+ DFGLS + + Y + +
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY---------YKASKGKL 170
Query: 209 GIPYHGPE----------VDCWSLGVLLY-TLVYGAMPFDGSNFKRLVKQISNGDYFE-- 255
I + PE D W GV ++ L+ G PF G ++ +I NG+
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP 230
Query: 256 PKNQSTASPLIAEMLNINPSSR 277
P T L+ + +PS R
Sbjct: 231 PNCPPTLYSLMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 9e-24
Identities = 60/191 (31%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F +R++G G++G V + + VAIK + ++ I +E++ + +RHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHK 156
I + LVMEY G D L+ KK L E E + + Y H H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI---PYH 213
+ HRD+K NILL E G K+ DFG +++ + + F G+P + +PE++ + Y
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYD 192
Query: 214 GPEVDCWSLGV 224
G +VD WSLG+
Sbjct: 193 G-KVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKE--TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+++I +G+G YG+V K G+E AIK K K + REI ++ ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 95 HPNIIHIYEVF-ENREKMV-LVMEYAAGGELYDFLDQKKVLTEEEARRIFR--------Q 144
H N++ + EVF E+ +K V L+ +YA +D K + + I Q
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 145 IATAVYYCHKHKICHRDLKLENILL----DENGNAKIADFGLSNVF--------TESRFL 192
I V+Y H + + HRDLK NIL+ E G KI D GL+ +F +
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLG 223
T Y +PE++ G ++ +D W++G
Sbjct: 177 VTI----WYRAPELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-23
Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 32/232 (13%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGI-NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93
++ +++KLG G +G+V +G N T +VA+KT+K + E+ L E QIM +
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGTWNGNT--KVAVKTLKPGTMSPESFL----EEAQIMKKL 58
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLD--QKKVLTEEEARRIFRQIATAVYY 151
RH ++ +Y V + E + +V EY + G L DFL + + L + Q+A + Y
Sbjct: 59 RHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK-GI 210
+ HRDL+ NIL+ + KIADFGL+ + ++ Y + + K I
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE----------YTARQGAKFPI 167
Query: 211 PYHGPEV----------DCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNG 251
+ PE D WS G+LL LV G +P+ G N + +++Q+ G
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-23
Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 49/261 (18%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F V+ +G+G +G+V+L K+TG+ A+KT+ K ++ + L ++ E +++ P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ +Y F++ + + L+ME+ GG+L L + +E+ R + A+ HK
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF 122
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVF------------------------------- 186
HRD+K +NIL+D G+ K++DFGLS F
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 187 ---------------TESRFLSTF--CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTL 229
++R L + G+P Y +PEI Y G E D WSLG +++
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFEC 241
Query: 230 VYGAMPFDGSNFKRLVKQISN 250
+ G PF N ++I N
Sbjct: 242 LIGWPPFCSENSHETYRKIIN 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R+ I +G+G+YG V I+ TG++VAIK I E +D RI REI+++ +RHP
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHP 59
Query: 97 NIIHIYEVF---ENRE-KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
+I+ I + RE K + V+ +L+ + LT E + Q+ A+ Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE----SRFLSTFCGSPLYASPEIVK 208
H + HRDLK +NIL + + KI DFGL+ V + F + + + Y +PE+
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 209 GI-PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
+ P +D WS+G + ++ G F G N +V Q+
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---VVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 70/249 (28%), Positives = 116/249 (46%), Gaps = 12/249 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F R LG+G +G+V + TG+ A K ++K +I+ E QI+ V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF--RQIATAVYYCHKH 155
++ + +E ++ + LV+ GG+L + +E R +F +I + H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
+I +RDLK ENILLD+ G+ +I+D GL+ E + G+ Y +PE+VK Y
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TF 180
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFK-------RLVKQISNGDYFEPKNQSTASPLIAE 268
D W LG L+Y ++ G PF K R VK+ + + K A + +
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--EEYSEKFSEAARSICRQ 238
Query: 269 MLNINPSSR 277
+L +P R
Sbjct: 239 LLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 63/245 (25%), Positives = 117/245 (47%), Gaps = 26/245 (10%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
+G+G +G V LG + GQ+VA+K +K +A L E +M+++RHPN++ +
Sbjct: 14 IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLA----EASVMTTLRHPNLVQLLG 67
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRD 161
V + +V EY A G L D+L + V+T + + + Y + HRD
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRD 127
Query: 162 LKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-YASPEIVKGIPYHG---PEV 217
L N+L+ E+ AK++DFGL+ ++ + P+ + +PE ++ +
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL---PVKWTAPEALR----EKKFSTKS 180
Query: 218 DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLN----I 272
D WS G+LL+ + +G +P+ K +V + G E P + +++ +
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPE--GCPPEVYKVMKDCWEL 238
Query: 273 NPSSR 277
+P+ R
Sbjct: 239 DPAKR 243
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 4e-23
Identities = 54/154 (35%), Positives = 85/154 (55%), Gaps = 12/154 (7%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI------RIRREIQIMS 91
F IV+ + +G +GKV LG K + A+K +KK AD+I +++ E ++
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDALA 59
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYY 151
+ P I+H+Y ++ + LVMEY GG++ L EE A + ++A A+ Y
Sbjct: 60 LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDY 119
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185
H+H I HRDLK +N+L+ G+ K+ DFGLS V
Sbjct: 120 LHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-23
Identities = 74/250 (29%), Positives = 119/250 (47%), Gaps = 26/250 (10%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R+ ++ +G G +G V ++ TGQ VAIK I K T R RE++++ +RH
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYRELKLLKHLRHE 69
Query: 97 NIIHIYEVF-ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
NII + ++F E + V E G +L+ L + L ++ + QI + Y H
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
+ HRDLK NIL++EN + KI DFGL+ + + ++ + + Y +PEI+ +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPS 275
EVD WS G + ++ G F G + V Q S +I ++L P
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDH---VNQFS---------------IITDLLG-TPP 226
Query: 276 SRADISVICS 285
I+ ICS
Sbjct: 227 DDV-INTICS 235
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-23
Identities = 66/204 (32%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G YG V + T +AIK I + + EI + S ++H NI+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP---ERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIF--RQIATAVYYCHKHKICHR 160
+ ME GG L L K L + E IF +QI + Y H ++I HR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 161 DLKLENILLDE-NGNAKIADFGLS------NVFTESRFLSTFCGSPLYASPEIV-KGIPY 212
D+K +N+L++ +G KI+DFG S N TE TF G+ Y +PE++ KG
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE-----TFTGTLQYMAPEVIDKGPRG 187
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPF 236
+G D WSLG + + G PF
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 7e-23
Identities = 83/261 (31%), Positives = 130/261 (49%), Gaps = 26/261 (9%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R D+ KLGQG +G+V +G T +VAIKT+K + EA L +E QIM +RH
Sbjct: 9 RLDV--KLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFL----QEAQIMKKLRHD 61
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHK 154
++ +Y V + E + +V E+ G L DFL + K L + + QIA + Y +
Sbjct: 62 KLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS-PL-YASPEIVKGIPY 212
HRDL+ NIL+ +N KIADFGL+ + ++ + + P+ + +PE
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----L 176
Query: 213 HGP---EVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAE 268
+G + D WS G+LL LV G +P+ G + +++Q+ G Y P Q L E
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESL-HE 234
Query: 269 MLNI----NPSSRADISVICS 285
++ + +P R I S
Sbjct: 235 LMKLCWKKDPDERPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-23
Identities = 66/224 (29%), Positives = 114/224 (50%), Gaps = 14/224 (6%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
Q+ + +G+G +G V G + TGQ+VA+K IK C + +A L E +M+ + H
Sbjct: 6 QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIK-CDVTAQAFL----EETAVMTKLHH 58
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCH 153
N++ + V + + +VME + G L +FL + +++ + + +A + Y
Sbjct: 59 KNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
K+ HRDL NIL+ E+G AK++DFGL+ V S + + +PE +K +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKWTAPEALKHKKF- 174
Query: 214 GPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEP 256
+ D WS GVLL+ + YG P+ + K + + + G EP
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP 218
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-23
Identities = 71/217 (32%), Positives = 114/217 (52%), Gaps = 18/217 (8%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY 102
KLGQG +G+V +G T + VAIKT+K + EA L +E Q+M +RH ++ +Y
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLY 67
Query: 103 EVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
V + E + +V EY + G L DFL + K L + + QIA+ + Y + HR
Sbjct: 68 AVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 161 DLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS-PL-YASPEIVKGIPYHGP--- 215
DL+ NIL+ EN K+ADFGL+ + ++ + + P+ + +PE +G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFTI 182
Query: 216 EVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNG 251
+ D WS G+LL L G +P+ G + ++ Q+ G
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 20/237 (8%)
Query: 59 ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL-VMEY 117
TG EVAIK ++ E E R RRE + + + HPNI+ + + E ++ V EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 118 AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG---N 174
G L + L L E R+ Q+ A+ H I HRDLK +NI++ + G +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 175 AKIADFGLSNVFT------ESRFLST--FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLL 226
AK+ DFG+ + + T G+P Y +PE ++G P P D ++ G++
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSDLYAWGLIF 179
Query: 227 YTLVYGAMPFDGSNFKR-LVKQISNGDYFEPKNQSTASPLIAEML----NINPSSRA 278
+ G G++ L +Q+S D P A + ++L N +P RA
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLP--PWIAGHPLGQVLRKALNKDPRQRA 234
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-22
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIK---KCKIETEADLIRIRREIQIMSSVRHPNIIH 100
LG+G YG V G+ GQ +A+K ++ + E + +++ E+ ++ S++H NI+
Sbjct: 8 LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
+ + + ME+ GG + L++ L E + +QI V Y H + + HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 161 DLKLENILLDENGNAKIADFGLSNVF-------TESRFLSTFCGSPLYASPEIVKGIPYH 213
D+K N++L NG K+ DFG + T S L + G+P + +PE++ Y
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY- 185
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
G + D WS+G ++ + G P ++ RL
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPPL--ASMDRL 214
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-22
Identities = 62/222 (27%), Positives = 114/222 (51%), Gaps = 11/222 (4%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
+++LG G +G V LG + + VAIK I + + +E D I E ++M + HP ++
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAM-SEEDFIE---EAKVMMKLSHPKLVQ 63
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICH 159
+Y V ++ + +V E+ G L ++L Q++ L+++ + + + + Y ++ H
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS--PLYASPEIVKGIPYHGPEV 217
RDL N L+ G K++DFG++ + + S+ G+ P+ SP V + +
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 218 DCWSLGVLLY-TLVYGAMPFDGSNFKRLVKQISNGD-YFEPK 257
D WS GVL++ G MPF+ + +V+ IS G + PK
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 61/203 (30%), Positives = 110/203 (54%), Gaps = 6/203 (2%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIET---EADLIRIRREIQIMSSVRHPNIIH 100
+G+G +G+V +TG+ A+K + K +I+ E + R + ++S+ P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
+ F +K+ +++ GG+L+ L Q V +E E R +I + + H + +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 161 DLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV-KGIPYHGPEVDC 219
DLK NILLDE+G+ +I+D GL+ F++ + ++ G+ Y +PE++ KG+ Y D
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDS-SADW 179
Query: 220 WSLGVLLYTLVYGAMPFDGSNFK 242
+SLG +L+ L+ G PF K
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 76/320 (23%), Positives = 136/320 (42%), Gaps = 51/320 (15%)
Query: 38 FDIVRK------LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
F++ K +G+G YG V N ET ++VAIK I + D R REI+++
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTLREIKLLR 59
Query: 92 SVRHPNIIHIYEVFE--NRE--KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
+ H N+I I ++ +RE V ++ +L+ + + L+++ + Q+
Sbjct: 60 HLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTFCGSPLYASPEI 206
+ Y H + HRDLK N+LL+ N + KI DFGL+ +E F++ + + Y +PE+
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179
Query: 207 VKGIPYHGPEVDCWSLGVL---------------------LYTLVYGAMP------FDGS 239
+ + +D WS+G + L T + G+
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239
Query: 240 NFKRLVKQISN------GDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293
+R ++ + F P A L+ +ML +PS R + +H ++ H
Sbjct: 240 KARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298
Query: 294 SVACLEEAEELANQTPVRLD 313
+ ++E QTP D
Sbjct: 299 -----DPSDEPVCQTPFSFD 313
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 4/196 (2%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQIMSSVRHPNIIH 100
+G+G +G+V +TG+ A+K + K +I + E + R + ++S+ P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
+ F +K+ +++ GG+L+ L Q V +E+E R +I + + H + +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 161 DLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCW 220
DLK NILLDE+G+ +I+D GL+ F++ + ++ G+ Y +PE+++ + D +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWF 180
Query: 221 SLGVLLYTLVYGAMPF 236
SLG +L+ L+ G PF
Sbjct: 181 SLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE--ADLIRIRREIQIMSSVRHPNIIH 100
KLG+G+Y V G +K TGQ VA+K I+ +E E A IR E ++ ++H NI+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIR-EASLLKDLKHANIVT 67
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR-QIATAVYYCHKHKICH 159
++++ ++ + LV EY +L ++D R+F Q+ + YCH+ ++ H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPYHGPEVD 218
RDLK +N+L+ E G K+ADFGL+ + S+ S + Y P+++ G + +D
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLD 186
Query: 219 CWSLGVLLYTLVYGAMPFDGS 239
W +G + Y + G F GS
Sbjct: 187 MWGVGCIFYEMATGRPLFPGS 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-22
Identities = 70/244 (28%), Positives = 121/244 (49%), Gaps = 11/244 (4%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G +G+V + TG+ A K + K +++ E +I++ V I+ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 104 VFENREKMVLVMEYAAGGEL----YDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
F+ + + LVM GG+L Y+ ++ E A QI + + + H+ +I +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFLST-FCGSPLYASPEIVKGIPYHGPEVD 218
RDLK EN+LLD +GN +I+D GL+ + + + + G+P + +PE+++G Y VD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF-SVD 179
Query: 219 CWSLGVLLYTLVYGAMPF----DGSNFKRLVKQISNGDYFEPKNQSTASPLIAE-MLNIN 273
++LGV LY ++ PF + K L ++I N P S AS E +L +
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239
Query: 274 PSSR 277
P R
Sbjct: 240 PEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-22
Identities = 72/238 (30%), Positives = 121/238 (50%), Gaps = 28/238 (11%)
Query: 44 LGQGNYGKVQLGINKETGQEV--AIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIH 100
+G+GN+G+V + K+ G ++ AIK +K+ +E D E++++ + HPNII+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEA-------------RRIFR---Q 144
+ ENR + + +EYA G L DFL + +VL + A +++ +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
+AT + Y + + HRDL N+L+ EN +KIADFGLS E ++ G L
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGR-LPVRW 184
Query: 205 EIVKGIPY--HGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKN 258
++ + Y + + D WS GVLL+ +V G P+ G L +++ G E P+N
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRN 242
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-22
Identities = 61/247 (24%), Positives = 110/247 (44%), Gaps = 49/247 (19%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F ++ LG G +G+V L +T A+KT++K + + ++ E I++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ +Y F++++ + VM+Y GG++ L + + E+ AR ++ AV HK
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFT---ESRFLS--------------------- 193
HRD+K +NIL+D +G+ K+ DFGL F +S++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 194 ------------------------TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTL 229
+ G+P Y +PE++ Y D WS+GV+LY +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEM 241
Query: 230 VYGAMPF 236
+ G PF
Sbjct: 242 LVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-22
Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 14/222 (6%)
Query: 43 KLGQGNYGKVQLGI--NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
+LG GN+G V+ G+ K++ + VA+K +K A + RE +M + +P I+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKN-DNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
+ + E E +LVME A G L FL + K +TE+ + Q++ + Y + HR
Sbjct: 61 MIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 161 DLKLENILLDENGNAKIADFGLSNVFT--ESRFLSTFCGS-PL-YASPEIVKGIPYH--G 214
DL N+LL AKI+DFGLS E+ + + G P+ + +PE + Y+
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN---YYKFS 176
Query: 215 PEVDCWSLGVLLY-TLVYGAMPFDGSNFKRLVKQISNGDYFE 255
+ D WS GVL++ YG P+ G + + I +G+ E
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME 218
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 7e-22
Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 5/203 (2%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++ + KLG+G+Y V G +K G+ VA+K I+ E E RE ++ ++H N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL--QEEEGTPFTAIREASLLKGLKHAN 64
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCHKHK 156
I+ ++++ +E + LV EY +L ++D+ L E + Q+ + Y H+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPYHGP 215
I HRDLK +N+L+ + G K+ADFGL+ + S S + Y P+++ G +
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 216 EVDCWSLGVLLYTLVYGAMPFDG 238
+D W +G + ++ G F G
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 7e-22
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 3/203 (1%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F R LG+G +G+V + TG+ A K ++K +I+ E QI+ V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF--RQIATAVYYCHKH 155
++++ +E ++ + LV+ GG+L + EE R +F +I + H+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
+RDLK ENILLD+ G+ +I+D GL+ E + G+ Y +PE++ Y
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 216 EVDCWSLGVLLYTLVYGAMPFDG 238
D W LG L+Y ++ G PF G
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKC-KIETEADLIRIRREIQIMSSVR-H 95
++I+ +G+G YGKV +NK+ G + A+K + I+ E I E I+ ++ H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE-----IEAEYNILKALSDH 74
Query: 96 PNIIHIYEVF-----ENREKMVLVMEYAAGGELYD----FLDQKKVLTEEEARRIFRQIA 146
PN++ Y ++ +N +++ LV+E GG + D FL + + + E I +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSPLYASPE 205
+ + H +K HRD+K NILL G K+ DFG+S T +R +T G+P + +PE
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 206 IV----KGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
++ + + D WSLG+ L G P
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-21
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 10/213 (4%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL-IRIRREIQIMSSVRHPNIIHIY 102
LG+GN+G+V G K+ VA+KT CK + +L I+ E +I+ HPNI+ +
Sbjct: 3 LGKGNFGEVFKGTLKDK-TPVAVKT---CKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRD 161
V R+ + +VME GG+ FL +KK L ++ + A + Y HRD
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 162 LKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS-PL-YASPEIVKGIPYHGPEVDC 219
L N L+ EN KI+DFG+S + + S+ P+ + +PE + Y E D
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY-SSESDV 177
Query: 220 WSLGVLLY-TLVYGAMPFDGSNFKRLVKQISNG 251
WS G+LL+ T G P+ G ++ +Q+ G
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 59/202 (29%), Positives = 112/202 (55%), Gaps = 14/202 (6%)
Query: 36 QRFDIVRKLGQGNYGKVQLGIN-KETGQEVAIKTIKKCKIETEADLIRIRREIQIM---S 91
Q+++ V ++G+G YGKV + K G+ VA+K ++ + E + RE+ ++
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLE 59
Query: 92 SVRHPNIIHIYEVFE----NRE-KMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQ 144
+ HPN++ +++V +RE K+ LV E+ +L +LD+ + + E + + Q
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
+ + + H H++ HRDLK +NIL+ +G K+ADFGL+ +++ L++ + Y +P
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 205 EIVKGIPYHGPEVDCWSLGVLL 226
E++ Y P VD WS+G +
Sbjct: 179 EVLLQSSYATP-VDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 30/224 (13%)
Query: 43 KLGQGNYGKVQLGINKETGQE---VAIKTIKKCKI-ETEADLIRIRREIQIMSSVRHPNI 98
KLG G++G V+ G +G + VA+K +K K+ + D ++ E IM S+ H N+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK---EAAIMHSLDHENL 58
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYCHKHK 156
I +Y V +++V E A G L D L D QIA + Y +
Sbjct: 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK-GIPYHGP 215
HRDL NILL + KI DFGL + Y E +K + P
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQ--------NEDHYVMEEHLKVPFAWCAP 169
Query: 216 EV----------DCWSLGVLLYTL-VYGAMPFDGSNFKRLVKQI 248
E D W GV L+ + YG P+ G + +++K+I
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 2e-21
Identities = 82/274 (29%), Positives = 136/274 (49%), Gaps = 36/274 (13%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
+++++K+G G +G+V L +K T + K I ++ E + ++ E+ +M ++H N
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKN 73
Query: 98 IIHIYEVFENR--EKMVLVMEYAAGGELYDFLDQKKVL---TEEEA-RRIFRQIATAVYY 151
I+ + F N+ +K+ ++ME+ G+L + + + EE A I RQ+ A+ Y
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133
Query: 152 CHKHK-------ICHRDLKLENILLDE---------------NGN--AKIADFGLS-NVF 186
CH K + HRDLK +NI L NG AKI DFGLS N+
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193
Query: 187 TESRFLSTFCGSPLYASPE-IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF-DGSNFKRL 244
ES S G+P Y SPE ++ + + D W+LG ++Y L G PF +NF +L
Sbjct: 194 IESMAHSC-VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252
Query: 245 VKQISNGDYFEPKNQSTA-SPLIAEMLNINPSSR 277
+ ++ G K +S + LI +LN++ R
Sbjct: 253 ISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286
|
Length = 1021 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 72/255 (28%), Positives = 115/255 (45%), Gaps = 46/255 (18%)
Query: 36 QRFDIV--RKLGQGNYGKVQLG-----INKETGQEVAIKTIKK-CKIETEADLIRIRREI 87
QR IV R+LG+G +GKV LG + + VA+KT+K+ + D RE
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDF---EREA 59
Query: 88 QIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--------------DQKKVL 133
+++++ +H NI+ Y V + ++V EY G+L FL L
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 134 TEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTE---- 188
T + +I QIA+ + Y HRDL N L+ + KI DFG+S +V+T
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 189 ---SRFLSTFCGSPL-YASPEIVKGIPYH--GPEVDCWSLGVLLYTL-VYGAMPFDGSNF 241
L P+ + PE + Y E D WS GV+L+ + YG P+ G +
Sbjct: 180 VGGHTML------PIRWMPPESIM---YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230
Query: 242 KRLVKQISNGDYFEP 256
+ +++ I+ G +
Sbjct: 231 EEVIECITQGRLLQR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-21
Identities = 70/225 (31%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHP 96
++I+ +G+G YGKV NK+ G A+K + E I E I+ S+ HP
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE----EIEAEYNILQSLPNHP 79
Query: 97 NIIHIYEVFENREKMV-----LVMEYAAGGELYDF----LDQKKVLTEEEARRIFRQIAT 147
N++ Y +F +K+V LV+E GG + + L + L E I
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSPLYASPEI 206
+ + H ++I HRD+K NILL G K+ DFG+S T +R +T G+P + +PE+
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
Query: 207 V---KGIPY-HGPEVDCWSLGVLLYTLVYGAMP-FDGSNFKRLVK 246
+ + Y + D WSLG+ L G P FD K L K
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 62/249 (24%), Positives = 111/249 (44%), Gaps = 53/249 (21%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F ++ LG G +G+V L +T A+KT++K + + ++ E I++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ +Y F++++ + VM+Y GG++ L + +V E AR ++ A+ HK
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 158 CHRDLKLENILLDENGNAKIADFGL---------------------------------SN 184
HRD+K +NIL+D +G+ K+ DFGL SN
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 185 VFTESRFLS---------------TFCGSPLYASPEIV--KGIPYHGPEVDCWSLGVLLY 227
R + + G+P Y +PE++ KG + D WS+GV+L+
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG---YTQLCDWWSVGVILF 239
Query: 228 TLVYGAMPF 236
++ G PF
Sbjct: 240 EMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-21
Identities = 69/213 (32%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI-RIRREIQIMSSVRHP 96
F+ + +LG GN G V +K +G +A K I +E + + +I RE+Q++ P
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSP 63
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV-----YY 151
I+ Y F + ++ + ME+ GG L L + K + EE I +++ AV Y
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE----ILGKVSIAVLRGLAYL 119
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIP 211
KH+I HRD+K NIL++ G K+ DFG+S +S ++F G+ Y SPE ++G
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH 178
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
Y + D WS+G+ L L G P + K L
Sbjct: 179 Y-SVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 4e-21
Identities = 62/226 (27%), Positives = 117/226 (51%), Gaps = 20/226 (8%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
+L +R+ ++++G G YG V I+K TG++VAIK + + ++E R RE+ ++
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKH 70
Query: 93 VRHPNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKV----LTEEEARRIF 142
++H N+I + +VF + + LVM Y D +K+ L+E++ + +
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-------QTDLQKIMGHPLSEDKVQYLV 123
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYA 202
Q+ + Y H I HRDLK N+ ++E+ KI DFGL+ ++ + + Y
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYR 181
Query: 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
+PE++ ++ VD WS+G ++ ++ G F G ++ + QI
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-21
Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 66/305 (21%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIK---KCKIETEADLIRIRREIQIMSSVR 94
F+ + +LG GN G V +++ +G +A K I K I + I RE++++
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQ-----IIRELKVLHECN 57
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC-- 152
P I+ Y F + ++ + ME+ GG L DQ VL ++A RI I +
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSL----DQ--VL--KKAGRIPENILGKISIAVL 109
Query: 153 -------HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
KHKI HRD+K NIL++ G K+ DFG+S +S ++F G+ Y SPE
Sbjct: 110 RGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE 168
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-------FKRLVKQISNGDYFEPKN 258
++G Y + D WSLG+ L + G P + F R V + + P +
Sbjct: 169 RLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227
Query: 259 ----QSTASPLIAEMLNI----------------------------NPSSRADISVICSH 286
S I E+L+ NP RAD+ + H
Sbjct: 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287
Query: 287 WWIDK 291
+I +
Sbjct: 288 PFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-21
Identities = 71/238 (29%), Positives = 115/238 (48%), Gaps = 28/238 (11%)
Query: 44 LGQGNYGKVQLGINKETGQEV--AIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIH 100
+G+GN+G+V K+ G + AIK +K+ ++ D E++++ + HPNII+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEA-------------RRIFR---Q 144
+ E+R + L +EYA G L DFL + +VL + A +++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
+A + Y + + HRDL NIL+ EN AKIADFGLS + ++ G L
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR-LPVRW 177
Query: 205 EIVKGIPY--HGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKN 258
++ + Y + D WS GVLL+ +V G P+ G L +++ G E P N
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-21
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 9/211 (4%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL-IRIRREIQIMSSVRHPNII 99
+ KLG+G+Y V GI++ GQ VA+K I ++TE + RE ++ ++H NI+
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR-QIATAVYYCHKHKIC 158
++++ +E + V EY +L ++ Q R+F Q+ + Y H I
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 159 HRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPYHGPEV 217
HRDLK +N+L+ G K+ADFGL+ + S+ S+ + Y P+++ G + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185
Query: 218 DCWSLGVLLYTLVYGAMPFDG--SNFKRLVK 246
D W G + ++ G F G F++L K
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-21
Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 43 KLGQGNYGKVQLGINKETGQE--VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
+LG GN+G V+ G+ K ++ VAIK +K ++ D + RE +IM + +P I+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD--EMMREAEIMHQLDNPYIVR 59
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICH 159
+ V E E ++LVME A+GG L FL KK +T + Q++ + Y H
Sbjct: 60 MIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 160 RDLKLENILLDENGNAKIADFGLSNVF--TESRFLSTFCGS-PL-YASPEIVKGIPYH-- 213
RDL N+LL AKI+DFGLS +S + + G PL + +PE I +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC---INFRKF 175
Query: 214 GPEVDCWSLGVLLY-TLVYGAMPF 236
D WS G+ ++ YG P+
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQL----GINKETGQEVAIKTIKK-CKIETEADLIRIR 84
H+R LK+ +R LG+G++GKV L N TG+ VA+KT+K+ C + + +
Sbjct: 2 HKRYLKK----IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK-- 55
Query: 85 REIQIMSSVRHPNIIHIYEVFENR--EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF 142
EI I+ ++ H NI+ + + + L+MEY G L D+L + K+ + +F
Sbjct: 56 -EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL--LF 112
Query: 143 -RQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF---LSTFCGS 198
+QI + Y H HRDL N+LLD + KI DFGL+ E + S
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 199 PLY-ASPEIVKGIPYHGPEVDCWSLGVLLYTLV 230
P++ + E +K + D WS GV LY L+
Sbjct: 173 PVFWYAVECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 74/256 (28%), Positives = 119/256 (46%), Gaps = 22/256 (8%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIK---KCKIETEADLIRIRREIQIMSSVR 94
F+ + +LG GN G V +K +G +A K I K I + I RE+Q++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ-----IIRELQVLHECN 61
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV----- 149
P I+ Y F + ++ + ME+ GG L L + + E+ I +++ AV
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----ILGKVSIAVIKGLT 117
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
Y KHKI HRD+K NIL++ G K+ DFG+S +S ++F G+ Y SPE ++G
Sbjct: 118 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG 176
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPF---DGSNFKRLVKQISNGDYFEPKNQSTASPLI 266
Y + D WS+G+ L + G P D + + GD E + P
Sbjct: 177 THY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235
Query: 267 AEMLNINPSSRADISV 282
+ + P SR +++
Sbjct: 236 RPLSSYGPDSRPPMAI 251
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 58/221 (26%), Positives = 114/221 (51%), Gaps = 9/221 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
++ +R+ + +G G YG V + +TG VA+K + + ++ R RE++++
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKH 72
Query: 93 VRHPNIIHIYEVFENREKM-----VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
++H N+I + +VF + V ++ + G +L + + +K LT++ + + QI
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILR 131
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV 207
+ Y H I HRDLK N+ ++E+ KI DFGL+ + ++ + + Y +PEI+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIM 189
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
++ VD WS+G ++ L+ G F G++ +K I
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 68/244 (27%), Positives = 124/244 (50%), Gaps = 19/244 (7%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGI-NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93
++ + +KLG G +G+V + NK T +VA+KT+K + EA L E +M ++
Sbjct: 5 RESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFL----AEANVMKTL 58
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRI--FRQIATAVYY 151
+H ++ ++ V +E + ++ E+ A G L DFL + + + I QIA + +
Sbjct: 59 QHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS-PL-YASPEIVKG 209
+ HRDL+ NIL+ + KIADFGL+ V ++ + + P+ + +PE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE---A 174
Query: 210 IPYHGPEV--DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLI 266
I + + D WS G+LL +V YG +P+ G + +++ + G Y P+ ++ L
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELY 233
Query: 267 AEML 270
M+
Sbjct: 234 NIMM 237
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 70/228 (30%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ-IMSSVRHPNIIHIY 102
+G+G +G V ++K +G +A+K I+ E E R+ ++ +M S P I+ Y
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 103 EVFENR-------EKMVLVMEYAAGGELYDF--LDQKKVLTEEEARRIFRQIATAV---- 149
E M + ++ + Y + K V+ EE I +IA A
Sbjct: 70 GALFREGDCWICMELMDISLD-----KFYKYVYEVLKSVIPEE----ILGKIAVATVKAL 120
Query: 150 -YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK 208
Y + KI HRD+K NILLD NGN K+ DFG+S +S + G Y +PE +
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 180
Query: 209 GIPYHGPEV--DCWSLGVLLYTLVYGAMPFDGSN--FKRLVKQISNGD 252
G +V D WSLG+ LY + G P+ N F +L Q+ GD
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL-TQVVKGD 227
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 60/222 (27%), Positives = 118/222 (53%), Gaps = 11/222 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
++ R+ ++++G G YG V +++ TG +VAIK + + ++E R RE++++
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKH 70
Query: 93 VRHPNIIHIYEVFENREKM------VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
++H N+I + +VF + LVM + G +L + +K L+E+ + + Q+
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQFLVYQML 128
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206
+ Y H I HRDLK N+ ++E+ KI DFGL+ T+S ++ + + Y +PE+
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE-MTGYVVTRWYRAPEV 186
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
+ ++ VD WS+G ++ ++ G F G + + +I
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 40 IVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKK-CKIETEADLIRIRREIQIMSSV 93
++R LG G +G+V G+ +VA+KT+ + C + E+D + E IMS
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM---EALIMSKF 66
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-------DQKKVLTEEEARRIFRQIA 146
H NI+ + V R +++E AGG+L FL ++ LT ++ R +A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGN---AKIADFGLS-NVFTESRFLSTFCGS-PL- 200
Y ++ HRD+ N LL G AKIADFG++ +++ S + P+
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 201 YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEP 256
+ PE + GI + D WS GVLL+ + G MP+ G + +++ ++ G +P
Sbjct: 187 WMPPEAFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP 242
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 58/222 (26%), Positives = 116/222 (52%), Gaps = 11/222 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
++ +R+ + +G G YG V + Q+VA+K + + ++ R RE++++
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKH 70
Query: 93 VRHPNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
++H N+I + +VF EN ++ LV G +L + + +K L++E + + Q+
Sbjct: 71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQK-LSDEHVQFLIYQLL 128
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206
+ Y H I HRDLK N+ ++E+ +I DFGL+ + ++ + + Y +PEI
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEI 186
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
+ ++ VD WS+G ++ L+ G F G+++ +K+I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-20
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSVR 94
+++ V ++G G YG V + +G VA+K+++ ++T D + + RE+ ++ +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLE 57
Query: 95 ---HPNIIHIYEVFE----NRE-KMVLVMEYAAGGELYDFLDQKKV--LTEEEARRIFRQ 144
HPNI+ + +V +RE K+ LV E+ +L +LD+ L E + + RQ
Sbjct: 58 AFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
+ + H + I HRDLK ENIL+ G K+ADFGL+ +++ L+ + Y +P
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAP 176
Query: 205 EIVKGIPYHGPEVDCWSLGVLL 226
E++ Y P VD WS+G +
Sbjct: 177 EVLLQSTYATP-VDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-20
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 41 VRKLGQGNYGKVQL----GINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+++LG+GN+G V+L + TG+ VA+K ++ E D REI+I+ S++H
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDF---EREIEILKSLQHD 65
Query: 97 NIIHIYEVF--ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR---QIATAVYY 151
NI+ V R + LVMEY G L D+L + + + R++ QI + Y
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEY 123
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR--FLSTFCG-SPL--YASPEI 206
+ HRDL NIL++ KI DFGL+ V + + + G SP+ YA +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 207 VKGIPYHGPEVDCWSLGVLLYTL 229
+ D WS GV+LY L
Sbjct: 184 TESKFSV--ASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 14/246 (5%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHI 101
R LG+G +G+V + TG+ A K ++K +I+ E +I+ V ++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF--RQIATAVYYCHKHKICH 159
+E ++ + LV+ GG+L + +E R IF ++ + + +I +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY-HGPEVD 218
RDLK ENILLD+ G+ +I+D GL+ E + G+ Y +PE++ Y P D
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP--D 183
Query: 219 CWSLGVLLYTLVYGAMPFDGSNFKRLVKQ-------ISNGDYFEPKNQSTASPLIAEMLN 271
W LG L+Y ++ G PF K VK+ + + + K A + +L
Sbjct: 184 WWGLGCLIYEMIQGQSPF--RKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 272 INPSSR 277
NP R
Sbjct: 242 KNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 13/218 (5%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SVRHP 96
+ + ++G G G+V K+TG +A+K +++ + E RI ++ ++ S P
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCP 74
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYC-H 153
I+ Y F + + ME + D L + + + E+ ++ I A++Y
Sbjct: 75 YIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE---IVKGI 210
KH + HRD+K NILLD +GN K+ DFG+S +S+ + G Y +PE
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 211 PYHGPEVDCWSLGVLLYTLVYGAMPFDGSN--FKRLVK 246
P + D WSLG+ L L G P+ F+ L K
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK 230
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 81/292 (27%), Positives = 125/292 (42%), Gaps = 59/292 (20%)
Query: 41 VRKLGQGNYGKV----QLGINKETGQEVAIKTIKKCKIETEADL-IRIRREIQIMSSVRH 95
VR +GQG +G+V G+ + + +K K E AD+ +RE +M+ H
Sbjct: 10 VRDIGQGAFGRVFQARAPGL--LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH 67
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL----------------------DQKKVL 133
PNI+ + V + M L+ EY A G+L +FL L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 134 TEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFT----- 187
+ E I +Q+A + Y + K HRDL N L+ EN KIADFGLS N+++
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 188 --ESRFLSTFCGSPL-YASPEIVKGIPY--HGPEVDCWSLGVLLYTLV-YGAMPFDGSNF 241
E+ + P+ + PE I Y + E D W+ GV+L+ + YG P+ G
Sbjct: 188 ASENDAI------PIRWMPPE---SIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238
Query: 242 KRLVKQISNGDYFE-PKNQSTASPLIAEML---NINPSSR---ADISVICSH 286
+ ++ + +G+ P N L M + PS R A I+ I
Sbjct: 239 EEVIYYVRDGNVLSCPDN--CPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 18/226 (7%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQE--VAIKTIKKC---KIETEADLIRIRREIQIMS 91
R++++++LGQG YG V N ET +E VAIK I KI + R RE++++
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAK----RALRELKLLR 56
Query: 92 SVR-HPNIIHIYE---VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
R H NI +Y+ VF + + E +L+ + + LT+ + QI
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-----NVFTESRFLSTFCGSPLYA 202
+ Y H + HRDLK N+L++ + KI DFGL+ N + F++ + + Y
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176
Query: 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
+PEI+ + +D WS+G +L L+ F G ++ + QI
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-19
Identities = 72/219 (32%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 44 LGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRR----EIQIMSSVRHP 96
+G G +G+V G K G+ VAIKT+K E + RR E IM HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE------KQRRDFLSEASIMGQFDHP 65
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKH 155
NIIH+ V ++++ E+ G L FL Q T + + R IA + Y +
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIP--YH 213
HRDL NIL++ N K++DFGL SRFL P Y S K IP +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGL------SRFLEDDTSDPTYTSSLGGK-IPIRWT 178
Query: 214 GPEV----------DCWSLGVLLYTLV-YGAMPF-DGSN 240
PE D WS G++++ ++ YG P+ D SN
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 69/253 (27%), Positives = 110/253 (43%), Gaps = 37/253 (14%)
Query: 44 LGQGNYGKVQLGINKETG-----QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
LG+G +GKV VA+K +K+ +E L + E ++ V HP++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLKQVNHPHV 65
Query: 99 IHIYEVFENREKMVLVMEYAAGGEL------------------------YDFLDQKKVLT 134
I +Y ++L++EYA G L Y ++ LT
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 135 EEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLS 193
+ QI+ + Y + K+ HRDL N+L+ E KI+DFGLS +V+ E ++
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 194 TFCGS-PL-YASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISN 250
G P+ + + E + Y + D WS GVLL+ +V G P+ G +RL +
Sbjct: 186 RSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244
Query: 251 GDYFE-PKNQSTA 262
G E P+N S
Sbjct: 245 GYRMERPENCSEE 257
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 10/194 (5%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR-IRREIQIMSSVRHPNIIHIY 102
LG GN G V + T + +A+K I ++ +L + I E++I+ P II Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIP---LDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
F ++ + E+ GG L D + + E RI + + Y KI HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 163 KLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSL 222
K N+L++ G K+ DFG+S S T+ G+ Y +PE + G Y G D WSL
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQY-GIHSDVWSL 179
Query: 223 GVLLYTLVYGAMPF 236
G+ L G P+
Sbjct: 180 GISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 27/243 (11%)
Query: 35 KQRFDIVRKLGQGNYGKV----QLGINKETGQEVAIKTIKKCKIE-TEADLIRIRREIQI 89
+ + + + LG+G +G+V LGI+K+ +E +K K + TE DL + E+++
Sbjct: 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73
Query: 90 MSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR----- 143
M + +H NII++ + +++EYA+ G L ++L ++ E + I R
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 144 -----------QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRF 191
Q+A + Y K HRDL N+L+ EN KIADFGL+ +V +
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193
Query: 192 LSTFCGS-PL-YASPEIVKGIPYHGPEVDCWSLGVLLYTL-VYGAMPFDGSNFKRLVKQI 248
T G P+ + +PE + Y + D WS GVL++ + G P+ G + L K +
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252
Query: 249 SNG 251
G
Sbjct: 253 KEG 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 61/227 (26%), Positives = 115/227 (50%), Gaps = 20/227 (8%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+ ++LK +++ +G+G +G V LG + G +VA+K IK +A E +
Sbjct: 4 NMKELK----LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASV 52
Query: 90 MSSVRHPNIIHIYEVF-ENREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIA 146
M+ +RH N++ + V E + + +V EY A G L D+L + VL + + +
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-YASPE 205
A+ Y + HRDL N+L+ E+ AK++DFGL+ + ++ P+ + +PE
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPE 169
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
++ + + D WS G+LL+ + +G +P+ K +V ++ G
Sbjct: 170 ALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 215
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+R+ ++ +G G G V + G VA+K + + + + R RE+ ++ V H
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNH 79
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
NII + VF E + + LVME L + + L E + Q+ +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME--LDHERMSYLLYQMLCGI 136
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
+ H I HRDLK NI++ + KI DFGL+ + ++ + + Y +PE++ G
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG 196
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+ Y VD WS+G ++ LV G++ F G++
Sbjct: 197 MGYK-ENVDIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 15/253 (5%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEA-DLIRIRREIQIMSS 92
I + +G G +G+V G K G+ VAIKT+K E + D + E IM
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS---EASIMGQ 61
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYY 151
HPNIIH+ V + +++V EY G L FL + T + + R IA+ + Y
Sbjct: 62 FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT---ESRFLSTFCGSPL-YASPEIV 207
HRDL NIL++ N K++DFGLS V E+ + + P+ + +PE +
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 208 KGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLI 266
+ D WS G++++ ++ YG P+ + + ++K I G Y P + L
Sbjct: 182 AYRKFTSAS-DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAALH 239
Query: 267 AEMLNINPSSRAD 279
ML+ R +
Sbjct: 240 QLMLDCWQKDRNE 252
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 34/231 (14%)
Query: 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTI-----KKCKIETEADLIRIRREIQ 88
L R+ +R LG G+ G V ++ + + VA+K I + K REI+
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK--------HALREIK 54
Query: 89 IMSSVRHPNIIHIYEVF-----ENREKM---------VLVMEYAAGGELYDFLDQKKVLT 134
I+ + H NI+ +YEV + E + +V EY +L + L+Q L+
Sbjct: 55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGP-LS 112
Query: 135 EEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD-ENGNAKIADFGLSNV----FTES 189
EE AR Q+ + Y H + HRDLK N+ ++ E+ KI DFGL+ + ++
Sbjct: 113 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172
Query: 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+LS + Y SP ++ + +D W+ G + ++ G F G++
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-18
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 14/218 (6%)
Query: 44 LGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
+G G +G+V GI K G++ VAIKT+K TE E IM H NII
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
+ V + +++ EY G L +L D + + + R IA + Y H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 160 RDLKLENILLDENGNAKIADFGLSNV---FTESRFLSTFCGSPL-YASPEIVKGIPYHGP 215
RDL NIL++ N K++DFGLS V E + ++ P+ + +PE + +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190
Query: 216 EVDCWSLGVLLY-TLVYGAMPF-DGSNFKRLVKQISNG 251
D WS G++++ + +G P+ D SN ++K I++G
Sbjct: 191 S-DVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDG 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-18
Identities = 69/240 (28%), Positives = 116/240 (48%), Gaps = 28/240 (11%)
Query: 36 QRFDIV--RKLGQGNYGKVQLGINKETGQE-----VAIKTIKKCKIETEADLIRIRREIQ 88
+R +IV R+LG+G +GKV L E VA+KT+K D RE +
Sbjct: 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDF---HREAE 59
Query: 89 IMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-------------DQKKVLTE 135
++++++H +I+ Y V + +++V EY G+L FL ++ LT+
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 136 EEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRF-LS 193
+ I +QIA + Y HRDL N L+ EN KI DFG+S +V++ + +
Sbjct: 120 SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179
Query: 194 TFCGSPL-YASPEIVKGIPYHGPEVDCWSLGVLLYTL-VYGAMPFDGSNFKRLVKQISNG 251
P+ + PE + + E D WSLGV+L+ + YG P+ + +++ I+ G
Sbjct: 180 GHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 70/234 (29%), Positives = 111/234 (47%), Gaps = 27/234 (11%)
Query: 44 LGQGNYGKVQLGINKETG--QEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIH 100
+G+GN+G+V K+ G + AIK +K+ ++ D E++++ + HPNII+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQ---------------- 144
+ E+R + L +EYA G L DFL + +VL + A I
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
+A + Y + + HRDL NIL+ EN AKIADFGLS + ++ G L
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR-LPVRW 189
Query: 205 EIVKGIPY--HGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE 255
++ + Y + D WS GVLL+ +V G P+ G L +++ G E
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-18
Identities = 58/229 (25%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQ----EVAIKTIKKCKIETEADLIR-IRREIQIMS 91
+ ++ LG G +G V G+ G+ VAIK +++ ET + I E +M+
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE---ETSPKANKEILDEAYVMA 64
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF---RQIATA 148
SV HP+++ + + + ++ L+ + G L D++ K ++ + QIA
Sbjct: 65 SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKG 121
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT--ESRFLSTFCGSPL-YASPE 205
+ Y + ++ HRDL N+L+ + KI DFGL+ + E + + P+ + + E
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 206 -IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGD 252
I+ I H + D WS GV ++ L+ +GA P++G + + G+
Sbjct: 182 SILHRIYTH--KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 28/239 (11%)
Query: 44 LGQGNYGKVQLGINKE-----TG-QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
LG G +G+V G + +G VA+KT++K + E +E +MS+ HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-------LTEEEARRIFRQIATAVY 150
I+ + V E ++ME GG+L +L +V LT +E I +A
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 151 YCHKHKICHRDLKLENILLDENGNA-----KIADFGLSNVFTESRFLSTFCGSPL---YA 202
Y + HRDL N L+ E G KI DFGL+ +S + L +
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 203 SPE-IVKGIPYHGPEVDCWSLGVLLY-TLVYGAMPFDG-SNFKRLVKQISNGDYFEPKN 258
+PE ++ G + D WS GVL++ L G P+ +N + L + G +P+N
Sbjct: 181 APESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 74/251 (29%), Positives = 120/251 (47%), Gaps = 33/251 (13%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHI-- 101
+G G++G V I +T ++VAIK + + D RE+ IM ++ H NII +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQ-------DPQYKNRELLIMKNLNHINIIFLKD 126
Query: 102 ---YEVFENREKMV---LVMEY---AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
E F+ EK + +VME+ + + L + Q+ A+ Y
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 153 HKHKICHRDLKLENILLDENGNA-KIADFGLS-NVFTESRFLSTFCGSPLYASPEIVKGI 210
H ICHRDLK +N+L+D N + K+ DFG + N+ R +S C S Y +PE++ G
Sbjct: 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC-SRFYRAPELMLGA 245
Query: 211 PYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEPKNQSTASPLIAEM 269
+ +D WSLG ++ ++ G F G S+ +LV+ I Q +P ++
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII----------QVLGTPTEDQL 295
Query: 270 LNINPSSRADI 280
+NP+ ADI
Sbjct: 296 KEMNPNY-ADI 305
|
Length = 440 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 78/272 (28%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 35 KQRFDIVRKLGQGNYGKV----QLGINKETG-QEVAIKTIKKCKIETEADLIRIRREIQI 89
+ R + + LG+G +G+V +G++ VA+K +K TE DL + E+++
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEM 68
Query: 90 MSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR----- 143
M + +H NII++ V + +V+EYAA G L DFL ++ E + R
Sbjct: 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 144 -----------QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRF 191
Q+A + + K HRDL N+L+ E+ KIADFGL+ ++ +
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 192 LSTFCGS-PL-YASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQI 248
T G P+ + +PE + Y + D WS GVLL+ + G P+ G + L K +
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247
Query: 249 SNGDYFEPKNQSTASPLIAEMLNI---NPSSR 277
G E K Q+ L M + PS R
Sbjct: 248 KEGYRME-KPQNCTQELYHLMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 32/240 (13%)
Query: 37 RFDIVRKLGQGNYGKVQLG-----INKETGQEVAIKTIK-KCKIETEADLIRIRREIQIM 90
RF + +LG+ +GKV G E Q VAIKT+K K + + + E +
Sbjct: 8 RF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEF---KHEAMMR 62
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-------------DQKKV---LT 134
S ++HPNI+ + V + + ++ Y + +L++FL D K V L
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 135 EEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194
+ I QIA + + H + H+DL N+L+ + N KI+D GL + +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 195 FCGSPL---YASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISN 250
S L + SPE + + + D WS GV+L+ + YG P+ G + + +++ I N
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 65/249 (26%), Positives = 110/249 (44%), Gaps = 12/249 (4%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL-IRIRREIQIMSSVRHPNIIHI 101
++G+GN+G+V G + VA+K+ C+ DL + +E +I+ HPNI+ +
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKS---CRETLPPDLKAKFLQEARILKQYSHPNIVRL 58
Query: 102 YEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
V ++ + +VME GG+ FL + L +E ++ A + Y HR
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 161 DLKLENILLDENGNAKIADFGLSNVFTESRFLST--FCGSPL-YASPEIVKGIPYHGPEV 217
DL N L+ E KI+DFG+S + + ST P+ + +PE + Y E
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY-SSES 177
Query: 218 DCWSLGVLLY-TLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ--STASPLIAEMLNINP 274
D WS G+LL+ GA+P+ + ++ + I G L+ +P
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237
Query: 275 SSRADISVI 283
R S +
Sbjct: 238 GQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 29/177 (16%)
Query: 35 KQRFDIVRKLGQGNYGKVQL--------------GINKETGQE--VAIKTIKKCKIETEA 78
+Q + V KLG+G +G+V L N VA+K ++ +
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA- 62
Query: 79 DLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ--------- 129
+E++I+S + PNI + V + ++MEY G+L FL +
Sbjct: 63 -REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 130 --KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184
K L+ + QIA+ + Y HRDL N L+ +N KIADFG+S
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+R+ ++ +G G G V + + VAIK + + + + R RE+ +M V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
NII + VF E + + LVME L + + L E + Q+ +
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGI 132
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
+ H I HRDLK NI++ + KI DFGL+ S ++ + + Y +PE++ G
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF 241
+ Y VD WS+G ++ +V + F G ++
Sbjct: 193 MGYK-ENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 11/212 (5%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+R+ ++ +G G G V + + VAIK + + + + R RE+ +M V H
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
NII + VF E + + +VME L + + L E + Q+ +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGI 139
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
+ H I HRDLK NI++ + KI DFGL+ S ++ + + Y +PE++ G
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF 241
+ Y VD WS+G ++ ++ G + F G++
Sbjct: 200 MGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDH 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 68/250 (27%), Positives = 115/250 (46%), Gaps = 37/250 (14%)
Query: 51 KVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110
KV L ++ T Q +K ++K ++ R R I I V PN++ +++ + +
Sbjct: 8 KVLLVMDTRTQQTFILKGLRKS-----SEYSRERLTI-IPHCV--PNMVCLHKYIVSEDS 59
Query: 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD 170
+ LV+++A GG+L+ + + + EE +R ++ A+ H+ I RDL NILLD
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 171 ENGNAKIADFGLSNVFTESRFLSTFCG---SPLYASPEIVKGIPYHGPEVDCWSLGVLLY 227
+ G+ ++ F + +S G +Y +PE V GI D WSLG +L+
Sbjct: 120 DRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPE-VGGISEETEACDWWSLGAILF 173
Query: 228 TLVYGAMPFDGSNFKRLVKQISNG-----DYFEPKNQST-ASPLIAEMLNINPSSR---- 277
L+ G K LV+ +G P+ S A L+ ++L NP+ R
Sbjct: 174 ELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224
Query: 278 -ADISVICSH 286
A + I SH
Sbjct: 225 VAGVEDIKSH 234
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI-MSSVRHP 96
+++ +LG+G YG V + TG +A+K I+ E R+ ++ I M SV P
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK--RLLMDLDISMRSVDCP 60
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDF----LDQKKVLTEEEARRIFRQIATAVYYC 152
+ Y + + ME L F D+ + E+ +I I A+ Y
Sbjct: 61 YTVTFYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 153 H-KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG-I 210
H K + HRD+K N+L++ NG K+ DFG+S +S + G Y +PE + +
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179
Query: 211 PYHGPEV--DCWSLGVLLYTLVYGAMPFD--GSNFKRLVKQI 248
G +V D WSLG+ + L G P+D + F++L KQ+
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL-KQV 220
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKK-CKIETEADLIRIRREIQIMSSVRH 95
R+ ++ +G G G V + TGQ VAIK + + + T A R RE+ +M V H
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK--RAYRELVLMKLVNH 74
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDF-LDQ--KKVLTEEEARRIFRQIA 146
NII + VF E + + LVME L D L Q + L E + Q+
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQML 128
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206
+ + H I HRDLK NI++ + KI DFGL+ S ++ + + Y +PE+
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 188
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+ G+ Y VD WS+G ++ ++ G + F G++
Sbjct: 189 ILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQL------GINKETGQEVAIKTIKKCKIETE-ADLIRI 83
+R LK+ +R LG+G++GKV+L G N TG++VA+K++K ADL
Sbjct: 3 KRFLKR----IRDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADL--- 53
Query: 84 RREIQIMSSVRHPNIIHIYEVFENR--EKMVLVMEYAAGGELYDFLDQKKV-LTEEEARR 140
++EI+I+ ++ H NI+ + + L+ME+ G L ++L + K + ++ +
Sbjct: 54 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK 113
Query: 141 IFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF---CG 197
QI + Y + HRDL N+L++ KI DFGL+ + T
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 198 SPLY-ASPEIVKGIPYHGPEVDCWSLGVLLYTLV 230
SP++ +PE + ++ D WS GV LY L+
Sbjct: 174 SPVFWYAPECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 67/247 (27%), Positives = 115/247 (46%), Gaps = 31/247 (12%)
Query: 36 QRFDIV--RKLGQGNYGKVQLG--INKETGQE---VAIKTIKKCKIETEADLIRIRREIQ 88
+R DIV R+LG+G +GKV L N ++ VA+K +K + D +RE +
Sbjct: 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAE 59
Query: 89 IMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL----DQKKVLTEEEARR---- 140
++++++H +I+ Y V + + +++V EY G+L FL +L + + R+
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 141 --------IFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192
I QIA+ + Y HRDL N L+ N KI DFG+S + +
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179
Query: 193 STFCGSPL---YASPEIVKGIPYHGPEVDCWSLGVLLYTL-VYGAMPFDGSNFKRLVKQI 248
+ L + PE + + E D WS GV+L+ + YG P+ + +++ I
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 249 SNGDYFE 255
+ G E
Sbjct: 239 TQGRVLE 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
K F I+ G G I+ +T + V IK ++ TEA ++R ++
Sbjct: 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILR---------AIN 141
Query: 95 HPNIIHIYEVFENREKMVLVM-EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
HP+II + F + L++ Y +LY +L K+ + + I R + A+ Y H
Sbjct: 142 HPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLH 199
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNV---FTESRFLSTFCGSPLYASPEIVKGI 210
+++I HRD+K ENI ++ G+ + DFG + +++ + G+ +PE++
Sbjct: 200 ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG-WAGTIATNAPELLARD 258
Query: 211 PYHGPEVDCWSLGVLLYTLVYG 232
PY GP VD WS G++L+ +
Sbjct: 259 PY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIK-------TIKKCKIETEADLIRIRREIQIMSSVR 94
R +G G +G V + G+ VA+K + CK R+ RE++++ +
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK--------RVFRELKMLCFFK 57
Query: 95 HPNIIHIYEVFEN------REKMVL--VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
H N++ ++ + E V+ +M+ +L+ + + L+ + + QI
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQ----SDLHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV--FTESRFLSTFCGSPLYASP 204
+ Y H I HRD+K N+L++ N KI DFGL+ V ES+ ++ + Y +P
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
EI+ G ++ VD WS+G + L+ + F +
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-16
Identities = 68/252 (26%), Positives = 116/252 (46%), Gaps = 30/252 (11%)
Query: 35 KQRFDIVRKLGQGNYGKV----QLGINKETGQEVAIKTIKKCKIE-TEADLIRIRREIQI 89
+ R + + LG+G +G+V GI+K + +K K T+ DL + E+++
Sbjct: 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL 70
Query: 90 MSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR----- 143
M + +H NII++ V + +++EYAA G L +FL ++ + I +
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 144 -----------QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRF 191
Q+A + Y + HRDL N+L+ E+ KIADFGL+ V +
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 192 LSTFCGS-PL-YASPEIVKGIPY-HGPEVDCWSLGVLLYTL-VYGAMPFDGSNFKRLVKQ 247
T G P+ + +PE + Y H + D WS G+L++ + G P+ G + L K
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTH--QSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 248 ISNGDYFE-PKN 258
+ G + P N
Sbjct: 249 LREGHRMDKPSN 260
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-16
Identities = 60/244 (24%), Positives = 112/244 (45%), Gaps = 23/244 (9%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+++ ++R+LGQG++G V G + E VA+KT+ + E I E +
Sbjct: 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER--IEFLNEASV 62
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTE----------EEAR 139
M +++ + V + ++VME A G+L +L + E +E
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199
++ +IA + Y + K HRDL N ++ + KI DFG++ E+ +
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 200 L---YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGA-MPFDGSNFKRLVKQISNGDYFE 255
L + +PE +K + D WS GV+L+ + A P+ G + ++++K + +G Y +
Sbjct: 183 LPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241
Query: 256 -PKN 258
P N
Sbjct: 242 QPDN 245
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 31/245 (12%)
Query: 35 KQRFDIVRKLGQGNYGKV----QLGINKETGQE---VAIKTIKKCKIETEADLIRIRREI 87
+ R + + LG+G +G+V +GI+K+ + VA+K +K T+ DL + E+
Sbjct: 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD--DATDKDLSDLVSEM 68
Query: 88 QIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK--------------- 131
++M + +H NII++ + +++EYA+ G L ++L ++
Sbjct: 69 EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 132 -VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTES 189
LT ++ Q+A + Y K HRDL N+L+ E+ KIADFGL+ +V
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 190 RFLSTFCGS-PL-YASPEIVKGIPYHGPEVDCWSLGVLLYTL-VYGAMPFDGSNFKRLVK 246
+ T G P+ + +PE + Y + D WS GVLL+ + G P+ G + L K
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247
Query: 247 QISNG 251
+ G
Sbjct: 248 LLKEG 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 38 FDIVRKLGQGNYGKV---QLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
F + R LG+G +G V QL + Q+VA+K +K I + +D+ RE M
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 95 HPNIIHIYEV-FENREKMVL-----VMEYAAGGELYDFLDQKKV------LTEEEARRIF 142
HPN+I + V +R K L ++ + G+L+ FL ++ L + R
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYA 202
IA+ + Y HRDL N +L+EN +ADFGLS + C S L
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 203 SPEIVKGIP--YHGPEVDCWSLGVLLYTLV-YGAMPFDG 238
++ + + D W+ GV ++ ++ G P+ G
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 29/244 (11%)
Query: 35 KQRFDIVRKLGQGNYGKVQL----GINKETGQEVAIKTIKKCKIE-TEADLIRIRREIQI 89
+ R + + LG+G +G+V + G++KE V +K K + TE DL + E+++
Sbjct: 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 76
Query: 90 MSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK----------------V 132
M + +H NII++ + +++EYA+ G L ++L ++
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 133 LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192
L+ ++ Q+A + Y K HRDL N+L+ E+ KIADFGL+ +
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 193 STFCGSPL---YASPE-IVKGIPYHGPEVDCWSLGVLLYTL-VYGAMPFDGSNFKRLVKQ 247
L + +PE + I H + D WS GVLL+ + G P+ G + L K
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTH--QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
Query: 248 ISNG 251
+ G
Sbjct: 255 LKEG 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 28/175 (16%)
Query: 35 KQRFDIVRKLGQGNYGKVQL------------GINKETGQE--VAIKTIKKCKIETEADL 80
+Q+ + KLG+G +G+V L G + GQ VA+K ++ +T +
Sbjct: 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN- 62
Query: 81 IRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-------- 132
+EI+IMS +++PNII + V + + + ++ EY G+L FL Q+++
Sbjct: 63 -DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHAN 121
Query: 133 ----LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
++ + QIA+ + Y HRDL N L+ + KIADFG+S
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 36 QRFDIVRK--LGQGNYGKVQLG--INKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
+R DIV K LG+G +GKV L N Q+ + +K K +E+ +RE ++++
Sbjct: 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 62
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL----DQKKVLTEEEAR-------- 139
++H +I+ Y V +++V EY G+L FL K+L E
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 140 ---RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFC 196
I QIA+ + Y HRDL N L+ + KI DFG+S + +
Sbjct: 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 197 GSPL---YASPEIVKGIPYHG--PEVDCWSLGVLLYTL-VYGAMPF 236
+ L + PE I Y E D WS GV+L+ + YG P+
Sbjct: 183 RTMLPIRWMPPE---SILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 41 VRKLGQGNYGKVQLG----INKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ +LG+ +GK+ G + Q VAIKT+K I ++E +M+ + HP
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHP 67
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL-------------DQ----KKVLTEEEAR 139
NI+ + V + + ++ EY G+L++FL D+ K L +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199
I QIA + Y H H+DL NIL+ E + KI+D GLS + + S
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 200 L---YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQI 248
L + PE I+ G + D WS GV+L+ + +G P+ G + + +++ +
Sbjct: 188 LPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 85 REIQIMSSVRHPNIIHIYEVFENREKMVLVM-EYAAGGELYDFLDQKKVLTEEEARRIFR 143
REI I+ ++ H II++ + + + +VM +Y +L+ ++D+ L E+A I R
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC--DLFTYVDRSGPLPLEQAITIQR 192
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST---FCGSPL 200
++ A+ Y H I HRD+K ENI LDE NA + DFG + + G+
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252
Query: 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS 260
SPE++ PY + D WS G++L F+ VK ++ F + +S
Sbjct: 253 TNSPELLALDPY-CAKTDIWSAGLVL--------------FEMSVKNVT---LFGKQVKS 294
Query: 261 TASPL--IAEMLNINPSS--RADISVICSHW 287
++S L I + ++P + + +C H+
Sbjct: 295 SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325
|
Length = 392 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQL-GINKETGQEVAIKTI---------------KKCK 73
H + F ++ L G +GK+ + + T + A + + K+ K
Sbjct: 142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK 201
Query: 74 IETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM---EYAAGGELYD-FLDQ 129
+ A I++ EI + + H NI+ I E+ + ++ ++ +YD D
Sbjct: 202 AGSRA-AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 130 KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189
K ++ R I +Q+ AV Y H K+ HRD+KLENI L+ +G + DFG + F +
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 190 R--FLSTFCGSPLYASPEIVKGIPYHGPEV-DCWSLGVLLYTLV 230
R F + G+ SPEI+ G Y E+ D WS G++L ++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGY--CEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 8e-15
Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 25/174 (14%)
Query: 35 KQRFDIVRKLGQGNYGKVQL----GINKETGQEVAIKTIKKCKIETEADLIR-------- 82
++R KLG+G +G+V L G+ K ++ ++ + ++R
Sbjct: 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR 63
Query: 83 --IRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ---KKVLTEEE 137
+EI+IMS ++ PNII + V + + ++ EY G+L FL + ++ + +
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123
Query: 138 ARRI--------FRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
I QIA+ + Y HRDL N L+ +N KIADFG+S
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 43 KLGQGNYGKVQLGINKETG--QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
K+G+G YG V K+ +E A+K I+ I A REI ++ ++HPN+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-----CREIALLRELKHPNVIA 62
Query: 101 IYEVF--ENREKMVLVMEYAAGGELYDFLDQKKV---------LTEEEARRIFRQIATAV 149
+ +VF + K+ L+ +YA +L+ + + L + + QI +
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 150 YYCHKHKICHRDLKLENILL----DENGNAKIADFGLSNVFTES----RFLSTFCGSPLY 201
+Y H + + HRDLK NIL+ E G KIAD G + +F L + Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLV 230
+PE++ G ++ +D W++G + L+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 40/270 (14%)
Query: 42 RKLGQGNYGKV----QLGINKE-TGQEVAIKTIKKC--KIETEADLIRIRREIQIMSSV- 93
+ LG G +GKV G++K +VA+K +K E EA + E++IMS +
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA----LMSELKIMSHLG 96
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYY 151
H NI+++ ++++ EY G+L +FL +K+ LT E+ Q+A + +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGS---PL-YASPE- 205
HRDL N+LL KI DFGL+ ++ +S ++ G+ P+ + +PE
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK--GNARLPVKWMAPES 214
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLV------YGAMPFDGSNFKRLVKQISNGDYFEPKNQ 259
I + + E D WS G+LL+ + Y MP D S F +L+K + +
Sbjct: 215 IFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIK-----EGYRMAQP 266
Query: 260 STASPLIAEML----NINPSSRADISVICS 285
A I +++ + +P R I
Sbjct: 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 65/262 (24%), Positives = 114/262 (43%), Gaps = 23/262 (8%)
Query: 44 LGQGNYGKVQLGINKETGQE-----VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
LG+G +G+V L K +E V +K ++K K E RRE+ + + H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKLSHKNV 70
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKV-------LTEEEARRIFRQIATAV 149
+ + + E +++EY G+L FL + K L+ ++ + QIA +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSN-VFTESRFLSTFCGSPL-YASPEIV 207
+ + HRDL N L+ K++ LS V+ + PL + +PE V
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190
Query: 208 KGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLI 266
+ + + D WS GVL++ + G +PF G + + ++ ++ G P + S L
Sbjct: 191 QEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249
Query: 267 AEMLN---INPSSRADISVICS 285
M +NP R S + S
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 43 KLGQGNYGKVQLGINKE--TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
K+G+G YG V K+ ++ A+K I+ I A REI ++ ++HPN+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-----CREIALLRELKHPNVIS 62
Query: 101 IYEVFENR--EKMVLVMEYAAGGELYDFL--------DQKKV-LTEEEARRIFRQIATAV 149
+ +VF + K+ L+ +YA +L+ + ++K V L + + QI +
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 150 YYCHKHKICHRDLKLENILL----DENGNAKIADFGLSNVFTES----RFLSTFCGSPLY 201
+Y H + + HRDLK NIL+ E G KIAD G + +F L + Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLV 230
+PE++ G ++ +D W++G + L+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 50/203 (24%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
+ +++ L G+ G+V + V +K +K EA L++ +V HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQ---------NVNHPS 118
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHK 156
+I + + + +V+ + + +LY +L ++ + L ++A I +QI + Y H +
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNV-FTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
I HRD+K ENI +++ I D G + FL G+ +PE++ Y+
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETNAPEVLARDKYNS- 235
Query: 216 EVDCWSLGVLLY-TLVYGAMPFD 237
+ D WS G++L+ L Y + F+
Sbjct: 236 KADIWSAGIVLFEMLAYPSTIFE 258
|
Length = 357 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-14
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 46 QGNYGKVQLGI-NKETG---QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHI 101
+G +G++ GI E +EV +KT+K E + L+ +E ++ + H NI+ I
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL--QESCLLYGLSHQNILPI 73
Query: 102 YEV-FENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR--------QIATAVYYC 152
V E+ E ++ Y G L FL Q ++ + + QIA + Y
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLS-NVF---------TESRFLSTFCGSPL-Y 201
HK + H+D+ N ++DE KI D LS ++F E+R P+ +
Sbjct: 134 HKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR--------PVKW 185
Query: 202 ASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPF 236
+ E +V +V WS GVLL+ L+ G P+
Sbjct: 186 MALESLVNKEYSSASDV--WSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 42 RKLGQGNYGKVQLGI--NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
+ LG+G +G V G ++ +VA+KT+K I T +++ E M HPN++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMK-IAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 100 HIYEV-FENREKM-----VLVMEYAAGGELYDFL------DQKKVLTEEEARRIFRQIAT 147
+ V + E V+++ + G+L+ FL D + L + + IA+
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
+ Y HRDL N +L+EN N +ADFGLS
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 39 DIVRKLGQG--NYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+++ +G+ + V L +K T VA+K I E DL +++EI ++HP
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKE-DLKLLQQEIITSRQLQHP 59
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHK 154
NI+ F ++ +V A G D L + L E I + + A+ Y H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSN---VFTESRFLSTFCGSPLYA-------SP 204
HR +K +ILL +G ++ GL + + P + SP
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 205 EIV-KGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
E++ + + + + D +S+G+ L G +PF
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 23/244 (9%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+++ + R+LGQG++G V GI K E VAIKT+ + E I E +
Sbjct: 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASV 62
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTE----------EEAR 139
M +++ + V + +++ME G+L +L + E ++
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199
++ +IA + Y + +K HRDL N ++ E+ KI DFG++ E+ +
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 200 L---YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGA-MPFDGSNFKRLVKQISNGDYFE 255
L + SPE +K + D WS GV+L+ + A P+ G + +++++ + G +
Sbjct: 183 LPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241
Query: 256 -PKN 258
P N
Sbjct: 242 KPDN 245
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 42 RKLGQGNYGKVQLG-INKETG--QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
+ LG+G +G V G ++++ G +VA+KT+K I T +++ E M HPN+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 99 IHIYEV-FENREKM-----VLVMEYAAGGELYDFL------DQKKVLTEEEARRIFRQIA 146
+ + V FE ++++ + G+L+ FL + L + + IA
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGSPLYASPE 205
+ Y HRDL N +L E+ +ADFGLS +++ + +
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG------RIAKM 177
Query: 206 IVKGIPY-------HGPEVDCWSLGVLLY-TLVYGAMPFDG 238
VK I + + D W+ GV ++ G P+ G
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 42 RKLGQGNYGKVQLG-INKE-TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
+++G G +GKV LG +N T +V +K ++ + + ++ E Q S++H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKKV---LTEEEA--RRIFRQIATAVYYCHK 154
+LVME+ G+L +L + +T + +R+ +IA + + HK
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFL-STFCGSPL-YASPEIVKGIP 211
+ H DL L N LL + KI D+GLS N + E ++ PL + +PE+V +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV- 177
Query: 212 YHG--------PEVDCWSLGVLLYTLV-YGAMPF 236
HG E + WSLGV ++ L G+ P+
Sbjct: 178 -HGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 59/236 (25%), Positives = 110/236 (46%), Gaps = 20/236 (8%)
Query: 42 RKLGQGNYGKVQLG-INKETGQ-EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
++G G +GKV LG ++ + V +K ++ E L +E+Q + HPN++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL--QEVQPYRELNHPNVL 58
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEAR-----RIFRQIATAVYYCHK 154
+LV+E+ G+L ++L + + + A+ R+ ++A+ + + H+
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGS-PL-YASPEIVKGIP 211
H DL L N L + + KI D+GL+ + E +++ C + PL + +PE+V+
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 212 YHGPEVD------CWSLGVLLYTLV-YGAMPF-DGSNFKRLVKQISNGDYFEPKNQ 259
D WSLGV ++ L P+ D S+ + L + + D PK Q
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 44 LGQGNYGKVQLGINKETGQE----VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
LG G +G V GI G VAIKTI+ I + M S+ H I+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKIC 158
+ + + LV + + G L D + Q + L + QIA +YY +H++
Sbjct: 73 RLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV 131
Query: 159 HRDLKLENILLDENGNAKIADFGLSNVF--TESRFLSTFCGSPL--YASPEIVKGIPYHG 214
HR+L NILL + +IADFG++++ + ++ + +P+ A I+ G H
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH- 190
Query: 215 PEVDCWSLGVLLYTLV-YGAMPFDG 238
+ D WS GV ++ ++ YGA P+ G
Sbjct: 191 -QSDVWSYGVTVWEMMSYGAEPYAG 214
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 61 GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY----EVFENREKMVLVME 116
+EV I+T KK + + EI+ + + NI+ IY ++ ++ ++ L++E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNA 175
Y G L + LD++K L+ + + +Y +K+ +++L + L+ EN
Sbjct: 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKL 162
Query: 176 KIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI-PYHGPEVDCWSLGVLLYTLVYGAM 234
KI GL + + F + +Y S +++ I + + D +SLGV+L+ + G +
Sbjct: 163 KIICHGLEKILSSPPFKNV--NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220
Query: 235 PFDGSNFKRLVKQISNGDYFEP 256
PF+ K + I N +
Sbjct: 221 PFENLTTKEIYDLIINKNNSLK 242
|
Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 60/232 (25%), Positives = 107/232 (46%), Gaps = 16/232 (6%)
Query: 32 RKLKQ-RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI--- 87
R LK+ F ++ LG G +G V G+ G++V I K EA + +EI
Sbjct: 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV--AIKELREATSPKANKEILDE 59
Query: 88 -QIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQI 145
+M+SV +P++ + + + L+ + G L D++ + K + + QI
Sbjct: 60 AYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118
Query: 146 ATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT--ESRFLSTFCGSPL--Y 201
A + Y + ++ HRDL N+L+ + KI DFGL+ + E + + P+
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGD 252
A I+ I H + D WS GV ++ L+ +G+ P+DG + + G+
Sbjct: 179 ALESILHRIYTH--QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 34/227 (14%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
QRF I+ LG+G +GKV +++ + A+K ++ T I EIQ M VR
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKI----EIQFMEKVRQ 184
Query: 96 PN------IIHIYEVFENRE-KMVLVM-EYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
+ ++ I F+N M +VM +Y G L D++ + + +I Q
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGV 242
Query: 148 AVYYCHKH-KICHRDLKLENILLDENGNA----------------KIADFGLSNVFTESR 190
A+ Y H + H DLK ENIL++ + +I D G SR
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR 302
Query: 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFD 237
+ + Y SPE+V G+ + D WS+G ++Y L G + +D
Sbjct: 303 --TAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 20/259 (7%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE---VAIKTIKK-CKIETEADLIRIRREIQIMSSVRH 95
I R LG G +G++ G K + VAI T++ C + + E + H
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA---EALTLGQFDH 65
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHK 154
NI+ + V M++V EY + G L FL + + L + + +A+ + Y +
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 155 HKICHRDLKLENILLDENGNAKIADFG-LSNVFTESRFLSTFCGSP-LYASPEIVKGIPY 212
H+ L +L++ + KI+ F L +E+ + + SP L+A+PE I Y
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE---AIQY 182
Query: 213 H--GPEVDCWSLGVLLY-TLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEM 269
H D WS G++++ + YG P+ + + ++K + +G + P ++ + L M
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPAPRNCPNLLHQLM 241
Query: 270 LNI---NPSSRADISVICS 285
L+ R S I S
Sbjct: 242 LDCWQKERGERPRFSQIHS 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 7/218 (3%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL--IRIRREIQIMSSVRHPNI 98
V+ LG G +G V GI G+ V I K ET + E IM+S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+ + V + + LV + G L D++ + K + + QIA + Y + ++
Sbjct: 72 VRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHG--P 215
HRDL N+L+ + KI DFGL+ + G + ++ I Y
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190
Query: 216 EVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGD 252
+ D WS GV ++ L+ +G P+DG + + + G+
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 39/185 (21%)
Query: 35 KQRFDIVRKLGQGNYGKVQL--------------GINKETGQE--VAIKTIK-KCKIETE 77
+ KLG+G +G+V L N G+ VA+K ++
Sbjct: 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR 63
Query: 78 ADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEE 137
D ++ E++I+S ++ PNII + V + + + ++ EY G+L FL + +EE
Sbjct: 64 NDFLK---EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 138 AR-------------------RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIA 178
+ QIA+ + Y HRDL N L+ EN KIA
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIA 180
Query: 179 DFGLS 183
DFG+S
Sbjct: 181 DFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 66/257 (25%), Positives = 115/257 (44%), Gaps = 16/257 (6%)
Query: 42 RKLGQGNYGKVQLG-INKETGQEV--AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
R +G+G++G V G + GQ++ A+K++ + I ++ + +E IM HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 99 IHIYEVFENREKMVLV-MEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHK 156
+ + + E LV + Y G+L +F+ + T ++ Q+A + Y K
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF--CGSPLYASPEIVKGIPYH- 213
HRDL N +LDE+ K+ADFGL+ + + S G+ L ++ +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 214 -GPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEML- 270
+ D WS GVLL+ L+ GA P+ + + + G + + PL ML
Sbjct: 179 FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL-LQPEYCPDPLYEVMLS 237
Query: 271 --NINPSSRADISVICS 285
+ P R S + S
Sbjct: 238 CWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F I R L G+ G V + + Q V +K EA L+R + HP
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLR---------RLSHPA 221
Query: 98 IIHIYEVFENREKMVLVM-EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKH 155
++ + +V LV+ +Y + +LY +L + + L + + RQ+ +A+ Y H
Sbjct: 222 VLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE 279
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESR---FLSTFCGSPLYASPEIVKGIPY 212
I HRD+K EN+L++ + + DFG + S F G+ +PE++ G PY
Sbjct: 280 GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY 339
Query: 213 HGPEVDCWSLGVLLY-TLVYGAMPFDGS 239
P VD WS G++++ V+ A F S
Sbjct: 340 -TPSVDIWSAGLVIFEAAVHTASLFSAS 366
|
Length = 461 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 6e-10
Identities = 34/104 (32%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 82 RIRREIQIMSSVRHP--NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEAR 139
R RRE +IMS R N+ +Y V ++VMEY G L D ++ + E +R
Sbjct: 45 RTRREARIMSRARKAGVNVPAVYFVDPE--NFIIVMEYIEGEPLKDLINSNGMEELELSR 102
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
I R + H I H DL N++L G + DFGL+
Sbjct: 103 EIGRLVGKL----HSAGIIHGDLTTSNMIL-SGGKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCK----IETEADLIRIRREIQIMSSVRHPN 97
+++G G +GKV L T VA +K+ K + + + ++ +I+ +HPN
Sbjct: 1 QEIGNGWFGKVLLS-EIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL---QHPN 56
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEE----EARRIFRQIATAVYYCH 153
I+ +LV EY G+L +L Q++ +R+ +IA V + H
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST---FCGSPLYASPEIVKGI 210
KH H DL L N L + K+ D+G+ + ++ T C + +PE+V
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG-- 174
Query: 211 PYHGPEV--------DCWSLGVLLYTL 229
+HG + + W+LGV L+ L
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 130 KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTE 188
KKVLT E+ Q+A + + K HRDL NILL EN KI DFGL+ +++ +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 189 SRFLSTFCGS-PL-YASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNF-KRL 244
++ PL + +PE + Y + D WS GVLL+ + GA P+ G +
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291
Query: 245 VKQISNGDYFEPKNQSTASPLIAEMLNI---NPSSRADISVICSH 286
+++ G + +T + ML+ PS R S + H
Sbjct: 292 CRRLKEGTRMRAPDYTT-PEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-08
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 12/116 (10%)
Query: 73 KIETEADLIRIRREIQIMSSVRHPNII--HIYEVFENREKMVLVMEYAAGGELYDFLDQK 130
+ RE+ I+ + + + E+ L+ME+ G L +
Sbjct: 28 INPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE----- 82
Query: 131 KVLTEEEARRIFRQIATAVYYCHKHKI---CHRDLKLENILLDENGNAKIADFGLS 183
++EEE I Q+A + H+ + CH DL NIL+D+ I D+ +
Sbjct: 83 --VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 41 VRKLGQGNYGKVQLGINKETGQEVAIK-TIKKCKIETEADLIR-IRREIQIMSSVRHPNI 98
V+ LG G +G V GI G+ V I IK + T + I E +M+ V P +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+ + + LV + G L D++ + K + ++ QIA + Y + ++
Sbjct: 72 CRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVF--TESRFLSTFCGSPL--YASPEIVKGIPYH 213
HRDL N+L+ + KI DFGL+ + E+ + + P+ A I+ H
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190
Query: 214 GPEVDCWSLGVLLYTLV-YGAMPFDG 238
+ D WS GV ++ L+ +GA P+DG
Sbjct: 191 --QSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGS---P 199
Q+A + + K HRDL NILL EN KI DFGL+ +++ + ++ GS P
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK--GSARLP 239
Query: 200 L-YASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDG 238
L + +PE + Y + D WS GVLL+ + GA P+ G
Sbjct: 240 LKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 43/164 (26%), Positives = 64/164 (39%), Gaps = 36/164 (21%)
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
Q+A + + K HRDL NILL EN KI DFGL+ +Y
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--------------DIYKD 226
Query: 204 PEIVKG------IPYHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSNF-KRLV 245
P+ V+ + + PE D WS GVLL+ + GA P+ G +
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC 286
Query: 246 KQISNGDYFEPKNQSTASPLIAEMLNI---NPSSRADISVICSH 286
+++ G +T + + ML+ NP R S +
Sbjct: 287 RRLKEGTRMRAPEYATPE-IYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 12/104 (11%)
Query: 82 RIRREIQIMSSVRHPNII--HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEAR 139
R R E +++S R + +Y+V + +VMEY G L K + EE
Sbjct: 43 RTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVMEYIEGKPL-------KDVIEEGND 93
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
+ R+I V HK I H DL NI++ + + DFGL
Sbjct: 94 ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP 256
G+P Y +PE++ G P HGP VD W+LGV L+ + G PF+ +++ + I N D P
Sbjct: 542 GTPDYLAPELLLGKP-HGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 257 KNQS----TASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTP 309
+ + A I +L ++P+ RA + + K H + + E L NQT
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKEL-------KQHPLFHGVDWENLQNQTM 650
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 17/113 (15%)
Query: 73 KIETEADLIRIRREIQIMSSVRHPNII--HIYEVFENREKMVLVMEYAAGGELYDFLDQK 130
++ TE R R E +++S R + IY+V + E+ +VMEY G +L D L+
Sbjct: 377 RLRTE----RTRAEARLLSEARRAGVPTPVIYDV--DPEEKTIVMEYIGGKDLKDVLEG- 429
Query: 131 KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
E R++ +A HK I H DL N ++ ++ I DFGL
Sbjct: 430 ---NPELVRKVGEIVAK----LHKAGIVHGDLTTSNFIVRDDRLYLI-DFGLG 474
|
Length = 535 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 58/247 (23%), Positives = 109/247 (44%), Gaps = 24/247 (9%)
Query: 43 KLGQG--NYGKVQLGINKETGQEVAIK--TIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
++G+G N V L + TG V ++ ++ C TE L ++ E+ + RHPNI
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFRHPNI 61
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHK 156
+ + VF + ++ + A G L + ++E I + Y H++
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRF---------LSTFCGSPL-YASPEI 206
HR++K +IL+ +G ++ GLS++++ R F S L + SPE+
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 207 VKGIPYHGPEV--DCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264
++ +G V D +S+G+ L G +PF +++ Q G + P + +T
Sbjct: 180 LRQ-DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238
Query: 265 LIAEMLN 271
+ M N
Sbjct: 239 EESRMKN 245
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 12/106 (11%)
Query: 82 RIRREIQIMSSVRHP--NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEAR 139
R RRE +I++ R + +Y+V + ++VMEY G L D L++ + + R
Sbjct: 45 RTRREARILAKAREAGVPVPIVYDVDPDN--GLIVMEYIEGELLKDALEEARP---DLLR 99
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185
+ R + HK I H DL NI+L G DFGL
Sbjct: 100 EVGRLVGKL----HKAGIVHGDLTTSNIIL-SGGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 15/115 (13%)
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGS---P 199
Q+A + + HRDL NILL KI DFGL+ ++ +S ++ G+ P
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK--GNARLP 279
Query: 200 L-YASPEIVKGIPYHGPEVDCWSLGVLLYTLV------YGAMPFDGSNFKRLVKQ 247
+ + +PE + Y E D WS G+LL+ + Y MP D S F +++K+
Sbjct: 280 VKWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKE 332
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|218977 pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/WaaP) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 7/99 (7%)
Query: 82 RIRREIQIMSSVRHPNIIHIYEVFENREKM------VLVMEYAAGGE-LYDFLDQKKVLT 134
R RE +++ +R + V K+ L+ E G + L +L Q
Sbjct: 57 RSFREFRLLRRLREAGVPVPKPVAAGAVKVGGEYQADLLTERLEGAQDLVTWLAQWADPA 116
Query: 135 EEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG 173
EE R ++R + + H+ + H DL NILLD
Sbjct: 117 EELRRALWRAVGRLIARMHRAGVNHTDLNAHNILLDTGE 155
|
These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica. Length = 206 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 44/166 (26%)
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGSPLYA 202
Q+A + + HRD+ N+LL + AKI DFGL+ ++ +S +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY----------- 268
Query: 203 SPEIVKG-----IPYHGPE--VDC--------WSLGVLLYTLV-YGAMPFDG----SNFK 242
+VKG + + PE DC WS G+LL+ + G P+ G S F
Sbjct: 269 ---VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325
Query: 243 RLVK---QISNGDYFEPKNQSTASPLIAEML-NINPSSRADISVIC 284
++VK Q+S D F P + I +M N+ P+ R S I
Sbjct: 326 KMVKRGYQMSRPD-FAPPEIYS----IMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 33/214 (15%)
Query: 44 LGQGNYGKVQLGINKETGQ-------EVAIKTI-KKCKIETEADLIRIRREIQIMSSVRH 95
LGQG + K+ GI +E G EV +K + K + +E+ +MS + H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFF----EAASMMSQLSH 58
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHK 154
+++ Y V ++ ++V EY G L +L + K ++ + +Q+A A+++
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEI-VKGIPYH 213
+ H ++ +N+LL + K + F + LS S EI ++ IP+
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTG----NPPFIK---LSDPGISITVLPKEILLERIPWV 171
Query: 214 GPE-----------VDCWSLGVLLYTLVYGA-MP 235
PE D WS G L+ + G P
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 56/208 (26%), Positives = 80/208 (38%), Gaps = 48/208 (23%)
Query: 35 KQRFDIVRKLGQGNYGKV--QLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
K F + +KLG+G +G V +NK++ +E +KK EI +
Sbjct: 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKY-VLKKATEYGAV-------EIWMNER 182
Query: 93 VRH--PNII--HIYEVFEN-----REKMVLVMEYAAGGELYDFLDQK------------- 130
VR PN +Y E ++ LV Y L D + K
Sbjct: 183 VRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGK 242
Query: 131 -----KVLTEEEA--RRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADFGL 182
K L E + I RQI A+ H I HRD+K +NI+ E +G+ KI D G
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGA 302
Query: 183 SNVFTESRF-----LSTFCGSPLYASPE 205
+ + R F P YA+PE
Sbjct: 303 A---ADLRVGINYIPKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 9e-05
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 43/222 (19%)
Query: 44 LGQGNYGKVQLGI--------NKETGQEVAIKTIKKCKIETEADL-IRIRREIQIMSSVR 94
LG+G ++ GI + E IK I K + D+ + +M V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCH 153
H +I+ +Y V + ++V E+ G L F+ +K VLT ++ +Q+A+A+ Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 154 KHKICHRDLKLENILLDENG-------NAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206
+ H ++ +NILL G K++D G+ + SR E
Sbjct: 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSR-------------QEC 168
Query: 207 VKGIPYHGPE-----------VDCWSLGVLLYTLVY-GAMPF 236
V+ IP+ PE D WS G L+ + Y G +P
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 5/98 (5%)
Query: 139 RRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCG- 197
+ + RQ+ T + H+ I HRD+K EN+L+ +G KI DFG + + G
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGM 371
Query: 198 -SPLYASPEIVKGIPYHGPEVDCWSLGVLL--YTLVYG 232
P Y+ PE + +P P ++ LL + +YG
Sbjct: 372 LDPRYSPPEELV-MPQSCPRAPAPAMAALLSPFAWLYG 408
|
Length = 507 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 49/221 (22%)
Query: 42 RKLGQGNYGKVQLGINKETGQE----------VAIKTIKKCKIETEADLIRIRREIQIMS 91
LGQG + + G+ + V +K + ++ A +MS
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA----FFETASLMS 56
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVY 150
+ H +++ +Y V R++ ++V EY G L FL +K ++ + +Q+A+A++
Sbjct: 57 QLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALH 115
Query: 151 YCHKHKICHRDLKLENILL----DENGN---AKIADFGLSNVFTESRFLSTFCGSPLYAS 203
Y K+ H ++ +NIL+ G K++D G+ + +
Sbjct: 116 YLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI--------------PITVLSR 161
Query: 204 PEIVKGIPYHGPE------------VDCWSLGVLLYTLVYG 232
E V+ IP+ PE D WS G L +
Sbjct: 162 EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFL---STFCGSP 199
Q+A + + HRDL N+L+ E KI DFGL+ ++ +S ++ STF P
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL--P 304
Query: 200 L-YASPEIVKGIPYHGPEVDCWSLGVLLYTL-VYGAMPF 236
L + +PE + Y D WS G+LL+ + G P+
Sbjct: 305 LKWMAPESIFNNLYTTLS-DVWSFGILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 7/100 (7%)
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFL---STFCGSP 199
Q+A + + HRDL N+LL + KI DFGL+ ++ +S ++ STF
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304
Query: 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDG 238
A I + + D WS G+LL+ + G P+ G
Sbjct: 305 WMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 39/168 (23%), Positives = 72/168 (42%), Gaps = 28/168 (16%)
Query: 40 IVRKLGQGNYGKV---QLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
I + +G G +G V Q + + K I+ + ET I E + +++
Sbjct: 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAK-IENLENET------IVMETLVYNNIYDI 68
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTE---EEARRIFRQIA------- 146
+ I +++ N + + + Y G + + +L E E + IF++I
Sbjct: 69 DKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLI 128
Query: 147 --------TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186
T + Y H+H I H D+K ENI++D N I D+G+++ F
Sbjct: 129 KNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 44/212 (20%)
Query: 52 VQLGINKETGQEVAIKTIKKCKIETEA---DLIR-IRREIQIMSSVRHPNIIHIYEVFEN 107
V L K TG+ V ++ +I EA +++ ++ E+ + HPNI+ F
Sbjct: 16 VNLARYKPTGEYVTVR-----RINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 70
Query: 108 REKMVLVMEYAAGGELYD-----FLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
++ +V + A G D F+D ++E I + + A+ Y H HR +
Sbjct: 71 DNELWVVTSFMAYGSAKDLICTHFMDG---MSELAIAYILQGVLKALDYIHHMGYVHRSV 127
Query: 163 KLENILLDENGNAKIADFGLSNVFT------ESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
K +IL+ +G K+ GL + + R + F P Y+ VK +P+ PE
Sbjct: 128 KASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDF---PKYS----VKVLPWLSPE 178
Query: 217 V------------DCWSLGVLLYTLVYGAMPF 236
V D +S+G+ L G +PF
Sbjct: 179 VLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|234975 PRK01723, PRK01723, 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 19/52 (36%), Positives = 27/52 (51%), Gaps = 4/52 (7%)
Query: 129 QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180
Q+ L+EE+ + I + IA H + H DL NILLD +G + DF
Sbjct: 139 QEAPLSEEQWQAIGQLIARF----HDAGVYHADLNAHNILLDPDGKFWLIDF 186
|
Length = 239 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
RE + + + +P + + + + +VMEY G ELY L +E +I
Sbjct: 157 EREFEALQRL-YPEGVKVPKPIAW-NRHAVVMEYIEGVELYR-LRLDVENPDEILDKILE 213
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180
++ A Y I H DL NIL+ E+G+ + D+
Sbjct: 214 EVRKA-YRRG---IVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 26/113 (23%), Positives = 44/113 (38%), Gaps = 20/113 (17%)
Query: 78 ADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDF-------LDQK 130
A+ R R + V P +Y + R VL ME+ G ++ D +D+K
Sbjct: 213 ANAERFRENFKDDPDVYVP---KVYWEYTTRR--VLTMEWIDGIKISDIAALKSAGIDRK 267
Query: 131 KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
++ A + R + + H D NIL+ +G + DFG+
Sbjct: 268 EL-----AELLVRAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIV 312
|
Length = 517 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 36/216 (16%)
Query: 89 IMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEAR-RIFRQIAT 147
+MS V H ++ ++ V + ++V E+ G L L ++K + + +Q+A+
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLAS 128
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNA-------KIADFGLSNVFT----ESRFLSTFC 196
A+ Y + H ++ +NILL G A K++D G+S FT E R
Sbjct: 129 ALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERVERI-- 184
Query: 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF- 254
P A PE V G D WS G L + + G +P + S + F
Sbjct: 185 --PWIA-PECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE-------RTPSEKERFY 234
Query: 255 -------EPKNQSTASPLIAEMLNINPSSRADISVI 283
EP + A+ LI++ L P+ R I
Sbjct: 235 EKKHRLPEPSCKELAT-LISQCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 335 | |||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| KOG2345|consensus | 302 | 100.0 | ||
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG1989|consensus | 738 | 100.0 | ||
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG2052|consensus | 513 | 100.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0200|consensus | 609 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1167|consensus | 418 | 99.98 | ||
| KOG1152|consensus | 772 | 99.98 | ||
| KOG1024|consensus | 563 | 99.97 | ||
| KOG1345|consensus | 378 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590|consensus | 601 | 99.95 | ||
| KOG1164|consensus | 322 | 99.94 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| KOG1165|consensus | 449 | 99.93 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163|consensus | 341 | 99.92 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0603|consensus | 612 | 99.9 | ||
| KOG1240|consensus | 1431 | 99.9 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG1166|consensus | 974 | 99.88 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195|consensus | 448 | 99.88 | ||
| KOG0606|consensus | 1205 | 99.87 | ||
| KOG4158|consensus | 598 | 99.86 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1023|consensus | 484 | 99.79 | ||
| KOG1033|consensus | 516 | 99.79 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| KOG0590|consensus | 601 | 99.72 | ||
| KOG1266|consensus | 458 | 99.72 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG0601|consensus | 524 | 99.67 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG1243|consensus | 690 | 99.64 | ||
| KOG0606|consensus | 1205 | 99.57 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.49 | |
| KOG0601|consensus | 524 | 99.48 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG3087|consensus | 229 | 99.41 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.31 | |
| KOG2137|consensus | 700 | 99.29 | ||
| KOG3741|consensus | 655 | 99.29 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.18 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.98 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.86 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.86 | |
| KOG1035|consensus | 1351 | 98.74 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.69 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.62 | |
| KOG1235|consensus | 538 | 98.51 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.47 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.34 | |
| KOG0576|consensus | 829 | 98.31 | ||
| KOG2268|consensus | 465 | 98.3 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.19 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.09 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.85 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.84 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.74 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.69 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.67 | |
| KOG1093|consensus | 725 | 97.67 | ||
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.66 | |
| KOG2270|consensus | 520 | 97.64 | ||
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.49 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.45 | |
| KOG1826|consensus | 2724 | 97.45 | ||
| PLN02236 | 344 | choline kinase | 97.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.07 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.89 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.82 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.77 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.51 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.5 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.29 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.92 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.76 | |
| KOG1236|consensus | 565 | 95.74 | ||
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.37 |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-56 Score=404.67 Aligned_cols=263 Identities=35% Similarity=0.582 Sum_probs=246.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
.+|...+.||+|||+.+|.+++..+|+.||+|++.+.........+++.+|+++.+.++|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 58999999999999999999999999999999999888888888999999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~~ 194 (335)
|.|..++|.+++++++++++.++..+++||+.||.|||+.+|+|||||..|++++++.++||+|||+|+..... .....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988754 55668
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCchHHHHHHhcccC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~d 273 (335)
.+|||.|.|||++..... +.++||||+||++|-|+.|++||...+..+....+....+.. ...+.+..+||++||++|
T Consensus 178 lCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~ 256 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN 256 (592)
T ss_pred ecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence 899999999999997665 999999999999999999999999999999999999888754 456779999999999999
Q ss_pred CCCCCCHHHHhcCCCcCCCCcchhhH
Q psy2306 274 PSSRADISVICSHWWIDKDHSVACLE 299 (335)
Q Consensus 274 p~~Rps~~~ll~~~~~~~~~~~~~~~ 299 (335)
|.+|||+++||.|+||.....+.+++
T Consensus 257 P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 257 PSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred cccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 99999999999999997666555443
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-57 Score=391.88 Aligned_cols=262 Identities=37% Similarity=0.618 Sum_probs=234.7
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH----HHHHHHHHHHHHHHcCCCCcccceeEEEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE----ADLIRIRREIQIMSSVRHPNIIHIYEVFE 106 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 106 (335)
...+++.|.+.+.||+|+||.|-+|..+.+|+.||+|++++...... .....+.+|+++|++++|||||+++++|.
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 34588999999999999999999999999999999999987544331 12344679999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC---CCeEEeecccc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN---GNAKIADFGLS 183 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~---~~~kL~df~~~ 183 (335)
..+..|+|+||++||.|.+.+-.++.+.+..-+.+++||+.|+.|||+.||+||||||+|||++.+ ..+||.|||++
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999999999999999999999999999999999999999999999999766 67999999999
Q ss_pred ccccCCccccccccCCccCChhhhcCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHhcCCCCCC----
Q psy2306 184 NVFTESRFLSTFCGSPLYASPEIVKGIP--YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR-LVKQISNGDYFEP---- 256 (335)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~---- 256 (335)
...+........||||.|.|||++.... ++..++|+|||||++|-|++|.+||.+..... +.+++..+.+...
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 9999888888999999999999997553 44558899999999999999999998876655 8888888876433
Q ss_pred -CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 257 -KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 257 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
..+.+..++|.+||..||++|||+.|+|+||||+..
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 236689999999999999999999999999999864
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-55 Score=375.56 Aligned_cols=255 Identities=31% Similarity=0.478 Sum_probs=232.7
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-eEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE-KMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv 114 (335)
.+.+..+.||+|..|+||+++++.+++-+|+|++.. ..+++..+++.+|+++++..+||+||.+|+.|.+.+ .+.++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 377888999999999999999999999999999954 346778889999999999999999999999999998 49999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
||||++|+|.+++...+++++..+..++.++++||.|||. .+|+||||||+||||+..|.+||||||.+..+.+. ...
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~ 235 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IAN 235 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcc
Confidence 9999999999999988999999999999999999999995 99999999999999999999999999999888766 667
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhcCCCC--CC-CCCCchHHH
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS-----NFKRLVKQISNGDYF--EP-KNQSTASPL 265 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~--~~-~~~~~l~~l 265 (335)
...||..|||||.+.+..| +.++||||||++++||++|+.||... +..++...|..+..+ +. .+++++.+|
T Consensus 236 tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred cccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 8899999999999999988 99999999999999999999999774 677788888875432 22 367789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 266 IAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
|..||++||.+||++.|+++|||+++...
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999999999999999999999996544
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=374.15 Aligned_cols=261 Identities=36% Similarity=0.605 Sum_probs=242.0
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|.+.+.||+|+||.||.++.+++++-||+|++++.........+....|..+|..++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45999999999999999999999999999999999987777777888999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCcccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~ 193 (335)
+||+.||.|...|++.+.+++..+..++.+|+.||.|||++|||||||||+|||++.+|+++|+|||++...- ......
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~ 183 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATR 183 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998543 334445
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCC-CCCchHHHHHHhcc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD-YFEPK-NQSTASPLIAEMLN 271 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~l~~li~~~l~ 271 (335)
..+||+.|||||++.+..+ +.++|+||||+++|+|++|.+||...+..++.+.+..++ ...+. .+.+.+++++++|.
T Consensus 184 tfcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~ 262 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLK 262 (357)
T ss_pred cccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhc
Confidence 6799999999999999887 999999999999999999999999999999999999988 44444 78899999999999
Q ss_pred cCCCCCC----CHHHHhcCCCcCCCCcch
Q psy2306 272 INPSSRA----DISVICSHWWIDKDHSVA 296 (335)
Q Consensus 272 ~dp~~Rp----s~~~ll~~~~~~~~~~~~ 296 (335)
.||++|. ++.+|-+||||+...+..
T Consensus 263 rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 263 RDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred cCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 9999995 899999999999876554
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=375.35 Aligned_cols=261 Identities=35% Similarity=0.577 Sum_probs=240.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 113 (335)
-++|..++.||.|+|++|++|+++.+++.||+|++.+.....+.-.+.+..|-..|..| .||+|++++..|.|+..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 34899999999999999999999999999999999887776777777888999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc-
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL- 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~- 192 (335)
|+||+++|+|.++|++.+.+++.....++.+|+.||+|||++|||||||||+|||++.+++++|.|||.+..+.+....
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999887532211
Q ss_pred -------------cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCC
Q psy2306 193 -------------STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKN 258 (335)
Q Consensus 193 -------------~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~ 258 (335)
.+.+||..|.+||++..... ++.+|+|+|||++|+|+.|.+||.+.+..-+.+.|..-.+ +++..
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~f 310 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGF 310 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCC
Confidence 34789999999999999887 8999999999999999999999999999999999988766 56667
Q ss_pred CCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 259 QSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 259 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
++.+.+||+++|..||.+|+++.+|-+||||....+..
T Consensus 311 p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 311 PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred CHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 88999999999999999999999999999999876554
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-52 Score=359.49 Aligned_cols=258 Identities=34% Similarity=0.626 Sum_probs=237.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+... .....+.+..|+.+|+.++|||||.+++++.+++.+|+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 35689999999999999999999999999999999987544 55677888999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC------CCeEEeecccccccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN------GNAKIADFGLSNVFT 187 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~------~~~kL~df~~~~~~~ 187 (335)
|||||+||+|.+++++++.+++..++.++.||+.||++||+++||||||||.|||++.. -.+||.|||+++.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999865 468999999999999
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCC----CCCchH
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPK----NQSTAS 263 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~l~ 263 (335)
+.......+|++.|||||+++...| +.|+|+||+|+++|+|++|..||...+..++...+..+....+. ......
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~Y-dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQY-DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccc-cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence 9988999999999999999998887 89999999999999999999999999999999888877653333 355777
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
+++...|+.+|..|.+..+-+.|+++....
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 999999999999999999999999998664
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-52 Score=346.16 Aligned_cols=261 Identities=33% Similarity=0.593 Sum_probs=243.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|.+.+.||.|+||.|.+++.+.+|..+|+|++.+...-.-...+...+|-.+|+.+.||+++++++.|.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 48999999999999999999999999999999999877777777888999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||++||.|..++++.+++++..++.++.|++.||+|||+.+|++||+||+|||++.+|++|+.|||++...... ....
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~Tl 201 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTL 201 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999887665 5678
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-CCCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-KNQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp 274 (335)
||||.|+|||++...++ ..++|.|+||+++|||+.|.+||.+.++..+.++|..++...| ..+++++++|+++|+.|-
T Consensus 202 CGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~ 280 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDL 280 (355)
T ss_pred cCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhh
Confidence 99999999999999888 8899999999999999999999999999999999999987554 468899999999999999
Q ss_pred CCC-----CCHHHHhcCCCcCCCCcchhhH
Q psy2306 275 SSR-----ADISVICSHWWIDKDHSVACLE 299 (335)
Q Consensus 275 ~~R-----ps~~~ll~~~~~~~~~~~~~~~ 299 (335)
.+| ...++|..||||+...+.+...
T Consensus 281 t~R~gnlknG~~dIk~H~wF~~v~W~~i~~ 310 (355)
T KOG0616|consen 281 TKRFGNLKNGVEDIKNHPWFKGVDWEAILQ 310 (355)
T ss_pred HhhhcCcCCCccccccCcccccccHHHHhh
Confidence 999 4778999999999877665444
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-51 Score=368.67 Aligned_cols=260 Identities=46% Similarity=0.811 Sum_probs=239.0
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-C-HHHHHHHHHHHHHHHcCC-CCcccceeEEEEeC
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-T-EADLIRIRREIQIMSSVR-HPNIIHIYEVFENR 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 108 (335)
....++|.+++.||+|+||.|+.|.+..+|..||+|++...... . ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 45677999999999999999999999999999999977653221 1 134556778999999999 99999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-CCeEEeeccccccc-
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-GNAKIADFGLSNVF- 186 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~-~~~kL~df~~~~~~- 186 (335)
..+++||||+.||+|.+++...+++.+..+..+++|++.|++|+|++||+||||||+||+++.+ +++||+|||++...
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 99999999999988
Q ss_pred cCCccccccccCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCC--CCchH
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKN--QSTAS 263 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~l~ 263 (335)
.........+|++.|+|||++.+.. |.+.++||||+|++||.|++|..||.+.+...+...+..+.+..+.. +.++.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEAR 252 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHH
Confidence 4666677889999999999999988 87899999999999999999999999999999999999988766665 78999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
+++++||..||.+|+++.+|+.||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999997
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-51 Score=366.26 Aligned_cols=259 Identities=31% Similarity=0.546 Sum_probs=234.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|.+++.||+|+||.||+|+.+.||..+|+|+++++........+.++.|-.+|....++.||+++..|.+.+++||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 58999999999999999999999999999999999987777778889999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-------
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE------- 188 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~------- 188 (335)
||++||++..+|.+.+.+++..+..++.+++.|+..||+.|++||||||+|+||+..||+||+|||++.....
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999743210
Q ss_pred ------------------C-----------------------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHH
Q psy2306 189 ------------------S-----------------------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLY 227 (335)
Q Consensus 189 ------------------~-----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~ 227 (335)
. ....+.+|||.|+|||++.+..+ +..+|+|||||++|
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG~Imy 379 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLGCIMY 379 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHHHHHH
Confidence 0 00123679999999999999887 99999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhcCC--CC---CCCCCCchHHHHHHhcccCCCCCC---CHHHHhcCCCcCCCCcch
Q psy2306 228 TLVYGAMPFDGSNFKRLVKQISNGD--YF---EPKNQSTASPLIAEMLNINPSSRA---DISVICSHWWIDKDHSVA 296 (335)
Q Consensus 228 ~l~tg~~p~~~~~~~~~~~~~~~~~--~~---~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~~~~ 296 (335)
||+.|.+||.+.++.+...++.+.+ +. ....+++..++|.+||. ||.+|. .++||-+||||+...+.-
T Consensus 380 EmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 380 EMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 9999999999999999999998865 22 23346699999999999 999996 699999999999876653
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=369.97 Aligned_cols=270 Identities=30% Similarity=0.480 Sum_probs=243.1
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
..-...|+...+||+|+.|.||.|....+++.||+|.+....... .+-+.+|+.+++..+|+|||++++.|...+.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 444568999999999999999999999999999999998754333 44678999999999999999999999989999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR- 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~- 190 (335)
|+||||++||+|.+.+... .+++.++..++++++.||+|||.+||+|+|||.+||+++.+|.+||+|||++.......
T Consensus 346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999999999999754 49999999999999999999999999999999999999999999999999998876554
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCchHHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTASPLI 266 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li 266 (335)
......|||.|||||+.....| +++.||||||++++||+.|++||-+.++.+.+..+..+..+ +...++.+++|+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 5678899999999999999888 99999999999999999999999999888888877766543 344577999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHhc
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELAN 306 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~ 306 (335)
.+||+.|+.+|+++.+||+||||+.....+++..+...++
T Consensus 504 ~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi~~~~ 543 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEHPFLKMAKPESSLNPLILAAR 543 (550)
T ss_pred HHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHHHHHH
Confidence 9999999999999999999999999999988887776654
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=366.47 Aligned_cols=261 Identities=30% Similarity=0.500 Sum_probs=229.0
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCC-
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENRE- 109 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~- 109 (335)
-.+-+||+++++||.|.||.||+|+.+.+|..||+|.|+.... .-++ -.-.+|+..|+++. ||||+++.+++.+.+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 3567899999999999999999999999999999999987432 2222 23458999999998 999999999999888
Q ss_pred eEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
.+++||||| ..+|.++++. +.++++..+..|+.||++||+|+|++|++|||+||+|||+.....+||+|||+|+....
T Consensus 84 ~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 999999999 5699999986 45799999999999999999999999999999999999999899999999999999999
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-----------------
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG----------------- 251 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~----------------- 251 (335)
....+..+.|.||+|||++....+|+...|||++||+++|+.+-++.|.+.+.-+.+.+|..-
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 888999999999999999999888899999999999999999999999987766655555530
Q ss_pred ----CC----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 252 ----DY----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 252 ----~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.+ ..+..+.+..++|.+||++||.+||||.|+|+||||+.....
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 00 122346688899999999999999999999999999865433
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-51 Score=371.07 Aligned_cols=261 Identities=43% Similarity=0.748 Sum_probs=245.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+-|++++.||.|+.|.|-+|.+..||+..|||++.+...........+.+|+-+++.+.|||+++++++|++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 47999999999999999999999999999999998754344445567789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||++||.|++++-.++++++.+...+++||+.|+.|.|..+|+|||+||+|+|++..+++||+|||.|....+.......
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS 171 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS 171 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988888999
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCC-CCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPK-NQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp 274 (335)
||+|.|.+||++.+.+|++.++||||.|++||.|++|..||++.+...++.++..+.+..+. .+.++++||++||..||
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp 251 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDP 251 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCc
Confidence 99999999999999999999999999999999999999999999999999999999986554 68899999999999999
Q ss_pred CCCCCHHHHhcCCCcCCCCcch
Q psy2306 275 SSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 275 ~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
.+|.|.+||++|||+.......
T Consensus 252 ~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 252 STRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred cccccHHHHhhCchhhcCCCCC
Confidence 9999999999999999765553
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=353.36 Aligned_cols=278 Identities=61% Similarity=1.078 Sum_probs=265.2
Q ss_pred CCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccc
Q psy2306 21 STGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100 (335)
Q Consensus 21 ~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 100 (335)
..-++..+.....++.||.+.+.||+|.||.|-+|.+...|+.||+|.+.+....++.+.-.+++|++++..++||||+.
T Consensus 38 k~~gvkrhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~ 117 (668)
T KOG0611|consen 38 KMSGVKRHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQ 117 (668)
T ss_pred ccccccccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceee
Confidence 35566677788889999999999999999999999998999999999999999999999999999999999999999999
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeec
Q psy2306 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180 (335)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df 180 (335)
++.+|+..+.+.+||||..+|.|.+++..++.+++.+...+++||..|+.|.|+++++|||||.+|||++.++++||.||
T Consensus 118 IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 118 IYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred hhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCC
Q psy2306 181 GLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS 260 (335)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (335)
|++..+.........+|+|.|.+||+..+.+|-+++.|.||||++||-|..|..||++.+...+..++.++.+..+..+.
T Consensus 198 GLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PS 277 (668)
T KOG0611|consen 198 GLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPS 277 (668)
T ss_pred chhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhh
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACL 298 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 298 (335)
...-+|+.||..+|++|.|+++|.+|+|+.=.+.....
T Consensus 278 dA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V~ 315 (668)
T KOG0611|consen 278 DASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPVI 315 (668)
T ss_pred hHHHHHHHHHhcCcccchhHHHHhhhheeecccccccc
Confidence 99999999999999999999999999999855444333
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-51 Score=340.60 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=217.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|....++|+|+||+||+|++++||+-||+|.+..+. ++....+-..+|+++|++++|+|+|.++.+|......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 47888999999999999999999999999999997643 34555667789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~ 194 (335)
|||+..-|.++-.....++.+.++++++|++.|+.|+|+++++||||||+||+|+.+|.+||||||+|+... +....+.
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 999774444444334458999999999999999999999999999999999999999999999999999887 5666778
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---------------CCC------
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---------------GDY------ 253 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---------------~~~------ 253 (335)
.+.|.||+|||.+.+...|+..+|||++||++.||++|.+.|++...-+....|.. +.+
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 89999999999999977679999999999999999999999988765444443332 111
Q ss_pred CC-----------CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 254 FE-----------PKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 254 ~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
+. +..+.-+.+|++.||..||.+|++.+|+|.|+||.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 11 11233567899999999999999999999999993
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=339.92 Aligned_cols=245 Identities=31% Similarity=0.578 Sum_probs=221.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeE-EEEeCCe-E
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE-VFENREK-M 111 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~-~ 111 (335)
--..|+|.++||+|.||.||++++..+|+.+|+|.++. ..-+......+..|+.+|++++||||+++++ .|..++. +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f-~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF-GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch-hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 34479999999999999999999999999999999984 4456677889999999999999999999998 5555554 8
Q ss_pred EEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHH--CC--cEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 112 VLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHK--HK--ICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~--~g--ivH~di~p~nili~~~~~~kL~df~~~ 183 (335)
+++||+|++|+|.++++. +..+++..+|+++.|++.||..+|+ .. ++||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999974 5679999999999999999999998 45 999999999999999999999999999
Q ss_pred ccccCCcc-ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC---CCCC
Q psy2306 184 NVFTESRF-LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE---PKNQ 259 (335)
Q Consensus 184 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 259 (335)
+.+..... ..+.+|||.||+||.+.+.+| +.+|||||+||++|||+.-++||.+.+..+++++|..+.+.+ ..++
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhh
Confidence 98865544 467899999999999999998 999999999999999999999999999999999999998743 2367
Q ss_pred CchHHHHHHhcccCCCCCCCH
Q psy2306 260 STASPLIAEMLNINPSSRADI 280 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~ 280 (335)
.++..+|..|+..||..||+.
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hHHHHHHHHHccCCcccCCCc
Confidence 899999999999999999984
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=363.69 Aligned_cols=257 Identities=35% Similarity=0.620 Sum_probs=236.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+... .+.+...+++|+++++.++||||+.++++|+...+.|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 579999999999999999999999999999999987553 4566788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-ccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-~~~ 194 (335)
||+.| +|..++...+.++++.+..++.+++.||.|||+.+|.|+|+||.||++...|++||||||+++.+..... ...
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 99976 9999999999999999999999999999999999999999999999999999999999999998875443 467
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~d 273 (335)
..|||.|||||.+.+.++ +..+|+|||||++|||+.|++||......++.+.|...... +...+..+.+|++.+|.+|
T Consensus 160 ikGtPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred ccCcccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcC
Confidence 789999999999998887 89999999999999999999999999999999999988654 4456779999999999999
Q ss_pred CCCCCCHHHHhcCCCcCCCCcc
Q psy2306 274 PSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 274 p~~Rps~~~ll~~~~~~~~~~~ 295 (335)
|.+|.+..+++.|||.+.....
T Consensus 239 P~~RltW~~Ll~HpF~k~~~~~ 260 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKGKINI 260 (808)
T ss_pred hhhcccHHHHhcChHHhhhhhh
Confidence 9999999999999999865333
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=351.05 Aligned_cols=255 Identities=27% Similarity=0.500 Sum_probs=226.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+|+.|++|.+...........+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987643333445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~ 158 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL 158 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998765432 2235
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp 274 (335)
.|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+...... +...+..+.++|++||+.||
T Consensus 159 ~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp 237 (291)
T cd05612 159 CGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDR 237 (291)
T ss_pred cCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCH
Confidence 68899999999988776 89999999999999999999999998888877777766543 34457789999999999999
Q ss_pred CCCCC-----HHHHhcCCCcCCCC
Q psy2306 275 SSRAD-----ISVICSHWWIDKDH 293 (335)
Q Consensus 275 ~~Rps-----~~~ll~~~~~~~~~ 293 (335)
.+||+ ++++++||||....
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred HHccCCccCCHHHHhcCccccCCC
Confidence 99995 99999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=354.09 Aligned_cols=255 Identities=29% Similarity=0.547 Sum_probs=227.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+++.|++|.+...........+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999998644334445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||+++++|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 175 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTL 175 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--cee
Confidence 999999999999988889999999999999999999999999999999999999999999999999987654332 235
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-CCCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-KNQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp 274 (335)
.|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+..+....+ ..+..+.++|++||+.||
T Consensus 176 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP 254 (329)
T PTZ00263 176 CGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDH 254 (329)
T ss_pred cCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCH
Confidence 68999999999988776 8999999999999999999999999888888777777655433 356789999999999999
Q ss_pred CCCCC-----HHHHhcCCCcCCCC
Q psy2306 275 SSRAD-----ISVICSHWWIDKDH 293 (335)
Q Consensus 275 ~~Rps-----~~~ll~~~~~~~~~ 293 (335)
.+|++ ++++++||||+...
T Consensus 255 ~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 255 TKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred HHcCCCCCCCHHHHhcCCccCCCC
Confidence 99986 79999999998743
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=347.60 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=218.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC--eEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE--KMV 112 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 112 (335)
..+|+..+.||+|+||+||++.+..+|...|+|.+.... ....+.+.+|+.+|+.++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 347889999999999999999999999999999987642 122667889999999999999999999754444 799
Q ss_pred EEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEeeccccccccC--
Q psy2306 113 LVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADFGLSNVFTE-- 188 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~df~~~~~~~~-- 188 (335)
+.|||+++|+|.+++.+.+ .+++..+..+.+|+++||+|||++|++|+||||+|||++. ++.+||+|||.+.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999866 7999999999999999999999999999999999999999 69999999999877663
Q ss_pred --CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcCC---CCCCCCCCch
Q psy2306 189 --SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGD---YFEPKNQSTA 262 (335)
Q Consensus 189 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~~---~~~~~~~~~l 262 (335)
........|++.|||||++........++|||||||++.||+||..||.. .........+.... ..+...+.+.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 22234578999999999998643324599999999999999999999987 44444444444333 3445567789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
.+|+.+|+..||.+||||+++|.|||......
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987655
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=339.49 Aligned_cols=262 Identities=30% Similarity=0.432 Sum_probs=227.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
-.+.|++...||.|..++||+|+...++..|+||++..... ..+.+.+++|+..++.++||||++++..|..+..+|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 35699999999999999999999999999999999987443 3347889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 114 VMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
||.||.+|++.++++.. ..+++..+..+++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+.....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999999863 3499999999999999999999999999999999999999999999999998765543222
Q ss_pred c-----cccccCCccCChhh-hcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC---------
Q psy2306 192 L-----STFCGSPLYASPEI-VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP--------- 256 (335)
Q Consensus 192 ~-----~~~~~~~~~~aPE~-~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 256 (335)
. ....|+++|||||+ +....-|+.|+||||||++..||++|..||...-+.+++-.-..+.++.+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 1 34579999999999 55555569999999999999999999999999888876665555544311
Q ss_pred --CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchh
Q psy2306 257 --KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVAC 297 (335)
Q Consensus 257 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 297 (335)
..+..+..+|..||++||.+|||++++|+|+||+.....+.
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY 304 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence 22557889999999999999999999999999997765543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=350.65 Aligned_cols=251 Identities=34% Similarity=0.619 Sum_probs=222.1
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..+++|||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998644334445567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCCc
Q psy2306 122 ELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPL 200 (335)
Q Consensus 122 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~~ 200 (335)
+|.+++..+..+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++.... .........|++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 999999888889999999999999999999999999999999999999999999999999986532 2223345678999
Q ss_pred cCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCC-
Q psy2306 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRA- 278 (335)
Q Consensus 201 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp- 278 (335)
|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..... .+...+.++.++|++||+.||.+||
T Consensus 161 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred ccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 999999988776 8999999999999999999999999888887777766544 3445678999999999999999999
Q ss_pred ----CHHHHhcCCCcCCCC
Q psy2306 279 ----DISVICSHWWIDKDH 293 (335)
Q Consensus 279 ----s~~~ll~~~~~~~~~ 293 (335)
++.++++||||+...
T Consensus 240 ~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 240 GGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 899999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=339.11 Aligned_cols=269 Identities=26% Similarity=0.467 Sum_probs=232.8
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN- 107 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 107 (335)
.....+..+|...+.||+|+||.|+.+.++.+|+.||+|.+.. .+......++..+|+.+|+.++|+||+.+++++..
T Consensus 15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP 93 (359)
T ss_pred eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence 3445567788889999999999999999999999999999874 35667778899999999999999999999999854
Q ss_pred ----CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 108 ----REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 108 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
-+.+|+|+|+| +.+|.+.++++..+++..+..+++|++.||.|+|+.|++|||+||+|++++.++.+|+||||++
T Consensus 94 ~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 45799999999 6699999999888999999999999999999999999999999999999999999999999999
Q ss_pred ccccC---CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc----------
Q psy2306 184 NVFTE---SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---------- 250 (335)
Q Consensus 184 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---------- 250 (335)
+.... ....+..+.|.||.|||++.....++.+.||||.||++.||++|++.|.+.+.-+.++.+..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 88864 45557788899999999998777779999999999999999999999988764433333322
Q ss_pred --------------CCC--------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhH
Q psy2306 251 --------------GDY--------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLE 299 (335)
Q Consensus 251 --------------~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~ 299 (335)
... ..+..++...+++.+||..||.+|+|++|+|+|||++..+.++..+
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 000 1345577889999999999999999999999999999887775544
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=349.42 Aligned_cols=263 Identities=29% Similarity=0.525 Sum_probs=229.5
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCC-cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETG-QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN 107 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~-~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 107 (335)
.....-.++|++.+.||+|+||.||+|.+..++ ..|++|.+...........+.+.+|+.+++.++||||+++++++.+
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence 334445568999999999999999999876654 6899999876443344456678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
.+..+++|||+++++|.+++..++.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHH
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLI 266 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 266 (335)
.. .....|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..... .+...++.+.++|
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 183 TR--TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred CC--cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 32 234568999999999987766 8899999999999999999999999888877777776654 3445677899999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCcCCCCc
Q psy2306 267 AEMLNINPSSRA-----DISVICSHWWIDKDHS 294 (335)
Q Consensus 267 ~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 294 (335)
++||+.||.+|+ +++++++||||+...+
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999995 8999999999987543
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=351.85 Aligned_cols=275 Identities=29% Similarity=0.489 Sum_probs=245.1
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
....|+..+.||+|.||.||+|++..+++.||+|++... .....++.+.+|+.+|..++++||.++|+.+..+..+|+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le--~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE--EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechh--hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 345889999999999999999999999999999999863 345567889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc-
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL- 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~- 192 (335)
+|||+.||++.++++....+.+..+..++++++.|+.|||..+.+|+|||+.||++..+|.+||+|||.+..+......
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999887654333
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHHHHhc
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLIAEML 270 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l 270 (335)
....||+.|||||++.+..| +.++||||||++.+||++|.+|+....+......|-...++ ...+++.+++||..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y-~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGY-DTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccc-cchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 67899999999999997666 89999999999999999999999998886665555554432 2345668999999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHhccCccc
Q psy2306 271 NINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTPVR 311 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (335)
++||+.||+|.++|+|+|++...+...+.++...++++...
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~~ 288 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRVK 288 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhhc
Confidence 99999999999999999999988777788888877777665
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=348.21 Aligned_cols=254 Identities=31% Similarity=0.529 Sum_probs=224.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+++.|++|++.............+.+|+.++..++||||+++++++.+.+..|++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998644334445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... .....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~ 158 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV 158 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999876543 23455
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCC-------CCCCchHHHH
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEP-------KNQSTASPLI 266 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~-------~~~~~l~~li 266 (335)
.|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+..... ..+ ..+.++.++|
T Consensus 159 ~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 159 VGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred ccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 78999999999988766 8999999999999999999999998888777666554221 111 3367899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+||+.+|.+||++.++++||||...
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=317.52 Aligned_cols=255 Identities=30% Similarity=0.503 Sum_probs=218.7
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
.+|...+.||+|.||+||+|++..+|+.||+|.+...... ........+|+..|+.++|+||+.++++|.+.+..-+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4788999999999999999999999999999999875332 223446779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc-c
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-S 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~-~ 193 (335)
||++ .+|+..++. ...++..+++.++.+++.|++|+|++.|+||||||+|+||+.+|.+||+|||+++........ .
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 9995 599999975 457999999999999999999999999999999999999999999999999999998755443 3
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc----C------------------
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN----G------------------ 251 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~----~------------------ 251 (335)
..+.|.||.|||.+.+...|+...||||.||++.||+-|.+-|.+.+.-+....+-. .
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 347899999999999998889999999999999999999988877654443333221 0
Q ss_pred -------CCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 252 -------DYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 252 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
....+..+.+..+++.+||..||.+|+++.|+|+|+||+..
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 00122335577899999999999999999999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=342.75 Aligned_cols=248 Identities=31% Similarity=0.534 Sum_probs=219.7
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCH
Q psy2306 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGEL 123 (335)
Q Consensus 44 ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 123 (335)
||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+.+..+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999764434445566788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-CccccccccCCccC
Q psy2306 124 YDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFLSTFCGSPLYA 202 (335)
Q Consensus 124 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~~~~~~~~~~~~ 202 (335)
.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... ........|++.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99998888899999999999999999999999999999999999999999999999999875432 22233456899999
Q ss_pred ChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCC---
Q psy2306 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRA--- 278 (335)
Q Consensus 203 aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp--- 278 (335)
|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..... .+...++++.+++.+||+.||.+||
T Consensus 161 aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 161 APELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred CHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 9999988776 8999999999999999999999998888887777766544 3445678999999999999999997
Q ss_pred CHHHHhcCCCcCCC
Q psy2306 279 DISVICSHWWIDKD 292 (335)
Q Consensus 279 s~~~ll~~~~~~~~ 292 (335)
++.+++.||||.+.
T Consensus 240 ~~~e~l~hp~~~~~ 253 (312)
T cd05585 240 GAQEIKNHPFFSQL 253 (312)
T ss_pred CHHHHHcCCCcCCC
Confidence 58999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=350.08 Aligned_cols=255 Identities=35% Similarity=0.638 Sum_probs=224.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.+..+|+.||+|++.............+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998644333345667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-----
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR----- 190 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~----- 190 (335)
||+++++|.+++.....+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987654432
Q ss_pred -------------------------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q psy2306 191 -------------------------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV 245 (335)
Q Consensus 191 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~ 245 (335)
......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 2234568999999999988876 89999999999999999999999988877777
Q ss_pred HHHhc--CCCC---CCCCCCchHHHHHHhcccCCCCCCC-HHHHhcCCCcCCC
Q psy2306 246 KQISN--GDYF---EPKNQSTASPLIAEMLNINPSSRAD-ISVICSHWWIDKD 292 (335)
Q Consensus 246 ~~~~~--~~~~---~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~~~~~~~ 292 (335)
..+.. .... ....++++.++|.+||. ||.+||+ ++++++||||+..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 66665 2221 22247799999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=325.76 Aligned_cols=271 Identities=34% Similarity=0.585 Sum_probs=240.7
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
+-.+.+.|.+.+.||+|.|++|+++....+|+.+++|++....+... ..+++.+|+++-+.++||||+++++.+.+.+.
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 34578899999999999999999999999999999999876554333 67788999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CCCeEEeecccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NGNAKIADFGLSNVFT 187 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~~~kL~df~~~~~~~ 187 (335)
.|+|+|+++|++|..-|-++...++..+--.++||+++|.|.|.+||||||++|+|+++-. ..-+||+|||++...+
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999999765555566889999999999999999999999999999999999954 3369999999999988
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCCch
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQSTA 262 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~l 262 (335)
.........|+|.|||||+++..++ +..+|||+.|+++|-|+.|.+||.+.+..++.+++..+.+.. +...++.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 7777778899999999999999998 889999999999999999999999999999999999886532 2346689
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHH
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEE 303 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~ 303 (335)
+++|++||..||.+|.|+.|.|+|||+.+....++....++
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~d 284 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQD 284 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHH
Confidence 99999999999999999999999999998877766554443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=343.85 Aligned_cols=251 Identities=34% Similarity=0.619 Sum_probs=221.2
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
+.||+|+||.||++.+..+|..||+|.+.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998644334455667788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-CccccccccCCc
Q psy2306 122 ELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFLSTFCGSPL 200 (335)
Q Consensus 122 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~~~~~~~~~~ 200 (335)
+|..++.....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..... ........|++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 9999998888899999999999999999999999999999999999999999999999998865322 222334568999
Q ss_pred cCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCC-
Q psy2306 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRA- 278 (335)
Q Consensus 201 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp- 278 (335)
|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..... .+...++++.++|.+||+.||.+|+
T Consensus 161 y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence 999999988776 8999999999999999999999998888877777765543 3455678999999999999999998
Q ss_pred ----CHHHHhcCCCcCCCC
Q psy2306 279 ----DISVICSHWWIDKDH 293 (335)
Q Consensus 279 ----s~~~ll~~~~~~~~~ 293 (335)
++.++++||||....
T Consensus 240 ~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 240 GGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=343.40 Aligned_cols=251 Identities=34% Similarity=0.618 Sum_probs=221.1
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
+.||+|+||.||++.+..+|+.||+|++.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998654444455677889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCCc
Q psy2306 122 ELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPL 200 (335)
Q Consensus 122 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~~ 200 (335)
+|..++.....+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.... .........|++.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 999999888889999999999999999999999999999999999999999999999999986532 2222334568999
Q ss_pred cCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCC-
Q psy2306 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRA- 278 (335)
Q Consensus 201 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp- 278 (335)
|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..... .+...+.++.++|++||+.||.+|+
T Consensus 161 y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred ccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999988776 8999999999999999999999998888777777665544 3445677999999999999999997
Q ss_pred ----CHHHHhcCCCcCCCC
Q psy2306 279 ----DISVICSHWWIDKDH 293 (335)
Q Consensus 279 ----s~~~ll~~~~~~~~~ 293 (335)
++.++++||||....
T Consensus 240 ~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 240 GGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 899999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=346.10 Aligned_cols=257 Identities=26% Similarity=0.477 Sum_probs=220.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|..++..++|++|+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997644334455667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-----
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR----- 190 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~----- 190 (335)
||+++++|.+++.+++.+++..+..++.|++.||.|||+.|++||||||+||+++.+++++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986542210
Q ss_pred -------------------------------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy2306 191 -------------------------------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS 239 (335)
Q Consensus 191 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~ 239 (335)
.....+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0123478999999999988776 88999999999999999999999998
Q ss_pred cHHHHHHHHhcCC--C-CC--CCCCCchHHHHHHhccc--CCCCCCCHHHHhcCCCcCCCC
Q psy2306 240 NFKRLVKQISNGD--Y-FE--PKNQSTASPLIAEMLNI--NPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 240 ~~~~~~~~~~~~~--~-~~--~~~~~~l~~li~~~l~~--dp~~Rps~~~ll~~~~~~~~~ 293 (335)
+..+....+.... . .+ ...++++.++|.+|+.. ++..||++++|++||||+...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCC
Confidence 8888777776532 1 12 23466899999997752 233568999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=348.58 Aligned_cols=256 Identities=30% Similarity=0.522 Sum_probs=221.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++|+||+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998644334455667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-----
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR----- 190 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~----- 190 (335)
||+++++|.+++..++.+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999886542211
Q ss_pred ----------------------------------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy2306 191 ----------------------------------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236 (335)
Q Consensus 191 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~ 236 (335)
......|++.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 0112458999999999988776 89999999999999999999999
Q ss_pred CCCcHHHHHHHHhcCCC--C-C--CCCCCchHHHHHHhcccCCCCCCC---HHHHhcCCCcCCCC
Q psy2306 237 DGSNFKRLVKQISNGDY--F-E--PKNQSTASPLIAEMLNINPSSRAD---ISVICSHWWIDKDH 293 (335)
Q Consensus 237 ~~~~~~~~~~~~~~~~~--~-~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~ 293 (335)
...+..+....+..... . + ...++++.++|++||. +|.+|++ ++++++||||+...
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 98888777666654321 1 1 1346689999999997 9999997 99999999998753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=336.57 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=217.3
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++|++++++++++.+.+..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999876443333444567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 117 YAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
|+++++|..++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 9999999888754 34689999999999999999999999999999999999999999999999999877654444445
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHHhcCC-CCCCCCCCchHHHHHHh
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK----RLVKQISNGD-YFEPKNQSTASPLIAEM 269 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~----~~~~~~~~~~-~~~~~~~~~l~~li~~~ 269 (335)
..|+..|+|||++.+..+ +.++||||||+++|+|++|..||...+.. .....+.... ......+.++.+++++|
T Consensus 161 ~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 161 RVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 678999999999988776 88999999999999999999999875432 2222222222 23345677899999999
Q ss_pred cccCCCCCCC-----HHHHhcCCCcCCC
Q psy2306 270 LNINPSSRAD-----ISVICSHWWIDKD 292 (335)
Q Consensus 270 l~~dp~~Rps-----~~~ll~~~~~~~~ 292 (335)
|+.||.+||+ ++++++||||...
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999997 8999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=332.20 Aligned_cols=258 Identities=33% Similarity=0.523 Sum_probs=232.7
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|++.+.||+|.-|+||++.+..++..+|+|++.+..........++..|-++|+.+.||.++.+|..|+.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 78999999999999999999999999999999998777667777888999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC------
Q psy2306 117 YAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE------ 188 (335)
Q Consensus 117 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~------ 188 (335)
||+||+|..+++++ +.+++..++.++.+++.||+|||-.|||.|||||+||||.++|++.|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 99999999998764 5699999999999999999999999999999999999999999999999987532100
Q ss_pred -----------------------------C----------------------ccccccccCCccCChhhhcCCCCCCCcc
Q psy2306 189 -----------------------------S----------------------RFLSTFCGSPLYASPEIVKGIPYHGPEV 217 (335)
Q Consensus 189 -----------------------------~----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 217 (335)
. ....+.+||-.|.|||++.+... +.++
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH-gsAV 316 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH-GSAV 316 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC-Cchh
Confidence 0 00123568889999999999886 8999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCC---CchHHHHHHhcccCCCCCCC----HHHHhcCCCcC
Q psy2306 218 DCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ---STASPLIAEMLNINPSSRAD----ISVICSHWWID 290 (335)
Q Consensus 218 Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps----~~~ll~~~~~~ 290 (335)
|+|+||+++|||+.|..||.+.+.++...++.......+..+ ..+++||+++|.+||++|.. |.||-+||||+
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~ 396 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFE 396 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcccc
Confidence 999999999999999999999999999999998877666665 68999999999999999998 99999999999
Q ss_pred CCCcc
Q psy2306 291 KDHSV 295 (335)
Q Consensus 291 ~~~~~ 295 (335)
...+.
T Consensus 397 gVnWa 401 (459)
T KOG0610|consen 397 GVNWA 401 (459)
T ss_pred CCChh
Confidence 87666
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=351.89 Aligned_cols=259 Identities=33% Similarity=0.558 Sum_probs=236.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 113 (335)
-++|++.+.||+|.||.|+++..+.+++.||||++++...-...+.+....|-+++.... ||.++.++..|...+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 458999999999999999999999999999999999988888888999999999998885 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~ 192 (335)
||||+.||++..+ .+...+++..+..++.+++.||.|||++|||+||||.+|||+|.+|++||+|||++...- .....
T Consensus 447 vmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T 525 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT 525 (694)
T ss_pred EEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence 9999999995444 345679999999999999999999999999999999999999999999999999997643 55567
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCC-CCCchHHHHHHhcc
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPK-NQSTASPLIAEMLN 271 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~ 271 (335)
+..+|||.|+|||++.+..| +.++|+|+||++||||+.|+.||.+.+.+++...|.+.....|. .+.+..++++++|.
T Consensus 526 sTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~ 604 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLR 604 (694)
T ss_pred ccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhc
Confidence 78999999999999999998 99999999999999999999999999999999999998876555 57799999999999
Q ss_pred cCCCCCCC-----HHHHhcCCCcCCCCcc
Q psy2306 272 INPSSRAD-----ISVICSHWWIDKDHSV 295 (335)
Q Consensus 272 ~dp~~Rps-----~~~ll~~~~~~~~~~~ 295 (335)
++|++|.. +++|..||||+.-.+.
T Consensus 605 k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 605 KNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred cCcccccCCCCCCchhhhhCCccccCCHH
Confidence 99999974 6899999999976544
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=339.16 Aligned_cols=261 Identities=34% Similarity=0.643 Sum_probs=226.2
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-----------CHHHHHHHHHHHHHHHcCCCCccc
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-----------TEADLIRIRREIQIMSSVRHPNII 99 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i~ 99 (335)
+...-++|++.+.||+|.||.|-+|++..+++.||+|++.+.... .....+++++|+.++++++|+|||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 445556999999999999999999999999999999998753211 112356899999999999999999
Q ss_pred ceeEEEEe--CCeEEEEEecCCCCCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 100 HIYEVFEN--REKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 100 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
+++.+..+ .+.+|+|+|||..|.+...-. .++ +++.+.++++++++.||+|||.+||+||||||+|+|++.+|++|
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 99999865 458999999999887754433 344 99999999999999999999999999999999999999999999
Q ss_pred Eeecccccccc------CCccccccccCCccCChhhhcC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q psy2306 177 IADFGLSNVFT------ESRFLSTFCGSPLYASPEIVKG---IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQ 247 (335)
Q Consensus 177 L~df~~~~~~~------~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~ 247 (335)
|+|||.+.... .........|||.|+|||...+ ..+.+.+.||||+|++||.|+.|+.||.+....++..+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 99999987662 2223345789999999999876 34557889999999999999999999999999999999
Q ss_pred HhcCCCCCCCC---CCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 248 ISNGDYFEPKN---QSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 248 ~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
|.+.....+.. .+.++++|.+||.+||++|.++.+|..|||....
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 99988766655 5689999999999999999999999999999866
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=333.95 Aligned_cols=252 Identities=29% Similarity=0.471 Sum_probs=211.3
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|+++.+++.|++|++..... .....+.+.+|+..++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999876432 2334567788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc--ccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR--FLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~--~~~ 193 (335)
||++++.+..+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 999987777666556679999999999999999999999999999999999999999999999999987654322 223
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---------------------C
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---------------------D 252 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---------------------~ 252 (335)
...+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 4567899999999988776 88999999999999999999999876543322221110 0
Q ss_pred CC------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 YF------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 ~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.. ....+.++.+++++||+.||.+|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 01135568999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=337.69 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=218.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||.||++++..+|..+++|.+.... .......+.+|++.++.++|+||+++++++.+.+..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 569999999999999999999999999999999987532 344566789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
|||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 160 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 160 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccc
Confidence 99999999999999888899999999999999999999986 6999999999999999999999999998765432 223
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC----------------------
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---------------------- 251 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---------------------- 251 (335)
...+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..++...+...
T Consensus 161 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 4568899999999988776 89999999999999999999999876655543322210
Q ss_pred ------------------------C---CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 252 ------------------------D---YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 252 ------------------------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
. ......++++.+||.+||+.||++|||+++|++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0 0111245678999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=338.46 Aligned_cols=256 Identities=32% Similarity=0.541 Sum_probs=223.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC-CcccceeEEEEeCCeEEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH-PNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 115 (335)
+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+..|...+..++| ++|+.+++++.+.+..|++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986443344456677889999999976 56888999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~ 194 (335)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.... .......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999999999999888889999999999999999999999999999999999999999999999999886432 2223344
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~d 273 (335)
..|++.|+|||++.+..+ +.++||||+|+++|+|++|..||...+..+....+...... +...+.++.+++++||..|
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239 (324)
T ss_pred ecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 568999999999988776 88999999999999999999999998888888877766543 3456778999999999999
Q ss_pred CCCCCCH-----HHHhcCCCcCCCC
Q psy2306 274 PSSRADI-----SVICSHWWIDKDH 293 (335)
Q Consensus 274 p~~Rps~-----~~ll~~~~~~~~~ 293 (335)
|.+|++. +++++||||+...
T Consensus 240 P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 240 PAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999976 8999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=339.10 Aligned_cols=261 Identities=31% Similarity=0.514 Sum_probs=224.1
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
.-..+..+.|..+++||+|.||.||+|++..+|+.||+|.+.... ..+.....+.+|+.+|+++.||||+++.+...+.
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 334556678999999999999999999999999999999998743 3455667788999999999999999999998765
Q ss_pred --CeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 109 --EKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 109 --~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
..+|+|+|||+. +|.-++.. .-.+++.+++-++.||++||+|+|++||+|||||.+||||+.+|.+||+|||++++
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceee
Confidence 789999999966 88888876 44799999999999999999999999999999999999999999999999999997
Q ss_pred ccCCc--cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---C---CCCC--
Q psy2306 186 FTESR--FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---G---DYFE-- 255 (335)
Q Consensus 186 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---~---~~~~-- 255 (335)
..... ..+..+.|.||.|||.+.+...|+.+.|+||.|||+.||++|++.|.+.+.-+.+..|-. . ..+.
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 76543 467778899999999999988889999999999999999999999998876554444332 1 0010
Q ss_pred ----------------------CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 256 ----------------------PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 256 ----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
...+....+|+..||..||.+|.||.++|.++||..
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 122556778999999999999999999999999943
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=338.68 Aligned_cols=246 Identities=33% Similarity=0.548 Sum_probs=214.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcE-EEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-eEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQE-VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE-KMVL 113 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~-valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~l 113 (335)
....+.+.||+|+||+||+|... |.. ||+|.+......... .+.+.+|+.+|.+++||||++++|++.+.. ..++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 35566777999999999999877 556 999999875544444 789999999999999999999999998887 7999
Q ss_pred EEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCC-cEecCCCCCCEEEccCC-CeEEeeccccccccCC
Q psy2306 114 VMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHK-ICHRDLKLENILLDENG-NAKIADFGLSNVFTES 189 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~g-ivH~di~p~nili~~~~-~~kL~df~~~~~~~~~ 189 (335)
||||+++|+|.+++.. ...++...+..++.||+.|+.|||+++ |||+||||+|||++.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999999987 678999999999999999999999999 99999999999999997 9999999999887654
Q ss_pred -ccccccccCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchH
Q psy2306 190 -RFLSTFCGSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTAS 263 (335)
Q Consensus 190 -~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 263 (335)
.......||+.|||||++.+ ..+ +.++||||||+++|||+||..||.+....+....+..... .+...++.+.
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 33445789999999999994 465 9999999999999999999999999988777666654332 2333677999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy2306 264 PLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.++.+||+.||.+||++.+|+.
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999883
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=339.20 Aligned_cols=251 Identities=34% Similarity=0.601 Sum_probs=219.5
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.++.+++.||+|++...........+.+..|...+..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999998764333344556677888888776 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|.+++.....+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.... .........|++
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 9999999888889999999999999999999999999999999999999999999999999886532 222334456899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+....... ...+.++.+++++||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 161 DYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred cccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 9999999988776 889999999999999999999999998888888887765533 34677899999999999999999
Q ss_pred CH------HHHhcCCCcCCCC
Q psy2306 279 DI------SVICSHWWIDKDH 293 (335)
Q Consensus 279 s~------~~ll~~~~~~~~~ 293 (335)
++ +++++||||....
T Consensus 240 ~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 240 GSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCCCHHHHHcCCCcCCCC
Confidence 98 9999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=314.18 Aligned_cols=255 Identities=38% Similarity=0.612 Sum_probs=237.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|.+++.||+|-||.||+|+.+.++--||+|++.++.........++++|+++...++||||++++++|.+...+|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 48999999999999999999999999999999999877777777789999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 116 EYAAGGELYDFLD--QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
||...|++...++ ...++++...+.++.|++.|+.|+|.++++||||+|+|+|++..+.+|++|||.+...+ .+...
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~ 180 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRK 180 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCce
Confidence 9999999999998 56779999999999999999999999999999999999999999999999999997765 55567
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhccc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNI 272 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~ 272 (335)
..+||..|.+||...+..+ +..+|+|++|++.||++.|.+||......+..+.+...... +...+.+..++|.+||.+
T Consensus 181 tlcgt~dyl~pEmv~~~~h-d~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~ 259 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGH-DKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVK 259 (281)
T ss_pred eeecccccCCHhhcCCCCc-cchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhcc
Confidence 8899999999999999887 88999999999999999999999999999999999887664 455688999999999999
Q ss_pred CCCCCCCHHHHhcCCCcCCC
Q psy2306 273 NPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 273 dp~~Rps~~~ll~~~~~~~~ 292 (335)
+|.+|.+..|++.|||+...
T Consensus 260 ~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 260 NPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred CccccccHHHHhhhHHHHhc
Confidence 99999999999999998754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=332.70 Aligned_cols=251 Identities=28% Similarity=0.486 Sum_probs=210.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||.|+||.||+|.+..++..|++|.+..... ......+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 479999999999999999999999999999999875322 222345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||.+...... ....
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 99975 898888654 45799999999999999999999999999999999999999999999999998654322 2223
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC-------------------C-
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD-------------------Y- 253 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-------------------~- 253 (335)
...+++.|+|||++.+...++.++||||+|+++|+|++|..||.+.+..+....+.... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 45678899999998765545889999999999999999999998877655444332100 0
Q ss_pred -----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 254 -----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 254 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
..+..+.+..++|.+||+.||.+|||++|+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 012235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=340.97 Aligned_cols=251 Identities=34% Similarity=0.612 Sum_probs=220.5
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
+.||+|+||.||++.+..+|+.|++|++.............+.+|...++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998644444445567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 122 ELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 122 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
+|..++.....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.... .........|++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999888889999999999999999999997 799999999999999999999999999886532 222233456899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+.+.....+..... .+...++++.++|++||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 161 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred ccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence 9999999988776 8999999999999999999999999888877777766544 3445678999999999999999996
Q ss_pred -----CHHHHhcCCCcCCCC
Q psy2306 279 -----DISVICSHWWIDKDH 293 (335)
Q Consensus 279 -----s~~~ll~~~~~~~~~ 293 (335)
++.++++||||....
T Consensus 240 ~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 240 GGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=343.90 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=218.8
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999986544455566788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-------
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES------- 189 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~------- 189 (335)
|+++++|.+++.+...+++..+..++.|++.||.|||+.|++||||||+||+++.+++++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999987532100
Q ss_pred -----------------------------------------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHH
Q psy2306 190 -----------------------------------------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYT 228 (335)
Q Consensus 190 -----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~ 228 (335)
.......|++.|+|||++.+..+ +.++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHHH
Confidence 00123468999999999988776 899999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcC--CCC---CCCCCCchHHHHHHhcc--cCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 229 LVYGAMPFDGSNFKRLVKQISNG--DYF---EPKNQSTASPLIAEMLN--INPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 229 l~tg~~p~~~~~~~~~~~~~~~~--~~~---~~~~~~~l~~li~~~l~--~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
|++|..||...+..+....+... ... ....++++.++|.+|+. .++..|++++++++||||++..+
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 99999999887776655555432 111 12357789999999664 45556999999999999987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=345.84 Aligned_cols=255 Identities=30% Similarity=0.526 Sum_probs=217.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987643334445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-----
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR----- 190 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~----- 190 (335)
||+++++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999885321100
Q ss_pred -------------------------------------------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHH
Q psy2306 191 -------------------------------------------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLY 227 (335)
Q Consensus 191 -------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~ 227 (335)
......|++.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 0012468999999999988776 89999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhcCC--CCCC---CCCCchHHHHHHhcccCCCCC---CCHHHHhcCCCcCCC
Q psy2306 228 TLVYGAMPFDGSNFKRLVKQISNGD--YFEP---KNQSTASPLIAEMLNINPSSR---ADISVICSHWWIDKD 292 (335)
Q Consensus 228 ~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~~~~~~~ 292 (335)
+|++|..||...+..+....+.... ...+ ..+.++.++|.+||. +|.+| +++.+++.||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999998887776666665421 1111 346689999999998 66665 699999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=338.48 Aligned_cols=261 Identities=38% Similarity=0.662 Sum_probs=238.6
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENR 108 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 108 (335)
....+...|.+.+.||+|.||.||.++.+.+|+.+|+|.+.+.........+.+.+|+.+|+++. ||||+.+++.|++.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 45678889999999999999999999999999999999999877666667788999999999998 99999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC----CCeEEeeccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN----GNAKIADFGLSN 184 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~----~~~kL~df~~~~ 184 (335)
+.+++|||++.||.|.+.+... .+++..+..++.|+++++.|||+.|++|+||||+|+|+... +.++++|||++.
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999999999876 49999999999999999999999999999999999999643 479999999999
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-----CCCCC
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-----EPKNQ 259 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~ 259 (335)
...........+|++.|+|||++...++ +..+||||+|+++|.|++|..||...+.......+..+.+. .+..+
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 9888777888999999999999998887 99999999999999999999999999988888888877652 22336
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 260 STASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
..+.++|++||..||.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 689999999999999999999999999999964
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=334.20 Aligned_cols=255 Identities=25% Similarity=0.446 Sum_probs=207.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||.||+|.+..+++.|++|++..... ......+.+|+.+++.++||||+++++++.+....+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999875332 12233567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccc
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~ 192 (335)
|||++ ++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.+...... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 99995 577777654 456899999999999999999999999999999999999999999999999988654322 222
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhc----CC------------C--
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-KRLVKQISN----GD------------Y-- 253 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~----~~------------~-- 253 (335)
....+++.|+|||++.+...++.++||||||+++|+|++|..||.+... ......+.. .. .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 3456788999999987665558899999999999999999999976432 222221110 00 0
Q ss_pred ---------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 ---------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 ---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.....++.+.+++.+||+.||.+|||+.++++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000123567899999999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=336.18 Aligned_cols=254 Identities=34% Similarity=0.580 Sum_probs=218.4
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHH---HcCCCCcccceeEEEEeCCeEEEE
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM---SSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
|++.+.||+|++|.||+|.+..+|+.|++|++...........+.+.+|...+ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999864333334455666666555 566799999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-Ccccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~~~ 193 (335)
|||+++++|...+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999999999988864 5699999999999999999999999999999999999999999999999998765322 22234
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhccc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNI 272 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~ 272 (335)
...|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..+....+..... .+...+..+.++|++||+.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 238 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR 238 (324)
T ss_pred ccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence 4668999999999988776 8899999999999999999999999888887777766544 3445677899999999999
Q ss_pred CCCCCC-----CHHHHhcCCCcCCCC
Q psy2306 273 NPSSRA-----DISVICSHWWIDKDH 293 (335)
Q Consensus 273 dp~~Rp-----s~~~ll~~~~~~~~~ 293 (335)
||.+|| ++.++++||||+...
T Consensus 239 dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 239 NPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred CHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 999999 799999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=344.32 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=219.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999976443344556788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-------
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES------- 189 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~------- 189 (335)
|+++++|.+++.+.+.+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999987432100
Q ss_pred -----------------------------------------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHH
Q psy2306 190 -----------------------------------------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYT 228 (335)
Q Consensus 190 -----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~ 228 (335)
.......|++.|+|||++.+..+ +.++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHHH
Confidence 00112468999999999988776 899999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcCC--C---CCCCCCCchHHHHHHhcccCCCCCCC---HHHHhcCCCcCCCC
Q psy2306 229 LVYGAMPFDGSNFKRLVKQISNGD--Y---FEPKNQSTASPLIAEMLNINPSSRAD---ISVICSHWWIDKDH 293 (335)
Q Consensus 229 l~tg~~p~~~~~~~~~~~~~~~~~--~---~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~ 293 (335)
|++|..||...+..+....+.... . .....++++.++|.+|+ .+|.+|++ +.++++||||+...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 999999999888776666655422 1 12235778999999986 59999987 99999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=336.89 Aligned_cols=252 Identities=33% Similarity=0.561 Sum_probs=220.4
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.+..+++.|++|++...........+.+..|..++..+ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999864433445556677888888766 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-CccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~~~~~~~~~ 199 (335)
++|...+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... ........|++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 99999998888899999999999999999999999999999999999999999999999998865322 22233456899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+....... ...+.++.+++.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 161 DYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred cccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 9999999988776 889999999999999999999999999888888887765533 34577999999999999999999
Q ss_pred -------CHHHHhcCCCcCCCCc
Q psy2306 279 -------DISVICSHWWIDKDHS 294 (335)
Q Consensus 279 -------s~~~ll~~~~~~~~~~ 294 (335)
++.++++||||....+
T Consensus 240 ~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 240 GCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred CCCCCCCCHHHHhcCCccCCCCH
Confidence 9999999999976533
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=334.81 Aligned_cols=256 Identities=31% Similarity=0.530 Sum_probs=223.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+|++.+.||+|+||.||+|.+..+++.|++|++...........+....|..++..+ +|++|+.+++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999864433344455666777888777 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~ 194 (335)
||+++++|.+.+.....+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.... .......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999986543 2223345
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~d 273 (335)
..|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+...... +...+.++.+++.+||+.|
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~ 239 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239 (323)
T ss_pred CCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence 678999999999988776 89999999999999999999999998888888777766543 3456779999999999999
Q ss_pred CCCCCCH-----HHHhcCCCcCCCC
Q psy2306 274 PSSRADI-----SVICSHWWIDKDH 293 (335)
Q Consensus 274 p~~Rps~-----~~ll~~~~~~~~~ 293 (335)
|.+|++. .++++||||+...
T Consensus 240 p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 240 PGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999974 8999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=336.80 Aligned_cols=251 Identities=33% Similarity=0.577 Sum_probs=215.6
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHH-HHHcCCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ-IMSSVRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||+||+|.+..+|+.|++|++.............+..|.. +++.++||||+++++.+.+.+..+++|||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999997643333333344444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|..++.....+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.... .........|++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 9999999888889999999999999999999999999999999999999999999999999886532 222334456899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..... ..+..+..+.++|++||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 161 EYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence 9999999988776 8899999999999999999999999888887777766543 3455688999999999999999999
Q ss_pred CH----HHHhcCCCcCCCC
Q psy2306 279 DI----SVICSHWWIDKDH 293 (335)
Q Consensus 279 s~----~~ll~~~~~~~~~ 293 (335)
++ .++++||||....
T Consensus 240 ~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 240 GAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 87 6999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.74 Aligned_cols=256 Identities=30% Similarity=0.520 Sum_probs=221.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+|+.|++|.+.............+.+|..+++.++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654434455667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc--
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-- 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~-- 192 (335)
||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999875 67999999999999999999999999999999999999999999999999999766443322
Q ss_pred cccccCCccCChhhhcC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----CCCCCCCch
Q psy2306 193 STFCGSPLYASPEIVKG-----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-----FEPKNQSTA 262 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~-----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~l 262 (335)
....+++.|+|||++.. ...++.++||||||+++|+|++|..||...+.......+..... ..+..+.++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 23468899999999863 22347899999999999999999999988887776666654321 122356789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.++++.||+ +|.+||++++++.||||+..
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=344.63 Aligned_cols=255 Identities=26% Similarity=0.467 Sum_probs=218.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
.+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+.+.+.++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37999999999999999999999999999999987543333344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC------
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES------ 189 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~------ 189 (335)
||+++++|.+++...+.+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999987432100
Q ss_pred --------------------------------------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh
Q psy2306 190 --------------------------------------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY 231 (335)
Q Consensus 190 --------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t 231 (335)
.......|++.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 00112468999999999988776 899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCC-----CCCCCCCchHHHHHHhcccCCCCCC---CHHHHhcCCCcCCC
Q psy2306 232 GAMPFDGSNFKRLVKQISNGDY-----FEPKNQSTASPLIAEMLNINPSSRA---DISVICSHWWIDKD 292 (335)
Q Consensus 232 g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~ 292 (335)
|..||...+..+....+..... .....+.++.++|.+|+ .+|.+|+ ++.++++||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999998887766555544221 11235668899999977 5999999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=340.90 Aligned_cols=257 Identities=30% Similarity=0.482 Sum_probs=221.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45899999999999999999999999999999999754333344455678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--c
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--L 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--~ 192 (335)
|||+++++|.+++... .+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 9999999999998754 589999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccCCccCChhhhcCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CC-C--CCCCCchHH
Q psy2306 193 STFCGSPLYASPEIVKGIP---YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--YF-E--PKNQSTASP 264 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~~-~--~~~~~~l~~ 264 (335)
....|++.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+.... .. + ...+.++.+
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHH
Confidence 3456899999999986542 34789999999999999999999999988877777776532 11 1 235678999
Q ss_pred HHHHhcccCCCC--CCCHHHHhcCCCcCCC
Q psy2306 265 LIAEMLNINPSS--RADISVICSHWWIDKD 292 (335)
Q Consensus 265 li~~~l~~dp~~--Rps~~~ll~~~~~~~~ 292 (335)
+|.+||+.+|.+ |+++++++.||||+..
T Consensus 281 li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 281 LICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999999998 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=335.87 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=210.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC-----CeE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR-----EKM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 111 (335)
+|++.+.||+|+||.||+|++..+|..|++|.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 6999999999999999999999999999999987432 2233345678999999999999999999988543 358
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR- 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~- 190 (335)
|++|||+. ++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999994 6999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred ---cccccccCCccCChhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH------------------
Q psy2306 191 ---FLSTFCGSPLYASPEIVKGI-PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI------------------ 248 (335)
Q Consensus 191 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~------------------ 248 (335)
......+++.|+|||++.+. ..++.++||||||+++|+|++|..||...+.......+
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 12345689999999998652 23488999999999999999999999776543222111
Q ss_pred ---------hcCCC-----CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 249 ---------SNGDY-----FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 249 ---------~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
..... ..+..++.+.+++.+||+.||++|||++++++||||......
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 00000 112346678999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=333.81 Aligned_cols=251 Identities=33% Similarity=0.564 Sum_probs=219.6
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.+..++..||+|++.............+..|..+++.+ +||||+++++++.+.+.++++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999864433444556677888888877 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|...+.+...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 9999999888889999999999999999999999999999999999999999999999999886532 222233456889
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+...... +...+..+.++|++||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 161 DYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred cccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence 9999999988776 88999999999999999999999988888877777665543 334677999999999999999999
Q ss_pred CH-----HHHhcCCCcCCCC
Q psy2306 279 DI-----SVICSHWWIDKDH 293 (335)
Q Consensus 279 s~-----~~ll~~~~~~~~~ 293 (335)
++ .+++.||||+...
T Consensus 240 s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 240 GCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 99 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=334.84 Aligned_cols=250 Identities=32% Similarity=0.554 Sum_probs=213.0
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.+..+++.||+|++.............+..|..++..+ +||||+++++++.+.+..|++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999875444555566788899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc-cCCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~-~~~~~~~~~~~~~ 199 (335)
++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++... ..........|++
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 999999988888999999999999999999999999999999999999999999999999988643 2222334567899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------cHHHHHHHHhcCCC-CCCCCCCchHHHHHHh
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---------NFKRLVKQISNGDY-FEPKNQSTASPLIAEM 269 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---------~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~ 269 (335)
.|+|||++.+..+ +.++|+||||+++|+|++|..||... ......+.+..... .+...+.++.++|++|
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999988776 88999999999999999999999531 11223333444333 3345677899999999
Q ss_pred cccCCCCCCC------HHHHhcCCCcCCC
Q psy2306 270 LNINPSSRAD------ISVICSHWWIDKD 292 (335)
Q Consensus 270 l~~dp~~Rps------~~~ll~~~~~~~~ 292 (335)
|+.||.+|++ ++++++||||...
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999987 7899999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=333.01 Aligned_cols=251 Identities=31% Similarity=0.542 Sum_probs=215.5
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.++.+|+.||+|.+................|...+... +|++|+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999764322223345566777777654 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|..++..+..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.... .........|++
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999886432 222234566899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+...... +...+.++.+++++||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 161 DYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred CccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999988776 89999999999999999999999988888877777665443 333567899999999999999999
Q ss_pred CH-HHHhcCCCcCCCC
Q psy2306 279 DI-SVICSHWWIDKDH 293 (335)
Q Consensus 279 s~-~~ll~~~~~~~~~ 293 (335)
++ ++++.||||....
T Consensus 240 ~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 240 GVVGNIRGHPFFKTIN 255 (316)
T ss_pred CChHHHHcCCCcCCCC
Confidence 98 5899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=340.52 Aligned_cols=257 Identities=27% Similarity=0.511 Sum_probs=221.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+.|++.+.||+|+||.||+|.+..+++.||+|++.............+..|..++..++|++|+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997644334455677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-----
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR----- 190 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~----- 190 (335)
||+++++|.+++.+...+++..+..++.|++.||.|||+.|++||||||+||+++.+++++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999876442110
Q ss_pred -------------------------------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy2306 191 -------------------------------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS 239 (335)
Q Consensus 191 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~ 239 (335)
......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence 0123468999999999988776 88999999999999999999999998
Q ss_pred cHHHHHHHHhcCC--C-CCC--CCCCchHHHHHHhcccCCCCCC---CHHHHhcCCCcCCCCc
Q psy2306 240 NFKRLVKQISNGD--Y-FEP--KNQSTASPLIAEMLNINPSSRA---DISVICSHWWIDKDHS 294 (335)
Q Consensus 240 ~~~~~~~~~~~~~--~-~~~--~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~~ 294 (335)
+.......+.... . .++ ..+.++.++|.+|+ .||.+|+ +++++++||||....+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 8887777666432 1 111 24668999999987 4999998 5899999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=319.14 Aligned_cols=268 Identities=27% Similarity=0.394 Sum_probs=222.6
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE--eCC
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE--NRE 109 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~ 109 (335)
++=-+.|.....|+.|+||.||+|+|+.|++-||+|.++... +.+-.-.--.+|+.+|.+++|||||.+-.+.. +-+
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 334457999999999999999999999999999999998643 22222234468999999999999999988875 345
Q ss_pred eEEEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
.+|+|||||+. +|..++..-+ ++...+++.+..|++.|++|||.+.|+||||||+|+|++..|.+|++|||+|+..+.
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 79999999966 9999998744 899999999999999999999999999999999999999999999999999998876
Q ss_pred C-ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc----C--CCC-------
Q psy2306 189 S-RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN----G--DYF------- 254 (335)
Q Consensus 189 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~----~--~~~------- 254 (335)
+ ...+..+-|.||.|||.+.+.+-|+.+.|+||+||++.||+++.+.|.+....+.+..|-. . ..+
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 5 4456778899999999999998889999999999999999999999988765544444332 0 000
Q ss_pred --------------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHH
Q psy2306 255 --------------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEA 301 (335)
Q Consensus 255 --------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~ 301 (335)
....+..-.+++..+|..||.+|.||++.|.|+||.+...+.+-...
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMF 376 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhc
Confidence 00123566789999999999999999999999999986555444433
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=332.58 Aligned_cols=251 Identities=34% Similarity=0.562 Sum_probs=215.6
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.+..+++.||+|.+...........+....|...+... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999864333333444555666666654 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-CccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~~~~~~~~~ 199 (335)
++|..++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++..... ........|++
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875432 23334567899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+...... +...+.++.+++.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 161 DYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred cccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999988776 89999999999999999999999998888887777665443 344577899999999999999999
Q ss_pred CHH-HHhcCCCcCCCC
Q psy2306 279 DIS-VICSHWWIDKDH 293 (335)
Q Consensus 279 s~~-~ll~~~~~~~~~ 293 (335)
++. +++.||||....
T Consensus 240 ~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 240 GVDGDIRQHPFFRGID 255 (316)
T ss_pred CChHHHHcCcccCCCC
Confidence 864 888999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=326.54 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=217.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|++.+.||+|+||.||++.+..++..||+|.+.............+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999998999999999876443334445567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 117 YAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999887643 4689999999999999999999999999999999999999999999999999877654444445
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHHhcCC-CCCCCCCCchHHHHHHh
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL----VKQISNGD-YFEPKNQSTASPLIAEM 269 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~l~~li~~~ 269 (335)
..+++.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.... ...+.... ..+...+..+.+++.+|
T Consensus 161 ~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 161 RVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred ccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 578899999999987776 8899999999999999999999987654332 22222222 22344677899999999
Q ss_pred cccCCCCCC-----CHHHHhcCCCcCCC
Q psy2306 270 LNINPSSRA-----DISVICSHWWIDKD 292 (335)
Q Consensus 270 l~~dp~~Rp-----s~~~ll~~~~~~~~ 292 (335)
|+.||.+|| +++++++||||...
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=333.42 Aligned_cols=251 Identities=36% Similarity=0.595 Sum_probs=217.8
Q ss_pred eeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCc-CCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 42 RKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKI-ETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
+.||+|+||.||++.+. .+++.||+|++..... ........+.+|+.+++.++||||+++++.+...+..|++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999864 4688999999876332 1223345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-Cccccccc
Q psy2306 118 AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFLSTFC 196 (335)
Q Consensus 118 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~~~~~~ 196 (335)
+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC 161 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccC
Confidence 99999999999888899999999999999999999999999999999999999999999999999865332 22233456
Q ss_pred cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCC
Q psy2306 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPS 275 (335)
Q Consensus 197 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~ 275 (335)
|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..... .+...++.+.++|++||+.||+
T Consensus 162 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 240 (323)
T cd05584 162 GTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240 (323)
T ss_pred CCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHh
Confidence 8999999999988776 8899999999999999999999999888877777766654 3445677899999999999999
Q ss_pred CCC-----CHHHHhcCCCcCCCC
Q psy2306 276 SRA-----DISVICSHWWIDKDH 293 (335)
Q Consensus 276 ~Rp-----s~~~ll~~~~~~~~~ 293 (335)
+|| +++++++||||....
T Consensus 241 ~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 241 SRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HcCCCCCCCHHHHhcCCCcCCCC
Confidence 999 899999999998653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=330.69 Aligned_cols=252 Identities=33% Similarity=0.523 Sum_probs=215.8
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHc-CCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS-VRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.+..+++.||+|.+................|...+.. ++||||+++++++.+.+..+++|||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999986432222334455667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .........|++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 9999999887889999999999999999999999999999999999999999999999999886532 222234456899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+....+...... +...+.++.+++.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 161 DYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred cccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence 9999999988776 89999999999999999999999988888877777655443 334567899999999999999999
Q ss_pred CHH-HHhcCCCcCCCCc
Q psy2306 279 DIS-VICSHWWIDKDHS 294 (335)
Q Consensus 279 s~~-~ll~~~~~~~~~~ 294 (335)
++. +++.||||+....
T Consensus 240 ~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 240 GVKGDIRQHPFFREIDW 256 (316)
T ss_pred CChHHHHcCcccCCCCH
Confidence 997 8999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=338.37 Aligned_cols=256 Identities=30% Similarity=0.559 Sum_probs=235.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe-EEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK-MVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv 114 (335)
++|..++.+|+|+||.+++++.+.+++.|++|.+....... ...+...+|+.++++++||||+.+.+.|...+. .+|+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 57999999999999999999999999999999998765444 344488899999999999999999999998888 9999
Q ss_pred EecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-c
Q psy2306 115 MEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-F 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~ 191 (335)
|+|++||++.+.+.+. ..++++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.++|+|||++..+.... .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999999999999764 469999999999999999999999999999999999999999999999999999998876 7
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
.....||+.|+.||.+.+.+| ..++|||||||++|||++-+++|...+...++.++..... .+..+..++..+|+.|
T Consensus 163 a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence 778999999999999999998 9999999999999999999999999999999999998864 3445677999999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 270 LNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
|..+|..||++.++|.+|..+...
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhhHH
Confidence 999999999999999999988654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=332.69 Aligned_cols=256 Identities=34% Similarity=0.569 Sum_probs=215.8
Q ss_pred ceeEEeeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCc-CCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKI-ETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 111 (335)
+|++.+.||+|+||.||++.+. .+++.|++|++..... ......+.+..|..+++.++ |++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998764 4789999999875332 22334567788999999995 89999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC--
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-- 189 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-- 189 (335)
+++|||+++++|.+++..+..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998764322
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcCCC-CCCCCCCchHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS----NFKRLVKQISNGDY-FEPKNQSTASP 264 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~----~~~~~~~~~~~~~~-~~~~~~~~l~~ 264 (335)
.......|++.|+|||++.+...++.++||||||+++|+|++|..||... ........+..... .+...+..+.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 22234568999999999987654588999999999999999999999642 33344444443332 33456778999
Q ss_pred HHHHhcccCCCCCC-----CHHHHhcCCCcCCC
Q psy2306 265 LIAEMLNINPSSRA-----DISVICSHWWIDKD 292 (335)
Q Consensus 265 li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~ 292 (335)
++.+||+.||++|| +++++++||||+..
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 88899999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=332.19 Aligned_cols=250 Identities=32% Similarity=0.559 Sum_probs=212.4
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.+..+++.|++|++.............+.+|...+..+ +||||+++++++.+.+..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999875444555666788888888776 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|..++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.... .........|++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999886532 222233457899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC---------CcHHHHHHHHhcCCC-CCCCCCCchHHHHHHh
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG---------SNFKRLVKQISNGDY-FEPKNQSTASPLIAEM 269 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~---------~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~ 269 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||.. .........+..... .+...+..+.+++++|
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999988776 8899999999999999999999952 112223333433332 3445677899999999
Q ss_pred cccCCCCCCC------HHHHhcCCCcCCC
Q psy2306 270 LNINPSSRAD------ISVICSHWWIDKD 292 (335)
Q Consensus 270 l~~dp~~Rps------~~~ll~~~~~~~~ 292 (335)
|+.||.+||+ +.++++||||+..
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999998 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=336.94 Aligned_cols=258 Identities=28% Similarity=0.486 Sum_probs=219.5
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||++.+..+++.+|+|++.............+.+|..+++.++||||+++++.+.+.+..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 34689999999999999999999999999999999875433344445667889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-- 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-- 191 (335)
||||+++++|.+++... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 99999999999999754 589999999999999999999999999999999999999999999999999876643322
Q ss_pred ccccccCCccCChhhhcCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CC-C--CCCCCchH
Q psy2306 192 LSTFCGSPLYASPEIVKGIP---YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--YF-E--PKNQSTAS 263 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~~-~--~~~~~~l~ 263 (335)
.....|++.|+|||++.+.. .++.++|+||||+++|+|++|..||...+.......+.... .. + ...+..+.
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 23456899999999987543 24789999999999999999999999888777766665432 11 1 12466889
Q ss_pred HHHHHhcccCCCC--CCCHHHHhcCCCcCCC
Q psy2306 264 PLIAEMLNINPSS--RADISVICSHWWIDKD 292 (335)
Q Consensus 264 ~li~~~l~~dp~~--Rps~~~ll~~~~~~~~ 292 (335)
+++.+||..++.+ |+++.++++||||+..
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999999866554 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=329.78 Aligned_cols=256 Identities=31% Similarity=0.534 Sum_probs=221.6
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+..|..++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998643333444556778888888886 578888999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~~ 194 (335)
||+++++|.+++.....+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 99999999999988888999999999999999999999999999999999999999999999999988654322 22334
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~d 273 (335)
..|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+...... +...+.++.+++.+||+.+
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239 (323)
T ss_pred ccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence 568999999999988776 88999999999999999999999998888877777765543 3456778999999999999
Q ss_pred CCCCCC-----HHHHhcCCCcCCCC
Q psy2306 274 PSSRAD-----ISVICSHWWIDKDH 293 (335)
Q Consensus 274 p~~Rps-----~~~ll~~~~~~~~~ 293 (335)
|.+|++ .+++++||||+...
T Consensus 240 p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 240 PSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HhhCCCCCCCCHHHHhcCcccCCCC
Confidence 999997 57999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=313.04 Aligned_cols=261 Identities=36% Similarity=0.573 Sum_probs=234.0
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCC-----cCCHHHHHHHHHHHHHHHcC-CCCcccceeE
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCK-----IETEADLIRIRREIQIMSSV-RHPNIIHIYE 103 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~-----~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 103 (335)
....+-..|.-.+.||+|..++|-++..+.+|+.+++|++.... .+-.+..+.-++|+.+|+++ .||+|+.+.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 34556678899999999999999999999999999999986422 12233456778999999998 5999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
+|+.+...++|+|.|+.|.|.+++.+...+++.....+++|+++|++|||..+|||+||||+|||++++.+++|+|||++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccccccccCCccCChhhhc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC--C
Q psy2306 184 NVFTESRFLSTFCGSPLYASPEIVK-----GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE--P 256 (335)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~ 256 (335)
+...........+|||+|.|||.+. +.+-++.+.|+|++|+++|-|+.|.+||......-+...+..+++.. +
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9999999999999999999999874 33445889999999999999999999999888888888888887643 2
Q ss_pred C---CCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 257 K---NQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 257 ~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
. .+.+.+++|.+||+.||.+|.|++|+|.||||.
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 2 356899999999999999999999999999993
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=334.16 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=209.8
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC---
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE--- 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 109 (335)
.+.++|++.+.||+|+||.||++.+..+|..|++|.+.... ........+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 57789999999999999999999999999999999987532 23344567779999999999999999999986443
Q ss_pred ---eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 110 ---KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 110 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
..|++|||+++ +|.+.+. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999965 6766664 34889999999999999999999999999999999999999999999999998765
Q ss_pred cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-----------------
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS----------------- 249 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~----------------- 249 (335)
..........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 44444445678899999999988776 889999999999999999999998765432211111
Q ss_pred -----cCCC---------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 250 -----NGDY---------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 250 -----~~~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.... .....++++.++|.+||+.||.+|||+.|+|.||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 0000 001124578999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=330.62 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=216.9
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||.|+||.||++.+..++..+++|.+.... .......+.+|+++++.++|+||+++++++.+.+..++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3579999999999999999999999999999999987532 34456678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+|||+++++|.+++...+.+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~ 159 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence 999999999999999888899999999999999999999975 7999999999999999999999999988654332 12
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-----------------------
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS----------------------- 249 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~----------------------- 249 (335)
....++..|+|||++.+..+ +.++|+|||||++|+|++|..||......+....+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 34467889999999987765 889999999999999999999997665544332211
Q ss_pred ---------------------cCCC---CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 250 ---------------------NGDY---FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 250 ---------------------~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.... .....+.++.+|+.+||+.||++|||+.+++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 1000 0112345788999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=324.86 Aligned_cols=251 Identities=27% Similarity=0.467 Sum_probs=204.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECC-CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC---CCCcccceeEEEE-----
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKE-TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV---RHPNIIHIYEVFE----- 106 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~----- 106 (335)
++|++.+.||+|+||.||+|.+.. ++..||+|.+....... .......+|+..++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 46889999987543222 1222344566666555 6999999999985
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.....++++|+++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 5899888653 458999999999999999999999999999999999999999999999999987
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----------
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----------- 253 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----------- 253 (335)
............+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 7655544455678999999999987776 8899999999999999999999988776555544432100
Q ss_pred -----------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 254 -----------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 254 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
..+..+..+.+++.+||+.||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012345677899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=332.96 Aligned_cols=251 Identities=32% Similarity=0.560 Sum_probs=214.8
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHH-HHHcCCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ-IMSSVRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.+..+|+.+++|++.............+..|.. +++.++||||+++++.+...+..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999997643323333344445544 56778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.... .........|++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 9999999888889999999999999999999999999999999999999999999999999986532 222334556899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..... ..+..+..+.+++++||+.+|.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 161 EYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence 9999999988776 8899999999999999999999999888877777666543 3445677899999999999999999
Q ss_pred CH----HHHhcCCCcCCCC
Q psy2306 279 DI----SVICSHWWIDKDH 293 (335)
Q Consensus 279 s~----~~ll~~~~~~~~~ 293 (335)
++ .++++||||....
T Consensus 240 ~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 240 GAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 77 5999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=323.19 Aligned_cols=258 Identities=34% Similarity=0.602 Sum_probs=227.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||++.+..+++.+++|.+...........+.+.+|++.++.++||||+++++++.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997654444455678889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||+++++|.+++.....+++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 158 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL 158 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence 99999999999988888999999999999999999999999999999999999999999999999998776544 2344
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp 274 (335)
.+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+..+.. .+...+..+.+++.+||+.||
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 237 (290)
T cd05580 159 CGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDL 237 (290)
T ss_pred CCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCH
Confidence 67889999999877665 8899999999999999999999988887766666655443 344567799999999999999
Q ss_pred CCCC-----CHHHHhcCCCcCCCCcch
Q psy2306 275 SSRA-----DISVICSHWWIDKDHSVA 296 (335)
Q Consensus 275 ~~Rp-----s~~~ll~~~~~~~~~~~~ 296 (335)
.+|+ +++++++||||+...+..
T Consensus 238 ~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 238 TKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred HHccCcccCCHHHHHcCcccccCCHHH
Confidence 9999 999999999998765443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=335.70 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=214.7
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC---CCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV---RHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 44 ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
||+|+||+||+|.+..+|+.||+|++................|..++... +||+|+++++.+.+.+..+++|||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999998754333333444555666666655 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|.+++...+.+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.... .........|++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999986542 222334567899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC--CCCCchHHHHHHhcccCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP--KNQSTASPLIAEMLNINPSSR 277 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~R 277 (335)
.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+..+....+ ..+.++.++|++||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 999999997665458899999999999999999999999888888887776554333 357789999999999999999
Q ss_pred C----CHHHHhcCCCcCCCC
Q psy2306 278 A----DISVICSHWWIDKDH 293 (335)
Q Consensus 278 p----s~~~ll~~~~~~~~~ 293 (335)
| ++.++++||||....
T Consensus 241 ~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 241 LGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCHHHHhcCccccCCC
Confidence 8 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=342.72 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=206.5
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC---
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--- 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 108 (335)
....++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 345568999999999999999999999999999999885421 1234699999999999999999887432
Q ss_pred -----CeEEEEEecCCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-CeEEe
Q psy2306 109 -----EKMVLVMEYAAGGELYDFLD----QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-NAKIA 178 (335)
Q Consensus 109 -----~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-~~kL~ 178 (335)
..++++|||+++ +|.+++. ....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 247799999965 7776664 356799999999999999999999999999999999999998665 69999
Q ss_pred eccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-------
Q psy2306 179 DFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG------- 251 (335)
Q Consensus 179 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------- 251 (335)
|||++.............+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9999987655444455678999999999877655589999999999999999999999887654433322210
Q ss_pred -------C----------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 252 -------D----------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 252 -------~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
. ..+...+.++.+||.+||+.||.+|||+.|+|.||||...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0 0112345689999999999999999999999999999753
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=330.76 Aligned_cols=251 Identities=31% Similarity=0.550 Sum_probs=214.0
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHH-HHHHcCCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI-QIMSSVRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.+..+++.|++|++.............+..|. .+++.++|+||+++++.+.+.+..+++|||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998764332333334444454 457889999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|...+.....+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.... .........|++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999886532 222234456899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..... .+...+..+.+++.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 161 EYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred ccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence 9999999988776 8899999999999999999999999888877777766544 3344566899999999999999998
Q ss_pred CH----HHHhcCCCcCCCC
Q psy2306 279 DI----SVICSHWWIDKDH 293 (335)
Q Consensus 279 s~----~~ll~~~~~~~~~ 293 (335)
++ .++++|+||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 240 GAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCCHHHHhCCCCcCCCC
Confidence 75 5999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=328.17 Aligned_cols=258 Identities=29% Similarity=0.493 Sum_probs=217.3
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||++.+..+++.||+|++.+.........+.+.+|..++..++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997643334445566888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--c
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--L 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--~ 192 (335)
||+++++|.+++.+ ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976 45799999999999999999999999999999999999999999999999999866543322 1
Q ss_pred cccccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---C---CCCCCCch
Q psy2306 193 STFCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---F---EPKNQSTA 262 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~---~~~~~~~l 262 (335)
....|++.|+|||++.. ...++.++||||||+++|+|++|..||...+..+....+..... . ....+..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23468999999999863 23347899999999999999999999988877766666654321 1 12346689
Q ss_pred HHHHHHhcccCCCC--CCCHHHHhcCCCcCCCC
Q psy2306 263 SPLIAEMLNINPSS--RADISVICSHWWIDKDH 293 (335)
Q Consensus 263 ~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~ 293 (335)
.+++++||..++++ |++++++++||||....
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 99999999765544 88999999999998653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=320.60 Aligned_cols=254 Identities=29% Similarity=0.474 Sum_probs=217.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE---- 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 109 (335)
..-.|+..+.+|+|+||+||.|...++++.||+|..-...... .+|+.+++.++||||+++..+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 4448999999999999999999999999999999976543322 37899999999999999998885322
Q ss_pred -eEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-CCeEEeecccc
Q psy2306 110 -KMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-GNAKIADFGLS 183 (335)
Q Consensus 110 -~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~-~~~kL~df~~~ 183 (335)
...+|+||++. +|.+.++. +..++...++-+.+||+.||+|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 45689999954 99988874 5779999999999999999999999999999999999999986 89999999999
Q ss_pred ccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-------------
Q psy2306 184 NVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN------------- 250 (335)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~------------- 250 (335)
..........+...+..|+|||.+.+...++.+.||||.||++.||+-|++.|.+.+.......+..
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 9988777778888899999999999998889999999999999999999999988765544443332
Q ss_pred --C---------------CCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 251 --G---------------DYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 251 --~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
. +......+++..+|+.++|..+|.+|.++.|+|.||||.+....
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0 11233447789999999999999999999999999999865444
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=333.39 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=219.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||+|.++.+++.+|+|++.............+.+|..+++.++||||+++++.+.+.+..++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 34799999999999999999999999999999999875433334445667889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-- 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-- 191 (335)
+|||+++++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence 99999999999998754 589999999999999999999999999999999999999999999999999876643322
Q ss_pred ccccccCCccCChhhhcCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----CCCCCCCchH
Q psy2306 192 LSTFCGSPLYASPEIVKGIP---YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-----FEPKNQSTAS 263 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~ 263 (335)
.....|++.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+..... .....+..+.
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHH
Confidence 23456899999999987543 247899999999999999999999999888777777765321 1124567899
Q ss_pred HHHHHhcccCCCC--CCCHHHHhcCCCcCCC
Q psy2306 264 PLIAEMLNINPSS--RADISVICSHWWIDKD 292 (335)
Q Consensus 264 ~li~~~l~~dp~~--Rps~~~ll~~~~~~~~ 292 (335)
++|.+||..++.+ |++++++++|+||...
T Consensus 280 ~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 280 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999854443 7899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=331.49 Aligned_cols=249 Identities=32% Similarity=0.548 Sum_probs=216.8
Q ss_pred eeeeccCCeEEEEEEE---CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecC
Q psy2306 42 RKLGQGNYGKVQLGIN---KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYA 118 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~---~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 118 (335)
+.||+|+||.||++.+ ..+|+.|++|++..... .......+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999876 35789999999976332 2223445678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccccccc
Q psy2306 119 AGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLSTFCG 197 (335)
Q Consensus 119 ~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~~~~~ 197 (335)
++++|.+++.+...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...... .......|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 99999999988888999999999999999999999999999999999999999999999999998765433 23345678
Q ss_pred CCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccCCCC
Q psy2306 198 SPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNINPSS 276 (335)
Q Consensus 198 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~ 276 (335)
++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..+....+...... +...++.+.+++++||+.||.+
T Consensus 161 ~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~ 239 (318)
T cd05582 161 TVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239 (318)
T ss_pred ChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhH
Confidence 999999999988766 88999999999999999999999998888777777665443 3446778999999999999999
Q ss_pred CCC-----HHHHhcCCCcCCC
Q psy2306 277 RAD-----ISVICSHWWIDKD 292 (335)
Q Consensus 277 Rps-----~~~ll~~~~~~~~ 292 (335)
||+ +++++.||||+..
T Consensus 240 R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 240 RLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred cCCCCCCCHHHHhCCCCcCCC
Confidence 999 7789999999865
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=320.95 Aligned_cols=251 Identities=39% Similarity=0.667 Sum_probs=212.3
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
|++.+.||+|+||+||++.+..+++.+++|.+....... .......+|+..++.++|+||+++++++.+....+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 889999999999999999999999999999998754322 2233445699999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc-cCCccccccc
Q psy2306 118 AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFC 196 (335)
Q Consensus 118 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~-~~~~~~~~~~ 196 (335)
+++++|.+++.....++...++.++.|+++||++||+.|++|+||+|+||+++.++.++|+|||.+... ..........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999997788999999999999999999999999999999999999999999999999998763 3333445667
Q ss_pred cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhcCCC-----CCCCCCCchHHHHHH
Q psy2306 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN---FKRLVKQISNGDY-----FEPKNQSTASPLIAE 268 (335)
Q Consensus 197 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~---~~~~~~~~~~~~~-----~~~~~~~~l~~li~~ 268 (335)
++..|+|||++......+.++|+||||+++++|++|..||.... ............. .......++.+++.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence 88899999999833334999999999999999999999998873 2333332222211 111123689999999
Q ss_pred hcccCCCCCCCHHHHhcCCCc
Q psy2306 269 MLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~~~~~ 289 (335)
||+.||++||++.++++||||
T Consensus 240 ~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 240 MLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HSSSSGGGSTTHHHHHTSGGG
T ss_pred HccCChhHCcCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=329.40 Aligned_cols=251 Identities=32% Similarity=0.562 Sum_probs=213.7
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHH-HHHHHcCCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRRE-IQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e-~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||+||+|.+..+++.|++|++.............+..| ...++.++|+||+++++++...+..+++|||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999875332222223333444 3456788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.... .........|++
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999986532 222334557899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..... ..+..+..+.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 161 EYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred cccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 9999999988776 8899999999999999999999998888777777665543 3456788999999999999999999
Q ss_pred CHH----HHhcCCCcCCCC
Q psy2306 279 DIS----VICSHWWIDKDH 293 (335)
Q Consensus 279 s~~----~ll~~~~~~~~~ 293 (335)
++. ++++|+||....
T Consensus 240 ~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 240 GAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CCCCCHHHHhcCcccCCCC
Confidence 876 899999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=322.04 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=209.0
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCH
Q psy2306 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGEL 123 (335)
Q Consensus 44 ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 123 (335)
||+|+||+||++.+..+|+.|++|.+...........+.+..|+.+++.++|++|+++.+++...+..+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998764433344456678899999999999999999999999999999999999999
Q ss_pred HHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cccccccC
Q psy2306 124 YDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTFCGS 198 (335)
Q Consensus 124 ~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~~~~~ 198 (335)
...+.. +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......|+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 887742 4568999999999999999999999999999999999999999999999999987654332 22345688
Q ss_pred CccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhcCC-CCCCCCCCchHHHHHHhcccC
Q psy2306 199 PLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF----KRLVKQISNGD-YFEPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 199 ~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~----~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~d 273 (335)
+.|+|||++.+..+ +.++|+||||+++|+|++|..||..... ......+.... ..+...+..+.+++.+||+.|
T Consensus 161 ~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 161 PGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred cCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence 99999999988776 8899999999999999999999976432 22223222222 223456778999999999999
Q ss_pred CCCCC-----CHHHHhcCCCcCCC
Q psy2306 274 PSSRA-----DISVICSHWWIDKD 292 (335)
Q Consensus 274 p~~Rp-----s~~~ll~~~~~~~~ 292 (335)
|.+|| +++++++||||+..
T Consensus 240 P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 240 PEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999 88999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=315.18 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=217.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC--HHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET--EADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
+.|++.+.||+|++|.||.|.+..+++.+++|.+....... ......+.+|+..+++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47999999999999999999999999999999987543221 2234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc-
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL- 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~- 192 (335)
++||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998654332111
Q ss_pred ---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHHH
Q psy2306 193 ---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPLI 266 (335)
Q Consensus 193 ---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 266 (335)
....++..|+|||...+..+ +.++||||||+++|+|++|..||...+............. .+...+..+.+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 23456788999999988775 8999999999999999999999987665554444433221 3345677899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCc
Q psy2306 267 AEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
++||+.+|.+|||+.++++|+||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=324.91 Aligned_cols=254 Identities=25% Similarity=0.474 Sum_probs=211.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.++.++..|++|.+...... .....+.+|+..++.++|+||+++++++...+..+++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 5899999999999999999999999999999998753322 22335678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccc
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~ 193 (335)
||+++ +|.+++.. +..++...+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+....... ...
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 99965 88887765 3458999999999999999999999999999999999999999999999999986543322 223
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC----------------------
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---------------------- 251 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---------------------- 251 (335)
...+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 4467889999999876554588999999999999999999999887655443332210
Q ss_pred --CC-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 252 --DY-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 252 --~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.. ..+..+.++.++|++||+.||.+|||+.++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 00 012346678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=330.37 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=211.9
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC---
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--- 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 108 (335)
..+.++|++.+.||+|+||.||+|.+..+++.|++|.+.... ........+.+|+.+++.++|+||+++++++...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 346789999999999999999999999999999999987532 2334456778899999999999999999987543
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 109 ---EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 109 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 357999999965 77777753 478999999999999999999999999999999999999999999999999977
Q ss_pred ccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--------------
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------------- 251 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------- 251 (335)
...........++..|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+...
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 655444455678999999999988776 88999999999999999999999876654433332210
Q ss_pred --------CC---------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 252 --------DY---------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 252 --------~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.. .....+.++.++|.+||+.||.+|||+.++|+||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00 000113467899999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=315.25 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=219.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc-ccceeEEEEeCC----
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN-IIHIYEVFENRE---- 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~---- 109 (335)
-..|...++||.|+||+||+|+++.+|+.||+|.+...... +-.-....+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34677888999999999999999999999999999864321 112335678999999999999 999999998877
Q ss_pred --eEEEEEecCCCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 110 --KMVLVMEYAAGGELYDFLDQKK----VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 110 --~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
..++|+||+ ..+|..++.... .++...++.+++||+.||+|||++||+||||||.||+|+++|.+||+|||++
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 559999998644 5788999999999999999999999999999999999999999999999999
Q ss_pred cccc-CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc----C--CCC--
Q psy2306 184 NVFT-ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN----G--DYF-- 254 (335)
Q Consensus 184 ~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~----~--~~~-- 254 (335)
.... +........+|.+|+|||++.+...++...||||+||++.||+++...|.+....+....+-. . ..+
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 8776 444467788999999999999997789999999999999999999999988766544433322 0 000
Q ss_pred -----------------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchh
Q psy2306 255 -----------------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVAC 297 (335)
Q Consensus 255 -----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 297 (335)
.+..+....+++.+||+.+|.+|.|++.+|+||||.+.....+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 0111347888999999999999999999999999998755543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.50 Aligned_cols=254 Identities=23% Similarity=0.410 Sum_probs=213.7
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-----eE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE-----KM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 111 (335)
+|++.+.||+|+||.||+|.+..+|+.|++|.+... .........+.+|+.+++.++|+||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478899999999999999999999999999998643 223344567889999999999999999999998776 78
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC--
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-- 189 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-- 189 (335)
++++||+. ++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999995 588888887888999999999999999999999999999999999999999999999999998765322
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-------------------
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN------------------- 250 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~------------------- 250 (335)
.......+++.|+|||.+.+...++.++|||||||++|+|++|..||...+..+....+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 2223446788999999998766558899999999999999999999987765544333321
Q ss_pred ----CCC----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 251 ----GDY----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 251 ----~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
... .....+.++.++|.+||+.||.+|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 100 112335678999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=327.21 Aligned_cols=251 Identities=33% Similarity=0.542 Sum_probs=213.6
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||+|+||.||+|.+..+++.|++|++...........+.+.+|..++..+ +|++|+.+++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999875444455667788999999888 599999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCC
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~ 199 (335)
++|..++.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.... .........|++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999886532 223334567899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-------cHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcc
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS-------NFKRLVKQISNGDY-FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~-------~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~ 271 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||... ........+..... .+...+..+.+++++||+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999988776 88999999999999999999999531 22233333333322 344457789999999999
Q ss_pred cCCCCCCC------HHHHhcCCCcCCCC
Q psy2306 272 INPSSRAD------ISVICSHWWIDKDH 293 (335)
Q Consensus 272 ~dp~~Rps------~~~ll~~~~~~~~~ 293 (335)
.||.+|++ +++++.||||+...
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 99999997 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=332.75 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=205.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
-.++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 34689999999999999999999999999999997432 245689999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC--cc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES--RF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~--~~ 191 (335)
++|++. ++|..++.....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999994 689999888788999999999999999999999999999999999999999999999999998654321 22
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHH----------------
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-------FKRLVKQI---------------- 248 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-------~~~~~~~~---------------- 248 (335)
.....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.... .......+
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 334578999999999988776 899999999999999999998764321 11111100
Q ss_pred ----------hcCCCCC----------CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 249 ----------SNGDYFE----------PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 249 ----------~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
....... ...+.++.++|.+||+.||.+|||++|+|+||||+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0000000 1224578899999999999999999999999999763
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=340.47 Aligned_cols=253 Identities=28% Similarity=0.510 Sum_probs=220.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCC-CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKET-GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
...|.+.+.||+|++|.||.|.+..+ +..|++|.+.. ........+.+|+..++.++||||+++++.+...+..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML---NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998877 78899997654 234455677889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 114 VMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
||||+++++|.+++.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987753 457899999999999999999999999999999999999999999999999999765433
Q ss_pred c---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHH
Q psy2306 190 R---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASP 264 (335)
Q Consensus 190 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 264 (335)
. ......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+..+.. .+...+.++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 2 1334568999999999988776 8999999999999999999999998888887777766544 23456778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
+|.+||+.||++||++++++.|+|++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999864
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=335.17 Aligned_cols=255 Identities=30% Similarity=0.500 Sum_probs=217.8
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-C-----CcccceeE
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-H-----PNIIHIYE 103 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~ 103 (335)
..+.+.-+|.+.+.||+|+||.|-+|.|..|++.||||+++. ......+...|+.+|..++ | -|+|++++
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 455666699999999999999999999999999999999986 4455667788999999996 3 59999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC--CCeEEee
Q psy2306 104 VFENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN--GNAKIAD 179 (335)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~--~~~kL~d 179 (335)
+|...++.|||+|.+ +.+|.++++.+. .++...+..++.||+.||.+||+.||||+||||+|||+... ..+|++|
T Consensus 256 ~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred ccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEe
Confidence 999999999999999 669999998754 58999999999999999999999999999999999999653 4799999
Q ss_pred ccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--------
Q psy2306 180 FGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------- 251 (335)
Q Consensus 180 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------- 251 (335)
||.++.....-. ..+.+..|+|||++.+.+| +.+.||||||||+.||++|.+.|.+.+..+.+..|..-
T Consensus 335 FGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY-~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 335 FGSSCFESQRVY--TYIQSRFYRAPEVILGLPY-DTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccccccCCcce--eeeeccccccchhhccCCC-CCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999988765543 6778899999999999998 88999999999999999999999887655554444330
Q ss_pred --------------------------------------------CCCCC------------CCCCchHHHHHHhcccCCC
Q psy2306 252 --------------------------------------------DYFEP------------KNQSTASPLIAEMLNINPS 275 (335)
Q Consensus 252 --------------------------------------------~~~~~------------~~~~~l~~li~~~l~~dp~ 275 (335)
....+ .....+.+|+++||.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00000 0122568899999999999
Q ss_pred CCCCHHHHhcCCCcCCC
Q psy2306 276 SRADISVICSHWWIDKD 292 (335)
Q Consensus 276 ~Rps~~~ll~~~~~~~~ 292 (335)
+|+|+.++|+|||+...
T Consensus 492 ~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGT 508 (586)
T ss_pred hcCCHHHHhcCcccccc
Confidence 99999999999999954
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=318.88 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=215.4
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|++.+.||+|+||.||++.+..+++.|++|.+.............+..|+.+++.++|++++.+++.+.+.+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999876544444445567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 117 YAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 99999999988643 3589999999999999999999999999999999999999999999999999876544433344
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHhc--CCCCCCCCCCchHHHHHHh
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK---RLVKQISN--GDYFEPKNQSTASPLIAEM 269 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~---~~~~~~~~--~~~~~~~~~~~l~~li~~~ 269 (335)
..|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...... +....+.. ........++++.+++++|
T Consensus 161 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 161 RVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 578899999999988776 88999999999999999999999764321 11111111 1122345677899999999
Q ss_pred cccCCCCCCC-----HHHHhcCCCcCCC
Q psy2306 270 LNINPSSRAD-----ISVICSHWWIDKD 292 (335)
Q Consensus 270 l~~dp~~Rps-----~~~ll~~~~~~~~ 292 (335)
|+.||.+||| ++++++||||.+.
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999999 9999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=320.44 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=202.8
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC---CCCcccceeEEEEe-----C
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV---RHPNIIHIYEVFEN-----R 108 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~ 108 (335)
+|++.+.||+|+||+||+|.++.+|+.|++|.+....... .......+|+..++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6899999999999999999999999999999987532221 1122344556655554 79999999998854 3
Q ss_pred CeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
...++++|++++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999964 898888753 34899999999999999999999999999999999999999999999999998776
Q ss_pred cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---------------
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--------------- 251 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 251 (335)
..........++..|+|||++.+..+ +.++||||||+++|+|++|.+||...........+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 54444445567889999999987776 89999999999999999999999776654443333210
Q ss_pred ---CC----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 252 ---DY----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 252 ---~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.+ ..+..+..+.+++.+||+.||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 112345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=328.73 Aligned_cols=255 Identities=26% Similarity=0.442 Sum_probs=210.4
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC----
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR---- 108 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 108 (335)
.+.++|++.+.||+|+||.||+|.+..+++.|++|.+.... ........+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 46789999999999999999999999999999999987532 2334456777899999999999999999998643
Q ss_pred --CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 109 --EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 109 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
...+++|||+++ ++.+.+.. .++...++.++.|+++||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999965 67776653 4889999999999999999999999999999999999999999999999999776
Q ss_pred cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc----------------
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---------------- 250 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---------------- 250 (335)
..........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 55544455678999999999988776 8899999999999999999999987654332221110
Q ss_pred ------CCC---------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 251 ------GDY---------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 251 ------~~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
... .....+.++.++|.+||+.||.+|||+.|+|+||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 001123467899999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=315.36 Aligned_cols=252 Identities=29% Similarity=0.507 Sum_probs=223.1
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||.|++|.||+|.+..+++.|++|.+...........+.+.+|+..+++++||||+++++.+.+.+..++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999986554444567788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccc
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFC 196 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~ 196 (335)
|+.+++|.+.+....++++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 99999999999887789999999999999999999999999999999999999999999999999987765544444566
Q ss_pred cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHh-cCCCCCCCCCCchHHHHHHhccc
Q psy2306 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN---FKRLVKQIS-NGDYFEPKNQSTASPLIAEMLNI 272 (335)
Q Consensus 197 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~---~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 272 (335)
++..|+|||.+.+... +.++|+||||+++|+|++|..||...+ ......... .....+...+..+.++|.+||+.
T Consensus 161 ~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 161 GTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred CChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccC
Confidence 7888999999987775 889999999999999999999998766 455554444 23344555678999999999999
Q ss_pred CCCCCCCH--HHHhcCCCc
Q psy2306 273 NPSSRADI--SVICSHWWI 289 (335)
Q Consensus 273 dp~~Rps~--~~ll~~~~~ 289 (335)
||.+||++ .++++||||
T Consensus 240 ~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 240 DPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ChhHcCCccHHHHhcCCCC
Confidence 99999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=320.54 Aligned_cols=256 Identities=34% Similarity=0.556 Sum_probs=221.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||+|.+..+++.+++|.+.............+.+|++.++.++|+||+++++.+.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998755444456678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--
Q psy2306 116 EYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-- 191 (335)
Q Consensus 116 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-- 191 (335)
||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998753 5689999999999999999999999999999999999999999999999998765422110
Q ss_pred ----------------------------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy2306 192 ----------------------------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR 243 (335)
Q Consensus 192 ----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~ 243 (335)
.....|+..|+|||.+.+..+ +.++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 112356788999999987766 889999999999999999999998887766
Q ss_pred HHHHHhcCCCCCCC---CCCchHHHHHHhcccCCCCCCC----HHHHhcCCCcCCC
Q psy2306 244 LVKQISNGDYFEPK---NQSTASPLIAEMLNINPSSRAD----ISVICSHWWIDKD 292 (335)
Q Consensus 244 ~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps----~~~ll~~~~~~~~ 292 (335)
....+.......+. .+..+.+++.+||..||++||+ +++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 66655544332222 4678999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=315.67 Aligned_cols=266 Identities=32% Similarity=0.508 Sum_probs=228.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||.|++|.||+|.+..++..+++|.+.... .......+.+|+..++.++|+|++++++++.+....++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47899999999999999999999999999999987532 2334556789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~~ 194 (335)
||+++++|.+++..+ ++++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 999999999999865 7899999999999999999999999999999999999999999999999998776543 22334
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC--CCC-CCCchHHHHHHhcc
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF--EPK-NQSTASPLIAEMLN 271 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~-~~~~l~~li~~~l~ 271 (335)
..+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+...... ... .+.++.+++.+||.
T Consensus 158 ~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 567788999999988775 89999999999999999999999877766655555544322 112 56789999999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHh
Q psy2306 272 INPSSRADISVICSHWWIDKDHSVACLEEAEELA 305 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~ 305 (335)
.+|.+||+++++++||||...........+....
T Consensus 237 ~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~ 270 (274)
T cd06609 237 KDPKERPSAKELLKHKFIKKAKKTSYLTLLIERI 270 (274)
T ss_pred CChhhCcCHHHHhhChhhcCCCcccHHHHHHHHH
Confidence 9999999999999999999887776666555444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=316.97 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=217.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|+..+.||+|+||+||+|.+..+++.+++|.+.............+.+|+.+++.++|++++.+.+.+...+..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999876444344445567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 117 YAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
|+++++|.+++.. ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 9999999988864 34699999999999999999999999999999999999999999999999998866544333344
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh----cCC-CCCCCCCCchHHHHHHh
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS----NGD-YFEPKNQSTASPLIAEM 269 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~----~~~-~~~~~~~~~l~~li~~~ 269 (335)
..++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+. ... ......+.++.+++.+|
T Consensus 161 ~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 578899999999987776 889999999999999999999998766543333322 211 22344667899999999
Q ss_pred cccCCCCCCC-----HHHHhcCCCcCCC
Q psy2306 270 LNINPSSRAD-----ISVICSHWWIDKD 292 (335)
Q Consensus 270 l~~dp~~Rps-----~~~ll~~~~~~~~ 292 (335)
|+.||.+||+ +.+++.|+||+..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999 8899999999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=337.19 Aligned_cols=275 Identities=26% Similarity=0.425 Sum_probs=244.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+.|.-.+.||+|+||.||.|+|..+...||||.+..+..+..+....+..|+..|++++|||++.+.++|..+...|+|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34788889999999999999999999999999999998888889999999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
|||| -|+-.+++.- .+++-+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.+..+.+. +
T Consensus 105 MEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---n 180 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---N 180 (948)
T ss_pred HHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---h
Confidence 9999 5588887763 578999999999999999999999999999999999999999999999999999887665 5
Q ss_pred ccccCCccCChhhh---cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC---CCCCCCCCchHHHHH
Q psy2306 194 TFCGSPLYASPEIV---KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD---YFEPKNQSTASPLIA 267 (335)
Q Consensus 194 ~~~~~~~~~aPE~~---~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~ 267 (335)
+.+|||.|||||++ ..+.| +-++||||||++..||...++|+.+.+..-.+..|..+. ...+.++..+.+||.
T Consensus 181 sFvGTPywMAPEVILAMDEGqY-dgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheecccccc-CCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 78899999999997 34455 889999999999999999999999988877776666554 345667889999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHhccCccchhh
Q psy2306 268 EMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTPVRLDL 314 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (335)
.||++-|.+|||.+++|.|+|+....+...+-+++...+..-..++.
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTKdaVrELDN 306 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 306 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999988888777777665444334443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=317.09 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=207.7
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCH
Q psy2306 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGEL 123 (335)
Q Consensus 44 ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 123 (335)
||+|+||.||++.++.+|+.|++|.+.............+..|.++++.++||||+++++.+.+....+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998754333333344556799999999999999999999999999999999999999
Q ss_pred HHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCCcc
Q psy2306 124 YDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLY 201 (335)
Q Consensus 124 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~ 201 (335)
.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.............++..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 9888643 35889999999999999999999999999999999999999999999999998776554444456688999
Q ss_pred CChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhcCCC--CCCCCCCchHHHHHHhcccCCC
Q psy2306 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF----KRLVKQISNGDY--FEPKNQSTASPLIAEMLNINPS 275 (335)
Q Consensus 202 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~----~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~ 275 (335)
+|||++.+..+ +.++|+||||+++|+|++|..||..... .+.......... .....+.++.+++++||+.||.
T Consensus 161 ~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 161 MAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred cCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 99999988775 8999999999999999999999975432 233333332222 1234677899999999999999
Q ss_pred CCCCH----HHHhcCCCcCCC
Q psy2306 276 SRADI----SVICSHWWIDKD 292 (335)
Q Consensus 276 ~Rps~----~~ll~~~~~~~~ 292 (335)
+||++ ++++.||||+..
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hCCCCccchhhhhcChhhcCC
Confidence 99999 678899999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=337.62 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=200.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC------CCcccceeEEEEeC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR------HPNIIHIYEVFENR 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~ 108 (335)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ........|+.+++.++ |.+++.+++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 578999999999999999999999999999999986421 22233455666666654 34588888888654
Q ss_pred -CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCC-------------
Q psy2306 109 -EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENG------------- 173 (335)
Q Consensus 109 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~------------- 173 (335)
.+++++++++ +++|.+++.+.+.+++..+..++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 77999999888889999999999999999999998 5999999999999998665
Q ss_pred ---CeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc
Q psy2306 174 ---NAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN 250 (335)
Q Consensus 174 ---~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 250 (335)
.+||+|||.+..... ......|++.|+|||++.+..+ +.++|||||||++|||++|+.||...+..+....+..
T Consensus 283 ~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 499999998754332 2345678999999999988877 8999999999999999999999987665443322211
Q ss_pred CC------------------------CC-------------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCC
Q psy2306 251 GD------------------------YF-------------------EPKNQSTASPLIAEMLNINPSSRADISVICSHW 287 (335)
Q Consensus 251 ~~------------------------~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 287 (335)
.. .. ....++.+.+||.+||+.||.+|||++|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 00 00 001133567999999999999999999999999
Q ss_pred CcCCC
Q psy2306 288 WIDKD 292 (335)
Q Consensus 288 ~~~~~ 292 (335)
||.+.
T Consensus 440 ~~~~~ 444 (467)
T PTZ00284 440 YVLKY 444 (467)
T ss_pred ccccc
Confidence 99864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.76 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=208.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
-++|++.+.||+|+||.||+|.+..+++.|++|++.... .......+.+|+.+++.++|+||+++++++.+.+.++++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 357888999999999999999999999999999986532 344566788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~ 193 (335)
+||+++++|... ...++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++....... ...
T Consensus 151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence 999999998643 335778889999999999999999999999999999999999999999999987654322 223
Q ss_pred ccccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhcCC--CCCCCCCCchHH
Q psy2306 194 TFCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN---FKRLVKQISNGD--YFEPKNQSTASP 264 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~---~~~~~~~~~~~~--~~~~~~~~~l~~ 264 (335)
...|+..|+|||++.. ..+.+.++||||||+++|+|++|..||.... .......+.... ......+.++.+
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 306 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH 306 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHH
Confidence 4568999999998743 2334568999999999999999999997433 222222222221 223445678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
+|.+||+.||++||++.|+++||||.+.
T Consensus 307 li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 307 FISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999999999999999999875
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=324.75 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=217.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||++.++.+++.+++|++.............+.+|..++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987533333344556788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--c
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--L 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--~ 192 (335)
||+++++|.+++.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999976 46789999999999999999999999999999999999999999999999998865433222 2
Q ss_pred cccccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CC---CCCCCch
Q psy2306 193 STFCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FE---PKNQSTA 262 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~---~~~~~~l 262 (335)
....|++.|+|||++.. ...++.++||||||+++|+|++|..||...+..+....+..... .+ ...+.++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 23568999999999863 23348899999999999999999999998888777777765432 11 2346789
Q ss_pred HHHHHHhcccCCCC--CCCHHHHhcCCCcCCCC
Q psy2306 263 SPLIAEMLNINPSS--RADISVICSHWWIDKDH 293 (335)
Q Consensus 263 ~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~ 293 (335)
.+++++||..++.+ |++++++++||||....
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 99999999765554 68999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.28 Aligned_cols=268 Identities=28% Similarity=0.487 Sum_probs=225.0
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|++|.||+|.+..++..+++|.+..... ...+.+.+|+..++.++|+|++++++.+......+
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 345699999999999999999999999999999999876332 23456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-c
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-F 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~ 191 (335)
+|+||+++++|.+++.. ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999999999864 458999999999999999999999999999999999999999999999999886543322 2
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHHHHH
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASPLIA 267 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~ 267 (335)
.....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+............. .+...+..+.+++.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred cCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 233467889999999987666 8899999999999999999999987766443333332221 12334567899999
Q ss_pred HhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHh
Q psy2306 268 EMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELA 305 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~ 305 (335)
+||..+|.+||++.+++.||||..........++.+..
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~~~~~ 289 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAA 289 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhccCCccccHHHHHHH
Confidence 99999999999999999999999877766666555544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=337.90 Aligned_cols=259 Identities=31% Similarity=0.525 Sum_probs=222.9
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE- 109 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 109 (335)
.....++|++.+.||+|+||+||+|.+..+|+.||+|.+..... .......+.+|+..+..++|+++++++..+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34456799999999999999999999999999999999876433 3455667889999999999999999988774322
Q ss_pred -------eEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEe
Q psy2306 110 -------KMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIA 178 (335)
Q Consensus 110 -------~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~ 178 (335)
.++++|||+++++|.+++.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence 47899999999999998864 3468999999999999999999999999999999999999999999999
Q ss_pred eccccccccCC---ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--
Q psy2306 179 DFGLSNVFTES---RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-- 253 (335)
Q Consensus 179 df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-- 253 (335)
|||++...... .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..+..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 99998765432 12234568999999999988776 8999999999999999999999999888877777666543
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
.+...++++.+++.+||+.||.+||++.++++|||++.
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 34556789999999999999999999999999999864
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=317.18 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=214.7
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||++.+..++..+++|.+.... .......+.+|+++++.++||||+++++.+.+.+..++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999987532 3445567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
||+++++|.+++...+++++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANS 157 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-ccc
Confidence 999999999999888889999999999999999999997 699999999999999999999999999886553322 234
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---------------------
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--------------------- 253 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--------------------- 253 (335)
..++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 567889999999877665 8899999999999999999999976554443332221100
Q ss_pred ------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 ------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.....+.++.+++.+||+.+|++||++.+++.||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011235578999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=323.32 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=217.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|..++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987533333444556788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc--
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-- 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~-- 192 (335)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999986 567999999999999999999999999999999999999999999999999998765433222
Q ss_pred cccccCCccCChhhhcCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CC---CCCCCch
Q psy2306 193 STFCGSPLYASPEIVKGI----PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FE---PKNQSTA 262 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~---~~~~~~l 262 (335)
....|++.|+|||++.+. ..++.++||||||+++|+|++|..||...+..+....+..... .+ ...+.++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 235689999999998652 2237899999999999999999999998887777666655321 11 2246689
Q ss_pred HHHHHHhcccCCCC--CCCHHHHhcCCCcCCCC
Q psy2306 263 SPLIAEMLNINPSS--RADISVICSHWWIDKDH 293 (335)
Q Consensus 263 ~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~ 293 (335)
.+++.+||..++.+ |++++++++||||+...
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 99999999976655 57999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=324.70 Aligned_cols=265 Identities=37% Similarity=0.655 Sum_probs=243.4
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.+..+.+-|.+.+.||+|-|++|-+|++--+|..||+|++.+... +......+.+|++.++.++|||||++|.+...+.
T Consensus 12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 356788999999999999999999999999999999999987654 3345567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEeecccccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADFGLSNVFT 187 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~df~~~~~~~ 187 (335)
.+|+++|.-++|+|.++|-+ ...+.++...+++.||+.|+.|.|+..+|||||||+||++.+ -|-+||.|||++..+.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999999999865 446999999999999999999999999999999999998865 5899999999999999
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHH
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLI 266 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 266 (335)
+.......+|+..|.|||++.+..|+.++.||||||++||-|.+|++||...+..+.+..|...++ .+...+.+.+++|
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHH
Confidence 999999999999999999999999999999999999999999999999999988888888888877 4555688999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.+||..||++|.+.++|.+++|++...+.
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCCC
Confidence 99999999999999999999999966444
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=317.49 Aligned_cols=255 Identities=26% Similarity=0.469 Sum_probs=211.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
-++|++.+.||.|++|.||+|.+..++..|++|.+..... ......+.+|+..++.++|+||+++++++...+..+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 3589999999999999999999999999999999875332 22233567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
+||++ ++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 99996 588888765 4568999999999999999999999999999999999999999999999999986543322 22
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC----------------CC---
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG----------------DY--- 253 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~----------------~~--- 253 (335)
....+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+... ..
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 33456888999999877655588999999999999999999999887765443322210 00
Q ss_pred ------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 ------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 ------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.....++.+.++|.+||+.||.+|||+.++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 012346678899999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=310.59 Aligned_cols=252 Identities=27% Similarity=0.494 Sum_probs=215.4
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC------HHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET------EADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
+|++...||.|++|.||+|.+..++..+++|.+....... ....+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999999889999999887543222 2234678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
.++++||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999887654211
Q ss_pred c-------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCCCCCCc
Q psy2306 191 F-------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--YFEPKNQST 261 (335)
Q Consensus 191 ~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 261 (335)
. .....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.... ..+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 112346788999999987776 889999999999999999999998766554444433322 233456778
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 262 ASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
+.+++++||+.||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=306.50 Aligned_cols=251 Identities=31% Similarity=0.523 Sum_probs=219.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+..++.++|+|++++++++.+.+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 48899999999999999999999999999999875433 34456678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-cc
Q psy2306 117 YAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LS 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-~~ 193 (335)
|+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999999764 5789999999999999999999999999999999999999999999999998876543322 23
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHHHHhcc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLIAEMLN 271 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~ 271 (335)
...+++.|+|||+..+..+ +.++|+||||+++++|++|..||...+.......+...... ....+.++.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 4467889999999988776 88999999999999999999999988877776666655432 22456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCc
Q psy2306 272 INPSSRADISVICSHWWI 289 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~ 289 (335)
.+|++||++.++++|||+
T Consensus 239 ~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 239 KDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCcccCcCHHHHhhCCCC
Confidence 999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=313.21 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=212.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||+|.++.+|+.|++|.+..... .....+.+.+|+.+++.++|+|++++++++......++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875332 2223345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~ 194 (335)
||+++++|..++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 999998888888777779999999999999999999999999999999999999999999999999987665433 2233
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---------------C------C
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---------------D------Y 253 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---------------~------~ 253 (335)
..++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+... . .
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 456788999999877554588999999999999999999999876554333222110 0 0
Q ss_pred C-----------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 254 F-----------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 254 ~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
. .+..+..+.+++.+||+.+|++||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 12335678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=312.76 Aligned_cols=271 Identities=34% Similarity=0.583 Sum_probs=245.5
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
--++|...+.||+|.||.|-+++.+.+|+.||+|++++.-....+....-..|-++|+..+||.+..+...|+..+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 34589999999999999999999999999999999998777677778888899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc-cCCccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~-~~~~~~ 192 (335)
||||.+||.|.-.+.+...+++.....+..+|+.||.|||+.+||.||||.+|.+++.+|++|+.|||++..- ......
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccccee
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998654 344455
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcc
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~ 271 (335)
...+|+|.|.|||++....| +.+.|.|.+|+++|||++|+.||.+.+.+.+...|..+.. ++...+++.+.++..+|.
T Consensus 326 kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~ 404 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLK 404 (516)
T ss_pred ccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhh
Confidence 67899999999999999888 8999999999999999999999999999999999888766 455678899999999999
Q ss_pred cCCCCCC-----CHHHHhcCCCcCCCCcchhhHHHHHHh
Q psy2306 272 INPSSRA-----DISVICSHWWIDKDHSVACLEEAEELA 305 (335)
Q Consensus 272 ~dp~~Rp-----s~~~ll~~~~~~~~~~~~~~~~~~~~~ 305 (335)
+||.+|. .+.||.+|+||+...+.+....-.+.+
T Consensus 405 kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PP 443 (516)
T KOG0690|consen 405 KDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPP 443 (516)
T ss_pred cChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCC
Confidence 9999995 688999999999988776655443333
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=313.06 Aligned_cols=267 Identities=29% Similarity=0.445 Sum_probs=222.1
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...+.|++.+.||+|++|.||+|.+..++..+++|.+... .....+.+.+|+..++.++|+|++++++.+..++..+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 3456899999999999999999999999999999998752 3455677888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-c
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-R 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~ 190 (335)
++|||+++++|..++.+ ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999999999887754 456899999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccccCCccCChhhhcCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCch
Q psy2306 191 FLSTFCGSPLYASPEIVKGI----PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTA 262 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l 262 (335)
......+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||...+.......+...... +...+.++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence 22345578899999998521 22377899999999999999999999877766555555443221 23345688
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHH
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAE 302 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~ 302 (335)
.+++++||+.+|++||+++++++||||...........+.
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~ 285 (292)
T cd06644 246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELV 285 (292)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCccccccccchhHHHHH
Confidence 9999999999999999999999999998765555444333
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=325.32 Aligned_cols=258 Identities=24% Similarity=0.439 Sum_probs=211.6
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC---
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--- 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 108 (335)
..+.++|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 446679999999999999999999999999999999987532 2223445677899999999999999999887533
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 109 ---EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 109 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
...+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 4578999998 7799888764 5699999999999999999999999999999999999999999999999999876
Q ss_pred ccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC-------------
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD------------- 252 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 252 (335)
.... .....+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....
T Consensus 168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 5432 2345688999999999875555889999999999999999999998766544333322100
Q ss_pred ------------C-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 253 ------------Y-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 253 ------------~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
. .....++.+.++|.+||+.||.+|||+.+++.||||.+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0 00123446789999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=305.83 Aligned_cols=251 Identities=31% Similarity=0.566 Sum_probs=215.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-CCeEEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN-REKMVLVM 115 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 115 (335)
.|++.+.||.|++|.||++.+..+++.+++|.+..... .....+.+.+|+..++.++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999875332 33445678889999999999999999998764 45689999
Q ss_pred ecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccc
Q psy2306 116 EYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFL 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~ 192 (335)
||+++++|.+++.. ...+++.+++.++.+++.|+++||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99999999999875 345899999999999999999999999999999999999999999999999998765432 222
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhc
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEML 270 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l 270 (335)
....+++.|+|||++.+..+ +.++|+||||+++++|++|..||...+.......+..+.. .....++.+.+++.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence 34457889999999988776 8899999999999999999999988877766666555443 23446778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCc
Q psy2306 271 NINPSSRADISVICSHWWI 289 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~~~~ 289 (335)
+.+|.+||++.++++||||
T Consensus 239 ~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 239 SKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=309.29 Aligned_cols=248 Identities=35% Similarity=0.595 Sum_probs=217.0
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCH
Q psy2306 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGEL 123 (335)
Q Consensus 44 ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 123 (335)
||.|++|.||+|.+..+++.+++|.+...........+.+.+|+..++.++|+||+++++.+.+.+..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999989999999999875544445567899999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCCccCC
Q psy2306 124 YDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203 (335)
Q Consensus 124 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~a 203 (335)
.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.............+++.|++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 99998888899999999999999999999999999999999999999999999999999887655433344567889999
Q ss_pred hhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhc--CC-CCCCCCCCchHHHHHHhcccCCCCCC
Q psy2306 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN--FKRLVKQISN--GD-YFEPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 204 PE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~--~~~~~~~~~~--~~-~~~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
||.+.+..+ +.++|+||+|+++|+|++|..||.... ..+....+.. .. ..+...+.++.++|.+||+.+|.+||
T Consensus 161 PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 161 PEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 999877666 889999999999999999999998776 5555555552 22 23334467999999999999999999
Q ss_pred C-----HHHHhcCCCcCCC
Q psy2306 279 D-----ISVICSHWWIDKD 292 (335)
Q Consensus 279 s-----~~~ll~~~~~~~~ 292 (335)
+ ++|+++||||.+.
T Consensus 240 ~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 240 GNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCcccCHHHHhcChhhhCC
Confidence 9 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=308.75 Aligned_cols=251 Identities=24% Similarity=0.443 Sum_probs=212.7
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc---CCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
+|++.+.||+|+||.||+|.+. +|..+++|.+..... ........+.+|++.++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999864 688999999875321 123345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-----
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE----- 188 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~----- 188 (335)
++||+++++|.+++.+..++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999998878899999999999999999999999999999999999999999999999998865421
Q ss_pred --CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC----CCCCCCCCch
Q psy2306 189 --SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD----YFEPKNQSTA 262 (335)
Q Consensus 189 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~l 262 (335)
........++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.... ..+...+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 111233457888999999987766 889999999999999999999998766544433333321 2333456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.+++++||+.+|.+||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=313.70 Aligned_cols=257 Identities=30% Similarity=0.517 Sum_probs=220.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||++.+..+++.|++|.+.............+.+|+..++.++|+||+++++.+...+..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987644333445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC------
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES------ 189 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~------ 189 (335)
||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999987532100
Q ss_pred ----------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC----
Q psy2306 190 ----------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE---- 255 (335)
Q Consensus 190 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---- 255 (335)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||.+.+..+............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 00112356778999999887665 899999999999999999999999888877777766543221
Q ss_pred CCCCCchHHHHHHhcccCCCCCCC---HHHHhcCCCcCCCC
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRAD---ISVICSHWWIDKDH 293 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~ 293 (335)
...+.++.++|.+||+.||.+||+ +.++++||||....
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 134668999999999999999997 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=310.30 Aligned_cols=252 Identities=28% Similarity=0.442 Sum_probs=211.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||+|.+..+++.|++|++.... ......+.+|+..++.++|+||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3458999999999999999999999999999999987532 2234467789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
++||+++++|.+++..+.++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987654322 22
Q ss_pred cccccCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC------CCCCCchHH
Q psy2306 193 STFCGSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE------PKNQSTASP 264 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~ 264 (335)
....+++.|+|||.+.. ....+.++|+||+|+++|+|++|..||......+....+....... ...+..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 34567889999998742 2223778999999999999999999997655444333332222211 124568999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCC
Q psy2306 265 LIAEMLNINPSSRADISVICSHWW 288 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~ 288 (335)
++++||+.+|++||+++++++|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=311.45 Aligned_cols=256 Identities=32% Similarity=0.494 Sum_probs=219.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||.|++|.||++.+..++..+++|.+... .....+.+.+|+.+++.++|+|++++++.+......+++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998752 344556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
|||+++++|.+++.. ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 999999999999876 4569999999999999999999999999999999999999999999999999876543322 22
Q ss_pred cccccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCchHH
Q psy2306 193 STFCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTASP 264 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~ 264 (335)
....+++.|++||.+.. ....+.++|+||||+++|+|++|..||...+..+....+...... +...+.++.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 34457888999999752 222377899999999999999999999888776666666554321 2345678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
++.+||+.+|.+||++.++++||||....
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 241 FLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 99999999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=314.53 Aligned_cols=261 Identities=29% Similarity=0.496 Sum_probs=218.9
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
....++|++.+.||+|++|.||+|.+..++..|++|.+..... ...+.+.+|+..++.++|+|++++++.+...+..
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 3455799999999999999999999999999999999875332 2345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
++++||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999999999865 4589999999999999999999999999999999999999999999999998876543322
Q ss_pred -ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHHHH
Q psy2306 192 -LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASPLI 266 (335)
Q Consensus 192 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li 266 (335)
.....+++.|++||.+.+..+ +.++|+||||+++|++++|..||...+.......+..... .+...+..+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred CcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 234467888999999988766 8899999999999999999999977665433322222211 1223456788999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCCCcchh
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKDHSVAC 297 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 297 (335)
.+||..+|.+||++++++.||||+.......
T Consensus 250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 9999999999999999999999986555444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=313.33 Aligned_cols=257 Identities=30% Similarity=0.477 Sum_probs=213.4
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC--CHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE--TEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
+|++.+.||.|++|.||+|.+..+|+.|++|.+...... .......+..|+..++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999989999999999764432 123345667899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 115 MEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
|||+ +++|.+++.... .+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999998766 79999999999999999999999999999999999999999999999999987665432 22
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC----------------C---
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD----------------Y--- 253 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----------------~--- 253 (335)
....++..|+|||.+.+....+.++|+||||+++|+|++|.++|...+..+....+.... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 333457789999998665555889999999999999999988887665444333332100 0
Q ss_pred ----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 254 ----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 254 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
.....+.++.++|.+||++||.+|||+.+++.|+||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 01223557889999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=330.54 Aligned_cols=255 Identities=25% Similarity=0.474 Sum_probs=225.8
Q ss_pred cce-eEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCC-cCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe--E
Q psy2306 36 QRF-DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCK-IETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK--M 111 (335)
Q Consensus 36 ~~y-~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~ 111 (335)
+|| +....||+|+|-+||+|.|..+|..||+-.++... ...+...+++..|+.+|+.|+|+||++++++|.+... +
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 344 45678999999999999999999999988776433 3456678899999999999999999999999987665 8
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC--CcEecCCCCCCEEEcc-CCCeEEeeccccccccC
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH--KICHRDLKLENILLDE-NGNAKIADFGLSNVFTE 188 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~--givH~di~p~nili~~-~~~~kL~df~~~~~~~~ 188 (335)
.+|+|.+.+|+|+.++++.+.++...++.|++||+.||.|||++ .|+|||||.+||+|+. .|.|||+|+|+|+.+..
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 89999999999999999999999999999999999999999988 5999999999999987 58999999999998876
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHHhcCCCC---CCCCCCchHH
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFD-GSNFKRLVKQISNGDYF---EPKNQSTASP 264 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~-~~~~~~~~~~~~~~~~~---~~~~~~~l~~ 264 (335)
.... ...|||.|||||.+.. .| ...+|||||||+++||+|+..||. ..++.++++++..+..+ ..-.++++++
T Consensus 199 s~ak-svIGTPEFMAPEmYEE-~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~ 275 (632)
T KOG0584|consen 199 SHAK-SVIGTPEFMAPEMYEE-NY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVRE 275 (632)
T ss_pred cccc-eeccCccccChHHHhh-hc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHH
Confidence 5433 4899999999999983 44 899999999999999999999996 48889999999988653 2234779999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
||.+||.. ...|||+.|+|.||||+....
T Consensus 276 fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 276 FIEKCLAT-KSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred HHHHHhcC-chhccCHHHHhhChhhccccc
Confidence 99999999 999999999999999998755
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=304.93 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=217.4
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc--CCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI--ETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ...+..+.+.+|+..++.++|+|++++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57888999999999999999998899999999875332 2234567888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
+||+++++|.+++.+..++++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999998876654443345
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-C--CCCCCCCCCchHHHHHHhcc
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN-G--DYFEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~li~~~l~ 271 (335)
..++..|++||.+......+.++|+||||+++|+|++|..||...........+.. . ...+...+..+.+++++||+
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 240 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence 56788899999987665348899999999999999999999977665444444333 1 12334456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCc
Q psy2306 272 INPSSRADISVICSHWWI 289 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~ 289 (335)
.+|.+||++.+++.|||+
T Consensus 241 ~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 241 RDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cCcccCcCHHHHhcCCCC
Confidence 999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=306.29 Aligned_cols=252 Identities=28% Similarity=0.475 Sum_probs=215.3
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||.|++|+||+|.+..++..+++|++..... ......+.+|+..++.++|+|++++++.+...+..++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 479999999999999999999988999999999875332 225678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 116 EYAAGGELYDFLDQK---KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
|++++++|.+++... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999988765543222
Q ss_pred -----cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-------CCCCC
Q psy2306 193 -----STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-------PKNQS 260 (335)
Q Consensus 193 -----~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~ 260 (335)
....++..|++||.+......+.++|+||||+++++|++|..||...+..+............ ...+.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 234578889999998776445899999999999999999999998776655444444332211 13356
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.+.+++.+||+.||.+||++.+|+.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 78999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=303.14 Aligned_cols=251 Identities=35% Similarity=0.608 Sum_probs=218.9
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|++|.||+|.+..++..+++|.+..... .......+.+|+..++.++|+|++++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999876443 33446778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-CeEEeeccccccccCCcccc
Q psy2306 117 YAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-NAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-~~kL~df~~~~~~~~~~~~~ 193 (335)
|+++++|.+++... ..+++..+..++.+++.+|++||++|++|+||+|+||+++.++ .++|+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999999763 3589999999999999999999999999999999999998654 57999999998766554444
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~ 271 (335)
...++..|+|||.+.+... +.++|+||||+++++|++|..||...+.......+..... .....+.++.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (256)
T cd08220 160 TVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238 (256)
T ss_pred ccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence 5567889999999987665 8899999999999999999999988877766666655433 233467789999999999
Q ss_pred cCCCCCCCHHHHhcCCCc
Q psy2306 272 INPSSRADISVICSHWWI 289 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~ 289 (335)
.+|.+|||++++++||||
T Consensus 239 ~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 239 LDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=304.38 Aligned_cols=250 Identities=30% Similarity=0.502 Sum_probs=215.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||.|++|.||+|.+..+++.+++|.+.... ....+.+.+|+..++.++|+|++++++++.+.+..+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 468999999999999999999999889999999998643 23567888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 115 MEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999999999999775 789999999999999999999999999999999999999999999999999887654322 22
Q ss_pred cccccCCccCChhhhcCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC------CCCCCCchH
Q psy2306 193 STFCGSPLYASPEIVKGI---PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF------EPKNQSTAS 263 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~l~ 263 (335)
....++..|+|||.+.+. .+ +.++|+||||+++|+|++|..||...+..+....+...... ....+.++.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred ccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 344677889999998765 55 78999999999999999999999887665555544444221 122355789
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCC
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWW 288 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~ 288 (335)
+++++||+.+|.+||++.+++.|+|
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=310.25 Aligned_cols=251 Identities=28% Similarity=0.474 Sum_probs=206.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||.|++|.||+|.+..++..|++|.+..... .......+.+|+..++.++|+|++++++++.+++..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999875332 22234567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 117 YAAGGELYDFLDQ---KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 117 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
|++ ++|.+++.. +..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 996 588888764 2568999999999999999999999999999999999999999999999999986553321 22
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-C--------------------
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN-G-------------------- 251 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~-------------------- 251 (335)
....+++.|+|||++.+....+.++||||||+++|+|++|..||...+.......+.. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 3345678899999987665558899999999999999999999976544322111100 0
Q ss_pred --C-------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 252 --D-------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 252 --~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
. ......+.++.++|++||+.||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 0112346688899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=319.71 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=211.4
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC----
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR---- 108 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 108 (335)
.+.++|++.+.||+|++|.||+|.+..+|+.|++|.+.... ........+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 67899999999999999999999999999999999986432 2334455677899999999999999999988543
Q ss_pred --CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 109 --EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 109 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
...|+++||+. ++|.+.+... ++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 35799999995 5888887654 899999999999999999999999999999999999999999999999999776
Q ss_pred cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc----------------
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---------------- 250 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---------------- 250 (335)
..........++..|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 55443344567889999999988776 8999999999999999999999976654332222111
Q ss_pred ------CCC---------------C-------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 251 ------GDY---------------F-------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 251 ------~~~---------------~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
... . ....++.+.++|.+||+.||.+|||+.++|.||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 000 0 0012446789999999999999999999999999985443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=311.30 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=217.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+.+|+..++.++|+|++++++.+...+..++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 34689999999999999999999999999999999875332 234567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
++||+++++|.+++... .+++.++..++.+++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence 99999999999988754 58999999999999999999999999999999999999999999999999886654322 22
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHHHHHH
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASPLIAE 268 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~ 268 (335)
....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..... .+...+..+.++|++
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 33467889999999987766 8899999999999999999999988776554444433221 223456689999999
Q ss_pred hcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 269 MLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
||..||.+||++.+++.||||+...
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=308.21 Aligned_cols=256 Identities=30% Similarity=0.471 Sum_probs=216.1
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
-|++.+.||.|++|.||++.+..++..+++|.+... .....+.+.+|+..++.++|+|++++++.+...+..++++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 478889999999999999999999999999998642 34456678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccccc
Q psy2306 117 YAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~~ 194 (335)
|+++++|..++.+ ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 9999999988764 567999999999999999999999999999999999999999999999999988654322 22234
Q ss_pred cccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHHHH
Q psy2306 195 FCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASPLI 266 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li 266 (335)
..++..|+|||++.. ....+.++|+||+|+++|+|++|..||...+..+....+..... .+...+.++.++|
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 567889999999742 22237799999999999999999999988776665555544322 1233566899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.+||+.||.+||++.++++||||......
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred HHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence 99999999999999999999999875443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=313.37 Aligned_cols=251 Identities=29% Similarity=0.528 Sum_probs=205.7
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|++|.||+|.+..+|+.+++|.+..... .......+.+|+..++.++|+|++++++++.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 68999999999999999999999999999999875322 22223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccccc
Q psy2306 117 YAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~~ 194 (335)
|++ ++|.+++.. ...+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 996 478777754 567999999999999999999999999999999999999999999999999998755432 22233
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHhcC----------------C-----
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF-DGSNFKRLVKQISNG----------------D----- 252 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~-~~~~~~~~~~~~~~~----------------~----- 252 (335)
..++..|+|||.+.+...++.++||||||+++|+|++|..|+ ...+..+....+... .
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 456788999999877665588999999999999999998885 434433332222110 0
Q ss_pred ---------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 ---------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
...+..++++.++|++||+.||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0112345678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=320.84 Aligned_cols=242 Identities=28% Similarity=0.484 Sum_probs=213.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.++..+.||+|-||.||.|.... ..+|++|.+..... ..+.+.+|+.++++|+|++|++++++|..+..++||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 56678999999999999998764 34799999886432 23467799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 117 YAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
|++.|+|.++|+. +..+...++..++.||++|++||+++++|||||...||||+.+..+|++|||+++...+......
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 9999999999986 56799999999999999999999999999999999999999999999999999996554444332
Q ss_pred cc--cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 195 FC--GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 195 ~~--~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
.. -...|.|||.+....+ +.+|||||||++|||++| |+.||...+..+.++.+..+.. .+...|+++.+++..|
T Consensus 362 ~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 22 2446999999999888 999999999999999997 9999999999999999999864 3455788999999999
Q ss_pred cccCCCCCCCHHHHh
Q psy2306 270 LNINPSSRADISVIC 284 (335)
Q Consensus 270 l~~dp~~Rps~~~ll 284 (335)
|..+|++|||++.+.
T Consensus 441 W~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLR 455 (468)
T ss_pred hhCCcccCCCHHHHH
Confidence 999999999999765
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=309.08 Aligned_cols=250 Identities=28% Similarity=0.499 Sum_probs=211.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|++|.||+|.+..+++.|++|.++... ......+.+|+..++.++||||+++++.+...+..+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 458999999999999999999999999999999987532 23345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
+||+++++|.+++...+.+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999988654322 1223
Q ss_pred ccccCCccCChhhhc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC------CCCCchHH
Q psy2306 194 TFCGSPLYASPEIVK---GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP------KNQSTASP 264 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~---~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~ 264 (335)
...++..|+|||.+. ...+ +.++|+||||+++|+|++|..||..................++ .++..+.+
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred cccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 456788999999874 3334 7899999999999999999999876554443333332222211 24557889
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCC
Q psy2306 265 LIAEMLNINPSSRADISVICSHWW 288 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~ 288 (335)
++.+||+.+|++||++++++.|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=309.12 Aligned_cols=252 Identities=30% Similarity=0.519 Sum_probs=212.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||.|++|.||+|.+..+|..|++|.+...... ......+.+|+..++.++|+|++++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999999999999998864322 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc--ccc
Q psy2306 117 YAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR--FLS 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~--~~~ 193 (335)
|+ +++|.+++.. ..++++.+++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99 9999999864 4569999999999999999999999999999999999999999999999999987665432 233
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC---------------------
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--------------------- 252 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--------------------- 252 (335)
...++..|+|||.+.+....+.++||||+|+++++|++|.+||...+.......+....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 45678899999998766555889999999999999999988887665443332222100
Q ss_pred C----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 253 Y----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 253 ~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
+ ..+..+..+.++|++||+.+|.+||+++++++||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123456888999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.87 Aligned_cols=251 Identities=33% Similarity=0.621 Sum_probs=218.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|+||.+|.+.+..+|+.|++|.+..... .......+.+|+..++.++|+||+++++++...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 69999999999999999999999999999999875332 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc-c
Q psy2306 117 YAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-S 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~-~ 193 (335)
|+.+++|.+.+... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 99999999998753 35789999999999999999999999999999999999999999999999988765443221 2
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHHHHhcc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLIAEMLN 271 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~ 271 (335)
...+++.|+|||++.+... +.++|+||||+++++|++|..||...+..+....+..+... +...+.++.++|.+||+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence 3456788999999987766 88999999999999999999999988887777776665542 33456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCc
Q psy2306 272 INPSSRADISVICSHWWI 289 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~ 289 (335)
.+|.+||++.++++||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.43 Aligned_cols=251 Identities=33% Similarity=0.549 Sum_probs=220.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||.|++|.||.+.+..++..+++|.+..... .......+.+|+..++.++|+||+++++++.+.+..++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 69999999999999999999999999999999875432 33445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccc
Q psy2306 117 YAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLS 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~ 193 (335)
|+++++|.+++.+. ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999999764 468999999999999999999999999999999999999999999999999987654333 233
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC--CCCCCchHHHHHHhcc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE--PKNQSTASPLIAEMLN 271 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~ 271 (335)
...+++.|+|||...+..+ +.++|+||||+++++|++|..||...+..+....+..+.... ...+.++.+++.+||+
T Consensus 160 ~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred ccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 4567889999999987765 889999999999999999999999888887777776654432 3346789999999999
Q ss_pred cCCCCCCCHHHHhcCCCc
Q psy2306 272 INPSSRADISVICSHWWI 289 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~ 289 (335)
.+|.+||++.++++|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=319.15 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=201.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEE-----CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGIN-----KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENR 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 108 (335)
.++|++.+.||+|+||.||+|.+ ..++..||+|.+... ........+.+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 46899999999999999999975 234578999998753 2334456788999999999 899999999988654
Q ss_pred -CeEEEEEecCCCCCHHHHHhhC---------------------------------------------------------
Q psy2306 109 -EKMVLVMEYAAGGELYDFLDQK--------------------------------------------------------- 130 (335)
Q Consensus 109 -~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------- 130 (335)
+.++++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999998642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---ccccccCCccC
Q psy2306 131 -----KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYA 202 (335)
Q Consensus 131 -----~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~ 202 (335)
.++++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........ .....++..|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 2477888999999999999999999999999999999999999999999999876532211 12233457899
Q ss_pred ChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcH-HHHHHHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCC
Q psy2306 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNF-KRLVKQISNGDY--FEPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 203 aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~-~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
|||++.+..+ +.++||||||+++|+|++ |..||..... +.....+..+.. .+...++.+.+++.+||+.||.+||
T Consensus 244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999987776 899999999999999997 9999987543 333444443322 2334566899999999999999999
Q ss_pred CHHHHhc
Q psy2306 279 DISVICS 285 (335)
Q Consensus 279 s~~~ll~ 285 (335)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999983
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=329.74 Aligned_cols=261 Identities=28% Similarity=0.458 Sum_probs=229.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+-|.|+..||.|+||.||+|+.++++...|.|++.. ..++..+.+.-|+++|..+.||+|+++++.|..++.+|++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 3468899999999999999999999988889998864 4577788999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccc
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~ 192 (335)
.|||.||-+..++-. ..++++.++..+++|++.||.|||+.+|||||||..|||++-+|.++|.|||.+.... .....
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 999999998877754 5679999999999999999999999999999999999999999999999999875543 33445
Q ss_pred cccccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHH
Q psy2306 193 STFCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASP 264 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~ 264 (335)
.+..|||+|||||++.. ...|+.++||||||++|.+|..+.+|-...++...+-.+..... .+..++..+.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 67899999999998742 23348999999999999999999999999999998888887654 34566779999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhh
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVACL 298 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 298 (335)
|+.+||.+||..||++++||.||||+...+...+
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~i 301 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMI 301 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCcccccCCcchHH
Confidence 9999999999999999999999999965544333
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=319.60 Aligned_cols=246 Identities=21% Similarity=0.356 Sum_probs=199.8
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
...|++.+.||+|+||.||+|.+..++..|++|..... ....|+.+++.++|+||+++++++...+..+++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34799999999999999999999999999999985432 123588899999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
+|++. ++|.+++.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+..........
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 99995 578777754 5679999999999999999999999999999999999999999999999999987654433344
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCC-CCCc----------HHHHHHHHhcCC-----CC---
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF-DGSN----------FKRLVKQISNGD-----YF--- 254 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~-~~~~----------~~~~~~~~~~~~-----~~--- 254 (335)
...|+..|+|||++.+..+ +.++||||||+++|+|+++..++ .... ...+...+.... +.
T Consensus 215 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred cccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 5668999999999988776 89999999999999999854443 3211 111111111100 00
Q ss_pred --------------------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 255 --------------------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 255 --------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
....+.++.++|.+||+.||.+|||+.|+|+||||++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0123456677999999999999999999999999975
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=322.29 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=207.5
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEEC--CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINK--ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN 107 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 107 (335)
+...+..+|++.+.||.|+||.||+|... .++..|++|.+.... ...+|+.+++.++|+||+++++.+..
T Consensus 86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEee
Confidence 45556778999999999999999999764 356789999876421 24579999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
.+..+++||++. ++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999999999995 6898988777889999999999999999999999999999999999999999999999999987654
Q ss_pred CCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHH---hc-------
Q psy2306 188 ESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF----KRLVKQI---SN------- 250 (335)
Q Consensus 188 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~----~~~~~~~---~~------- 250 (335)
.... .....|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ..+...+ ..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 3222 234568999999999988776 8899999999999999999999965431 1111110 00
Q ss_pred ---------------C---CCC------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 251 ---------------G---DYF------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 251 ---------------~---~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
. ... ....+.++.++|++||..||++|||+.++|.||||.+.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0 000 01224578889999999999999999999999999864
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=303.74 Aligned_cols=249 Identities=35% Similarity=0.558 Sum_probs=214.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||.|++|.||+|.+..++..+++|.+.... ..+.+.+|+..++.++|+|++++++.+.+....+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 368999999999999999999999889999999986521 256888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
+|++++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 999999999999975 4568999999999999999999999999999999999999999999999999987665433 22
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCchHHHHHH
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTASPLIAE 268 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~ 268 (335)
....++..|+|||.+.+..+ +.++||||||+++|+|++|..||...........+...... ....+.++.+++.+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 34457888999999988766 88999999999999999999999877665544443332221 12345689999999
Q ss_pred hcccCCCCCCCHHHHhcCCCc
Q psy2306 269 MLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~~~~~ 289 (335)
||+.||.+|||+.+++.||||
T Consensus 236 ~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 236 CLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=315.62 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=203.5
Q ss_pred EEeeeecc--CCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 40 IVRKLGQG--NYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 40 ~~~~ig~g--~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
+.+.||+| ++++||++.++.+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 789999999999999999999875332 334556788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc----
Q psy2306 118 AAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF---- 191 (335)
Q Consensus 118 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~---- 191 (335)
+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++++||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999965 34589999999999999999999999999999999999999999999999976433221110
Q ss_pred ----ccccccCCccCChhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC------------
Q psy2306 192 ----LSTFCGSPLYASPEIVKGI-PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF------------ 254 (335)
Q Consensus 192 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~------------ 254 (335)
.....++..|+|||++.+. ..++.++|||||||++|+|++|..||..................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 1122456679999998763 23488999999999999999999999765543333222221100
Q ss_pred -----------------------------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 255 -----------------------------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 255 -----------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
....++++.+++.+||+.||.+|||++++++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 01124468899999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=302.18 Aligned_cols=251 Identities=32% Similarity=0.613 Sum_probs=219.6
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--CCeEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--REKMVLV 114 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 114 (335)
+|++.+.||.|++|.||++.+..++..+++|.+..... .....+.+..|+..++.++|+|++++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999876433 34556678899999999999999999998753 4578999
Q ss_pred EecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhH-----HCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 115 MEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCH-----KHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH-----~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
+||+++++|.+++.. ..++++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999875 457899999999999999999999 89999999999999999999999999999887
Q ss_pred ccCCcc-ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCch
Q psy2306 186 FTESRF-LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTA 262 (335)
Q Consensus 186 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l 262 (335)
...... .....+++.|+|||.+.+..+ +.++|+||||+++++|++|..||...+..+..+.+..... .+...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence 655433 334567889999999988775 8899999999999999999999998888787777776654 334456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.+++.+||+.+|.+||++.+|++|||+
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=310.52 Aligned_cols=253 Identities=29% Similarity=0.497 Sum_probs=211.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||+|.+..+++.|++|.+....... ...+.+.+|++.++.++|+||+++++++.+.+..++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999987533222 34556788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~ 194 (335)
||+++++|..+......+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 999999999888776679999999999999999999999999999999999999999999999999887654322 2233
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc--------------------CC--
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN--------------------GD-- 252 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~--------------------~~-- 252 (335)
..++..|+|||...+....+.++||||||+++++|++|..||......+....+.. ..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 45788899999987655558899999999999999999999976553322211111 00
Q ss_pred ----------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 ----------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
...+..+..+.+++.+||+.+|.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0012346678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=305.41 Aligned_cols=248 Identities=35% Similarity=0.575 Sum_probs=218.1
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCH
Q psy2306 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGEL 123 (335)
Q Consensus 44 ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 123 (335)
||.|++|.||++.+..+|+.+++|.+...........+.+.+|++.++.++|+|++++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999998765444445677888999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc---------cccc
Q psy2306 124 YDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR---------FLST 194 (335)
Q Consensus 124 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~---------~~~~ 194 (335)
.+++.+.+.+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999887789999999999999999999999999999999999999999999999999876543321 2233
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCC---CCchHHHHHHhcc
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKN---QSTASPLIAEMLN 271 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~ 271 (335)
..++..|++||....... +.++|+||||+++|++++|..||......+....+.......+.. +..+.+++++||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 456788999999987775 889999999999999999999999888888777777655433333 6789999999999
Q ss_pred cCCCCCCCH---HHHhcCCCcCCC
Q psy2306 272 INPSSRADI---SVICSHWWIDKD 292 (335)
Q Consensus 272 ~dp~~Rps~---~~ll~~~~~~~~ 292 (335)
.+|.+|||+ .++++||||++.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCC
Confidence 999999999 999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=312.35 Aligned_cols=267 Identities=30% Similarity=0.519 Sum_probs=234.9
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
..-.+-|.++++||.|+||.||+|+++++|..+|+|.+.. +.+...+..|+.++++++.+++|++|+.|.....+
T Consensus 29 K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 29 KPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred CChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 3344578899999999999999999999999999999764 45577889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-
Q psy2306 112 VLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES- 189 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~- 189 (335)
|+|||||..|++.+.++ +++++++.++..+++.-+.||+|||...-+|||||..|||++.+|+.||.|||.+..+...
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999999999997 4678999999999999999999999999999999999999999999999999999776542
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCchHHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTASPL 265 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~l 265 (335)
...+...|||.|||||++....| ..++||||||++..||..|++||.+-.+.+.+-.+-.+..+ +..++.++.+|
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY-~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGY-DTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred HhhCccccCcccccHHHHHHhcc-chhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHH
Confidence 33467789999999999999888 78999999999999999999999988776666555544321 23457789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHH
Q psy2306 266 IAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEEL 304 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~ 304 (335)
|+.||-+.|++|.|+.++++|||++.....+.+..+.+-
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~ 301 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQD 301 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHH
Confidence 999999999999999999999999998888776655443
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=303.65 Aligned_cols=252 Identities=28% Similarity=0.477 Sum_probs=210.8
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc--CCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--CCeEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI--ETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--REKMV 112 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 112 (335)
.|++.+.||+|++|.||+|.+..++..|++|.+..... ........+.+|+.+++.++|+||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68999999999999999999999999999999865322 223445678899999999999999999999865 46789
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc--
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-- 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-- 190 (335)
+++||+++++|.+++.....+++...+.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999887889999999999999999999999999999999999999999999999999886543211
Q ss_pred --cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHH
Q psy2306 191 --FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPL 265 (335)
Q Consensus 191 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 265 (335)
......++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||................. .+...+..+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 1123446788999999987766 8899999999999999999999987765554444433221 122345677888
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 266 IAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
+ +||..+|++||+++++++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 8 68888999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.54 Aligned_cols=263 Identities=27% Similarity=0.465 Sum_probs=218.6
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--C
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--R 108 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 108 (335)
+..+.++|++.+.||+|+||+||+|.+..++..+++|.+..... .......+..|+.+++.++||||++++++|.+ .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 45566799999999999999999999999999999999876433 33456678899999999999999999998854 4
Q ss_pred CeEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHC-------CcEecCCCCCCEEEccC-----
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKH-------KICHRDLKLENILLDEN----- 172 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~-------givH~di~p~nili~~~----- 172 (335)
..+|+||||+++++|.++|.. ...+++..++.|+.||+.||.|||+. +|+|+||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 579999999999999999875 35799999999999999999999984 49999999999999642
Q ss_pred ------------CCeEEeeccccccccCCccccccccCCccCChhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy2306 173 ------------GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI-PYHGPEVDCWSLGVLLYTLVYGAMPFDGS 239 (335)
Q Consensus 173 ------------~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~tg~~p~~~~ 239 (335)
+.++|+|||++.............+++.|+|||++.+. ..++.++|||||||++|+|++|..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 34899999999776554444556789999999998643 33488999999999999999999999764
Q ss_pred c-HHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 240 N-FKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 240 ~-~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
+ ...+...+..... .....+.++.+||..||+.+|.+||++.++|.|+|+.....
T Consensus 247 ~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred CcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 4 4455555544332 22345778999999999999999999999999999975433
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=306.34 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=209.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||+|.+..++..|++|.+.... .......+.+|+..+++++||||+++++.+...+..++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999987532 3344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence 99999998654 34789999999999999999999999999999999999999999999999998765432 22345
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHHhcCCC---CCCCCCCchHHH
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-------FKRLVKQISNGDY---FEPKNQSTASPL 265 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-------~~~~~~~~~~~~~---~~~~~~~~l~~l 265 (335)
.++..|+|||.+.+..+ +.++|+||||+++|+|++|..||.... .......+..... .....+.++.++
T Consensus 154 ~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 67889999999987776 889999999999999999999996422 1122222222211 223356689999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 266 IAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
+.+||+.+|.+||++++++.||||...
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=305.90 Aligned_cols=253 Identities=23% Similarity=0.419 Sum_probs=211.9
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC---CHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE---TEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
+|++.+.||+|++|.||++.+..+++.+++|.+...... .....+.+.+|+..++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999999999999999998753321 12345788899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-CeEEeeccccccccCCcc-
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-NAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-~~kL~df~~~~~~~~~~~- 191 (335)
++||+++++|.+++.+.+++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 599999999866543211
Q ss_pred ----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHhcC---CCCCCCCCCc
Q psy2306 192 ----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK---RLVKQISNG---DYFEPKNQST 261 (335)
Q Consensus 192 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~---~~~~~~~~~---~~~~~~~~~~ 261 (335)
.....++..|+|||.+.+..+ +.++|+||||+++++|++|..||...... ......... ...+...+++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 123456788999999877665 88999999999999999999999654322 222222111 1223345678
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 262 ASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
+.+++.+||..+|.+||++.+++.||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=301.76 Aligned_cols=253 Identities=27% Similarity=0.482 Sum_probs=211.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCC--cCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--CCeE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCK--IETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--REKM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 111 (335)
.+|++.+.||+|+||.||.+.+..+|..|++|.+.... .......+.+.+|+..++.++|+||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47999999999999999999999999999999886422 2223456788899999999999999999999866 3568
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC--
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-- 189 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-- 189 (335)
++++||+++++|.+++.+...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999988778999999999999999999999999999999999999999999999999988754321
Q ss_pred --ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHH
Q psy2306 190 --RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASP 264 (335)
Q Consensus 190 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~ 264 (335)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||................. .+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 11223457888999999987665 8899999999999999999999987655544444443221 22334557889
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
++++|+. +|++||+++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=305.52 Aligned_cols=253 Identities=30% Similarity=0.485 Sum_probs=215.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||.|++|.||++.++.+++.+++|.+.... .......+.+|++.++.++||||+++++.+...+..++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 46888899999999999999999999999999987643 2345567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
||+++++|.+++... .++++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999999999999875 789999999999999999999999 99999999999999999999999999988655432222
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhcCCC--CCCC-CCCchHHH
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS-----NFKRLVKQISNGDY--FEPK-NQSTASPL 265 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~-----~~~~~~~~~~~~~~--~~~~-~~~~l~~l 265 (335)
...++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+..+.+..... .... .+.++.++
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred cccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 2567888999999988766 89999999999999999999999654 23333333333322 1112 56789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 266 IAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
|.+||..+|.+|||+.+++.||||+..
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.92 Aligned_cols=253 Identities=29% Similarity=0.493 Sum_probs=212.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+.+|+..++.++|+||+++++++.+.+..++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999875322 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc--ccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR--FLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~--~~~ 193 (335)
||++++.+..+..+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 999987777777766779999999999999999999999999999999999999999999999999987765443 233
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---------------C------C
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---------------G------D 252 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---------------~------~ 252 (335)
...++..|+|||++.+...++.++|+||||+++|+|++|..||...........+.. . .
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 456788899999998874458999999999999999999999976544332222111 0 0
Q ss_pred ------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 ------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
..+...+.++.++|++||+.+|++||+++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0111236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=323.33 Aligned_cols=247 Identities=22% Similarity=0.323 Sum_probs=202.1
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
....|.+.+.||+|+||.||+|.+..++..|++|.... ....+|+.+++.++|+||+++++++...+..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 34589999999999999999999999999999996432 134579999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-
Q psy2306 114 VMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~- 191 (335)
++|++. ++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 6888887653 5699999999999999999999999999999999999999999999999999876543221
Q ss_pred --ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHhcCCCC-------
Q psy2306 192 --LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS--------NFKRLVKQISNGDYF------- 254 (335)
Q Consensus 192 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~--------~~~~~~~~~~~~~~~------- 254 (335)
.....|+..|+|||++.+..+ +.++|||||||++|||++|..++... ...++.+.+......
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 223568999999999988776 89999999999999999887654221 122222222211100
Q ss_pred ----------------------C------CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 255 ----------------------E------PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 255 ----------------------~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
. ...+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 022457889999999999999999999999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.25 Aligned_cols=239 Identities=21% Similarity=0.295 Sum_probs=205.9
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe----CCeEEEEEec
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN----REKMVLVMEY 117 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~ 117 (335)
..||.|++|.||+|.. +|+.||+|.+...........+.+.+|+..+++++||||+++++++.+ ....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999977 588999999987554455556788899999999999999999999876 4578999999
Q ss_pred CCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccc
Q psy2306 118 AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFC 196 (335)
Q Consensus 118 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~ 196 (335)
+++++|.+++.....+++.....++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~ 181 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNV 181 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--cccc
Confidence 99999999999888899999999999999999999984 99999999999999999999999999987654322 2345
Q ss_pred cCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC--C-CCCCCCCchHHHHHHhcc
Q psy2306 197 GSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--Y-FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 197 ~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~~l~ 271 (335)
++..|+|||++.+ ..+ +.++||||||+++|+|++|..||...+..+....+.... . .+...+..+.+++.+||+
T Consensus 182 ~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred CcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 7889999999976 344 899999999999999999999999988877777664332 2 222567799999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy2306 272 INPSSRADISVICS 285 (335)
Q Consensus 272 ~dp~~Rps~~~ll~ 285 (335)
.||.+|||+++++.
T Consensus 261 ~dp~~Rps~~ell~ 274 (283)
T PHA02988 261 HDSIKRPNIKEILY 274 (283)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999983
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=308.35 Aligned_cols=264 Identities=27% Similarity=0.427 Sum_probs=221.0
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
....++|.+.+.||+|++|.||+|.+..+|+.|++|.+.............+.+|+..++.++|||++++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34556899999999999999999999989999999998765444555566788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
++++||+. +++.+++.. ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99999996 577776653 557999999999999999999999999999999999999999999999999988665433
Q ss_pred cccccccCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPL 265 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 265 (335)
....++..|+|||++.+ ....+.++||||||+++|+|++|..||.+.+.......+..... ....++..+.++
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 23456788999998742 22237899999999999999999999988777665555544322 122356689999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhH
Q psy2306 266 IAEMLNINPSSRADISVICSHWWIDKDHSVACLE 299 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~ 299 (335)
+.+||+.+|.+||++.+++.||||..........
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~ 280 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKHRFVLRERPPTVII 280 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcChhhcccCCcHHHH
Confidence 9999999999999999999999999876554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=310.66 Aligned_cols=265 Identities=26% Similarity=0.487 Sum_probs=222.4
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
......+.|.....||+|+||.||++.+..++..|++|.+... .....+.+.+|+..++.++|+|++++++.+...+
T Consensus 16 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 92 (292)
T cd06658 16 SPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD 92 (292)
T ss_pred ccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence 3444556777778899999999999999989999999998652 2344567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
..++++||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 99999999999999998864 46899999999999999999999999999999999999999999999999988654322
Q ss_pred -ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHH
Q psy2306 190 -RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASP 264 (335)
Q Consensus 190 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~ 264 (335)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..... .....+..+.+
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250 (292)
T ss_pred cccCceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHH
Confidence 22234567889999999987776 8899999999999999999999988776655544433211 11234667899
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhH
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVACLE 299 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~ 299 (335)
++.+||..||.+|||++++++||||.......+..
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~ 285 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIV 285 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhChhhhccCCccccc
Confidence 99999999999999999999999999877776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=299.61 Aligned_cols=252 Identities=29% Similarity=0.542 Sum_probs=214.3
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|++|.||+|.+..++..|++|.+...... ....+.+.+|+..++.++|+||+++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 689999999999999999999989999999999865432 4567889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc----
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL---- 192 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~---- 192 (335)
|+++++|.+++.....+++..+..++.+++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999988778999999999999999999999999999999999999999999999999998776443221
Q ss_pred -cccccCCccCChhhhcCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcCC--CCCCC--CCCchHH
Q psy2306 193 -STFCGSPLYASPEIVKGIP--YHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQISNGD--YFEPK--NQSTASP 264 (335)
Q Consensus 193 -~~~~~~~~~~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~~~~~~--~~~~~--~~~~l~~ 264 (335)
....++..|+|||.+.+.. ..+.++||||||++++++++|..||.... .......+.... ..+.. .+..+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 1345678899999987655 23889999999999999999999997653 223332233221 11222 2668899
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
++++||+.+|.+||++++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=306.67 Aligned_cols=253 Identities=33% Similarity=0.585 Sum_probs=221.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 114 (335)
++|.+.+.||+|++|.||+|.+..+|..|++|++.............+.+|..+++.++ |+||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999987655445555677889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--- 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--- 191 (335)
||++++++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999998876543221
Q ss_pred ------------------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC-
Q psy2306 192 ------------------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD- 252 (335)
Q Consensus 192 ------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~- 252 (335)
.....++..|++||....... +.++|+||||++++++++|..||...+.......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 123456788999999887665 889999999999999999999998877655555554433
Q ss_pred CCCCCCCCchHHHHHHhcccCCCCCCCH----HHHhcCCCc
Q psy2306 253 YFEPKNQSTASPLIAEMLNINPSSRADI----SVICSHWWI 289 (335)
Q Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~ll~~~~~ 289 (335)
..+...++.+.+++++||+.+|.+||++ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 3445567899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=320.19 Aligned_cols=264 Identities=46% Similarity=0.787 Sum_probs=243.6
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
...-.+.|.+.+.||+|.|+.|.+|.+..++..||+|.+.+...+. .....+.+|++++..+.||||++++.+...+..
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3445568999999999999999999999999999999998866544 344569999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+|+||||+.++.+++++.+++.+.+.....++.|++.|++|+|+++|+|||||++||+++.+.++||+|||++..+....
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-CCCCchHHHHHHh
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-KNQSTASPLIAEM 269 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~ 269 (335)
.....+|++.|.|||++.+.++.++++|+||+|+++|.|+.|..||++.+..++......+++..+ ..+.+..++|+++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHh
Confidence 888999999999999999999999999999999999999999999999998888887777766444 3577999999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 270 LNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
|-.+|.+|++.+++.+|.|....+..
T Consensus 290 lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hccCccccCCHHHhhhhcccchhhhh
Confidence 99999999999999999999876555
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.18 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=209.6
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCH
Q psy2306 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGEL 123 (335)
Q Consensus 44 ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 123 (335)
||+|+||+||+|.+..+|+.|++|.+.............+..|+.+++.++|||++++++++...+..|+++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999998764433344455667899999999999999999999999999999999999999
Q ss_pred HHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCCcc
Q psy2306 124 YDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLY 201 (335)
Q Consensus 124 ~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~ 201 (335)
.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99997655 7999999999999999999999999999999999999999999999999988765543333445677889
Q ss_pred CChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhcCC-CCCCCCCCchHHHHHHhcccCCCC
Q psy2306 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF----KRLVKQISNGD-YFEPKNQSTASPLIAEMLNINPSS 276 (335)
Q Consensus 202 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~----~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~ 276 (335)
+|||.+.+..+ +.++|+||||+++|+|++|..||..... .++........ ..+...++.+.++|++||+.||.+
T Consensus 161 ~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 161 MAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred CCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 99999987775 8899999999999999999999976543 22222222211 233446778999999999999999
Q ss_pred CC-----CHHHHhcCCCcCCC
Q psy2306 277 RA-----DISVICSHWWIDKD 292 (335)
Q Consensus 277 Rp-----s~~~ll~~~~~~~~ 292 (335)
|| ++.++++||||.+.
T Consensus 240 R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCCCcccHHHHHhChhhhcC
Confidence 99 88889999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=301.24 Aligned_cols=253 Identities=32% Similarity=0.501 Sum_probs=220.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|.+.+.||.|++|.||+|.+..+++.|++|.+..... ......+.+|+..+..++|+|++++++++...+..++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 368999999999999999999999999999999876432 245667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc-c
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-S 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~-~ 193 (335)
||+++++|.+++....++++..++.++.|++.|+.|||+ .|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 999999999999888889999999999999999999999 99999999999999999999999999988766543322 2
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhcCCC--CCCC-CCCchHHHHH
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---NFKRLVKQISNGDY--FEPK-NQSTASPLIA 267 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---~~~~~~~~~~~~~~--~~~~-~~~~l~~li~ 267 (335)
...++..|+|||.+....+ +.++|+||||+++|+|++|..||... ...+....+..... .... .+..+.++|.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 159 TFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237 (264)
T ss_pred ceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 4567888999999887765 88999999999999999999999776 55566666554432 2223 5678999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 268 EMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
+||+.+|++||++.++++|||++.
T Consensus 238 ~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHccCChhhCCCHHHHHhCHHHHh
Confidence 999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=304.90 Aligned_cols=252 Identities=30% Similarity=0.450 Sum_probs=209.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEe-----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFEN----- 107 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----- 107 (335)
..++|++.+.||+|+||.||+|.+..+++.+++|.+.... .....+.+|+..++.+ +|+|++++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4568999999999999999999999999999999987532 2234677889999888 69999999999865
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 108 -REKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 108 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
...+++++||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 34689999999999999998863 468999999999999999999999999999999999999999999999999987
Q ss_pred cccCC-ccccccccCCccCChhhhcCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCC
Q psy2306 185 VFTES-RFLSTFCGSPLYASPEIVKGI----PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEP 256 (335)
Q Consensus 185 ~~~~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~ 256 (335)
..... .......++..|+|||++... ..++.++|+||+|+++|+|++|..||................. ...
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 65322 223345678899999998632 2247899999999999999999999977665544444333221 223
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
..+.++.+++.+||+.+|.+|||+.+++.||||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 456789999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=305.58 Aligned_cols=248 Identities=27% Similarity=0.485 Sum_probs=204.2
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeC--CeEEEE
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENR--EKMVLV 114 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv 114 (335)
|++.+.||+|++|.||+|.+..++..|++|.+..... .... ....+|+..+.++. |+|++++++++.+. +..+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999875322 2222 23446888888885 99999999999887 899999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
+||+++ +|.+.+.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++. +.++|+|||.+..........
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 999965 77777765 457899999999999999999999999999999999999999 999999999997765544444
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---------------CC---C--
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---------------GD---Y-- 253 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---------------~~---~-- 253 (335)
...++..|+|||.+......+.++|+||||+++|+|++|..||...+..+....+.. .. .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 456788999999876555558899999999999999999999987665443332221 00 0
Q ss_pred ----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 254 ----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 254 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
..+..+.++.++|.+||+.+|.+||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 012346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=302.13 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=209.3
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.++|++.+.||+|+||.||+|.++ ..+..|++|.++... .....+.+.+|+..++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 347999999999999999999765 346789999987532 334456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999999763 578999999999999999999999999999999999999999999999999875543222
Q ss_pred ccc--ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 FLS--TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 ~~~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
... ...++..|+|||.+.+..+ +.++||||||+++|++++ |..||...+..+....+..... .+...+..+.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 111 1223567999999988776 889999999999999875 9999998888877777765432 233456789999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+||+.+|.+||++++|++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=299.25 Aligned_cols=247 Identities=32% Similarity=0.615 Sum_probs=215.3
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+.+|+..++.++|+|++++++.+.+.+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986532 33456678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-cc
Q psy2306 117 YAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LS 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-~~ 193 (335)
|+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9999999998864 34589999999999999999999999999999999999999999999999999876644322 23
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~ 271 (335)
...+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. .+...+..+.+++++||+
T Consensus 159 ~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence 4567888999999987776 8899999999999999999999998888777777765544 233456789999999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy2306 272 INPSSRADISVICSH 286 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~ 286 (335)
.||.+||++.++++.
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=297.82 Aligned_cols=251 Identities=36% Similarity=0.656 Sum_probs=221.1
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||.|++|.||++.+..++..+++|.+..... .......+.+|++.++.++|+|++++.+.+...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999998999999999876432 33556678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-c
Q psy2306 117 YAAGGELYDFLDQK----KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-F 191 (335)
Q Consensus 117 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~ 191 (335)
++++++|.+.+... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999999763 679999999999999999999999999999999999999999999999999987765443 2
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
.....+++.|+|||...+..+ +.++|+||+|+++++|++|..||...+..+.......... .+...+.++.+++++|
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred ecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 334567888999999887776 8899999999999999999999988887777777665533 2334567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCc
Q psy2306 270 LNINPSSRADISVICSHWWI 289 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~ 289 (335)
|+.+|.+||++.++|+||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=304.68 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=210.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeC----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENR---- 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~---- 108 (335)
..++|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+..++.+ +|+|++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4679999999999999999999999999999999986532 2234567888889888 799999999998643
Q ss_pred -CeEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 109 -EKMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 109 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
+..++++||+++++|.++++. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999999999998863 457899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCc-cccccccCCccCChhhhcCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----
Q psy2306 184 NVFTESR-FLSTFCGSPLYASPEIVKGIP----YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF---- 254 (335)
Q Consensus 184 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~----~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~---- 254 (335)
....... ......++..|+|||.+.... ..+.++|+||||+++|+|++|..||...+.......+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence 7654322 123345788899999986433 1378999999999999999999999887765555554433221
Q ss_pred CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 255 EPKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
.......+.++|.+||+.+|++||++.++++||||+
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 223455789999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=305.66 Aligned_cols=255 Identities=29% Similarity=0.525 Sum_probs=218.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
...|+..+.||.|++|.||.|.+..++..|++|.+.... .......+.+|+..++.+.|+||+++++.+.+.+..+++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 357888999999999999999999899999999987532 234567888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~ 193 (335)
|||+++++|.+++.. .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 999999999999875 568999999999999999999999999999999999999999999999999986654322 223
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~ 271 (335)
...++..|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+..... .....+..+.+++.+||+
T Consensus 160 ~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred cccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 3456788999999987766 8899999999999999999999988776665555433322 222346688999999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCCC
Q psy2306 272 INPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.+|++||++.+++.|+||....
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred cCcccCcCHHHHHhChHhhhcc
Confidence 9999999999999999997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=303.04 Aligned_cols=252 Identities=31% Similarity=0.466 Sum_probs=210.9
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCC---
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENRE--- 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~--- 109 (335)
..++|++.+.||.|++|.||+|.+..++..+++|.+.... ...+.+.+|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3579999999999999999999999889999999987532 2345788999999999 6999999999996644
Q ss_pred ---eEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 110 ---KMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 110 ---~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
.+++++||+++++|.+++.. +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999998865 35799999999999999999999999999999999999999999999999998
Q ss_pred cccccCC-ccccccccCCccCChhhhcCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC--
Q psy2306 183 SNVFTES-RFLSTFCGSPLYASPEIVKGI----PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-- 255 (335)
Q Consensus 183 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-- 255 (335)
+...... .......++..|+|||++... ..++.++||||||+++|+|++|..||...........+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence 8665332 222345578889999987532 234778999999999999999999998766655555555443211
Q ss_pred --CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 256 --PKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 256 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
..++..+.+++.+||..||++|||+.++++|||+
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1245688999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=308.23 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=209.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--CeEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--EKMVL 113 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 113 (335)
+.|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+..++.++||||+++++++... +..++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4799999999999999999999999999999999754322 22334566899999999999999999999877 89999
Q ss_pred EEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cc
Q psy2306 114 VMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~ 191 (335)
++||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 9999964 999888764 35899999999999999999999999999999999999999999999999988766543 22
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--------------------
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------------------- 251 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------- 251 (335)
.....+++.|+|||.+.+....+.++|+||||+++++|++|..||......+....+...
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 334556788999999877655588999999999999999999999876654443332110
Q ss_pred ------------CCCCCC-CCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 252 ------------DYFEPK-NQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 252 ------------~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
...... .++.+.++|++||+.+|++|||+.|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 000111 36678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.92 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=210.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--CeEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--EKMV 112 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 112 (335)
.++|++.+.||.|++|.||+|.+..+|..|++|.+....... .......+|+.+++.++|+|++++++++... +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 458999999999999999999999999999999987533221 2223456799999999999999999998654 5789
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-c
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-R 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~ 190 (335)
+++||+++ +|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99999964 88888875 467899999999999999999999999999999999999999999999999998766533 2
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC------------------
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD------------------ 252 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------ 252 (335)
......++..|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 22233457789999998775555889999999999999999999998877666554443210
Q ss_pred -CC------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 253 -YF------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 253 -~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.. ....++++.++|.+||+.||++|||+.+++.||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 00 01135677899999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=310.69 Aligned_cols=243 Identities=27% Similarity=0.457 Sum_probs=191.0
Q ss_pred EeeeeccCCeEEEEEEEC--CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--CCeEEEEEe
Q psy2306 41 VRKLGQGNYGKVQLGINK--ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--REKMVLVME 116 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 116 (335)
..+||+|+||+||+|.++ .+++.|++|.+..... ...+.+|+.+++.++||||+++++.+.. ....++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999865 4678999999865321 2246689999999999999999999854 457899999
Q ss_pred cCCCCCHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE----ccCCCeEEeecccc
Q psy2306 117 YAAGGELYDFLDQK---------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL----DENGNAKIADFGLS 183 (335)
Q Consensus 117 ~~~~~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili----~~~~~~kL~df~~~ 183 (335)
|+. ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5888877531 258999999999999999999999999999999999999 45578999999999
Q ss_pred ccccCCc----cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH----------HHHHHHHh
Q psy2306 184 NVFTESR----FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF----------KRLVKQIS 249 (335)
Q Consensus 184 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~----------~~~~~~~~ 249 (335)
....... ......+++.|+|||++.+...++.++||||+||++|+|++|..||..... ..+...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7654321 123456789999999998766558999999999999999999999964321 11100000
Q ss_pred ---------------------------cCCC-----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 250 ---------------------------NGDY-----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 250 ---------------------------~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.... .....+..+.++|++||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 001123467899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=297.18 Aligned_cols=251 Identities=29% Similarity=0.525 Sum_probs=218.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--CeEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--EKMVLV 114 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 114 (335)
+|++.+.||+|++|.||+|.+..++..+++|++..... .....+.+.+|+..+++++|+||+++++.+.+. +..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 58899999999999999999998999999999876432 245567889999999999999999999999988 899999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--- 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--- 191 (335)
+|++++++|.+++.+...+++..++.++.+++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998877899999999999999999999999999999999999999999999999999877765543
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhc---CCCCCCCCCCchHHHHH
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQISN---GDYFEPKNQSTASPLIA 267 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~~~~---~~~~~~~~~~~l~~li~ 267 (335)
.....++..|++||....... +.++|+||||+++++|++|..||.... .......+.. ....+...+..+.+++.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 344567889999999987765 899999999999999999999997765 3333333332 12233445779999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCc
Q psy2306 268 EMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
+||+.+|.+||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=301.66 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=211.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-------CHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-------TEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
+|.+.+.||.|++|.||+|.+..+|+.+++|.+...... .....+.+.+|+..++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 688999999999999999999989999999988642111 1123456788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
..++++||+++++|.+++...+++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999988665322
Q ss_pred c---cccccccCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---C----CCCC
Q psy2306 190 R---FLSTFCGSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---F----EPKN 258 (335)
Q Consensus 190 ~---~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~----~~~~ 258 (335)
. ......++..|+|||.+.... .++.++|+||||++++++++|..||...........+..... . ....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1 122345778899999987654 348899999999999999999999976555443333222211 1 1234
Q ss_pred CCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 259 QSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 259 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
+.++.+++.+||+.+|.+||+++++++|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 6789999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=301.07 Aligned_cols=248 Identities=29% Similarity=0.505 Sum_probs=208.7
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHH-HcCCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM-SSVRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
+.||.|++|.||+|.+..+|+.|++|.+.............+..|...+ ...+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999999999999998754332223333444554444 445899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCCc
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL 200 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~ 200 (335)
++|.+++...+++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ....++..
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFVGTPD 158 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc---ccCCCCcC
Confidence 999999988888999999999999999999999999999999999999999999999999988654332 23457788
Q ss_pred cCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----CCCCCCCchHHHHHHhcccCCC
Q psy2306 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-----FEPKNQSTASPLIAEMLNINPS 275 (335)
Q Consensus 201 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~ 275 (335)
|++||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..... .....++++.+++.+||+.+|.
T Consensus 159 y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 159 YLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred ccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 999999987764 8999999999999999999999998888777666654432 1224577999999999999999
Q ss_pred CCC---CHHHHhcCCCcCCCC
Q psy2306 276 SRA---DISVICSHWWIDKDH 293 (335)
Q Consensus 276 ~Rp---s~~~ll~~~~~~~~~ 293 (335)
+|| +++|++.||||+...
T Consensus 238 ~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 238 KRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HccCCCcHHHHHcChHhhcCC
Confidence 999 557999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=312.21 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=209.0
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC-----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR----- 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 108 (335)
+.++|++.+.||+|++|.||+|.+..+|+.|++|.+... ........+.+|+..++.++|+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 457999999999999999999999999999999998642 2233455677899999999999999999887543
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
...++++||+. ++|.+++. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred ceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 35899999995 48888775 45699999999999999999999999999999999999999999999999998866533
Q ss_pred Ccc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc--------------
Q psy2306 189 SRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN-------------- 250 (335)
Q Consensus 189 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-------------- 250 (335)
... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||...+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 211 12346788899999876554448899999999999999999999976554322211110
Q ss_pred -------------CCC-----CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 251 -------------GDY-----FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 251 -------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
... ..+..+.++.+++.+||+.||.+|||+.++++||||++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 000 112346789999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=302.68 Aligned_cols=255 Identities=28% Similarity=0.531 Sum_probs=216.3
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC---CCcccceeEEEEeCCeEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR---HPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 113 (335)
.|++.+.||+|++|.||+|.+..+++.+++|.+.... .......+.+|+.+++.++ |+|++++++++.+....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999999999999987532 2334556778999998886 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
+|||+++++|.+++..+ .+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 99999999999998754 78999999999999999999999999999999999999999999999999887664332 22
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC---CCCCCCchHHHHHHh
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF---EPKNQSTASPLIAEM 269 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~ 269 (335)
....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+...... ....+.++.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence 33467888999999876555588999999999999999999999887766555444333221 112566899999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 270 LNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
|+.||.+||++.+++.|+||++...
T Consensus 239 l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 239 LDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred cCCCcccCcCHHHHhhChHhhcccc
Confidence 9999999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=302.68 Aligned_cols=254 Identities=28% Similarity=0.516 Sum_probs=217.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
.+|...+.||.|++|.||++.+..++..+++|.+... .....+.+.+|+..++.++|+|++++++++...+..++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 3566678999999999999999989999999998642 2333456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~ 194 (335)
||+++++|.+++.. .++++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 99999999999986 568999999999999999999999999999999999999999999999999876543221 2233
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC----CCCCCchHHHHHHhc
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE----PKNQSTASPLIAEML 270 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l 270 (335)
..+++.|+|||...+..+ +.++|+||+|+++|+|++|..||...+.......+....... ...+..+.+++++||
T Consensus 175 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 457889999999987775 889999999999999999999998887766666655543211 124568999999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 271 NINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
+.+|++||++.++++||||+....
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ccChhhCcCHHHHccCcccccCCC
Confidence 999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=305.68 Aligned_cols=251 Identities=30% Similarity=0.494 Sum_probs=207.3
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|++.+.||.|++|.||+|.+..+|..|++|.+..... .......+.+|++.+++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999865332 22234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccc
Q psy2306 117 YAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLS 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~ 193 (335)
|+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 995 588888865 3568999999999999999999999999999999999999999999999999886554321 223
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-C--------------------
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-D-------------------- 252 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~-------------------- 252 (335)
...++..|+|||.+.+....+.++|+||||+++|+|+||..||...+.......+... .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 3446788999999877665588999999999999999999999776543322221110 0
Q ss_pred ---------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 ---------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
...+..+.++.++|.+||+.||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0012345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=299.55 Aligned_cols=249 Identities=27% Similarity=0.501 Sum_probs=212.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..++..|++|.+.............+.+|+..++.++|||++++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999987654445566677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 116 EYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 116 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
||+++++|.+++.. ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988853 34589999999999999999999999999999999999999999999999998876543222
Q ss_pred -ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhcCCCCC---CCCCCchHHH
Q psy2306 192 -LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN--FKRLVKQISNGDYFE---PKNQSTASPL 265 (335)
Q Consensus 192 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~---~~~~~~l~~l 265 (335)
.....+++.|+|||.+.+... +.++|+||||+++|+|++|..||.... .......+......+ ...+..+.++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240 (267)
T ss_pred HHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 223457788999999987766 889999999999999999999996543 345555554433322 2345689999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+||+.+|.+||+++++++
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHCCCCcccCcCHHHHHH
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=306.20 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=203.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECC----------------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKE----------------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 97 (335)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+..+..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35699999999999999999997542 34579999987532 3445667889999999999999
Q ss_pred ccceeEEEEeCCeEEEEEecCCCCCHHHHHhhC-------------------CCCCHHHHHHHHHHHHHHHHHhHHCCcE
Q psy2306 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQK-------------------KVLTEEEARRIFRQIATAVYYCHKHKIC 158 (335)
Q Consensus 98 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~i~~~l~~~l~~LH~~giv 158 (335)
|+++++++.+.+..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999998643 2367788999999999999999999999
Q ss_pred ecCCCCCCEEEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh--CC
Q psy2306 159 HRDLKLENILLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY--GA 233 (335)
Q Consensus 159 H~di~p~nili~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t--g~ 233 (335)
|+||||+||+++.++.+||+|||++........ .....++..|+|||++....+ +.++||||||+++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999876543221 122344678999999987776 889999999999999986 66
Q ss_pred CCCCCCcHHHHHHHHhc----C-----CCCCCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 234 MPFDGSNFKRLVKQISN----G-----DYFEPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 234 ~p~~~~~~~~~~~~~~~----~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
.||...+..+....... . ...++..+..+.+++.+||+.||.+|||+.+|.
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 78877666555443321 1 112345577899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=306.57 Aligned_cols=266 Identities=30% Similarity=0.502 Sum_probs=221.8
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||.||++.+..++..|++|.+.... ....+.+.+|+..++.++|||++++++++...+..+++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 469999999999999999999998889999999986422 22345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~ 193 (335)
+||+++++|.+++.+. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 9999999999998754 47899999999999999999999999999999999999999999999999876554322 223
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHHHHHHh
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASPLIAEM 269 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~ 269 (335)
...+++.|++||.+.+..+ +.++|+||||+++|++++|..||...+.......+..... .....+..+.+++++|
T Consensus 174 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred cccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 3467888999999987766 8899999999999999999999987665443333222211 1112355789999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHh
Q psy2306 270 LNINPSSRADISVICSHWWIDKDHSVACLEEAEELA 305 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~ 305 (335)
|+.+|.+||++++++.|+||+.....+.+..+...+
T Consensus 253 l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~~~~~ 288 (293)
T cd06647 253 LEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAAA 288 (293)
T ss_pred ccCChhhCcCHHHHhcCHHHhcCcccccccchHHHh
Confidence 999999999999999999999887777666554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=304.18 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=212.3
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCC-----cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETG-----QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
++|++.+.||+|++|.||+|.+...+ ..|++|.+... ........+.+|+..++.++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 47999999999999999999876544 67999998653 234455678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQK----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
.++++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 99999999999999999754 45788999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCc---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy2306 175 AKIADFGLSNVFTESR---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISN 250 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~ 250 (335)
++|+|||++....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+....+....+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999986543221 1223445778999999987776 899999999999999997 9999998888888877766
Q ss_pred CCCC--CCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 251 GDYF--EPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 251 ~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.... +...+.++.+++.+||+.||.+||++.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5432 34567799999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=306.97 Aligned_cols=254 Identities=30% Similarity=0.535 Sum_probs=216.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+.|++.+.||+|++|.||+|.+..++..|++|.+.... .....+.+.+|+..++.++|+||+++++.+...+..++|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 456788899999999999999999899999999987532 234556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-cc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-~~ 193 (335)
+||+++++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 999999999998864 5689999999999999999999999999999999999999999999999999876543221 22
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~ 271 (335)
...++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+..... .....+.++.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 3456788999999987766 8899999999999999999999987666555544433322 222345689999999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCC
Q psy2306 272 INPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+|.+||++.+++.||||...
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=305.16 Aligned_cols=256 Identities=28% Similarity=0.484 Sum_probs=213.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||++.+..+|..|++|.+... ........+.+|+..++.++|+||+++++.+...+..++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 4789999999999999999999999999999988652 23444567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 116 EYAAGGELYDFLDQK---KVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 116 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
||+++++|..++... ..+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999998763 368999999999999999999996 599999999999999999999999999886653322
Q ss_pred ccccccCCccCChhhhcCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---HhcCC--CCCCCCCCc
Q psy2306 192 LSTFCGSPLYASPEIVKGIP-----YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQ---ISNGD--YFEPKNQST 261 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~-----~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~---~~~~~--~~~~~~~~~ 261 (335)
.....+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||........... +.... ..+...+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 22345677899999985432 237789999999999999999999976554443332 22221 233446778
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 262 ASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
+.+++.+||+.+|.+||++.+++.||||.....
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=302.87 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=202.0
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHH---HcCCCCcccceeEEEEeCCeEEEEEecCC
Q psy2306 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM---SSVRHPNIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 43 ~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
.||+|+||.||++.+..+++.+++|.+...............+|...+ ...+|++++.+++.+...+..+++|||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998764433222222333444333 33479999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCC
Q psy2306 120 GGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199 (335)
Q Consensus 120 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~ 199 (335)
+++|.+++..++.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .....++.
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence 99999999888889999999999999999999999999999999999999999999999999986554322 22346789
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhc-CCCCCCCCCCchHHHHHHhcccCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN---FKRLVKQISN-GDYFEPKNQSTASPLIAEMLNINPS 275 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~---~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~ 275 (335)
.|+|||.+......+.++|+||+|+++|+|++|..||.... .......... ....+...+.++.++|.+||+.||.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 239 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence 99999998754444889999999999999999999996532 2222222211 2223445677999999999999999
Q ss_pred CCC-----CHHHHhcCCCcCCC
Q psy2306 276 SRA-----DISVICSHWWIDKD 292 (335)
Q Consensus 276 ~Rp-----s~~~ll~~~~~~~~ 292 (335)
+|| ++.++++||||+..
T Consensus 240 ~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 240 KRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HhcCCCCCCHHHHHhCccccCC
Confidence 999 69999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=302.81 Aligned_cols=250 Identities=28% Similarity=0.519 Sum_probs=208.8
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||.|++|.||+|.+..+|..|++|.+..... ......+.+|+..++.++|+||+++++++.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999876432 2223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccc
Q psy2306 117 YAAGGELYDFLDQK---KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFL 192 (335)
Q Consensus 117 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~ 192 (335)
|+++ +|.+++... .++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9975 888888653 36899999999999999999999999999999999999999999999999988655332 122
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--------------------C
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--------------------D 252 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--------------------~ 252 (335)
....++..|++||.+.+...++.++|+|+||+++|+|++|..||...+..+....+... .
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 33456788999999877655588999999999999999999999877655443332210 0
Q ss_pred ----------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 ----------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
...+..+..+.+++.+||+.||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0112346788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=302.82 Aligned_cols=252 Identities=30% Similarity=0.434 Sum_probs=208.1
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE------
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE------ 106 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------ 106 (335)
..++|++.+.||.|+||.||+|.+..+++.+++|.+... ......+..|+..++.+ +|+|++++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 446999999999999999999999999999999998652 23345677888889888 6999999999984
Q ss_pred eCCeEEEEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
..+..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 35678999999999999999975 3458899999999999999999999999999999999999999999999999886
Q ss_pred cccCC-ccccccccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCC
Q psy2306 185 VFTES-RFLSTFCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEP 256 (335)
Q Consensus 185 ~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~ 256 (335)
..... .......+++.|+|||.+.. ...++.++|+||||+++|+|++|..||...........+..... ...
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 55322 22234567889999998753 22237789999999999999999999977655443333333221 222
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
..+.++.++|++||+.||.+||++.+|+.||||
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 457789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.32 Aligned_cols=251 Identities=33% Similarity=0.662 Sum_probs=215.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|++|.||++.++.+|..+++|.+..... .....+.+.+|+..++.++|+|++++++.+.+.+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999876432 22334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC-eEEeeccccccccCCccc-
Q psy2306 117 YAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN-AKIADFGLSNVFTESRFL- 192 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~-~kL~df~~~~~~~~~~~~- 192 (335)
|+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999987543 4799999999999999999999999999999999999988764 699999988766543222
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhc
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEML 270 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l 270 (335)
....+++.|+|||...+..+ +.++|+||||+++++|++|..||...+..+....+..... ..+..+.++.+++.+||
T Consensus 160 ~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred cccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 23457888999999887765 8899999999999999999999988877776666555433 23345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCc
Q psy2306 271 NINPSSRADISVICSHWWI 289 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~~~~ 289 (335)
+.+|++|||+.+++.||||
T Consensus 239 ~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 239 KVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccChhhCcCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=293.52 Aligned_cols=251 Identities=27% Similarity=0.479 Sum_probs=218.4
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|++|.||++.+..+++.|++|.+...... ....+.+.+|++.+++++|+|++++++++.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999989999999999875432 3556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-cccc
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTF 195 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-~~~~ 195 (335)
++++++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 999999999998888899999999999999999999999999999999999999999999999999877654332 2334
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcccC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~d 273 (335)
.++..|++||...+... +.++|+|++|+++++|++|..||...+............. .+...+..+.+++.+||+.+
T Consensus 160 ~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 160 VGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 57888999999887664 8899999999999999999999987665444444333222 33445678999999999999
Q ss_pred CCCCCCHHHHhcCCCc
Q psy2306 274 PSSRADISVICSHWWI 289 (335)
Q Consensus 274 p~~Rps~~~ll~~~~~ 289 (335)
|++||++.+++.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=305.75 Aligned_cols=260 Identities=27% Similarity=0.494 Sum_probs=219.3
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|.....||+|+||.||+|.+..++..|++|.+..... ...+.+.+|+..++.++|||++++++.+...+..++++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 45556689999999999999998999999999865322 234567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccccc
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTF 195 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~~ 195 (335)
|+++++|..++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 9999999998764 568999999999999999999999999999999999999999999999999886543322 12345
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHHHHHHhcc
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~ 271 (335)
.++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+....+..... .....+..+.+++++||+
T Consensus 178 ~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 178 VGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred ecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 67889999999987776 8899999999999999999999988776666555544322 122346688999999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCCCcchhhHHH
Q psy2306 272 INPSSRADISVICSHWWIDKDHSVACLEEA 301 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~ 301 (335)
.+|.+||+++++++||||.+..-..|.-.+
T Consensus 257 ~~P~~Rps~~~ll~~~~~~~~~~~~~~~~~ 286 (297)
T cd06659 257 REPQERATAQELLDHPFLLQTGLPECLVPL 286 (297)
T ss_pred CCcccCcCHHHHhhChhhccCCCcccccch
Confidence 999999999999999999987766664433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=303.70 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=215.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|+||++.+..+|+.|++|++.... .....+.+.+|+++++.++|+||+++++.+...+.+++++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 58999999999999999999999999999999987532 3444667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
||+++++|.+++...+++++..+..++.+++.+|.|||+ .|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~~ 161 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-ADT 161 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cCc
Confidence 999999999999888889999999999999999999996 699999999999999999999999999876543221 224
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-----------HHHHHHhcCCCC---CCCCCC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-----------RLVKQISNGDYF---EPKNQS 260 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-----------~~~~~~~~~~~~---~~~~~~ 260 (335)
..++..|+|||++.+..+ +.++|+||||+++|++++|..||...... .....+...... ....+.
T Consensus 162 ~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 467889999999877665 88999999999999999999999764431 222333322211 122556
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
++.+++.+||+.||.+|||+.++++|+||.+...
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 8999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=311.12 Aligned_cols=258 Identities=26% Similarity=0.470 Sum_probs=211.8
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC-----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR----- 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 108 (335)
+.++|++.+.||+|++|+||+|.+..++..|++|.+..... .......+.+|+..++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 46789999999999999999999999999999999875322 233345667899999999999999999987643
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
...++++||+. ++|.+++...+++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999995 68999998888899999999999999999999999999999999999999999999999999876543
Q ss_pred C-ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-----------------
Q psy2306 189 S-RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN----------------- 250 (335)
Q Consensus 189 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~----------------- 250 (335)
. .......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3 2223445788899999987644358899999999999999999999976553322211110
Q ss_pred ----------CC-----CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 251 ----------GD-----YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 251 ----------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.. ...+..+.++.++|++||+.+|.+|||++++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00 01234567889999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.39 Aligned_cols=256 Identities=30% Similarity=0.541 Sum_probs=218.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+-|++.+.||.|+||.||+|.+..++..+++|.+.... .......+.+|+..++.++|+||+++++.+...+..+++
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 356888999999999999999999899999999976532 234456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-cc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-~~ 193 (335)
+||+++++|.+++.. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 999999999999874 4689999999999999999999999999999999999999999999999998865543221 22
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~ 271 (335)
...++..|+|||.+.+... +.++|+||||+++|+|++|..||...........+..... .....+.++.+++.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 3457788999999987666 7899999999999999999999988776666655544322 233456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 272 INPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
.+|.+||++.++++||||.+...
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhhhh
Confidence 99999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.16 Aligned_cols=252 Identities=27% Similarity=0.489 Sum_probs=204.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
-++|++.+.||.|++|.||+|.++.+++.|++|.+...... .....+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 36899999999999999999999989999999998753221 1123456799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 115 MEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
|||+++ +|.+++... ..+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 999975 899888653 468999999999999999999999999999999999999999999999999886543221 11
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcC--------------------
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQISNG-------------------- 251 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~~~~~-------------------- 251 (335)
....++..|+|||.+.+....+.++||||+|+++|+|++|..||.... ..+....+...
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 223457789999998765545889999999999999999999997654 22222211100
Q ss_pred ---CC--------CCCCCC--CchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 252 ---DY--------FEPKNQ--STASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 252 ---~~--------~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.. .....+ .++.+++.+||+.+|.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 001122 677899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.96 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=207.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE-----
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE----- 106 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~----- 106 (335)
...++|++.+.||+|++|.||+|.+..+++.+++|.+.... .....+.+|+..++.+ +|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 45679999999999999999999999999999999876422 1234567889999998 6999999999873
Q ss_pred eCCeEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
..+..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 45678999999999999988753 35689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCc-cccccccCCccCChhhhcCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----
Q psy2306 183 SNVFTESR-FLSTFCGSPLYASPEIVKGI----PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---- 253 (335)
Q Consensus 183 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---- 253 (335)
+....... ......+++.|+|||++... ..++.++||||||+++|+|++|..||.................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T cd06638 171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250 (286)
T ss_pred eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCccc
Confidence 87654322 22344678899999987532 2237899999999999999999999987665444333322211
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.+...+.++.+++.+||+.||.+|||+.++++|+||
T Consensus 251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 112235579999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=300.61 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=205.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHH-HHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI-MSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
++|++.+.||+|+||.||++.+..+|+.|++|.+..... ... ...+..|... ++.++|+|++++++++...+..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876432 222 2344445554 5667899999999999999999999
Q ss_pred EecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 115 MEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
+||++ ++|.+++.. ...+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 588777753 34689999999999999999999997 9999999999999999999999999998765443
Q ss_pred ccccccccCCccCChhhhcCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHHhcCCC--CCCCCCCch
Q psy2306 190 RFLSTFCGSPLYASPEIVKGI---PYHGPEVDCWSLGVLLYTLVYGAMPFDGS--NFKRLVKQISNGDY--FEPKNQSTA 262 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~tg~~p~~~~--~~~~~~~~~~~~~~--~~~~~~~~l 262 (335)
.......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||... ..+.....+..... .....+.++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 333335678889999988642 22378999999999999999999999653 22333333322221 223456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.+++.+||+.+|.+||++.++++||||....
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=292.08 Aligned_cols=248 Identities=31% Similarity=0.576 Sum_probs=214.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|++.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+..++.++|++++++++.+...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999876332 355688899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 117 YAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 117 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
|+++++|.+++... ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99999999999876 57999999999999999999999999999999999999999999999999998776554323445
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCC--CCCchHHHHHHhcc
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPK--NQSTASPLIAEMLN 271 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~--~~~~l~~li~~~l~ 271 (335)
.++..|++||.+.+... +.++|+||||+++|+|++|..||...+............. .... ++..+.+++.+||+
T Consensus 158 ~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 158 VGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred ecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 67889999999987765 8899999999999999999999988755444444433221 1111 25689999999999
Q ss_pred cCCCCCCCHHHHhcCCC
Q psy2306 272 INPSSRADISVICSHWW 288 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~ 288 (335)
.||++|||+.++++|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=312.00 Aligned_cols=261 Identities=27% Similarity=0.496 Sum_probs=214.1
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE----eCC
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE----NRE 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~ 109 (335)
+.++|++.+.||+|++|.||+|.+..+|..|++|.+..... .......+.+|+.+++.++|+||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 45799999999999999999999999999999999875322 2234556778999999999999999999875 345
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
..++++||+. ++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7899999995 589999988888999999999999999999999999999999999999999999999999998665322
Q ss_pred c-----cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc--------------
Q psy2306 190 R-----FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN-------------- 250 (335)
Q Consensus 190 ~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-------------- 250 (335)
. ......++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 1 112346788999999987654458899999999999999999999977654322211110
Q ss_pred -------------CCC-----CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 251 -------------GDY-----FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 251 -------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
... ..+..+.++.++|++||+.+|.+||++++++.||||.+.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 000 0133567899999999999999999999999999998765553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=301.94 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=208.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||.|++|.||+|.+..+|+.|++|.+..... .....+.+.+|+..++.++|+||+++++++.+.+..++|+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999865332 2233456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEeeccccccccCC-cc
Q psy2306 116 EYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADFGLSNVFTES-RF 191 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~df~~~~~~~~~-~~ 191 (335)
||++ ++|.+.+.... .+++..++.++.|++.||+|||++|++|+||+|+||+++. ++.+||+|||.+...... ..
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9995 57887776543 3578889999999999999999999999999999999985 457999999998665332 12
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--------------------
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------------------- 251 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------- 251 (335)
.....+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 233456788999999877555588999999999999999999999876654443332210
Q ss_pred ---CC-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 252 ---DY-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 252 ---~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.. ..+..+.++.+++.+||+.+|++||++.++++||||.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 012356688999999999999999999999999999864
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.75 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=202.7
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||+|.+..+|..|++|.+...... .....+.+|+..++.++|+||+++++++.+.+..++++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999998753322 22235568999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccc
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~ 193 (335)
||+. +++.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 9996 577666543 4568889999999999999999999999999999999999999999999999886543221 223
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhc----------------CC----
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISN----------------GD---- 252 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~----------------~~---- 252 (335)
...+++.|+|||.+.+....+.++||||||+++|+|++|..||...... +....+.. ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 3456888999999876554478999999999999999999999764431 22111110 00
Q ss_pred CC-------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 YF-------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 ~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.. ....+..+.+++.+||..||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 01124578899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=301.99 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=205.3
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCe----
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREK---- 110 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~---- 110 (335)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... .......+.+|+..++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999765321 2223346778999999995 6999999999977665
Q ss_pred -EEEEEecCCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEeecccc
Q psy2306 111 -MVLVMEYAAGGELYDFLDQ-----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADFGLS 183 (335)
Q Consensus 111 -~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~df~~~ 183 (335)
.|++|||+++ +|.+++.. +..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 88888754 235799999999999999999999999999999999999998 889999999988
Q ss_pred ccccCC-ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-----------
Q psy2306 184 NVFTES-RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG----------- 251 (335)
Q Consensus 184 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~----------- 251 (335)
...... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 654322 22223356788999999876554588999999999999999999999876544333222110
Q ss_pred -----------C-------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 252 -----------D-------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 252 -----------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
. ...+..+.++.++|.+||+.||.+||++.+++.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 00134567899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=289.94 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=216.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+.+++..||+|.-|+|++++...+|...|+|.+.... ..++.+++...+.+..... +|+||+.+++|..+...++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4556788999999999999999999999999998743 4555667777777766654 899999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhH-HCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCH-KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH-~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
|.| +..++.++++ .+++++..+-++...++.||.||. ++|++|||+||+|||+++.|++||||||++..+....-.+
T Consensus 171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 999 5577777765 667999999999999999999998 6799999999999999999999999999999988777777
Q ss_pred ccccCCccCChhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcCCCCC----CCCCCchHHHH
Q psy2306 194 TFCGSPLYASPEIVKGI--PYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQISNGDYFE----PKNQSTASPLI 266 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~----~~~~~~l~~li 266 (335)
...|.+.|||||.+... +.|+.++||||||++++||.||+.||.+.+ .-+....+.++..+. ...++.+.+|+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFV 329 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHH
Confidence 77889999999998543 345889999999999999999999998733 334444454443321 12467899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
..||.+|+.+||...++|+|||+......
T Consensus 330 ~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 330 KDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred HHHhhcCcccCcchHHHhcCcceeecchh
Confidence 99999999999999999999999866444
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=294.84 Aligned_cols=250 Identities=35% Similarity=0.564 Sum_probs=219.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|++|.||++.+..+++.+++|.+..... .......+.+|+..++.++|+||+++++++.+....++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999876443 23445677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 117 YAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 117 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
|+++++|.+++.. ...+++..++.++.+++.||++||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence 9999999999876 356899999999999999999999999999999999999999999999999998776554 23
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHHHHhc
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLIAEML 270 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l 270 (335)
....++..|++||...+..+ +.++|+||||+++++|++|..||...+..+....+...... ....+.++.+++.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHc
Confidence 34557889999999987766 88999999999999999999999998887777766655432 2345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCc
Q psy2306 271 NINPSSRADISVICSHWWI 289 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~~~~ 289 (335)
+.+|.+||++.++++||++
T Consensus 238 ~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 238 QVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=309.81 Aligned_cols=259 Identities=30% Similarity=0.456 Sum_probs=213.0
Q ss_pred hhccceeE-EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHH-----------HHHHHHHHHHHHHcCCCCcccc
Q psy2306 33 KLKQRFDI-VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEA-----------DLIRIRREIQIMSSVRHPNIIH 100 (335)
Q Consensus 33 ~~~~~y~~-~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~ 100 (335)
.+.++|.. .+.||.|++|+||+|.+..+++.|++|.+......... ....+.+|+..++.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 46778875 57799999999999999999999999998753322110 0124678999999999999999
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeec
Q psy2306 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180 (335)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df 180 (335)
+++++...+..+++|||++ ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999996 599999988888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC---------------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q psy2306 181 GLSNVFTES---------------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV 245 (335)
Q Consensus 181 ~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~ 245 (335)
|.+...... .......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 988665411 11123345778999999877655588999999999999999999999887765544
Q ss_pred HHHhcC----CC-------------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 246 KQISNG----DY-------------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 246 ~~~~~~----~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
..+... .. .....+.++.++|.+||+.+|.+||++++++.||||+..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 333210 00 012235678899999999999999999999999999865
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=301.81 Aligned_cols=262 Identities=27% Similarity=0.426 Sum_probs=218.1
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.+..+.|...+.||+|++|.||+|.+..+|..|++|.+.............+.+|+..++.++|+|++++++++.+.+..
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 34555688889999999999999999999999999999765555555666788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
|+++||+. +++.+++.. ..++++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 99999996 477777654 557899999999999999999999999999999999999999999999999987643322
Q ss_pred cccccccCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPL 265 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 265 (335)
....++..|+|||.+.. ....+.++|+||||+++|+|++|..||...+.......+..... .....+..+.++
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 34467888999999742 22347899999999999999999999987766555544443322 223345679999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcCCCCcchh
Q psy2306 266 IAEMLNINPSSRADISVICSHWWIDKDHSVAC 297 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 297 (335)
+.+||+.+|.+||++.+++.||||+......-
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~ 284 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRDRPARV 284 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence 99999999999999999999999997654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.48 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=203.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECC--CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--CeEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKE--TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--EKMV 112 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 112 (335)
+|++.+.||+|++|.||+|.+.. ++..|++|.+...........+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999998864322233345677899999999999999999999888 8899
Q ss_pred EEEecCCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc----CCCeEEeecccc
Q psy2306 113 LVMEYAAGGELYDFLDQ-----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE----NGNAKIADFGLS 183 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~----~~~~kL~df~~~ 183 (335)
+|+||+++ ++.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999965 77776643 236899999999999999999999999999999999999998 899999999998
Q ss_pred ccccCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH-------------HHH
Q psy2306 184 NVFTESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR-------------LVK 246 (335)
Q Consensus 184 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~-------------~~~ 246 (335)
........ .....++..|+|||++.+...++.++||||||+++++|++|..||....... +..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76543222 2234567889999998776555889999999999999999999997543221 000
Q ss_pred HH----------------------hcCCCCCC------------CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 247 QI----------------------SNGDYFEP------------KNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 247 ~~----------------------~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.+ .......+ ..+.++.+++.+||+.||++|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 00000111 345578899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.35 Aligned_cols=248 Identities=28% Similarity=0.421 Sum_probs=205.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcE--EEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQE--VAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~--valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 112 (335)
++|++.+.||+|+||.||+|.+..++.. +++|.+.. .........+.+|+..+.++ +|+||+++++++.+.+.++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 4899999999999999999998877765 46666553 22344566788899999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 113 LVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
+++||+++++|.+++.... .+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 9999999999999997532 478999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--
Q psy2306 177 IADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY-- 253 (335)
Q Consensus 177 L~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~-- 253 (335)
|+|||++..............+..|+|||.+.+..+ +.++||||||+++|+|+| |..||...+..+....+.....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCC
Confidence 999998864322111112223567999999877665 889999999999999998 9999988877777666654422
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+...+.++.+++.+||+.+|++||++.+++.+
T Consensus 244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 223356789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=306.44 Aligned_cols=243 Identities=27% Similarity=0.457 Sum_probs=190.0
Q ss_pred EeeeeccCCeEEEEEEECC--CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE--eCCeEEEEEe
Q psy2306 41 VRKLGQGNYGKVQLGINKE--TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE--NREKMVLVME 116 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e 116 (335)
..+||+|+||.||+|.+.. ++..|++|.+..... ...+.+|+.+++.++||||+++++++. .....++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3689999999999998654 568899999865321 235678999999999999999999984 4567899999
Q ss_pred cCCCCCHHHHHhh---------CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE----ccCCCeEEeecccc
Q psy2306 117 YAAGGELYDFLDQ---------KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL----DENGNAKIADFGLS 183 (335)
Q Consensus 117 ~~~~~~L~~~l~~---------~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili----~~~~~~kL~df~~~ 183 (335)
|++ ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 995 478777742 2258899999999999999999999999999999999999 45678999999999
Q ss_pred ccccCCc----cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----------HHHHHHh
Q psy2306 184 NVFTESR----FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK----------RLVKQIS 249 (335)
Q Consensus 184 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~----------~~~~~~~ 249 (335)
....... ......+++.|+|||++.+...++.++||||||+++|+|+||..||.....+ .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 7654322 1234567889999999987655588999999999999999999999643211 0000000
Q ss_pred ---------------------------cCCC-----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 250 ---------------------------NGDY-----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 250 ---------------------------~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.... .....+..+.+++.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 011123467889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=294.10 Aligned_cols=245 Identities=39% Similarity=0.629 Sum_probs=216.6
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCH
Q psy2306 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGEL 123 (335)
Q Consensus 44 ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 123 (335)
||.|++|.||++.+..+++.+++|.+.............+..|+..++.++|+|++++++.+.+.+..+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999988999999999876555555677888999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccccccccCCccC
Q psy2306 124 YDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLSTFCGSPLYA 202 (335)
Q Consensus 124 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~~~~~~~~~~ 202 (335)
.+++.....+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 999998878999999999999999999999999999999999999999999999999998776443 2234456788899
Q ss_pred ChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCCCCCCCH-
Q psy2306 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINPSSRADI- 280 (335)
Q Consensus 203 aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~- 280 (335)
+||...+... +.++|+||||+++|++++|..||...+..+....+..... .+...+..+.+++++||..||.+||++
T Consensus 161 ~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 161 APEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred ChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 9999987665 8899999999999999999999988877666666665444 333447799999999999999999999
Q ss_pred --HHHhcCCCc
Q psy2306 281 --SVICSHWWI 289 (335)
Q Consensus 281 --~~ll~~~~~ 289 (335)
+++++||||
T Consensus 240 ~~~~l~~~~~f 250 (250)
T cd05123 240 GAEEIKAHPFF 250 (250)
T ss_pred cHHHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=303.14 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=203.9
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC---
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE--- 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 109 (335)
..-++|++.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+..+++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 344589999999999999999999999999999999865322 2222334567999999999999999999986543
Q ss_pred -----eEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 110 -----KMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 110 -----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
..++++||+. ++|.+++... ..+++.+++.++.|+++||+|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999995 4888777654 36899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCc-----cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--CC---
Q psy2306 184 NVFTESR-----FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--DY--- 253 (335)
Q Consensus 184 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--~~--- 253 (335)
....... ......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+..- ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 7653321 1123456778999999876654478999999999999999999999876654332222210 00
Q ss_pred ----------------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 254 ----------------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 254 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.....+..+.++|.+||+.||.+|||++++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 001123466789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.80 Aligned_cols=250 Identities=29% Similarity=0.474 Sum_probs=207.1
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
|++.+.||.|++|.||+|.+..+|..|++|.+..... .......+.+|+..++.++|+|++++++++.+.+..++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999875432 222334677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cccc
Q psy2306 118 AAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLST 194 (335)
Q Consensus 118 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~ 194 (335)
++ ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 95 68999987765 68999999999999999999999999999999999999999999999999986554221 1223
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-----------------------
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG----------------------- 251 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~----------------------- 251 (335)
..++..|+|||++.+...++.++|+||||+++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 355788999998876554588999999999999999999999776553322221110
Q ss_pred -------CCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 252 -------DYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 252 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
....+..+..+.+++.+||+.||.+||++++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00123345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=295.34 Aligned_cols=245 Identities=26% Similarity=0.441 Sum_probs=210.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
..|++.+.||+|++|.||+|.+..++..+++|.+... ......+.+|+..++.++|+||+++++++...+..+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 4799999999999999999999999999999998642 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 116 EYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
||+++++|.+++... ..+++..+..++.|+++||+|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999998753 358999999999999999999999999999999999999999999999999987665432211
Q ss_pred --ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC--CCCCCCCCchHHHHHH
Q psy2306 194 --TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGD--YFEPKNQSTASPLIAE 268 (335)
Q Consensus 194 --~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 268 (335)
....+..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+.... ..+...+.++.+++.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred cCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1223557999999987776 889999999999999998 999998888877766666532 2234456799999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy2306 269 MLNINPSSRADISVICS 285 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~ 285 (335)
||+.+|++||++.++++
T Consensus 241 cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999974
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=296.89 Aligned_cols=256 Identities=30% Similarity=0.451 Sum_probs=211.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--CCeEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--REKMVL 113 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 113 (335)
++|...+.||.|++|.||+|.+..+++.+++|.+.... .......+.+|++.++.++|+||+++++++.+ .+..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 47999999999999999999999999999999987532 23445678899999999999999999999854 447899
Q ss_pred EEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 114 VMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
+|||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887753 345899999999999999999999999999999999999999999999999998654432
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhcCCCC-C-------C
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS-----NFKRLVKQISNGDYF-E-------P 256 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~-~-------~ 256 (335)
.. ....++..|++||...+..+ +.++|+||||+++|+|++|..||... ...+....+...... . .
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred cc-ccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 21 23456778999999987776 88999999999999999999999765 233444443332111 1 1
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.+++.+.+++.+||..+|.+|||+.|++.||||......
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 224578999999999999999999999999999755443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=314.22 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=203.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEE-----CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGIN-----KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENR 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 108 (335)
.++|++.+.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999964 3457789999987532 233456788999999999 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhC----------------------------------------------------------
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQK---------------------------------------------------------- 130 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------- 130 (335)
+..+++|||+++|+|.+++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 9999999999999999988642
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc-
Q psy2306 131 -----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL- 192 (335)
Q Consensus 131 -----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~- 192 (335)
..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 14788889999999999999999999999999999999999999999999998765433221
Q ss_pred --cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH-HHHHHHhcCCC--CCCCCCCchHHHH
Q psy2306 193 --STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFK-RLVKQISNGDY--FEPKNQSTASPLI 266 (335)
Q Consensus 193 --~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~l~~li 266 (335)
....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...... .....+..+.. .+...+.++.+++
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 12233567999999988776 899999999999999997 89999775443 33333333321 2233466899999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q psy2306 267 AEMLNINPSSRADISVICSH 286 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+||+.||++||++.+|++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=299.85 Aligned_cols=259 Identities=29% Similarity=0.518 Sum_probs=221.6
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...+.|++...||.|++|.||+|.+..++..+++|++..... ..+.+.+|+..++.++|+|++++++.+...+..+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 356689999999999999999999998899999999876332 4557788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-
Q psy2306 113 LVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR- 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~- 190 (335)
+++||+++++|.+++.... .++...+..++.+++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999998876 89999999999999999999999999999999999999999999999999876543321
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCchHHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTASPLI 266 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li 266 (335)
......++..|++||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...... ....+..+.++|
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 1223346778999999987776 88999999999999999999999887766555554433221 112567899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
.+||+.+|.+||++.++++|+||.+.....
T Consensus 251 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHhccChhhCcCHHHHhhChHhhccCchH
Confidence 999999999999999999999999855443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=298.64 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=204.1
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHH---HHHHHcCCCCcccceeEEEEeCCeEEEEEecCC
Q psy2306 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRRE---IQIMSSVRHPNIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 43 ~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
.||+|+||.||+|.+..+++.|++|.+................| ...++...|++|+.+++.+.+.+..++++||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999876433222222223333 334455679999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCC
Q psy2306 120 GGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199 (335)
Q Consensus 120 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~ 199 (335)
|++|.+++...+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence 99999999888889999999999999999999999999999999999999999999999999886554322 22346889
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhcCC-CCCCCCCCchHHHHHHhcccCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---NFKRLVKQISNGD-YFEPKNQSTASPLIAEMLNINPS 275 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~ 275 (335)
.|+|||.+.+...++.++|+||+|+++|+|++|..||... ............. ..+...+.++.+++.+||..+|.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~ 239 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 239 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence 9999999976544488999999999999999999999765 3333333332222 23334577999999999999999
Q ss_pred CCC-----CHHHHhcCCCcCCCC
Q psy2306 276 SRA-----DISVICSHWWIDKDH 293 (335)
Q Consensus 276 ~Rp-----s~~~ll~~~~~~~~~ 293 (335)
+|| ++.++++||||+...
T Consensus 240 ~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 240 RRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred hccCCCCCCHHHHHhCccccCCC
Confidence 999 999999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=293.41 Aligned_cols=252 Identities=27% Similarity=0.489 Sum_probs=213.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCC--cCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--CeE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCK--IETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--EKM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 111 (335)
.+|++.+.||+|++|.||+|.+..+++.|++|.+.... .........+.+|+..++.++|+||+++++.+.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875421 12344567888999999999999999999998664 568
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC--
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-- 189 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-- 189 (335)
++++||+++++|.+++...+++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 899999999999999988788999999999999999999999999999999999999999999999999998765321
Q ss_pred --ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCchHH
Q psy2306 190 --RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---DYFEPKNQSTASP 264 (335)
Q Consensus 190 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 264 (335)
.......++..|+|||.+.+... +.++|+||||+++|+|++|..||...........+... ...+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 11123457888999999988665 88999999999999999999999876655544444432 2234456678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
++.+||+ +|.+||++.++++|||+
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=313.77 Aligned_cols=250 Identities=23% Similarity=0.383 Sum_probs=203.7
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE 106 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 106 (335)
.-.++|.+.+.||+|+||.||+|++.. ++..|++|.+.... .......+.+|+.+++.+ +|+||+++++.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 335589999999999999999998643 34579999987533 233456788999999999 7999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhC--------------------------------------------------------
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQK-------------------------------------------------------- 130 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------- 130 (335)
..+..+++|||+++++|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999988532
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc---c
Q psy2306 131 --------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL---S 193 (335)
Q Consensus 131 --------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~---~ 193 (335)
.++++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......... .
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 24788899999999999999999999999999999999999999999999998765432211 1
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHHHHHh
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPLIAEM 269 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~ 269 (335)
...++..|+|||++.+..+ +.++||||||+++|+|++ |..||................. .+...++++.+++.+|
T Consensus 273 ~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 273 NARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred CCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 2234567999999987776 899999999999999997 9999987655443333332221 2233467999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy2306 270 LNINPSSRADISVICS 285 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~ 285 (335)
|+.||.+|||+.++++
T Consensus 352 l~~dp~~RPs~~~l~~ 367 (374)
T cd05106 352 WNLEPTERPTFSQISQ 367 (374)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999974
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=300.17 Aligned_cols=250 Identities=31% Similarity=0.524 Sum_probs=209.2
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--CeEEEEE
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--EKMVLVM 115 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 115 (335)
|++.+.||.|++|.||+|.+..+++.+++|.+.... ........+.+|+..++.++|+|++++++++.+. +..++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998743 2333445677899999999999999999999888 8999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc--cc
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR--FL 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~--~~ 192 (335)
||+++ +|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 99965 898888765 579999999999999999999999999999999999999999999999999987665443 12
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-------------------
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY------------------- 253 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~------------------- 253 (335)
....++..|+|||.+.+...++.++||||||+++|+|++|..||...+.......+.....
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 3345677899999887654458899999999999999999999987766544443322100
Q ss_pred ------------CCCC-CCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 254 ------------FEPK-NQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 254 ------------~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.... .+..+.+++++||+.+|.+||+++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011 25678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=295.33 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=204.6
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.+.....||+|+||.||+|.+..++..|++|.+... .....+.+.+|+..++.++|+||+++++++...+..++++|
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 344456899999999999999989999999988653 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCC--CHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEeeccccccccCCcc-
Q psy2306 117 YAAGGELYDFLDQK-KVL--TEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 117 ~~~~~~L~~~l~~~-~~~--~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~df~~~~~~~~~~~- 191 (335)
|+++++|.+++... .++ ++..+..++.|++.||+|||+.|++|+||+|+||+++. ++.++|+|||.+........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 99999999999764 445 88889999999999999999999999999999999976 67999999998866543222
Q ss_pred ccccccCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHH--hcCCCCCCCCCCchHHHH
Q psy2306 192 LSTFCGSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR--LVKQI--SNGDYFEPKNQSTASPLI 266 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~--~~~~~--~~~~~~~~~~~~~l~~li 266 (335)
.....+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||....... ..... ......+...++++.+++
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 22345788999999986543 24789999999999999999999997543221 11111 111122334567899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCc
Q psy2306 267 AEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
++||+.+|.+|||+.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=297.76 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=208.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
..++|++.+.||+|++|.||+|.+.. ++..|++|.+.... .......+.+|+..++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45689999999999999999998642 35679999876422 233455688999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEe
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQK----------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIA 178 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~ 178 (335)
+..++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999998752 235778899999999999999999999999999999999999999999
Q ss_pred eccccccccCCccc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC-
Q psy2306 179 DFGLSNVFTESRFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY- 253 (335)
Q Consensus 179 df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~- 253 (335)
|||++......... ....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99988654332211 12234667999999987776 899999999999999998 7899988888777776665543
Q ss_pred -CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 254 -FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 254 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 233456689999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=299.64 Aligned_cols=244 Identities=33% Similarity=0.558 Sum_probs=204.0
Q ss_pred eEEeeeeccCCeEEEEEEEC----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 39 DIVRKLGQGNYGKVQLGINK----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 39 ~~~~~ig~g~~g~Vy~~~~~----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
++.+.||.|.||.||+|... ..+..|++|.+.. ....+..+.+.+|++.++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 57789999999999999887 4467899999965 33455678899999999999999999999999988889999
Q ss_pred EecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-
Q psy2306 115 MEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~- 191 (335)
+||+++++|.+++... ..++...++.|+.|++.||+|||+++++|++|+++||+++.++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 6799999999999999999999999999999999999999999999999999877632211
Q ss_pred --ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHH
Q psy2306 192 --LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLI 266 (335)
Q Consensus 192 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 266 (335)
.........|+|||.+....+ +.++||||||+++||+++ |..||.+.+..+....+...... +...+..+.+++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 123345678999999987776 999999999999999999 78999998888888887665442 334577899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy2306 267 AEMLNINPSSRADISVICS 285 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~ 285 (335)
.+||+.||.+||++.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=299.10 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=211.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
++|++.+.||+|++|.||+|.+.. ++..|++|.+.... ..+....+.+|+++++.++|+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 479999999999999999998743 46789999987532 33355688899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCC--------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 111 MVLVMEYAAGGELYDFLDQKK--------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
.+++|||+++++|.+++...+ .+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 999999999999999997542 478899999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC
Q psy2306 177 IADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGD 252 (335)
Q Consensus 177 L~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 252 (335)
|+|||.+........ .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+..+.
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999998865432211 122334678999999988776 889999999999999998 999998888888877777654
Q ss_pred CC--CCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 253 YF--EPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 253 ~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.. +...+..+.+++++||+.||.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 42 3345779999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=309.06 Aligned_cols=256 Identities=28% Similarity=0.482 Sum_probs=217.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-----eE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE-----KM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 111 (335)
+|++.+.||.|++|.||+|.+..+++.+++|.+.... ......+.+.+|+..++.++|+||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999889999999987532 22344567889999999999999999999987765 78
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR- 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~- 190 (335)
|+++||++ ++|.+++.++.++++..++.++.+++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999996 5899999887789999999999999999999999999999999999999999999999999988765443
Q ss_pred ---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--------------
Q psy2306 191 ---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-------------- 253 (335)
Q Consensus 191 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------- 253 (335)
......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 234456788999999998874458999999999999999999999988776554444332100
Q ss_pred ------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 254 ------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 254 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
..+..+.++.++|++||+++|.+||++++++.||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 01224667889999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=298.17 Aligned_cols=246 Identities=27% Similarity=0.437 Sum_probs=209.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.+.|++.+.||+|+||.||++.+. .++..+++|.+... .......+.+|+..++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 458999999999999999999853 34567899987642 3445667889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC-------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK-------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
..++++||+++++|.+++...+ .+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997543 489999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC
Q psy2306 177 IADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGD 252 (335)
Q Consensus 177 L~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 252 (335)
|+|||.+........ .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||......+....+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875533221 122334668999999987665 889999999999999998 999998888877777777665
Q ss_pred CC--CCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 253 YF--EPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 253 ~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
.. ....+.++.+++.+||+.||.+|||+.+++
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 32 234567999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=297.13 Aligned_cols=249 Identities=26% Similarity=0.441 Sum_probs=209.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.++|++.+.||+|++|.||+|.+.. ++..|++|.+.... .......+..|+..++.++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4689999999999999999999877 67889999876422 3334456888999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC-------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC---CeEEee
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK-------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG---NAKIAD 179 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~---~~kL~d 179 (335)
..++++||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997643 489999999999999999999999999999999999998755 589999
Q ss_pred ccccccccCCccc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--
Q psy2306 180 FGLSNVFTESRFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY-- 253 (335)
Q Consensus 180 f~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~-- 253 (335)
||.+......... .....+..|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+.....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9998765322211 12223457999999987776 899999999999999996 9999998887777766655432
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+...+..+.+++.+||+.+|.+||++.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 234457789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.09 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=214.6
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
...+.++|++.+.||+|++|.||+|.+..++..|++|.+.... ........+.+|+.+++.++|+|++++++++...+.
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 3456789999999999999999999999999999999986532 223344567789999999999999999988866554
Q ss_pred ------EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 111 ------MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 111 ------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.++++|++ +++|.+++.. .++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 6699999875 569999999999999999999999999999999999999999999999999987
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----------
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----------- 253 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----------- 253 (335)
..... .....++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65433 23345678899999987654458899999999999999999999987665544333222100
Q ss_pred ---------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 254 ---------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 254 ---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.....+.++.++|++||+.||.+|||+.+|++||||++....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 012346789999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.53 Aligned_cols=249 Identities=29% Similarity=0.521 Sum_probs=211.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||.|++|.||+|.+..+|+.|++|.++..........+.+.+|+..++.++|++++++++.+.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999899999999987644444555678889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-
Q psy2306 116 EYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR- 190 (335)
Q Consensus 116 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~- 190 (335)
||+++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999998864 3458999999999999999999999999999999999999999999999999886554322
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhcCCCC--C-CCCCCchHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN--FKRLVKQISNGDYF--E-PKNQSTASPL 265 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~--~~~~~~~~~~~~~~--~-~~~~~~l~~l 265 (335)
......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||.... ..+....+..+... + ...+..+.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence 2234567888999999987776 889999999999999999999996543 33444444443322 1 2456689999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+||+.+|++||++.+|++
T Consensus 241 i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=293.06 Aligned_cols=241 Identities=25% Similarity=0.422 Sum_probs=202.8
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
+.||+|+||.||+|.+..+++.+++|.+... ...+....+.+|++.++.++|+||+++++++...+..++++||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 4689999999999999999999999987642 23445567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc---cccc
Q psy2306 122 ELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS---TFCG 197 (335)
Q Consensus 122 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~---~~~~ 197 (335)
+|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......... ....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 999999754 468999999999999999999999999999999999999999999999999986544321111 1122
Q ss_pred CCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC--CCCCCCCCchHHHHHHhcccCC
Q psy2306 198 SPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGD--YFEPKNQSTASPLIAEMLNINP 274 (335)
Q Consensus 198 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp 274 (335)
+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+.... ..+...+..+.+++.+||+.+|
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 356999999987776 889999999999999997 999998777666655554432 2233456789999999999999
Q ss_pred CCCCCHHHHhc
Q psy2306 275 SSRADISVICS 285 (335)
Q Consensus 275 ~~Rps~~~ll~ 285 (335)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.35 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=219.2
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
+....+.|+..+.||+|+||.||++.+..++..+++|.+.............+.+|+..++.++|+|++++++++.+.+.
T Consensus 20 ~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 20 KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT 99 (317)
T ss_pred CCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence 34555679999999999999999999998999999999876554555566778899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.++++||+.+ ++.+.+.. ..++++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9999999965 77776653 567899999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccccCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASP 264 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~ 264 (335)
....++..|+|||.+.. ....+.++|+||||+++|+|++|..||...+.......+..... .....++.+.+
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 23457888999999742 22248899999999999999999999988776665555554432 22335668999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
++.+||+.+|.+||++.++++|+|+......
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 9999999999999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=293.17 Aligned_cols=242 Identities=29% Similarity=0.458 Sum_probs=211.5
Q ss_pred eeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecC
Q psy2306 42 RKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYA 118 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 118 (335)
+.||+|+||.||+|.+... +..+++|.+..... ....+.+.+|+..++.++|+|++++++++.+....++++||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999998866 88999999876432 224678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 119 AGGELYDFLDQK---------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 119 ~~~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
++++|.+++... ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999999776543
Q ss_pred c---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchH
Q psy2306 190 R---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTAS 263 (335)
Q Consensus 190 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 263 (335)
. ......++..|+|||.+....+ +.++||||||+++|+|++ |..||......+....+..... .+...+.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 2 2234456788999999987765 899999999999999998 6999999888888887776433 2344578999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q psy2306 264 PLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+++.+||+.+|.+|||+.+++.+
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=297.09 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=208.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.++|.+.+.||+|++|.||+|.+. .++..+++|.+... .......+.+|+..++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 347999999999999999999753 24566888887642 2344457889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG 173 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~ 173 (335)
..+++|||+++++|.+++..+. .+++..++.++.|++.||+|||++|++|+||+|+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997543 378999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q psy2306 174 NAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQIS 249 (335)
Q Consensus 174 ~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 249 (335)
.++|+|||.+........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999876543221 123345678999999987766 889999999999999998 999998888877777776
Q ss_pred cCCCC--CCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 250 NGDYF--EPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 250 ~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
.+... ....+..+.+++.+||+.+|.+||++.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~ 276 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY 276 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 65443 233566899999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=296.90 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=211.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.++|++.+.||+|+||.||+|.++. .+..|++|.+.... .......+.+|+..++.++|+||+++++++.+.+
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4699999999999999999997542 35579999876432 2333456778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEee
Q psy2306 110 KMVLVMEYAAGGELYDFLDQK----------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIAD 179 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~d 179 (335)
..+++|||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999999999752 2356778899999999999999999999999999999999999999999
Q ss_pred ccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC-
Q psy2306 180 FGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF- 254 (335)
Q Consensus 180 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~- 254 (335)
||++........ .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.++....+......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 998875433221 112234567999999987776 889999999999999998 78999888888777766655432
Q ss_pred -CCCCCCchHHHHHHhcccCCCCCCCHHHHhc------CCCcCCC
Q psy2306 255 -EPKNQSTASPLIAEMLNINPSSRADISVICS------HWWIDKD 292 (335)
Q Consensus 255 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------~~~~~~~ 292 (335)
+...+..+.+++.+||+.||++|||+.++++ ||||+..
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 2334668999999999999999999999987 8988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=293.60 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=210.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
++|++.+.||+|+||.||+|.++.+ ...|++|.+.... .......+.+|+..++.++|+||+++++.+...+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 4799999999999999999988654 4579999886532 3445567888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-Cc
Q psy2306 113 LVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SR 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~ 190 (335)
++|||+++++|.+++... +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..... ..
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999999999763 4689999999999999999999999999999999999999999999999999877642 11
Q ss_pred ccc--ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 FLS--TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 ~~~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
... ...++..|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+..... .....+..+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111 2233567999999987766 889999999999999997 9999988887777777765432 234457799999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q psy2306 266 IAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~ 286 (335)
+.+||+.+|++||++.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=296.15 Aligned_cols=248 Identities=28% Similarity=0.527 Sum_probs=210.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||++.+..++..+++|.+.............+.+|+..++.++|+||+++++++.+.+..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47889999999999999999999899999999887654444555678889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 116 EYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 116 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 45689999999999999999999999999999999999999999999999998876543322
Q ss_pred -ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHhcCCCC---CCCCCCchHHH
Q psy2306 192 -LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF--KRLVKQISNGDYF---EPKNQSTASPL 265 (335)
Q Consensus 192 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~--~~~~~~~~~~~~~---~~~~~~~l~~l 265 (335)
.....++..|+|||...+... +.++|+||||+++|+|++|..||..... ......+...... ....+.++.++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240 (267)
T ss_pred ccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence 233467889999999987776 8899999999999999999999965433 3444444333222 12346689999
Q ss_pred HHHhcccCCCCCCCHHHHh
Q psy2306 266 IAEMLNINPSSRADISVIC 284 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll 284 (335)
+.+||+.||++|||+.+|+
T Consensus 241 i~~~l~~~p~~Rpt~~~i~ 259 (267)
T cd08229 241 VNMCINPDPEKRPDITYVY 259 (267)
T ss_pred HHHhcCCCcccCCCHHHHH
Confidence 9999999999999999877
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=292.55 Aligned_cols=244 Identities=24% Similarity=0.454 Sum_probs=206.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||++..+. +..+++|.+.... ...+.+.+|+..++.++||||+++++++...+..+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 479999999999999999998764 5679999876432 12346778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc-
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS- 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~- 193 (335)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999999999875 3468999999999999999999999999999999999999999999999999887654322221
Q ss_pred -ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHHHHh
Q psy2306 194 -TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLIAEM 269 (335)
Q Consensus 194 -~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~ 269 (335)
...++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+....+..+... +...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 2234557999999987766 889999999999999999 89999988887777777765332 233456799999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy2306 270 LNINPSSRADISVICS 285 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~ 285 (335)
|+.+|++||++.++++
T Consensus 238 ~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 238 WHEKPEGRPTFAELLR 253 (256)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.44 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=213.2
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
=+...+.+.+...||+|.||+||+|.+..+ ||||++...... .+..+.|++|+..|++.+|.||+-+.|++..+..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 344455788899999999999999988754 999999886654 4588899999999999999999999999998877
Q ss_pred EEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc--
Q psy2306 111 MVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-- 187 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-- 187 (335)
.||+.+|+|.+|..++.- ...+...+...|++|+++|+.|||.++|||+|||..||++.+++.|||+|||+++...
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999999999974 3468999999999999999999999999999999999999999999999999986643
Q ss_pred -CCccccccccCCccCChhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC------CCCCC
Q psy2306 188 -ESRFLSTFCGSPLYASPEIVKGI--PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY------FEPKN 258 (335)
Q Consensus 188 -~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~------~~~~~ 258 (335)
.........|...|||||+++.. ..+++.+|||+||+|+|||++|..||.....++++-.+-.+.. .....
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 33334445567789999998533 2349999999999999999999999998787777776666632 22334
Q ss_pred CCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 259 QSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 259 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+.++++|+..||.+++++||.+.+||.
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 568999999999999999999999983
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=294.77 Aligned_cols=245 Identities=31% Similarity=0.507 Sum_probs=202.1
Q ss_pred hccceeEEeee--eccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCe
Q psy2306 34 LKQRFDIVRKL--GQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREK 110 (335)
Q Consensus 34 ~~~~y~~~~~i--g~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 110 (335)
+.+.|++.+.+ |+|+||.||++.++.++..+++|.+........ |......+ +|+|++++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34577777776 999999999999999999999999876332211 22222222 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-CeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-NAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-~~kL~df~~~~~~~~~ 189 (335)
.+++|||+++++|.+++..+.++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999999998887899999999999999999999999999999999999999988 9999999988765433
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-----HHHHHHhcCCCCCCCCCCchHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-----RLVKQISNGDYFEPKNQSTASP 264 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~ 264 (335)
. ...++..|+|||++.+..+ +.++|+||+|+++|+|++|..||.....+ ................++.+.+
T Consensus 164 ~---~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 S---CYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred c---cCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 2 3357889999999988776 88999999999999999999999754332 2222222222233346789999
Q ss_pred HHHHhcccCCCCCCC-HHHHhcCCCcC
Q psy2306 265 LIAEMLNINPSSRAD-ISVICSHWWID 290 (335)
Q Consensus 265 li~~~l~~dp~~Rps-~~~ll~~~~~~ 290 (335)
+|.+||+.+|.+||+ ++++|+||||.
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999996 69999999995
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=327.50 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=206.3
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999999999999999987644444555677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-----------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 116 EYAAGGELYDFLDQK-----------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
||++|++|.+++... ...+...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999988641 235667788999999999999999999999999999999999999999999987
Q ss_pred cccCCc-------------------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q psy2306 185 VFTESR-------------------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV 245 (335)
Q Consensus 185 ~~~~~~-------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~ 245 (335)
...... ......|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 652100 0112468999999999988776 89999999999999999999999876554433
Q ss_pred HHHhcCCC----CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 246 KQISNGDY----FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 246 ~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
........ .....++.+.+++.+||+.||++||+..+.+.
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22111111 11245678999999999999999987665553
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=304.08 Aligned_cols=261 Identities=25% Similarity=0.450 Sum_probs=214.2
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
..-..+.++|++.+.||+|++|.||+|.+..+|..|++|.+... .........+.+|+..++.++|+||+++++++...
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07880 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD 86 (343)
T ss_pred hhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence 34566788999999999999999999999999999999998642 22334455678999999999999999999998654
Q ss_pred C------eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 109 E------KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 109 ~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
. .+++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 3 468999999 7799888864 5699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC----------
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD---------- 252 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---------- 252 (335)
+...... .....+++.|++||.+.+....+.++|+||||+++|+|++|..||...+.......+....
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 8765432 2234568889999998764445889999999999999999999998765433322221100
Q ss_pred ----------------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 253 ----------------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 253 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
......+..+.++|.+||+.||.+|||+.+++.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 011244667899999999999999999999999999986533
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=314.18 Aligned_cols=239 Identities=28% Similarity=0.493 Sum_probs=214.1
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
.+-||.|+.|.||+|+.. ++.||||.++.. . ..++.-|++|+|+||+.+.++|...-.+||+||||..
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el---k-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL---K-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhh---h-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 456899999999999776 679999987641 1 1467889999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCCc
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL 200 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~ 200 (335)
|.|.++|+.+.+++...+..|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.+..........+..||..
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHh
Confidence 99999999999999999999999999999999999999999999999999999999999999988877777778999999
Q ss_pred cCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHHHHHhcccCCCCC
Q psy2306 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPLIAEMLNINPSSR 277 (335)
Q Consensus 201 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R 277 (335)
|||||+++..+. +.++||||||++||||+||.-||.+-+...++--+-.+.. .+...++.++=||+.||+..|.+|
T Consensus 277 WMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 277 WMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNR 355 (904)
T ss_pred hhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence 999999999998 9999999999999999999999988777666655555533 455567889999999999999999
Q ss_pred CCHHHHhcCCCcCCC
Q psy2306 278 ADISVICSHWWIDKD 292 (335)
Q Consensus 278 ps~~~ll~~~~~~~~ 292 (335)
|++++||.|.-+...
T Consensus 356 PSFrqil~HldIa~p 370 (904)
T KOG4721|consen 356 PSFRQILLHLDIASP 370 (904)
T ss_pred ccHHHHHHHHhhcCH
Confidence 999999999665543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=299.29 Aligned_cols=258 Identities=26% Similarity=0.491 Sum_probs=217.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|.....||+|++|.||++.+..+|..|++|.+... .......+.+|+..++.++|+|++++++.+...+..+++||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 444457899999999999999999999999987542 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccccc
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTF 195 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~~ 195 (335)
|+++++|.+++.. ..+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 9999999998764 468999999999999999999999999999999999999999999999999876553321 22345
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHHHHHHhcc
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~ 271 (335)
.+++.|++||.+.+..+ +.++|+||+|+++|+|++|..||......+....+..... .....+..+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 67888999999877666 8899999999999999999999988776655554433221 122356789999999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCCCcchhhH
Q psy2306 272 INPSSRADISVICSHWWIDKDHSVACLE 299 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~~~~~~~~ 299 (335)
.+|.+||++.++++||||.+...+.|..
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~~~~~~ 283 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGPPSCIV 283 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCCCcccc
Confidence 9999999999999999999887766544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=298.43 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=206.7
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCc--EEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQ--EVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~--~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 112 (335)
++|++.+.||+|+||.||+|.+..++. .+++|.++. .......+.+.+|+..+.++ +||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 589999999999999999999887764 468887763 22334456788899999999 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 113 LVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
+++||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 488899999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--
Q psy2306 177 IADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY-- 253 (335)
Q Consensus 177 L~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~-- 253 (335)
|+|||++..............+..|+|||.+....+ +.++||||||+++|+|++ |..||...+..+....+..+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999998864322111112223456999999987776 889999999999999997 9999998888877776665432
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+...+..+.+++.+||+.+|.+||+++++++.
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 233467789999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=301.80 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=204.9
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC---
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--- 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 108 (335)
....++|++.+.||.|++|.||+|.+..++..+++|.+....... .......+|++.++.++|+||+++++++.+.
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 344689999999999999999999999999999999986533211 1223556899999999999999999887443
Q ss_pred -----CeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 109 -----EKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 109 -----~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
..+++++||+.+ ++...+.. ...+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 357999999965 67766654 45799999999999999999999999999999999999999999999999998
Q ss_pred cccccCCcc------------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc
Q psy2306 183 SNVFTESRF------------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN 250 (335)
Q Consensus 183 ~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 250 (335)
+........ .....+++.|+|||.+.+...++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 876543221 11234577899999987655458899999999999999999999987765544333221
Q ss_pred CCC-------------------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 251 GDY-------------------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 251 ~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
... ........+.++|.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 001223567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=305.15 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=206.1
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC-----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR----- 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 108 (335)
+.++|++.+.||.|++|.||+|.+..+|+.|++|.+..... ...+.+.+|+..++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45799999999999999999999999999999999875432 3455678899999999999999999776543
Q ss_pred ---------CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEe
Q psy2306 109 ---------EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIA 178 (335)
Q Consensus 109 ---------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~ 178 (335)
...++++||++ ++|.+++.. ..+++..++.++.|+++||.|||+.|++|+||+|+||+++. ++.++|+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 36799999996 589888864 46899999999999999999999999999999999999975 4578999
Q ss_pred eccccccccCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC--
Q psy2306 179 DFGLSNVFTESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD-- 252 (335)
Q Consensus 179 df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-- 252 (335)
|||.+........ .....++..|+|||.+.+....+.++||||||+++|+|++|..||...+..+....+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999876532211 1223567889999987665445889999999999999999999998765544333322110
Q ss_pred ----------------------C-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 253 ----------------------Y-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 253 ----------------------~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
. ..+..+.++.+++++||+.||.+|||+.+++.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 012345678899999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=300.26 Aligned_cols=256 Identities=29% Similarity=0.508 Sum_probs=208.5
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC--
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE-- 109 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 109 (335)
.+..++|++.+.||.|++|.||+|.++.+|+.|++|.+..... .......+.+|+..++.++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 4566799999999999999999999999999999999875332 2223346678999999999999999999986654
Q ss_pred --------eEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeec
Q psy2306 110 --------KMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180 (335)
Q Consensus 110 --------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df 180 (335)
.+++++||+++ ++...+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999976 777766643 46899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCc--cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---CC--
Q psy2306 181 GLSNVFTESR--FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---DY-- 253 (335)
Q Consensus 181 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---~~-- 253 (335)
|.+....... ......++..|+|||.+.+....+.++||||||+++++|++|..||...+..+....+... ..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 9987654332 1222345778999999876554588999999999999999999999876554433332221 00
Q ss_pred --------------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 254 --------------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 254 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.....+..+.+++.+||+.||.+||++++++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 011246789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.05 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=208.3
Q ss_pred cceeEEeeeeccCCeEEEEEEEC----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINK----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
..|++.+.||+|+||.||+|.+. .++..+++|.+... ........+.+|+..++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 47999999999999999999853 45678999998752 2344556788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhC-----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 112 VLVMEYAAGGELYDFLDQK-----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
+++|||+++++|.+++..+ ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999999999998532 23788899999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy2306 175 AKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISN 250 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~ 250 (335)
++|+|||++........ .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999876533221 122334567999999987766 899999999999999998 9999988777766666665
Q ss_pred CCCC--CCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 251 GDYF--EPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 251 ~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.... +...+..+.+++.+||+.||.+||++.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5432 33457789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=297.04 Aligned_cols=249 Identities=32% Similarity=0.504 Sum_probs=207.4
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEEEe
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 116 (335)
|++.+.||+|++|+||+|.+..+++.|++|.+...... .......+|+..++.++ |+|++++++++.+.+..+++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999988999999998753321 22223456889999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 117 YAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
|+ +++|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 99 779998887654 789999999999999999999999999999999999999999999999999877665444445
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------C---
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------------------D--- 252 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------~--- 252 (335)
..++..|+|||++......+.++|+||||+++++|++|..||...........+... .
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 567889999999866555588999999999999999999999776544333222110 0
Q ss_pred ---------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 ---------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
...+..+..+.+++++||+.+|.+||+++|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0011224678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.25 Aligned_cols=247 Identities=22% Similarity=0.370 Sum_probs=206.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcE----EEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQE----VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~----valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.+|++.+.||+|+||.||+|.+..++.. |++|.+... ......+.+.+|+..++.++|+||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 4899999999999999999988665554 899998642 2344556788999999999999999999998764 56
Q ss_pred EEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+++++|+++++|.+++... ..++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 7999999999999999864 458899999999999999999999999999999999999999999999999998765332
Q ss_pred cc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHH
Q psy2306 191 FL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASP 264 (335)
Q Consensus 191 ~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 264 (335)
.. .....+..|++||.+.+..+ +.++||||||+++|+|++ |..||.+....+....+..... .+...+.++.+
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 242 (316)
T ss_pred cceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 21 12223567999999988776 899999999999999997 9999988777666555554432 23345668999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q psy2306 265 LIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~ 286 (335)
++.+||+.+|.+||++.+++.+
T Consensus 243 li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 243 IMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.49 Aligned_cols=249 Identities=29% Similarity=0.478 Sum_probs=204.7
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC---CCCcccceeEEEEeCCe----
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV---RHPNIIHIYEVFENREK---- 110 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~---- 110 (335)
|++.+.||.|++|.||+|.++.+++.+++|.+..... .......+.+|+..++++ .|+|++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999998899999999975432 222233455677666555 59999999999987776
Q ss_pred -EEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 111 -MVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 111 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
.++++|++++ +|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999965 8988887643 48999999999999999999999999999999999999999999999999987765
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--------------
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-------------- 253 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------- 253 (335)
.........++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred CCcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 5444444557888999999988776 8899999999999999999999987766554444322100
Q ss_pred --------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 254 --------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 254 --------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
..+..+..+.+++++||+.||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001224567889999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.39 Aligned_cols=266 Identities=25% Similarity=0.380 Sum_probs=210.8
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMV 112 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 112 (335)
....|++.++||+||.+.||++...+.+ -|++|.+... ..+.....-+.+|+.+|.+++ |.+|++++++-..++.+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3458999999999999999999866544 4555554432 235667788999999999996 899999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+|||+= ..+|.++|+++.. ++...++.+..||+.|+.++|++||||.||||.|+++ -.|.+||+|||++........
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence 999987 6699999987654 3335888999999999999999999999999999999 778999999999987754332
Q ss_pred ---ccccccCCccCChhhhcCCCC----------CCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcCCC--CC
Q psy2306 192 ---LSTFCGSPLYASPEIVKGIPY----------HGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQISNGDY--FE 255 (335)
Q Consensus 192 ---~~~~~~~~~~~aPE~~~~~~~----------~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~~~~~~~--~~ 255 (335)
....+||+.||+||.+..... .+.++|||||||+||+|+.|+.||..-. ...-...+..... ..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 356789999999998843221 2678999999999999999999996532 2222333333321 22
Q ss_pred CCC--CCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC-CCcchhhHHHHH
Q psy2306 256 PKN--QSTASPLIAEMLNINPSSRADISVICSHWWIDK-DHSVACLEEAEE 303 (335)
Q Consensus 256 ~~~--~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~-~~~~~~~~~~~~ 303 (335)
+.. ..++.++++.||..||.+||+..++|+|||++- ....+..+.++.
T Consensus 595 p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~m~~~~~ 645 (677)
T KOG0596|consen 595 PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQMAKLTT 645 (677)
T ss_pred cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchHHHHHHH
Confidence 222 225999999999999999999999999999996 555555554443
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=281.83 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=202.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-----CC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN-----RE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~ 109 (335)
.+||+|.+.||.|||+-||++..-.+++.||+|.+.... .+..+...+|++..++++|||+++++++... ..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 569999999999999999999988999999999998743 5667789999999999999999999887643 33
Q ss_pred eEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~~~~~~kL~df~~~ 183 (335)
..|++++|...|+|.+.+.. +..+++.++.+|+.++++||.+||... ++|+||||.||++++.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 58999999999999998874 347999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCC----------ccccccccCCccCChhhhcCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHh
Q psy2306 184 NVFTES----------RFLSTFCGSPLYASPEIVKGIP--YHGPEVDCWSLGVLLYTLVYGAMPFDGSNF--KRLVKQIS 249 (335)
Q Consensus 184 ~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~--~~~~~~~~ 249 (335)
+...-. +.......+..|.|||.+.-.. ..+.++|||||||++|.|+.|..||+..-. .-+...+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 765421 1122345688999999885332 238899999999999999999999953110 00000111
Q ss_pred cCCC---CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 250 NGDY---FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 250 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+... ....+++.+.++|+.||+.||.+||++.+++++
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111 223367789999999999999999999999854
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=293.71 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=210.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCC-----CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKET-----GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
..++|++.+.||+|+||.||+|.+... +..|++|.+.... .......+.+|+..++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 356999999999999999999987643 4789999986532 334456788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEe
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQK----------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIA 178 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~ 178 (335)
...++++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999999653 236788999999999999999999999999999999999999999999
Q ss_pred eccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC-
Q psy2306 179 DFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY- 253 (335)
Q Consensus 179 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~- 253 (335)
|||++........ .....++..|+|||.+.+..+ +.++||||||+++|++++ |..||...+..+....+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999876543221 122345678999999977665 889999999999999998 9999988888887777775433
Q ss_pred -CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 254 -FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 254 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+...+.++.+++.+||+.+|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 23445778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.27 Aligned_cols=245 Identities=25% Similarity=0.463 Sum_probs=208.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.++||+|++|.||+|.+. ++..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+.+.+..+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 358999999999999999999865 46779999876422 2356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+||+++++|.+++.. ...++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999999865 356889999999999999999999999999999999999999999999999999765433221
Q ss_pred --cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHHH
Q psy2306 193 --STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLIA 267 (335)
Q Consensus 193 --~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~ 267 (335)
....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+...... ....+.++.+++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred ccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 12234567999999987766 889999999999999998 99999888877777776654322 2345678999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q psy2306 268 EMLNINPSSRADISVICS 285 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~ 285 (335)
+||+.+|++||+++++++
T Consensus 239 ~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 239 TCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=290.50 Aligned_cols=245 Identities=28% Similarity=0.462 Sum_probs=208.0
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|++|.||+|.+.. ++.|++|.+..... ..+.+.+|+..++.++|+||+++++++...+..+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 3579999999999999999998754 57899999875332 234677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+|++++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999997644 6899999999999999999999999999999999999999999999999998766532221
Q ss_pred c--ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 193 S--TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 193 ~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
. ....+..|+|||...+..+ +.++|+||||+++|+|++ |..||.+.+.......+..... .+...+..+.+++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238 (261)
T ss_pred ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 1 1122357999999887766 889999999999999998 9999988887777776655432 23445779999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q psy2306 268 EMLNINPSSRADISVICS 285 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~ 285 (335)
+||+.+|.+||++.++++
T Consensus 239 ~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 239 DCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHhhcCcccCCCHHHHHH
Confidence 999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=297.59 Aligned_cols=259 Identities=26% Similarity=0.433 Sum_probs=216.3
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|+..+.||+|++|.||+|++..++..+++|.+.............+.+|+..++.++|+|++++++++...+..++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 44568889999999999999999999999999999876444445556678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 114 VMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
++||+. +++.+++. ...++++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 999996 57777664 3556899999999999999999999999999999999999999999999999988765432
Q ss_pred cccccCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHHHH
Q psy2306 193 STFCGSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPLIA 267 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~ 267 (335)
....+++.|+|||.+.+ ....+.++||||||+++|+|++|..||...+.......+..... .....+..+.++|+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence 23456788999999752 22237899999999999999999999987665554444443322 23346678999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 268 EMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
+||+.+|.+||++.+++.|||+.......
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~ 277 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHRFVLRERPPT 277 (308)
T ss_pred HHhhCCcccCCCHHHHhhCccccccCChh
Confidence 99999999999999999999999865543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=290.38 Aligned_cols=245 Identities=23% Similarity=0.437 Sum_probs=206.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|++|.||.+.+.. +..+++|.+..... ..+.+.+|+..++.++||||+++++++...+..+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 479999999999999999997654 45699998765322 2346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc-
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS- 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~- 193 (335)
||+.+++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999999999763 468999999999999999999999999999999999999999999999999887654332211
Q ss_pred -ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 194 -TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 194 -~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
...++..|++||...+..+ +.++||||||+++|+|++ |..||...+..+....+..... .....+..+.+++.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 2234567999999987766 889999999999999998 9999988777766666655433 2333466899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q psy2306 270 LNINPSSRADISVICSH 286 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~ 286 (335)
|+.+|.+||++.+|+.+
T Consensus 238 l~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 238 WHEKAEERPTFQQLLSS 254 (256)
T ss_pred cCCCcccCCCHHHHHHh
Confidence 99999999999999854
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.44 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=211.9
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR-- 108 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 108 (335)
-..+.++|++.+.||+|+||.||+|.+..+|+.|++|.+.... ......+.+.+|+..+++++|+||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 3556789999999999999999999999999999999987532 2233345677899999999999999999988543
Q ss_pred ----CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 109 ----EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 109 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
+..+++++++ +++|.++++.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478888887 77998888654 58999999999999999999999999999999999999999999999999987
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC------------
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD------------ 252 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------ 252 (335)
..... .....++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 65332 2334678889999998764444889999999999999999999997665443322221100
Q ss_pred ------------C--------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 253 ------------Y--------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 253 ------------~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
. .....++++.++|.+||+.||.+||++.+++.||||++...+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 0 0112466789999999999999999999999999999765544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.92 Aligned_cols=257 Identities=28% Similarity=0.492 Sum_probs=208.8
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC---
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--- 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 108 (335)
.++.++|.+.+.||+|++|.||+|.+..+|+.|++|.+.... ........+.+|+..++.++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 456789999999999999999999999899999999987532 2223345677899999999999999999998654
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 109 ---EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 109 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
..+++++||+. .+|..++ ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 90 DEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 35699999995 4777665 34589999999999999999999999999999999999999999999999999865
Q ss_pred ccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--------------
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------------- 251 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------- 251 (335)
.... .....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+...
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 4332 223456788999999876544488999999999999999999999877654433222210
Q ss_pred -----------CC-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 252 -----------DY-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 252 -----------~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
.. ..+..+..+.++|.+||+.||.+||++.+++.||||.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 01234567889999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=289.04 Aligned_cols=240 Identities=27% Similarity=0.441 Sum_probs=203.0
Q ss_pred eeeccCCeEEEEEEE--CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 43 KLGQGNYGKVQLGIN--KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 43 ~ig~g~~g~Vy~~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
.||+|+||.||+|.+ ..++..+++|++.... ......+.+.+|+..++.++|+||+++++++. .+..++++||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 4567899999986532 33455677889999999999999999999875 4567899999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc----cccc
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL----STFC 196 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~----~~~~ 196 (335)
++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999988888999999999999999999999999999999999999999999999999998765433221 1122
Q ss_pred cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcccC
Q psy2306 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 197 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~d 273 (335)
++..|+|||.+....+ +.++|+||||+++|+|++ |..||...+..+....+..... .+...++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 3468999999877665 889999999999999997 9999998887777777776543 33446789999999999999
Q ss_pred CCCCCCHHHHhc
Q psy2306 274 PSSRADISVICS 285 (335)
Q Consensus 274 p~~Rps~~~ll~ 285 (335)
|.+||++++|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=296.47 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=205.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+|...+.||+|+||.||++.+..++..+++|.+..... ......+.+|+..+.++. |+||+++++++...+..++++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 56677899999999999999999999999999875332 244567788999999996 999999999999999999999
Q ss_pred ecCCCCCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 116 EYAAGGELYDFLD-----QKKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 116 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
|++. +++.++.. ....+++..+..++.+++.||+|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 9985 46555432 246799999999999999999999974 9999999999999999999999999998765444
Q ss_pred ccccccccCCccCChhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhcCCC---C---CCCCCC
Q psy2306 190 RFLSTFCGSPLYASPEIVKGI--PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-KRLVKQISNGDY---F---EPKNQS 260 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~~---~---~~~~~~ 260 (335)
.......++..|+|||++.+. ..++.++||||||+++|+|++|..||..... .+....+..... . ....+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 333444678889999999776 2448899999999999999999999976442 122222222211 1 112456
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
++.+++.+||+.+|.+|||+++|+.||||+..
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 78999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=288.74 Aligned_cols=255 Identities=35% Similarity=0.605 Sum_probs=218.0
Q ss_pred hhhccceeEE-eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE---
Q psy2306 32 RKLKQRFDIV-RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE--- 106 (335)
Q Consensus 32 ~~~~~~y~~~-~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~--- 106 (335)
-.+.++|++. +.||-|-.|.|-.+..+.+|+++|+|++..+ .+.++|+++.-.. .|+|||.++++|+
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3466677774 6789999999999999999999999997642 2567888877666 4999999999985
Q ss_pred -eCCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC---CCeEEeec
Q psy2306 107 -NREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN---GNAKIADF 180 (335)
Q Consensus 107 -~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~---~~~kL~df 180 (335)
....+.+|||.++||.|+..++.++ .+++.++.+|++||..|+.|||+.+|.||||||+|+|.+.+ ..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 3457889999999999999998765 49999999999999999999999999999999999999754 47999999
Q ss_pred cccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhcCCCC--
Q psy2306 181 GLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN----FKRLVKQISNGDYF-- 254 (335)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~----~~~~~~~~~~~~~~-- 254 (335)
|++............+.||.|.|||++...++ +...|+||+|+++|-|++|.+||.+.. ...+...|..+.+-
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 99998887777778889999999999988776 888999999999999999999997654 33456666666553
Q ss_pred CCCC---CCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 255 EPKN---QSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 255 ~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.+++ ++..+++|+.+|..+|.+|.|+.+++.|||+.+...+
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence 3333 5588999999999999999999999999999976544
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=290.02 Aligned_cols=244 Identities=29% Similarity=0.482 Sum_probs=204.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.++||+|++|.||+|.+..+ ..|++|.+..... ..+.+.+|+..++.++|+||+++++.+. .+..+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 46899999999999999999988765 4599999875332 2246788999999999999999999875 4567999
Q ss_pred EecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999999753 35789999999999999999999999999999999999999999999999998765433221
Q ss_pred --cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 193 --STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 193 --~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
....++..|+|||...+..+ +.++|+||||+++|+|++ |..||.+....+....+..... .....+..+.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 237 (262)
T ss_pred cccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 12345667999999887776 889999999999999999 8889988877776666655422 23446778999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q psy2306 268 EMLNINPSSRADISVICS 285 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~ 285 (335)
+||+.+|.+||++.++++
T Consensus 238 ~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 238 QCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.33 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=206.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCC----------------cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETG----------------QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~----------------~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 98 (335)
.++|++.+.||+|+||.||+|.+...+ ..|++|.+.... .....+.+.+|++.++.++|+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence 458999999999999999999876543 458999987532 23456778899999999999999
Q ss_pred cceeEEEEeCCeEEEEEecCCCCCHHHHHhhCC-----------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCE
Q psy2306 99 IHIYEVFENREKMVLVMEYAAGGELYDFLDQKK-----------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENI 167 (335)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ni 167 (335)
+++++++...+..++++|++++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997655 689999999999999999999999999999999999
Q ss_pred EEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCcHH
Q psy2306 168 LLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY--GAMPFDGSNFK 242 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t--g~~p~~~~~~~ 242 (335)
+++.++.++|+|||.+........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999876533221 123345678999999887665 899999999999999998 77888776666
Q ss_pred HHHHHHhcC---------CCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 243 RLVKQISNG---------DYFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 243 ~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+........ ...+...+.++.+++.+||+.||.+|||+.+|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 655554432 1112234568999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=295.10 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=209.3
Q ss_pred ceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
+|++.+.||.|+||.||+|.+.. ++..|++|.+.... .....+.+.+|..++..++||||+++++++.+.+..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 68888999999999999998754 35789999987532 334456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCe
Q psy2306 112 VLVMEYAAGGELYDFLDQK----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA 175 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~ 175 (335)
++++||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence 9999999999999998532 347888999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcC
Q psy2306 176 KIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNG 251 (335)
Q Consensus 176 kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~ 251 (335)
||+|||++........ .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+....+....+...
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999998876543222 123345678999999987776 889999999999999998 88999888888888877776
Q ss_pred CC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 252 DY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 252 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.. .+...+..+.+++.+||+.+|.+||++++|+..
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 243 QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 54 234567789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=304.73 Aligned_cols=258 Identities=30% Similarity=0.512 Sum_probs=210.8
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEe--C
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFEN--R 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~ 108 (335)
..+.++|++.+.||+|++|.||+|.+..+|..+++|.+.... ........+.+|+..++.+ +|+||+++++++.. .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 457789999999999999999999999889999999886432 2223345667899999999 99999999999864 3
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
...++++||++ ++|.+++..+ .+++...+.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 46899999996 5999988765 789999999999999999999999999999999999999999999999998876543
Q ss_pred Cc------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-----------
Q psy2306 189 SR------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG----------- 251 (335)
Q Consensus 189 ~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~----------- 251 (335)
.. ......++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 22 1223457888999998876555588999999999999999999999765543332221110
Q ss_pred ----------------C-----CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 252 ----------------D-----YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 252 ----------------~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
. ...+..+.++.++|.+||+.||.+|||+.+++.|||+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112346688999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.36 Aligned_cols=249 Identities=28% Similarity=0.450 Sum_probs=210.0
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCC-----CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKET-----GQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENR 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 108 (335)
.++|++.+.||+|++|.||++..... ...+++|.+.... .......+.+|+..++.+ +|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 35899999999999999999987643 3679999987532 334456788999999999 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhh----------------CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQ----------------KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN 172 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~----------------~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~ 172 (335)
+..+++|||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 999999999999999999964 2458899999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCccc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q psy2306 173 GNAKIADFGLSNVFTESRFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQI 248 (335)
Q Consensus 173 ~~~kL~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~ 248 (335)
+.++|+|||.+......... ....++..|+|||.+.+..+ +.++||||||+++|++++ |..||......+....+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 99999999998765433221 11223467999999877666 889999999999999997 99999988888777777
Q ss_pred hcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 249 SNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 249 ~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..... .+...+..+.+++.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66543 233456789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=318.25 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=197.2
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCC-CcEEEEE--------------EeecCCcCCHHHHHHHHHHHHHHHcCCC
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKET-GQEVAIK--------------TIKKCKIETEADLIRIRREIQIMSSVRH 95 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~-~~~valK--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~~ 95 (335)
+..+.++|++.+.||+|+||.||+|..+.. +...+.| .+.+...........+.+|+.+++.++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 455678999999999999999999876432 2222222 1111111223345678899999999999
Q ss_pred CcccceeEEEEeCCeEEEEEecCCCCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc
Q psy2306 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK-----KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD 170 (335)
Q Consensus 96 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~ 170 (335)
+||+++++++.+.+..|++++++. ++|.+++... .......+..++.|++.||.|||++||+|+||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999999999994 5777766432 2244667888999999999999999999999999999999
Q ss_pred cCCCeEEeeccccccccCCcc--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCC--cH-HHH
Q psy2306 171 ENGNAKIADFGLSNVFTESRF--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMP-FDGS--NF-KRL 244 (335)
Q Consensus 171 ~~~~~kL~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p-~~~~--~~-~~~ 244 (335)
.++.+||+|||++........ .....|+..|+|||++.+..+ +.++|||||||++|+|++|..+ +... .. .++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999976644322 234578999999999988776 8999999999999999998754 4322 11 222
Q ss_pred HHHHhcCC-----C---------------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 245 VKQISNGD-----Y---------------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 245 ~~~~~~~~-----~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+.+.... + .....+..+.++|.+||+.||.+|||+.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 22111100 0 001234467778999999999999999999999999875
Q ss_pred C
Q psy2306 293 H 293 (335)
Q Consensus 293 ~ 293 (335)
.
T Consensus 461 ~ 461 (501)
T PHA03210 461 E 461 (501)
T ss_pred C
Confidence 3
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.81 Aligned_cols=250 Identities=30% Similarity=0.491 Sum_probs=209.0
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+..++.++|++|+++++++.+.+..++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67789999999999999999989999999998764322 23456778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccccc
Q psy2306 118 AAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTF 195 (335)
Q Consensus 118 ~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~~ 195 (335)
+++ ++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 965 88877765 4579999999999999999999999999999999999999999999999999987665443 22334
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC-----------------------
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD----------------------- 252 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----------------------- 252 (335)
.++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+....+....
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 567889999998876445899999999999999999999998776544433322100
Q ss_pred --------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 --------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
...+..+.++.++|.+||+.||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0011245678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=302.98 Aligned_cols=249 Identities=25% Similarity=0.423 Sum_probs=201.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEe-
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFEN- 107 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~- 107 (335)
.++|++.+.||+|+||.||+|.+.. +++.|++|.+.... .......+..|+..+.++ +|+||+++++.+..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3589999999999999999997533 45789999987532 234456678899999999 79999999998864
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC---------------------------------------------------------
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQK--------------------------------------------------------- 130 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------- 130 (335)
...+++++||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45788999999999999988542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---ccccccCCccCC
Q psy2306 131 ----KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYAS 203 (335)
Q Consensus 131 ----~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~a 203 (335)
.++++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ .....++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578999999999999999999999999999999999999999999999999876532211 122344667999
Q ss_pred hhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH-HHHHHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCC
Q psy2306 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFK-RLVKQISNGDY--FEPKNQSTASPLIAEMLNINPSSRAD 279 (335)
Q Consensus 204 PE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps 279 (335)
||++.+..+ +.++|||||||++|+|++ |..||...... .....+..... .+...+.++.+++.+||+.+|++||+
T Consensus 244 PE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999988777 899999999999999997 99999765433 23333333222 23345668999999999999999999
Q ss_pred HHHHhcC
Q psy2306 280 ISVICSH 286 (335)
Q Consensus 280 ~~~ll~~ 286 (335)
+.++++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=290.90 Aligned_cols=247 Identities=23% Similarity=0.395 Sum_probs=204.3
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCc--EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe------CC
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQ--EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN------RE 109 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~--~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 109 (335)
|.+.+.||+|+||.||+|.+..++. .+++|.+.... ......+.+.+|+..++.++|+||+++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4577899999999999999877665 68999887532 244556778899999999999999999998743 23
Q ss_pred eEEEEEecCCCCCHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ------KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
..++++||+.+++|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 234889999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCC
Q psy2306 184 NVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPK 257 (335)
Q Consensus 184 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~ 257 (335)
........ .....+++.|++||...+..+ +.++||||||+++|+|++ |..||......+....+..+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 76543221 112234667999999988776 889999999999999998 8999988777777777766543 2344
Q ss_pred CCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 258 NQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+..+.+++.+||+.||.+|||+.+|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 56789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=330.48 Aligned_cols=261 Identities=30% Similarity=0.460 Sum_probs=228.4
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
.-.++|.|++.||+|+||.|.+++.+.+++.||+|++.+-.--.......|+.|-.++..-..+=|+.++..|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34569999999999999999999999999999999988633333344557888888888888999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+||||++||+|..++.+..++++..+..++..|+.||..||+.|+|||||||+|||++..|++||.|||.+-.+...+..
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999887755543
Q ss_pred --cccccCCccCChhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCC---CCCCCc
Q psy2306 193 --STFCGSPLYASPEIVK----GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--DYFE---PKNQST 261 (335)
Q Consensus 193 --~~~~~~~~~~aPE~~~----~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~---~~~~~~ 261 (335)
...+|||.|.+||+++ +...|+..+|+||+|+++|||+.|..||...+.-+.+..|.+. .+.+ ...+.+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 4578999999999984 2134589999999999999999999999998888888888776 2322 346779
Q ss_pred hHHHHHHhcccCCCCCCC---HHHHhcCCCcCCCCc
Q psy2306 262 ASPLIAEMLNINPSSRAD---ISVICSHWWIDKDHS 294 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 294 (335)
.++||.+++. +|..|.. ++++-.||||....|
T Consensus 312 akdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 312 AKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 9999999985 5888887 999999999998766
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=287.77 Aligned_cols=240 Identities=27% Similarity=0.434 Sum_probs=202.6
Q ss_pred eeeeccCCeEEEEEEECCCC---cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecC
Q psy2306 42 RKLGQGNYGKVQLGINKETG---QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYA 118 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 118 (335)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+.+|+..++.+.|+|++++++++. .+..++++||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876544 78999998764332 45567889999999999999999999876 45689999999
Q ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc----c
Q psy2306 119 AGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS----T 194 (335)
Q Consensus 119 ~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~----~ 194 (335)
++++|.+++.....+++..+..++.|++.||++||..|++|+||+|+||+++.++.++|+|||.+.......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999887889999999999999999999999999999999999999999999999999987654332211 1
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcc
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~ 271 (335)
..++..|+|||.+.+..+ +.++||||||+++|++++ |..||...+..+....+..... .+...+..+.+++.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 112357999999987776 889999999999999997 9999988888777777766543 233456789999999999
Q ss_pred cCCCCCCCHHHHhc
Q psy2306 272 INPSSRADISVICS 285 (335)
Q Consensus 272 ~dp~~Rps~~~ll~ 285 (335)
.+|.+||++.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999873
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.73 Aligned_cols=244 Identities=26% Similarity=0.468 Sum_probs=205.8
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|++|.||++.++ ++..+++|.+..... ....+.+|+..++.++|+||+++++++...+..++++|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 6899999999999999999876 466799999865322 22356789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc--
Q psy2306 117 YAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS-- 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~-- 193 (335)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 9999999999875 3468999999999999999999999999999999999999999999999999887654322111
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC--CCCCCCCCchHHHHHHhc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGD--YFEPKNQSTASPLIAEML 270 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l 270 (335)
...++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+....+.... ..+...+.++.+++.+||
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 238 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW 238 (256)
T ss_pred CCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence 1122347999999988776 889999999999999998 899998877777776666542 223446779999999999
Q ss_pred ccCCCCCCCHHHHhcC
Q psy2306 271 NINPSSRADISVICSH 286 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~ 286 (335)
+.+|++|||+.++++.
T Consensus 239 ~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 239 HEKPEDRPAFKKLLSQ 254 (256)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=290.88 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=206.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCc----EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQ----EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
.++|++.+.||.|+||+||+|.+..+|. .|++|.+... ........+.+|...++.++|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 4589999999999999999998776665 4899998653 234445678899999999999999999999875 45
Q ss_pred EEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.+++++++++++|.+++.. .+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 6789999999999999976 456899999999999999999999999999999999999999999999999998766432
Q ss_pred ccc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchH
Q psy2306 190 RFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTAS 263 (335)
Q Consensus 190 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 263 (335)
... ....++..|+|||...+..+ +.++||||||+++|||++ |..||...........+...... +...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 221 12234567999999987776 889999999999999998 99999887777666666554332 334567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy2306 264 PLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+++.+||+.||.+||++.+++.
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.94 Aligned_cols=250 Identities=31% Similarity=0.521 Sum_probs=209.2
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
|++.+.||+|++|.||+|.+..+++.+++|.+.... ......+.+..|+..++.++|++++++++++.+.+..++++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999998643 2233345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccccc
Q psy2306 118 AAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTF 195 (335)
Q Consensus 118 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~~ 195 (335)
++ ++|.+++.+. ..+++..+..++.+++.||++||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 97 5999999876 579999999999999999999999999999999999999999999999999887654432 22334
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--------------------C---
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--------------------D--- 252 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--------------------~--- 252 (335)
.++..|+|||.+.+....+.++|+||||++++++++|..||...+.......+... .
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 45678999999877644588999999999999999999999876654433322210 0
Q ss_pred -------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 253 -------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 253 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
...+..+..+.+++++||+.+|.+||++++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0111235679999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.13 Aligned_cols=246 Identities=28% Similarity=0.465 Sum_probs=210.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
..+|++.+.||.|++|.||+|.+.. +..+++|.+.... ......+..|+..++.++|+||+++++++.+.+..+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4579999999999999999999887 8899999987532 33355688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999999975 346899999999999999999999999999999999999999999999999998765433221
Q ss_pred -cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHH
Q psy2306 193 -STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAE 268 (335)
Q Consensus 193 -~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 268 (335)
....++..|++||.+.+..+ +.++|+||||+++|+|++ |..||...+..+....+..... .+...+..+.+++.+
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred ccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHH
Confidence 22334567999999987766 889999999999999998 8999988877777666665422 234567789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy2306 269 MLNINPSSRADISVICS 285 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~ 285 (335)
||+.||.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 240 CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HcCCCchhCcCHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.88 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=207.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
..+|...+.||+|+||.||++... .++..+++|.+... .......+.+|++.++.++|+||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 458899999999999999999743 34678899987642 3455668899999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC---------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK---------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
..++++||+++++|.+++.... .+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999997643 4789999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy2306 175 AKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISN 250 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~ 250 (335)
++|+|||.+........ .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999998865533221 112234578999999987776 899999999999999998 9999988777666666655
Q ss_pred CCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 251 GDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 251 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+.. .+...++.+.+++.+||+.||.+||++++|+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 432 23345778999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=296.40 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=208.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECC-------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKE-------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVF 105 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 105 (335)
..++|.+.+.||+|+||.||++.+.. +...+++|.+.... .......+.+|+..++.+ +|+||+++++++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34689999999999999999998643 23569999987532 334456788899999999 799999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE
Q psy2306 106 ENREKMVLVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL 169 (335)
Q Consensus 106 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili 169 (335)
...+..++++||+++++|.+++..+. .+++.++..++.|++.||+|||+.|++|+||+|+||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 99999999999999999999997542 47889999999999999999999999999999999999
Q ss_pred ccCCCeEEeeccccccccCCccc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q psy2306 170 DENGNAKIADFGLSNVFTESRFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLV 245 (335)
Q Consensus 170 ~~~~~~kL~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~ 245 (335)
+.++.++|+|||.+......... ....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.....++..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 99999999999998655432211 11223467999999987766 889999999999999998 89999888887777
Q ss_pred HHHhcCCCC--CCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 246 KQISNGDYF--EPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 246 ~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
..+...... +...+.++.+++.+||..+|.+||++.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 776665432 2345678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=314.58 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=210.9
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
-.||+|.||+||.|+|..+...+|+|.+... ......-+.+|+.+.++++|.|||+++|.+...+.+-+.||.++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 3699999999999999999999999998753 3455667889999999999999999999999999999999999999
Q ss_pred CHHHHHhh-CCCC--CHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEeeccccccccCCcc-ccccc
Q psy2306 122 ELYDFLDQ-KKVL--TEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADFGLSNVFTESRF-LSTFC 196 (335)
Q Consensus 122 ~L~~~l~~-~~~~--~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~df~~~~~~~~~~~-~~~~~ 196 (335)
+|.++++. -+|+ .+.++..+.+||++||.|||.+.|||||||-+||+|+. .|.+||+|||.+..+..-++ .....
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 99999975 5677 89999999999999999999999999999999999975 78999999999977755444 34678
Q ss_pred cCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHH-h--cCCCCCCCCCCchHHHHHHhcc
Q psy2306 197 GSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV-KQI-S--NGDYFEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 197 ~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~-~~~-~--~~~~~~~~~~~~l~~li~~~l~ 271 (335)
||..|||||++..++ -++.++|||||||++.||.||++||-.....+.. -++ . .....+...+.+.+.||.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 999999999997654 3588999999999999999999999654332221 111 1 1122333446688899999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCC
Q psy2306 272 INPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~ 292 (335)
+||..||+|.++|..||++..
T Consensus 818 pd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCcccCccHHHhccCcccccC
Confidence 999999999999999999966
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=316.91 Aligned_cols=244 Identities=36% Similarity=0.585 Sum_probs=205.8
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEE-E---e--
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVF-E---N-- 107 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~-~---~-- 107 (335)
..+++|.+.|.+|||+.||+|++...|..||+|++-. .++...+.+.+|+++++.|+ |+|||.+++.. . .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 4489999999999999999999998889999999875 36788899999999999997 99999999943 1 1
Q ss_pred -CCeEEEEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 108 -REKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 108 -~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~~~~~~kL~df~~ 182 (335)
.-.++|+||||.|+.|-++++. ...+++.++++|++++++|+++||... +||||||-+||||+.+|++||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 2357899999999999999985 345999999999999999999999887 99999999999999999999999998
Q ss_pred cccccCCc-ccc---------ccccCCccCChhhh---cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh
Q psy2306 183 SNVFTESR-FLS---------TFCGSPLYASPEIV---KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS 249 (335)
Q Consensus 183 ~~~~~~~~-~~~---------~~~~~~~~~aPE~~---~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~ 249 (335)
++...... ... ....|+.|++||.+ .+.++ +.|+|||+|||+||.|+....||+..... .|.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIl 267 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AIL 267 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEE
Confidence 86543222 111 12358899999976 46666 99999999999999999999999876432 344
Q ss_pred cCCCCC---CCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 250 NGDYFE---PKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 250 ~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+..+.. +.++..+.+||+.||+.||.+||++-|++.+
T Consensus 268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 454433 3556699999999999999999999999876
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=289.54 Aligned_cols=247 Identities=21% Similarity=0.352 Sum_probs=205.1
Q ss_pred eeEEeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe----
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK---- 110 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 110 (335)
|++.+.||+|+||.||.|.+..+ +..|++|.++... ........+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999987653 4789999987533 234456678899999999999999999998865443
Q ss_pred --EEEEEecCCCCCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 111 --MVLVMEYAAGGELYDFLDQK------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 111 --~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
.++++||+++++|..++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999888432 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCC
Q psy2306 183 SNVFTESRFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEP 256 (335)
Q Consensus 183 ~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~ 256 (335)
+......... .....+..|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+..+.. .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 8765433211 12234567999999877666 889999999999999998 9999988877777777665543 234
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..+..+.+++.+||+.||.+||++.+++.+
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 456799999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=287.24 Aligned_cols=245 Identities=29% Similarity=0.472 Sum_probs=208.5
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|++|.||+|.+. ++..+++|.+..... ....+.+|+..++.++|+|++++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 4569999999999999999999876 457799999875332 23467889999999999999999999999899999
Q ss_pred EEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 114 VMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
++||+++++|.+++... ..+++..+..++.+++.|+.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999999999764 3689999999999999999999999999999999999999999999999999876543211
Q ss_pred c--cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC--CCCCCCCCchHHHH
Q psy2306 192 L--STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGD--YFEPKNQSTASPLI 266 (335)
Q Consensus 192 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 266 (335)
. .....+..|+|||.+.+... +.++|+||||++++++++ |..||...+.......+.... ..+...+.++.+++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM 237 (261)
T ss_pred hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1 12223567999999987666 889999999999999998 999998888777777776542 22334577899999
Q ss_pred HHhcccCCCCCCCHHHHh
Q psy2306 267 AEMLNINPSSRADISVIC 284 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll 284 (335)
.+||+.+|.+||++++++
T Consensus 238 ~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 238 LQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred HHHcccCcccCCCHHHHH
Confidence 999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=300.63 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=227.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+.|+..+.||+||||.||-++.+.||+-||+|.+.+.............+|-.+|.+++.+.||.+-..|+..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 45899999999999999999999999999999998776555555566778899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+..|+||+|.-.|.+.+ .+++..+..++.+|+.||++||+.+||.||+||+|||+|+.|+++|+|+|+++........
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999999987776544 6999999999999999999999999999999999999999999999999999999988888
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcCC-CCCCCCCCchHHHHH
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS----NFKRLVKQISNGD-YFEPKNQSTASPLIA 267 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~----~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 267 (335)
....||.+|||||++.+..| +...|.|+|||++|+|+.|..||... ..+++-+.+.... ..+...+++++++.+
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~ 422 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCE 422 (591)
T ss_pred ccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHH
Confidence 88899999999999999886 99999999999999999999999653 2234444443332 244667889999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCCcCCCC
Q psy2306 268 EMLNINPSSRA-----DISVICSHWWIDKDH 293 (335)
Q Consensus 268 ~~l~~dp~~Rp-----s~~~ll~~~~~~~~~ 293 (335)
.+|.+||.+|. .+.++-+||||+...
T Consensus 423 ~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 423 GLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred HHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 99999999996 677999999999743
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=294.56 Aligned_cols=248 Identities=26% Similarity=0.447 Sum_probs=207.3
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-------CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-------ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE 106 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 106 (335)
.++|++.+.||+|++|.||+|.+. ..+..+++|.+... ........+..|+..++.+ +|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 458999999999999999999753 23457899987642 2344566788899999999 5999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQK----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD 170 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~ 170 (335)
+.+..++++||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 999999999999999999999653 3488899999999999999999999999999999999999
Q ss_pred cCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q psy2306 171 ENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVK 246 (335)
Q Consensus 171 ~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~ 246 (335)
.++.++|+|||.+........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||......+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999876543211 111223457999999987666 889999999999999998 899998888877777
Q ss_pred HHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 247 QISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 247 ~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+..... .+...+.++.+++.+||+.+|.+||++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7766543 23345668999999999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.17 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=200.2
Q ss_pred eeeecc--CCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCC
Q psy2306 42 RKLGQG--NYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 42 ~~ig~g--~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
..||+| +||+||++.+..+|+.|++|.+..... .....+.+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 999999999999999999999875432 33456788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc----c-
Q psy2306 120 GGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF----L- 192 (335)
Q Consensus 120 ~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~----~- 192 (335)
+++|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++||+.+........ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998864 3489999999999999999999999999999999999999999999999975433211100 0
Q ss_pred ---cccccCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC--------------
Q psy2306 193 ---STFCGSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-------------- 254 (335)
Q Consensus 193 ---~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------------- 254 (335)
....++..|++||++.+.. .++.++||||||+++|+|++|..||..................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0112345699999987642 2378999999999999999999999876544433222211100
Q ss_pred ----------------------------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 255 ----------------------------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 255 ----------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
....+..+.+++++||+.||.+|||+.++++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 01124468899999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=287.92 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=208.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCc---EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQ---EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
.+|++.+.||+|+||.||+|.++.+++ .|++|.+... ........+..|+..++.++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 468999999999999999999887665 5999998653 23455678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+++||+++++|.+++.. .+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999999875 45689999999999999999999999999999999999999999999999998866543221
Q ss_pred c---c-ccc--cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCch
Q psy2306 192 L---S-TFC--GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTA 262 (335)
Q Consensus 192 ~---~-~~~--~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l 262 (335)
. . ... .+..|+|||.+.+..+ +.++||||||+++||+++ |..||...+..+....+..... .+...+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 240 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL 240 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence 1 1 111 1346999999987776 889999999999999886 9999988877777776654422 233456689
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy2306 263 SPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+++.+||+.+|.+||++++++.
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 241 HQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=293.17 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=206.8
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEE-----CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGIN-----KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEV 104 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 104 (335)
.....++|.+.+.||+|+||.||++.+ ..++..+++|.+.... .....+.+.+|+..++++ +|+||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 344556999999999999999999975 3346689999887532 334456788999999999 79999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 105 FENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 105 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
+...+..++++||+++++|.+++.... .+++.++..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997543 389999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHH-HHHhcCCC--CC
Q psy2306 183 SNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLV-KQISNGDY--FE 255 (335)
Q Consensus 183 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~-~~~~~~~~--~~ 255 (335)
+........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||......... ..+..... .+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence 875543221 112334677999999988776 889999999999999998 99999776654433 33332211 22
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
...+.++.+++.+||+.+|++||++.++++
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 335678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=285.74 Aligned_cols=242 Identities=24% Similarity=0.460 Sum_probs=208.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||.|++|.||+|... |+.+++|.+..... ..+.+.+|+..++.++|+|++++++++.+.+..+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 348899999999999999999765 78999999875321 456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999999998655 699999999999999999999999999999999999999999999999999876633221
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
....+..|+|||.+....+ +.++|+||||++++++++ |..||......+....+..... .+...++.+.+++.+|
T Consensus 158 -~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred -cCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 2334567999999987766 889999999999999997 9999988888777766655422 2334567899999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy2306 270 LNINPSSRADISVICS 285 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~ 285 (335)
|+.+|++||++.+++.
T Consensus 236 l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 236 WELDPAKRPTFKQLRE 251 (256)
T ss_pred hccChhhCcCHHHHHH
Confidence 9999999999999984
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=291.85 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=208.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.++|++.+.||+|+||.||+|.+. .++..+++|.+.... .......+.+|+..++.++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 458999999999999999999874 357889999987532 3344567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC----------------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCE
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK----------------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENI 167 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ni 167 (335)
..++++||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999996432 378888999999999999999999999999999999
Q ss_pred EEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH
Q psy2306 168 LLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKR 243 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~ 243 (335)
+++.++.++|+|||.+........ ......+..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999998865432211 112233567999999887776 889999999999999997 888998888888
Q ss_pred HHHHHhcCCCC--CCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 244 LVKQISNGDYF--EPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 244 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
....+...... +...+.++.+++.+||+.||.+|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77777665543 3345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=296.33 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=209.9
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-CCeE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN-REKM 111 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 111 (335)
.+.++|++.+.||.|+||.||+|.+..+++.|++|.+..... .....+.+.+|+..++.++|||++++.+++.. .+..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 367899999999999999999999999999999998764321 22334567789999999999999999999865 5678
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
++++||+ +++|.++++. .++++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 9999999 5689888864 45889999999999999999999999999999999999999999999999988754332
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh----------------------
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS---------------------- 249 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~---------------------- 249 (335)
.....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 2234567889999998764445899999999999999999999997655422111100
Q ss_pred -----cCCC-----CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 250 -----NGDY-----FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 250 -----~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.... ..+..+..+.++|++||+.+|++||++++++.||||.....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 0000 012346789999999999999999999999999999866554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=285.58 Aligned_cols=245 Identities=29% Similarity=0.482 Sum_probs=210.0
Q ss_pred eeEEeeeeccCCeEEEEEEECCCC----cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETG----QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
+++.+.||.|+||.||++.+..++ ..+++|.+.... .......+..|+..++.++|+||+++++.+.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467899999999999999988766 889999986532 22256688899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 114 VMEYAAGGELYDFLDQKKV--LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+||++++++|.+++..... +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999986554 89999999999999999999999999999999999999999999999999876654322
Q ss_pred cc--ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHH
Q psy2306 192 LS--TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLI 266 (335)
Q Consensus 192 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 266 (335)
.. ...+++.|++||...+..+ +.++|+||||+++++|++ |..||...+.....+.+..... .....+.++.+++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 22 1235678999999966555 899999999999999998 8899988887777777766543 2333567899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy2306 267 AEMLNINPSSRADISVICS 285 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~ 285 (335)
.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHCcCChhhCcCHHHHHh
Confidence 9999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=291.59 Aligned_cols=246 Identities=27% Similarity=0.420 Sum_probs=205.1
Q ss_pred ceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+..++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 23568888876422 334456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhC------------------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCE
Q psy2306 112 VLVMEYAAGGELYDFLDQK------------------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENI 167 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ni 167 (335)
++++||+.+++|.+++... .++++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988642 2478899999999999999999999999999999999
Q ss_pred EEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH
Q psy2306 168 LLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKR 243 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~ 243 (335)
+++.++.++|+|||++........ .....++..|+|||...+..+ +.++||||||+++++|++ |..||.+....+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999876533221 122334568999999877665 899999999999999998 999999888877
Q ss_pred HHHHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 244 LVKQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 244 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+...+..... .+...+.++.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7766655422 23345678999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=287.25 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=207.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCC---cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETG---QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
++|++.+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+.+|+..++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 48999999999999999999886544 368999886532 3345667889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
++|||+++++|.+++... ..++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999999764 4689999999999999999999999999999999999999999999999999876543321
Q ss_pred c----cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHH
Q psy2306 192 L----STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASP 264 (335)
Q Consensus 192 ~----~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 264 (335)
. ....++..|++||.+.+..+ +.++|+||||+++|++++ |..||......+....+..... .....+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ 240 (267)
T ss_pred eeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence 1 11122457999999987666 889999999999999886 9999988777766666665432 22335678999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy2306 265 LIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~ 285 (335)
++.+||+.+|.+||++.++++
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHcccCchhCCCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=289.00 Aligned_cols=251 Identities=32% Similarity=0.563 Sum_probs=209.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC--CHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE--TEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
+|.+.+.||+|++|.||++.+..++..+++|.++..... .......+..|+..++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999998877777777776542211 122334566788999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 115 MEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 456999999999999999999999999999999999999964 679999999887654332
Q ss_pred -cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 191 -FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 191 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. .+...+.++.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 2234457788999999877665 7899999999999999999999987777666666554432 23345678999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCc
Q psy2306 268 EMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
+||+.+|.+||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=291.90 Aligned_cols=258 Identities=23% Similarity=0.387 Sum_probs=207.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 113 (335)
.+.|++.+.||+|++|.||+|.+..++..|++|.+.... .......+..|...+... .|+||+++++++.+....++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 358999999999999999999999889999999987533 222344555666666666 49999999999999999999
Q ss_pred EEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 114 VMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+|||+. +++.+++.. ..++++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 999995 477777765 4578999999999999999999997 6999999999999999999999999999876654433
Q ss_pred ccccccCCccCChhhhcCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhcCCC--CC--CCCCCchH
Q psy2306 192 LSTFCGSPLYASPEIVKGIP---YHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-KRLVKQISNGDY--FE--PKNQSTAS 263 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~~--~~--~~~~~~l~ 263 (335)
.....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||..... .+....+..... .. ...+.++.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence 34445678899999987543 237899999999999999999999976332 233333333221 11 12466899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
+++.+||+.||.+||++++++.||||......
T Consensus 251 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 282 (296)
T cd06618 251 SFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282 (296)
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence 99999999999999999999999999865444
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=297.52 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=206.1
Q ss_pred ceeEEeeeeccCCeEEEEEEECCC--CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEe----CC
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKET--GQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFEN----RE 109 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~ 109 (335)
+|++.+.||+|+||.||++.+..+ +..|++|.+.... ........+.+|+..++.+ .|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999887 8999999986422 2223345677899999999 49999999987532 24
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
..+++++++. ++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6789999985 699999988888999999999999999999999999999999999999999999999999998755322
Q ss_pred c-----cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc--------------
Q psy2306 190 R-----FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN-------------- 250 (335)
Q Consensus 190 ~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-------------- 250 (335)
. ......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+..
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 1 122346788999999987654448899999999999999999999987654332221111
Q ss_pred -C------------C-----CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 251 -G------------D-----YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 251 -~------------~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
. . ...+..+..+.+++.+||+.||.+|||+.+++.|||+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0 0 01123456899999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=292.69 Aligned_cols=250 Identities=25% Similarity=0.438 Sum_probs=209.5
Q ss_pred hccceeEEeeeeccCCeEEEEEEEC-------CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINK-------ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVF 105 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 105 (335)
-.++|++.+.||+|+||.||+|.+. .++..+++|.+... ........+.+|+..++.+ +|+||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 4569999999999999999999742 23457999988642 2344556788999999999 799999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE
Q psy2306 106 ENREKMVLVMEYAAGGELYDFLDQK----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL 169 (335)
Q Consensus 106 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili 169 (335)
......+++|||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 9999999999999999999999753 247788899999999999999999999999999999999
Q ss_pred ccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q psy2306 170 DENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLV 245 (335)
Q Consensus 170 ~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~ 245 (335)
+.++.++|+|||.+........ .....++..|+|||++.+..+ +.++||||||+++|+|++ |..||......+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999999999876643221 122234567999999987666 889999999999999998 88999888888888
Q ss_pred HHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 246 KQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 246 ~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..+..... .+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 77766543 233456789999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=288.72 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=202.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCc----EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQ----EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
++|++.+.||+|+||+||+|.+..++. .+++|.+.. .........+..|+..+..+.||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc--ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 489999999999999999999877666 467777643 2223344567788888999999999999998754 557
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 789999999999999975 4568999999999999999999999999999999999999999999999999987653322
Q ss_pred c---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCC--CCCCCchHH
Q psy2306 191 F---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYFE--PKNQSTASP 264 (335)
Q Consensus 191 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ 264 (335)
. .....++..|++||.+.+..+ +.++||||||+++||+++ |..||.+.........+..+.... ...+..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM 242 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence 1 123345668999999987776 899999999999999998 999998887777666665544322 224557889
Q ss_pred HHHHhcccCCCCCCCHHHHh
Q psy2306 265 LIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll 284 (335)
++.+||..||.+|||+.+++
T Consensus 243 li~~c~~~~p~~Rps~~el~ 262 (279)
T cd05111 243 VMVKCWMIDENVRPTFKELA 262 (279)
T ss_pred HHHHHcCCCcccCcCHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=285.26 Aligned_cols=261 Identities=33% Similarity=0.544 Sum_probs=220.7
Q ss_pred hhhhhccceeEE-eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEe
Q psy2306 30 HRRKLKQRFDIV-RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFEN 107 (335)
Q Consensus 30 ~~~~~~~~y~~~-~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 107 (335)
...++.+-|++. +.||.|+++.|..++...+|..||+|++.+. ..-...++.+|++.+.+.+ |+||+.++++|++
T Consensus 71 ~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 71 LSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred ccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 445566667664 6789999999999999999999999999874 3345668889999999996 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC---CeEEeeccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG---NAKIADFGLSN 184 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~---~~kL~df~~~~ 184 (335)
+..+|+|||.+.||+|...|.++..+++.++.+++.+|+.||.|||.+||.|||+||+|||-.... -+|||||.+..
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 999999999999999999999999999999999999999999999999999999999999986544 58999999875
Q ss_pred cccCC--------ccccccccCCccCChhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-------------
Q psy2306 185 VFTES--------RFLSTFCGSPLYASPEIVK----GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS------------- 239 (335)
Q Consensus 185 ~~~~~--------~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~------------- 239 (335)
..... ......+|+..|||||+.. ...+|+.+.|.||||+++|-|++|++||.+.
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 54221 1223456788899999863 3345688999999999999999999999653
Q ss_pred --cHHHHHHHHhcCCCCCCCC-----CCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 240 --NFKRLVKQISNGDYFEPKN-----QSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 240 --~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
....+...|..+.+-.|+. +.+.++++..+|..|+.+|.++.+++.|||++...
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 2456677777777654432 66889999999999999999999999999998653
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=286.87 Aligned_cols=244 Identities=27% Similarity=0.477 Sum_probs=204.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|++|.||+|.+. ++..+++|.+...... .+.+.+|+..++.++|++++++++++. .+..++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 4568999999999999999999876 4667999998753321 246788999999999999999999875 456889
Q ss_pred EEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 114 VMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+|||+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999999753 3589999999999999999999999999999999999999999999999999876543221
Q ss_pred c--cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHH
Q psy2306 192 L--STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLI 266 (335)
Q Consensus 192 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 266 (335)
. ....++..|+|||...+..+ +.++|+||||+++|+|++ |..||.+.+..+....+..... .+...+..+.+++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1 12234567999999877666 889999999999999999 8999988887777777765422 2334566899999
Q ss_pred HHhcccCCCCCCCHHHHh
Q psy2306 267 AEMLNINPSSRADISVIC 284 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll 284 (335)
.+||..+|.+|||+++++
T Consensus 237 ~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred HHHcccCcccCcCHHHHH
Confidence 999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=290.68 Aligned_cols=257 Identities=34% Similarity=0.577 Sum_probs=212.6
Q ss_pred ceeEEeeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCc-CCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKI-ETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 111 (335)
.|++.+.||.|+||.||.|.+. .+|..|++|.+..... ......+.+.+|+.+++.+ +|++|+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 4789999999875322 1223345677899999999 589999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR- 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~- 190 (335)
++++||+++++|.+++....++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999887654322
Q ss_pred -cccccccCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcCC-CCCCCCCCchH
Q psy2306 191 -FLSTFCGSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGS----NFKRLVKQISNGD-YFEPKNQSTAS 263 (335)
Q Consensus 191 -~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~----~~~~~~~~~~~~~-~~~~~~~~~l~ 263 (335)
......++..|++||.+.+.. ..+.++||||||+++|+|++|..||... ...+....+.... ..+...+..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 122345788999999986532 3478899999999999999999999643 2334444443332 23344567889
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCCCcCCCC
Q psy2306 264 PLIAEMLNINPSSRA-----DISVICSHWWIDKDH 293 (335)
Q Consensus 264 ~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~ 293 (335)
+++++||+.||.+|| ++.+++.||||....
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999999999997 899999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=298.18 Aligned_cols=249 Identities=30% Similarity=0.430 Sum_probs=202.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE- 109 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 109 (335)
-....+.|.-...||+|+||+||+|...+ |..||+|.+....... ..++.+|+.++.+++|+|+++++|+|.+.+
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 44555799999999999999999998775 4899999877643321 335999999999999999999999999888
Q ss_pred eEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCC---cEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHK---ICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~g---ivH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
..++||||++.|+|.+.+.... +++|.++.+|+.+++.||+|||... |+||||||+|||+|.+...||+|||++.
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 5999999999999999998654 8999999999999999999999753 9999999999999999999999999996
Q ss_pred cccC-Ccccccc-ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc------HHHH-HHHHhcCC---
Q psy2306 185 VFTE-SRFLSTF-CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN------FKRL-VKQISNGD--- 252 (335)
Q Consensus 185 ~~~~-~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~------~~~~-~~~~~~~~--- 252 (335)
.... ....... .|+.+|++||....+.. +.++||||||+++.|++||+.+.+... .-++ ...+..+.
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~e 304 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLRE 304 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhh
Confidence 6554 3333333 78999999999988666 999999999999999999998876432 1121 11222211
Q ss_pred CCC-----CCCC--C---chHHHHHHhcccCCCCCCCHHHHh
Q psy2306 253 YFE-----PKNQ--S---TASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 253 ~~~-----~~~~--~---~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
... ...+ . .+..+..+|++.+|.+||++.|++
T Consensus 305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 111 1222 1 355688999999999999999975
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=286.36 Aligned_cols=246 Identities=26% Similarity=0.458 Sum_probs=206.2
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.++||+|+||.||+|.++ +++.|++|.+..... ..+.+.+|+.+++.++|+|++++++++. .+..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45679999999999999999999865 467899999875332 2346788999999999999999999874 45789
Q ss_pred EEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 113 LVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+++||+.+++|.+++.. ...+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999865 3468999999999999999999999999999999999999999999999999986654222
Q ss_pred c--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 F--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
. .....++..|+|||.+....+ +.++|+||||+++|++++ |..||.+.+..+....+..... .....+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 122334567999999987776 889999999999999998 9999988887777776655432 223346689999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+||+.+|++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=287.42 Aligned_cols=241 Identities=29% Similarity=0.435 Sum_probs=198.9
Q ss_pred eeeeccCCeEEEEEEECCCCc--EEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEEecC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQ--EVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYA 118 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~--~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~ 118 (335)
+.||+|+||.||+|.+..++. .+++|.+... ......+.+.+|+..+.++ +||||+++++++...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988775 4678877642 2334456788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 119 AGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 119 ~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
++++|.+++..+. .+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997532 478999999999999999999999999999999999999999999999998
Q ss_pred cccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCC
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQ 259 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 259 (335)
+..............+..|+|||++....+ +.++|+||||+++|+|++ |..||...+.......+..... .+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence 753322111111223557999999877665 889999999999999996 9999988887777766655432 223346
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 260 STASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.++.+++.+||+.+|.+|||+.+++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 238 DEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHH
Confidence 68999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=285.43 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=208.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCc---EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQ---EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
++|+..+.||+|++|.||+|.++.++. .+++|.+.... .....+.+..|+..++.++|+|++++.+++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 488999999999999999999876654 68999876532 3344567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
++|||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 99999999999999975 45789999999999999999999999999999999999999999999999999876543221
Q ss_pred cc----ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHH
Q psy2306 192 LS----TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASP 264 (335)
Q Consensus 192 ~~----~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ 264 (335)
.. ....+..|+|||.+....+ +.++||||||+++|+|++ |..||...+..+....+...... ....+.++.+
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 11 1122346999999987666 889999999999999997 99999888777777777654332 2235678999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy2306 265 LIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~ 285 (335)
++.+||+.+|.+||++.++++
T Consensus 242 li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 242 LMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=303.46 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=202.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENR 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 108 (335)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+... ......+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 4589999999999999999998643 2357999998753 23444567889999999996 99999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhC----------------------------------------------------------
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQK---------------------------------------------------------- 130 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------- 130 (335)
+..+++|||+++++|.+++..+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999888542
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC
Q psy2306 131 --------------------------------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN 172 (335)
Q Consensus 131 --------------------------------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~ 172 (335)
..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 237788889999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH-HHHH
Q psy2306 173 GNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKR-LVKQ 247 (335)
Q Consensus 173 ~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~-~~~~ 247 (335)
+.++|+|||++........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||....... ....
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999876533221 122345678999999987776 899999999999999997 999997754433 3333
Q ss_pred HhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 248 ISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 248 ~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+..... .+...+.++.+++.+||+.||++||++.+|.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333221 23345678999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.59 Aligned_cols=240 Identities=25% Similarity=0.482 Sum_probs=203.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEE-EeCCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVF-ENREKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv 114 (335)
++|++.+.||+|++|.||++... |..+++|.+... ...+.+.+|+..++.++|++++++++++ ...+..+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 48999999999999999999665 778999997642 2244678899999999999999999976 455678999
Q ss_pred EecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+||+++++|.+++..+. .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999999997643 48899999999999999999999999999999999999999999999999886543322
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
.....+..|+|||...+..+ +.++||||||+++|+|++ |..||...+..+....+..+.. .....++.+.+++.+|
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred CCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 22234567999999987766 889999999999999997 9999998888777777665432 2334577899999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy2306 270 LNINPSSRADISVICS 285 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~ 285 (335)
|+.+|.+|||+.++++
T Consensus 236 l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 236 WHLDAATRPSFLQLRE 251 (256)
T ss_pred hcCChhhCcCHHHHHH
Confidence 9999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=291.64 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=203.0
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCC--------------CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccc
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKET--------------GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~--------------~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 100 (335)
.++|++.+.||+|+||.||+|.+..+ ...|++|.+.... .......+.+|++.++.++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 45899999999999999999987543 2358999987532 3445567889999999999999999
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhhCC------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEE
Q psy2306 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKK------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENIL 168 (335)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nil 168 (335)
+++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986432 3688899999999999999999999999999999999
Q ss_pred EccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCcHHH
Q psy2306 169 LDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY--GAMPFDGSNFKR 243 (335)
Q Consensus 169 i~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t--g~~p~~~~~~~~ 243 (335)
++.++.++|+|||++........ .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999876533221 122334668999999987776 899999999999999998 678888766665
Q ss_pred HHHHHhc-----CC----CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 244 LVKQISN-----GD----YFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 244 ~~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
....+.. .. ...+..+..+.+++.+||+.||.+||++++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5444321 11 112335678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.94 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=197.6
Q ss_pred ccce-eEEeeeeccCCeEEEEEE----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--
Q psy2306 35 KQRF-DIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN-- 107 (335)
Q Consensus 35 ~~~y-~~~~~ig~g~~g~Vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 107 (335)
.+|| ++.+.||+|+||+||++. ...++..|++|.+.... .......+.+|+..++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4566 999999999999998864 33568899999987532 23345677889999999999999999998765
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
....+++|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 34689999999999999999764 49999999999999999999999999999999999999999999999999987654
Q ss_pred CCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH--H-------------HHHHH
Q psy2306 188 ESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK--R-------------LVKQI 248 (335)
Q Consensus 188 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~--~-------------~~~~~ 248 (335)
.... .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... + ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 3221 112234556999999987766 88999999999999999999998543211 1 11111
Q ss_pred hcCC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 249 SNGD--YFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 249 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.... ..+...+.++.+++.+||+.+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111 112345678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=284.79 Aligned_cols=244 Identities=30% Similarity=0.456 Sum_probs=203.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|++|.||+|.+..+ ..+++|.+..... ..+.+.+|+.+++.++|++++++++++. .+..+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46899999999999999999987754 4699998765322 2346778999999999999999999875 4568899
Q ss_pred EecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-
Q psy2306 115 MEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~- 191 (335)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999999999753 3478999999999999999999999999999999999999999999999999876543221
Q ss_pred -ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 192 -LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 192 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
.....++..|+|||...+... +.++|+||||+++|+|++ |..||.+....+....+..... .+...+..+.++++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred ccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 122334567999999887766 889999999999999999 9999988877777666655422 22345678999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q psy2306 268 EMLNINPSSRADISVICS 285 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~ 285 (335)
+||+.||.+||+++++++
T Consensus 238 ~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 238 LCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=288.93 Aligned_cols=239 Identities=21% Similarity=0.354 Sum_probs=196.9
Q ss_pred eeeeccCCeEEEEEEECCCCc-------EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 42 RKLGQGNYGKVQLGINKETGQ-------EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~-------~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
+.||+|+||.||+|.+..++. .+++|.+... .....+.+.+|...++.++|||++++++++...+..+++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 468999999999998865443 4888887542 234455778899999999999999999999998999999
Q ss_pred EecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC--------eEEeecccccc
Q psy2306 115 MEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN--------AKIADFGLSNV 185 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~--------~kL~df~~~~~ 185 (335)
|||+++++|.+++..++ .+++..+..++.|++.||+|||++|++|+||+|+||+++.++. ++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 5899999999999999999999999999999999999987764 69999998865
Q ss_pred ccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcCCCCCCCCCCchHH
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 264 (335)
.... ....++..|+|||++.+...++.++||||||+++|+|++| ..||...+..............+.....++.+
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELAN 234 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHH
Confidence 5432 2345677899999998755458899999999999999998 57776666655544444443444455678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q psy2306 265 LIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~ 286 (335)
++.+||+.||++|||+++|++.
T Consensus 235 li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 235 LINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHhccChhhCCCHHHHHHh
Confidence 9999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.14 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=208.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCC-------CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKET-------GQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE 106 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 106 (335)
..+|++.+.||+|+||.||+|.+... +..+++|.+... ........+.+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34899999999999999999976432 236899987642 2344566788999999999 7999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD 170 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~ 170 (335)
+.+..++++||+++++|.+++.+.. .++...+..++.|++.||.|||++|++|+||+|+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 9999999999999999999997532 377888999999999999999999999999999999999
Q ss_pred cCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q psy2306 171 ENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVK 246 (335)
Q Consensus 171 ~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~ 246 (335)
.++.++|+|||.+........ .....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+.++...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999876543221 112223457999999988776 889999999999999998 899999888888877
Q ss_pred HHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 247 QISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 247 ~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+..... .+...+.++.+++.+||+.+|.+||++.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7766543 223446689999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=316.94 Aligned_cols=149 Identities=34% Similarity=0.600 Sum_probs=139.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+..|+..+..++|+||+++++.+...+.+|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999998755555666678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
||+.+++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999887889999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=289.61 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=201.8
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC----------------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE----------------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 98 (335)
.++|++.+.||+|+||.||++.+.. ++..+++|.+.... .......+.+|+..++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999985432 34568999987532 34445678899999999999999
Q ss_pred cceeEEEEeCCeEEEEEecCCCCCHHHHHhhCC-----------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCE
Q psy2306 99 IHIYEVFENREKMVLVMEYAAGGELYDFLDQKK-----------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENI 167 (335)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ni 167 (335)
+++++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987532 366778999999999999999999999999999999
Q ss_pred EEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCcHH
Q psy2306 168 LLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY--GAMPFDGSNFK 242 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t--g~~p~~~~~~~ 242 (335)
+++.++.++|+|||.+........ ......+..|++||...+..+ +.++|+||||+++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999876533221 112233567999998877776 889999999999999998 78899776665
Q ss_pred HHHHHHhc-------CC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 243 RLVKQISN-------GD--YFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 243 ~~~~~~~~-------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+....... .. ..+...+..+.+++.+||+.||.+||++.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54433211 11 122345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=286.23 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=208.0
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-CC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN-RE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 109 (335)
.++|++.+.||+|+||.||.|.+.. ++..|++|.+.. .........+.+|+..++.++|+|++++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD--HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC--CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4589999999999999999999876 357899998764 2345556778899999999999999999998765 57
Q ss_pred eEEEEEecCCCCCHHHHHhhC--------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQK--------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFG 181 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~ 181 (335)
..+++++|+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999999999998653 458999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CC
Q psy2306 182 LSNVFTESRFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FE 255 (335)
Q Consensus 182 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~ 255 (335)
++......... ....++..|+|||.+.+..+ +.++||||||+++|++++ |..||...+..++...+..... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 98765332211 12334567999999987766 899999999999999998 9999988887777666665432 22
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
...++++.+++.+||+.||++|||+.+++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 270 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLV 270 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 33467899999999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=288.17 Aligned_cols=238 Identities=21% Similarity=0.272 Sum_probs=193.4
Q ss_pred eeeccCCeEEEEEEECC------------------------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc
Q psy2306 43 KLGQGNYGKVQLGINKE------------------------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98 (335)
Q Consensus 43 ~ig~g~~g~Vy~~~~~~------------------------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 98 (335)
+||+|+||.||+|.... ....|++|.+... .......+.+|+.+++.++|+||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999987432 1245888887642 23344567888999999999999
Q ss_pred cceeEEEEeCCeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC----
Q psy2306 99 IHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG---- 173 (335)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~---- 173 (335)
+++++++.+....++||||+++++|..++.. .+.+++..+..++.|++.||+|||+.|++|+||+|+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 56789999999999999999999999999999999999997643
Q ss_pred ---CeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHh
Q psy2306 174 ---NAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQIS 249 (335)
Q Consensus 174 ---~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-tg~~p~~~~~~~~~~~~~~ 249 (335)
.++++|||.+...... ....++..|+|||.+.+....+.++||||||+++|+++ +|..||......+......
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 235 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence 3799999987543222 22346778999999876554589999999999999985 7999998776655544444
Q ss_pred cCCCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 250 NGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.....+......+.+++.+||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 236 KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 3333344455689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=284.44 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=205.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.++|++.+.||+|++|.||+|.+... ...+++|...... .....+.+.+|+..++.++|+||+++++++.+ +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 34799999999999999999987543 3568999876532 24456678899999999999999999999875 457
Q ss_pred EEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
++++||+++++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999997643 58999999999999999999999999999999999999999999999999987654432
Q ss_pred ccc--ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 FLS--TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 ~~~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
... ...++..|+|||.+....+ +.++||||||+++|++++ |..||...+..+....+..... .+...+..+.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240 (270)
T ss_pred ceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 211 2223457999999877665 889999999999999986 9999988877766666665432 334567799999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+||..+|.+|||+.+++.
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=285.26 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=208.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCc----EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQ----EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
.++|++.+.||+|+||.||+|.+..+|. .+++|.+.... .......+.+|+..++.++|+|++++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 3589999999999999999999876654 58999876532 34456678899999999999999999999987 78
Q ss_pred EEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 8999999999999999876 346899999999999999999999999999999999999999999999999998765433
Q ss_pred cccc---ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchH
Q psy2306 190 RFLS---TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTAS 263 (335)
Q Consensus 190 ~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 263 (335)
.... ...++..|++||.+....+ +.++|+||||+++|++++ |..||......+....+...... +...+..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 2211 1223457999999877666 889999999999999998 99999998888877777765432 233456889
Q ss_pred HHHHHhcccCCCCCCCHHHHh
Q psy2306 264 PLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll 284 (335)
+++.+||..+|.+||++.+++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHH
Confidence 999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.30 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=193.6
Q ss_pred eeeeccCCeEEEEEEECC------------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 42 RKLGQGNYGKVQLGINKE------------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~------------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
+.||+|++|.||+|.... ....+++|.+... .......+.+|+..++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999997532 2335888887652 2334556788899999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC-------eEEeecc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN-------AKIADFG 181 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~-------~kL~df~ 181 (335)
..++++||+++++|..++.. ..++++..+..++.|+++||+|||+.|++|+||+|+||+++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999988875 456899999999999999999999999999999999999986654 8999999
Q ss_pred ccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcCCCCCCCCCC
Q psy2306 182 LSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQS 260 (335)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (335)
.+...... ....++..|+|||.+.....++.++||||||+++|+|+ +|..||......+...............+.
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCK 234 (262)
T ss_pred CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChH
Confidence 88654322 23346778999999875454588999999999999998 588888776655544433333223333456
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
++.+++.+||+.||.+||++.+|+.+
T Consensus 235 ~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 235 ELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 88999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=282.58 Aligned_cols=239 Identities=27% Similarity=0.420 Sum_probs=199.2
Q ss_pred eeeccCCeEEEEEEEC--CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 43 KLGQGNYGKVQLGINK--ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 43 ~ig~g~~g~Vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
.||+|+||.||+|.+. .++..|++|.+... ......+.+.+|+..+++++|+||+++++++. ....++++||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999765 34567999998653 23445567889999999999999999999885 4578999999999
Q ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc----ccc
Q psy2306 121 GELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL----STF 195 (335)
Q Consensus 121 ~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~----~~~ 195 (335)
++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999875 457899999999999999999999999999999999999999999999999998755332211 112
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhccc
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLNI 272 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~ 272 (335)
.++..|+|||.+....+ +.++||||||+++|++++ |..||......+....+..+.. .+...+.++.+++.+||+.
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 22467999999887666 889999999999999996 9999998887777766665432 3344577999999999999
Q ss_pred CCCCCCCHHHHhc
Q psy2306 273 NPSSRADISVICS 285 (335)
Q Consensus 273 dp~~Rps~~~ll~ 285 (335)
+|++||++.+|.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=283.04 Aligned_cols=240 Identities=26% Similarity=0.402 Sum_probs=202.3
Q ss_pred eeeeccCCeEEEEEEECC-CC--cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecC
Q psy2306 42 RKLGQGNYGKVQLGINKE-TG--QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYA 118 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~-~~--~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 118 (335)
+.||+|++|.||+|.+.. ++ ..+++|.+...... ...+.+.+|+..+++++|+||+++++.+.+ ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999998765 33 36899998764432 566788899999999999999999999988 8999999999
Q ss_pred CCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc----c
Q psy2306 119 AGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF----L 192 (335)
Q Consensus 119 ~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~----~ 192 (335)
++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999997654 689999999999999999999999999999999999999999999999999876643211 1
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHHHHH
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPLIAE 268 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~ 268 (335)
....++..|+|||.+....+ +.++||||||+++|+|++ |..||...+..+....+..... .+...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 12345678999999887766 889999999999999998 9999988777776666554222 223346789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy2306 269 MLNINPSSRADISVICS 285 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~ 285 (335)
||+.+|++||++.+++.
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999984
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=279.95 Aligned_cols=240 Identities=28% Similarity=0.434 Sum_probs=201.8
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
+.||+|++|.||+|... ++..+++|.+.... .......+.+|+..++.++|+||+++++++...+..+++|||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 57889999986532 3344556889999999999999999999999999999999999999
Q ss_pred CHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc--cccccC
Q psy2306 122 ELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL--STFCGS 198 (335)
Q Consensus 122 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~--~~~~~~ 198 (335)
+|.+++.. ...+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......... ....++
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 99999875 345899999999999999999999999999999999999999999999999988654332211 112335
Q ss_pred CccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcccCCC
Q psy2306 199 PLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLNINPS 275 (335)
Q Consensus 199 ~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~ 275 (335)
..|+|||++....+ +.++|+||||+++|++++ |..||...........+..... .+...+..+.+++.+||+.+|+
T Consensus 158 ~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 67999999987766 889999999999999998 9999988877776666655432 2344577999999999999999
Q ss_pred CCCCHHHHhc
Q psy2306 276 SRADISVICS 285 (335)
Q Consensus 276 ~Rps~~~ll~ 285 (335)
+||++.++++
T Consensus 237 ~Rp~~~~l~~ 246 (250)
T cd05085 237 NRPKFSELQK 246 (250)
T ss_pred cCCCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.29 Aligned_cols=248 Identities=24% Similarity=0.412 Sum_probs=209.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
++|++.+.||+|+||.||+|..+. +.+.+++|.+... ........+.+|+.+++.++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 589999999999999999998653 3567999987652 233356678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKK---------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFG 181 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~ 181 (335)
.++++||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999998655 68999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCc--cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC---CC
Q psy2306 182 LSNVFTESR--FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY---FE 255 (335)
Q Consensus 182 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~---~~ 255 (335)
++....... ......++..|+|||.+.+... +.++||||||+++|++++ |..||...........+..... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 876443221 1223345667999999887766 789999999999999998 8889987777676666664432 23
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
...+..+.+++.+||+.+|.+||++.+++..
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 3456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=281.56 Aligned_cols=244 Identities=25% Similarity=0.462 Sum_probs=206.8
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|++.+.||+|++|.||++.+. ++..+++|.+..... ....+.+|+..++.++|++++++++++......++++|
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 7999999999999999999876 367899998865332 12357789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc--c
Q psy2306 117 YAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL--S 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~--~ 193 (335)
|+++++|.+++... .++++..++.++.+++.++++||+.|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999998753 46899999999999999999999999999999999999999999999999988655432211 1
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEML 270 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l 270 (335)
...++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..+.. .+...+..+.+++.+||
T Consensus 160 ~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 238 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW 238 (256)
T ss_pred CCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence 2234567999999987665 889999999999999998 9999998888887777765422 23335678999999999
Q ss_pred ccCCCCCCCHHHHhcC
Q psy2306 271 NINPSSRADISVICSH 286 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~ 286 (335)
+.+|.+||++.+++++
T Consensus 239 ~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 239 KERPEDRPSFSLLLHQ 254 (256)
T ss_pred ccChhhCCCHHHHHHh
Confidence 9999999999999854
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=287.30 Aligned_cols=257 Identities=34% Similarity=0.564 Sum_probs=210.9
Q ss_pred ceeEEeeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCc-CCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKI-ETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 111 (335)
+|++.+.||+|++|.||++.+. .++..|++|.+..... ......+.+.+|+..+..+ +|++|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 4678899999875332 1233455678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
++||||+++++|.+.+..+..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998777899999999999999999999999999999999999999999999999998866543321
Q ss_pred --ccccccCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcCCC-CCCCCCCchH
Q psy2306 192 --LSTFCGSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGS----NFKRLVKQISNGDY-FEPKNQSTAS 263 (335)
Q Consensus 192 --~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~----~~~~~~~~~~~~~~-~~~~~~~~l~ 263 (335)
.....++..|++||.+.+.. ..+.++|+||||+++|+|++|..||... ...+....+..... .+...+..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 22345788999999986654 2478999999999999999999999543 23333333333322 3334577899
Q ss_pred HHHHHhcccCCCCCCC---HHHHhcCCCcCCCC
Q psy2306 264 PLIAEMLNINPSSRAD---ISVICSHWWIDKDH 293 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~ 293 (335)
+++.+||+.||++||| +.++|+||||+...
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 9999999999999998 56789999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=300.89 Aligned_cols=260 Identities=31% Similarity=0.555 Sum_probs=226.9
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
.+.||+|-||+||-|+.+.+|+.||+|++.+-.+.... ...+++|+.+|+.+.||.|+.+.-.|+..+.+++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 48899999999999999999999999999876654433 36899999999999999999999999999999999999954
Q ss_pred CCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC---CCeEEeeccccccccCCcccccc
Q psy2306 121 GELYDFLD--QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN---GNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 121 ~~L~~~l~--~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~---~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
++.++|- +.+++++...+.++.||+.||.|||-+||+|+||||+|||+... ..+||||||++++.++.....+.
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV 726 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV 726 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence 6666664 36789999999999999999999999999999999999999654 37999999999999998888899
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-----CCCCchHHHHHHhc
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-----KNQSTASPLIAEML 270 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l 270 (335)
.|||.|.|||+++...| ...-|+||.|+++|--+.|..||.. .+++..+|.+-.+..+ +.+.+..++|..+|
T Consensus 727 VGTPAYLaPEVLrnkGy-NrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGY-NRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred cCCccccCHHHHhhccc-cccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 99999999999999888 7889999999999999999999954 3455666666655332 23568899999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHh
Q psy2306 271 NINPSSRADISVICSHWWIDKDHSVACLEEAEELA 305 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~ 305 (335)
+..-.+|.|.++.|+|||++.......+.+++...
T Consensus 804 qVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~i 838 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRI 838 (888)
T ss_pred HHHHHHhcchHhhccchhhhcchHHHHHHHHHHhh
Confidence 99999999999999999999887776666665444
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=289.77 Aligned_cols=245 Identities=21% Similarity=0.295 Sum_probs=196.5
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCHHHHH
Q psy2306 48 NYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL 127 (335)
Q Consensus 48 ~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 127 (335)
++|.||.+....+++.|++|.+.... ......+.+.+|+..++.++|+||+++++++.+.+..+++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 55667777777789999999998642 23456678999999999999999999999999999999999999999999999
Q ss_pred hhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--------cccccc
Q psy2306 128 DQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--------LSTFCG 197 (335)
Q Consensus 128 ~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--------~~~~~~ 197 (335)
... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+||+.+........ .....+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 753 4589999999999999999999999999999999999999999999999998765432111 123345
Q ss_pred CCccCChhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHHhcCCC----------------------
Q psy2306 198 SPLYASPEIVKGI-PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV-KQISNGDY---------------------- 253 (335)
Q Consensus 198 ~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~-~~~~~~~~---------------------- 253 (335)
+..|+|||++... ..++.++|+||+|+++++|++|..||......... ..+.....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 6789999998763 22378999999999999999999999876543332 22211100
Q ss_pred ------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 254 ------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 254 ------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.....+.++.+++++||+.||++|||++++|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000123577899999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=280.36 Aligned_cols=240 Identities=28% Similarity=0.422 Sum_probs=202.9
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
+.||.|++|.||++.+.. ++.|++|.+..... ....+.+.+|+..++.++|+||+++++++.+.+..++++||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999887 89999999876432 245667889999999999999999999999999999999999999
Q ss_pred CHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc---ccccc
Q psy2306 122 ELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL---STFCG 197 (335)
Q Consensus 122 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~---~~~~~ 197 (335)
+|.+++.. ...+++..+..++.+++.+|.|||++|++|+||+|+||+++.++.++|+|||.+......... .....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999865 456899999999999999999999999999999999999999999999999998765422111 11222
Q ss_pred CCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcccCC
Q psy2306 198 SPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLNINP 274 (335)
Q Consensus 198 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp 274 (335)
+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..... .+...+.++.+++.+||+.+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 456999999887765 899999999999999998 8999988777666666655422 233456799999999999999
Q ss_pred CCCCCHHHHhc
Q psy2306 275 SSRADISVICS 285 (335)
Q Consensus 275 ~~Rps~~~ll~ 285 (335)
.+||++.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999984
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=286.22 Aligned_cols=247 Identities=28% Similarity=0.466 Sum_probs=197.8
Q ss_pred ccceeEEeeeeccCCeEEEEEE----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--C
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--R 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 108 (335)
.++|++.+.||+|+||.||.+. +..++..|++|.+... .....+.+.+|+..++.++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 3589999999999999999987 4457889999998753 34456678899999999999999999998743 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
...++++||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 5689999999999999999753 468999999999999999999999999999999999999999999999999987654
Q ss_pred CCccc----cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----------------HHHHH
Q psy2306 188 ESRFL----STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK----------------RLVKQ 247 (335)
Q Consensus 188 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~----------------~~~~~ 247 (335)
..... ....++..|+|||.+.+..+ +.++|+||||+++|+|++|..++...... .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 32211 11123345999999987766 88999999999999999987775433211 11111
Q ss_pred HhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 248 ISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 248 ~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+..... .....+.++.+++.+||+.+|++|||+.+|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111111 22345668999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=283.27 Aligned_cols=249 Identities=31% Similarity=0.542 Sum_probs=210.7
Q ss_pred ceeEEeeeeccCCeEEEEEEECC-CCcEEEEEEeecCC-------cCCHHHHHHHHHHHHHHHc-CCCCcccceeEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKE-TGQEVAIKTIKKCK-------IETEADLIRIRREIQIMSS-VRHPNIIHIYEVFEN 107 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~-~~~~valK~~~~~~-------~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~ 107 (335)
.|++.+.||+|++|.||+|.+.. +++.+++|.+.... .........+.+|+..+.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999887 67889999876422 1233455667788887765 789999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
.+..++++||+++++|.+++.. ...+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 4568999999999999999999996 7899999999999999999999999999
Q ss_pred cccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC---CCC
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP---KNQ 259 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 259 (335)
+.............++..|++||.+.+..+ +.++|+||||+++|+|++|..||...+.......+......+. ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 877655444445667889999999988776 8899999999999999999999988877776666655543322 346
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 260 STASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..+.+++++||+.||.+||++.++.++
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=280.61 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=205.0
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||++.+. ++..+++|.+... ......+.+|+.+++.++|+|++++++.+.. ...++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4679999999999999999999765 4567999987642 2345678889999999999999999999887 78899
Q ss_pred EEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 114 VMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999999753 4578889999999999999999999999999999999999999999999998865543221
Q ss_pred --ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHH
Q psy2306 192 --LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLI 266 (335)
Q Consensus 192 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 266 (335)
.....++..|+|||.+....+ +.++|+||||+++|++++ |..||...+..+....+..... .....+.++.+++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 112234567999999987665 889999999999999998 9999988877777766665432 2234566899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q psy2306 267 AEMLNINPSSRADISVICS 285 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~ 285 (335)
.+||+.+|++||++.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=333.16 Aligned_cols=260 Identities=29% Similarity=0.507 Sum_probs=224.4
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
+.+.-+|.-...||.|.||.||.|++.++|...|+|.+.-.... ......+.+|..++..+.|||+|+++++-.+.+..
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34445899999999999999999999999999999998764433 55567788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC--
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-- 189 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-- 189 (335)
+|.||||++|+|.++++.+.-.++.....+..|++.|++|||++|||||||||.||+++.+|.+|++|||.+....+.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999999999998877888888889999999999999999999999999999999999999999998776443
Q ss_pred ---ccccccccCCccCChhhhcCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcCCC--CCCCCCCc
Q psy2306 190 ---RFLSTFCGSPLYASPEIVKGIP--YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNGDY--FEPKNQST 261 (335)
Q Consensus 190 ---~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~ 261 (335)
.......||+-|||||++.+.. -+..+.||||||||+.||+||+.||...+.+ ++...+..+.. .+...+++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 3345678999999999997654 3467899999999999999999999876554 44444444433 33446778
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 262 ASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
-.+||.+||..||++|.++.||++|-|-...
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 8999999999999999999999999997654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=282.15 Aligned_cols=236 Identities=20% Similarity=0.324 Sum_probs=194.3
Q ss_pred eeeeccCCeEEEEEEECCCC----------cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 42 RKLGQGNYGKVQLGINKETG----------QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~----------~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+..++.++|+||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998766 357788765422 115678889999999999999999999987 778
Q ss_pred EEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-------CeEEeecccc
Q psy2306 112 VLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-------NAKIADFGLS 183 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-------~~kL~df~~~ 183 (335)
++++||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998755 789999999999999999999999999999999999998877 7999999998
Q ss_pred ccccCCccccccccCCccCChhhhcCC-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCCCCCc
Q psy2306 184 NVFTESRFLSTFCGSPLYASPEIVKGI-PYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYFEPKNQST 261 (335)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (335)
...... ....+...|+|||.+.+. ..++.++|+||||+++|+|++ |..||...+..+..................
T Consensus 156 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (259)
T cd05037 156 ITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAE 232 (259)
T ss_pred cccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchH
Confidence 765442 233456779999998776 334889999999999999998 588887765444433333333333334478
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 262 ASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 233 LANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=285.46 Aligned_cols=248 Identities=24% Similarity=0.440 Sum_probs=199.9
Q ss_pred cceeEEeeeeccCCeEEEEEEE----CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--C
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGIN----KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--E 109 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 109 (335)
+-|++.+.||+|+||.||++.. ..++..|++|.+.... .......+.+|+..++.++|+|++++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3579999999999999999974 4568899999986532 344456788999999999999999999998765 5
Q ss_pred eEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
..+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 789999999999999999764 3589999999999999999999999999999999999999999999999999876543
Q ss_pred Ccc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------------cHHHHHHHHh
Q psy2306 189 SRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---------------NFKRLVKQIS 249 (335)
Q Consensus 189 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---------------~~~~~~~~~~ 249 (335)
... .....++..|+|||.+.+..+ +.++||||||+++|+|+++..|+... ........+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 221 123345667999999887665 88999999999999999987664221 1112222222
Q ss_pred cCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 250 NGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 250 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.... .....+..+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2222 233456789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=294.10 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=199.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEE-----CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEe-
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGIN-----KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFEN- 107 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~- 107 (335)
.++|++.+.||+|+||.||+|.+ ..+++.||+|.+.... .......+.+|+..+..+ +|+||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 35899999999999999999984 3467889999987532 234456788999999999 68999999998864
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC---------------------------------------------------------
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQK--------------------------------------------------------- 130 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------- 130 (335)
....++++||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45688999999999999998642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---cccccc
Q psy2306 131 ----------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF---LSTFCG 197 (335)
Q Consensus 131 ----------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~---~~~~~~ 197 (335)
..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........ .....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 2367788889999999999999999999999999999999999999999999876432211 112234
Q ss_pred CCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcH-HHHHHHHhcCCC--CCCCCCCchHHHHHHhcccC
Q psy2306 198 SPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNF-KRLVKQISNGDY--FEPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 198 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~-~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~d 273 (335)
+..|+|||.+.+..+ +.++||||||+++|+|++ |..||..... ......+..+.. .+...++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 567999999987766 889999999999999996 9999976543 233333333322 22234668999999999999
Q ss_pred CCCCCCHHHHhcC
Q psy2306 274 PSSRADISVICSH 286 (335)
Q Consensus 274 p~~Rps~~~ll~~ 286 (335)
|.+||++.+|++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999965
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=299.66 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=213.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCc---E-EEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQ---E-VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~---~-valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
++-.+.++||+|+||.||+|..+..+. . ||+|..........+....+.+|+++++.++||||++++|+..+...+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 355667999999999999998765322 3 899998864555678889999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
++|||+|+||+|.++|++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+|++|||+++......
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999999999999999876 49999999999999999999999999999999999999999999999999987654211
Q ss_pred ccc-ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHH
Q psy2306 191 FLS-TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPL 265 (335)
Q Consensus 191 ~~~-~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 265 (335)
... ...-...|+|||.+....+ +.++||||||+++||+++ |..||.+....+....+....+ .+...+.++..+
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred eccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 111 1123567999999998865 999999999999999997 8999999999999999944332 334456688999
Q ss_pred HHHhcccCCCCCCCHHHHh
Q psy2306 266 IAEMLNINPSSRADISVIC 284 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll 284 (335)
+.+|+..+|+.||++.++.
T Consensus 396 ~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred HHHhccCChhhccCHHHHH
Confidence 9999999999999999987
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=279.38 Aligned_cols=239 Identities=26% Similarity=0.444 Sum_probs=201.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||.+. .+++.+++|.+.... ....+.+|+..++.++|+|++++++++... ..++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 479999999999999999985 467889999986421 234678899999999999999999998654 478999
Q ss_pred ecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 116 EYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+...... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VD 155 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CC
Confidence 9999999999997643 4899999999999999999999999999999999999999999999999988654322 12
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHHHHhc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLIAEML 270 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l 270 (335)
....+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+....+...... ....+..+.+++++||
T Consensus 156 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHc
Confidence 2234567999999887776 889999999999999997 99999988887777776655322 2334668999999999
Q ss_pred ccCCCCCCCHHHHhc
Q psy2306 271 NINPSSRADISVICS 285 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~ 285 (335)
+.+|.+||++.+++.
T Consensus 235 ~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 235 ETEPKKRPSFHKLRE 249 (254)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999984
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=279.61 Aligned_cols=274 Identities=27% Similarity=0.442 Sum_probs=214.7
Q ss_pred cCCCCccchhhhh--hhccceeEEeeeeccCCeEEEEEEECCCC----cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC
Q psy2306 20 ESTGGVRLHNHRR--KLKQRFDIVRKLGQGNYGKVQLGINKETG----QEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93 (335)
Q Consensus 20 ~~~~~~~~~~~~~--~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l 93 (335)
+..+.+++.+.+. .....|++.+.||+|.||.||+|..+.++ +.+|+|.++..... .-......+|+.+++.+
T Consensus 6 ~~~~~~~~~ser~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl 84 (438)
T KOG0666|consen 6 DYDFKSKLASERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLREL 84 (438)
T ss_pred cccchhhhhhhhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHh
Confidence 3445555555555 44558999999999999999999765543 36899998764221 12223566899999999
Q ss_pred CCCcccceeEEEEe-CCeEEEEEecCCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCE
Q psy2306 94 RHPNIIHIYEVFEN-REKMVLVMEYAAGGELYDFLDQ-----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENI 167 (335)
Q Consensus 94 ~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ni 167 (335)
+|+|++.+..+|.. +..+++++||.+. +|.++|+- ...++...++.++.||+.|+.|||++=++||||||.||
T Consensus 85 ~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNI 163 (438)
T KOG0666|consen 85 KHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANI 163 (438)
T ss_pred cCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceE
Confidence 99999999999866 8899999999966 89998863 34699999999999999999999999999999999999
Q ss_pred EEccC----CCeEEeeccccccccCCc----cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy2306 168 LLDEN----GNAKIADFGLSNVFTESR----FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS 239 (335)
Q Consensus 168 li~~~----~~~kL~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~ 239 (335)
+|..+ |.+||+|||+++.+.++- .....+-|.+|.|||.+.+...+|.+.|||++||++.||+|-.+.|.+.
T Consensus 164 lvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 164 LVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred EEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99887 899999999998876542 2345667899999999999998899999999999999999988877542
Q ss_pred c-------------HHHHH------------------------HHHhcCCCCC----------CCCCCchHHHHHHhccc
Q psy2306 240 N-------------FKRLV------------------------KQISNGDYFE----------PKNQSTASPLIAEMLNI 272 (335)
Q Consensus 240 ~-------------~~~~~------------------------~~~~~~~~~~----------~~~~~~l~~li~~~l~~ 272 (335)
. ...+. ..+....... ..-++...+++.+||+.
T Consensus 244 E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~y 323 (438)
T KOG0666|consen 244 EEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTY 323 (438)
T ss_pred hhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhcc
Confidence 1 00111 1111010100 01144578899999999
Q ss_pred CCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 273 NPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 273 dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
||.+|.|+++.++|+||.+...+
T Consensus 324 DP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 324 DPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred CchhhccHHHHhcccccccCCCC
Confidence 99999999999999999987444
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=285.29 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=204.3
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCc----EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQ----EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
.++|++.+.||+|+||.||+|.+..+|. .+++|.+.... .......+.+|+.+++.++|+||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 3588999999999999999999877765 46888876532 334445678899999999999999999998654 4
Q ss_pred EEEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.++++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 678999999999999987643 5899999999999999999999999999999999999999999999999999765432
Q ss_pred cc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchH
Q psy2306 190 RF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTAS 263 (335)
Q Consensus 190 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 263 (335)
.. .....++..|++||.+.+..+ +.++||||||+++|+|++ |..||.+....+....+...... +...+..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 21 112334568999999987776 889999999999999997 99999887766666555554332 233466889
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q psy2306 264 PLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+++.+||..+|++||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=309.31 Aligned_cols=245 Identities=29% Similarity=0.465 Sum_probs=215.7
Q ss_pred ceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
+-...+.||+|+||.||+|.... +...||||.++.. .+.....+|++|++++..++|||||+++|+|...+..
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 56678999999999999997542 3466999998863 3455788999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhC--------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEE
Q psy2306 112 VLVMEYAAGGELYDFLDQK--------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKI 177 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL 177 (335)
++|+|||..|+|.++|..+ .+++..+...|+.||+.|+.||-++.+|||||-+.|+||.++..|||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 9999999999999999642 23889999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCcccc---ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC
Q psy2306 178 ADFGLSNVFTESRFLS---TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY 253 (335)
Q Consensus 178 ~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 253 (335)
+|||+++..-...+.. ...-..+|||||.+..+++ |.+|||||+|++|||+++ |..||.+...++.++.+..+..
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 9999998765443322 2233568999999999998 999999999999999995 9999999999999999999986
Q ss_pred C--CCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 254 F--EPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 254 ~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
. +...|.++.+++.+||+.+|.+||++.||-
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 4 445688999999999999999999999985
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=296.48 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=202.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEe
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFEN 107 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 107 (335)
-.++|.+.+.||+|+||.||+|.+. .+++.|++|++.... .....+.+.+|+.++..+. ||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3457889999999999999999864 345689999997532 2333456889999999997 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCC--------------------------------------------------------
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKK-------------------------------------------------------- 131 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------- 131 (335)
.+..++++||+++++|.+++.+.+
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986431
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE
Q psy2306 132 ------------------------------------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL 169 (335)
Q Consensus 132 ------------------------------------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili 169 (335)
.+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 25667788999999999999999999999999999999
Q ss_pred ccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHH-
Q psy2306 170 DENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRL- 244 (335)
Q Consensus 170 ~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~- 244 (335)
+.++.++|+|||++........ .....++..|+|||.+.+..+ +.++||||||+++|||++ |..||......+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999875432211 122345678999999987766 889999999999999998 8999976554443
Q ss_pred HHHHhcCC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 245 VKQISNGD--YFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 245 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
...+..+. ..+...+.++.+++.+||+.+|.+||++++|+.
T Consensus 352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33333332 123345678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=282.42 Aligned_cols=252 Identities=17% Similarity=0.223 Sum_probs=194.7
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHH--------HHHHHHHHHHHHcCCCCcccc
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEAD--------LIRIRREIQIMSSVRHPNIIH 100 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~ 100 (335)
+...++|++.+.||+|+||.||+|.+..+ +..+++|............ ......+...+..+.|+++++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 45567999999999999999999998877 6677777644322111000 011223334456678999999
Q ss_pred eeEEEEeCC----eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 101 IYEVFENRE----KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 101 ~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
+++.+.... ..+++++++ ..++.+.+......++..+..++.|++.||.|||+.|++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 998765443 457788887 447777777666678899999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCc--------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-H-----
Q psy2306 177 IADFGLSNVFTESR--------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-K----- 242 (335)
Q Consensus 177 L~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-~----- 242 (335)
|+|||++....... ......|++.|+|||+..+..+ +.++||||||+++|+|++|..||..... .
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999987653211 1123468999999999988776 9999999999999999999999976521 1
Q ss_pred ---HHHHHHhcCCCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 243 ---RLVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 243 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+....+..+....+..+..+.+++..|++.+|.+||++++|++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2334444444445566788999999999999999999999874
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=257.54 Aligned_cols=255 Identities=29% Similarity=0.505 Sum_probs=216.4
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+|.-.++||+|.||+||+|++.++++-|++|.+..... ++..-....+|+.+|+.++|.||++++++...+...-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 56677899999999999999999999999999986432 22233467799999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cccc
Q psy2306 117 YAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~ 194 (335)
||+ ..|..+..+ ++.++.+.+..++.|++.||.|.|++++.|||+||.|.+|+.+|++||.|||+++.++-+- -.+.
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 995 488888865 6789999999999999999999999999999999999999999999999999998887553 3455
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcC------CCC-------------
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG------DYF------------- 254 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-tg~~p~~~~~~~~~~~~~~~~------~~~------------- 254 (335)
..-+.+|.+|.++.+.+.++...|+||-||++.|+. .|.+.|.+.+..+....+-.. ..+
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 677999999999999998899999999999999999 588889888776665554321 000
Q ss_pred -----------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 255 -----------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 255 -----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
-+.....-+++++++|.-+|.+|.+++..++||||.+..
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 011233456899999999999999999999999998643
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=277.75 Aligned_cols=241 Identities=23% Similarity=0.371 Sum_probs=196.0
Q ss_pred eeeeccCCeEEEEEEECC---CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE-eCCeEEEEEec
Q psy2306 42 RKLGQGNYGKVQLGINKE---TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE-NREKMVLVMEY 117 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~ 117 (335)
+.||+|+||.||+|.+.. ++..+++|.+... ......+.+.+|+..++.++|||++++++++. .++..++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 3457999987542 23445667888999999999999999999775 45568999999
Q ss_pred CCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-----
Q psy2306 118 AAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF----- 191 (335)
Q Consensus 118 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~----- 191 (335)
+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999999763 3467888899999999999999999999999999999999999999999999875433211
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHHHH
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLIAE 268 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 268 (335)
.....++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+..+....+...... ....+..+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 112334667999999987776 889999999999999999 56778777777766666654332 22246689999999
Q ss_pred hcccCCCCCCCHHHHhc
Q psy2306 269 MLNINPSSRADISVICS 285 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~ 285 (335)
||+.+|++||++.+++.
T Consensus 238 cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 238 CWHPKPEMRPTFSELVS 254 (262)
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999984
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=299.65 Aligned_cols=245 Identities=30% Similarity=0.478 Sum_probs=210.7
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKM 111 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 111 (335)
.+.+.|.+...+|.|+|+.|-.+.+..+++..++|++..... ...+|+..+... +|+|++++++.+.+....
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 356789999999999999999999999999999999987522 223456555444 699999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE-ccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL-DENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili-~~~~~~kL~df~~~~~~~~~~ 190 (335)
|+|||.+.|+.+.+.+...+.+. ..+..|+.+|+.|+.|||.+|+|||||||+|||+ +..++++|+|||++......
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999998888777655444 7888899999999999999999999999999999 58899999999999877655
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhcCCCCCCCCCCchHHHHHHh
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-KRLVKQISNGDYFEPKNQSTASPLIAEM 269 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~ 269 (335)
....+-|..|.|||+.....+ ++++|+||||++||+|++|..||..... .++...+..+.+. ...+.+.+++|+.|
T Consensus 470 -~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s-~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS-ECVSDEAKDLLQQL 546 (612)
T ss_pred -hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc-cccCHHHHHHHHHh
Confidence 233456788999999997776 9999999999999999999999976444 4666666666553 66788999999999
Q ss_pred cccCCCCCCCHHHHhcCCCc
Q psy2306 270 LNINPSSRADISVICSHWWI 289 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~ 289 (335)
|+.||.+|+++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 99999999999999999999
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=281.01 Aligned_cols=241 Identities=27% Similarity=0.444 Sum_probs=199.9
Q ss_pred eeeeccCCeEEEEEEECCCC------cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 42 RKLGQGNYGKVQLGINKETG------QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~------~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+.||+|++|.||+|.+...+ ..+++|.+.... .......+.+|+..++.++||||+++++++.+.+..++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876433 679999876422 2334567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-----CeEEeecccc
Q psy2306 116 EYAAGGELYDFLDQK-------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-----NAKIADFGLS 183 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-----~~kL~df~~~ 183 (335)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999999877 8999999988
Q ss_pred ccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCC
Q psy2306 184 NVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPK 257 (335)
Q Consensus 184 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~ 257 (335)
........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+..+.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 65533211 112234578999999988776 899999999999999998 9999988777776666654432 2344
Q ss_pred CCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 258 NQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+..+.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5778999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=278.16 Aligned_cols=229 Identities=24% Similarity=0.343 Sum_probs=189.0
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCHHHH
Q psy2306 47 GNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDF 126 (335)
Q Consensus 47 g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 126 (335)
|.+|.||++.++.+++.|++|.+.... ...+|...+....|||++++++++.+.+..+++|||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 889999999999999999999987532 122344444555799999999999999999999999999999999
Q ss_pred HhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCCccCChhh
Q psy2306 127 LDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206 (335)
Q Consensus 127 l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~ 206 (335)
+.+..++++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ....++..|+|||.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~ 153 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEV 153 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCCcc
Confidence 9887789999999999999999999999999999999999999999999999999775554322 23345677999999
Q ss_pred hcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCchHHHHHHhcccCCCCCCCH-----H
Q psy2306 207 VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADI-----S 281 (335)
Q Consensus 207 ~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ 281 (335)
..+..+ +.++|+||+|+++|+|++|..|+...... ... ......+...+..+.++|.+||+.||.+||++ +
T Consensus 154 ~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~ 229 (237)
T cd05576 154 GGISEE-TEACDWWSLGAILFELLTGKTLVECHPSG-INT--HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE 229 (237)
T ss_pred cCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchh-ccc--ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence 877666 88999999999999999999887543211 000 00111234456789999999999999999986 9
Q ss_pred HHhcCCCc
Q psy2306 282 VICSHWWI 289 (335)
Q Consensus 282 ~ll~~~~~ 289 (335)
++++||||
T Consensus 230 ~~~~h~~~ 237 (237)
T cd05576 230 DIKSHPFF 237 (237)
T ss_pred HHHcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=315.98 Aligned_cols=255 Identities=29% Similarity=0.514 Sum_probs=211.0
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe----
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN---- 107 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 107 (335)
.+...+|.....||+||||.||+++++-+|..||||++.... ......++.+|+..|.+++||||++++..|..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 467788999999999999999999999999999999998744 55667789999999999999999999844310
Q ss_pred --------------------------------------------------------------------------C-----
Q psy2306 108 --------------------------------------------------------------------------R----- 108 (335)
Q Consensus 108 --------------------------------------------------------------------------~----- 108 (335)
.
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence 0
Q ss_pred ------------------------------------CeEEEEEecCCCCCHHHHHhhCCCC-CHHHHHHHHHHHHHHHHH
Q psy2306 109 ------------------------------------EKMVLVMEYAAGGELYDFLDQKKVL-TEEEARRIFRQIATAVYY 151 (335)
Q Consensus 109 ------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~i~~~l~~~l~~ 151 (335)
..+||.||||+..++.+++.++... .....|.++++|++||+|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 1368899999888888888776654 588899999999999999
Q ss_pred hHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-------------------CCccccccccCCccCChhhhcCCC-
Q psy2306 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-------------------ESRFLSTFCGSPLYASPEIVKGIP- 211 (335)
Q Consensus 152 LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~- 211 (335)
+|+.|+|||||||.||+++.++.|||+|||+++... +....++..||..|+|||++.+..
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999999999999999998721 111335678999999999997766
Q ss_pred -CCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcCCCCCC---C--CCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 212 -YHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEP---K--NQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 212 -~~~~~~Dv~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~---~--~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
.++.++|+||||++++||+. ||.. +.....+..+..+..+.+ . .-+.-..+|+.||+.||.+||||.|+|
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 46999999999999999996 4543 344455666666655444 1 123567799999999999999999999
Q ss_pred cCCCcCC
Q psy2306 285 SHWWIDK 291 (335)
Q Consensus 285 ~~~~~~~ 291 (335)
.+.||-.
T Consensus 870 ~s~llpp 876 (1351)
T KOG1035|consen 870 NSELLPP 876 (1351)
T ss_pred hccCCCc
Confidence 9999984
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=311.58 Aligned_cols=251 Identities=26% Similarity=0.469 Sum_probs=215.1
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCC-Cc----EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKET-GQ----EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE 106 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~-~~----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 106 (335)
..-....+....||+|.||.||.|..... |. .|++|.+.. ..+......|.+|..+++.++||||++++|++.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 34456888999999999999999986643 32 388888775 456778889999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEee
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQK-------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIAD 179 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~d 179 (335)
+....++++|||.||+|..+|++. ..++..++..++.|++.|+.||+++++|||||..+|+|++....+|++|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999999864 3599999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccc---ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh-cCCCC
Q psy2306 180 FGLSNVFTESRFLSTF---CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQIS-NGDYF 254 (335)
Q Consensus 180 f~~~~~~~~~~~~~~~---~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~-~~~~~ 254 (335)
||+++........... .-...|||||.+....+ +.++||||||+++||++| |..||.+.+..++..... .++..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 9999855433332211 22356999999998777 999999999999999997 999999998888877444 44443
Q ss_pred -CCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 255 -EPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 255 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+...+..+.+++..||+.+|++||++..|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 3446779999999999999999999999997
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=276.87 Aligned_cols=242 Identities=21% Similarity=0.375 Sum_probs=190.4
Q ss_pred eeeeccCCeEEEEEEECC--CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCC
Q psy2306 42 RKLGQGNYGKVQLGINKE--TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
+.||+|+||.||+|.... ....+++|.+... ........+.+|+..++.++|+||+++++.+.+....+++|||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996533 3457888876542 233445567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---
Q psy2306 120 GGELYDFLDQKK-----VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--- 191 (335)
Q Consensus 120 ~~~L~~~l~~~~-----~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--- 191 (335)
+++|.+++.... ..++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999997643 246778899999999999999999999999999999999999999999998865432211
Q ss_pred ccccccCCccCChhhhcCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC-------CCCC
Q psy2306 192 LSTFCGSPLYASPEIVKGI------PYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY-------FEPK 257 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~------~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~-------~~~~ 257 (335)
.....++..|+|||++... ...+.++||||||+++|+|++ |..||......+.......... ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1223345679999997531 233789999999999999998 7889987766555444433221 1223
Q ss_pred CCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 258 NQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+..+.+++..|+ .||.+||++++|++-
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 4557788999998 599999999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=276.71 Aligned_cols=241 Identities=22% Similarity=0.356 Sum_probs=191.1
Q ss_pred eeeeccCCeEEEEEEECC--CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCC
Q psy2306 42 RKLGQGNYGKVQLGINKE--TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
+.||+|+||.||+|.+.. ++..+++|.+.... .......+.+|+..++.++||||+++++.+.+....+++|||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999997643 45679999876533 23334568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---
Q psy2306 120 GGELYDFLDQK-----KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--- 191 (335)
Q Consensus 120 ~~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--- 191 (335)
+++|.+++... ...++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999998742 2456778889999999999999999999999999999999999999999998865433221
Q ss_pred ccccccCCccCChhhhcCCC------CCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC---CCC----CC
Q psy2306 192 LSTFCGSPLYASPEIVKGIP------YHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGD---YFE----PK 257 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~------~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~---~~~----~~ 257 (335)
.....++..|+|||++.+.. ..+.++|+||||+++|+|++ |..||......+......... ... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 12334567899999986432 13779999999999999996 999998776655443322221 111 12
Q ss_pred CCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 258 NQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+..+.+++.+|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 3557888999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=277.24 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=201.4
Q ss_pred eeEEeeeeccCCeEEEEEEECC---CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-----
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKE---TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE----- 109 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 109 (335)
|++.+.||+|+||.||+|.+.. ++..+++|.+.... ......+.+.+|+..++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998653 57889999987533 34445677889999999999999999999885432
Q ss_pred -eEEEEEecCCCCCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 110 -KMVLVMEYAAGGELYDFLDQK------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 110 -~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
..+++++|+.+++|.+++... ..++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247889999999998877431 2478999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCC
Q psy2306 183 SNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEP 256 (335)
Q Consensus 183 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~ 256 (335)
+........ .....+++.|++||......+ +.++||||||+++|+|++ |..||...+..+....+..... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 876543221 112234567999999887766 889999999999999998 8999988777766666655432 233
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
..+..+.+++.+||+.+|.+||++.+++.
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 45678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=284.15 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=210.0
Q ss_pred hhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-C-C----cccce
Q psy2306 28 HNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-H-P----NIIHI 101 (335)
Q Consensus 28 ~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~-~----~i~~~ 101 (335)
-..++.+.++|.+...+|+|.||.|-.+.|..++..||+|+++.. ....+...-|++.|+++. + | -++.+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 346788899999999999999999999999999999999999863 334456667899999983 2 2 35566
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc--------
Q psy2306 102 YEVFENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-------- 171 (335)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-------- 171 (335)
.++|.-.++.|+|+|.+ |.|+.+++..+. +++...+..+++|+++++++||+.+++|-||||+||++..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 67788899999999999 779999998754 6999999999999999999999999999999999999931
Q ss_pred ------------CCCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy2306 172 ------------NGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS 239 (335)
Q Consensus 172 ------------~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~ 239 (335)
+..++++|||.++...... ...+.|..|.|||++.+..+ +..+||||+||+|+|+.+|...|...
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccC
Confidence 2358999999997654433 56778999999999999999 99999999999999999999998664
Q ss_pred cHHH---HHHHHhcCCC------------------C-C-------------------------CCCCCchHHHHHHhccc
Q psy2306 240 NFKR---LVKQISNGDY------------------F-E-------------------------PKNQSTASPLIAEMLNI 272 (335)
Q Consensus 240 ~~~~---~~~~~~~~~~------------------~-~-------------------------~~~~~~l~~li~~~l~~ 272 (335)
+..+ +.+.+....+ . + .....++.+|+++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 4333 2333322100 0 0 00122578899999999
Q ss_pred CCCCCCCHHHHhcCCCcCCC
Q psy2306 273 NPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 273 dp~~Rps~~~ll~~~~~~~~ 292 (335)
||.+|+|+.|+|.||||...
T Consensus 393 DP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFARL 412 (415)
T ss_pred CccccccHHHHhcCHHhhcC
Confidence 99999999999999999854
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=278.73 Aligned_cols=247 Identities=27% Similarity=0.472 Sum_probs=201.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECC----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--CC
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKE----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--RE 109 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 109 (335)
+.|++.+.||+|+||.||+|.... +++.+++|.+...... ...+.+.+|+..++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 478889999999999999998643 4789999998764322 456688999999999999999999999877 56
Q ss_pred eEEEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
..++++||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 8999999999999999997644 589999999999999999999999999999999999999999999999999877653
Q ss_pred Cccc----cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH---------------HHHHHHHh
Q psy2306 189 SRFL----STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF---------------KRLVKQIS 249 (335)
Q Consensus 189 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~---------------~~~~~~~~ 249 (335)
.... ....++..|++||...+..+ +.++|+||||+++++|++|..|+..... ......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 2211 11233456999999987766 8899999999999999999999865322 22223333
Q ss_pred cCCCC--CCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 250 NGDYF--EPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 250 ~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
..... +...+.++.+++.+||+.+|.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 32221 2334568999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=294.78 Aligned_cols=261 Identities=31% Similarity=0.498 Sum_probs=239.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
.-.+++++..||-||||.|-++..+.....+|+|.+++...-+....+.+..|-+++...+.|.|+++|..|.++..+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 34477889999999999999998776656699999998777777788899999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
+||-|-||.|+..++.++.+++.....++..+++|++|||++|||.|||||+|.+++.+|-+||.|||++..........
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCcee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999899
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHHHHHhc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPLIAEML 270 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l 270 (335)
..+|||.|.|||++.+... +.++|.|+||+++|||++|.+||.+.++....+.|.++-. ++........++|+++-
T Consensus 578 TFcGTpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eecCCcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 9999999999999988776 8899999999999999999999999999999988888742 45667889999999999
Q ss_pred ccCCCCCCC-----HHHHhcCCCcCCCCcc
Q psy2306 271 NINPSSRAD-----ISVICSHWWIDKDHSV 295 (335)
Q Consensus 271 ~~dp~~Rps-----~~~ll~~~~~~~~~~~ 295 (335)
..+|.+|.. +.+|-.|-||..-.+.
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 999999974 8999999999864443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=267.96 Aligned_cols=239 Identities=45% Similarity=0.744 Sum_probs=209.1
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCHHHHH
Q psy2306 48 NYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL 127 (335)
Q Consensus 48 ~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 127 (335)
+||.||+|.+..+|+.+++|++........ .+.+.+|+..++.++|++++++++.+......++++|++++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999876433221 568889999999999999999999999999999999999999999999
Q ss_pred hhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCCccCChhhh
Q psy2306 128 DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV 207 (335)
Q Consensus 128 ~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 207 (335)
.....++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|++||..
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 87766899999999999999999999999999999999999999999999999999877665444556678899999999
Q ss_pred cCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcCCCCCCC----CCCchHHHHHHhcccCCCCCCCHHH
Q psy2306 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEPK----NQSTASPLIAEMLNINPSSRADISV 282 (335)
Q Consensus 208 ~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ 282 (335)
.+... +.++|+|+||++++++++|..||.. .+.......+......... .+.++.+++.+||..+|.+||++.+
T Consensus 159 ~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 159 LGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred ccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 87666 7899999999999999999999987 5666666665555443222 6678999999999999999999999
Q ss_pred HhcCCCc
Q psy2306 283 ICSHWWI 289 (335)
Q Consensus 283 ll~~~~~ 289 (335)
+++||||
T Consensus 238 ~~~~~~~ 244 (244)
T smart00220 238 ALQHPFF 244 (244)
T ss_pred HhhCCCC
Confidence 9999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=280.29 Aligned_cols=264 Identities=31% Similarity=0.513 Sum_probs=231.0
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCe
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREK 110 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 110 (335)
.....+|..+..||+|+||.|-+|..+.+.+.||+|++++.......+.+--..|-++|... +-|.++.++..|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 33445899999999999999999999999999999999886655555555555677777666 46899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc-cCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF-TES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~-~~~ 189 (335)
+|+||||++||+|--.+++-+.+-+..+..++.+|+-||-+||++||+.||||.+||+++.+|++||.|||.+..- ...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999998653 334
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAE 268 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~ 268 (335)
......+|||.|+|||++.-.+| +..+|+|++|++||||+.|++||++.+.+++.+.|...... +...+.+..++.+.
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg 583 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKG 583 (683)
T ss_pred cceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHH
Confidence 44557899999999999999888 88999999999999999999999999999999999887654 44567799999999
Q ss_pred hcccCCCCCCC-----HHHHhcCCCcCCCCcch
Q psy2306 269 MLNINPSSRAD-----ISVICSHWWIDKDHSVA 296 (335)
Q Consensus 269 ~l~~dp~~Rps-----~~~ll~~~~~~~~~~~~ 296 (335)
.|.+.|.+|.. -++|-.||||+...+..
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 99999999953 35799999999765554
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=269.84 Aligned_cols=241 Identities=22% Similarity=0.334 Sum_probs=189.2
Q ss_pred eeeeccCCeEEEEEEECCC--CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCC
Q psy2306 42 RKLGQGNYGKVQLGINKET--GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
+.||+|+||.||++....+ ...+++|.+.... .....+.+.+|+..++.++||||+++++.+.+....+++|||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3689999999999975433 3346677665422 23446688899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc---cc
Q psy2306 120 GGELYDFLDQK----KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR---FL 192 (335)
Q Consensus 120 ~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~---~~ 192 (335)
+++|.+++.+. ...+...++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999999753 346777888999999999999999999999999999999999999999999875432211 12
Q ss_pred cccccCCccCChhhhcCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC-------CCCCC
Q psy2306 193 STFCGSPLYASPEIVKGI------PYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY-------FEPKN 258 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~------~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 258 (335)
....++..|+|||++... ...+.++||||||+++|+|++ |..||...+..+....+..+.. .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 234567889999987532 112678999999999999996 5778877666555554433321 12234
Q ss_pred CCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 259 QSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 259 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
++.+.++++.|| .+|.+||++.+|++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 667888999999 67999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=269.05 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=209.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
..+-...||.|+||+|++-.++.+|+..|+|.+..... +.+..++..|.+...+- .+||||+++|.+..++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 44446789999999999999999999999999987443 45566777887776555 6999999999999999999999
Q ss_pred ecCCCCCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 116 EYAAGGELYDFLD-----QKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 116 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
|.| ..||..+-+ +...++++.+..+.-..+.||.||.. ..++|||+||+|||++..|.+||||||++..+.+.
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 999 557766554 35679999999999999999999984 58999999999999999999999999999887666
Q ss_pred ccccccccCCccCChhhhcCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhcCCCCCC-------CCCC
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPY-HGPEVDCWSLGVLLYTLVYGAMPFDGS-NFKRLVKQISNGDYFEP-------KNQS 260 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Dv~slG~~l~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~-------~~~~ 260 (335)
--.+...|...|||||.+..... ++.+||+||||++|||++||..||..- +..+.+.++..+.++.. ..+.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 55556678889999999865543 588999999999999999999999762 22333444444443221 2355
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+..+|..||.+|-..||...+++++||++..
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 78999999999999999999999999999854
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=275.63 Aligned_cols=145 Identities=27% Similarity=0.430 Sum_probs=127.6
Q ss_pred CCCCccchhhhhhhc-cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-----
Q psy2306 21 STGGVRLHNHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR----- 94 (335)
Q Consensus 21 ~~~~~~~~~~~~~~~-~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~----- 94 (335)
..||||++..++.|+ +||.+.++||.|-|++||+|-|..+.+.||+|+.+.... ..+....|+.+|++++
T Consensus 62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~ 137 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPN 137 (590)
T ss_pred hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCC
Confidence 578999999999999 899999999999999999999999999999999886443 3345567999998884
Q ss_pred ---CCcccceeEEEEe----CCeEEEEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhH-HCCcEecCCCC
Q psy2306 95 ---HPNIIHIYEVFEN----REKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCH-KHKICHRDLKL 164 (335)
Q Consensus 95 ---~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH-~~givH~di~p 164 (335)
..+||++++.|.. ..++|+|+|++ |.+|..+|.. ...++...+++|++|++.||.||| ++||||-||||
T Consensus 138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKP 216 (590)
T KOG1290|consen 138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKP 216 (590)
T ss_pred CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCc
Confidence 2589999999964 55899999999 7799999976 345999999999999999999999 56999999999
Q ss_pred CCEEEc
Q psy2306 165 ENILLD 170 (335)
Q Consensus 165 ~nili~ 170 (335)
+|||+.
T Consensus 217 ENvLl~ 222 (590)
T KOG1290|consen 217 ENVLLC 222 (590)
T ss_pred ceeeee
Confidence 999993
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.41 Aligned_cols=270 Identities=24% Similarity=0.408 Sum_probs=228.4
Q ss_pred hcccccCCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC
Q psy2306 15 IMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94 (335)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~ 94 (335)
+--|=+...||.-+..+..+..+|.+....|+|-||+|..|.|..-|..||||++... +.-.+.-..|+++|++|.
T Consensus 411 L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~ 486 (752)
T KOG0670|consen 411 LQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLN 486 (752)
T ss_pred cccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhh
Confidence 3444557788999999999999999999999999999999999998999999999863 333344568999999995
Q ss_pred C------CcccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCC
Q psy2306 95 H------PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK---VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLE 165 (335)
Q Consensus 95 ~------~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ 165 (335)
. -|.++++..|...+++|+|+|.+ ..+|.++++..+ .+....+..++.||+.||..|.++||+|.||||+
T Consensus 487 ~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 487 DADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred ccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 2 58899999999999999999999 679999998743 5888999999999999999999999999999999
Q ss_pred CEEEccC-CCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH
Q psy2306 166 NILLDEN-GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244 (335)
Q Consensus 166 nili~~~-~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~ 244 (335)
|||+++. ..+||||||.+....... .+.+.-+..|.|||++.+.+| +...|+||.||+||||.||+..|++.+..++
T Consensus 566 NiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~y-d~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 566 NILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPY-DYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred ceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcc-cCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 9999875 468999999998776543 445556778999999999998 8999999999999999999999999888887
Q ss_pred HHHHhcCCCCCC------------------------------------------------------CC-------CCchH
Q psy2306 245 VKQISNGDYFEP------------------------------------------------------KN-------QSTAS 263 (335)
Q Consensus 245 ~~~~~~~~~~~~------------------------------------------------------~~-------~~~l~ 263 (335)
+.......-..+ .+ -.++.
T Consensus 644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r 723 (752)
T KOG0670|consen 644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR 723 (752)
T ss_pred HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence 766554110000 00 11467
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
+|+..||..||++|.|.+++|.||||..
T Consensus 724 dLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 8999999999999999999999999974
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=284.77 Aligned_cols=254 Identities=26% Similarity=0.482 Sum_probs=219.8
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
-|..++.||-|+||.|.++...++...||+|.+.+.+.-.......+..|-.+|..-..+-||+++..|.+.+++|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 68899999999999999999888999999999998877777778888899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc---C-----
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT---E----- 188 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~---~----- 188 (335)
|++||++-.+|-+-+-+.+..+..++.++.+|+++.|+.|+|||||||+|||||.+|++||.|||+++.+. +
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999986541 0
Q ss_pred -C----------------------------------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCC
Q psy2306 189 -S----------------------------------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGA 233 (335)
Q Consensus 189 -~----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~ 233 (335)
. ......+||+.|+|||++....+ +.-+|+||.|++||||+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHhhCC
Confidence 0 00113568999999999998887 89999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcCCC-----CCCCCCCchHHHHHHhcccCCCCCC---CHHHHhcCCCcCCC
Q psy2306 234 MPFDGSNFKRLVKQISNGDY-----FEPKNQSTASPLIAEMLNINPSSRA---DISVICSHWWIDKD 292 (335)
Q Consensus 234 ~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~ 292 (335)
.||-..++.+....+.+-+. ...+.+.+..++|.++. -+++.|. .+++|-.||||+.-
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 99988877666555554321 23455778888888865 4567775 56789999999864
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=265.77 Aligned_cols=259 Identities=33% Similarity=0.559 Sum_probs=225.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 114 (335)
++|.+...||+|+|+.|-+++.+.+.+-||+|++++..+...++++-.+.|-.+..+- +||.++-++..|..++.+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 4899999999999999999999999999999999988888888888888888888776 599999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc-cCCcccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~-~~~~~~~ 193 (335)
.||++||+|--.++++..++++.+..+..+|+.||.|||+.||+.+|||.+||+++.+|++||.|+|.+..- .+....+
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ts 409 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTS 409 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccc
Confidence 999999999888888888999999999999999999999999999999999999999999999999988653 4555567
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCC-------CCcHHHHHHH-HhcCCC-CCCCCCCchHH
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFD-------GSNFKRLVKQ-ISNGDY-FEPKNQSTASP 264 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~-------~~~~~~~~~~-~~~~~~-~~~~~~~~l~~ 264 (335)
..+|||.|.|||++++..| +...|.|+||++++||+.|+.||+ ..+.++.+-+ +..... .+...+-....
T Consensus 410 tfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~ 488 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASH 488 (593)
T ss_pred cccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHH
Confidence 8899999999999999998 999999999999999999999994 2334444333 333333 33344557788
Q ss_pred HHHHhcccCCCCCC------CHHHHhcCCCcCCCCcc
Q psy2306 265 LIAEMLNINPSSRA------DISVICSHWWIDKDHSV 295 (335)
Q Consensus 265 li~~~l~~dp~~Rp------s~~~ll~~~~~~~~~~~ 295 (335)
+++..|++||.+|. .++++-.|+||+...+.
T Consensus 489 vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 489 VLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred HHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 99999999999995 57899999999954443
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=282.26 Aligned_cols=283 Identities=27% Similarity=0.444 Sum_probs=227.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCC--C--cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKET--G--QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~--~--~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
..+..+.||.|-||.||.|+...- | -.||+|..+.. -..+..+.|..|..+++.++||||++++|+|.+ ...|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 445578899999999999986532 3 34888887763 344557899999999999999999999999974 5789
Q ss_pred EEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+|||.++-|.|+.+++.++ .++...+..+++||+.||+|||+..+|||||...|||+....-+||+|||+++.+.....
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999999999998754 589999999999999999999999999999999999999999999999999998876655
Q ss_pred cccccc--CCccCChhhhcCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHH
Q psy2306 192 LSTFCG--SPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLI 266 (335)
Q Consensus 192 ~~~~~~--~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 266 (335)
.....| ..-|||||.+.-..+ +.++|||.||+++||++ .|..||.+-...+.+..+.++.. .++..++.+..++
T Consensus 547 YkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred hhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHH
Confidence 443333 345999999988787 99999999999999998 59999988777777777777653 4667899999999
Q ss_pred HHhcccCCCCCCCHHHHhcC--CCcCCCCcchhhHHHHHHhccCccchhhh--cccCCCCCh
Q psy2306 267 AEMLNINPSSRADISVICSH--WWIDKDHSVACLEEAEELANQTPVRLDLL--LSLAPSPST 324 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~ 324 (335)
.+||+.||.+||.+.+|... .-++ .......+-+...++.++..|+.. ..++|.||+
T Consensus 626 skcWayeP~kRPrftei~~~lsdv~q-eek~~~~Eq~r~~R~~a~~~~~~~~~~e~PPKPSR 686 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEIKAILSDVLQ-EEKINSSEQLRRQRKVASMIWQNSDDIEIPPKPSR 686 (974)
T ss_pred HHHhccCcccCCcHHHHHHHHHHHHH-HhhhhhHHHHHhhhcccceeeccCCccCCCCCccc
Confidence 99999999999999887632 1111 112223333334556666666653 456677776
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=288.64 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=221.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEE-----e
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFE-----N 107 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-----~ 107 (335)
-.+.|.+.+.||.|.+|.||++....+|...|+|++..... ..+.+..|.++|+... |||++.++++|. .
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 45689999999999999999999999999999999887432 2335567888998885 999999999984 4
Q ss_pred CCeEEEEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
++.+|||||||.|||..++++. ...+.+..+..|++.++.|+.+||++.++|+|||=.|||++.++.+||+|||.+..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 6789999999999999999986 55799999999999999999999999999999999999999999999999999877
Q ss_pred ccC-CccccccccCCccCChhhhcCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CC
Q psy2306 186 FTE-SRFLSTFCGSPLYASPEIVKGIP----YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EP 256 (335)
Q Consensus 186 ~~~-~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~ 256 (335)
+.. ........|||.|||||++...+ -++.++|+||||++..||.-|.+|+.+..+...+-.+..+..+ +.
T Consensus 173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~ 252 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPK 252 (953)
T ss_pred eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchh
Confidence 653 33446678999999999985443 2367899999999999999999999999988877777666442 34
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.+..++.+||..||.+|-.+||+..++|.|||+.+..
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 4567899999999999999999999999999999654
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=263.55 Aligned_cols=264 Identities=26% Similarity=0.473 Sum_probs=214.0
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE---
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE--- 106 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 106 (335)
+.......|.-..+||+|.||.||+|+.+.+|+.|++|..-... +.+..-....+|+.+|..++|+|++.++..|.
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 45566778888999999999999999999999999998753211 11222234568999999999999999988874
Q ss_pred -----eCCeEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeec
Q psy2306 107 -----NREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180 (335)
Q Consensus 107 -----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df 180 (335)
+...+|+|+.+|+. +|.-++... ..++..++++++.++++||.|+|+..|+|||+|+.|++|+.+|.+||.||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 33468999999965 888888765 67999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcc-----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---CC
Q psy2306 181 GLSNVFTESRF-----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---GD 252 (335)
Q Consensus 181 ~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---~~ 252 (335)
|+++.+..... .+..+-|.+|.+||.+.+...+++..|||+-||++.+|+|+.+.+.+.+..+.+..+.. ..
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99966543221 23345589999999999988889999999999999999999999987766554444332 10
Q ss_pred ---CC------------------------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 253 ---YF------------------------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 253 ---~~------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.+ +-.-+++..+++..||..||.+|+++.+++.|.||.....+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 00 00114467789999999999999999999999999877655
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=289.74 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=176.9
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCC----CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEE-----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKET----GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEV----- 104 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~----~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~----- 104 (335)
-.++|.+.+.||+|+||.||+|.+..+ +..|++|.+....... ....+ .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 346899999999999999999999988 8999999876422111 11111 1111112222222111
Q ss_pred -EEeCCeEEEEEecCCCCCHHHHHhhCCC--------------------CCHHHHHHHHHHHHHHHHHhHHCCcEecCCC
Q psy2306 105 -FENREKMVLVMEYAAGGELYDFLDQKKV--------------------LTEEEARRIFRQIATAVYYCHKHKICHRDLK 163 (335)
Q Consensus 105 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~i~~~l~~~l~~LH~~givH~di~ 163 (335)
.......++++||+++++|.+++..... .....+..++.|++.||.|||+.||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456689999999999999999875321 1234467899999999999999999999999
Q ss_pred CCCEEEcc-CCCeEEeeccccccccCC--ccccccccCCccCChhhhcCCCC---------------------CCCcchH
Q psy2306 164 LENILLDE-NGNAKIADFGLSNVFTES--RFLSTFCGSPLYASPEIVKGIPY---------------------HGPEVDC 219 (335)
Q Consensus 164 p~nili~~-~~~~kL~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~---------------------~~~~~Dv 219 (335)
|+|||++. ++.+||+|||++...... .......+++.|+|||.+..... ++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 579999999999765322 22235677899999997643221 1345699
Q ss_pred HHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--------CCCC--------------CCCchHHHHHHhcccCCCCC
Q psy2306 220 WSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--------FEPK--------------NQSTASPLIAEMLNINPSSR 277 (335)
Q Consensus 220 ~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~--------------~~~~l~~li~~~l~~dp~~R 277 (335)
|||||++|||+++..++... ...+...+..... .... ......+||.+||+.||.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999999987765432 1122221111100 0000 11234589999999999999
Q ss_pred CCHHHHhcCCCcCCCCcc
Q psy2306 278 ADISVICSHWWIDKDHSV 295 (335)
Q Consensus 278 ps~~~ll~~~~~~~~~~~ 295 (335)
||+.++|+||||+.....
T Consensus 442 ~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 442 ISAKAALAHPYFDREGLL 459 (566)
T ss_pred CCHHHHhCCcCcCCCCcc
Confidence 999999999999876543
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=289.92 Aligned_cols=241 Identities=32% Similarity=0.498 Sum_probs=198.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC------
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE------ 109 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 109 (335)
.-|...+.||+|+||.||+++++.+|+.||+|.+.... .....+...+|++++++++|+|||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 46778899999999999999999999999999998744 3344567789999999999999999999865443
Q ss_pred eEEEEEecCCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC--C--CeEEeeccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ---KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN--G--NAKIADFGL 182 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~--~--~~kL~df~~ 182 (335)
...++||||.||+|+..+++ ...+++.++..++.++..||.|||.+||+||||||.||++... | -.||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 46899999999999999975 3459999999999999999999999999999999999999532 3 479999999
Q ss_pred cccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhcCCC-----
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN----FKRLVKQISNGDY----- 253 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~----~~~~~~~~~~~~~----- 253 (335)
++.........+..||+.|.+||.+....+++..+|.||||+++|+++||..||.... ..+....+...+.
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 9999998899999999999999999875556999999999999999999999996532 2223222222111
Q ss_pred ----------------C-CCCC----CCchHHHHHHhcccCCCCCC
Q psy2306 254 ----------------F-EPKN----QSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 254 ----------------~-~~~~----~~~l~~li~~~l~~dp~~Rp 278 (335)
+ +... ...+..++..+|..+|.+|-
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0 0011 12345689999999999998
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=272.08 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=217.3
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHH----HHHHHHHHHHHHHcCCCCcccceeEEEE-
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEA----DLIRIRREIQIMSSVRHPNIIHIYEVFE- 106 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~- 106 (335)
..+++||-+.+.||+|||+.||+|.|-...+.||+|+-.....+.++ ..+...+|.++.+.+.||.||+++++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 45888999999999999999999999988999999997654444333 3455678999999999999999999995
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC--CcEecCCCCCCEEEc---cCCCeEEeecc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH--KICHRDLKLENILLD---ENGNAKIADFG 181 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~--givH~di~p~nili~---~~~~~kL~df~ 181 (335)
+.+.+|.|+|||+|.+|.-+++.++.+++.++..|+.||+.||.||... .|+|-||||.|||+- ..|.+||.|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 6678899999999999999999999999999999999999999999965 699999999999994 34789999999
Q ss_pred ccccccCCcc--------ccccccCCccCChhhhcC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-
Q psy2306 182 LSNVFTESRF--------LSTFCGSPLYASPEIVKG---IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS- 249 (335)
Q Consensus 182 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~- 249 (335)
++.++..... .+...||.||++||.+.- .+..+.++||||+|+++|.|+.|+.||......+-+.+-+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9999865433 234568999999998742 3445889999999999999999999998765433222211
Q ss_pred ---cCC--C-CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 250 ---NGD--Y-FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 250 ---~~~--~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
... + ..+..+++..+||++||+.--+.|...-++..||+|..
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 111 1 23445779999999999999999999999999999975
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=274.20 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=213.7
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
..+.-.+...++++||+|-||.|.+|.-.. +.+||+|.++... .......+.+|+.+|.+++||||++++++|..++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 344556688999999999999999997553 6899999998743 3445678999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKV--LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
.+++++||++.|+|.+++.++.. ........++.||+.|++||.+.++|||||.+.|+|++.++++|++|||.++-+-
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999999999988743 3456677799999999999999999999999999999999999999999997654
Q ss_pred CCccc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHH--hCCCCCCCCcHHHHHHHHhcCC---------C
Q psy2306 188 ESRFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV--YGAMPFDGSNFKRLVKQISNGD---------Y 253 (335)
Q Consensus 188 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~--tg~~p~~~~~~~~~~~~~~~~~---------~ 253 (335)
..... ....-..+|||||.+..+++ +.++|+|+||+++||++ +...||...+.++..++...-- .
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 33322 22344678999999988888 99999999999999987 5899999998888877665421 1
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.++-.+..+.+++.+||..|..+||+++++-.
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 34445778999999999999999999999853
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=275.36 Aligned_cols=243 Identities=26% Similarity=0.445 Sum_probs=216.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+.+..++||.|-||.||.|.++.-.-.||+|.++. +....+.|..|+.+++.++|||+|+++++|..+-.+||++|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 66778999999999999999998888999999875 44567789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc-
Q psy2306 117 YAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS- 193 (335)
Q Consensus 117 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~- 193 (335)
||..|+|.+++++. ..++...+.+++.||..|++||..+++|||||...|+|+.++..+|+.|||+++++....+..
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 99999999999863 457888899999999999999999999999999999999999999999999999987654432
Q ss_pred -ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 194 -TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 194 -~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
......-|.|||-+.-..+ +.++|||+||++|||+.| |-.||.+-+..+.+..+.++-. .+...++.+.++++.|
T Consensus 424 AGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRAC 502 (1157)
T ss_pred cCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHH
Confidence 2233556999999988777 899999999999999996 9999999999999888887754 3455788999999999
Q ss_pred cccCCCCCCCHHHHh
Q psy2306 270 LNINPSSRADISVIC 284 (335)
Q Consensus 270 l~~dp~~Rps~~~ll 284 (335)
|++.|..||+++++-
T Consensus 503 W~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 503 WNWSPSDRPSFAEIH 517 (1157)
T ss_pred hcCCcccCccHHHHH
Confidence 999999999999874
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=282.66 Aligned_cols=246 Identities=28% Similarity=0.425 Sum_probs=219.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCC---cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETG---QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..+|.+.||.|-||.||.|+.+..| ..||||.++. -..+.....|..|+.++-+++||||+++.++.......+|
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~--GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA--GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeecc--CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 6789999999999999999988765 4699999886 3466778899999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-
Q psy2306 114 VMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~- 191 (335)
++|||+.|+|..+|+.+ +.++..++..+++.|+.|+.||-+.|+|||||...|||++.+-..|++|||+++...+...
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 99999999999999864 5699999999999999999999999999999999999999999999999999988754332
Q ss_pred -cccc--ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 192 -LSTF--CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 192 -~~~~--~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
.+.. ....+|.|||.+...++ |.++||||+|++|||.+ .|..||-+.+..+.++.+..+-. .+.+.+..+.+|
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qL 866 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQL 866 (996)
T ss_pred cccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHH
Confidence 1222 22467999999998888 99999999999999988 59999999999999999998754 455678899999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+..||++|-.+||.+.||++
T Consensus 867 MldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 867 MLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHhhcCCCHHHHHH
Confidence 99999999999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.75 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=182.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC----------------CCCcEEEEEEeecCCcCCHH-----------HHHHHHHHH
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK----------------ETGQEVAIKTIKKCKIETEA-----------DLIRIRREI 87 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~----------------~~~~~valK~~~~~~~~~~~-----------~~~~~~~e~ 87 (335)
.++|++.++||+|+||+||+|.+. ..++.|++|.+......... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 569999999999999999999752 24567999998643211100 011223456
Q ss_pred HHHHcCCCCcc-----cceeEEEEe--------CCeEEEEEecCCCCCHHHHHhhC------------------------
Q psy2306 88 QIMSSVRHPNI-----IHIYEVFEN--------REKMVLVMEYAAGGELYDFLDQK------------------------ 130 (335)
Q Consensus 88 ~~l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~------------------------ 130 (335)
..+.+++|.++ ++++++|.. .+..++||||+++++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 66666665443 566666642 35689999999999999988632
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc--cccCCccCChhhhc
Q psy2306 131 KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST--FCGSPLYASPEIVK 208 (335)
Q Consensus 131 ~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~--~~~~~~~~aPE~~~ 208 (335)
..+++..++.++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++........... ..+++.|+|||.+.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 1235677889999999999999999999999999999999999999999999866543322222 23478999999875
Q ss_pred CCCC---------------------CCCcchHHHHHHHHHHHHhCCC-CCCCCcHHH-HH----------HHHhcCCCC-
Q psy2306 209 GIPY---------------------HGPEVDCWSLGVLLYTLVYGAM-PFDGSNFKR-LV----------KQISNGDYF- 254 (335)
Q Consensus 209 ~~~~---------------------~~~~~Dv~slG~~l~~l~tg~~-p~~~~~~~~-~~----------~~~~~~~~~- 254 (335)
.... .....|+||+||++|+|++|.. ||.+..... .. .........
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 4321 0124799999999999999875 665321110 00 111111111
Q ss_pred --CCCCCCchHHHHHHhcccCC---CCCCCHHHHhcCCCcCC
Q psy2306 255 --EPKNQSTASPLIAEMLNINP---SSRADISVICSHWWIDK 291 (335)
Q Consensus 255 --~~~~~~~l~~li~~~l~~dp---~~Rps~~~ll~~~~~~~ 291 (335)
....++...+++.+||..+| .+|+|++|+|+||||..
T Consensus 464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 12345678999999999866 68999999999999964
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=275.83 Aligned_cols=254 Identities=25% Similarity=0.415 Sum_probs=217.3
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCC-C--cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKET-G--QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~-~--~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.+..++.++||+|.||+|+.|.++.. | ..||||.+....... ....|.+|+..+.+++|+|++++|++..+ ...
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 34677889999999999999988753 3 358999987644322 56789999999999999999999999987 788
Q ss_pred EEEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 112 VLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.+|+|.++.|+|.+.|.+ +..+....+..++.||+.|+.||.++++|||||-..|+++-....+||+|||+.+.++..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999999976 456888999999999999999999999999999999999998899999999999887654
Q ss_pred ccccc----cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC--CCCCCCch
Q psy2306 190 RFLST----FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF--EPKNQSTA 262 (335)
Q Consensus 190 ~~~~~----~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l 262 (335)
..... ..-...|+|||.++...+ +.++|||++|+++|||++ |..||.+....++++.+..+... +...+.++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDI 344 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHH
Confidence 43322 223456999999999988 999999999999999996 89999999999999999876543 34457799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+++..||..+|.+||++..|.+.-+.++.
T Consensus 345 Y~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 999999999999999999999766555543
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=282.84 Aligned_cols=242 Identities=31% Similarity=0.475 Sum_probs=195.4
Q ss_pred ceeEEeeeeccCCeE-EEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEE
Q psy2306 37 RFDIVRKLGQGNYGK-VQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~-Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 114 (335)
-|.-.+.+|.|+.|+ ||+|... |+.||+|.+-. +....+.+|+..|+.-+ ||||+++++.-.++...|++
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 455567788988765 7899765 78999998753 34457789999999985 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCC----CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---C--CCeEEeecccccc
Q psy2306 115 MEYAAGGELYDFLDQKKV----LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---N--GNAKIADFGLSNV 185 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~--~~~kL~df~~~~~ 185 (335)
.|.| ..+|.+++..... ......+.++.|+++||++||+.+||||||||.||||+. + .+++|+|||++..
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999 5699999986311 111446788999999999999999999999999999976 3 4789999999988
Q ss_pred ccCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcCCC----CCC
Q psy2306 186 FTESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGSNFKRLVKQISNGDY----FEP 256 (335)
Q Consensus 186 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~----~~~ 256 (335)
+..... .....|+.+|+|||++..... +.++|||||||++|+.++| .+||.+.-..+. +|..+.. ..+
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEP 737 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeecc
Confidence 765433 345678999999999998877 7899999999999999985 999976544332 3344332 122
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
..+.+..++|.+|++++|..||+|.++|.||||=
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 2222889999999999999999999999999995
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=241.24 Aligned_cols=251 Identities=26% Similarity=0.504 Sum_probs=209.8
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCC--
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENRE-- 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-- 109 (335)
--.++|.+.+++|+|-++.||.|+...+++++++|++++ -..+++.+|+.+|+.++ +|||+.++++..++.
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 345699999999999999999999989999999999876 23557899999999997 999999999987644
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-CCeEEeeccccccccC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-GNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~-~~~kL~df~~~~~~~~ 188 (335)
...+++||++..+...+- +.++...+..++.+++.||.|.|+.||+|||+||.|++|+.. ..++|+|+|++.+..+
T Consensus 109 tpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred CchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 578999999887766554 347888999999999999999999999999999999999875 5799999999999988
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC--CcHHHHHH------------HHhc----
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG--SNFKRLVK------------QISN---- 250 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~--~~~~~~~~------------~~~~---- 250 (335)
....+-...+..|--||.+...+.++..-|+|||||++..|+..+.||.. .+.+++.. .+..
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 88888888889999999998888789999999999999999999999843 22222221 1110
Q ss_pred --------------C---CCCC----CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 251 --------------G---DYFE----PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 251 --------------~---~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
. .+.. -...++..+++.++|..|-++|+|+.|.+.||||...
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0 0001 1125688999999999999999999999999999754
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=274.38 Aligned_cols=273 Identities=26% Similarity=0.443 Sum_probs=237.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
.-+++|..+..+|.|.+|.||+++|+.+++..++|+++... .....-+.+|+-.++..+|+||+.+++.+......|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 45679999999999999999999999999999999998633 344556778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cc
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~ 191 (335)
++||||.||+|.+.-.-.+++++.++..+++.-+.+++|||+.|-+|||||=.||+++..|.+||.|||.+...... ..
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 99999999999998888899999999999999999999999999999999999999999999999999988665432 23
Q ss_pred ccccccCCccCChhhh---cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCC------CCch
Q psy2306 192 LSTFCGSPLYASPEIV---KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKN------QSTA 262 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~---~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~l 262 (335)
..+..|++.|||||+. +...| ...+|+|++|++..|+..-++|..+..+.+....+....+.++.. .+.+
T Consensus 169 rksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 3577899999999986 23344 889999999999999999999988888888888888877766544 4468
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHhccCc
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTP 309 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (335)
-+|++.+|.++|++||+++.+|.|||+....+.+-..++-+..+..+
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 89999999999999999999999999998866665555555555554
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=249.43 Aligned_cols=252 Identities=28% Similarity=0.484 Sum_probs=210.0
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC---
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE--- 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 109 (335)
+...||--.+.+|.|.- .|..|.|.-.+.+|++|.+... +......++..+|...+..+.|+|+++++.+|....
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 45568999999999998 8888999989999999998764 444556778889999999999999999999995443
Q ss_pred ---eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 110 ---KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 110 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
..|+|||++ ..+|.+.+. -.++-..+..++.|++.|+.+||+.||+||||||+||++..++.+|+.|||++...
T Consensus 92 ~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 92 EFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 579999999 558888887 34788999999999999999999999999999999999999999999999999887
Q ss_pred cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc----------------
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---------------- 250 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---------------- 250 (335)
+..-..+....+..|.|||++.+..+ ...+||||+||++.||++|...|.+.+.-....++..
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred CcccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 77666778889999999999999885 8999999999999999999999876542211111110
Q ss_pred ----------------CC-C----CC------CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 251 ----------------GD-Y----FE------PKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 251 ----------------~~-~----~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
.+ + ++ +.....+++++.+||-.||++|.|++++|+|||++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00 0 00 01123578899999999999999999999999997
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.95 Aligned_cols=237 Identities=19% Similarity=0.306 Sum_probs=185.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+.|+..+.||+|+||.||+|.+..++..|++|.+....... ..|+..+++++||||+++++++.+.+..++|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc-------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 346777889999999999999998899999999986432111 2357788999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhH---HCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH---KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH---~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
|||+++++|.++++. +++..+..++.|++.||+||| +.+++||||||+||+++.++..++. ++........
T Consensus 762 ~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 762 HEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred EeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 999999999999963 789999999999999999999 6799999999999999988877765 4444322211
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHHhcC--------CCCCCC-
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-----FKRLVKQISNG--------DYFEPK- 257 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-----~~~~~~~~~~~--------~~~~~~- 257 (335)
....+++.|+|||+..+..+ +.++||||||+++|||++|+.||.... ..+........ ......
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 12356789999999988776 899999999999999999999985321 11111111100 000000
Q ss_pred -----CCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 258 -----NQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 258 -----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
...++.+++.+||+.||++||+++++++.
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11246679999999999999999999843
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=249.91 Aligned_cols=254 Identities=24% Similarity=0.435 Sum_probs=210.3
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-----eE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE-----KM 111 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 111 (335)
+..-.+.||-|+||+||.+.|..+|+.|++|.+... +..-...+.+.+|+.+|..++|.|++..+++....+ .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 445568999999999999999999999999998753 344556678889999999999999999999876544 46
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC--C
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE--S 189 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~--~ 189 (335)
|+++|.+ ..+|-+++-+..+++.+.++-+++||+.||.|||+.||.||||||.|.+++.+..+|+||||+++.... .
T Consensus 133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 7888888 558888888888899999999999999999999999999999999999999999999999999987643 3
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-------------------
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN------------------- 250 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~------------------- 250 (335)
...+...-|..|.|||++.+...++.+.||||.||++.||+..+-.|...++-+..+.+..
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 4455667788999999999998889999999999999999988888876665444433332
Q ss_pred ----CCCCCCCC------------CCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 251 ----GDYFEPKN------------QSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 251 ----~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.....+.. ..+...++..||.+||.+|.+.++.+.|++..+.
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11111111 2245678999999999999999999999998754
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=225.61 Aligned_cols=214 Identities=23% Similarity=0.397 Sum_probs=179.0
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 113 (335)
.+...-+..||+|++|.|-+.++..+|.-.|+|.+...-. .....++.+|+.+..+. .+|+++.+++........|+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3455567889999999999999999999999999986432 44455677888877665 69999999999999999999
Q ss_pred EEecCCCCCHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 114 VMEYAAGGELYDFL----DQKKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 114 v~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
.||.| ..||..+- +.++.+++..+-+++..+++||.|||++ .++|||+||+||||+.+|++|+||||++..+.+
T Consensus 123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99999 45776554 4578899999999999999999999965 999999999999999999999999999988876
Q ss_pred CccccccccCCccCChhhhcCC---CCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcC
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGI---PYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNG 251 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~ 251 (335)
.--.+...|...|||||.+... ..|+.++||||||+++.||.+++.||+. .++-+.+.++...
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 6555556788899999988532 2348899999999999999999999976 4555555555554
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=262.07 Aligned_cols=244 Identities=24% Similarity=0.385 Sum_probs=208.9
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCC----cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETG----QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
..+..+.||+|+||+||+|.+--.| .+|++|++... ........+.+|+-.+.+++|||++++++++.... ..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 5566789999999999999875434 46888888763 34455668889999999999999999999998665 88
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
||++|+++|+|.++++. +.++-......|..||++|+.|||.++++||||-..|||+..-.++|+.|||++........
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999999986 56788999999999999999999999999999999999999999999999999988765433
Q ss_pred cc---ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 192 LS---TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 192 ~~---~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
.. ...-.+.|||-|.+....+ +.++||||+|+++||++| |..||.+...+++-..+..+.. .++..+-++..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHH
Confidence 22 1222456999999988787 999999999999999996 9999999999998888887654 445566799999
Q ss_pred HHHhcccCCCCCCCHHHHh
Q psy2306 266 IAEMLNINPSSRADISVIC 284 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll 284 (335)
+.+||..|+..||+++++.
T Consensus 933 mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHHHhccCcccCccHHHHH
Confidence 9999999999999999876
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.50 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=198.0
Q ss_pred CCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC--CCCcccc
Q psy2306 23 GGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV--RHPNIIH 100 (335)
Q Consensus 23 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~ 100 (335)
|+..+-=.-+++.++.++.+.||+|.||.||+|.+. |+.||||++...+ .+...+|.++++.. +|+||+.
T Consensus 198 GSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 198 GSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred CCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhh
Confidence 333333346889999999999999999999999777 8899999987522 22455788888664 8999999
Q ss_pred eeEEEEeC----CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC--------CcEecCCCCCCEE
Q psy2306 101 IYEVFENR----EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH--------KICHRDLKLENIL 168 (335)
Q Consensus 101 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~--------givH~di~p~nil 168 (335)
+++.-..+ ..+|||++|.+.|||.++|.+ ..++.+...+++..++.||++||-. .|.|||||..||+
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 99876433 368999999999999999987 6699999999999999999999942 5999999999999
Q ss_pred EccCCCeEEeeccccccccCC-----ccccccccCCccCChhhhcCCCC----CC-CcchHHHHHHHHHHHHh----C--
Q psy2306 169 LDENGNAKIADFGLSNVFTES-----RFLSTFCGSPLYASPEIVKGIPY----HG-PEVDCWSLGVLLYTLVY----G-- 232 (335)
Q Consensus 169 i~~~~~~kL~df~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~----~~-~~~Dv~slG~~l~~l~t----g-- 232 (335)
|..++...|+|+|++...... -..+..+||.+|||||++...-. .+ ..+||||||.++||++. |
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 999999999999999665433 12346789999999999965421 11 25899999999999983 2
Q ss_pred ----CCCCCC-----CcHHHHHHHHhcCCCCC---CCCCC-----chHHHHHHhcccCCCCCCCHHHHh
Q psy2306 233 ----AMPFDG-----SNFKRLVKQISNGDYFE---PKNQS-----TASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 233 ----~~p~~~-----~~~~~~~~~~~~~~~~~---~~~~~-----~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
+.||.+ ...+++.+-+.-.+..+ ..+.. .+..+++.||..+|..|.|+-.|-
T Consensus 429 ~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred ehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 577754 45666666555444321 22211 456799999999999999987664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=226.88 Aligned_cols=212 Identities=45% Similarity=0.758 Sum_probs=187.1
Q ss_pred eeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCCCCCH
Q psy2306 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGEL 123 (335)
Q Consensus 44 ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 123 (335)
||.|++|.||++.+..+++.+++|.+....... ....+.+|+..++.++|++++++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999988643221 456788999999999999999999999999999999999998999
Q ss_pred HHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEeeccccccccCCc-cccccccCCc
Q psy2306 124 YDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADFGLSNVFTESR-FLSTFCGSPL 200 (335)
Q Consensus 124 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~df~~~~~~~~~~-~~~~~~~~~~ 200 (335)
.+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+||+.+....... ......+...
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 9999865 57899999999999999999999999999999999999999 8999999999987665432 1233556788
Q ss_pred cCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCchHHHHHHhcccCCCCCCCH
Q psy2306 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADI 280 (335)
Q Consensus 201 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 280 (335)
|++||........+.++|+|++|++++++ ..+.+++.+|++.+|.+||++
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 99999998763448899999999999999 678889999999999999999
Q ss_pred HHHhcCC
Q psy2306 281 SVICSHW 287 (335)
Q Consensus 281 ~~ll~~~ 287 (335)
.++++++
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=263.22 Aligned_cols=247 Identities=25% Similarity=0.438 Sum_probs=206.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC-------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE-------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFE 106 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 106 (335)
.++..+.+.||.|.||.|++|.... ....||+|..+.... ....+.+..|+..++.+. |+||+.+++.+.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 3455677799999999999987431 145699999876443 366788999999999995 999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD 170 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~ 170 (335)
..+..+++.||+..|+|.++++... .++..++..++.||+.|++||++.+++||||-..||+++
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 9999999999999999999998654 489999999999999999999999999999999999999
Q ss_pred cCCCeEEeeccccccccCCccccc--cc--cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc-HHHH
Q psy2306 171 ENGNAKIADFGLSNVFTESRFLST--FC--GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSN-FKRL 244 (335)
Q Consensus 171 ~~~~~kL~df~~~~~~~~~~~~~~--~~--~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~-~~~~ 244 (335)
.+..+|++|||+++.......... .. -...|||||.+....+ +.++||||+|+++||+++ |..||.+-. ..++
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 999999999999986554433321 11 1345999999999665 999999999999999996 899998744 5666
Q ss_pred HHHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 245 VKQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 245 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
.+.+..+.. .+...+.++.++++.||+.+|++||++.++.
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 666666543 3444577999999999999999999999987
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=244.44 Aligned_cols=239 Identities=21% Similarity=0.361 Sum_probs=190.0
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC--CCCcccceeEEEEeCC---
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV--RHPNIIHIYEVFENRE--- 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~--- 109 (335)
.......+.||+|.||.||+|+.. ++.||||++.. ...+.+..|-++++.. +|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 346677899999999999999665 68999999874 4455677777777664 7999999999875444
Q ss_pred -eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH---------CCcEecCCCCCCEEEccCCCeEEee
Q psy2306 110 -KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK---------HKICHRDLKLENILLDENGNAKIAD 179 (335)
Q Consensus 110 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~---------~givH~di~p~nili~~~~~~kL~d 179 (335)
.++||++|.+.|+|.++++.+. +++....+++..|+.||+|||. -.|+|||||..||||..+++..|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 8999999999999999998655 8999999999999999999995 3599999999999999999999999
Q ss_pred ccccccccCCcc---ccccccCCccCChhhhcCCCCCC-----CcchHHHHHHHHHHHHhCC------------CCCC--
Q psy2306 180 FGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHG-----PEVDCWSLGVLLYTLVYGA------------MPFD-- 237 (335)
Q Consensus 180 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~-----~~~Dv~slG~~l~~l~tg~------------~p~~-- 237 (335)
||++-.+..... .....||.+|||||++.+.-... .+.||||+|.++||+++.. .||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999988764433 23478999999999997654322 2579999999999999643 2232
Q ss_pred ---CCcHHHHHHHHhcCCCCC---CC-----CCCchHHHHHHhcccCCCCCCCHHH
Q psy2306 238 ---GSNFKRLVKQISNGDYFE---PK-----NQSTASPLIAEMLNINPSSRADISV 282 (335)
Q Consensus 238 ---~~~~~~~~~~~~~~~~~~---~~-----~~~~l~~li~~~l~~dp~~Rps~~~ 282 (335)
..+.+++...+...+..+ .. ....+.+.+..||+.||+.|.|+.=
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 235666666665543321 11 1235778999999999999999863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-31 Score=223.46 Aligned_cols=213 Identities=46% Similarity=0.768 Sum_probs=184.4
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
|++.+.||.|++|.||++.+..+++.+++|.+...... ...+.+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999998864332 2566888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc--cccc
Q psy2306 118 AAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR--FLST 194 (335)
Q Consensus 118 ~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~--~~~~ 194 (335)
+++++|.+++..... +++..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999999987666 8999999999999999999999999999999999999999999999999987765543 3344
Q ss_pred cccCCccCChhhh-cCCCCCCCcchHHHHHHHHHHHHhCCCCCCC--CcHHHHHHHHhcCCC
Q psy2306 195 FCGSPLYASPEIV-KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG--SNFKRLVKQISNGDY 253 (335)
Q Consensus 195 ~~~~~~~~aPE~~-~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~--~~~~~~~~~~~~~~~ 253 (335)
..+...|++||.. ....+ +.++|+|+||+++++|++|..||.. .....+.+.+..+..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred eeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 5677889999998 44444 7799999999999999999999977 444466777766654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=240.85 Aligned_cols=262 Identities=24% Similarity=0.395 Sum_probs=207.8
Q ss_pred cchhhhhhhccceeEEeeeeccCCeEEEEEEECC---CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccce
Q psy2306 26 RLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKE---TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHI 101 (335)
Q Consensus 26 ~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~ 101 (335)
.+......+.+.|+..++||.|.|++||++.+.. .++.|++|.+..... -.++..|++.|..+. +.||+++
T Consensus 26 ~l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~ 100 (418)
T KOG1167|consen 26 QLRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKL 100 (418)
T ss_pred HHHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcc
Confidence 3444566788899999999999999999999877 688999999876332 236889999999995 8999999
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEeec
Q psy2306 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADF 180 (335)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~df 180 (335)
.+.+...+...+|+||++.....++... ++...+..+++.++.||+++|++|||||||||+|++.+. .++-.|+||
T Consensus 101 ~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 101 NGCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred hhhhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEec
Confidence 9999999999999999999988888764 678899999999999999999999999999999999976 578999999
Q ss_pred cccccccCC---------------------------------------------ccccccccCCccCChhhhcCCCCCCC
Q psy2306 181 GLSNVFTES---------------------------------------------RFLSTFCGSPLYASPEIVKGIPYHGP 215 (335)
Q Consensus 181 ~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~ 215 (335)
|++...... .......||++|.|||++...+.-+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 998621000 00012448999999999988777789
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCc--------------HHHHH--------------------------------HHHh
Q psy2306 216 EVDCWSLGVLLYTLVYGAMPFDGSN--------------FKRLV--------------------------------KQIS 249 (335)
Q Consensus 216 ~~Dv~slG~~l~~l~tg~~p~~~~~--------------~~~~~--------------------------------~~~~ 249 (335)
++||||.|+++.-++++..||.... ..++. ..+.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999999999984310 00000 0000
Q ss_pred cCCC-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 250 NGDY-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 250 ~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
+... .....+..+.+++.+||..||.+|.|++++|.||||.+....
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~ 390 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT 390 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence 0000 000113367889999999999999999999999999965444
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=246.87 Aligned_cols=201 Identities=38% Similarity=0.665 Sum_probs=177.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHH-----HHHHHHHHHHHHHcCC---CCcccceeEEEEeC
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEA-----DLIRIRREIQIMSSVR---HPNIIHIYEVFENR 108 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~ 108 (335)
.|+..+.+|.|+||.|++|+++.+...|++|.+.+...--.. ..-.+-.|+.+|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 599999999999999999999999999999998764321111 1122346889998886 99999999999999
Q ss_pred CeEEEEEecCC-CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 109 EKMVLVMEYAA-GGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 109 ~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
+.+|++||-.. |.+|+++|..++.+++.+.+.|++|+..|+++||+.||||||||-+||.++.+|-+||+|||.+....
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc
Confidence 99999999875 45899999999999999999999999999999999999999999999999999999999999886543
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG 238 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~ 238 (335)
.++.....||..|.|||++.+.+|.+..-|||+||+++|-+.....||.+
T Consensus 722 -sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 722 -SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred -CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 34566788999999999999999989999999999999999998888854
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=228.44 Aligned_cols=247 Identities=22% Similarity=0.350 Sum_probs=211.3
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCC-----CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEE-EeC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKET-----GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVF-ENR 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~ 108 (335)
.+|++....+-+|.||.||.|++.+. .+.|.+|.++.. .++.....+..|...+..+.|||+..+.+++ ++.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 45899999999999999999976542 345667766542 2455667888999999999999999999998 456
Q ss_pred CeEEEEEecCCCCCHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeec
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQ--------KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df 180 (335)
...++++.+..-++|..++.. ...++..++..++.|++.|++|||++|++|.||...|.+|++.-.+||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 678999999998999999972 224788889999999999999999999999999999999999999999999
Q ss_pred cccccccCCccc---cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--C
Q psy2306 181 GLSNVFTESRFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--F 254 (335)
Q Consensus 181 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~ 254 (335)
.+++.+.+.... ...-....||+||.+....+ +.++|+||||+++|||+| |+.||..-++.++...+..+.. .
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 999887655432 22334567999999999888 999999999999999997 9999999999999999888754 5
Q ss_pred CCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 255 EPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
+.+.++++..++.-||..+|++||+++|+.
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 667899999999999999999999999987
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=217.91 Aligned_cols=255 Identities=23% Similarity=0.426 Sum_probs=197.0
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEE-EEeC
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEV-FENR 108 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~~ 108 (335)
.-.+.+.|+|.+.+|.|.||.+-++.++.++..+++|.++.. ....+.+.+|...--.|. |.||+.-+++ |+..
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 456788999999999999999999999999999999998762 234567888888777775 8899987765 6778
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC--CCeEEeeccccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN--GNAKIADFGLSNVF 186 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~--~~~kL~df~~~~~~ 186 (335)
+.+++++||++.|+|..-+...+ +-+...+.++.|+++||.|+|++++||||||.+||||... -++||||||.....
T Consensus 95 d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 89999999999999998887544 7888999999999999999999999999999999999543 48999999998765
Q ss_pred cCCccccccccCCccCChhhhcCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhcCCC----
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIP----YHGPEVDCWSLGVLLYTLVYGAMPFDGS-----NFKRLVKQISNGDY---- 253 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Dv~slG~~l~~l~tg~~p~~~~-----~~~~~~~~~~~~~~---- 253 (335)
+..- ........|.+||+..... ...+.+|+|.||+++|.++||..||... ...+..+-......
T Consensus 174 g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 GTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred Ccee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 5332 1222345699999874332 1256789999999999999999999532 11122111111111
Q ss_pred CCCCCCCchHHHHHHhcccCCCCC---CCHHHHhcCCCcCCC
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSR---ADISVICSHWWIDKD 292 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~~~~~~~ 292 (335)
.....++.+..++++-|.++|++| .++..-...-|....
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 223346678889999999999999 666666666676543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=261.02 Aligned_cols=193 Identities=18% Similarity=0.204 Sum_probs=142.5
Q ss_pred CcccceeEEE-------EeCCeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCE
Q psy2306 96 PNIIHIYEVF-------ENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENI 167 (335)
Q Consensus 96 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ni 167 (335)
.||++++++| .....++.++|++ +++|.+++.. ..++++.+++.++.||++||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4677777766 2334677888988 6699999975 45699999999999999999999999999999999999
Q ss_pred EEccCCCeE-------------------EeeccccccccCC-----------------ccccccccCCccCChhhhcCCC
Q psy2306 168 LLDENGNAK-------------------IADFGLSNVFTES-----------------RFLSTFCGSPLYASPEIVKGIP 211 (335)
Q Consensus 168 li~~~~~~k-------------------L~df~~~~~~~~~-----------------~~~~~~~~~~~~~aPE~~~~~~ 211 (335)
||+..+.++ ++|||.+...... .......++++|+|||++.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 996655555 4555544321100 0001134788899999998887
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC--CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE--PKNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 212 ~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
+ +.++|||||||++|||++|..|+..... ....+......+ .........++.+||+++|.+||++.++++||||
T Consensus 192 ~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 192 S-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred C-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence 7 8999999999999999999888754321 111111111111 1123456789999999999999999999999999
Q ss_pred CCC
Q psy2306 290 DKD 292 (335)
Q Consensus 290 ~~~ 292 (335)
.+.
T Consensus 269 ~~~ 271 (793)
T PLN00181 269 NEP 271 (793)
T ss_pred hhh
Confidence 764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=200.80 Aligned_cols=157 Identities=23% Similarity=0.281 Sum_probs=126.7
Q ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCC
Q psy2306 121 GELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199 (335)
Q Consensus 121 ~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~ 199 (335)
|+|.+++.. +.++++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+....... ..+++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 589999986 456999999999999999999999998 999999999999999 99887665432 25789
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhcCCC-C-------CCCCCC--chHHHHHH
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-KRLVKQISNGDY-F-------EPKNQS--TASPLIAE 268 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~~-~-------~~~~~~--~l~~li~~ 268 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..||..... ......+..... . ...... ++.+++.+
T Consensus 69 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 69 YFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred cccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 9999999988877 8899999999999999999999976432 222222221111 0 011122 58999999
Q ss_pred hcccCCCCCCCHHHHhcCCCcC
Q psy2306 269 MLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
||+.+|.+||++.+++.|+|+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=233.42 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=204.0
Q ss_pred ccce-eEEeeeeccCCeEEEEEEECCCCcEEEEEEeec---CCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 35 KQRF-DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKK---CKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 35 ~~~y-~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~---~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
.+.| .....+|.|++|.|+.+......+....|.+.. ...........+..|+.+-..++|+|++..+..+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3445 677889999999888887776666666665542 111222222336677777788899999888777766666
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
..-.|||+++ +|..++...+.+...++..++.|++.|+.|||+.|+.|+|+|++|++++.+|.+|++|||.+..+..+.
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6666999999 999999988789999999999999999999999999999999999999999999999999987765433
Q ss_pred c-----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHHhcCCC---------CC
Q psy2306 191 F-----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV-KQISNGDY---------FE 255 (335)
Q Consensus 191 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~-~~~~~~~~---------~~ 255 (335)
. ....+|+..|+|||++.+..|.....||||.|++++.|.+|+.||.....++.. ........ ..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 3 346788999999999999999888899999999999999999999765443222 11111111 12
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
...+.+.+.+|.+||+.||.+|.|+++|++.+||++.
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 2336677889999999999999999999999999864
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-25 Score=199.03 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=189.9
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCC-cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC----CCcccceeEEE-EeCCe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETG-QEVAIKTIKKCKIETEADLIRIRREIQIMSSVR----HPNIIHIYEVF-ENREK 110 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~-~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~ 110 (335)
+|++.+.||+|+||.||.|.+..++ ..+|+|........... .+..|..++..+. .+++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988764 57888887653222111 4556777777775 36899999999 57888
Q ss_pred EEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-----CCeEEeecccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-----GNAKIADFGLS 183 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~-----~~~kL~df~~~ 183 (335)
.|+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 88999988653 579999999999999999999999999999999999999764 35999999999
Q ss_pred c--ccc-CC-------cc-ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHh
Q psy2306 184 N--VFT-ES-------RF-LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK---RLVKQIS 249 (335)
Q Consensus 184 ~--~~~-~~-------~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~---~~~~~~~ 249 (335)
+ ... .. .. .....||..|+++....+... +.+.|+||++.++.++..|..||...... .......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8 321 11 11 123458999999999999887 99999999999999999999999664422 1111111
Q ss_pred cCCCC---CCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 250 NGDYF---EPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 250 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..... ....+.++..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 11111 12234567777777777899999999887744
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-24 Score=191.16 Aligned_cols=252 Identities=38% Similarity=0.617 Sum_probs=210.1
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCC-cccceeEEEEeCCeEEEEEe
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP-NIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 116 (335)
|++.+.||.|+||.||.+.+. ..+++|.+.............+.+|...++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999877 78999998875544444677888999999999987 79999999988888899999
Q ss_pred cCCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-CeEEeeccccccccCCc--
Q psy2306 117 YAAGGELYDFLDQKK---VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-NAKIADFGLSNVFTESR-- 190 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-~~kL~df~~~~~~~~~~-- 190 (335)
++.++++.+++.... .++......++.|++.++.++|+.|++|+|++|+||+++..+ .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887664 799999999999999999999999999999999999999988 79999999987654433
Q ss_pred -----cccccccCCccCChhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhcCCCC--CCC
Q psy2306 191 -----FLSTFCGSPLYASPEIVKGI--PYHGPEVDCWSLGVLLYTLVYGAMPFDGSN----FKRLVKQISNGDYF--EPK 257 (335)
Q Consensus 191 -----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~----~~~~~~~~~~~~~~--~~~ 257 (335)
......++..|++||...+. ...+...|+|++|++++++++|..||.... .......+...... ...
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 24567889999999999874 345889999999999999999999987765 34555544444322 111
Q ss_pred CC--------CchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 258 NQ--------STASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 258 ~~--------~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.. ..+.+++.+++..+|..|.+..+...+++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 11 368899999999999999999999988666543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=197.59 Aligned_cols=236 Identities=22% Similarity=0.272 Sum_probs=159.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC----------CcccceeEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH----------PNIIHIYEV 104 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~----------~~i~~~~~~ 104 (335)
...+.....||.|+++.||.+.+.++|+.+++|++...........+.+.+|.-....+.+ -.++-.++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 3477889999999999999999999999999999886655555567778777766555322 233333444
Q ss_pred EEe------------CC-----eEEEEEecCCCCCHHHHHhh---CC----CCCHHHHHHHHHHHHHHHHHhHHCCcEec
Q psy2306 105 FEN------------RE-----KMVLVMEYAAGGELYDFLDQ---KK----VLTEEEARRIFRQIATAVYYCHKHKICHR 160 (335)
Q Consensus 105 ~~~------------~~-----~~~lv~e~~~~~~L~~~l~~---~~----~~~~~~~~~i~~~l~~~l~~LH~~givH~ 160 (335)
... .+ +.+++|+-+ .++|.+++.. .. .+.......+..|++..+++||+.|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 321 11 236788888 5688877642 11 13334445667899999999999999999
Q ss_pred CCCCCCEEEccCCCeEEeeccccccccCCccccccccCCccCChhhhcCC-------CCCCCcchHHHHHHHHHHHHhCC
Q psy2306 161 DLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI-------PYHGPEVDCWSLGVLLYTLVYGA 233 (335)
Q Consensus 161 di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Dv~slG~~l~~l~tg~ 233 (335)
||+|+|++++.+|.+.|+||+.....+..... ...+..|.|||..... ...+.+.|.|+||+++|.|+||.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999999877665543322 3445779999976432 12378899999999999999999
Q ss_pred CCCCCCcHHHHHH-HHhcCCCCCCCCCCchHHHHHHhcccCCCCC
Q psy2306 234 MPFDGSNFKRLVK-QISNGDYFEPKNQSTASPLIAEMLNINPSSR 277 (335)
Q Consensus 234 ~p~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 277 (335)
.||.......... .+. ... ..++.++++|+.+|+++|.+|
T Consensus 248 lPf~~~~~~~~~~~~f~---~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEWDFS---RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGGGGT---TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccccch---hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9998654432222 111 222 678899999999999999988
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=185.83 Aligned_cols=197 Identities=23% Similarity=0.419 Sum_probs=171.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 113 (335)
.-.|+++++||.|.||+++.|.+--++++||||.-.. .....+++.|.+.++.|. .++|..++.+.....+-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 3489999999999999999999999999999998543 223447888999999885 7999999988888888899
Q ss_pred EEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-----CeEEeecccccccc
Q psy2306 114 VMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-----NAKIADFGLSNVFT 187 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-----~~kL~df~~~~~~~ 187 (335)
|+|.+ |.+|+++..- ...++..++..++.||+.-++++|.+.+|.|||||+|+||...+ .+.++|||.+....
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99999 8899999874 55699999999999999999999999999999999999996543 58999999998765
Q ss_pred CCc--------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy2306 188 ESR--------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG 238 (335)
Q Consensus 188 ~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~ 238 (335)
++. ...+..||.+||+-....+... +.+.|+-+||-++++.+-|..||.+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCcccc
Confidence 432 2346779999999999999887 8999999999999999999999965
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=195.04 Aligned_cols=170 Identities=22% Similarity=0.232 Sum_probs=133.2
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECC-CCcEEEEEEeecCCc--CCHHHHHHHHHHHHHHHcCCCCcccceeEEEE
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKE-TGQEVAIKTIKKCKI--ETEADLIRIRREIQIMSSVRHPNIIHIYEVFE 106 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~-~~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 106 (335)
+-..+.++|++.+.||+|+||+||+|.+.. ++..+|+|....... ......+.+.+|+.+++.++|+++++.+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 456678899999999999999999998876 677789998653211 133456678999999999999999863332
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCC-CCCCEEEccCCCeEEeecccccc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL-KLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di-~p~nili~~~~~~kL~df~~~~~ 185 (335)
.+..|++|||++|++|... .. .. ...++.+++++|.|||+.|++|||| ||+||+++.++.++|+|||++..
T Consensus 90 -~~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred -cCCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 2568999999999999632 11 11 1467899999999999999999999 99999999899999999999987
Q ss_pred ccCCccc---------cccccCCccCChhhhcC
Q psy2306 186 FTESRFL---------STFCGSPLYASPEIVKG 209 (335)
Q Consensus 186 ~~~~~~~---------~~~~~~~~~~aPE~~~~ 209 (335)
....... ....+++.|++||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 6543321 23456777999998853
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=176.99 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=192.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCC
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENRE 109 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 109 (335)
.-...+.|+++++||+|+||.+|.|....+|+.||+|+-....... .+..|..+++.++ ...|+.+..++.+..
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-----QLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-----chhHHHHHHHHhccCCCCchhhhhccccc
Confidence 4456679999999999999999999999999999999966533222 5667888999997 578888888888889
Q ss_pred eEEEEEecCCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CCCeEEeecccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NGNAKIADFGLSNV 185 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~~~kL~df~~~~~ 185 (335)
.-.+||+.+ |.+|+++++ ....++..++.-++-|++.-++|+|.++++||||||+|++..- ...+.|+|||++..
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 999999999 889999987 3556999999999999999999999999999999999999953 34689999999977
Q ss_pred ccCC--------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHhcCCC-
Q psy2306 186 FTES--------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK---RLVKQISNGDY- 253 (335)
Q Consensus 186 ~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~---~~~~~~~~~~~- 253 (335)
.-+. .......||..|.+-....+... +.+.|+-|+|.++.++.-|..||.+.... +-.+.+...+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 6432 22335678899999888877766 88999999999999999999999774332 22233332221
Q ss_pred -----CCCCCCCchHHHHHHhcccCCCCCCCHH
Q psy2306 254 -----FEPKNQSTASPLIAEMLNINPSSRADIS 281 (335)
Q Consensus 254 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~ 281 (335)
.....|.++.-.+.-|-..--++-|...
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 2334566777777777666666666543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=181.13 Aligned_cols=177 Identities=19% Similarity=0.217 Sum_probs=139.4
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHH------HHHHHHHHHcCCCCcccceeEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR------IRREIQIMSSVRHPNIIHIYEV 104 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~------~~~e~~~l~~l~~~~i~~~~~~ 104 (335)
...++++|++.+.||.|+||.||++.+ ++..+++|++.......+..... +.+|+..+.++.|++|..+.++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 677899999999999999999999644 46689999998655444444334 5789999999999999999988
Q ss_pred EEeC--------CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 105 FENR--------EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 105 ~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
+... +..+++|||++|.+|.++.. +++ ....++..++..+|+.|++|||++|+||+++.+| ++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 7643 35789999999999988742 333 2456999999999999999999999999999888 99
Q ss_pred EeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHH
Q psy2306 177 IADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV 230 (335)
Q Consensus 177 L~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 230 (335)
|+|||............ .......+ ..++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~d-----------~~vler~y-~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAKD-----------RIDLERHY-GIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhHH-----------HHHHHhHh-cccccccceeEeehHHH
Confidence 99999876553222111 13334445 47899999999887665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=175.06 Aligned_cols=144 Identities=20% Similarity=0.218 Sum_probs=112.7
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHH-----------------------HHHHHHHHHHHHHcCCCCc
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEA-----------------------DLIRIRREIQIMSSVRHPN 97 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~~ 97 (335)
...||+|++|.||+|.+. +|+.||+|+++........ .......|...+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999999764321111 0123345899999998777
Q ss_pred ccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh-HHCCcEecCCCCCCEEEccCCCeE
Q psy2306 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC-HKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 98 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~L-H~~givH~di~p~nili~~~~~~k 176 (335)
+.....+... ..++||||++|+++........+++...+..++.|++.+|.+| |+.|++||||||+||+++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6444433222 2389999999887765544456799999999999999999999 799999999999999997 57899
Q ss_pred EeeccccccccC
Q psy2306 177 IADFGLSNVFTE 188 (335)
Q Consensus 177 L~df~~~~~~~~ 188 (335)
|+|||++.....
T Consensus 158 LiDFG~a~~~~~ 169 (190)
T cd05147 158 IIDVSQSVEHDH 169 (190)
T ss_pred EEEccccccCCC
Confidence 999999975433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-25 Score=202.42 Aligned_cols=241 Identities=31% Similarity=0.538 Sum_probs=201.6
Q ss_pred eeccCCeEEEEEE---ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEEEecCC
Q psy2306 44 LGQGNYGKVQLGI---NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 44 ig~g~~g~Vy~~~---~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
+|.|++|.|+++. -.+.|.-+++|+..+......... ....|-.++...+ ||.+++++..++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6899999999754 234578899999876543222222 4456777788886 9999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCC
Q psy2306 120 GGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199 (335)
Q Consensus 120 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~ 199 (335)
|+.|...+.....+++.....+...++.+++++|+.|++|+|+|++||+++.+|++++.|||.+...-..... +|+.
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~ 157 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY 157 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence 9999999988888899999999999999999999999999999999999999999999999999776554433 8899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCchHHHHHHhcccCCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD-YFEPKNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rp 278 (335)
.|||||+..+ +..++|.||+|+++++|+||..||.. +....|.... ..+......+.++++.++..+|.+|.
T Consensus 158 eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 158 EYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred hhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence 9999999993 37789999999999999999999987 4555555533 34555677899999999999999996
Q ss_pred C-----HHHHhcCCCcCCCCcc
Q psy2306 279 D-----ISVICSHWWIDKDHSV 295 (335)
Q Consensus 279 s-----~~~ll~~~~~~~~~~~ 295 (335)
. +.++++|+||+.-.+.
T Consensus 231 g~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 231 GAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ccCcchhHHHhccchheeeeHh
Confidence 4 4799999999865443
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=206.47 Aligned_cols=250 Identities=25% Similarity=0.318 Sum_probs=186.3
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-CHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-TEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
....+...|...+.||++.|=.|.+|++.+ | .|++|++-+.... .-....+...|+. ....++||.+++.-+...+
T Consensus 17 yfsd~~~e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~ 93 (1431)
T KOG1240|consen 17 YFSDLSVECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD 93 (1431)
T ss_pred HhhcCccceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh
Confidence 344455588999999999999999997764 4 4999998765422 2223333344444 5666899999998887778
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc--
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF-- 186 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~-- 186 (335)
...|+|-+|... +|.+.+..++.+..-+.+.++.|++.||...|+.||+|||||.+||||+.-+-+.|.||....-.
T Consensus 94 kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 94 KAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC
Confidence 888999999965 99999999998999999999999999999999999999999999999999889999999754221
Q ss_pred cCCcc--ccc----cccCCccCChhhhcCC----------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q psy2306 187 TESRF--LST----FCGSPLYASPEIVKGI----------PYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQIS 249 (335)
Q Consensus 187 ~~~~~--~~~----~~~~~~~~aPE~~~~~----------~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 249 (335)
+..++ ..- ...--.|.|||.+... +..+++-||||+||++.||++ |++||.- .++.....
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aYr~ 249 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAYRS 249 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhHhc
Confidence 11111 111 1122359999987431 213778999999999999996 6888732 22222222
Q ss_pred cCCC-----CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 250 NGDY-----FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 250 ~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+.. ...-.+..++++|..|++.||.+|.+|++.|+.
T Consensus 250 ~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2111 112235589999999999999999999999965
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=166.55 Aligned_cols=144 Identities=19% Similarity=0.227 Sum_probs=114.1
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH-----------------------HHHHHHHHHHHHHHcCCCCc
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE-----------------------ADLIRIRREIQIMSSVRHPN 97 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~~~~ 97 (335)
.+.||+|++|.||+|.+. +|+.||+|++........ ........|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 478999999999999987 899999999986421100 01223467889999999888
Q ss_pred ccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeE
Q psy2306 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 98 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~k 176 (335)
+.....+.... .+++|||++|+++........+++......++.+++.++.+||+ .|++|+||||+||+++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75555444332 48999999887554433334568889999999999999999999 9999999999999998 88999
Q ss_pred EeeccccccccC
Q psy2306 177 IADFGLSNVFTE 188 (335)
Q Consensus 177 L~df~~~~~~~~ 188 (335)
|+|||++.....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=195.40 Aligned_cols=238 Identities=22% Similarity=0.327 Sum_probs=181.1
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
...-.+.|.|.+.||.|+||.||.|...+ |+.||||+-++...+.--...++...+. ..--+.|..+...+.-.+.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCCc
Confidence 34445689999999999999999998776 9999999987655444332233322222 1113456666666667888
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-------CCCeEEeecccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-------NGNAKIADFGLS 183 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-------~~~~kL~df~~~ 183 (335)
.++|+||.+.|+|.++++..+.+++..+..++.||+..++.||..|||||||||+|++|.. .--++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 8999999999999999999899999999999999999999999999999999999999953 235899999998
Q ss_pred ccc---cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCC--
Q psy2306 184 NVF---TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKN-- 258 (335)
Q Consensus 184 ~~~---~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 258 (335)
-.+ .+.......+++..|-.+|...+.++ ++.+|.|+|+.+++-|+.|..- + ..++..+....
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y~----------q-~~~g~~~~~~~~~ 916 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKYM----------E-VKNGSSWMVKTNF 916 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHHH----------H-hcCCcceeccccc
Confidence 665 34445667788999999999999999 9999999999999999998643 1 33333222221
Q ss_pred ----C-CchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 259 ----Q-STASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 259 ----~-~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
. ...-.|+..+|+.|-..=|...+|.
T Consensus 917 ~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 917 PRYWKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred hhhhhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 1 1234588999994444445555443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-21 Score=160.74 Aligned_cols=188 Identities=16% Similarity=0.169 Sum_probs=142.4
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH-HHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEEE
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE-ADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+.+...|++|+||+||.+.. .+.+++.+.+........ .....+.+|+++|+++. ++++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 44678899999999998754 578888887765332211 12335789999999995 5889999886 4569999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCC-CCCCEEEccCCCeEEeeccccccccCCcccc-
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL-KLENILLDENGNAKIADFGLSNVFTESRFLS- 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di-~p~nili~~~~~~kL~df~~~~~~~~~~~~~- 193 (335)
||+.|.+|.+.+.. ....++.|++.+|.++|+.|++|+|| +|+||+++.++.++|+|||++..........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999998755421 12357889999999999999999999 7999999999999999999998655433210
Q ss_pred -------------ccccCCccCChhhhcCCCCCC-CcchHHHHHHHHHHHHhCCCCCCC
Q psy2306 194 -------------TFCGSPLYASPEIVKGIPYHG-PEVDCWSLGVLLYTLVYGAMPFDG 238 (335)
Q Consensus 194 -------------~~~~~~~~~aPE~~~~~~~~~-~~~Dv~slG~~l~~l~tg~~p~~~ 238 (335)
-...++.++.|+...-..-.+ .+.+.++.|+-+|.++|+..+.-.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 122477788888765432213 578999999999999999888643
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.4e-23 Score=169.89 Aligned_cols=239 Identities=22% Similarity=0.352 Sum_probs=188.9
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
...+..+|.....|..|+|++. |..++.|++..... .....+.+.+|.-.|+-+.||||+++++.|....+..++..
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 4556778889999999999877 55778888765333 23334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEccCCCeEEe--eccccccccCCc
Q psy2306 117 YAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLDENGNAKIA--DFGLSNVFTESR 190 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~~~~~~kL~--df~~~~~~~~~~ 190 (335)
|++.++|..++.... ..+..+..+++.+++.|++|||+.. +--..++...++|+++.+.+|. |--++...
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe---- 343 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---- 343 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec----
Confidence 999999999998643 4778889999999999999999874 3344688999999988765543 43322111
Q ss_pred cccccccCCccCChhhhcCCCCC--CCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC---CCCCCCCCchHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYH--GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD---YFEPKNQSTASPL 265 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~--~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l 265 (335)
....-.|.|++||.++..+-+ -.++|+|||++++|||.|...||.+-.+.+.--++.-+. ..++..+..+..+
T Consensus 344 --~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 344 --VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred --cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 112236789999999876542 357899999999999999999999887776655444332 3567778889999
Q ss_pred HHHhcccCCCCCCCHHHHh
Q psy2306 266 IAEMLNINPSSRADISVIC 284 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll 284 (335)
+.-|++.||.+||.+..|+
T Consensus 422 m~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHhcCCCCcCCCcceeh
Confidence 9999999999999988765
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=192.96 Aligned_cols=220 Identities=32% Similarity=0.506 Sum_probs=171.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
...|..++.|..|++|.||+++++.+.+.+++|+ ++... +.+- ++.....|.++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--cccccCCccee---------------
Confidence 4589999999999999999999999999999954 32110 1110 22222333332
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-----
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES----- 189 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~----- 189 (335)
|+-..+++.-++++... +.+++|||+.||+|+|++|+|.+|+.-|++||.|||+...-...
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 34445555555555444 78899999999999999999999999999999999987542110
Q ss_pred -----------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC--
Q psy2306 190 -----------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-- 256 (335)
Q Consensus 190 -----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 256 (335)
-.....+|++.|.|||++....| +.-+|+|++|+++|+.+-|..||.+.+++++..++.......+
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 01124589999999999988777 7889999999999999999999999999999988887654222
Q ss_pred --CCCCchHHHHHHhcccCCCCC---CCHHHHhcCCCcCCCCcc
Q psy2306 257 --KNQSTASPLIAEMLNINPSSR---ADISVICSHWWIDKDHSV 295 (335)
Q Consensus 257 --~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~~~~~~~~~~ 295 (335)
..++++++++.++|..+|..| +.+-++-+|+||+...+.
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 235689999999999999999 477789999999977665
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=171.04 Aligned_cols=187 Identities=27% Similarity=0.407 Sum_probs=137.9
Q ss_pred CCCcccceeEEEEe---------------------------CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHH
Q psy2306 94 RHPNIIHIYEVFEN---------------------------REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146 (335)
Q Consensus 94 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~ 146 (335)
+||||+++...|.+ ....|+||...+ .+|.+++..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999988743 236899999884 59999998655 46666777889999
Q ss_pred HHHHHhHHCCcEecCCCCCCEEEc--cCC--CeEEeeccccccccC-------CccccccccCCccCChhhhcCCCC---
Q psy2306 147 TAVYYCHKHKICHRDLKLENILLD--ENG--NAKIADFGLSNVFTE-------SRFLSTFCGSPLYASPEIVKGIPY--- 212 (335)
Q Consensus 147 ~~l~~LH~~givH~di~p~nili~--~~~--~~kL~df~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~--- 212 (335)
+|+.|||++|+.|||+|.+||++. +++ .+++.|||++-.-.. ....-...|...-||||+....+-
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 333 578999997633221 122234557778999999864431
Q ss_pred --CCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHHhc-CCCCCCCCCCchHHHHHHhcccCCCCCCCHHH
Q psy2306 213 --HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL--VKQISN-GDYFEPKNQSTASPLIAEMLNINPSSRADISV 282 (335)
Q Consensus 213 --~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~--~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 282 (335)
+-.++|.|+.|.+.||+++...||.......+ ...... -...+...++.+++++..+|+.||++|++++-
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 23479999999999999999999976322111 001111 11234456778999999999999999998653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=159.53 Aligned_cols=147 Identities=21% Similarity=0.221 Sum_probs=115.9
Q ss_pred ceeEEeeeeccCCeEEEEEE-ECCCCcEEEEEEeecCCcCC---------------------HHHHHHHHHHHHHHHcCC
Q psy2306 37 RFDIVRKLGQGNYGKVQLGI-NKETGQEVAIKTIKKCKIET---------------------EADLIRIRREIQIMSSVR 94 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~-~~~~~~~valK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~ 94 (335)
-|++.+.||+|++|.||+|. +..+|..|++|.+....... ......+..|+..+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 66789999999987543210 011234568999999997
Q ss_pred CC--cccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCC-cEecCCCCCCEEEcc
Q psy2306 95 HP--NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK-ICHRDLKLENILLDE 171 (335)
Q Consensus 95 ~~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~g-ivH~di~p~nili~~ 171 (335)
+. .++++++. ...++||||++|.+|.........+....+..++.|++.++.+||+.| ++|+||+|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 33444442 235899999999888776544556677778899999999999999999 99999999999998
Q ss_pred CCCeEEeeccccccccC
Q psy2306 172 NGNAKIADFGLSNVFTE 188 (335)
Q Consensus 172 ~~~~kL~df~~~~~~~~ 188 (335)
++.++|+|||.+.....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 88999999998865443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-19 Score=151.00 Aligned_cols=135 Identities=21% Similarity=0.224 Sum_probs=106.6
Q ss_pred EEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-----CCCcccceeEEEEeCC---e-
Q psy2306 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-----RHPNIIHIYEVFENRE---K- 110 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~- 110 (335)
-.+.||+|++|.||. ++.++.. ++|++..... ...+.+.+|+..++.+ .||||+++++++++.. .
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 6666665 6998875322 2345789999999999 5799999999998764 3
Q ss_pred EEEEEec--CCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHH-HHhHHCCcEecCCCCCCEEEccC----CCeEEeecccc
Q psy2306 111 MVLVMEY--AAGGELYDFLDQKKVLTEEEARRIFRQIATAV-YYCHKHKICHRDLKLENILLDEN----GNAKIADFGLS 183 (335)
Q Consensus 111 ~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l-~~LH~~givH~di~p~nili~~~----~~~kL~df~~~ 183 (335)
+.+|+|| +.+++|.+++++. .+++. ..++.+++.++ +|||+++|+|+||||+||+++.. +.++|+|++.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 3478999 4478999999764 46655 35677888777 99999999999999999999743 37999994433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.6e-19 Score=148.48 Aligned_cols=137 Identities=28% Similarity=0.400 Sum_probs=115.4
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH-----HHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE-----ADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
+.||+|++|.||+|.. +|..+++|.......... .....+.+|+..+..+.++++.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999976 577899998664332221 123467789999999999998888777777888899999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
|++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999875432 8889999999999999999999999999999998 78999999998865
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=160.76 Aligned_cols=197 Identities=24% Similarity=0.415 Sum_probs=157.3
Q ss_pred HHcCCCCcccceeEEEEeCCeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCc-EecCCCCCCE
Q psy2306 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKI-CHRDLKLENI 167 (335)
Q Consensus 90 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~gi-vH~di~p~ni 167 (335)
|+.+.|.|+.++++.+.++...+++.+||..|+|.+.+.. ...+++--...++++++.||+|||+..+ +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999986 4468888888999999999999997765 9999999999
Q ss_pred EEccCCCeEEeeccccccccC---CccccccccCCccCChhhhcCCCC------CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy2306 168 LLDENGNAKIADFGLSNVFTE---SRFLSTFCGSPLYASPEIVKGIPY------HGPEVDCWSLGVLLYTLVYGAMPFDG 238 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Dv~slG~~l~~l~tg~~p~~~ 238 (335)
+++..-.+||.|||+...... ............|.|||.+..... .+.+.|+||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999877643 111112223456999999876421 36779999999999999999999965
Q ss_pred ----CcHHHHHHHHhc-CC-CCCC------CCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 239 ----SNFKRLVKQISN-GD-YFEP------KNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 239 ----~~~~~~~~~~~~-~~-~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..+.+....+.. +. ...| ..++++..++++||..+|.+||+++++-..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 233456666555 22 1222 223468899999999999999999987643
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-20 Score=165.90 Aligned_cols=173 Identities=27% Similarity=0.451 Sum_probs=137.3
Q ss_pred eEEEEEecCCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK---VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
..|+.|++|.-.+|.+|+.++. ..+....+.++.|+..++.| +|.+|+|++|.||+...++.+||+|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5789999999999999997543 36778899999999999999 99999999999999999999999999998777
Q ss_pred cCCc-------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcCCCCCC--
Q psy2306 187 TESR-------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGSNFKRLVKQISNGDYFEP-- 256 (335)
Q Consensus 187 ~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~-- 256 (335)
.... ..+...|+.+||+||.+.+..+ +.++|||+||++++|++.- ...+.. ......+..+.+++.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFL 482 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHh
Confidence 6544 4567789999999999999888 9999999999999999961 112111 112222333333211
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
...+.-..|+..||.+.|.+||++.+.-.|+|.
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 123355689999999999999988887777775
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=144.09 Aligned_cols=133 Identities=25% Similarity=0.336 Sum_probs=108.6
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC-----HHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET-----EADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 43 ~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
.||+|++|.||+|.. +|..+++|......... ......+.+|+.++..++++++.....++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 479999999999973 57889999865432211 12346678899999999888766666666667778999999
Q ss_pred CCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 118 AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 118 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998865321 7899999999999999999999999999998 88999999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=145.14 Aligned_cols=141 Identities=22% Similarity=0.310 Sum_probs=109.8
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH-------------------HHHHHHHHHHHHHHcCCCC-
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE-------------------ADLIRIRREIQIMSSVRHP- 96 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~~~- 96 (335)
.|.+.+.||+|++|.||++... +|+.|++|++........ ........|...+..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 799999999765321000 1112356788888888766
Q ss_pred -cccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCe
Q psy2306 97 -NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA 175 (335)
Q Consensus 97 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~ 175 (335)
.++..++ .+..+++|||++|++|..+... .....++.+++.++.++|+.|++|+||+|+||+++.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 3444443 3455899999999998776431 3456788999999999999999999999999999999999
Q ss_pred EEeeccccccccC
Q psy2306 176 KIADFGLSNVFTE 188 (335)
Q Consensus 176 kL~df~~~~~~~~ 188 (335)
+|+|||.+.....
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999865544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-17 Score=158.39 Aligned_cols=140 Identities=24% Similarity=0.317 Sum_probs=113.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc-----CCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI-----ETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
..|...+.||+|+||+||++.... ..+++|....... ......+.+.+|+.+++.++|++++....++.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345678999999999999997653 3445554322111 111234568899999999999999888877777778
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
.+++|||+++++|.+++. ....++.+++.+|.+||+.|++||||+|+||++ .++.++|+|||++...
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999999885 356789999999999999999999999999999 6789999999998653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=136.26 Aligned_cols=140 Identities=21% Similarity=0.320 Sum_probs=99.4
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHH---------------------HHHHHHHHHcCCCC--c
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR---------------------IRREIQIMSSVRHP--N 97 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~~~--~ 97 (335)
.+.||+|+||.||.|.+. +|..|++|++............. ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999877 78999999987643221111111 13455556555433 2
Q ss_pred ccceeEEEEeCCeEEEEEecCCCCCHH-HHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCe
Q psy2306 98 IIHIYEVFENREKMVLVMEYAAGGELY-DFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNA 175 (335)
Q Consensus 98 i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~ 175 (335)
+.++++. ...+++|||++++.+. ..+.... . ......++.+++.++.++|+ .|++|+||+|+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 2458999999884332 1111111 1 16688899999999999999 9999999999999999 8999
Q ss_pred EEeeccccccccC
Q psy2306 176 KIADFGLSNVFTE 188 (335)
Q Consensus 176 kL~df~~~~~~~~ 188 (335)
+|+|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-19 Score=170.71 Aligned_cols=256 Identities=30% Similarity=0.529 Sum_probs=206.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC-CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE-TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMV 112 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 112 (335)
...|.+.+.||+|+++.|-.+.... ....++.|.+.... ......+.+..|...-+.+. |.|++..++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 3478888999999999999987644 34556777665433 33444556666777777776 999999999999999999
Q ss_pred EEEecCCCCCHHHHH-hhCC-CCCHHHHHHHHHHHHHHHHHhH-HCCcEecCCCCCCEEEccCC-CeEEeeccccccccC
Q psy2306 113 LVMEYAAGGELYDFL-DQKK-VLTEEEARRIFRQIATAVYYCH-KHKICHRDLKLENILLDENG-NAKIADFGLSNVFTE 188 (335)
Q Consensus 113 lv~e~~~~~~L~~~l-~~~~-~~~~~~~~~i~~~l~~~l~~LH-~~givH~di~p~nili~~~~-~~kL~df~~~~~~~~ 188 (335)
+.+++..|+++.+-+ .... ..+......++.|+..++.|+| ..++.|+||+|+|.+++..+ .+++.|||+++....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999888 5444 6788888999999999999999 99999999999999999999 999999999987654
Q ss_pred ----Ccccccccc-CCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHHhcC----CCCCCC
Q psy2306 189 ----SRFLSTFCG-SPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL--VKQISNG----DYFEPK 257 (335)
Q Consensus 189 ----~~~~~~~~~-~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~--~~~~~~~----~~~~~~ 257 (335)
.......+| ++.|+|||...+..+..+..|+||.|+++..+++|..|+........ ...+... ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 222345667 99999999999877778899999999999999999999866443221 1111111 122334
Q ss_pred CCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 258 NQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
......+++.+++..+|..|.+.+++-.++|+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 5667888999999999999999999999999987
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-18 Score=149.50 Aligned_cols=246 Identities=19% Similarity=0.281 Sum_probs=171.3
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCcCCH-HHHHHHHHHHHHHHcCCCCcccceeEEEEeC-----CeEEEEEecCCCC
Q psy2306 48 NYGKVQLGINKETGQEVAIKTIKKCKIETE-ADLIRIRREIQIMSSVRHPNIIHIYEVFENR-----EKMVLVMEYAAGG 121 (335)
Q Consensus 48 ~~g~Vy~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~ 121 (335)
+.-.||++.+.+.|.+|....++....... +..++...-+..|-.+-|.||++++.++.+. ....+++||+..|
T Consensus 78 gid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssg 157 (458)
T KOG1266|consen 78 GIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSG 157 (458)
T ss_pred chHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccch
Confidence 444578887777787777665543222111 1122333445556666799999999998543 3578999999999
Q ss_pred CHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHC--CcEecCCCCCCEEEccCCCeEEeeccccccccC-----Cc
Q psy2306 122 ELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKH--KICHRDLKLENILLDENGNAKIADFGLSNVFTE-----SR 190 (335)
Q Consensus 122 ~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~--givH~di~p~nili~~~~~~kL~df~~~~~~~~-----~~ 190 (335)
++..+|++ +..+.....++|+-||+.||.|||+. -++|+++..+.|++..+|-+|++--........ ..
T Consensus 158 s~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~ 237 (458)
T KOG1266|consen 158 SLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREA 237 (458)
T ss_pred hHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHh
Confidence 99999975 45688999999999999999999987 599999999999999999888764322211111 11
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhcCCCCCCCCCCchHHHHHHh
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS-NFKRLVKQISNGDYFEPKNQSTASPLIAEM 269 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 269 (335)
......+-++|.+||.-..... +-++|||++|++..+|.-|..--.+. ..-.....+.+ .........-+.++++|
T Consensus 238 Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~--~i~~len~lqr~~i~kc 314 (458)
T KOG1266|consen 238 EKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN--VIIGLENGLQRGSITKC 314 (458)
T ss_pred hhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh--heeeccCccccCcCccc
Confidence 1123345778999998665555 66899999999999998765432221 11111111111 11222233445689999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 270 LNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
|+..|..||++++++.||..-..+...
T Consensus 315 l~~eP~~rp~ar~llfHpllfeVhslk 341 (458)
T KOG1266|consen 315 LEGEPNGRPDARLLLFHPLLFEVHSLK 341 (458)
T ss_pred ccCCCCCCcchhhhhcCceeeecchHH
Confidence 999999999999999999998877664
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.9e-16 Score=133.66 Aligned_cols=138 Identities=20% Similarity=0.314 Sum_probs=104.6
Q ss_pred eeee-ccCCeEEEEEEECCCCcEEEEEEeecCCc----------CCHHHHHHHHHHHHHHHcCCCCcc--cceeEEEEeC
Q psy2306 42 RKLG-QGNYGKVQLGINKETGQEVAIKTIKKCKI----------ETEADLIRIRREIQIMSSVRHPNI--IHIYEVFENR 108 (335)
Q Consensus 42 ~~ig-~g~~g~Vy~~~~~~~~~~valK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~ 108 (335)
..|| .||.|+||.+... +..+++|.+..... ........+.+|+.++..++++++ ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4566 7888888888654 77899998853211 112334577889999999988775 6666664332
Q ss_pred -C---eEEEEEecCCC-CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 109 -E---KMVLVMEYAAG-GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 109 -~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
. ..++++|+++| .+|.+++.. .+++... +.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999997 689988865 3455543 568999999999999999999999999999899999999988
Q ss_pred ccc
Q psy2306 184 NVF 186 (335)
Q Consensus 184 ~~~ 186 (335)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 653
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.4e-17 Score=150.27 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=198.1
Q ss_pred hhhhhccceeEEeeeec--cCCeEEEEEEE--CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEE
Q psy2306 30 HRRKLKQRFDIVRKLGQ--GNYGKVQLGIN--KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEV 104 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~--g~~g~Vy~~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~ 104 (335)
....+...|-+.+.+|. |.+|.||.+.. ..++..+++|.-+... ........-.+|+.....++ |++.++.+..
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcc
Confidence 45567778999999999 99999999988 8889999999844311 11122223345666666665 8999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHH----HHHHhHHCCcEecCCCCCCEEEccC-CCeEEe
Q psy2306 105 FENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIAT----AVYYCHKHKICHRDLKLENILLDEN-GNAKIA 178 (335)
Q Consensus 105 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~----~l~~LH~~givH~di~p~nili~~~-~~~kL~ 178 (335)
++..+..++-+|.+ +.+|..+..... .++...++..+.++.. |+.++|+.+++|.+++|.||+...+ ...+++
T Consensus 187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 187 WEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecC
Confidence 99999999999999 467777776544 4899999999999999 9999999999999999999999998 789999
Q ss_pred eccccccccCCcccc------ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHh
Q psy2306 179 DFGLSNVFTESRFLS------TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---NFKRLVKQIS 249 (335)
Q Consensus 179 df~~~~~~~~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---~~~~~~~~~~ 249 (335)
||+............ ...+...|++||...+.. +...|+|++|.++.+-.++..+.... .+.+..+...
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 999988776554322 125677899999998754 78899999999999999887765433 2222111111
Q ss_pred cCCCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 250 NGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.. ......+.++...+..|++.+|..|++++.+..++++.+.
T Consensus 344 p~-e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 344 PL-EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ch-hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 11 1122234466679999999999999999999999998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.3e-16 Score=122.49 Aligned_cols=132 Identities=24% Similarity=0.294 Sum_probs=111.0
Q ss_pred EEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC--CcccceeEEEEeCCeEEEEEec
Q psy2306 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH--PNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
+.+.||+|.++.||++.+.. ..+++|....... ...+.+|...++.+++ .++++++.+....+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999998753 7899999865322 3467789999999976 5889999988888899999999
Q ss_pred CCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC---CcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 118 AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH---KICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 118 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~---givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
+++.++..+ +......++.+++++++.||.. +++|+|++|+||+++..+.++++||+.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988777544 5567778899999999999984 799999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.5e-15 Score=139.27 Aligned_cols=184 Identities=20% Similarity=0.316 Sum_probs=142.3
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
-|++ ...+-++.+..-.|..+.++.+|.+..+..... +......+.+..|+.++||||+++++.++..+..|+|+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 4555 444444544433577778899999999876332 445677888999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhH-HCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-ccc
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH-KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LST 194 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH-~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-~~~ 194 (335)
.+. +|..++++.+ ...+..-+.||+.||.||| +++++|++|+-+.|+|+..|+.||++|..+........ ...
T Consensus 90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~ 164 (690)
T KOG1243|consen 90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS 164 (690)
T ss_pred ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc
Confidence 993 7887887643 7778888999999999997 78999999999999999999999999998866543321 111
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG 232 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg 232 (335)
..--..|..|+.+....+ ..|.|.|||++++++.|
T Consensus 165 ~~~~~s~~~P~~~~~s~~---s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 165 LYLIESFDDPEEIDPSEW---SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhcccChhhcCcccc---chhhhhHHHHHHHHhCc
Confidence 111223666666554332 47999999999999998
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-15 Score=148.11 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=202.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+.+.+.+.+.+|.++.++.+.-..+|.....|+......-.....+..+.+-..+-..++|.+++..-.+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 46778889999999999998777777666666554322222222333333433333344566666655555677889999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-------
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE------- 188 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~------- 188 (335)
++..+++|...++..++.+.+.....+..+..++++||+..+.|+|++|.|+++..+++.++.+|+.....+-
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 9999999999999888888888888899999999999999999999999999999999999999974322110
Q ss_pred -------------------------CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy2306 189 -------------------------SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR 243 (335)
Q Consensus 189 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~ 243 (335)
........+++.|.+||...+... ...+|+|+.|.++++.++|..||....+++
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 011123457889999999988776 788999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCC----CCCchHHHHHHhcccCCCCCCCHH---HHhcCCCcCCCCcc
Q psy2306 244 LVKQISNGDYFEPK----NQSTASPLIAEMLNINPSSRADIS---VICSHWWIDKDHSV 295 (335)
Q Consensus 244 ~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~---~ll~~~~~~~~~~~ 295 (335)
..+.+.+.....+. .+.+..+++.+.|..+|.+|..+. ++-.|+||+...+.
T Consensus 1043 ~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1043 IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 99888887654433 356889999999999999998887 99999999976554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.7e-14 Score=133.19 Aligned_cols=143 Identities=23% Similarity=0.305 Sum_probs=97.6
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHH-------------------------------HH------HHHH
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEA-------------------------------DL------IRIR 84 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~-------------------------------~~------~~~~ 84 (335)
+.||.|++|.||+|+.+ +|+.||||+.++.....-. .. -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999876 6899999998653110000 00 1234
Q ss_pred HHHHHHHcCC-----CCcccceeEEEEeCCeEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHH-HHHHhHHCCc
Q psy2306 85 REIQIMSSVR-----HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIAT-AVYYCHKHKI 157 (335)
Q Consensus 85 ~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~-~l~~LH~~gi 157 (335)
+|+..+.+++ ++++.-..-+....+..+++|||++|++|.++.... ... ....++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 4555554442 233222222222344578999999999998876532 112 23456666665 4678999999
Q ss_pred EecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 158 CHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 158 vH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
+|+|++|.||+++.++.++|+|||.+.....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.4e-13 Score=112.15 Aligned_cols=143 Identities=20% Similarity=0.201 Sum_probs=103.2
Q ss_pred EeeeeccCCeEEEEEEECC------CCcEEEEEEeecCCc--C-----------------CHHHHHHH----HHHHHHHH
Q psy2306 41 VRKLGQGNYGKVQLGINKE------TGQEVAIKTIKKCKI--E-----------------TEADLIRI----RREIQIMS 91 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~------~~~~valK~~~~~~~--~-----------------~~~~~~~~----~~e~~~l~ 91 (335)
...||.|-.+.||.|.... .+..+|+|++..... . .......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997653 357899999753211 0 01112223 38999998
Q ss_pred cCCC--CcccceeEEEEeCCeEEEEEecCCCCCHH-HHHhhCCCCCHHHHHHHHHHHHHHHHHh-HHCCcEecCCCCCCE
Q psy2306 92 SVRH--PNIIHIYEVFENREKMVLVMEYAAGGELY-DFLDQKKVLTEEEARRIFRQIATAVYYC-HKHKICHRDLKLENI 167 (335)
Q Consensus 92 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~i~~~l~~~l~~L-H~~givH~di~p~ni 167 (335)
++.. -+++.++++ ...+++|||+.+..+. ..++ ...++......+..+++.+|..| |+.|++||||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8853 456666654 5668999999764332 2222 23456667788899999999998 899999999999999
Q ss_pred EEccCCCeEEeeccccccccCC
Q psy2306 168 LLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~~ 189 (335)
+++ ++.+.|+||+.+.....+
T Consensus 157 L~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred EEE-CCcEEEEECCCceeCCCC
Confidence 996 578999999988665443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-14 Score=135.51 Aligned_cols=145 Identities=23% Similarity=0.352 Sum_probs=95.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC---------------------------H----HHHHH--
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET---------------------------E----ADLIR-- 82 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~---------------------------~----~~~~~-- 82 (335)
..|.. +.||+|++|.||.|+.+.+|+.||+|+.++.-... . +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 79999999999999999889999999987531000 0 11122
Q ss_pred ----HHHHHHHHHcCC----CCcccceeEEEE-eCCeEEEEEecCCCCCHHHH--HhhCC----CCCHHHHHHHHHHHHH
Q psy2306 83 ----IRREIQIMSSVR----HPNIIHIYEVFE-NREKMVLVMEYAAGGELYDF--LDQKK----VLTEEEARRIFRQIAT 147 (335)
Q Consensus 83 ----~~~e~~~l~~l~----~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~--l~~~~----~~~~~~~~~i~~~l~~ 147 (335)
+.+|+....+++ +...+.+-.++. -.+..+++|||++|+++.++ +...+ .+.+..+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 233444444332 332233323332 24567899999999999874 33322 1333333334444
Q ss_pred HHHHhHHCCcEecCCCCCCEEEccCC----CeEEeeccccccccC
Q psy2306 148 AVYYCHKHKICHRDLKLENILLDENG----NAKIADFGLSNVFTE 188 (335)
Q Consensus 148 ~l~~LH~~givH~di~p~nili~~~~----~~kL~df~~~~~~~~ 188 (335)
+...|++|+|+||.||+++.++ .++++|||.+.....
T Consensus 276 ----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4468999999999999999888 999999999876643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.8e-13 Score=107.51 Aligned_cols=134 Identities=25% Similarity=0.320 Sum_probs=104.2
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecC-----CcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKC-----KIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
..+++|+.+.+|.+... |.++++|.=.+. .....-..++..+|+.++..++--.|....-+..+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999999554 556777753221 12223345677899999999987777777777778888899999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
|++|..|.+.+... ...++..+=.-+.-||..||+||||.++||++..+ .+.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 99999999898765 25566777778889999999999999999999655 499999999864
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.1e-14 Score=131.59 Aligned_cols=264 Identities=19% Similarity=0.162 Sum_probs=192.9
Q ss_pred CCCCccchhh-hhhhccceeEEeeeeccCCeEEEEEEEC-CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCc
Q psy2306 21 STGGVRLHNH-RRKLKQRFDIVRKLGQGNYGKVQLGINK-ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPN 97 (335)
Q Consensus 21 ~~~~~~~~~~-~~~~~~~y~~~~~ig~g~~g~Vy~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~ 97 (335)
++..+....- ..+...+|..+..||.|.|+.|+.+... .++..|++|.......... ....-..|+-+...+ .|.+
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccc
Confidence 5566666665 7788889999999999999999987644 6788899998876443333 333444566666666 4888
Q ss_pred ccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-CCeE
Q psy2306 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-GNAK 176 (335)
Q Consensus 98 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~-~~~k 176 (335)
++..+..|......|+--||+.++++...+....-+.+..++.+..|++.++.++|+..++|+|++|+||++..+ +..+
T Consensus 328 ~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred cCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhh
Confidence 999888888878888999999998876655444557888899999999999999999999999999999999876 6788
Q ss_pred EeeccccccccCCccccccccCCccC-ChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-CCC
Q psy2306 177 IADFGLSNVFTESRFLSTFCGSPLYA-SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-DYF 254 (335)
Q Consensus 177 L~df~~~~~~~~~~~~~~~~~~~~~~-aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~ 254 (335)
++||++.+.+.... .......++. ..|++.....+..+.|+|+||..+.+.++|...-...+... .+..+ ...
T Consensus 408 ~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~~~p~ 482 (524)
T KOG0601|consen 408 LGDFGCWTRLAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSGDTPN 482 (524)
T ss_pred ccccccccccceec--ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecccccC
Confidence 99999886422111 1112223344 35555554445889999999999999998865433322111 12222 122
Q ss_pred CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 255 EPKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
.+.....+..+.+.++.+++..||.+.++..|.-|-
T Consensus 483 ~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 483 LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred CCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 233346777899999999999999999998887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.7e-13 Score=108.66 Aligned_cols=127 Identities=22% Similarity=0.246 Sum_probs=94.2
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc-cceeEEEEeCCeEEEEEecCC
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI-IHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~ 119 (335)
.+.|+.|.++.||++... +..|++|....... .......|+..++.+.+.++ ++++... ....+++||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 467889999999999765 77899999765321 12234678888888765443 4455443 334579999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCc-----EecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 120 GGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI-----CHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 120 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~gi-----vH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
|.++... .......+.++..+|+.||+.++ +|+|++|+||+++ ++.++++||+.+.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9877543 01123456789999999999885 9999999999998 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.2e-12 Score=101.18 Aligned_cols=145 Identities=25% Similarity=0.353 Sum_probs=112.6
Q ss_pred EEeeeeccCCeEEEEEEECCCCcEEEEEEe-----ecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTI-----KKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~~~valK~~-----~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
....|-+|+.+.|+++.+. |+.+++|.= .....+..-...+..+|++.|.++.--.|.-..-++.+...-.+.
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678899999999999655 888888852 222233344567788999999998766777777777788888999
Q ss_pred EecCCC-CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC---CeEEeeccccccc
Q psy2306 115 MEYAAG-GELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG---NAKIADFGLSNVF 186 (335)
Q Consensus 115 ~e~~~~-~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~---~~kL~df~~~~~~ 186 (335)
|||++| .++.+++... ..........++.++=+.+.-||..+++||||.++||++..++ .+.|+|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999977 4778877652 2233334478899999999999999999999999999997765 4589999988553
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.4e-11 Score=105.22 Aligned_cols=233 Identities=15% Similarity=0.212 Sum_probs=156.4
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEE-----E--EeCC
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEV-----F--ENRE 109 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~-----~--~~~~ 109 (335)
-.....||+|+-+.+|..-.- ...+.|+++....... . +.+..|... .||-+-.-+.+ + ..+.
T Consensus 13 i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred cCCCccccCCccceeeecchh---hchhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 345678999999999976222 2356788876332211 1 122223333 35533221111 0 1233
Q ss_pred eEEEEEecCCCCC-HHHHHh------hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 110 KMVLVMEYAAGGE-LYDFLD------QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 110 ~~~lv~e~~~~~~-L~~~l~------~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
.+.++|..+.+.. +..+.+ +.....+.-+.++++.++.+.+.||..|.+-||++++|+|+++++.+.|.|-+.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 4788888887652 222222 233588899999999999999999999999999999999999999999999776
Q ss_pred cccccCCccccccccCCccCChhhhc-----CCCCCCCcchHHHHHHHHHHHHhC-CCCCCCC-------cHHHHHHHHh
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVK-----GIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGS-------NFKRLVKQIS 249 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Dv~slG~~l~~l~tg-~~p~~~~-------~~~~~~~~~~ 249 (335)
.....+.....+..|...|.+||... +... +...|.|.||+++++++.| ++||.+- ++.+ ..|.
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~Ia 240 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDIA 240 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhhh
Confidence 65556666667788999999999865 2233 6789999999999999976 9999652 1111 1111
Q ss_pred cCCC-----------------CCCCCCCchHHHHHHhccc--CCCCCCCHHH
Q psy2306 250 NGDY-----------------FEPKNQSTASPLIAEMLNI--NPSSRADISV 282 (335)
Q Consensus 250 ~~~~-----------------~~~~~~~~l~~li~~~l~~--dp~~Rps~~~ 282 (335)
.+.+ +..-.++.+..++.+|+.. .+.-|||++.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1111 1112366788888888875 4678999864
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-12 Score=122.50 Aligned_cols=148 Identities=20% Similarity=0.323 Sum_probs=110.3
Q ss_pred HHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc----------cccccCCccCChhhhcCCCC
Q psy2306 144 QIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL----------STFCGSPLYASPEIVKGIPY 212 (335)
Q Consensus 144 ~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~ 212 (335)
+...|+.|+|+ .++||++|.|++|+++..+.+||+.|+++....++... ........|.|||++.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 34489999995 59999999999999999999999999987665442111 11223557999999988655
Q ss_pred CCCcchHHHHHHHHHHHH-hCCCCCCCCcH-HHHHHHHh---cCCC-CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 213 HGPEVDCWSLGVLLYTLV-YGAMPFDGSNF-KRLVKQIS---NGDY-FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 213 ~~~~~Dv~slG~~l~~l~-tg~~p~~~~~~-~~~~~~~~---~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+.++|+||+|+++|.+. .|...+..... ........ ...+ .....++++++-+.++|..++.-||++.+++..
T Consensus 187 -~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 -TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred -cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 89999999999999999 55555543321 11111111 1111 234568899999999999999999999999999
Q ss_pred CCcCCC
Q psy2306 287 WWIDKD 292 (335)
Q Consensus 287 ~~~~~~ 292 (335)
|||.+.
T Consensus 266 ~ff~D~ 271 (700)
T KOG2137|consen 266 PFFSDP 271 (700)
T ss_pred cccCCc
Confidence 999864
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.3e-11 Score=108.53 Aligned_cols=213 Identities=18% Similarity=0.242 Sum_probs=155.5
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE----eCCeEEEEEecCCCC-C
Q psy2306 48 NYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE----NREKMVLVMEYAAGG-E 122 (335)
Q Consensus 48 ~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~lv~e~~~~~-~ 122 (335)
-..+.|++....+|..|++|+++-....... +.-.-++.++++.|.|++++.++|. .+..+++||+|.++. +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 3468899999999999999999533222221 2334577899999999999998885 466899999999864 6
Q ss_pred HHHHHh---------------hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 123 LYDFLD---------------QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 123 L~~~l~---------------~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
|.++-- ++...++..+|.++.|+..||.++|+.|+..+-+.|.+|+++.+.+++|...|+.....
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 666542 12347899999999999999999999999999999999999999899999888876665
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHhcCCCCCCCCCCchHHHH
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMP-FDGSNFKRLVKQISNGDYFEPKNQSTASPLI 266 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 266 (335)
... . |.+.+ -.+-|.-.||.+++.|.||..- +.......... ......++.+++++|
T Consensus 445 ~d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~-----~~I~~~yS~D~rn~v 502 (655)
T KOG3741|consen 445 EDP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL-----TRITTTYSTDLRNVV 502 (655)
T ss_pred CCC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHH-----HHhhhhhhHHHHHHH
Confidence 442 0 11111 2357999999999999998533 21122222211 112334566788888
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q psy2306 267 AEMLNINPSSRADISVICSH 286 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~ 286 (335)
.-+....+++ -++.+++.+
T Consensus 503 ~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhcCccc-ccHHHHHHH
Confidence 8888887776 677777755
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.2e-11 Score=100.82 Aligned_cols=140 Identities=21% Similarity=0.295 Sum_probs=102.6
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC--CcccceeEEEEeC---CeEEEEEe
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH--PNIIHIYEVFENR---EKMVLVME 116 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~lv~e 116 (335)
+.|+.|..+.+|++...+ |+.+++|........ .....+..|...++.+.+ ..+++++.+.... +..+++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 578999999999997653 688999997653321 123467789999999875 3456777776543 36789999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH------------------------------------------
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK------------------------------------------ 154 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~------------------------------------------ 154 (335)
+++|.++.+.+.. ..++......++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 345666666666666666666663
Q ss_pred --------------CCcEecCCCCCCEEEcc--CCCeEEeecccccc
Q psy2306 155 --------------HKICHRDLKLENILLDE--NGNAKIADFGLSNV 185 (335)
Q Consensus 155 --------------~givH~di~p~nili~~--~~~~kL~df~~~~~ 185 (335)
..++|+|++|+||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999988 56689999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.8e-11 Score=100.22 Aligned_cols=142 Identities=25% Similarity=0.320 Sum_probs=109.9
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecC-------------------CcCCHHHHHHHHHHHHHHHcCCCC-
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKC-------------------KIETEADLIRIRREIQIMSSVRHP- 96 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~-------------------~~~~~~~~~~~~~e~~~l~~l~~~- 96 (335)
-+.++..||-|--|.||.|.+. .|.++++|.=... ..+-........+|.++|+.+...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 4678899999999999999887 5889999973210 011123456678999999999644
Q ss_pred -cccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCe
Q psy2306 97 -NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA 175 (335)
Q Consensus 97 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~ 175 (335)
.+++.++ .+...++||+++|..|...- ++......++..|++.+.-+-..|+||||+++-||+++++|.+
T Consensus 171 ~~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 171 VKVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 6777766 57778999999997775432 2455666777778888777779999999999999999999999
Q ss_pred EEeeccccccccC
Q psy2306 176 KIADFGLSNVFTE 188 (335)
Q Consensus 176 kL~df~~~~~~~~ 188 (335)
.++||-.+.....
T Consensus 242 ~vIDwPQ~v~~~h 254 (304)
T COG0478 242 VVIDWPQAVPISH 254 (304)
T ss_pred EEEeCcccccCCC
Confidence 9999987754433
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.1e-10 Score=94.37 Aligned_cols=130 Identities=27% Similarity=0.357 Sum_probs=86.2
Q ss_pred EEEEEEECCCCcEEEEEEeecCC-----------------------cCCHHHHHHHHHHHHHHHcCCCC--cccceeEEE
Q psy2306 51 KVQLGINKETGQEVAIKTIKKCK-----------------------IETEADLIRIRREIQIMSSVRHP--NIIHIYEVF 105 (335)
Q Consensus 51 ~Vy~~~~~~~~~~valK~~~~~~-----------------------~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~ 105 (335)
.||.|... +|..+|+|+..... ...........+|.+.|..+... ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999775 47799999975311 11222356778999999999765 466666542
Q ss_pred EeCCeEEEEEecCC--CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHH-hHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 106 ENREKMVLVMEYAA--GGELYDFLDQKKVLTEEEARRIFRQIATAVYY-CHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 106 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~-LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
..++||||++ |..+..+.... ++......++.+++..+.. +|+.|++|||+++.||+++++ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3469999998 66665554422 1244567778888885555 689999999999999999776 999999998
Q ss_pred cccccC
Q psy2306 183 SNVFTE 188 (335)
Q Consensus 183 ~~~~~~ 188 (335)
+.....
T Consensus 153 av~~~~ 158 (188)
T PF01163_consen 153 AVDSSH 158 (188)
T ss_dssp EEETTS
T ss_pred ceecCC
Confidence 865543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-09 Score=95.48 Aligned_cols=133 Identities=16% Similarity=0.141 Sum_probs=94.4
Q ss_pred EEEEEEECCCCcEEEEEEeecCCcCC---H-----HHHHHHHHHHHHHHcCCCCc--ccceeEEEEe-----CCeEEEEE
Q psy2306 51 KVQLGINKETGQEVAIKTIKKCKIET---E-----ADLIRIRREIQIMSSVRHPN--IIHIYEVFEN-----REKMVLVM 115 (335)
Q Consensus 51 ~Vy~~~~~~~~~~valK~~~~~~~~~---~-----~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~-----~~~~~lv~ 115 (335)
.|+.+.. .|+.|.+|......... . .-...+.+|...+..+...+ .+.++.+.+. ....++|+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555533 47789999774322100 0 00113668888888875333 3344555543 23578999
Q ss_pred ecCCCC-CHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-------CCCeEEeecccccc
Q psy2306 116 EYAAGG-ELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-------NGNAKIADFGLSNV 185 (335)
Q Consensus 116 e~~~~~-~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-------~~~~kL~df~~~~~ 185 (335)
|++++. +|.+++.. ..+.+......++.++...+..||..|++|+|+++.||+++. +..+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999886 89998864 345667778899999999999999999999999999999975 45799999998753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.1e-09 Score=85.32 Aligned_cols=139 Identities=18% Similarity=0.190 Sum_probs=100.3
Q ss_pred eccCCeEEEEEEECCCCcEEEEEEeecCCcCC---HHHHHHHHHHHHHHHcCCCC--cccceeEEEEe----CCeEEEEE
Q psy2306 45 GQGNYGKVQLGINKETGQEVAIKTIKKCKIET---EADLIRIRREIQIMSSVRHP--NIIHIYEVFEN----REKMVLVM 115 (335)
Q Consensus 45 g~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~----~~~~~lv~ 115 (335)
|+||-+.|+..... |+.+-+|......... +.-..-+.+|...+..+... .++++...... .-..+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56899999987544 4578999865211100 22345678888888888532 24444422111 22478999
Q ss_pred ecCCC-CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC--eEEeecccccc
Q psy2306 116 EYAAG-GELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN--AKIADFGLSNV 185 (335)
Q Consensus 116 e~~~~-~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~--~kL~df~~~~~ 185 (335)
|-+++ .+|.+++... .+.+......++.++..+++-||+.|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 4899888653 35677888899999999999999999999999999999986676 99999986643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.7e-09 Score=88.35 Aligned_cols=106 Identities=25% Similarity=0.310 Sum_probs=84.8
Q ss_pred HHHHHHHHHHHcCCC--CcccceeEEEEeC----CeEEEEEecCCCC-CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhH
Q psy2306 81 IRIRREIQIMSSVRH--PNIIHIYEVFENR----EKMVLVMEYAAGG-ELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153 (335)
Q Consensus 81 ~~~~~e~~~l~~l~~--~~i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH 153 (335)
....+|...+..+.. =.+++++++.... ...++++|++++. +|.+++......+......++.++...++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 356778887777743 2345556665442 2468999999875 89999987555778888999999999999999
Q ss_pred HCCcEecCCCCCCEEEccCC---CeEEeeccccccc
Q psy2306 154 KHKICHRDLKLENILLDENG---NAKIADFGLSNVF 186 (335)
Q Consensus 154 ~~givH~di~p~nili~~~~---~~kL~df~~~~~~ 186 (335)
..|++|+|+++.|||++.++ .+.|+||+-+...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999998887 8999999977543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.3e-09 Score=86.20 Aligned_cols=143 Identities=23% Similarity=0.297 Sum_probs=94.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHH------HHHHHHHHHHcC---CCCcccce
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI------RIRREIQIMSSV---RHPNIIHI 101 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~------~~~~e~~~l~~l---~~~~i~~~ 101 (335)
...++++|.+.+.+-.....-|.+. .-+|+.+++|.........+.... ...+.+.....+ ....+..+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 5667889999999988877667666 445789999997653221111111 112233333333 23333333
Q ss_pred eEEE-----EeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 102 YEVF-----ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 102 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
+.+. .-....+++|||++|..|.++.. +++ .+...+.+++..||+.|++|||.+|.|++++.+ .++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEE
Confidence 3332 22345679999999988876543 222 244567788999999999999999999999754 599
Q ss_pred Eeeccccc
Q psy2306 177 IADFGLSN 184 (335)
Q Consensus 177 L~df~~~~ 184 (335)
++|++...
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.3e-08 Score=96.09 Aligned_cols=172 Identities=20% Similarity=0.263 Sum_probs=106.3
Q ss_pred ChhhhhhhcccccCCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC-----------
Q psy2306 8 PQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET----------- 76 (335)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~----------- 76 (335)
|+..+...-.-++..-|....+....++. ..|+.++-|.||.|+.++ |+.||||+.++.-...
T Consensus 102 pp~~~~~~~~iie~eLG~~iee~F~eF~~-----~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~ 175 (517)
T COG0661 102 PPFPFEEAERIIEEELGRPIEELFSEFEP-----EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRL 175 (517)
T ss_pred CCCCHHHHHHHHHHHhCCCHHHHHHHcCC-----CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHH
Confidence 33333333333333333344444444444 789999999999999885 9999999965411100
Q ss_pred ----------------H----HH------HHHHHHHHHHHHcCC-----CCcccceeEEEEeCCeEEEEEecCCCCCHHH
Q psy2306 77 ----------------E----AD------LIRIRREIQIMSSVR-----HPNIIHIYEVFENREKMVLVMEYAAGGELYD 125 (335)
Q Consensus 77 ----------------~----~~------~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 125 (335)
. +. .-.+.+|...+.+++ .+++.-..-+++-.+...++|||++|..+.+
T Consensus 176 a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d 255 (517)
T COG0661 176 ARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISD 255 (517)
T ss_pred HHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEeccc
Confidence 0 00 112344555554442 3443333333344567789999999998888
Q ss_pred HH--hhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 126 FL--DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 126 ~l--~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
.. +. ...+...+.....++. +..+=..|++|+|.+|.||+++.+|++.+.|||......+
T Consensus 256 ~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 256 IAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 74 43 3355444333322222 2334458999999999999999999999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.7e-08 Score=82.88 Aligned_cols=133 Identities=17% Similarity=0.236 Sum_probs=84.1
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCC--cccceeEEEEeCCeEEEEEecCC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP--NIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
..||+|..+.||+. .|..+++|...... ....+.+|.+.++.+..- .+++++++..+.+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999984 25568899976522 123457899999888633 35778888888888899999998
Q ss_pred CCC-HHHHHh--------------h------C---CCCCHHHHHH-HHH----------HHHHH-HHHhH----HCCcEe
Q psy2306 120 GGE-LYDFLD--------------Q------K---KVLTEEEARR-IFR----------QIATA-VYYCH----KHKICH 159 (335)
Q Consensus 120 ~~~-L~~~l~--------------~------~---~~~~~~~~~~-i~~----------~l~~~-l~~LH----~~givH 159 (335)
|.+ +.+.+. + . .......... +.. .+... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 221110 0 0 0111111010 100 01111 11222 224789
Q ss_pred cCCCCCCEEEccCCCeEEeeccccc
Q psy2306 160 RDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 160 ~di~p~nili~~~~~~kL~df~~~~ 184 (335)
||++|.||++++++ +.++||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999998888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.5e-07 Score=93.98 Aligned_cols=209 Identities=17% Similarity=0.178 Sum_probs=150.1
Q ss_pred HHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE----EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH
Q psy2306 79 DLIRIRREIQIMSSVRHPNIIHIYEVFENREKM----VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154 (335)
Q Consensus 79 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~ 154 (335)
.+.....|...+..+.|+|+..++.+....... .+..++++..++...++.-+..+......+..++++||+++|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344445677777888999999999887543332 3455788888999999988889999999999999999999999
Q ss_pred CCcEecCCCCC---CEEEccCCCeEEe--eccccccccCCccccccccCCccCChhhhcCCCCC-CCcchHHHHHHHHHH
Q psy2306 155 HKICHRDLKLE---NILLDENGNAKIA--DFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH-GPEVDCWSLGVLLYT 228 (335)
Q Consensus 155 ~givH~di~p~---nili~~~~~~kL~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~Dv~slG~~l~~ 228 (335)
....|.-+..+ +.-++.++.+... ||+...................+.++|........ ....|+|++|.....
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 87666655555 3444455666666 88887776665555555556677888877665441 334799999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 229 LVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 229 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
+..|..+-.... .... +.......+..+.+.+|+..++++|+++.+++.|+|.+.....
T Consensus 385 ~~~~~~i~~~~~---~~~~-----~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 385 LSQGEDISEKSA---VPVS-----LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred hhhcCccccccc---chhh-----hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccc
Confidence 998765521111 0001 1111112267889999999999999999999999999865444
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=4e-07 Score=76.78 Aligned_cols=150 Identities=22% Similarity=0.235 Sum_probs=98.2
Q ss_pred hhccceeEEe---eeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHH---------------------HHHHHHHHHH
Q psy2306 33 KLKQRFDIVR---KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEA---------------------DLIRIRREIQ 88 (335)
Q Consensus 33 ~~~~~y~~~~---~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~---------------------~~~~~~~e~~ 88 (335)
.+..+..+.. .|+.|--+.||+|.. .++..+|+|++......... ...-...|+.
T Consensus 42 ~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~ 120 (268)
T COG1718 42 RLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFR 120 (268)
T ss_pred HHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHH
Confidence 3444444444 555677888999865 35889999998653321111 1123356777
Q ss_pred HHHcCC--CCcccceeEEEEeCCeEEEEEecCCCCC-HHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCC
Q psy2306 89 IMSSVR--HPNIIHIYEVFENREKMVLVMEYAAGGE-LYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKL 164 (335)
Q Consensus 89 ~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p 164 (335)
.|+++. +-.+++.+.+. .-.++|||+.... -.-.|+ ..++...+...+..++++.+.-|-. .|+||+||+.
T Consensus 121 NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSE 195 (268)
T COG1718 121 NLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSE 195 (268)
T ss_pred HHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchh
Confidence 777764 23444455543 3469999995431 111111 1223333677788889998888876 8999999999
Q ss_pred CCEEEccCCCeEEeeccccccccCC
Q psy2306 165 ENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 165 ~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
-|||+. ++.+.++||+.+....++
T Consensus 196 yNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 196 YNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred hheEEE-CCeEEEEECccccccCCC
Confidence 999997 889999999988766544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.4e-07 Score=76.56 Aligned_cols=137 Identities=23% Similarity=0.289 Sum_probs=81.4
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCC--cccceeEEE---EeCCeEEEEE
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP--NIIHIYEVF---ENREKMVLVM 115 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~lv~ 115 (335)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+... .+++++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4678999999999997664 48999996542 4455677888888777532 356666644 2344679999
Q ss_pred ecCCCCCHHH----------------HHh---hC----CCCCHHH------HHHH---------------HHHHHH-HHH
Q psy2306 116 EYAAGGELYD----------------FLD---QK----KVLTEEE------ARRI---------------FRQIAT-AVY 150 (335)
Q Consensus 116 e~~~~~~L~~----------------~l~---~~----~~~~~~~------~~~i---------------~~~l~~-~l~ 150 (335)
++++|.++.. .+. +. .+..... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 111 01 1111100 0000 111222 233
Q ss_pred HhH-------HCCcEecCCCCCCEEEc-cCCCeEEeeccccc
Q psy2306 151 YCH-------KHKICHRDLKLENILLD-ENGNAKIADFGLSN 184 (335)
Q Consensus 151 ~LH-------~~givH~di~p~nili~-~~~~~kL~df~~~~ 184 (335)
.++ ...++|+|++|+||+++ .++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24699999999999999 55666899998774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.5e-07 Score=84.92 Aligned_cols=170 Identities=19% Similarity=0.276 Sum_probs=102.6
Q ss_pred cChhhhhhhcccccCCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC----------
Q psy2306 7 VPQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET---------- 76 (335)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~---------- 76 (335)
+|+.++..+-.-.+..-+-.+......+.. +.||..+.|.||+|+.+. |+.||+|+-++.-...
T Consensus 137 ~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~-----~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~ 210 (538)
T KOG1235|consen 137 APPFPWEEAFKIFEEELGAPIEDIFSEFDE-----EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRL 210 (538)
T ss_pred CCCCCHHHHHHHHHHHhCCCHHHHHHhcCc-----chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHH
Confidence 344444444444444445555555555554 789999999999999886 9999999955421100
Q ss_pred ------------------HHHHHHHH------HHHHHHHc----CCCCc------ccceeEEEEeCCeEEEEEecCCCCC
Q psy2306 77 ------------------EADLIRIR------REIQIMSS----VRHPN------IIHIYEVFENREKMVLVMEYAAGGE 122 (335)
Q Consensus 77 ------------------~~~~~~~~------~e~~~l~~----l~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~ 122 (335)
.+..+.+. +|++...+ ++|-+ |++++.. -.....++|||++|..
T Consensus 211 ~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~ 288 (538)
T KOG1235|consen 211 LAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIK 288 (538)
T ss_pred HHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCcc
Confidence 11112222 22222222 22333 3333332 2456789999999986
Q ss_pred HHHH--HhhCCCCCHHHHHHHHHHHHHHHH-HhHHCCcEecCCCCCCEEEcc----CCCeEEeeccccccccC
Q psy2306 123 LYDF--LDQKKVLTEEEARRIFRQIATAVY-YCHKHKICHRDLKLENILLDE----NGNAKIADFGLSNVFTE 188 (335)
Q Consensus 123 L~~~--l~~~~~~~~~~~~~i~~~l~~~l~-~LH~~givH~di~p~nili~~----~~~~kL~df~~~~~~~~ 188 (335)
+.++ +.+.+ ++... ++..+.++.. .+=..|++|+|=+|.||++++ ++.+.+.|||+......
T Consensus 289 i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 289 INDLDAIDKRG-ISPHD---ILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCCHHHHHHcC-CCHHH---HHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 6543 44443 45553 3344444322 234679999999999999984 56899999998866543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.6e-06 Score=73.67 Aligned_cols=133 Identities=12% Similarity=0.087 Sum_probs=81.3
Q ss_pred eeccCC-eEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEEEecCCCC
Q psy2306 44 LGQGNY-GKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 44 ig~g~~-g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
|..|.+ +.||++... +..+++|...... ...+.+|+..++.+. +--+++++++....+..+++||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 344444 788998543 4689999876432 224557888877774 344667788777667789999999998
Q ss_pred CHHHHHh----------------h--CC-----CCCH---HHHHHHHH-------------------HHHHHHHHhH---
Q psy2306 122 ELYDFLD----------------Q--KK-----VLTE---EEARRIFR-------------------QIATAVYYCH--- 153 (335)
Q Consensus 122 ~L~~~l~----------------~--~~-----~~~~---~~~~~i~~-------------------~l~~~l~~LH--- 153 (335)
++..... + .. +... ........ .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7764320 0 00 1110 00000000 0111122221
Q ss_pred ----HCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 154 ----KHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 154 ----~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
...++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999887777899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.4e-06 Score=66.85 Aligned_cols=135 Identities=21% Similarity=0.261 Sum_probs=94.3
Q ss_pred eEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc-cceeEEEEeCCeEEEEEec
Q psy2306 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI-IHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 39 ~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~ 117 (335)
++.+.|++|.+|.||++... |..+++|+-... .....+..|+++|..+.-.++ .+++.+.. .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 44688999999999999665 678999986543 234467789999988875444 34555432 2455999
Q ss_pred CCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCC-CCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 118 AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLK-LENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 118 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~-p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
.+|-+|.++.... +... +..+++.-.-|-..||-|+.|+ |...+|-.++.+.|+||.-++....++.
T Consensus 94 i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p~N 161 (201)
T COG2112 94 IDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKPRN 161 (201)
T ss_pred hcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCCch
Confidence 9998887765432 2233 3445566556788899999996 5555555666999999999975544433
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.4e-07 Score=88.75 Aligned_cols=239 Identities=18% Similarity=0.165 Sum_probs=164.7
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc-ccceeEEEEeCCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN-IIHIYEVFENREKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv 114 (335)
+-+...+.+++++++.+++.+...+...+ .+.+... ...+-++++|.+++||| .+..++-+..+...++.
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34556678899999999999776554433 5554431 24556888999999999 77777777788899999
Q ss_pred EecCCCC-CHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGG-ELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~-~L~~~l-~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
++++.++ +....+ ...-.+...+...+.+.-+.++++||+.--+|+| ||+.+ ++..++.+|+....+......
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccccc
Confidence 9999876 222111 1111244445566677778889999988767887 66664 467899999988777766556
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCCch-HHHH
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQSTA-SPLI 266 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~l-~~li 266 (335)
....+++.+++||+.....+ ....|.|++|.-..++.-|.+|-.. +......+..+.-.+ ..+.... .++.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~-~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~ 464 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTI-DGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFP 464 (829)
T ss_pred ccCCCCCCCCCchhhccccc-ccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCc
Confidence 67788999999999988887 7789999999877777777666422 100000111110000 0111111 2477
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
..|+...|..|+.....+-|.+|..
T Consensus 465 ~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 465 APCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred ccccCCCCCCCcchhhHHHHHHhcc
Confidence 8899999999999999999988864
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.3e-06 Score=76.46 Aligned_cols=137 Identities=14% Similarity=0.211 Sum_probs=100.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeec-------------------CCcCCHHHHHHHHHHHHHHHcCCC--
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKK-------------------CKIETEADLIRIRREIQIMSSVRH-- 95 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~-------------------~~~~~~~~~~~~~~e~~~l~~l~~-- 95 (335)
-+.++..||-|--+.+|.+.+. .|.+.++|.-.. ...+-..+.-...+|+..++.+..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4778999999999999999766 488899996321 011112233455678888887742
Q ss_pred CcccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCe
Q psy2306 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA 175 (335)
Q Consensus 96 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~ 175 (335)
--+++.++ .+..++|||++.|.+|.+.-+- .....+...+..-+--|..+|+||||+.--||+|.+++.+
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 23444554 4667899999999888765432 2234556677777788999999999999999999999999
Q ss_pred EEeeccccc
Q psy2306 176 KIADFGLSN 184 (335)
Q Consensus 176 kL~df~~~~ 184 (335)
+++||-...
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999997653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.5e-05 Score=80.93 Aligned_cols=145 Identities=19% Similarity=0.327 Sum_probs=90.7
Q ss_pred EEeeeeccCCeEEEEEEECCCC--cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcc--cceeEEEEeC---CeE
Q psy2306 40 IVRKLGQGNYGKVQLGINKETG--QEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNI--IHIYEVFENR---EKM 111 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~--~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~ 111 (335)
..+.|+.|.+..+|+......+ ..+++|+........ ....+.+|..+++.+. |.++ ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3577899999999998765432 468888865432111 2336778999999985 5554 7778877654 467
Q ss_pred EEEEecCCCCCHHH--------------------HHh---hC----------C-C--CCHHHHHHHHHH-----------
Q psy2306 112 VLVMEYAAGGELYD--------------------FLD---QK----------K-V--LTEEEARRIFRQ----------- 144 (335)
Q Consensus 112 ~lv~e~~~~~~L~~--------------------~l~---~~----------~-~--~~~~~~~~i~~~----------- 144 (335)
|+|||+++|..+.+ .+. .- + + ....++..|..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998864321 111 00 0 0 011233322222
Q ss_pred ----HHHHHHHhHH-----------CCcEecCCCCCCEEEccC-CC-eEEeeccccccc
Q psy2306 145 ----IATAVYYCHK-----------HKICHRDLKLENILLDEN-GN-AKIADFGLSNVF 186 (335)
Q Consensus 145 ----l~~~l~~LH~-----------~givH~di~p~nili~~~-~~-~kL~df~~~~~~ 186 (335)
+...+.+|.. ..++|||+++.||+++.+ +. .-+.||+.+..-
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233556631 259999999999999853 34 578999987654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.24 E-value=6.7e-06 Score=70.70 Aligned_cols=73 Identities=10% Similarity=0.045 Sum_probs=46.1
Q ss_pred eeeeccCCe-EEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCC---cccceeEEEEeC---CeEEEE
Q psy2306 42 RKLGQGNYG-KVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP---NIIHIYEVFENR---EKMVLV 114 (335)
Q Consensus 42 ~~ig~g~~g-~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv 114 (335)
+.|+.|+.. .||.. +..+++|..+.. .....+.+|...++.+... .+.++++..... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 567777666 58986 235788875531 1234677899988887532 344555544332 235889
Q ss_pred EecCCCCCHH
Q psy2306 115 MEYAAGGELY 124 (335)
Q Consensus 115 ~e~~~~~~L~ 124 (335)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.4e-05 Score=64.11 Aligned_cols=131 Identities=23% Similarity=0.306 Sum_probs=93.5
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc-------------CCHHHHHHHHHHHHHHHcCC------CCcccce
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI-------------ETEADLIRIRREIQIMSSVR------HPNIIHI 101 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~------~~~i~~~ 101 (335)
...||+|+.=.||.- + +....+||++..... .......+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999899876 3 244589999876440 01122455666776666665 7899999
Q ss_pred eEEEEeCCeEEEEEecCCC------CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC--
Q psy2306 102 YEVFENREKMVLVMEYAAG------GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-- 173 (335)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-- 173 (335)
+|+.++.....+|+|.+.. .+|.++++.. .++. .+. ..+-+-..+|-+.+|+.+|++|+||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999997642 3788888644 3555 333 3444555677899999999999999996532
Q ss_pred --CeEEee
Q psy2306 174 --NAKIAD 179 (335)
Q Consensus 174 --~~kL~d 179 (335)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=4e-05 Score=68.29 Aligned_cols=80 Identities=13% Similarity=0.108 Sum_probs=57.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC---CcccceeEEEEe---CCe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH---PNIIHIYEVFEN---REK 110 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~ 110 (335)
.-.-.+.||.|..+.||...+. +..+++|..+... ....+..|...|+.+.. -.++++++++.+ .+.
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS--QGNPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hhheeeecCCccceeEEEEEcC--CCCEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 4445678999999999998544 2357778754311 12367788888988853 368888888754 366
Q ss_pred EEEEEecCCCCCH
Q psy2306 111 MVLVMEYAAGGEL 123 (335)
Q Consensus 111 ~~lv~e~~~~~~L 123 (335)
.++|||+++|.++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.12 E-value=9.6e-05 Score=68.03 Aligned_cols=80 Identities=25% Similarity=0.253 Sum_probs=56.1
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc---C-CHHHHHHHHHHHHHHHcCC---CCcccceeEEEEeCCeEEE
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---E-TEADLIRIRREIQIMSSVR---HPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~---~-~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 113 (335)
.+.||.|.+..||++.+...++.+++|.-.+... . -....++...|.+.|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4678999999999998875446899998543211 1 0234557777888888763 2456777776 4566789
Q ss_pred EEecCCCCC
Q psy2306 114 VMEYAAGGE 122 (335)
Q Consensus 114 v~e~~~~~~ 122 (335)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.5e-05 Score=65.45 Aligned_cols=75 Identities=21% Similarity=0.315 Sum_probs=47.5
Q ss_pred EeeeeccCCeEEEEEEECC-CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc-ccceeEEEEeCCeEEEEEecC
Q psy2306 41 VRKLGQGNYGKVQLGINKE-TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN-IIHIYEVFENREKMVLVMEYA 118 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~ 118 (335)
.+.|..|-...+|++.... +++.|++|+...... ......+|..+++.+...+ .++++..+. + .+++||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4667888888999986543 357899998764211 1112346788888775333 344444332 2 4799999
Q ss_pred CCCCH
Q psy2306 119 AGGEL 123 (335)
Q Consensus 119 ~~~~L 123 (335)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.3e-05 Score=67.28 Aligned_cols=133 Identities=17% Similarity=0.109 Sum_probs=76.1
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc-cceeEEEEeCCeEEEEEecCCCC
Q psy2306 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI-IHIYEVFENREKMVLVMEYAAGG 121 (335)
Q Consensus 43 ~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~ 121 (335)
.+..|-...+|+.. .+++.+++|........- .....+|..+++.+...++ ++++... . -++|+||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL---GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc---cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 45667788999885 457789999865421110 0123568888888854333 4444443 2 36899999886
Q ss_pred CHHHH--------------Hhh-------CCCCCH-HHHHHHHHHH---------HHHHHHhHH--------CCcEecCC
Q psy2306 122 ELYDF--------------LDQ-------KKVLTE-EEARRIFRQI---------ATAVYYCHK--------HKICHRDL 162 (335)
Q Consensus 122 ~L~~~--------------l~~-------~~~~~~-~~~~~i~~~l---------~~~l~~LH~--------~givH~di 162 (335)
++... +.+ ..+++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65321 110 111121 1112221111 111222211 25899999
Q ss_pred CCCCEEEccCCCeEEeecccccc
Q psy2306 163 KLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 163 ~p~nili~~~~~~kL~df~~~~~ 185 (335)
.|.||++++++ +.|+||+.+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999998876 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.4e-05 Score=63.74 Aligned_cols=98 Identities=18% Similarity=0.177 Sum_probs=78.0
Q ss_pred HHHHHHHcCCC-CcccceeEEEEeCCeEEEEEecCCCCCHHH---HHhhCCCCCHHHHHHHHHHHHHHHHHhHH---CCc
Q psy2306 85 REIQIMSSVRH-PNIIHIYEVFENREKMVLVMEYAAGGELYD---FLDQKKVLTEEEARRIFRQIATAVYYCHK---HKI 157 (335)
Q Consensus 85 ~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~i~~~l~~~l~~LH~---~gi 157 (335)
.|.-+++.+++ +++++++|+|.. +++.|+...+++.. .+.+-...++..+.+++.++++.+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57788888875 699999999833 57889997665532 11122336899999999999999999986 458
Q ss_pred EecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 158 CHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 158 vH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
.-.|++++|+-++.++++|++|.+.+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00021 Score=59.15 Aligned_cols=128 Identities=19% Similarity=0.209 Sum_probs=88.9
Q ss_pred cceeEEeeeeccCC-eEEEEEEECCCCcEEEEEEeec---CCc-------CC-H-------HHHHHHHHHHHHHHcCC--
Q psy2306 36 QRFDIVRKLGQGNY-GKVQLGINKETGQEVAIKTIKK---CKI-------ET-E-------ADLIRIRREIQIMSSVR-- 94 (335)
Q Consensus 36 ~~y~~~~~ig~g~~-g~Vy~~~~~~~~~~valK~~~~---~~~-------~~-~-------~~~~~~~~e~~~l~~l~-- 94 (335)
..++..+.||.|.- |.||++... |+.||+|++.. ... .. + .....+..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 69999999999999 999999655 77999999321 111 00 0 22345677777777664
Q ss_pred -CCcc--cceeEEEEeC------------------CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhH
Q psy2306 95 -HPNI--IHIYEVFENR------------------EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153 (335)
Q Consensus 95 -~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH 153 (335)
+.++ ++++++..-. -...||-||.+... .++... +.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 4556 8888887321 12456777765532 233333 456677778899
Q ss_pred HCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 154 KHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 154 ~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
+.||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 3589999854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00031 Score=62.55 Aligned_cols=138 Identities=12% Similarity=0.070 Sum_probs=80.8
Q ss_pred eEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCC--cccceeEE------EEeCCe
Q psy2306 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP--NIIHIYEV------FENREK 110 (335)
Q Consensus 39 ~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~------~~~~~~ 110 (335)
.-.+.|..|....+|+... ++..+++|++.. .. ...+..|+.++..+.+. .+++++.. ....+.
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~---~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEK---VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCC---CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 3366777888889998853 345799998764 11 22455666666666422 24444432 233556
Q ss_pred EEEEEecCCCCCHHH----HH-------hh------CCCC--------CHHHH--H--------HHHHHHHHHHHHhHH-
Q psy2306 111 MVLVMEYAAGGELYD----FL-------DQ------KKVL--------TEEEA--R--------RIFRQIATAVYYCHK- 154 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~----~l-------~~------~~~~--------~~~~~--~--------~i~~~l~~~l~~LH~- 154 (335)
.++++++++|.++.. .. .+ .... .+... . .....+..++.++.+
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999998876421 11 00 0000 00000 0 011112233444442
Q ss_pred ------CCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 155 ------HKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 155 ------~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999887777899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00024 Score=63.26 Aligned_cols=143 Identities=15% Similarity=0.204 Sum_probs=89.1
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC--CcccceeEEEEeCC--eEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH--PNIIHIYEVFENRE--KMV 112 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~ 112 (335)
...+++.+..|-.-.+|...+. +++++++ .+. ............+|+..++.+.- --+.+.+++|.++. ..|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 3445566655555556666444 7889999 432 22233445566788888877742 34555677776655 779
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHH-HHHHHHHHhHHC------------------------------------
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFR-QIATAVYYCHKH------------------------------------ 155 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~-~l~~~l~~LH~~------------------------------------ 155 (335)
.+|++++|..+.+.+... ....+++. .+...|+.||+-
T Consensus 102 ~v~~~veGe~~~~~~~~~-----~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 102 YVMEWVEGEVVWSALPPE-----SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EEEEEecceeccCcCCcc-----cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 999999885332222110 00012222 444444444431
Q ss_pred ----------------------CcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 156 ----------------------KICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 156 ----------------------givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
.++|||+++.|++|++++.+-++||+.+..-.+
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 289999999999999988899999998876544
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00039 Score=62.79 Aligned_cols=77 Identities=22% Similarity=0.196 Sum_probs=52.0
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeecCCc----CCHHHHHHHHHHHHHHHcCC--CC-cccceeEEEEeCCeEEEEE
Q psy2306 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKI----ETEADLIRIRREIQIMSSVR--HP-NIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 43 ~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~----~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~ 115 (335)
.||.|....||++.+...++.++||.-.+... ..+...++...|...|+... .| .+++++.+ +.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999998764447899998543211 12344556677888887764 34 45555544 566677999
Q ss_pred ecCCCC
Q psy2306 116 EYAAGG 121 (335)
Q Consensus 116 e~~~~~ 121 (335)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00053 Score=61.43 Aligned_cols=140 Identities=13% Similarity=0.120 Sum_probs=79.4
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc--ccceeEEE------EeCC
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN--IIHIYEVF------ENRE 109 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~------~~~~ 109 (335)
....+.++.|....+|.+... +..+++|.+.... ... .+..|.+++..+...+ +++++... ...+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCCC--CHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 334667777877899988532 3468899876421 122 3345566666653222 34444321 2345
Q ss_pred eEEEEEecCCCCCHH-----------HHHh---h--CC-CCC-----HHHHHH----------------HHHHHHHHHHH
Q psy2306 110 KMVLVMEYAAGGELY-----------DFLD---Q--KK-VLT-----EEEARR----------------IFRQIATAVYY 151 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~-----------~~l~---~--~~-~~~-----~~~~~~----------------i~~~l~~~l~~ 151 (335)
..++++++++|.++. ..+. . .+ +.+ ....+. ....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999885431 1110 0 00 000 001000 01122334444
Q ss_pred hH-------HCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 152 CH-------KHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 152 LH-------~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
+. ..+++|+|+++.||+++.++...++||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 53 2689999999999999888767899999773
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00065 Score=62.50 Aligned_cols=84 Identities=15% Similarity=0.110 Sum_probs=55.6
Q ss_pred EEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc-CC---HHHHHHHHHHHHHHHcCC---CCcccceeEEEEeCCeEE
Q psy2306 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI-ET---EADLIRIRREIQIMSSVR---HPNIIHIYEVFENREKMV 112 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~-~~---~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~ 112 (335)
..+.||.|....||+..+. +..++||.-..... .. .....+...|...|+.+. ...+++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678899999999998764 45799998663221 11 113445556677777664 247788888876 4567
Q ss_pred EEEecCCC--CCHHHHH
Q psy2306 113 LVMEYAAG--GELYDFL 127 (335)
Q Consensus 113 lv~e~~~~--~~L~~~l 127 (335)
++||++++ ..+.+-+
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 88999976 2444433
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0016 Score=58.66 Aligned_cols=30 Identities=23% Similarity=0.390 Sum_probs=25.5
Q ss_pred CCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 155 HKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 155 ~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.|++|+|++|+||+++.+....++||+.++
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999866555899999774
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00017 Score=67.08 Aligned_cols=165 Identities=22% Similarity=0.278 Sum_probs=106.8
Q ss_pred HHHHHHHHHHcCCCCcccceeEEEEe-CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEec
Q psy2306 82 RIRREIQIMSSVRHPNIIHIYEVFEN-REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160 (335)
Q Consensus 82 ~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~ 160 (335)
++.-....++.+.|+++..++++-.. .....+|+|++ +.+|++.+..+. +-..... .+|+.|-
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccccee
Confidence 56667888999999999999888753 44588999999 679999987654 2211111 1122221
Q ss_pred CCCCCCEEEccCCCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q psy2306 161 DLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240 (335)
Q Consensus 161 di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~ 240 (335)
|+ ++..| -+. ... ..+. .+++|||++|.++.++.-|...+....
T Consensus 92 -----~~-------~~~td-~~~---t~~-------------------~~~~-~pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 92 -----NI-------IYITD-HFL---TKY-------------------PSPI-GPKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred -----hh-------hhccc-ccc---ccC-------------------CCCC-CcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 11 12222 000 000 0011 358999999999999999887776554
Q ss_pred HHHHHHHHhcCCC-------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhh
Q psy2306 241 FKRLVKQISNGDY-------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACL 298 (335)
Q Consensus 241 ~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 298 (335)
..+....+.+-.. .....+.....+...|+...|..||...++.+++-|.+....-+.
T Consensus 136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~~t~ 206 (725)
T KOG1093|consen 136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKDLTV 206 (725)
T ss_pred HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhhhhH
Confidence 4444433333211 112336677789999999999999999999999999877544444
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00041 Score=61.95 Aligned_cols=76 Identities=20% Similarity=0.240 Sum_probs=47.4
Q ss_pred EeeeeccCCeEEEEEEECC------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc-ccceeEEEEeCCeEEE
Q psy2306 41 VRKLGQGNYGKVQLGINKE------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN-IIHIYEVFENREKMVL 113 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~l 113 (335)
++.|..|-...+|++.... +++.+++|+..... .......+|..++..+...+ .++++.++.. ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556677777899886543 25789999976532 11224557777777775332 3455555432 35
Q ss_pred EEecCCCCCHH
Q psy2306 114 VMEYAAGGELY 124 (335)
Q Consensus 114 v~e~~~~~~L~ 124 (335)
|++|++|.++.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 88998887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00096 Score=59.86 Aligned_cols=146 Identities=21% Similarity=0.240 Sum_probs=96.6
Q ss_pred EEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc-----------------------CCHHHHHHHHHHHHHHHcCCCC
Q psy2306 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI-----------------------ETEADLIRIRREIQIMSSVRHP 96 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~-----------------------~~~~~~~~~~~e~~~l~~l~~~ 96 (335)
+-..|+-|-.+.||.|... +|..+|||+++.+-. ......--...|++.|.++...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4566777999999998644 688899999753211 0011122234677778777655
Q ss_pred cccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh-HHCCcEecCCCCCCEEEccCCCe
Q psy2306 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC-HKHKICHRDLKLENILLDENGNA 175 (335)
Q Consensus 97 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~L-H~~givH~di~p~nili~~~~~~ 175 (335)
.|+-.--+.. ....|||+|+.......-.-+...++...+..+-.+++.-+.-| |.+++||.||+--|+|+ .+|.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 5443322221 23468999995322111111234577778888888888888777 47899999999999998 77899
Q ss_pred EEeeccccccccCC
Q psy2306 176 KIADFGLSNVFTES 189 (335)
Q Consensus 176 kL~df~~~~~~~~~ 189 (335)
.++|.+.+.....+
T Consensus 304 yiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 304 YIIDVSQSVEHDHP 317 (520)
T ss_pred EEEEccccccCCCh
Confidence 99999877655443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00069 Score=59.67 Aligned_cols=30 Identities=30% Similarity=0.515 Sum_probs=25.0
Q ss_pred CcEecCCCCCCEEEccCCCe-EEeecccccc
Q psy2306 156 KICHRDLKLENILLDENGNA-KIADFGLSNV 185 (335)
Q Consensus 156 givH~di~p~nili~~~~~~-kL~df~~~~~ 185 (335)
.++|||++|.||+++.++.+ -++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999875654 6999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00093 Score=61.16 Aligned_cols=78 Identities=21% Similarity=0.231 Sum_probs=54.7
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCC---cCCHHHHHHHHHHHHHHHcCC--CC-cccceeEEEEeCCeEEEE
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCK---IETEADLIRIRREIQIMSSVR--HP-NIIHIYEVFENREKMVLV 114 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~---~~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv 114 (335)
.+.||.|....||++.+...++.++||.-.+.. ..-....++...|.+.|+... .| .+++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 578899999999999885446789999754321 122445667788888888774 34 45556554 56667788
Q ss_pred EecCCC
Q psy2306 115 MEYAAG 120 (335)
Q Consensus 115 ~e~~~~ 120 (335)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.002 Score=56.94 Aligned_cols=76 Identities=11% Similarity=0.100 Sum_probs=48.1
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC---CCcccceeEEEEeCCeEEEE
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR---HPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv 114 (335)
-+-.+.++.|....+|... .+++.+.+|.-... ....+..|..-|+.|. .-.+++++++....+..+++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 4456788889999999985 66889999986631 1225667888887773 45688899988877778999
Q ss_pred EecCCCC
Q psy2306 115 MEYAAGG 121 (335)
Q Consensus 115 ~e~~~~~ 121 (335)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.45 E-value=3e-05 Score=80.02 Aligned_cols=237 Identities=15% Similarity=0.046 Sum_probs=155.1
Q ss_pred EEEEEeecCCcCC--HHHHHHHHHHHHHHHcCCCCcccceeEEEEe--CCeEEEEEecCCCCCHHHHHhhC----CCCCH
Q psy2306 64 VAIKTIKKCKIET--EADLIRIRREIQIMSSVRHPNIIHIYEVFEN--REKMVLVMEYAAGGELYDFLDQK----KVLTE 135 (335)
Q Consensus 64 valK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~~~~ 135 (335)
+.+|+.+....+. +...+....|..-++...|+++.....-... ...-+..++++.+|.+.+.+-++ .+...
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 3555554332221 2233444555555666678877666555432 33457788899899999888642 33443
Q ss_pred HHHHHHHHHHHHHHHHhHHC-C----cEecCCCCCCEEEccCCCeEEeecccccccc-CCccccccccCCccCChhhhcC
Q psy2306 136 EEARRIFRQIATAVYYCHKH-K----ICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKG 209 (335)
Q Consensus 136 ~~~~~i~~~l~~~l~~LH~~-g----ivH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~ 209 (335)
.-+.....+.+....-.|+. | .+|.++++-|.+|..+-.++++++|+.+... .........+++.|+.|++...
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH
Confidence 33443334435555555532 2 6899999999999999999999999998433 3334455667888999999988
Q ss_pred CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC--CCCCchHHHHHHhcccCCCCCCCHHHHhcCC
Q psy2306 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP--KNQSTASPLIAEMLNINPSSRADISVICSHW 287 (335)
Q Consensus 210 ~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 287 (335)
-.+ +.++|+|..|+.+|.+.-|..+|-......+...+.+...... ..+.+.......+|.+.-..||.-...++-+
T Consensus 1415 ik~-t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d 1493 (2724)
T KOG1826|consen 1415 IKF-TKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRD 1493 (2724)
T ss_pred Hhh-hhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccc
Confidence 777 7779999999999999888877632222222222222222222 2245666677777888889999999999999
Q ss_pred CcCCCCcchhhHHH
Q psy2306 288 WIDKDHSVACLEEA 301 (335)
Q Consensus 288 ~~~~~~~~~~~~~~ 301 (335)
.|.......+-...
T Consensus 1494 ~~a~~~~d~~k~i~ 1507 (2724)
T KOG1826|consen 1494 HFAVGLRDICKMIY 1507 (2724)
T ss_pred cccccccCcchhHH
Confidence 98876666655443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0027 Score=57.85 Aligned_cols=139 Identities=19% Similarity=0.195 Sum_probs=80.8
Q ss_pred eeEEeeeeccCCeEEEEEEECC----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc-cceeEEEEeCCeEE
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKE----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI-IHIYEVFENREKMV 112 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~ 112 (335)
..-...|..|-.-.+|++.... +++.|++|+..... ...+ .-.+|..+++.+...++ +++++.+.. +
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g--- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G--- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceee-chHHHHHHHHHHHHcCCCCceEEEECC-c---
Confidence 3344566668888999986432 34789999886532 1111 22567888877754333 345565532 2
Q ss_pred EEEecCCCCCHHHH-------H-------h---hCC------CCCHHHHHHHHHHH-----------------HHHHHHh
Q psy2306 113 LVMEYAAGGELYDF-------L-------D---QKK------VLTEEEARRIFRQI-----------------ATAVYYC 152 (335)
Q Consensus 113 lv~e~~~~~~L~~~-------l-------~---~~~------~~~~~~~~~i~~~l-----------------~~~l~~L 152 (335)
.+++|+++.++... + . +.. +.....+..+..++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 57889877665311 1 0 000 11123333333221 1122222
Q ss_pred H--------HCCcEecCCCCCCEEEcc-CCCeEEeeccccc
Q psy2306 153 H--------KHKICHRDLKLENILLDE-NGNAKIADFGLSN 184 (335)
Q Consensus 153 H--------~~givH~di~p~nili~~-~~~~kL~df~~~~ 184 (335)
. ...++|+|+++.||++++ ++.+.++||+.+.
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999976 4689999999874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0041 Score=56.32 Aligned_cols=137 Identities=15% Similarity=0.211 Sum_probs=77.8
Q ss_pred EeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc-cceeEEEEeCCeEEEEEe
Q psy2306 41 VRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI-IHIYEVFENREKMVLVME 116 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e 116 (335)
.+.|..|-.-.+|++..... +..|++|+...... ..-.-.+|..+++.+...++ +++++++. .+ ++.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 34555677788998864432 34899998765321 12223467777877764444 34555552 22 4889
Q ss_pred cCCCCCHHH-------HH-------hh--CC-------CCCHHHHHHHHHHH----------------------HHHHHH
Q psy2306 117 YAAGGELYD-------FL-------DQ--KK-------VLTEEEARRIFRQI----------------------ATAVYY 151 (335)
Q Consensus 117 ~~~~~~L~~-------~l-------~~--~~-------~~~~~~~~~i~~~l----------------------~~~l~~ 151 (335)
|++|.++.. .+ ++ .. +.....+..+..++ ...+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 987765421 11 10 00 11223333332222 111222
Q ss_pred hH----HC----CcEecCCCCCCEEEcc-CCCeEEeecccccc
Q psy2306 152 CH----KH----KICHRDLKLENILLDE-NGNAKIADFGLSNV 185 (335)
Q Consensus 152 LH----~~----givH~di~p~nili~~-~~~~kL~df~~~~~ 185 (335)
+. .. -++|+|+.+.||++++ ++.++|+||+.+..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 22 11 2799999999999975 46899999998843
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.036 Score=49.67 Aligned_cols=30 Identities=23% Similarity=0.405 Sum_probs=27.4
Q ss_pred CcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 156 KICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 156 givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
+++|+|+.++|+++++++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999997753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0023 Score=53.92 Aligned_cols=30 Identities=37% Similarity=0.753 Sum_probs=21.3
Q ss_pred CcEecCCCCCCEEE-ccCCCeEEeecccccc
Q psy2306 156 KICHRDLKLENILL-DENGNAKIADFGLSNV 185 (335)
Q Consensus 156 givH~di~p~nili-~~~~~~kL~df~~~~~ 185 (335)
-++|+|+.|.||++ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998844
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.067 Score=47.85 Aligned_cols=29 Identities=31% Similarity=0.658 Sum_probs=25.4
Q ss_pred CCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 155 HKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 155 ~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.+++|||+++.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678999998663
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.021 Score=51.39 Aligned_cols=105 Identities=23% Similarity=0.315 Sum_probs=73.4
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
....|+++++. |+++.-. +.-...++..++.+++..+.-+.+ ..+-|+++.-.||+|+ +|++.|+||-+++..
T Consensus 298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 34567778877 5555432 224677888899998888888874 4789999999999998 999999999999854
Q ss_pred cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHH
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGV 224 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~ 224 (335)
..... .....+--|-.+.|.. +.+.+||-+--
T Consensus 372 ~~q~~----isy~rldhp~lF~G~d--d~QFeIYrlMr 403 (488)
T COG5072 372 YSQGI----ISYNRLDHPDLFNGVD--DYQFEIYRLMR 403 (488)
T ss_pred cCCce----eeccccCchhhhcCcc--ceeeeHHHHHH
Confidence 33322 2223344555555443 66788887643
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.067 Score=49.39 Aligned_cols=78 Identities=15% Similarity=0.108 Sum_probs=45.8
Q ss_pred eEEeeeeccCCeEEEEEEECCC-Cc-----EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCC-cccceeEEEEeCCeE
Q psy2306 39 DIVRKLGQGNYGKVQLGINKET-GQ-----EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP-NIIHIYEVFENREKM 111 (335)
Q Consensus 39 ~~~~~ig~g~~g~Vy~~~~~~~-~~-----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~ 111 (335)
...+.|..|-...+|++..... +. .|.++.... ..+..-.-.+|..+++.+... .-+++++.+. -
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~ 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----D 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----C
Confidence 3455666788899999865432 12 245554322 111112234678888888644 4445556553 2
Q ss_pred EEEEecCCCCCHH
Q psy2306 112 VLVMEYAAGGELY 124 (335)
Q Consensus 112 ~lv~e~~~~~~L~ 124 (335)
++++||++|.+|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 5899999887653
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.096 Score=44.31 Aligned_cols=75 Identities=16% Similarity=0.178 Sum_probs=51.9
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC---CCcccceeEEEEeCCeEEEEEecC
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR---HPNIIHIYEVFENREKMVLVMEYA 118 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~ 118 (335)
+.+..|..-..|...+. ..++.+|+=. .+....+..|+.-|+.+. .-.+.+++.+..+.++.|+|+||+
T Consensus 22 ~~v~gG~inea~~v~dg--~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRDG--TDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeecC--CcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 45555555556666433 4679999733 333456667777776664 456888899889999999999999
Q ss_pred CCCCHH
Q psy2306 119 AGGELY 124 (335)
Q Consensus 119 ~~~~L~ 124 (335)
+-+++.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876543
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.2 Score=47.19 Aligned_cols=76 Identities=17% Similarity=0.157 Sum_probs=46.0
Q ss_pred EEeeeeccCCeEEEEEEECCC--------CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCccc-ceeEEEEeCCe
Q psy2306 40 IVRKLGQGNYGKVQLGINKET--------GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII-HIYEVFENREK 110 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~--------~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~ 110 (335)
-++.|..|-.-.+|++..... ++.|++|+..... +....-..|..+++.+...+|- ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----DELYNPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----cceeCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 567777788888998865421 5689999976522 1111334566666666533333 3455442
Q ss_pred EEEEEecCCCCCH
Q psy2306 111 MVLVMEYAAGGEL 123 (335)
Q Consensus 111 ~~lv~e~~~~~~L 123 (335)
-+.+.+|++|.+|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2457899987643
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.058 Score=47.86 Aligned_cols=75 Identities=17% Similarity=0.096 Sum_probs=43.7
Q ss_pred eccCCeEEEEEEECC----C----CcEEEEEEeecCCc--CCHHHHHHHHHHHHHHHcCC-------------CCcccce
Q psy2306 45 GQGNYGKVQLGINKE----T----GQEVAIKTIKKCKI--ETEADLIRIRREIQIMSSVR-------------HPNIIHI 101 (335)
Q Consensus 45 g~g~~g~Vy~~~~~~----~----~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~-------------~~~i~~~ 101 (335)
|.|-.|.+|++.... + ...+++|....... ........+.+|+..++.+- ....+++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 567778888765422 2 34588888762211 11223456677877776551 1234566
Q ss_pred eEEEEeCCeEEEEEecCC
Q psy2306 102 YEVFENREKMVLVMEYAA 119 (335)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~ 119 (335)
+....+.+..+||+|.+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 666555556788888663
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.81 Score=41.31 Aligned_cols=28 Identities=21% Similarity=0.209 Sum_probs=23.8
Q ss_pred CCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 155 HKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 155 ~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.+++|+|+.+.||+++ + .+.++||+.++
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4789999999999994 4 57899999774
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.049 Score=49.89 Aligned_cols=61 Identities=23% Similarity=0.311 Sum_probs=45.7
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhH-HCCcEecCCCCCCEEEcc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH-KHKICHRDLKLENILLDE 171 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH-~~givH~di~p~nili~~ 171 (335)
...++-+|..|.++..+++..+ .++...++++.-...|+-.+- --+++|.|++|.||++..
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3456777888889999887544 466677777777777765543 568999999999999954
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.073 Score=46.10 Aligned_cols=80 Identities=13% Similarity=0.045 Sum_probs=53.3
Q ss_pred EEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecC-
Q psy2306 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYA- 118 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~- 118 (335)
....+..|..+.|+.++.. +|.+.++|+..+......+ ......|+...-...+++++.- .....+++|.+
T Consensus 6 ~~~~~~~g~~s~V~pv~~~-dG~~avLKl~~p~~~~~~E-----~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~ 77 (253)
T PF04655_consen 6 PDGPPAHGSSSLVVPVRRA-DGTPAVLKLAPPHAEAEHE-----ARGEAALRWWNGRGAVRLLAAD--PERGALLLERLD 77 (253)
T ss_pred cCCCCCCCcceEEEEEEcC-CCCeEEEEecCCcccchhh-----hhHHhHhheeCCCCceeeeccc--cccchhhhhhcc
Confidence 3455678999999999744 6899999998753321111 1122457777777888888864 34567888888
Q ss_pred CCCCHHHHH
Q psy2306 119 AGGELYDFL 127 (335)
Q Consensus 119 ~~~~L~~~l 127 (335)
++.+|.++.
T Consensus 78 ~g~~L~~~~ 86 (253)
T PF04655_consen 78 PGRSLASLP 86 (253)
T ss_pred CCCchhhcc
Confidence 445776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 335 | ||||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-64 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-64 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-64 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-64 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-63 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-63 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-63 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-63 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-63 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-62 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-62 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-62 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-61 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-60 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-60 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-59 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-59 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-59 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-49 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-45 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-44 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-44 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-43 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-42 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-42 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-42 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-40 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-40 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-40 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-40 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-40 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-40 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-40 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-40 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-40 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-39 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-39 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-39 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-39 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-39 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-39 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-39 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-39 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-39 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-39 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-39 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-39 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-39 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-39 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-39 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-39 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-39 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-39 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-39 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-39 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-39 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-39 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-39 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-39 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-39 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-39 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-39 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-39 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-39 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-39 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-39 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-39 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-39 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-39 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-39 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-39 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-39 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-39 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-38 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-38 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-38 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-38 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-38 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-38 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-38 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-38 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-38 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-38 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-38 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-38 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-38 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-38 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-38 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-38 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-38 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-38 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-37 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-37 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-37 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-37 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-37 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-37 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-37 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-37 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-37 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-37 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-37 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-37 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-37 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-37 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-37 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-37 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-37 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-37 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-37 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-37 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-37 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-37 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-36 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-36 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-36 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-36 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-36 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-36 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-36 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-36 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-36 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-36 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-36 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-36 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-36 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-36 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-36 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-36 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-36 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-36 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-36 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-36 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-36 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-36 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-35 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-35 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-35 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-35 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-35 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-35 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-34 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-34 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-34 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-34 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-34 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-33 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-33 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-33 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-33 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-33 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-33 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-33 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-33 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-33 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-33 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-32 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-32 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-32 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-32 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-32 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-32 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-31 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-31 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-31 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-31 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-31 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-31 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-31 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-31 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-31 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-31 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-31 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-31 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-31 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-31 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-30 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-30 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-30 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-30 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-30 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-30 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-30 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-30 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-30 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-30 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-30 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-30 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-30 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-30 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-30 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-29 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-29 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-29 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-28 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-28 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-28 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-28 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-28 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-28 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-28 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-28 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-28 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-28 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-28 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-28 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-28 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-28 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-28 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-28 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-27 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-27 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-27 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-27 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-27 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-27 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-27 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-27 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-27 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-27 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-27 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-27 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-27 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-27 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-27 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-27 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-27 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-27 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-27 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-27 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-27 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-27 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-27 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-27 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-27 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-27 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-27 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-27 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-27 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-27 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-26 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-26 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-26 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-26 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-26 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-26 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-26 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-26 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-26 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-26 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-26 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-26 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-26 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-26 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-26 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-26 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-26 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-26 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-26 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-26 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-26 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-25 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-25 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-25 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-25 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-25 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-25 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-24 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-24 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-24 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-24 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-24 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-24 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-24 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-24 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-24 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-24 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-24 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-24 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-24 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-24 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-24 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-24 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-24 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-24 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-24 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-23 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-23 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-23 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-23 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-23 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-23 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-23 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-23 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-22 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-21 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-20 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-20 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-19 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-19 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-19 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-17 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-14 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-13 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-12 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-12 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-12 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-12 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-12 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-12 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-12 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-12 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-12 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-12 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-12 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-12 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-12 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-12 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-12 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-12 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-12 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-12 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-09 |
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-135
Identities = 125/285 (43%), Positives = 179/285 (62%), Gaps = 4/285 (1%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ +++ +G+GN+ KV+L + TG+EVAIK I K ++ L ++ RE++IM + HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHP 74
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
NI+ ++EV E + + L+MEYA+GGE++D+L + E+EAR FRQI +AV YCH+ +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
I HRDLK EN+LLD + N KIADFG SN FT L FCG+P YA+PE+ +G Y GPE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPS 275
VD WSLGV+LYTLV G++PFDG N K L +++ G Y P ST L+ L +NP
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPI 254
Query: 276 SRADISVICSHWWIDKDHSVACLEEAEE--LANQTPVRLDLLLSL 318
R + I WI+ H L+ E L R+D+++ +
Sbjct: 255 KRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-134
Identities = 95/297 (31%), Positives = 148/297 (49%), Gaps = 13/297 (4%)
Query: 20 ESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEA- 78
++ L + Q++ + LG G +G V ++KE +EV +K IKK K+ +
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 79 ----DLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAA-GGELYDFLDQKKVL 133
L ++ EI I+S V H NII + ++FEN+ LVME G +L+ F+D+ L
Sbjct: 68 IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127
Query: 134 TEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193
E A IFRQ+ +AV Y I HRD+K ENI++ E+ K+ DFG + +
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187
Query: 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY 253
TFCG+ Y +PE++ G PY GPE++ WSLGV LYTLV+ PF +++
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAI 241
Query: 254 FEPKNQST-ASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTP 309
P S L++ +L P R + + + W+ + ++A E P
Sbjct: 242 HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKP 298
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 380 bits (978), Expect = e-133
Identities = 117/266 (43%), Positives = 172/266 (64%), Gaps = 2/266 (0%)
Query: 29 NHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI 87
H ++K + + LG G +GKV++G ++ TG +VA+K + + KI + + +I+REI
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 88 QIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
Q + RHP+II +Y+V +VMEY +GGEL+D++ + + E EARR+F+QI +
Sbjct: 63 QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV 207
AV YCH+H + HRDLK EN+LLD + NAKIADFGLSN+ ++ FL T CGSP YA+PE++
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLI 266
G Y GPEVD WS GV+LY L+ G +PFD + L K+I G ++ P+ + + L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242
Query: 267 AEMLNINPSSRADISVICSHWWIDKD 292
ML ++P RA I I H W +D
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-131
Identities = 119/295 (40%), Positives = 180/295 (61%), Gaps = 2/295 (0%)
Query: 26 RLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRR 85
+ + R + + LG G +GKV++G ++ TG +VA+K + + KI + + +IRR
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 86 EIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQI 145
EIQ + RHP+II +Y+V + +VMEY +GGEL+D++ + L E+E+RR+F+QI
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 146 ATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
+ V YCH+H + HRDLK EN+LLD + NAKIADFGLSN+ ++ FL T CGSP YA+PE
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 185
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASP 264
++ G Y GPEVD WS GV+LY L+ G +PFD + L K+I +G ++ P+ +
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTPVRLDLLLSLA 319
L+ ML ++P RA I I H W +D L + + T + + L +
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLP-KYLFPEDPSYSSTMIDDEALKEVC 299
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 366 bits (943), Expect = e-127
Identities = 115/258 (44%), Positives = 166/258 (64%), Gaps = 2/258 (0%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ I LG+G++GKV+L + +T Q+VA+K I + ++ +R+ REI + +RHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
+II +Y+V +V+V+EYA GGEL+D++ +KK +TE+E RR F+QI A+ YCH+HK
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
I HRDLK EN+LLD+N N KIADFGLSN+ T+ FL T CGSP YA+PE++ G Y GPE
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPS 275
VD WS G++LY ++ G +PFD L K++++ Y P S A LI M+ +P
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPM 248
Query: 276 SRADISVICSHWWIDKDH 293
R I I W + +
Sbjct: 249 QRITIQEIRRDPWFNVNL 266
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-127
Identities = 91/302 (30%), Positives = 143/302 (47%), Gaps = 27/302 (8%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEAD---LIRIRRE 86
+ L+ ++ + LG G +G V GI VAIK ++K +I + R+ E
Sbjct: 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96
Query: 87 IQIMSSVRH--PNIIHIYEVFENREKMVLVMEYAAG-GELYDFLDQKKVLTEEEARRIFR 143
+ ++ V +I + + FE + VL++E +L+DF+ ++ L EE AR F
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDEN-GNAKIADFGLSNVFTESRFLSTFCGSPLYA 202
Q+ AV +CH + HRD+K ENIL+D N G K+ DFG + ++ + F G+ +Y+
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYS 215
Query: 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST- 261
PE ++ YHG WSLG+LLY +V G +PF+ ++I G F + S+
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSE 269
Query: 262 ASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTPVRLDLLLSLAPS 321
LI L + PS R I +H W+ E L SL+P
Sbjct: 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH------------LHSLSPG 317
Query: 322 PS 323
PS
Sbjct: 318 PS 319
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 354 bits (910), Expect = e-123
Identities = 85/300 (28%), Positives = 136/300 (45%), Gaps = 23/300 (7%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEAD---LIRIRREI 87
R + + + LG+G +G V G +VAIK I + ++ + + E+
Sbjct: 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 88 QIMSSVR----HPNIIHIYEVFENREKMVLVMEYAA-GGELYDFLDQKKVLTEEEARRIF 142
++ V HP +I + + FE +E +LV+E +L+D++ +K L E +R F
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLD-ENGNAKIADFGLSNVFTESRFLSTFCGSPLY 201
Q+ A+ +CH + HRD+K ENIL+D G AK+ DFG + + + + F G+ +Y
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDFDGTRVY 204
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST 261
+ PE + YH WSLG+LLY +V G +PF+ ++I + P + S
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSP 258
Query: 262 -ASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTPVRLDLLLSLAP 320
LI L PSSR + I W+ E L L SL P
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA------EDVPLNPSKGGPAPLAWSLLP 312
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 352 bits (904), Expect = e-121
Identities = 95/279 (34%), Positives = 148/279 (53%), Gaps = 13/279 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R+D V+ +G GN+G +L +K T + VA+K I++ E ++REI S+RHP
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE----NVQREIINHRSLRHP 76
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
NI+ EV + ++MEYA+GGELY+ + +E+EAR F+Q+ + V YCH +
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 157 ICHRDLKLENILLDEN--GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHG 214
ICHRDLKLEN LLD + KI DFG S + G+P Y +PE++ Y G
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSN----FKRLVKQISNGDYFEPKNQ---STASPLIA 267
D WS GV LY ++ GA PF+ +++ +++I + Y P + LI+
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLIS 256
Query: 268 EMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELAN 306
+ +P++R I I +H W K+ + E+ +
Sbjct: 257 RIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQ 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 346 bits (891), Expect = e-120
Identities = 88/263 (33%), Positives = 139/263 (52%), Gaps = 9/263 (3%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+D+V+ LG+G YG+VQL +N+ T + VA+K + + + I++EI I + H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE 65
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
N++ Y L +EY +GGEL+D ++ + E +A+R F Q+ V Y H
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFT---ESRFLSTFCGSPLYASPEIVKGIPYH 213
I HRD+K EN+LLDE N KI+DFGL+ VF R L+ CG+ Y +PE++K +H
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEPKNQ---STASPLIAEM 269
VD WS G++L ++ G +P+D S+ + + + S L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 270 LNINPSSRADISVICSHWWIDKD 292
L NPS+R I I W +K
Sbjct: 246 LVENPSARITIPDIKKDRWYNKP 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-120
Identities = 88/298 (29%), Positives = 143/298 (47%), Gaps = 9/298 (3%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+D+V+ LG+G YG+VQL +N+ T + VA+K + + + I++EI I + H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE 65
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
N++ Y L +EY +GGEL+D ++ + E +A+R F Q+ V Y H
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFT---ESRFLSTFCGSPLYASPEIVKGIPYH 213
I HRD+K EN+LLDE N KI+DFGL+ VF R L+ CG+ Y +PE++K +H
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEPKNQ---STASPLIAEM 269
VD WS G++L ++ G +P+D S+ + + + S L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 270 LNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTPVRLDLLLSLAPSPSTDKI 327
L NPS+R I I W +K + + + +
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPV 303
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-120
Identities = 80/266 (30%), Positives = 138/266 (51%), Gaps = 3/266 (1%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+ ++R+ R LG+G + K + +T + A K + K + ++ EI I
Sbjct: 35 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 94
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
S+ H +++ + FE+ + + +V+E L + ++K LTE EAR RQI
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 154
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVK 208
Y H++++ HRDLKL N+ L+E+ KI DFGL+ + CG+P Y +PE++
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214
Query: 209 GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIA 267
H EVD WS+G ++YTL+ G PF+ S K +I +Y PK+ + A+ LI
Sbjct: 215 KKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273
Query: 268 EMLNINPSSRADISVICSHWWIDKDH 293
+ML +P++R I+ + + + +
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTSGY 299
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-118
Identities = 80/260 (30%), Positives = 136/260 (52%), Gaps = 3/260 (1%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+R+ R LG+G + K + +T + A K + K + ++ EI I S+ H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
+++ + FE+ + + +V+E L + ++K LTE EAR RQI Y H++
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPYHG 214
++ HRDLKL N+ L+E+ KI DFGL+ + CG+P Y +PE++ H
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HS 193
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNIN 273
EVD WS+G ++YTL+ G PF+ S K +I +Y PK+ + A+ LI +ML +
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253
Query: 274 PSSRADISVICSHWWIDKDH 293
P++R I+ + + + +
Sbjct: 254 PTARPTINELLNDEFFTSGY 273
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-118
Identities = 91/271 (33%), Positives = 139/271 (51%), Gaps = 11/271 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEAD-LIRIRREIQIMS 91
KL ++ + LG+G+YGKV+ ++ ET A+K +KK K+ + +++EIQ++
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 92 SVRHPNIIHIYEV--FENREKMVLVMEYAAGG--ELYDFLDQKKVLTEEEARRIFRQIAT 147
+RH N+I + +V E ++KM +VMEY G E+ D + +K+ +A F Q+
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLID 120
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV---FTESRFLSTFCGSPLYASP 204
+ Y H I H+D+K N+LL G KI+ G++ F T GSP + P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 205 EIVKGI-PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-A 262
EI G+ + G +VD WS GV LY + G PF+G N +L + I G Y P +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 263 SPLIAEMLNINPSSRADISVICSHWWIDKDH 293
S L+ ML P+ R I I H W K H
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-116
Identities = 98/269 (36%), Positives = 142/269 (52%), Gaps = 4/269 (1%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ F + LG+G++ V + TG EVAIK I K + + R++ E++I ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHK 154
P+I+ +Y FE+ + LV+E GE+ +L ++ K +E EAR QI T + Y H
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPYH 213
H I HRDL L N+LL N N KIADFGL+ T CG+P Y SPEI H
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AH 189
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNI 272
G E D WSLG + YTL+ G PFD K + ++ DY P S A LI ++L
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249
Query: 273 NPSSRADISVICSHWWIDKDHSVACLEEA 301
NP+ R +S + H ++ ++ S +E
Sbjct: 250 NPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-114
Identities = 71/346 (20%), Positives = 138/346 (39%), Gaps = 49/346 (14%)
Query: 8 PQASINNIMGGIESTGGVRLHNHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAI 66
P S+ +I+ + + + + + I+R L QG + K+ L ++ + A+
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYAL 59
Query: 67 KTIKKCKIETEADLI--------------RIRREIQIMSSVRHPNIIHIYEVFENREKMV 112
K +K +E + D + E+QI++ +++ + + N +++
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY 119
Query: 113 LVMEYAAGGELYDFL--------DQKKVLTEEEARRIFRQIATAVYYCHKHK-ICHRDLK 163
++ EY + F + + + + I + + + Y H K ICHRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 164 LENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG-IPYHGPEVDCWSL 222
NIL+D+NG K++DFG S + + + G+ + PE Y+G +VD WSL
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVDKK-IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238
Query: 223 GVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEPKNQSTASP----------------- 264
G+ LY + Y +PF + L I + P +++
Sbjct: 239 GICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNE 298
Query: 265 ---LIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQ 307
+ L NP+ R H W+ + E ++EL +
Sbjct: 299 DIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKK 344
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-112
Identities = 94/281 (33%), Positives = 155/281 (55%), Gaps = 4/281 (1%)
Query: 29 NHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI 87
+ +R+ + F+I R LG+G +G V L K++ +A+K + K ++E ++RRE+
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 88 QIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
+I S +RHPNI+ +Y F + ++ L++EYA G +Y L + E+ ++A
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV 207
A+ YCH ++ HRD+K EN+LL G KIADFG S V S + CG+ Y PE++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMI 179
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLI 266
+G + +VD WSLGVL Y + G PF+ + ++ K+IS ++ P + A LI
Sbjct: 180 EGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 267 AEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQ 307
+ +L NPS R + + H WI + S + +E A++
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-111
Identities = 94/264 (35%), Positives = 147/264 (55%), Gaps = 4/264 (1%)
Query: 31 RRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+RK FDI R LG+G +G V L K+ +A+K + K ++E E ++RREI+I
Sbjct: 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
S +RHPNI+ +Y F +R+++ L++E+A GELY L + E+ + ++A A+
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
+YCH+ K+ HRD+K EN+L+ G KIADFG S V S T CG+ Y PE+++G
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEG 186
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAE 268
+ +VD W GVL Y + G PFD + ++I N D P S + LI++
Sbjct: 187 KTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245
Query: 269 MLNINPSSRADISVICSHWWIDKD 292
+L +P R + + H W+ +
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKAN 269
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-109
Identities = 83/286 (29%), Positives = 138/286 (48%), Gaps = 32/286 (11%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---------------------- 74
++ + ++G+G+YG V+L N+ A+K + K K+
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 75 -ETEADLIRIRREIQIMSSVRHPNIIHIYEVFE--NREKMVLVMEYAAGGELYDFLDQKK 131
+ + ++ +EI I+ + HPN++ + EV + N + + +V E G + + K
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 132 VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-R 190
L+E++AR F+ + + Y H KI HRD+K N+L+ E+G+ KIADFG+SN F S
Sbjct: 134 -LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 191 FLSTFCGSPLYASPEIVKGI--PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
LS G+P + +PE + + G +D W++GV LY V+G PF L +I
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252
Query: 249 SNGDYFEPKNQSTASP---LIAEMLNINPSSRADISVICSHWWIDK 291
+ P A LI ML+ NP SR + I H W+ +
Sbjct: 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-106
Identities = 92/282 (32%), Positives = 147/282 (52%), Gaps = 17/282 (6%)
Query: 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI-----ETEADLI 81
+ + + L+ + + + LG G G+V+L ++T ++VAIK I K K +
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 82 RIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRI 141
+ EI+I+ + HP II I F+ E +V+E GGEL+D + K L E +
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 142 FRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGS 198
F Q+ AV Y H++ I HRDLK EN+LL +E+ KI DFG S + E+ + T CG+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 199 PLYASPEIVKGIPY--HGPEVDCWSLGVLLYTLVYGAMPF-DGSNFKRLVKQISNGDY-F 254
P Y +PE++ + + VDCWSLGV+L+ + G PF + L QI++G Y F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 255 EPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKD 292
P+ + S L+ ++L ++P +R H W+ +
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-105
Identities = 76/303 (25%), Positives = 135/303 (44%), Gaps = 40/303 (13%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
+ F+ + LGQG +G+V N + AIK I+ TE L I E+ +++S
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLAS 58
Query: 93 VRHPNIIHIYEVFENRE-------------KMVLVMEYAAGGELYDFLDQKKVLTEE-EA 138
+ H ++ Y + R + + MEY G LYD + + + + E
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 139 RRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES--------- 189
R+FRQI A+ Y H I HRDLK NI +DE+ N KI DFGL+ S
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 190 ------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR 243
L++ G+ +Y + E++ G ++ ++D +SLG++ + ++Y G
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVN 236
Query: 244 LVKQISNGDY-FEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHSVACL 298
++K++ + F P +I +++ +P+ R + + W+ H +
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296
Query: 299 EEA 301
+EA
Sbjct: 297 KEA 299
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-104
Identities = 91/272 (33%), Positives = 138/272 (50%), Gaps = 10/272 (3%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
K +D+ +LG+G + V+ ++K TG E A K I K+ D ++ RE +I
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRK 61
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
++HPNI+ +++ + LV + GGEL++ + ++ +E +A +QI ++ YC
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 153 HKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
H + I HR+LK EN+LL + K+ADFGL+ +S F G+P Y SPE++K
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP---- 264
PY VD W+ GV+LY L+ G PF + RL QI G Y + T +P
Sbjct: 182 DPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVA 296
LI ML +NP R WI VA
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERVA 272
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-104
Identities = 95/268 (35%), Positives = 144/268 (53%), Gaps = 13/268 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
+ Q + + +G+G++G+V++ + K T A K I K +E ++EI+IM S
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF---KQEIEIMKS 62
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
+ HPNII +YE FE+ + LVME GGEL++ + K+V E +A RI + + +AV YC
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 153 HKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
HK + HRDLK EN L + K+ DFGL+ F + + T G+P Y SP++++G
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP---- 264
Y GPE D WS GV++Y L+ G PF ++ +I G + F K+ SP
Sbjct: 183 -LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKD 292
LI +L +P R H W +K
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 307 bits (787), Expect = e-104
Identities = 63/313 (20%), Positives = 111/313 (35%), Gaps = 48/313 (15%)
Query: 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ 88
+ + + LGQG V G +K+TG AIK D RE +
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD--VQMREFE 59
Query: 89 IMSSVRHPNIIHIYEVFENREK--MVLVMEYAAGGELYDFLDQKK---VLTEEEARRIFR 143
++ + H NI+ ++ + E VL+ME+ G LY L++ L E E + R
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 144 QIATAVYYCHKHKICHRDLKLENILL----DENGNAKIADFGLSNVFTESRFLSTFCGSP 199
+ + + ++ I HR++K NI+ D K+ DFG + + + G+
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 200 LYASPEIVKGIP-------YHGPEVDCWSLGVLLYTLVYGAMPFD----GSNFKRLVKQI 248
Y P++ + +G VD WS+GV Y G++PF K ++ +I
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 249 SNGDYFEPKN--------------------------QSTASPLIAEMLNINPSSRADISV 282
G + Q +P++A +L +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 283 ICSHWWIDKDHSV 295
+
Sbjct: 300 FFAETSDILHRGN 312
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-103
Identities = 90/300 (30%), Positives = 148/300 (49%), Gaps = 16/300 (5%)
Query: 8 PQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIK 67
P+ + N + + ++ Q++D +G+G V+ +++ TG E A+K
Sbjct: 66 PKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVK 125
Query: 68 TIKKCKIETEADLI-----RIRREIQIMSSVR-HPNIIHIYEVFENREKMVLVMEYAAGG 121
++ + + RRE I+ V HP+II + + +E+ M LV + G
Sbjct: 126 IMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG 185
Query: 122 ELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFG 181
EL+D+L +K L+E+E R I R + AV + H + I HRDLK ENILLD+N +++DFG
Sbjct: 186 ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245
Query: 182 LSNVFTESRFLSTFCGSPLYASPEIVKGIPY-----HGPEVDCWSLGVLLYTLVYGAMPF 236
S L CG+P Y +PEI+K +G EVD W+ GV+L+TL+ G+ PF
Sbjct: 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305
Query: 237 DGSNFKRLVKQISNGDY-FEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDK 291
+++ I G Y F S LI+ +L ++P +R H + ++
Sbjct: 306 WHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 316 bits (810), Expect = e-103
Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 40/303 (13%)
Query: 23 GGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR 82
GG R + + +++ +LG G +G V I+++TG++VAIK ++ + R
Sbjct: 1 GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE--R 58
Query: 83 IRREIQIMSSVRHPNIIHIYEVFENREKM------VLVMEYAAGGELYDFLDQKK---VL 133
EIQIM + HPN++ EV + +K+ +L MEY GG+L +L+Q + L
Sbjct: 59 WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118
Query: 134 TEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA---KIADFGLSNVFTESR 190
E R + I++A+ Y H+++I HRDLK ENI+L KI D G + +
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-KRLVKQIS 249
+ F G+ Y +PE+++ Y VD WS G L + + G PF + + ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 250 NGDYFEPKNQSTAS------------------------PLIAEMLNINPSSRADISVICS 285
+ + ML + R +
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297
Query: 286 HWW 288
Sbjct: 298 VGC 300
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-103
Identities = 94/288 (32%), Positives = 142/288 (49%), Gaps = 10/288 (3%)
Query: 17 GGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET 76
G G + N K +D+ +LG+G + V+ ++K TG E A K I K+
Sbjct: 10 GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA 69
Query: 77 EADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEE 136
D ++ RE +I ++HPNI+ +++ + LV + GGEL++ + ++ +E
Sbjct: 70 R-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 137 EARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLS 193
+A +QI ++ YCH + I HR+LK EN+LL + K+ADFGL+ +S
Sbjct: 129 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY 253
F G+P Y SPE++K PY VD W+ GV+LY L+ G PF + RL QI G Y
Sbjct: 189 GFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 247
Query: 254 -FEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHSVA 296
+ T +P LI ML +NP R WI VA
Sbjct: 248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-102
Identities = 87/282 (30%), Positives = 135/282 (47%), Gaps = 17/282 (6%)
Query: 28 HNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI------ETEADLI 81
+ + ++ LG+G V+ I+K T +E A+K I E +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 82 RIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARR 140
+E+ I+ V HPNII + + +E LV + GEL+D+L +K L+E+E R+
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 141 IFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL 200
I R + + HK I HRDLK ENILLD++ N K+ DFG S L CG+P
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS 188
Query: 201 YASPEIVKGIPY-----HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-F 254
Y +PEI++ +G EVD WS GV++YTL+ G+ PF +++ I +G+Y F
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248
Query: 255 EPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKD 292
S L++ L + P R +H + +
Sbjct: 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-102
Identities = 86/270 (31%), Positives = 140/270 (51%), Gaps = 15/270 (5%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
+ F RKLG G +G V L + +G E IKTI K + + + +I EI+++ S
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME--QIEAEIEVLKS 76
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL----DQKKVLTEEEARRIFRQIATA 148
+ HPNII I+EVFE+ M +VME GGEL + + + K L+E + +Q+ A
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 149 VYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
+ Y H + H+DLK ENIL + KI DFGL+ +F + G+ LY +PE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-F--EPKNQS-T 261
+ K + D WS GV++Y L+ G +PF G++ + + ++ + + + E + +
Sbjct: 197 VFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254
Query: 262 ASPLIAEMLNINPSSRADISVICSHWWIDK 291
A L+ +ML +P R + + H W +
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-102
Identities = 91/280 (32%), Positives = 146/280 (52%), Gaps = 17/280 (6%)
Query: 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI-----ETEADLIRI 83
+ + L+ + + + LG G G+V+L ++T ++VAI+ I K K + +
Sbjct: 128 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV 187
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
EI+I+ + HP II I F+ E +V+E GGEL+D + K L E + F
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 144 QIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPL 200
Q+ AV Y H++ I HRDLK EN+LL +E+ KI DFG S + E+ + T CG+P
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 306
Query: 201 YASPEIVKGIPY--HGPEVDCWSLGVLLYTLVYGAMPF-DGSNFKRLVKQISNGDY-FEP 256
Y +PE++ + + VDCWSLGV+L+ + G PF + L QI++G Y F P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 257 KNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKD 292
+ + S L+ ++L ++P +R H W+ +
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = e-101
Identities = 98/270 (36%), Positives = 154/270 (57%), Gaps = 11/270 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
+R++IV LG+G++G+V ++ T QE A+K I K + + D I RE++++
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKK 77
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
+ HPNI+ ++E+ E+ +V E GGEL+D + ++K +E +A RI +Q+ + + Y
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 153 HKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
HKH I HRDLK ENILL +++ + KI DFGLS F ++ + G+ Y +PE+++G
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP---- 264
Y + D WS GV+LY L+ G PF G N ++K++ G Y F+ T S
Sbjct: 198 -TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKDHS 294
LI +ML +PS R + H WI K S
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 63/306 (20%), Positives = 111/306 (36%), Gaps = 48/306 (15%)
Query: 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ 88
+ + + LGQG V G +K+TG AIK D RE +
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD--VQMREFE 59
Query: 89 IMSSVRHPNIIHIYEVFE--NREKMVLVMEYAAGGELYDFLDQKK---VLTEEEARRIFR 143
++ + H NI+ ++ + E VL+ME+ G LY L++ L E E + R
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 144 QIATAVYYCHKHKICHRDLKLENILL----DENGNAKIADFGLSNVFTESRFLSTFCGSP 199
+ + + ++ I HR++K NI+ D K+ DFG + + + G+
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 200 LYASPEIVKGIP-------YHGPEVDCWSLGVLLYTLVYGAMPFD----GSNFKRLVKQI 248
Y P++ + +G VD WS+GV Y G++PF K ++ +I
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 249 SNGDYFEPKN--------------------------QSTASPLIAEMLNINPSSRADISV 282
G + Q +P++A +L +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 283 ICSHWW 288
+
Sbjct: 300 FFAETS 305
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 297 bits (764), Expect = e-101
Identities = 91/268 (33%), Positives = 146/268 (54%), Gaps = 13/268 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
+++ F + LG G + +V L + TG+ A+K IKK ++ + EI ++
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKK 62
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
++H NI+ + +++E+ LVM+ +GGEL+D + ++ V TE++A + +Q+ +AV Y
Sbjct: 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 153 HKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
H++ I HRDLK EN+L +EN I DFGLS ++ +ST CG+P Y +PE++
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS-KMEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP---- 264
PY VDCWS+GV+ Y L+ G PF +L ++I G Y FE S
Sbjct: 182 KPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKD 292
I +L +P+ R SH WID +
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-100
Identities = 107/314 (34%), Positives = 171/314 (54%), Gaps = 17/314 (5%)
Query: 13 NNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKC 72
++M + +T G+ + + R+ R LG+G++G+V L +K TGQE A+K I K
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 73 KIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV 132
+++ + D + RE+Q++ + HPNI+ +YE FE++ LV E GGEL+D + +K
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 133 LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTES 189
+E +A RI RQ+ + + Y HK+KI HRDLK EN+LL ++ N +I DFGLS F S
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS 249
+ + G+ Y +PE++ G + + D WS GV+LY L+ G PF+G+N ++K++
Sbjct: 183 KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240
Query: 250 NGDY-FEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEEL 304
G Y FE S LI +ML PS R H WI E++
Sbjct: 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY-------TKEQI 293
Query: 305 ANQTPVRLDLLLSL 318
+ P + +L++
Sbjct: 294 SVDVPSLDNAILNI 307
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = e-100
Identities = 96/273 (35%), Positives = 146/273 (53%), Gaps = 13/273 (4%)
Query: 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQIM 90
++ +++ +LG G + V+ K TG+E A K IKK ++ I RE+ I+
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
+RHPNII ++++FEN+ +VL++E +GGEL+DFL +K+ LTE+EA + +QI V+
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 151 YCHKHKICHRDLKLENILL----DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206
Y H +I H DLK ENI+L N K+ DFG+++ G+P + +PEI
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP- 264
V P G E D WS+GV+ Y L+ GA PF G + + IS +Y F+ + S S
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 265 ---LIAEMLNINPSSRADISVICSHWWIDKDHS 294
I +L +P R I+ H WI
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 4e-99
Identities = 99/278 (35%), Positives = 141/278 (50%), Gaps = 13/278 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQI 89
+ +D +LG G + V+ K TG + A K IKK + I RE+ I
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
+ ++HPN+I ++EV+EN+ ++L++E AGGEL+DFL +K+ LTEEEA +QI V
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 150 YYCHKHKICHRDLKLENILL----DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
YY H +I H DLK ENI+L KI DFGL++ G+P + +PE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP 264
IV P G E D WS+GV+ Y L+ GA PF G + + +S +Y FE + S S
Sbjct: 188 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 265 ----LIAEMLNINPSSRADISVICSHWWIDKDHSVACL 298
I +L +P R I H WI + L
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 284
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 300 bits (769), Expect = 5e-99
Identities = 98/292 (33%), Positives = 156/292 (53%), Gaps = 11/292 (3%)
Query: 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ 88
+ +R++IV LG+G++G+V ++ T QE A+K I K + + D I RE++
Sbjct: 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVE 73
Query: 89 IMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATA 148
++ + HPNI+ ++E+ E+ +V E GGEL+D + ++K +E +A RI +Q+ +
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 149 VYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
+ Y HKH I HRDLK ENILL +++ + KI DFGLS F ++ + G+ Y +PE
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP 264
+++G Y + D WS GV+LY L+ G PF G N ++K++ G Y F+ T S
Sbjct: 194 VLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251
Query: 265 ----LIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTPVRL 312
LI +ML +PS R + H WI K S +
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNI 303
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 1e-98
Identities = 96/295 (32%), Positives = 154/295 (52%), Gaps = 11/295 (3%)
Query: 8 PQASINNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIK 67
G +++T G+ + + + L + + V+KLG G YG+V L +K T E AIK
Sbjct: 9 SGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK 68
Query: 68 TIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL 127
I+K + T ++ E+ ++ + HPNI+ +Y+ FE++ LVME GGEL+D +
Sbjct: 69 IIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI 127
Query: 128 DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSN 184
+ E +A I +Q+ + V Y HKH I HRDLK EN+LL +++ KI DFGLS
Sbjct: 128 IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
VF + + G+ Y +PE+++ Y + D WS+GV+L+ L+ G PF G + +
Sbjct: 188 VFENQKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245
Query: 245 VKQISNGDY-FEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHS 294
++++ G Y F+ S LI +ML + R H WI + S
Sbjct: 246 LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 4e-98
Identities = 100/287 (34%), Positives = 146/287 (50%), Gaps = 13/287 (4%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQ 88
+K++ +DI +LG G + V+ K TG E A K IKK + I RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 89 IMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATA 148
I+ V H N+I +++V+ENR +VL++E +GGEL+DFL QK+ L+EEEA +QI
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 149 VYYCHKHKICHRDLKLENILL----DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
V Y H KI H DLK ENI+L + K+ DFGL++ + G+P + +P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTAS 263
EIV P G E D WS+GV+ Y L+ GA PF G + + I++ Y F+ + S S
Sbjct: 188 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 264 P----LIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELAN 306
I ++L R I H WI + + E + N
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVN 293
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 2e-97
Identities = 102/286 (35%), Positives = 145/286 (50%), Gaps = 13/286 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQI 89
K++ +DI +LG G + V+ K TG E A K IKK + I RE+ I
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
+ V HPNII +++V+ENR +VL++E +GGEL+DFL QK+ L+EEEA +QI V
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 150 YYCHKHKICHRDLKLENILL----DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
Y H KI H DLK ENI+L + K+ DFGL++ + G+P + +PE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP 264
IV P G E D WS+GV+ Y L+ GA PF G + + I+ Y F+ + S S
Sbjct: 189 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 265 ----LIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELAN 306
I ++L R I H WI + + E + N
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVN 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 4e-97
Identities = 102/300 (34%), Positives = 153/300 (51%), Gaps = 20/300 (6%)
Query: 13 NNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKC 72
N GI G+ + K+ + + VRKLG G YG+V L K E AIK IKK
Sbjct: 13 NLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKS 72
Query: 73 KIET----------EADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGE 122
+ + E I EI ++ S+ HPNII +++VFE+++ LV E+ GGE
Sbjct: 73 QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE 132
Query: 123 LYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIAD 179
L++ + + E +A I +QI + + Y HKH I HRD+K ENILL + N KI D
Sbjct: 133 LFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 180 FGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS 239
FGLS+ F++ L G+ Y +PE++K + + D WS GV++Y L+ G PF G
Sbjct: 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQ 250
Query: 240 NFKRLVKQISNGDY-FEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHS 294
N + ++K++ G Y F+ + S LI ML + + R + WI K +
Sbjct: 251 NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 2e-96
Identities = 90/273 (32%), Positives = 142/273 (52%), Gaps = 11/273 (4%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
+ + + + +LG+G + V+ + GQE A I K+ + D ++ RE +I
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRL 66
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
++HPNI+ +++ L+ + GGEL++ + ++ +E +A +QI AV +C
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 153 HKHKICHRDLKLENILL---DENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVK 208
H+ + HR+LK EN+LL + K+ADFGL+ E + F G+P Y SPE+++
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 209 GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP--- 264
PY G VD W+ GV+LY L+ G PF + RL +QI G Y F T +P
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 265 -LIAEMLNINPSSRADISVICSHWWIDKDHSVA 296
LI +ML INPS R + H WI +VA
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISHRSTVA 278
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 3e-96
Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 23/297 (7%)
Query: 17 GGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET 76
G++ + + I++++G G KV +N+ Q AIK + + +
Sbjct: 9 SGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD- 66
Query: 77 EADLIRIRREIQIMSSVRHPN--IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLT 134
L R EI ++ ++ + II +Y+ + + +VME +L +L +KK +
Sbjct: 67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSID 125
Query: 135 EEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF---TESRF 191
E + ++ + AV+ H+H I H DLK N L+ +G K+ DFG++N T S
Sbjct: 126 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 184
Query: 192 LSTFCGSPLYASPEIVKGIPY----------HGPEVDCWSLGVLLYTLVYGAMPFDG--S 239
+ G+ Y PE +K + P+ D WSLG +LY + YG PF +
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
Query: 240 NFKRLVKQISNGDYFE-PKNQST-ASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294
+L I E P ++ L +P R I + +H ++
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 4e-96
Identities = 100/323 (30%), Positives = 151/323 (46%), Gaps = 55/323 (17%)
Query: 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE--TEADLIRIR 84
+L++++ + +GQG+YG V++ I +T AIK + K KI D+ RI+
Sbjct: 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 85 REIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK------------- 131
E+++M + HPNI +YEV+E+ + + LVME GG L D L+
Sbjct: 77 TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 132 ---------------------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKL 164
V E+ I RQI +A++Y H ICHRD+K
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196
Query: 165 ENILL--DENGNAKIADFGLSNVFT-----ESRFLSTFCGSPLYASPEIVKGIPYH-GPE 216
EN L +++ K+ DFGLS F E ++T G+P + +PE++ GP+
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP----LIAEMLN 271
D WS GVLL+ L+ GA+PF G N + Q+ N FE N + SP L++ +LN
Sbjct: 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN 316
Query: 272 INPSSRADISVICSHWWIDKDHS 294
N R D H WI +
Sbjct: 317 RNVDERFDAMRALQHPWISQFSD 339
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 1e-95
Identities = 91/275 (33%), Positives = 142/275 (51%), Gaps = 15/275 (5%)
Query: 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRRE 86
++R L F++ +LG+G V K T + A+K +KK + +R E
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTE 98
Query: 87 IQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
I ++ + HPNII + E+FE ++ LV+E GGEL+D + +K +E +A +QI
Sbjct: 99 IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158
Query: 147 TAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
AV Y H++ I HRDLK EN+L + KIADFGLS + + T CG+P Y +
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDY-FEPKNQST 261
PEI++G Y GPEVD WS+G++ Y L+ G PF + + ++I N +Y F
Sbjct: 219 PEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE 277
Query: 262 ASP----LIAEMLNINPSSRADISVICSHWWIDKD 292
S L+ +++ ++P R H W+
Sbjct: 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-95
Identities = 80/279 (28%), Positives = 139/279 (49%), Gaps = 17/279 (6%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE--ADLIRIRREIQIM 90
+ +++ +G+G + V+ IN+ETGQ+ A+K + K + ++RE I
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK----VLTEEEARRIFRQIA 146
++HP+I+ + E + + + +V E+ G +L + ++ V +E A RQI
Sbjct: 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 147 TAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTE-SRFLSTFCGSPLYA 202
A+ YCH + I HRD+K +LL + + K+ FG++ E G+P +
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQST 261
+PE+VK PY G VD W GV+L+ L+ G +PF G+ +RL + I G Y P+ S
Sbjct: 201 APEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258
Query: 262 ASP----LIAEMLNINPSSRADISVICSHWWIDKDHSVA 296
S L+ ML ++P+ R + +H W+ + A
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 2e-94
Identities = 67/271 (24%), Positives = 127/271 (46%), Gaps = 13/271 (4%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
++L +++ I LG+G +G V + + + K +K + +++EI I++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILN 56
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVY 150
RH NI+H++E FE+ E++V++ E+ +G ++++ ++ L E E Q+ A+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 151 YCHKHKICHRDLKLENILL--DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK 208
+ H H I H D++ ENI+ + KI +FG + +P Y +PE+ +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 209 GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP--- 264
D WSLG L+Y L+ G PF +++++ I N +Y F+ + S
Sbjct: 177 HDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 265 -LIAEMLNINPSSRADISVICSHWWIDKDHS 294
+ +L SR S H W+ +
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 4e-94
Identities = 83/275 (30%), Positives = 138/275 (50%), Gaps = 14/275 (5%)
Query: 27 LHNHRRKLKQRFDIV-RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRR 85
+ + ++LG+G + V+ I+K TGQE A K +KK + + I
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILH 77
Query: 86 EIQIMSSVRH-PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV--LTEEEARRIF 142
EI ++ + P +I+++EV+EN +++L++EYAAGGE++ + ++E + R+
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLI 137
Query: 143 RQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSP 199
+QI VYY H++ I H DLK +NILL G+ KI DFG+S + L G+P
Sbjct: 138 KQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKN 258
Y +PEI+ P D W++G++ Y L+ PF G + + IS + + +
Sbjct: 198 EYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256
Query: 259 QSTASP----LIAEMLNINPSSRADISVICSHWWI 289
S+ S I +L NP R + SH W+
Sbjct: 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 5e-94
Identities = 85/284 (29%), Positives = 143/284 (50%), Gaps = 22/284 (7%)
Query: 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRRE 86
LH + + +++ +G G+Y + I+K T E A+K I K K + E
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-------TEE 65
Query: 87 IQIM-SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQI 145
I+I+ +HPNII + +V+++ + + +V E GGEL D + ++K +E EA + I
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125
Query: 146 ATAVYYCHKHKICHRDLKLENILL-DENGNA---KIADFGLSNVFT-ESRFLSTFCGSPL 200
V Y H + HRDLK NIL DE+GN +I DFG + E+ L T C +
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---NFKRLVKQISNGDY-FEP 256
+ +PE+++ Y D WSLGVLLYT++ G PF + ++ +I +G +
Sbjct: 186 FVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
Query: 257 KNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHSVA 296
++ S L+++ML+++P R +++ H WI +
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 1e-93
Identities = 81/272 (29%), Positives = 136/272 (50%), Gaps = 12/272 (4%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM 90
+ + +DI+ +LG G +G V + K TG+ K I + ++ EI IM
Sbjct: 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIM 102
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAV 149
+ + HP +I++++ FE++ +MVL++E+ +GGEL+D + + ++E E RQ +
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 162
Query: 150 YYCHKHKICHRDLKLENILL--DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV 207
+ H+H I H D+K ENI+ + + KI DFGL+ + + +A+PEIV
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP-- 264
P G D W++GVL Y L+ G PF G + ++ + D+ F+ S+ SP
Sbjct: 223 DREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281
Query: 265 --LIAEMLNINPSSRADISVICSHWWIDKDHS 294
I +L P R + H W+ DHS
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 1e-93
Identities = 69/280 (24%), Positives = 124/280 (44%), Gaps = 25/280 (8%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ + I++++G G KV +N+ Q AIK + + + L R EI ++ ++
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQ 65
Query: 95 HPN--IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
+ II +Y+ + + +VME +L +L +KK + E + ++ + AV+
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVF---TESRFLSTFCGSPLYASPEIVKG 209
H+H I H DLK N L+ +G K+ DFG++N T S + G+ Y PE +K
Sbjct: 125 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 210 IPY----------HGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEPKN 258
+ P+ D WSLG +LY + YG PF N + I + ++ E +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-EIEF 242
Query: 259 QSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHS 294
++ L +P R I + +H ++
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 1e-93
Identities = 69/280 (24%), Positives = 124/280 (44%), Gaps = 25/280 (8%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ + I++++G G KV +N+ Q AIK + + + L R EI ++ ++
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQ 112
Query: 95 HPN--IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
+ II +Y+ + + +VME +L +L +KK + E + ++ + AV+
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVF---TESRFLSTFCGSPLYASPEIVKG 209
H+H I H DLK N L+ +G K+ DFG++N T S + G+ Y PE +K
Sbjct: 172 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 210 IPY----------HGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEPKN 258
+ P+ D WSLG +LY + YG PF N + I + ++ E +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-EIEF 289
Query: 259 QSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHS 294
++ L +P R I + +H ++
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 2e-92
Identities = 81/267 (30%), Positives = 128/267 (47%), Gaps = 14/267 (5%)
Query: 33 KLKQRFDIVRK--LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM 90
+ + + + LG G +G+V TG ++A K IK ++ + + ++ EI +M
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE---VKNEISVM 140
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYD-FLDQKKVLTEEEARRIFRQIATAV 149
+ + H N+I +Y+ FE++ +VLVMEY GGEL+D +D+ LTE + +QI +
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGI 200
Query: 150 YYCHKHKICHRDLKLENILLDENGNA--KIADFGLSNVFTESRFLSTFCGSPLYASPEIV 207
+ H+ I H DLK ENIL KI DFGL+ + L G+P + +PE+V
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV 260
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP-- 264
D WS+GV+ Y L+ G PF G N + I + E + S
Sbjct: 261 NYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 265 --LIAEMLNINPSSRADISVICSHWWI 289
I+++L S R S H W+
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWL 346
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 5e-92
Identities = 82/299 (27%), Positives = 152/299 (50%), Gaps = 13/299 (4%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+++ ++K+G+G++GK L + E G++ IK I ++ + + RRE+ ++++++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKH 82
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCH 153
PNI+ E FE + +VM+Y GG+L+ ++ +K + E++ F QI A+ + H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTFCGSPLYASPEIVKGIPY 212
KI HRD+K +NI L ++G ++ DFG++ V + G+P Y SPEI + PY
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP----LIAE 268
+ D W+LG +LY L F+ + K LV +I +G + P S L+++
Sbjct: 203 -NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQ 259
Query: 269 MLNINPSSRADISVICSHWWIDKDHSVACLEEAEELANQTPVRLDLLLSLAPSPSTDKI 327
+ NP R ++ I +I K + + +A + ++ P P+
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAK--RIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPA 316
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 272 bits (699), Expect = 2e-91
Identities = 83/270 (30%), Positives = 132/270 (48%), Gaps = 16/270 (5%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ ++++ +G G+YG+ Q K G+ + K + + TEA+ + E+ ++ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 64
Query: 96 PNIIHIYEVFENREKMVL--VMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAV 149
PNI+ Y+ +R L VMEY GG+L + + ++ L EE R+ Q+ A+
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 150 YYCHK-----HKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTFCGSPLYAS 203
CH+ H + HRDLK N+ LD N K+ DFGL+ + F TF G+P Y S
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQST- 261
PE + + Y + D WSLG LLY L PF + K L +I G + P S
Sbjct: 185 PEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 262 ASPLIAEMLNINPSSRADISVICSHWWIDK 291
+ +I MLN+ R + I + I +
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 5e-91
Identities = 84/272 (30%), Positives = 144/272 (52%), Gaps = 24/272 (8%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIH 100
+ LG+G++ + ++K++ Q A+K I K ++EI + HPNI+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA------NTQKEITALKLCEGHPNIVK 70
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHR 160
++EVF ++ LVME GGEL++ + +KK +E EA I R++ +AV + H + HR
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 161 DLKLENILL---DENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
DLK EN+L ++N KI DFG + + +++ L T C + YA+PE++ Y
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY-DES 189
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSN-------FKRLVKQISNGDY-FEPKNQSTASP---- 264
D WSLGV+LYT++ G +PF + ++K+I GD+ FE + S
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVA 296
LI +L ++P+ R +S + + W+ ++
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 3e-90
Identities = 79/278 (28%), Positives = 141/278 (50%), Gaps = 12/278 (4%)
Query: 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRRE 86
+ + +DI +LG G +G V + TG A K + + +R+E
Sbjct: 148 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET---VRKE 204
Query: 87 IQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQI 145
IQ MS +RHP ++++++ FE+ +MV++ E+ +GGEL++ + D+ ++E+EA RQ+
Sbjct: 205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 264
Query: 146 ATAVYYCHKHKICHRDLKLENILL-DENGNA-KIADFGLSNVFTESRFLSTFCGSPLYAS 203
+ + H++ H DLK ENI+ + N K+ DFGL+ + + G+ +A+
Sbjct: 265 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 324
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTA 262
PE+ +G P G D WS+GVL Y L+ G PF G N ++ + + D+ + S
Sbjct: 325 PEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 383
Query: 263 SP----LIAEMLNINPSSRADISVICSHWWIDKDHSVA 296
S I ++L +P++R I H W+ ++
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 7e-90
Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 27/278 (9%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ + ++KLG+G + V L G A+K I + D +RE + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRLFNH 85
Query: 96 PNIIHIYEVFENRE----KMVLVMEYAAGGELYDFLDQKKV----LTEEEARRIFRQIAT 147
PNI+ + + L++ + G L++ +++ K LTE++ + I
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS----------TFCG 197
+ H HRDLK NILL + G + D G N S
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 198 SPLYASPEIVKGIPYH--GPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNGDYF 254
+ Y +PE+ + D WSLG +LY +++G P+D K V
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 255 EPKNQ---STASPLIAEMLNINPSSRADISVICSHWWI 289
P++ S L+ M+ ++P R I ++ S
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 2e-88
Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 40/300 (13%)
Query: 30 HRRKLKQRFDIVRK-LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ 88
+ + + + LG+G + +VQ IN T QE A+K I+K + + RE++
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV---FREVE 62
Query: 89 IMSSVR-HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
++ + H N++ + E FE ++ LV E GG + + +++ E EA + + +A+
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 148 AVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRF--------LSTFC 196
A+ + H I HRDLK ENIL ++ KI DF L + + L T C
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 197 GSPLYASPEIVKGIPY----HGPEVDCWSLGVLLYTLVYGAMPFDGSNF----------- 241
GS Y +PE+V+ + D WSLGV+LY L+ G PF G
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 242 ----KRLVKQISNGDY-FEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKD 292
L + I G Y F K+ + S LI+++L + R + + H W+
Sbjct: 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 3e-87
Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 30/289 (10%)
Query: 27 LHNHRRKLKQRFDIVRK-LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRR 85
+ + + + ++ LG G GKV ++ TGQ+ A+K + + R+
Sbjct: 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQ 70
Query: 86 EIQIMSSV-RHPNIIHIYEVFENREKMV----LVMEYAAGGELYDFLDQK--KVLTEEEA 138
E+ P+I+ I +V+EN ++ME GGEL+ + ++ + TE EA
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 139 RRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTF 195
I R I TA+ + H H I HRD+K EN+L +++ K+ DFG + T L T
Sbjct: 131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTP 189
Query: 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN----FKRLVKQISNG 251
C +P Y +PE++ Y D WSLGV++Y L+ G PF + + ++I G
Sbjct: 190 CYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248
Query: 252 DY-FEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHSV 295
Y F S S LI +L +P+ R I+ +H WI++ V
Sbjct: 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 1e-86
Identities = 87/273 (31%), Positives = 133/273 (48%), Gaps = 28/273 (10%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIH 100
+ LG G GKV NK T ++ A+K ++ C + RRE+++ + P+I+
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVR 119
Query: 101 IYEVFEN----REKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHK 154
I +V+EN R+ +++VME GGEL+ + + + TE EA I + I A+ Y H
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 155 HKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIP 211
I HRD+K EN+L N K+ DFG + T L+T C +P Y +PE++
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNF----KRLVKQISNGDY-FEPKNQSTASP-- 264
Y D WSLGV++Y L+ G PF ++ + +I G Y F S S
Sbjct: 240 Y-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 298
Query: 265 --LIAEMLNINPSSRADISVICSHWWIDKDHSV 295
LI +L P+ R I+ +H WI + V
Sbjct: 299 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 7e-86
Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 31/279 (11%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
++ F + +G G +G+V ++ G+ IK +K E + RE++ ++
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY---NNE----KAEREVKALA 59
Query: 92 SVRHPNIIHIYEVFENREKMV----------------LVMEYAAGGELYDFLDQKK--VL 133
+ H NI+H ++ + + ME+ G L ++++++ L
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 134 TEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193
+ A +F QI V Y H K+ +RDLK NI L + KI DFGL +
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY 253
G+ Y SPE + Y G EVD ++LG++L L++ + + +G
Sbjct: 180 RSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGII 236
Query: 254 FEPKNQST-ASPLIAEMLNINPSSRADISVICSHWWIDK 291
L+ ++L+ P R + S I + K
Sbjct: 237 --SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 4e-85
Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 40/286 (13%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ R + R L +G + V + +G+E A+K + E I +E+ M +
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS---NEEEKNRAIIQEVCFMKKLS 83
Query: 95 -HPNIIHIY-------EVFENREKMVLVMEYAAGGELYDFLDQ---KKVLTEEEARRIFR 143
HPNI+ E + + L++ G+L +FL + + L+ + +IF
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 144 QIATAVYYCHKHK--ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS-------- 193
Q AV + H+ K I HRDLK+EN+LL G K+ DFG + + S
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 194 -----TFCGSPLYASPEIV---KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV 245
T +P+Y +PEI+ P G + D W+LG +LY L + PF+ R
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260
Query: 246 KQISNGDYFEPKNQSTASP---LIAEMLNINPSSRADISVICSHWW 288
I NG Y P + + + LI ML +NP R I+ +
Sbjct: 261 --IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 3e-84
Identities = 74/278 (26%), Positives = 123/278 (44%), Gaps = 13/278 (4%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
F I +K+G+G + +V G VA+K ++ + +EI ++ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL----DQKKVLTEEEARRIFRQIATAVYY 151
PN+I Y F ++ +V+E A G+L + QK+++ E + F Q+ +A+ +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTFCGSPLYASPEIVKGI 210
H ++ HRD+K N+ + G K+ D GL F+ + G+P Y SPE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 211 PYHGPEVDCWSLGVLLYTLVYGAMPFDGS--NFKRLVKQISNGDYFEPKNQSTASP---- 264
Y + D WSLG LLY + PF G N L K+I DY P S
Sbjct: 212 GY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-PPLPSDHYSEELRQ 269
Query: 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAE 302
L+ +N +P R D++ + + + LE
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 7e-82
Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 10/268 (3%)
Query: 28 HNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI 87
+Q F + +LG G+YG+V +KE G+ A+K D R E+
Sbjct: 49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEV 107
Query: 88 QIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQI 145
V +HP + + + +E + L E G L L E + R
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 146 ATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
A+ + H + H D+K NI L G K+ DFGL + G P Y +PE
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGA-MPFDGSNFKRLVKQISNGDYFEPKNQST-AS 263
+++G Y G D +SLG+ + + +P G +++L + ++ S+
Sbjct: 227 LLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELR 282
Query: 264 PLIAEMLNINPSSRADISVICSHWWIDK 291
++ ML +P RA + + + +
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 3e-78
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 41/289 (14%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
F+ ++ LG+G +G V NK AIK I+ E + ++ RE++ ++ + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLEH 62
Query: 96 PNIIHIYEVFENREKMV------------LVMEYAAGGELYDFLDQKKVLTEEE---ARR 140
P I+ + + + + M+ L D+++ + + E E
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 141 IFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS------- 193
IF QIA AV + H + HRDLK NI + K+ DFGL +
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 194 ------TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFD-GSNFKRLVK 246
G+ LY SPE + G Y +VD +SLG++L+ L+Y PF R +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238
Query: 247 QISNGDYFEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDK 291
+ N + P + P ++ +ML+ +P R + I + +
Sbjct: 239 DVRNLKF--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 6e-77
Identities = 69/304 (22%), Positives = 116/304 (38%), Gaps = 51/304 (16%)
Query: 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRRE 86
+ N + LK + LG G+ G V G+ VA+K + + E
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD------IALME 58
Query: 87 IQIMS-SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-------LTEEEA 138
I++++ S HPN+I Y + + +E L D ++ K V E
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 139 RRIFRQIATAVYYCHKHKICHRDLKLENILLD-------------ENGNAKIADFGLSNV 185
+ RQIA+ V + H KI HRDLK +NIL+ EN I+DFGL
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 186 FTESRF-----LSTFCGSPLYASPEIVKGIP------YHGPEVDCWSLGVLLYT-LVYGA 233
+ L+ G+ + +PE+++ +D +S+G + Y L G
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 234 MPFDGSNFKRLVKQISNGDY----FEPKNQSTASP----LIAEMLNINPSSRADISVICS 285
PF + I G + + + + LI++M++ +P R +
Sbjct: 238 HPFGDKYSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
Query: 286 HWWI 289
H
Sbjct: 296 HPLF 299
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 1e-74
Identities = 61/273 (22%), Positives = 105/273 (38%), Gaps = 26/273 (9%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SV 93
K F LG G G + ++VA+K I RE+Q++ S
Sbjct: 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSF------ADREVQLLRESD 75
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYC 152
HPN+I + ++R+ + +E L ++++QK E + +Q + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 153 HKHKICHRDLKLENILLDENGN-----AKIADFGLSNVFTESR----FLSTFCGSPLYAS 203
H I HRDLK NIL+ A I+DFGL R S G+ + +
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 204 PEIVKGIPY--HGPEVDCWSLGVLLYT-LVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS 260
PE++ VD +S G + Y + G+ PF S ++ + +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254
Query: 261 TASP----LIAEMLNINPSSRADISVICSHWWI 289
LI +M+ ++P R + H +
Sbjct: 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 6e-74
Identities = 80/273 (29%), Positives = 121/273 (44%), Gaps = 49/273 (17%)
Query: 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIH 100
+ LG G GKV NK T ++ A+K ++ C + RRE+++ + P+I+
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVR 75
Query: 101 IYEVFEN----REKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHK 154
I +V+EN R+ +++VME GGEL+ + + + TE EA I + I A+ Y H
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 155 HKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIP 211
I HRD+K EN+L N K+ DFG + E
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTGE-K 174
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR----LVKQISNGDY-FEPKNQSTASP-- 264
Y D WSLGV++Y L+ G PF ++ + +I G Y F S S
Sbjct: 175 Y-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 233
Query: 265 --LIAEMLNINPSSRADISVICSHWWIDKDHSV 295
LI +L P+ R I+ +H WI + V
Sbjct: 234 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 9e-72
Identities = 37/310 (11%), Positives = 82/310 (26%), Gaps = 49/310 (15%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
R+ + + + LGQ + ++ETG+ + + + +++
Sbjct: 62 FRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121
Query: 85 REIQIMSSVR-------------------------HPNIIHIYEVFENREKM--VLVMEY 117
E+ + +R +I + + + +
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 181
Query: 118 AA------GGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE 171
G L K L ++ Q+ + H + + H L+ +I+LD+
Sbjct: 182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 241
Query: 172 NGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK----------GIPYHGPEVDCWS 221
G + F S + PE+ D W+
Sbjct: 242 RGGVFLTGFEHLVRDGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 222 LGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADIS 281
LG+++Y + +P + I P L+ L R
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIP---QPVRALLEGFLRYPKEDRLLPL 355
Query: 282 VICSHWWIDK 291
++
Sbjct: 356 QAMETPEYEQ 365
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 4e-69
Identities = 36/310 (11%), Positives = 82/310 (26%), Gaps = 45/310 (14%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
+ + + +++ +V L G+ V L + E ++ A+K + ++L R+
Sbjct: 51 TTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLH 110
Query: 85 REIQIMSSVRHPNIIHIYEVF--------------------------ENREKMVLVMEYA 118
+ + + + +L+M A
Sbjct: 111 EATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA 170
Query: 119 AG------GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN 172
+ L + + Q+ + H +N+ + +
Sbjct: 171 SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD 230
Query: 173 GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY-HGPEVDCWSLGVLLYTLVY 231
G + D YA E + ++ W LG+ +Y +
Sbjct: 231 GRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 232 GAMPFDGSN------FKRLVKQISNGDYFEPKNQSTASP----LIAEMLNINPSSRADIS 281
+PF +KR ++ D + + LI LN + R
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348
Query: 282 VICSHWWIDK 291
+
Sbjct: 349 EAMETPEFLQ 358
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 6e-68
Identities = 73/258 (28%), Positives = 133/258 (51%), Gaps = 7/258 (2%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+I+R +G+G++GKV + +T + A+K + K K ++ + +E+QIM + HP
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+++++ F++ E M +V++ GG+L L Q EE + ++ A+ Y +I
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV--KGIPYHGP 215
HRD+K +NILLDE+G+ I DF ++ + ++T G+ Y +PE+ + +
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSF 196
Query: 216 EVDCWSLGVLLYTLVYGAMPFDG---SNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLN 271
VD WSLGV Y L+ G P+ ++ K +V P S L+ ++L
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLE 256
Query: 272 INPSSR-ADISVICSHWW 288
NP R + +S + + +
Sbjct: 257 PNPDQRFSQLSDVQNFPY 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 8e-68
Identities = 38/270 (14%), Positives = 87/270 (32%), Gaps = 31/270 (11%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+ + LG+G + +V + Q+ +K K + + ++
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMER 120
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK-----VLTEEEARRIFRQ 144
+ + Y + VLV E + G L + ++ K V+ + +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 145 IATAVYYCHKHKICHRDLKLENILL-----------DENGNAKIADFGLS---NVFTESR 190
+ + H +I H D+K +N +L D + + D G S +F +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN 250
+ C + + E++ P+ ++D + + +Y +++G + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 251 GDYFEPKNQSTASPLIAEMLNINPSSRADI 280
+ MLNI
Sbjct: 300 RRLPHL---DMWNEFFHVMLNIPDCHHLPS 326
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-67
Identities = 89/257 (34%), Positives = 148/257 (57%), Gaps = 10/257 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
FD ++ LG+G +GKV L K TG+ A+K ++K I + ++ E +++ + RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+ + F+ +++ VMEYA GGEL+ L +++V TEE AR +I +A+ Y H +
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 158 CHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
+RD+KLEN++LD++G+ KI DFGL + + + TFCG+P Y +PE+++ Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDY-GR 184
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINP 274
VD W LGV++Y ++ G +PF + +RL + I + P+ S A L+A +L +P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 275 SSR-----ADISVICSH 286
R +D + H
Sbjct: 245 KQRLGGGPSDAKEVMEH 261
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-67
Identities = 76/244 (31%), Positives = 124/244 (50%), Gaps = 5/244 (2%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F + LG+G++ V L T +E AIK ++K I E + + RE +MS + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+ +Y F++ EK+ + YA GEL ++ + E R +I +A+ Y H I
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFL---STFCGSPLYASPEIVKGIPYHG 214
HRDLK ENILL+E+ + +I DFG + V + ++F G+ Y SPE++
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AC 210
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS-TASPLIAEMLNIN 273
D W+LG ++Y LV G PF N + ++I +Y P+ A L+ ++L ++
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 274 PSSR 277
+ R
Sbjct: 271 ATKR 274
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-67
Identities = 86/261 (32%), Positives = 139/261 (53%), Gaps = 14/261 (5%)
Query: 38 FDIVRKLGQGNYGKVQL---GINKETGQEVAIKTIKKCKIETEADLI-RIRREIQIMSSV 93
F+++R LG+G YGKV TG+ A+K +KK I A + E I+ V
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
+HP I+ + F+ K+ L++EY +GGEL+ L+++ + E+ A +I+ A+ + H
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASPEIVKGIP 211
+ I +RDLK ENI+L+ G+ K+ DFGL ++ + TFCG+ Y +PEI+
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV-THTFCGTIEYMAPEILMRSG 197
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEML 270
+ VD WSLG L+Y ++ GA PF G N K+ + +I P + A L+ ++L
Sbjct: 198 H-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 271 NINPSSR-----ADISVICSH 286
N +SR D + +H
Sbjct: 257 KRNAASRLGAGPGDAGEVQAH 277
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-67
Identities = 87/286 (30%), Positives = 149/286 (52%), Gaps = 15/286 (5%)
Query: 12 INNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQL---GINKETGQEVAIKT 68
+ + I T V+ + + Q F++++ LGQG++GKV L + Q A+K
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQ-FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV 59
Query: 69 IKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLD 128
+KK + D +R + E I+ V HP I+ ++ F+ K+ L++++ GG+L+ L
Sbjct: 60 LKKATL-KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 118
Query: 129 QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS--NVF 186
++ + TEE+ + ++A A+ + H I +RDLK ENILLDE G+ K+ DFGLS ++
Sbjct: 119 KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178
Query: 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVK 246
E + +FCG+ Y +PE+V + D WS GVL++ ++ G +PF G + K +
Sbjct: 179 HEKK-AYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
Query: 247 QISNGDYFEPKNQST-ASPLIAEMLNINPSSR-----ADISVICSH 286
I P+ S A L+ + NP++R + I H
Sbjct: 237 MILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 8e-67
Identities = 52/291 (17%), Positives = 102/291 (35%), Gaps = 37/291 (12%)
Query: 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ 88
+ + F + K+G G +G V + + G AIK KK + D RE+
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK-PLAGSVDEQNALREVY 62
Query: 89 IMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK----VLTEEEARRIFR 143
+ + +H +++ + + + M++ EY GG L D + + E E + +
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGN-------------------AKIADFGLSN 184
Q+ + Y H + H D+K NI + KI D G
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
+ + G + + E+++ H P+ D ++L + + +
Sbjct: 183 RISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q 236
Query: 245 VKQISNGDYFEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDK 291
+I G P+ S L+ M++ +P R + H +
Sbjct: 237 WHEIRQGRL--PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-66
Identities = 88/254 (34%), Positives = 139/254 (54%), Gaps = 7/254 (2%)
Query: 29 NHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI 87
+ + KLK + F + + LG+G++GKV L K+T Q AIK +KK + + D+ E
Sbjct: 9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 88 QIMS-SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
+++S + HP + H++ F+ +E + VMEY GG+L + A +I
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASP 204
+ + H I +RDLKL+NILLD++G+ KIADFG+ N+ +++ +TFCG+P Y +P
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAP 187
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-AS 263
EI+ G Y VD WS GVLLY ++ G PF G + + L I + F P+ A
Sbjct: 188 EILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 246
Query: 264 PLIAEMLNINPSSR 277
L+ ++ P R
Sbjct: 247 DLLVKLFVREPEKR 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-66
Identities = 83/268 (30%), Positives = 138/268 (51%), Gaps = 12/268 (4%)
Query: 29 NHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI 87
+R ++K F+ + LG+G++GKV L K T + A+K +KK + + D+ E
Sbjct: 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 71
Query: 88 QIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
++++ + P + ++ F+ +++ VMEY GG+L + Q E A +IA
Sbjct: 72 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASP 204
+++ I +RDLKL+N++LD G+ KIADFG+ N++ TFCG+P Y +P
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFCGTPDYIAP 190
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-AS 263
EI+ PY G VD W+ GVLLY ++ G PF+G + L + I + PK+ S A
Sbjct: 191 EIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 249
Query: 264 PLIAEMLNINPSSR-----ADISVICSH 286
+ ++ +P R I H
Sbjct: 250 AICKGLMTKHPGKRLGCGPEGERDIKEH 277
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 6e-65
Identities = 87/254 (34%), Positives = 140/254 (55%), Gaps = 7/254 (2%)
Query: 29 NHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI 87
N +L F+ +R LG+G++GKV L KETG A+K +KK I + D+ E
Sbjct: 15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 88 QIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
+I+S HP + ++ F+ +++ VME+ GG+L + + + E AR +I
Sbjct: 75 RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII 134
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASP 204
+A+ + H I +RDLKL+N+LLD G+ K+ADFG+ + +TFCG+P Y +P
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATFCGTPDYIAP 193
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-AS 263
EI++ + Y GP VD W++GVLLY ++ G PF+ N L + I N + P A+
Sbjct: 194 EILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDAT 252
Query: 264 PLIAEMLNINPSSR 277
++ + NP+ R
Sbjct: 253 GILKSFMTKNPTMR 266
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 8e-65
Identities = 80/259 (30%), Positives = 137/259 (52%), Gaps = 13/259 (5%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F I+R LG G++G+V L ++ G+ A+K +KK + + E ++S V HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF--RQIATAVYYCHKH 155
II ++ F++ +++ ++M+Y GGEL+ L + + A+ F ++ A+ Y H
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK--FYAAEVCLALEYLHSK 125
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
I +RDLK ENILLD+NG+ KI DFG + + + T CG+P Y +PE+V P +
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVSTKP-YNK 182
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINP 274
+D WS G+L+Y ++ G PF SN + ++I N + P + L++ ++ +
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 242
Query: 275 SSR-----ADISVICSHWW 288
S R + +H W
Sbjct: 243 SQRLGNLQNGTEDVKNHPW 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-64
Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SVRHP 96
F ++ +G+G++GKV L +K A+K ++K I + + I E ++ +V+HP
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
++ ++ F+ +K+ V++Y GGEL+ L +++ E AR +IA+A+ Y H
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 157 ICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASPEIVKGIPYHG 214
I +RDLK ENILLD G+ + DFGL N+ S STFCG+P Y +PE++ PY
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-TSTFCGTPEYLAPEVLHKQPY-D 217
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNIN 273
VD W LG +LY ++YG PF N + I N N + A L+ +L +
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 277
Query: 274 PSSR----ADISVICSH 286
+ R D I SH
Sbjct: 278 RTKRLGAKDDFMEIKSH 294
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-64
Identities = 89/272 (32%), Positives = 152/272 (55%), Gaps = 12/272 (4%)
Query: 25 VRLHNHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRI 83
V L + ++ F+ ++ LG+G +GKV L K TG+ A+K +KK I + ++
Sbjct: 136 VSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT 195
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
E +++ + RHP + + F+ +++ VMEYA GGEL+ L +++V +E+ AR
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 255
Query: 144 QIATAVYYCHKHK-ICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPL 200
+I +A+ Y H K + +RDLKLEN++LD++G+ KI DFGL + + + TFCG+P
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFCGTPE 314
Query: 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS 260
Y +PE+++ Y G VD W LGV++Y ++ G +PF + ++L + I + P+
Sbjct: 315 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 373
Query: 261 T-ASPLIAEMLNINPSSR-----ADISVICSH 286
A L++ +L +P R D I H
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 4e-64
Identities = 76/257 (29%), Positives = 131/257 (50%), Gaps = 9/257 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
FD ++ LG G++G+V L +KE+G A+K + K K+ + E +I+ +V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ + F++ + +VMEY AGGE++ L + +E AR QI Y H +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEV 217
+RDLK EN+L+D+ G ++ DFG + + T CG+P +PEI+ + V
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKG-YNKAV 219
Query: 218 DCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS-TASPLIAEMLNINPSS 276
D W+LGVL+Y + G PF ++ ++I +G P + S L+ +L ++ +
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTK 279
Query: 277 R-----ADISVICSHWW 288
R ++ I +H W
Sbjct: 280 RFGNLKNGVNDIKNHKW 296
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 207 bits (527), Expect = 6e-64
Identities = 43/338 (12%), Positives = 86/338 (25%), Gaps = 43/338 (12%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS---- 92
LGQ + ++ETG+ + + + +++ E+ +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 93 ------------------VRHPNIIHIYEVFENREKM-----VLVMEYAAG------GEL 123
V+ P + V + M + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 124 YDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
K L ++ Q+ + H + + H L+ +I+LD+ G + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 184 NVFTESRFLST--FCGSPLYASPEIVKGIPYH----GPEVDCWSLGVLLYTLVYGAMPFD 237
S P + ++ +H D W+LG+ +Y + +P
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 238 GSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVAC 297
+ I P+ L+ L R ++ +
Sbjct: 319 DDAALGGSEWIFRSCKNIPQP---VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375
Query: 298 LEEAEELANQTPVRLDLL-LSLAPSPSTDKILVGADAI 334
+ P R S P AI
Sbjct: 376 AALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAVTAI 413
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 7e-63
Identities = 97/279 (34%), Positives = 146/279 (52%), Gaps = 19/279 (6%)
Query: 29 NHRRKLK-QRFDIVRKLGQGNYGKVQL---GINKETGQEVAIKTIKKCKIETEADLI-RI 83
H K+ + F++++ LG G YGKV L +TG+ A+K +KK I +A
Sbjct: 46 GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 105
Query: 84 RREIQIMSSVRH-PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIF 142
R E Q++ +R P ++ ++ F+ K+ L+++Y GGEL+ L Q++ TE E +
Sbjct: 106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 165
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPL 200
+I A+ + HK I +RD+KLENILLD NG+ + DFGLS V E+ FCG+
Sbjct: 166 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 201 YASPEIVKGIPY-HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR----LVKQISNGDYFE 255
Y +P+IV+G H VD WSLGVL+Y L+ GA PF K + ++I +
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 256 PKNQST-ASPLIAEMLNINPSSR-----ADISVICSHWW 288
P+ S A LI +L +P R D I H +
Sbjct: 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 9e-63
Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 30 HRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ 88
L Q FD++R +G+G+Y KV L K+T + A+K +KK + + D+ ++ E
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 89 IMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
+ HP ++ ++ F+ ++ V+EY GG+L + +++ L EE AR +I+
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASPE 205
A+ Y H+ I +RDLKL+N+LLD G+ K+ D+G+ + STFCG+P Y +PE
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTPNYIAPE 180
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF---------DGSNFKRLVKQISNGDYFEP 256
I++G Y G VD W+LGVL++ ++ G PF D + L + I P
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 257 KNQST-ASPLIAEMLNINPSSR 277
++ S A+ ++ LN +P R
Sbjct: 240 RSLSVKAASVLKSFLNKDPKER 261
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-62
Identities = 80/298 (26%), Positives = 139/298 (46%), Gaps = 18/298 (6%)
Query: 8 PQASINNIMGGIESTGGVRLHNHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAI 66
P NI+ +E + +L + F+I++ +G+G +G+V + K + A+
Sbjct: 45 PLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAM 104
Query: 67 KTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDF 126
K + K ++ A+ R E ++ + I ++ F++ + LVM+Y GG+L
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTL 164
Query: 127 LDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-- 183
L + + L EE AR ++ A+ H+ HRD+K +NIL+D NG+ ++ADFG
Sbjct: 165 LSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 184 NVFTESRFLSTFCGSPLYASPEIVKGIP----YHGPEVDCWSLGVLLYTLVYGAMPFDGS 239
+ + S G+P Y SPEI++ + +GPE D WSLGV +Y ++YG PF
Sbjct: 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284
Query: 240 NFKRLVKQISNG--DYFEPKNQSTASP----LIAEMLNINPSSR---ADISVICSHWW 288
+ +I N + P + S LI ++ + R I H +
Sbjct: 285 SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPF 341
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-62
Identities = 87/288 (30%), Positives = 148/288 (51%), Gaps = 16/288 (5%)
Query: 4 NMVVPQASINNIMGGIESTGGVRLHNHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQ 62
N+ A + I E+ L Q FD++R +G+G+Y KV L K+T +
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDR 78
Query: 63 EVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGG 121
A++ +KK + + D+ ++ E + HP ++ ++ F+ ++ V+EY GG
Sbjct: 79 IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 138
Query: 122 ELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFG 181
+L + +++ L EE AR +I+ A+ Y H+ I +RDLKL+N+LLD G+ K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 182 LS--NVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF--- 236
+ + STFCG+P Y +PEI++G Y G VD W+LGVL++ ++ G PF
Sbjct: 199 MCKEGLRPGDT-TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIV 256
Query: 237 ------DGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPSSR 277
D + L + I P++ S A+ ++ LN +P R
Sbjct: 257 GSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 5e-62
Identities = 79/244 (32%), Positives = 131/244 (53%), Gaps = 6/244 (2%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHP 96
F+ + LG+G++GKV L K T + A+K +KK + + D+ E ++++ + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
+ ++ F+ +++ VMEY GG+L + Q E A +IA +++
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 157 ICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYASPEIVKGIPYHG 214
I +RDLKL+N++LD G+ KIADFG+ N++ TFCG+P Y +PEI+ PY G
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFCGTPDYIAPEIIAYQPY-G 520
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNIN 273
VD W+ GVLLY ++ G PF+G + L + I + PK+ S A + ++ +
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 580
Query: 274 PSSR 277
P R
Sbjct: 581 PGKR 584
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 9e-62
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 20/281 (7%)
Query: 26 RLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRR 85
RL R + F+I++ +G+G + +V + K+TGQ A+K + K + ++ R
Sbjct: 52 RLKEVRLQRDD-FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 86 EIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQ 144
E ++ + I ++ F++ + LVMEY GG+L L + + + E AR +
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYA 202
I A+ H+ HRD+K +NILLD G+ ++ADFG + G+P Y
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 203 SPEIVKG------IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--YF 254
SPEI++ +GPE D W+LGV Y + YG PF + +I +
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290
Query: 255 EPKNQSTASP----LIAEMLNINPSSR---ADISVICSHWW 288
P I +L P +R +H +
Sbjct: 291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-61
Identities = 76/264 (28%), Positives = 128/264 (48%), Gaps = 15/264 (5%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
+++V+ +G+G +G+VQL +K T + A+K + K ++ +D E IM+ P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
++ ++ F++ + +VMEY GG+L L + E+ AR ++ A+ H
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFL--STFCGSPLYASPEIVK---GIPY 212
HRD+K +N+LLD++G+ K+ADFG + + T G+P Y SPE++K G Y
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD-----YFEPKNQSTASPLIA 267
+G E D WS+GV LY ++ G PF + +I N + A LI
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 268 EMLNINPSSR---ADISVICSHWW 288
L + R + I H +
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLF 332
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 5e-59
Identities = 69/255 (27%), Positives = 121/255 (47%), Gaps = 9/255 (3%)
Query: 31 RRKL-KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
R+ + K F R LG+G +G+V + TG+ A K ++K +I+ E QI
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIAT 147
+ V ++ + +E ++ + LV+ GG+L + + E A +I
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV 207
+ H+ +I +RDLK ENILLD++G+ +I+D GL+ E + + G+ Y +PE+V
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN----FKRLVKQISNGDYFEPKNQST-A 262
K Y D W+LG LLY ++ G PF + + + + + S A
Sbjct: 358 KNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 263 SPLIAEMLNINPSSR 277
L +++L +P+ R
Sbjct: 417 RSLCSQLLCKDPAER 431
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 68/250 (27%), Positives = 114/250 (45%), Gaps = 11/250 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F R LG+G +G+V K TG+ A K + K +++ E +I++ V
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 98 IIHIYEVFENREKMVLVMEYAAGGEL----YDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
I+ + FE + + LVM GG++ Y+ + E A QI + + + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGSPLYASPEIVKGIPY 212
+ I +RDLK EN+LLD++GN +I+D GL+ + + G+P + +PE++ G Y
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQ----ISNGDYFEPKNQST-ASPLIA 267
VD ++LGV LY ++ PF K K+ + P S +
Sbjct: 367 -DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 268 EMLNINPSSR 277
+L +P R
Sbjct: 426 ALLQKDPEKR 435
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-57
Identities = 72/271 (26%), Positives = 136/271 (50%), Gaps = 10/271 (3%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ D K+G+G+ G V L K +G++VA+K + + + + E+ IM +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQ 100
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
H N++ +Y+ + E++ ++ME+ GG L D + Q + L EE+ + + A+ Y H
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHA 159
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSPLYASPEIVKGIPYH 213
+ HRD+K ++ILL +G K++DFG ++ + G+P + +PE++ Y
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY- 218
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPL----IAEM 269
EVD WSLG+++ +V G P+ + + +K++ + + KN SP+ + M
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 270 LNINPSSRADISVICSHWWIDKDHSVACLEE 300
L +P RA + H ++ + CL
Sbjct: 279 LVRDPQERATAQELLDHPFLLQTGLPECLVP 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 4e-57
Identities = 76/271 (28%), Positives = 137/271 (50%), Gaps = 10/271 (3%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
K+++ K+GQG G V ++ TGQEVAI+ + ++ + I EI +M +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENK 75
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
+PNI++ + + +++ +VMEY AGG L D + + + E + + R+ A+ + H
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS 134
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSPLYASPEIVKGIPYH 213
+++ HRD+K +NILL +G+ K+ DFG T + ST G+P + +PE+V Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPL----IAEM 269
GP+VD WSLG++ ++ G P+ N R + I+ E +N S + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 270 LNINPSSRADISVICSHWWIDKDHSVACLEE 300
L ++ R + H ++ ++ L
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 64/247 (25%), Positives = 120/247 (48%), Gaps = 8/247 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI--ETEADLIRIRREI-QIMSSVR 94
F + R +G+G +G+V +TG+ A+K + K +I + L R + ++S+
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
P I+ + F +K+ +++ GG+L+ L Q V +E + R +I + + H
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHG 214
+ +RDLK NILLDE+G+ +I+D GL+ F++ + G+ Y +PE+++ +
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYD 369
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFK---RLVKQISNGDYFEPKNQST-ASPLIAEML 270
D +SLG +L+ L+ G PF K + + P + S L+ +L
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 271 NINPSSR 277
+ + R
Sbjct: 430 QRDVNRR 436
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 7e-55
Identities = 79/277 (28%), Positives = 139/277 (50%), Gaps = 15/277 (5%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ ++IV +LG G +GKV NKETG A K I+ ++E +L EI+I+++
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCD 74
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCH 153
HP I+ + + + K+ +++E+ GG + + + + LTE + + + RQ+ A+ + H
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LSTFCGSPLYASPEIV----- 207
+I HRDLK N+L+ G+ ++ADFG+S ++ +F G+P + +PE+V
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPL-- 265
K PY + D WSLG+ L + P N R++ +I+ D S S
Sbjct: 195 KDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 266 --IAEMLNINPSSRADISVICSHWWIDKDHSVACLEE 300
+ L+ NP +R + + H ++ S L E
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 9e-55
Identities = 81/270 (30%), Positives = 135/270 (50%), Gaps = 11/270 (4%)
Query: 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRRE 86
+ N + ++ F + K+G+G++G+V GI+ T + VAIK I + E E + I+ +E
Sbjct: 13 MQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QE 70
Query: 87 IQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIA 146
I ++S P + Y + K+ ++MEY GG D L + L E + I R+I
Sbjct: 71 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREIL 129
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-STFCGSPLYASPE 205
+ Y H K HRD+K N+LL E+G K+ADFG++ T+++ +TF G+P + +PE
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPL 265
++K Y + D WSLG+ L G P + +++ I + P + S
Sbjct: 190 VIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--PPTLEGNYSKP 246
Query: 266 IAEM----LNINPSSRADISVICSHWWIDK 291
+ E LN PS R + H +I +
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFILR 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 5e-54
Identities = 59/293 (20%), Positives = 112/293 (38%), Gaps = 35/293 (11%)
Query: 28 HNHRRKLKQRFDIVRKLGQGNYGKV--------QLGINKETGQEVAIKTIKKCKIETEAD 79
R K+ + + KL + +E + + + +
Sbjct: 45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSP 104
Query: 80 LIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEE-- 137
+ +I+ M N + + + + + M+ L D+++++ L + E
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 138 -ARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES------- 189
IF QIA AV + H + HRDLK NI + K+ DFGL +
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 190 ------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFD-GSNFK 242
+ G+ LY SPE + G Y +VD +SLG++L+ L+Y F
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNY-SHKVDIFSLGLILFELLY---SFSTQMERV 280
Query: 243 RLVKQISNGDYFEPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDK 291
R++ + N + P + P ++ +ML+ +P+ R + + I + +
Sbjct: 281 RIITDVRNLKF--PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 17/79 (21%), Positives = 36/79 (45%), Gaps = 2/79 (2%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
+ F+ ++ +G+G +G V NK AIK I+ E + ++ RE++ ++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAK 60
Query: 93 VRHPNIIHIYEVFENREKM 111
+ HP I+ + +
Sbjct: 61 LEHPGIVRYFNAWLETPPE 79
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-54
Identities = 83/272 (30%), Positives = 136/272 (50%), Gaps = 12/272 (4%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ FD++ KLG+G+YG V I+KETGQ VAIK ++ E+DL I +EI IM
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQQCD 82
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCH 153
P+++ Y + + +VMEY G + D + K LTE+E I + + Y H
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-STFCGSPLYASPEIVKGIPY 212
+ HRD+K NILL+ G+AK+ADFG++ T++ +T G+P + +PE+++ I Y
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPL----IAE 268
D WSLG+ + G P+ + R + I + S + +
Sbjct: 203 -NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261
Query: 269 MLNINPSSRADISVICSHWWIDKDHSVACLEE 300
L +P RA + + H ++ V+ L +
Sbjct: 262 CLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-54
Identities = 65/262 (24%), Positives = 129/262 (49%), Gaps = 17/262 (6%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY 102
++G+G++ V G++ ET EVA ++ K+ T+++ R + E +++ ++HPNI+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 103 EVF----ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK-- 156
+ + + ++ +VLV E G L +L + KV+ + R RQI + + H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 157 ICHRDLKLENILLD-ENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
I HRDLK +NI + G+ KI D GL+ + S F G+P + +PE+ + +
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDE 208
Query: 216 EVDCWSLGVLLYTLVYGAMPF-DGSNFKRLVKQISNGDYFEPKNQSTASP----LIAEML 270
VD ++ G+ + + P+ + N ++ +++++G A P +I +
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPASFDKVAIPEVKEIIEGCI 267
Query: 271 NINPSSRADISVICSHWWIDKD 292
N R I + +H + ++
Sbjct: 268 RQNKDERYSIKDLLNHAFFQEE 289
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 8e-54
Identities = 67/247 (27%), Positives = 107/247 (43%), Gaps = 5/247 (2%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F+ + +LG GN G V +K +G +A K I A +I RE+Q++ P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH-KHK 156
I+ Y F + ++ + ME+ GG L L + + E+ ++ + + Y KHK
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
I HRD+K NIL++ G K+ DFG+S +S ++F G+ Y SPE ++G Y +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHY-SVQ 210
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPSS 276
D WS+G+ L + G P + K L + LN
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 277 RADISVI 283
I
Sbjct: 271 SRPPMAI 277
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-53
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
+I K+G G++G V G +VA+K + + + + RE+ IM +RHPNI
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH--GSDVAVKILME-QDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL---DQKKVLTEEEARRIFRQIATAVYYCHKH 155
+ + +V EY + G LY L ++ L E + +A + Y H
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 156 K--ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST-FCGSPLYASPEIVKGIPY 212
I HR+LK N+L+D+ K+ DFGLS + + S G+P + +PE+++ P
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY 253
+ D +S GV+L+ L P+ N ++V +
Sbjct: 217 -NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-53
Identities = 67/272 (24%), Positives = 116/272 (42%), Gaps = 10/272 (3%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ F +R++G G++G V + + VAIK + ++ I +E++ + +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
HPN I + LVMEY G KK L E E + + Y H
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV---KGIP 211
H + HRD+K NILL E G K+ DFG +++ + ++F G+P + +PE++
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQ 229
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--YFEPKNQSTA-SPLIAE 268
Y +VD WSLG+ L P N + I+ + + + S +
Sbjct: 230 Y-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288
Query: 269 MLNINPSSRADISVICSHWWIDKDHSVACLEE 300
L P R V+ H ++ ++ + +
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-53
Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR-IRREIQIMSSVRHPN 97
+ +G G +GKV G EVA+K + E + I +R+E ++ + ++HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK- 156
II + V + LVME+A GG L L K + + QIA + Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 157 --ICHRDLKLENILLDE--------NGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206
I HRDLK NIL+ + N KI DFGL+ + + + G+ + +PE+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEV 185
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY 253
++ + D WS GVLL+ L+ G +PF G + + ++
Sbjct: 186 IRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-52
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ +++ +G G VQ ++VAIK I K +T D + +EIQ MS
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--KEIQAMSQCH 71
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--------DQKKVLTEEEARRIFRQIA 146
HPNI+ Y F ++++ LVM+ +GG + D + + VL E I R++
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS------TFCGSPL 200
+ Y HK+ HRD+K NILL E+G+ +IADFG+S ++ TF G+P
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
+ +PE+++ + + + D WS G+ L GA P+
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-52
Identities = 63/258 (24%), Positives = 106/258 (41%), Gaps = 25/258 (9%)
Query: 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
+I +G+G +G+V G EVAI+ I + + E L +RE+ RH N+
Sbjct: 36 EIGELIGKGRFGQVYHGRWH---GEVAIRLIDI-ERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+ + + ++ G LY + D K VL + R+I ++I + Y H I
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFT------ESRFLSTFCGSPLYASPEIVKGIP 211
H+DLK +N+ D NG I DFGL ++ L G + +PEI++ +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 212 YHGPE--------VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263
E D ++LG + Y L PF + ++ Q+ G +Q
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-MKPNLSQIGMG 269
Query: 264 PLIAEML----NINPSSR 277
I+++L R
Sbjct: 270 KEISDILLFCWAFEQEER 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-52
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
LG+G +G+ ++ETG+ + +K + + ET+ +E+++M + HPN++
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT---FLKEVKVMRCLEHPNVL 70
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKIC 158
V +++ + EY GG L + + + IA+ + Y H I
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 159 HRDLKLENILLDENGNAKIADFGLSNVFTESRFLS---------------TFCGSPLYAS 203
HRDL N L+ EN N +ADFGL+ + + + T G+P + +
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG 238
PE++ G Y +VD +S G++L ++
Sbjct: 191 PEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 9e-52
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRI----RREIQIMSSV 93
+ +++G+G +G V G + VAIK++ E E ++I +RE+ IMS++
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYC 152
HPNI+ +Y + +VME+ G+LY L D+ + R+ IA + Y
Sbjct: 81 NHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 153 HKHK--ICHRDLKLENILLDENG-----NAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
I HRDL+ NI L AK+ADFGLS S +S G+ + +PE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPE 196
Query: 206 IVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF 241
+ Y + D +S ++LYT++ G PFD ++
Sbjct: 197 TIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSY 233
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-51
Identities = 61/265 (23%), Positives = 107/265 (40%), Gaps = 20/265 (7%)
Query: 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY 102
++G+G++G+V +K+TG + A+K K+ E E+ + + P I+ +Y
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVK-----KVRLEVFR---VEELVACAGLSSPRIVPLY 116
Query: 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162
+ + ME GG L + Q L E+ A Q + Y H +I H D+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 163 KLENILLDENGN-AKIADFGLSNVFTESRFLS------TFCGSPLYASPEIVKGIPYHGP 215
K +N+LL +G+ A + DFG + G+ + +PE+V G P
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DA 235
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPL----IAEMLN 271
+VD WS ++ ++ G P+ L +I++ + + +PL I E L
Sbjct: 236 KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLR 295
Query: 272 INPSSRADISVICSHWWIDKDHSVA 296
P RA +
Sbjct: 296 KEPVHRASAMELRRKVGKALQEVGG 320
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-51
Identities = 67/219 (30%), Positives = 115/219 (52%), Gaps = 28/219 (12%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSV 93
++++ + K+G+G+YG V N++TGQ VAIK K + +I+ REI+++ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYC 152
+HPN++++ EVF + ++ LV EY + LD+ ++ + E + I Q AV +C
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------Y 201
HKH HRD+K ENIL+ ++ K+ DFG + + P Y
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLL----------TGPSDYYDDEVATRWY 168
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
SPE++ G +GP VD W++G + L+ G + G +
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-51
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++ +G+G +G V + ++VAIK +IE+E++ E++ +S V HPN
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWR--AKDVAIK-----QIESESERKAFIVELRQLSRVNHPN 62
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV---LTEEEARRIFRQIATAVYYCHK 154
I+ +Y + LVMEYA GG LY+ L + T A Q + V Y H
Sbjct: 63 IVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 155 HK---ICHRDLKLENILLDENGN-AKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI 210
+ + HRDLK N+LL G KI DFG + ++ GS + +PE+ +G
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGS 178
Query: 211 PYHGPEVDCWSLGVLLYTLVYGAMPFDG 238
Y + D +S G++L+ ++ PFD
Sbjct: 179 NY-SEKCDVFSWGIILWEVITRRKPFDE 205
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-50
Identities = 60/251 (23%), Positives = 110/251 (43%), Gaps = 18/251 (7%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
+ +++G G++G V G +VA+K + T L + E+ ++ RH NI+
Sbjct: 28 VGQRIGSGSFGTVYKGKWH---GDVAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKIC 158
++ +V ++ G LY L + ++ I RQ A + Y H I
Sbjct: 84 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 159 HRDLKLENILLDENGNAKIADFGLSNVFT---ESRFLSTFCGSPLYASPEIVKGIPYH-- 213
HRDLK NI L E+ KI DFGL+ + S GS L+ +PE+++ +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGD--YFEPKNQSTASPLIAEML 270
+ D ++ G++LY L+ G +P+ +N ++++ + G K +S + ++
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLM 262
Query: 271 ----NINPSSR 277
R
Sbjct: 263 AECLKKKRDER 273
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-50
Identities = 59/268 (22%), Positives = 108/268 (40%), Gaps = 18/268 (6%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI-MSSVRHP 96
+ + +LG+G YG V+ + +GQ +A+K I+ + R+ ++ I M +V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVDCP 66
Query: 97 NIIHIYEVFENREKMVLVMEYAAGG--ELY-DFLDQKKVLTEEEARRIFRQIATAVYYCH 153
+ Y + + ME + Y +D+ + + E+ +I I A+ + H
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 154 -KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
K + HRD+K N+L++ G K+ DFG+S + G Y +PE +
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 213 HGP---EVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEPK-NQSTASP--- 264
+ D WSLG+ + L P+D + +KQ+ P+ S
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP--SPQLPADKFSAEFV 244
Query: 265 -LIAEMLNINPSSRADISVICSHWWIDK 291
++ L N R + H +
Sbjct: 245 DFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-50
Identities = 58/266 (21%), Positives = 107/266 (40%), Gaps = 15/266 (5%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET-EADLIRIRREIQI-MSSVRH 95
+ + ++G G G+V ++TG +A+K ++ + + RI ++ + + S
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSHDC 83
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH-K 154
P I+ + F + + ME + + E ++ I A+YY K
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHG 214
H + HRD+K NILLDE G K+ DFG+S + + G Y +PE +
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 215 PE----VDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYFEPKNQSTASP----L 265
P+ D WSLG+ L L G P+ ++ ++ + S
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263
Query: 266 IAEMLNINPSSRADISVICSHWWIDK 291
+ + L + R + + H +I +
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-50
Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 28/219 (12%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSV 93
++++ + +G+G+YG V NK+TG+ VAIK K + +++ REI+++ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYC 152
RH N++++ EV + +++ LV E+ + D L+ L + ++ QI + +C
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------Y 201
H H I HRD+K ENIL+ ++G K+ DFG + +P Y
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL----------AAPGEVYDDEVATRWY 190
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+PE++ G +G VD W++G L+ + G F G +
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 9e-50
Identities = 41/223 (18%), Positives = 90/223 (40%), Gaps = 15/223 (6%)
Query: 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
+ + KL + + G++ G + G ++ +K +K + E + HPN+
Sbjct: 13 NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNV 69
Query: 99 IHIYEVFEN--REKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYCHK 154
+ + ++ L+ + G LY+ L V+ + +A + +A + + H
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 155 HK--ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
+ I L ++++DE+ A+I+ + F +P + +PE ++ P
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPE 185
Query: 213 HGPE--VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY 253
D WS VLL+ LV +PF + + +++
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-49
Identities = 59/220 (26%), Positives = 110/220 (50%), Gaps = 29/220 (13%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSV 93
Q+++ + K+G+G YG V N+ET + VA+K + +++ + + + REI ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKEL 58
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYC 152
+H NI+ +++V + +K+ LV E+ +L + D L E + Q+ + +C
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------Y 201
H + HRDLK +N+L++ NG K+A+FGL+ F G P+ Y
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAF----------GIPVRCYSAEVVTLWY 167
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMP-FDGSN 240
P+++ G + +D WS G + L P F G++
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-49
Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 3/209 (1%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
+ + +R+ IV KLG G V L + +VAIK I E E L R RE+ S
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYY 151
+ H NI+ + +V E + LVMEY G L ++++ L+ + A QI + +
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST--FCGSPLYASPEIVKG 209
H +I HRD+K +NIL+D N KI DFG++ +E+ T G+ Y SPE KG
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDG 238
D +S+G++LY ++ G PF+G
Sbjct: 187 EAT-DECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 19/264 (7%)
Query: 44 LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103
LG+G YG V G + +AIK I + EI + ++H NI+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 104 VFENREKMVLVMEYAAGGELYDFLDQKK---VLTEEEARRIFRQIATAVYYCHKHKICHR 160
F + + ME GG L L K E+ +QI + Y H ++I HR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 161 DLKLENILLD-ENGNAKIADFGLSNVFTE-SRFLSTFCGSPLYASPEIVKGIPY-HGPEV 217
D+K +N+L++ +G KI+DFG S + TF G+ Y +PEI+ P +G
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 218 DCWSLGVLLYTLVYGAMPFDGSNFKRLVK---QISNGDYFEPKNQSTASPL----IAEML 270
D WSLG + + G PF ++ P+ + S I +
Sbjct: 207 DIWSLGCTIIEMATGKPPF--YELGEPQAAMFKVGMFKV-HPEIPESMSAEAKAFILKCF 263
Query: 271 NINPSSRADISVICSHWWIDKDHS 294
+P RA + + ++
Sbjct: 264 EPDPDKRACANDLLVDEFLKVSSK 287
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-48
Identities = 81/292 (27%), Positives = 124/292 (42%), Gaps = 59/292 (20%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRI--RREIQ 88
+ + K R++ + LG+G + V +K T Q VAIK IK D I REI+
Sbjct: 6 KSRAK-RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 89 IMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIAT 147
++ + HPNII + + F ++ + LV ++ +L + + LT +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL------- 200
+ Y H+H I HRDLK N+LLDENG K+ADFGL+ F GSP
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF----------GSPNRAYTHQV 173
Query: 201 ----YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN--------FKRL---- 244
Y +PE++ G +G VD W++G +L L+ G + F+ L
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233
Query: 245 ------VKQISNGDYFEPKNQ---------STASP----LIAEMLNINPSSR 277
+ + DY K+ S A LI + NP +R
Sbjct: 234 EEQWPDMCSLP--DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-48
Identities = 80/275 (29%), Positives = 123/275 (44%), Gaps = 27/275 (9%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIR-IRREIQIMSSV 93
F++V +G G YG+V G + +TGQ AIK ++ D I++EI ++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-----VMDVTGDEEEEIKQEINMLKKY 77
Query: 94 -RHPNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLD--QKKVLTEEEARRIFRQ 144
H NI Y F +++ LVME+ G + D + + L EE I R+
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS--NVFTESRFLSTFCGSPLYA 202
I + + H+HK+ HRD+K +N+LL EN K+ DFG+S T R +TF G+P +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWM 196
Query: 203 SPEIVK-----GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--YFE 255
+PE++ Y + D WSLG+ + GA P + R + I +
Sbjct: 197 APEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 255
Query: 256 PKNQSTA-SPLIAEMLNINPSSRADISVICSHWWI 289
K S I L N S R + H +I
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-48
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 14/226 (6%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI-MSSVRHP 96
+ ++G+G YG V ++K +GQ +A+K I+ E + ++ ++ + M S P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLD-----QKKVLTEEEARRIFRQIATAVYY 151
I+ Y + ME + F V+ EE +I A+ +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 152 CH-KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI 210
KI HRD+K NILLD +GN K+ DFG+S +S + G Y +PE +
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 211 PYHGP---EVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGD 252
D WSLG+ LY L G P+ ++ + Q+ GD
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 32/223 (14%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSV 93
R+ + KLG+G YG+V I+ T + VAIK + ++E E + + RE+ ++ +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
+H NII + V + ++ L+ EYA +L ++D+ ++ + Q+ V +CH
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 154 KHKICHRDLKLENILLD-----ENGNAKIADFGLSNVFTESRFLSTFCGSPL-------- 200
+ HRDLK +N+LL E KI DFGL+ F G P+
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF----------GIPIRQFTHEII 199
Query: 201 ---YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
Y PEI+ G ++ VD WS+ + ++ F G +
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 3e-47
Identities = 42/215 (19%), Positives = 85/215 (39%), Gaps = 14/215 (6%)
Query: 35 KQRFDIVRKLGQG--NYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
++++ +G+G + V L K TG+ V ++ I E + ++ E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE-MVTFLQGELHVSKL 82
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVY 150
HPNI+ F ++ +V + A G D + + E I + + A+
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR--------FLSTFCGSPLYA 202
Y H HR +K +IL+ +G ++ + F +
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 203 SPEIVK-GIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
SPE+++ + + + D +S+G+ L G +PF
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-47
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 29/219 (13%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSV 93
+++ + K+G+G YG V N G+ A+K K ++E E + I REI I+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALK---KIRLEKEDEGIPSTTIREISILKEL 57
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYC 152
+H NI+ +Y+V ++++VLV E+ +L LD + L A+ Q+ + YC
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------Y 201
H ++ HRDLK +N+L++ G KIADFGL+ F G P+ Y
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEIVTLWY 166
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+P+++ G + +D WS+G + +V G F G +
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-47
Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 29/219 (13%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR--REIQIMSSV 93
+++ + K+G+G YG V + G+ VA+K + +++ E + I REI ++ +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK---RIRLDAEDEGIPSTAIREISLLKEL 76
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYC 152
HPNI+ + +V + + LV E+ +L LD+ K L + + + Q+ V +C
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------Y 201
H+H+I HRDLK +N+L++ +G K+ADFGL+ F G P+ Y
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAF----------GIPVRSYTHEVVTLWY 185
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+P+++ G + VD WS+G + ++ G F G
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-47
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL-IRIRREIQIMSSVR 94
+ + + KLG+G Y V G +K T VA+K + ++E E RE+ ++ ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCTAIREVSLLKDLK 58
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCH 153
H NI+ ++++ + + LV EY +L +LD + + Q+ + YCH
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-----------YA 202
+ K+ HRDLK +N+L++E G K+ADFGL+ P Y
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAK----------SIPTKTYDNEVVTLWYR 167
Query: 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
P+I+ G + ++D W +G + Y + G F GS
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-46
Identities = 68/223 (30%), Positives = 112/223 (50%), Gaps = 34/223 (15%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE--ADLIRIRREIQIMSSVR 94
+F + KLG G Y V G+NK TG VA+K + K+++E IR EI +M ++
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALK---EVKLDSEEGTPSTAIR-EISLMKELK 61
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV------LTEEEARRIFRQIATA 148
H NI+ +Y+V K+ LV E+ +L ++D + V L + Q+
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-------- 200
+ +CH++KI HRDLK +N+L+++ G K+ DFGL+ F G P+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF----------GIPVNTFSSEVV 170
Query: 201 ---YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
Y +P+++ G + +D WS G +L ++ G F G+N
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-46
Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRI--RREIQIMSSVR 94
+++ + K+GQG +G+V +++TGQ+VA+K K +E E + I REI+I+ ++
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLLK 74
Query: 95 HPNIIHIYEVF--------ENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQI 145
H N++++ E+ + + LV ++ +L L V T E +R+ + +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 146 ATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL----- 200
+YY H++KI HRD+K N+L+ +G K+ADFGL+ F+ ++ +
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 201 YASPEIVKGIPYHGPEVDCWSLG 223
Y PE++ G +GP +D W G
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAG 216
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 9/207 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEAD---LIRIRREIQIMSSV 93
+ + R +G+G G V + + VA+K + + +D R++RE + +
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE---TLSSDPVFRTRMQREARTAGRL 91
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
+ P+++ I++ E ++ + M G +L L ++ L A I RQI +A+ H
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST--FCGSPLYASPEIVKGIP 211
HRD+K ENIL+ + A + DFG+++ T+ + G+ Y +PE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDG 238
D ++L +LY + G+ P+ G
Sbjct: 212 A-TYRADIYALTCVLYECLTGSPPYQG 237
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-45
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 9/215 (4%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
L R+++ LG G +V L + ++VA+K ++ + +R RRE Q +
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 92 SVRHPNIIHIYEVFENREKMV----LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
++ HP I+ +Y+ E +VMEY G L D + + +T + A +
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 148 AVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST----FCGSPLYAS 203
A+ + H++ I HRD+K NI++ K+ DFG++ +S T G+ Y S
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG 238
PE +G D +SLG +LY ++ G PF G
Sbjct: 188 PEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 6e-44
Identities = 71/309 (22%), Positives = 121/309 (39%), Gaps = 68/309 (22%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR-----REIQIM- 90
R++ V ++G G YG V + +G VA+K ++ RE+ ++
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGGGGGGGLPISTVREVALLR 66
Query: 91 --SSVRHPNIIHIYEVF-----ENREKMVLVMEYAAGGELYDFLDQKKV--LTEEEARRI 141
+ HPN++ + +V + K+ LV E+ +L +LD+ L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 142 FRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL- 200
RQ + + H + I HRDLK ENIL+ G K+ADFGL+ ++ +
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY----------SYQMA 175
Query: 201 ---------YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN--------FKR 243
Y +PE++ Y VD WS+G + + F G++ F
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 244 L----------VKQISNGDY--FEPKNQSTASP--------LIAEMLNINPSSRADISVI 283
+ + G + P+ + P L+ EML NP R
Sbjct: 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 284 CSHWWIDKD 292
H ++ KD
Sbjct: 295 LQHSYLHKD 303
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-43
Identities = 61/222 (27%), Positives = 110/222 (49%), Gaps = 10/222 (4%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ + KLG G YG+V G+ K+ VA+KT+K+ +E E L +E +M ++
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIK 274
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYC 152
HPN++ + V ++ E+ G L D+L ++ ++ + QI++A+ Y
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS-PL-YASPEIVKGI 210
K HR+L N L+ EN K+ADFGLS + T + + P+ + +PE +
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 211 PYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ + D W+ GVLL+ + YG P+ G + ++ + +
Sbjct: 395 KF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 26/226 (11%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
+ ++G+GN+G+V G + VA+K+ ++ + +E +I+ HPNI+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIV 175
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKIC 158
+ V ++ + +VME GG+ FL + L + ++ A + Y
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 159 HRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH--GPE 216
HRDL N L+ E KI+DFG+S + +YA+ ++ +P PE
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADG----------VYAASGGLRQVPVKWTAPE 285
Query: 217 V----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
D WS G+LL+ GA P+ + ++ + + G
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 18/220 (8%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKE-TGQEVAIKTIKKCKIETEADLI-RIRREIQI 89
+ ++++ + G G + L +++ G+ V +K + +A+ E Q
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAMAMAERQF 132
Query: 90 MSSVRHPNIIHIYEVFENREKMV-----LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQ 144
++ V HP+I+ I+ E+ ++ +VMEY G L QK L EA +
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLE 190
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
I A+ Y H + + DLK ENI+L E K+ D G + G+P + +P
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSF---GYLYGTPGFQAP 246
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
EIV+ P D +++G L L +G L
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 64/293 (21%), Positives = 124/293 (42%), Gaps = 66/293 (22%)
Query: 36 QRFDIVRKLGQGNYGKVQLGIN-KETGQEVAIKTIKKCKIETEADLIRIR--REIQIM-- 90
Q+++ V ++G+G YGKV + K G+ VA+K + +++T + + + RE+ ++
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRH 67
Query: 91 -SSVRHPNIIHIYEVF-----ENREKMVLVMEYAAGGELYDFLDQKKV--LTEEEARRIF 142
+ HPN++ +++V + K+ LV E+ +L +LD+ + E + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-- 200
Q+ + + H H++ HRDLK +NIL+ +G K+ADFGL+ ++ +
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----------SFQMAL 176
Query: 201 --------YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN--------FKRL 244
Y +PE++ Y VD WS+G + + F GS+ +
Sbjct: 177 TSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 245 ----------VKQISNGDYFEPKNQS------TASP----LIAEMLNINPSSR 277
+ + Q L+ + L NP+ R
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 49/300 (16%)
Query: 28 HNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREI 87
R + + + +G G++G V ++G+ VAIK K+ + RE+
Sbjct: 46 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKR--FKNREL 98
Query: 88 QIMSSVRHPNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQ----KKVLTEEE 137
QIM + H NI+ + F ++ + LV++Y +Y K+ L
Sbjct: 99 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIY 157
Query: 138 ARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-GNAKIADFGLSNVFTESRFLSTFC 196
+ Q+ ++ Y H ICHRD+K +N+LLD + K+ DFG + ++
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG------------------------ 232
S Y +PE++ G + +D WS G +L L+ G
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277
Query: 233 --AMPFDGSNFKRL----VKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSH 286
+ N+ +K F P+ A L + +L P++R C+H
Sbjct: 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-42
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 29/235 (12%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
R + + ++ +G+G YG+V G + G+ VA+K E R E+
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFR-ETELYNTV 57
Query: 92 SVRHPNIIHIY----EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIAT 147
+RH NI+ + ++ L+ Y G LYD+L Q L RI IA+
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIAS 116
Query: 148 AVYYCH--------KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-----ST 194
+ + H K I HRDLK +NIL+ +NG IAD GL+ + ++S +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 195 FCGSPLYASPEIVKGIPYHGPE-----VDCWSLGVLLYTLVYGAMPFDGSNFKRL 244
G+ Y +PE++ VD W+ G++L+ + + +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-42
Identities = 69/237 (29%), Positives = 100/237 (42%), Gaps = 24/237 (10%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
R LK + +LG+GN+G V+L TG VA+K ++ + + D R
Sbjct: 21 EERHLK----YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR--- 73
Query: 86 EIQIMSSVRHPNIIHIYEV--FENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIF 142
EIQI+ ++ I+ V R+ + LVMEY G L DFL + L
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR---FLSTFCGSP 199
QI + Y + HRDL NIL++ + KIADFGL+ + + + SP
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 200 L--YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGD 252
+ YA PE + I + D WS GV+LY L Y S +
Sbjct: 194 IFWYA-PESLSDNIFSR--QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-41
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 30/232 (12%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ + KLG G YG+V G+ K+ VA+KT+K+ +E E L +E +M ++
Sbjct: 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIK 67
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYC 152
HPN++ + V ++ E+ G L D+L ++ ++ + QI++A+ Y
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
K HRDL N L+ EN K+ADFGLS + T Y + K P
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----------TYTAHAGAK-FPI 176
Query: 213 H--GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
PE D W+ GVLL+ + YG P+ G + ++ + +
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-41
Identities = 57/205 (27%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR- 94
+ +VRKLG+G Y +V IN ++V +K +K K + +I+REI+I+ ++R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK------KIKREIKILENLRG 89
Query: 95 HPNIIHIYEVFENREKM--VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
PNII + ++ ++ LV E+ + LT+ + R +I A+ YC
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 146
Query: 153 HKHKICHRDLKLENILLD-ENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIP 211
H I HRD+K N+++D E+ ++ D+GL+ + + + S + PE++
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPF 236
+ +D WSLG +L ++++ PF
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 35/266 (13%), Positives = 78/266 (29%), Gaps = 37/266 (13%)
Query: 20 ESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEAD 79
V+L R R+ ++ G + ++ ++VA+ + + +
Sbjct: 15 APPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDV 74
Query: 80 LIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEAR 139
L +S + P + + +V R ++V E+ GG L + D + A
Sbjct: 75 LQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAI 132
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199
R + +A A H+ + + + +G+ +A
Sbjct: 133 RAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------ 174
Query: 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ 259
P+ D +G LY L+ P + + + +P
Sbjct: 175 -TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225
Query: 260 STASP--------LIAEMLNINPSSR 277
+ + A + + R
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-40
Identities = 69/251 (27%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLG----INKETGQEVAIKTIKKCKIETEADLIRIRR 85
R LK +++LG+GN+G V++ + TG+ VA+K ++ E D R
Sbjct: 8 EERHLK----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER--- 60
Query: 86 EIQIMSSVRHPNIIHIYEV--FENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIF 142
EI+I+ S++H NI+ V R + L+MEY G L D+L K+ + + +
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCG---SP 199
QI + Y + HRDL NIL++ KI DFGL+ V + + SP
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 200 L--YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV----------------YGAMPFDGSN 240
+ YA PE + + D WS GV+LY L G
Sbjct: 181 IFWYA-PESLTESKFSV--ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 241 FKRLVKQISNG 251
L++ + N
Sbjct: 238 VFHLIELLKNN 248
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 69/251 (27%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLG----INKETGQEVAIKTIKKCKIETEADLIRIRR 85
R LK +++LG+GN+G V++ + TG+ VA+K ++ E D R
Sbjct: 39 EERHLK----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER--- 91
Query: 86 EIQIMSSVRHPNIIHIYEV--FENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIF 142
EI+I+ S++H NI+ V R + L+MEY G L D+L K+ + + +
Sbjct: 92 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCG---SP 199
QI + Y + HRDL NIL++ KI DFGL+ V + + SP
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 200 L--YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV----------------YGAMPFDGSN 240
+ YA PE + + D WS GV+LY L G
Sbjct: 212 IFWYA-PESLTESKFSV--ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 241 FKRLVKQISNG 251
L++ + N
Sbjct: 269 VFHLIELLKNN 279
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-40
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ + +G G++G V E+ EVAIK K+ + RE+QIM V+HP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIK-----KVLQDKR--FKNRELQIMRIVKHP 92
Query: 97 NIIHIYEVF------ENREKMVLVMEYAAGGELYDFLD----QKKVLTEEEARRIFRQIA 146
N++ + F ++ + LV+EY +Y K+ + + Q+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 147 TAVYYCHKHKICHRDLKLENILLDEN-GNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
++ Y H ICHRD+K +N+LLD G K+ DFG + + ++ S Y +PE
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPE 211
Query: 206 IVKGIPYHGPEVDCWSLG 223
++ G + +D WS G
Sbjct: 212 LIFGATNYTTNIDIWSTG 229
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-40
Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 52/233 (22%)
Query: 25 VRLHNHRRKLKQRFDIVR-KLGQGNYGKVQLGINKE--TGQEVAIKTIKKCKIETEADLI 81
V+L + R +++ F+ K+G+G YG V K+ ++ A+K +IE +
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK-----QIEGTGISM 63
Query: 82 RIRREIQIMSSVRHPNIIHIYEVFENR--EKMVLVMEYAAGGE--LYDFLD--------- 128
REI ++ ++HPN+I + +VF + K+ L+ +YA E L+ +
Sbjct: 64 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANK 120
Query: 129 QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL----DENGNAKIADFGLSN 184
+ L + + QI ++Y H + + HRDLK NIL+ E G KIAD G +
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 185 VFTESRFLSTFCGSPL--------------YASPEIVKGIPYHGPEVDCWSLG 223
+F SPL Y +PE++ G ++ +D W++G
Sbjct: 181 LF----------NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 42 RKLGQGNYGKVQLGI--NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
++LG GN+G V+ G K+ + VA+K +K + A + E +M + +P I+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIV 81
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
+ + E E +LVME A G L +L Q + + ++ + Q++ + Y + H
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY--HGPEV 217
RDL N+LL AKI+DFGL S+ L Y + K P + PE
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGL------SKALRA--DENYYKAQTHGK-WPVKWYAPEC 191
Query: 218 ----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
D WS GVL++ YG P+ G + + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 30/231 (12%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
V+++G G +G V LG +VAIKTI++ + E + E ++M +
Sbjct: 7 PSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFI----EEAEVMMKLS 61
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCH 153
HP ++ +Y V + + LV E+ G L D+L Q+ + E + + + Y
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
+ + HRDL N L+ EN K++DFG++ + Y S K P
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----------QYTSSTGTK-FPVK 170
Query: 214 --GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
PEV D WS GVL++ + G +P++ + +V+ IS G
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 70/222 (31%), Positives = 116/222 (52%), Gaps = 12/222 (5%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ + KLGQG +G+V +G T + VAIKT+K + EA L +E Q+M +R
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL----QEAQVMKKLR 320
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYC 152
H ++ +Y V + E + +V EY + G L DFL + K L + + QIA+ + Y
Sbjct: 321 HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS-PL-YASPEIVKGI 210
+ HRDL+ NIL+ EN K+ADFGL+ + ++ + + P+ + +PE
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 211 PYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ + D WS G+LL L G +P+ G + ++ Q+ G
Sbjct: 440 RF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 28/224 (12%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++ +G +G V + VA+K + + E+ + ++H N
Sbjct: 26 LQLLEVKARGRFGCVWKAQLL--NEYVAVKIFP----IQDKQSWQNEYEVYSLPGMKHEN 79
Query: 98 IIHIY----EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
I+ + L+ + G L DFL + V++ E I +A + Y H
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLH 138
Query: 154 ----------KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL---STFCGSPL 200
K I HRD+K +N+LL N A IADFGL+ F + G+
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 201 YASPEIVKGIPYHGPE----VDCWSLGVLLYTLVYGAMPFDGSN 240
Y +PE+++G + +D +++G++L+ L DG
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-39
Identities = 71/249 (28%), Positives = 105/249 (42%), Gaps = 37/249 (14%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
H+R LK +R LG+G++GKV L N TG+ VA+K +K ++
Sbjct: 29 HKRYLK----KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQ 82
Query: 86 EIQIMSSVRHPNIIHIYEV--FENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
EI I+ ++ H +II + LVMEY G L D+L + + + +
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQ 141
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR---FLSTFCGSPL 200
QI + Y H HRDL N+LLD + KI DFGL+ E + SP+
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 201 --YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YG--------------AMPFDGSNFK 242
YA PE + + Y+ D WS GV LY L+ + +
Sbjct: 202 FWYA-PECLKEYKFYY--ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 243 RLVKQISNG 251
RL + + G
Sbjct: 259 RLTELLERG 267
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-39
Identities = 64/251 (25%), Positives = 112/251 (44%), Gaps = 33/251 (13%)
Query: 2 TVNMVVPQASINNIMGGIESTG---GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINK 58
++ + P S+ +++ +S+G G+ L R KQ +V+++G+G YG+V +G +
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQ-IQMVKQIGKGRYGEVWMGKWR 59
Query: 59 ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY----EVFENREKMVLV 114
G++VA+K EA R EI +RH NI+ + + ++ L+
Sbjct: 60 --GEKVAVKVFFT---TEEASWFR-ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113
Query: 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH--------KHKICHRDLKLEN 166
+Y G LYD+L + L + ++ + + + H K I HRDLK +N
Sbjct: 114 TDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 167 ILLDENGNAKIADFGLSNVFTESRFLSTF-----CGSPLYASPEIVKGIPYHGPE----- 216
IL+ +NG IAD GL+ F G+ Y PE++
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232
Query: 217 VDCWSLGVLLY 227
D +S G++L+
Sbjct: 233 ADMYSFGLILW 243
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 70/222 (31%), Positives = 116/222 (52%), Gaps = 12/222 (5%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ + KLGQG +G+V +G T + VAIKT+K + EA L +E Q+M +R
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL----QEAQVMKKLR 237
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYC 152
H ++ +Y V + E + +V EY + G L DFL + K L + + QIA+ + Y
Sbjct: 238 HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS-PL-YASPEIVKGI 210
+ HRDL+ NIL+ EN K+ADFGL+ + ++ + + P+ + +PE
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 211 PYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ + D WS G+LL L G +P+ G + ++ Q+ G
Sbjct: 357 RF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-39
Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 34/231 (14%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ +++ +G+G +G V LG + G +VA+K IK T + E +M+ +R
Sbjct: 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLA---EASVMTQLR 72
Query: 95 HPNIIHIYEV-FENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYY 151
H N++ + V E + + +V EY A G L D+L + VL + + + A+ Y
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIP 211
+ HRDL N+L+ E+ AK++DFGL+ + ++ P VK
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---P-------VKWTA 182
Query: 212 YHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
PE D WS G+LL+ + +G +P+ K +V ++ G
Sbjct: 183 ---PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 59/224 (26%), Positives = 109/224 (48%), Gaps = 20/224 (8%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ +++ +G+G +G V LG + G +VA+K IK T + E +M+ +R
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--DATAQAFLA---EASVMTQLR 244
Query: 95 HPNIIHIYEV-FENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYY 151
H N++ + V E + + +V EY A G L D+L + VL + + + A+ Y
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL-YASPEIVKGI 210
+ HRDL N+L+ E+ AK++DFGL+ + ++ P+ + +PE +
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPE---AL 358
Query: 211 PYH--GPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ D WS G+LL+ + +G +P+ K +V ++ G
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 62/232 (26%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ +V +LG G +G+V +G + VA+K++K+ + +A L E +M ++
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFL----AEANLMKQLQ 66
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYC 152
H ++ +Y V +E + ++ EY G L DFL LT + + QIA + +
Sbjct: 67 HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
+ HRDL+ NIL+ + + KIADFGL+ + ++ Y + E K P
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----------EYTAREGAK-FPI 174
Query: 213 H--GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
PE D WS G+LL +V +G +P+ G +++ + G
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 65/231 (28%), Positives = 96/231 (41%), Gaps = 27/231 (11%)
Query: 40 IVRKLGQGNYGKVQLGI-NKETGQE--VAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
++ KLG G++G V+ G + +G+ VA+K +K + + RE+ M S+ H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKH 155
N+I +Y V M +V E A G L D L + R Q+A + Y
Sbjct: 82 NLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH-- 213
+ HRDL N+LL KI DFGL R L Y E K +P+
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGL------MRALPQ--NDDHYVMQEHRK-VPFAWC 191
Query: 214 GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDY 253
PE D W GV L+ + YG P+ G N +++ +I
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 55/232 (23%), Positives = 104/232 (44%), Gaps = 32/232 (13%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGI-NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93
++ ++++LG G +G V+LG + +VA+K IK+ + + +E Q M +
Sbjct: 7 REEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDEFF----QEAQTMMKL 60
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYC 152
HP ++ Y V + +V EY + G L ++L K L + + + + +
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
H+ HRDL N L+D + K++DFG++ + +++S+ P
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK-----------FPV 169
Query: 213 H--GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
PEV D W+ G+L++ + G MP+D +V ++S G
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ + +KLG G +G+V + + + VA+KT+K + EA L E +M +++
Sbjct: 187 RESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL----AEANVMKTLQ 241
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYC 152
H ++ ++ V +E + ++ E+ A G L DFL D+ + QIA + +
Sbjct: 242 HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
+ HRDL+ NIL+ + KIADFGL+ V ++ Y + E K P
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----------YTAREGAK-FPI 349
Query: 213 H--GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
PE D WS G+LL +V YG +P+ G + +++ + G
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 64/229 (27%), Positives = 92/229 (40%), Gaps = 28/229 (12%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
I + +G G+ G+V G + GQ VAIK +K E + E IM HP
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--DFLSEASIMGQFDHP 110
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKH 155
NII + V ++V EY G L FL T + + R + + Y
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH-- 213
HRDL N+L+D N K++DFGLS R L P A IP
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLS------RVLE---DDPDAAYTTTGGKIPIRWT 221
Query: 214 GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
PE D WS GV+++ ++ YG P+ + ++ + G
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 40 IVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKK-CKIETEADLIRIRREIQIMSSVR 94
++ LG G +G V G+ ++ VAIK +++ + +++ E +M+SV
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVMASVD 75
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCH 153
+P++ + + + L+ + G L D++ + K + + QIA + Y
Sbjct: 76 NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
++ HRDL N+L+ + KI DFGL+ + L Y + I +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLA------KLLGA--EEKEYHAEGGKVPIKWM 186
Query: 214 GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
E D WS GV ++ L+ +G+ P+DG + + G
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 32/227 (14%)
Query: 40 IVRKLGQGNYGKVQLGI-NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI 98
+++LG G +G V+ G + +VAIK IK+ + + + E ++M ++ H +
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQY--DVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEKL 81
Query: 99 IHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+ +Y V + + ++ EY A G L ++L + + ++ + + + A+ Y +
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH--GP 215
HRDL N L+++ G K++DFGLS + Y S K P P
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----------EYTSSVGSK-FPVRWSPP 190
Query: 216 EV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
EV D W+ GVL++ + G MP++ + I+ G
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-38
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 28/226 (12%)
Query: 42 RKLGQGNYGKVQLGINKETGQE--VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
+LG GN+G V+ G+ + ++ VAIK +K+ +AD + RE QIM + +P I+
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIV 73
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKIC 158
+ V + E ++LVME A GG L+ FL +++ + + Q++ + Y +
Sbjct: 74 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 159 HRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH--GPE 216
HRDL N+LL AKI+DFGL S+ L Y + K P PE
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGL------SKALGA--DDSYYTARSAGK-WPLKWYAPE 183
Query: 217 V----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
D WS GV ++ + YG P+ ++ I G
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-38
Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 23/225 (10%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
+R LK +R LG+G++GKV+L TG++VA+K++K + +++
Sbjct: 19 EKRFLK----RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKK 72
Query: 86 EIQIMSSVRHPNIIHIYEV--FENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIF 142
EI+I+ ++ H NI+ + + + L+ME+ G L ++L K + ++ +
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR---FLSTFCGSP 199
QI + Y + HRDL N+L++ KI DFGL+ + + SP
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 200 L--YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSN 240
+ YA PE +++ Y D WS GV L+ L+ Y
Sbjct: 193 VFWYA-PECLMQSKFYI--ASDVWSFGVTLHELLTYCDSDSSPMA 234
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 30/229 (13%)
Query: 21 STGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL 80
S G+ L R + + +G+G +G+V G + G+EVA+K E
Sbjct: 28 SGSGLPLLVQRTIART-IVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSW 81
Query: 81 IRIRREIQIMSSVRHPNIIHIY----EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEE 136
R EI +RH NI+ + ++ LV +Y G L+D+L + +T E
Sbjct: 82 FR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE 139
Query: 137 EARRIFRQIATAVYYCH--------KHKICHRDLKLENILLDENGNAKIADFGLSNVF-- 186
++ A+ + + H K I HRDLK +NIL+ +NG IAD GL+
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
Query: 187 ---TESRFLSTFCGSPLYASPEIVKG-IPYHGPE----VDCWSLGVLLY 227
T + G+ Y +PE++ I E D +++G++ +
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
R++I +G G+YG V +K + VAIK I + E D RI REI I++ + H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNH 111
Query: 96 PNIIHIYEVF-----ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
+++ + ++ E +++ +V+E A + LTE + + + V
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL---------- 200
Y H I HRDLK N L++++ + K+ DFGL+ ++
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 201 ------------------YASPEIVKGIPYHGPEVDCWSLG 223
Y +PE++ + +D WS+G
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-37
Identities = 48/240 (20%), Positives = 88/240 (36%), Gaps = 45/240 (18%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQ-------EVAIKTIKKCKIETEADLIRIRREIQIMSS 92
LGQG + K+ G+ +E G EV +K + K +MS
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE---AASMMSK 68
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYY 151
+ H +++ Y V ++ +LV E+ G L +L K + + +Q+A A+++
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF 128
Query: 152 CHKHKICHRDLKLENILLD--------ENGNAKIADFGLSNVFTESRFLSTFCGSPLYAS 203
++ + H ++ +NILL K++D G+S
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---------LQE 179
Query: 204 PEIVKGIPYHGPEV-----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
IP+ PE D WS G L+ + G P + +R ++ +
Sbjct: 180 R-----IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 16/223 (7%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
I + +G G +G+V G K ++ VAIKT+K E + E IM HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKH 155
NII + V + +++V EY G L FL T + + R IA+ + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVF---TESRFLSTFCGSPL-YASPEIVKGIP 211
HRDL NIL++ N K++DFGL V E+ + + P+ + SPE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE---AIA 223
Query: 212 YHG--PEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
Y D WS G++L+ ++ YG P+ + + ++K + G
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 33/232 (14%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE----VAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ +G G +G+V G+ K + + VAIKT+K E + E IM H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSH 105
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHK 154
NII + V + M+++ EY G L FL ++ + + + R IA + Y
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG--IPY 212
HRDL NIL++ N K++DFGLS V + Y + G IP
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-------EATYTT----SGGKIPI 214
Query: 213 H--GPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
PE D WS G++++ ++ YG P+ + ++K I++G
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 35/231 (15%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE---VAIKTIKK-CKIETEADLIRIRREIQIMSSVRH 95
+ R LG+G +G+V G+ E VA+KT KK C ++ + + E IM ++ H
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKNLDH 72
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHK 154
P+I+ + + E E ++ME GEL +L K L QI A+ Y
Sbjct: 73 PHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG---IP 211
HRD+ + NIL+ K+ DFGLS + + Y + I
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---------YKA---SVTRLPIK 179
Query: 212 YHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ PE D W V ++ ++ +G PF K ++ + G
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-36
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 15/221 (6%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ R +G+G +G V GI VAIKT K C +++ + +E M HP
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHP 76
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKH 155
+I+ + V + ++ME GEL FL +K L Q++TA+ Y
Sbjct: 77 HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCG-SPL-YASPEIVKGIPYH 213
+ HRD+ N+L+ N K+ DFGLS +S + G P+ + +PE I +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE---SINFR 192
Query: 214 G--PEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
D W GV ++ ++ +G PF G ++ +I NG
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-36
Identities = 62/248 (25%), Positives = 109/248 (43%), Gaps = 20/248 (8%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+R+ ++ +G G G V + + VAIK + + + + R RE+ +M V H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNH 120
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
NII + VF E + + LVME L + + L E + Q+ +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGI 177
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
+ H I HRDLK NI++ + KI DFGL+ S ++ + + Y +PE++ G
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEM 269
+ Y VD WS+G ++ +V + F G ++ ++ + +P M
Sbjct: 238 MGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI---------EQLGTPCPEFM 287
Query: 270 LNINPSSR 277
+ P+ R
Sbjct: 288 KKLQPTVR 295
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++ +G+G YG V G + VA+K + I + I + + H N
Sbjct: 15 LKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSF---ANRQNFIN-EKNIYRVPLMEHDN 68
Query: 98 IIHIY-----EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
I + R + +LVMEY G L +L + R+ + + Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 153 H---------KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL---------ST 194
H K I HRDL N+L+ +G I+DFGLS T +R + +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 195 FCGSPLYASPEIVKG------IPYHGPEVDCWSLGVLLY 227
G+ Y +PE+++G +VD ++LG++ +
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 40 IVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
++ LG G +G V G+ ++ VAIK +++ + I E +M+SV +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDN 76
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHK 154
P++ + + + L+ + G L D++ + K + + QIA + Y
Sbjct: 77 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHG 214
++ HRDL N+L+ + KI DFGL ++ L Y + I +
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGL------AKLLGA--EEKEYHAEGGKVPIKWMA 187
Query: 215 PEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
E D WS GV ++ L+ +G+ P+DG + + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+G+G++G V G + + A+K++ + I ++ + E IM HP
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 150
Query: 97 NIIHIYEV-FENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHK 154
N++ + + + ++V+ Y G+L +F+ ++ T ++ Q+A + +
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS----PLYASPEIVKGI 210
K HRDL N +LDE K+ADFGL+ + F S + P VK +
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP-------VKWM 263
Query: 211 PYHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
E D WS GVLL+ L+ GA P+ N + + G
Sbjct: 264 A---LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 33/239 (13%)
Query: 30 HRRKLKQRFDIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
+L+ ++ LG G +G V G+ + V IK I+ +
Sbjct: 11 KETELR----KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTD 64
Query: 86 EIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQ 144
+ + S+ H +I+ + + + LV +Y G L D + + L + Q
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASP 204
IA +YY +H + HR+L N+LL ++ADFG+ + L
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV------ADLLPP---DDKQLLY 174
Query: 205 EIVKG-IPYHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
K I + E D WS GV ++ L+ +GA P+ G + + G
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-36
Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 16/224 (7%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+G+G++G V G + + A+K++ + I ++ + E IM HP
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHP 86
Query: 97 NIIHIYEV-FENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHK 154
N++ + + + ++V+ Y G+L +F+ ++ T ++ Q+A + Y
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS----PL-YASPE-IVK 208
K HRDL N +LDE K+ADFGL+ + + S + P+ + + E +
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 209 GIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ D WS GVLL+ L+ GA P+ N + + G
Sbjct: 207 QKFTT--KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 20/248 (8%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+R+ ++ +G G G V + + VAIK + + + + R RE+ +M V H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNH 83
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
NII + VF E + + +VME L + + L E + Q+ +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGI 140
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
+ H I HRDLK NI++ + KI DFGL+ S ++ + + Y +PE++ G
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 200
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEM 269
+ Y VD WS+G ++ ++ G + F G++ ++ + +P M
Sbjct: 201 MGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI---------EQLGTPCPEFM 250
Query: 270 LNINPSSR 277
+ P+ R
Sbjct: 251 KKLQPTVR 258
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 32/232 (13%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R +G+G++G V G + Q AIK++ + I + RE +M + HP
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGLLMRGLNHP 82
Query: 97 NIIHIYEV-FENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHK 154
N++ + + +++ Y G+L F+ ++ T ++ Q+A + Y +
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS----PLYASPEIVKGI 210
K HRDL N +LDE+ K+ADFGL+ + + S P VK
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP-------VKWT 195
Query: 211 PYHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
E D WS GVLL+ L+ GA P+ + L ++ G
Sbjct: 196 A---LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
RK RF + R GQG +G VQLG K TG VAIK + I+ R + +Q ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQIMQDLA 74
Query: 92 SVRHPNIIHIYEVF-------ENREKMVLVMEYAAGGELYDFLD----QKKVLTEEEARR 140
+ HPNI+ + F + +VMEY L+ ++ +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 141 IFRQIATAVYYCHK--HKICHRDLKLENILLD-ENGNAKIADFGLSNVFTESRFLSTFCG 197
Q+ ++ H +CHRD+K N+L++ +G K+ DFG + + S +
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 198 SPLYASPEIVKGIPYHGPEVDCWSLG 223
S Y +PE++ G ++ VD WS+G
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVG 219
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 64/226 (28%), Positives = 109/226 (48%), Gaps = 21/226 (9%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
H+H + R+++++ +G+G++G+V + + Q VA+K ++ K
Sbjct: 89 QVPHDH---VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE--- 142
Query: 85 REIQIMSSVRH------PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV--LTEE 136
EI+I+ +R N+IH+ E F R + + E LY+ + + K +
Sbjct: 143 -EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLP 200
Query: 137 EARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA--KIADFGLSNVFTESRFLST 194
R+ I + HK++I H DLK ENILL + G + K+ DFG S E + + T
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYT 258
Query: 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+ S Y +PE++ G Y G +D WSLG +L L+ G G +
Sbjct: 259 YIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGED 303
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 64/247 (25%), Positives = 107/247 (43%), Gaps = 35/247 (14%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
RR + + R+LG+G +GKV L + VA+K +K + D R
Sbjct: 14 RRDIV----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR--- 66
Query: 86 EIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL----------------DQ 129
E +++++++H +I+ Y V + + +++V EY G+L FL
Sbjct: 67 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 130 KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189
K L + I QIA+ + Y HRDL N L+ N KI DFG+S +
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 190 RFLSTFCGSPL---YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRL 244
+ + L + PE I+ E D WS GV+L+ + YG P+ + +
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
Query: 245 VKQISNG 251
++ I+ G
Sbjct: 245 IECITQG 251
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 50/241 (20%), Positives = 96/241 (39%), Gaps = 27/241 (11%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI---NKETGQEVAIKTIKKCKIETEADLIRIRREI 87
++ + R LG+G +G V+ + +VA+K +K I +D+ RE
Sbjct: 22 EQQFT----LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIASSDIEEFLREA 76
Query: 88 QIMSSVRHPNIIHIYEV------FENREKMVLVMEYAAGGELYDFL------DQKKVLTE 135
M HP++ + V ++++ + G+L+ FL + L
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 136 EEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLST 194
+ R IA + Y HRDL N +L E+ +ADFGLS +++ +
Sbjct: 137 QTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 195 FCGS-PL-YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISN 250
P+ + + E + + + D W+ GV ++ ++ G P+ G + +
Sbjct: 197 CASKLPVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
Query: 251 G 251
G
Sbjct: 255 G 255
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 28/225 (12%)
Query: 43 KLGQGNYGKVQLGINKETGQE--VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100
+LG GN+G V+ G+ + ++ VAIK +K+ +AD + RE QIM + +P I+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 101 IYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
+ V + E ++LVME A GG L+ FL +++ + + Q++ + Y + H
Sbjct: 401 LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH--GPEV 217
R+L N+LL AKI+DFGL S+ L Y + K P PE
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGL------SKALGA--DDSYYTARSAGK-WPLKWYAPEC 510
Query: 218 ----------DCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
D WS GV ++ + YG P+ ++ I G
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 15/231 (6%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMS 91
++R ++ R +G+G +G V GI VAIKT K C +++ + +E M
Sbjct: 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMR 446
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVY 150
HP+I+ + V + ++ME GEL FL +K L Q++TA+
Sbjct: 447 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCG-SPL-YASPEIVK 208
Y + HRD+ N+L+ N K+ DFGLS +S + G P+ + +PE
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE--- 562
Query: 209 GIPYHG--PEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEP 256
I + D W GV ++ ++ +G PF G ++ +I NG+
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 613
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 12/219 (5%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ + +G G YG V I+K +G++VAIK + + ++E R RE+ ++ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQH 82
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
N+I + +VF N LVM + +L + K +EE+ + + Q+ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLKGL 139
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
Y H + HRDLK N+ ++E+ KI DFGL+ ++ + + Y +PE++
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILS 197
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
++ VD WS+G ++ ++ G F G ++ + QI
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 54/248 (21%), Positives = 96/248 (38%), Gaps = 42/248 (16%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI---NKETGQEVAIKTIKKCKIETEADLIRIRREI 87
R L + + LG+G +G V G T +VA+KT+K ++ ++ E
Sbjct: 33 RNLLI----LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL-DNSSQREIEEFLSEA 87
Query: 88 QIMSSVRHPNIIHIYEV-----FENREKMVLVMEYAAGGELYDFL------DQKKVLTEE 136
M HPN+I + V + K ++++ + G+L+ +L K + +
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 137 EARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTF 195
+ IA + Y HRDL N +L ++ +ADFGLS +++ +
Sbjct: 148 TLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 196 CGS-PLYASPEIVKGIPYHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSNFKR 243
P VK I E D W+ GV ++ + G P+ G
Sbjct: 208 IAKMP-------VKWIA---IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
Query: 244 LVKQISNG 251
+ + +G
Sbjct: 258 MYDYLLHG 265
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 20/222 (9%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
R+ ++ LG G G V ++ + + VAIK K + + REI+I+ + H
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDH 67
Query: 96 PNIIHIYEVF--ENREKMVLVMEYAAGGELY---DFLD-------QKKVLTEEEARRIFR 143
NI+ ++E+ + V +Y ++++ ++ L EE AR
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 144 QIATAVYYCHKHKICHRDLKLENILLD-ENGNAKIADFGL----SNVFTESRFLSTFCGS 198
Q+ + Y H + HRDLK N+ ++ E+ KI DFGL ++ LS +
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 199 PLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
Y SP ++ + +D W+ G + ++ G F G++
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 16/227 (7%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI--------ETEADLIRIRREI 87
+ + R + G+YG V G++ G VAIK + R+ REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 88 QIMSSVRHPNIIHIYEVF-----ENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRI 141
++++ HPNI+ + ++F K+ LV E +L + DQ+ V++ + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 142 FRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLY 201
I ++ H+ + HRDL NILL +N + I DF L+ T + + Y
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWY 199
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
+PE+V VD WS G ++ + F GS F + +I
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 30/237 (12%)
Query: 40 IVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ +LG+G +GKV L ++ VA+K +K+ D R E ++++ ++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQ 101
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFL---------------DQKKVLTEEEAR 139
H +I+ + V +++V EY G+L FL L +
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199
+ Q+A + Y HRDL N L+ + KI DFG+S + + +
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 200 L---YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
L + PE I+ E D WS GV+L+ + YG P+ + + I+ G
Sbjct: 222 LPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 59/219 (26%), Positives = 111/219 (50%), Gaps = 11/219 (5%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+R+ + +G G YG V + +TG VA+K + + ++ R RE++++ ++H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKH 87
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
N+I + +VF E + LV G +L + + + + LT++ + + QI +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGL 145
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
Y H I HRDLK N+ ++E+ KI DFGL+ + ++ + + Y +PEI+
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLN 203
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI 248
++ VD WS+G ++ L+ G F G++ +K I
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 55/241 (22%), Positives = 108/241 (44%), Gaps = 28/241 (11%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
R K+ + R+LGQG++G V G+ E VAIKT+ + + + I
Sbjct: 24 REKIT----MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLN 77
Query: 86 EIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL----------DQKKVLTE 135
E +M +++ + V + +++ME G+L +L +
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 136 EEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLST 194
+ ++ +IA + Y + +K HRDL N ++ E+ KI DFG++ +++ +
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 195 FCGS-PL-YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISN 250
G P+ + SPE + G+ D WS GV+L+ + P+ G + +++++ +
Sbjct: 198 GKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 251 G 251
G
Sbjct: 256 G 256
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 68/266 (25%), Positives = 115/266 (43%), Gaps = 39/266 (14%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
F + LG+G YG V +K TG+ VAIK I+ + +R REI+I+ +H
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKILKHFKH 68
Query: 96 PNIIHIYEVF-----ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
NII I+ + EN ++ ++ E +L+ + ++L+++ + Q AV
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI-STQMLSDDHIQYFIYQTLRAVK 126
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL---------- 200
H + HRDLK N+L++ N + K+ DFGL+ + ES ++
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 201 -YASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ 259
Y +PE++ + +D WS G +L L F G ++ Q+
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQLL---------- 233
Query: 260 STASPLIAEMLNINPSSRADISVICS 285
LI ++ P S D+ I S
Sbjct: 234 -----LIFGIIG-TPHSDNDLRCIES 253
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-34
Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 56/260 (21%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLG-----INKETGQEVAIKTIKKCKIETE-ADLIRIR 84
R +L + LG G +GKV I + VA+K +K TE L+
Sbjct: 22 RNRLS----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS-- 75
Query: 85 REIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL---------------- 127
E++++S + H NI+++ +++ EY G+L +FL
Sbjct: 76 -ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 128 --DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-N 184
D + L E+ Q+A + + HRDL NILL KI DFGL+ +
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 185 VFTESRFLSTFCGS-PLYASPEIVKGIPYHGPEV----------DCWSLGVLLYTLV-YG 232
+ +S ++ P VK + PE D WS G+ L+ L G
Sbjct: 195 IKNDSNYVVKGNARLP-------VKWMA---PESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 233 AMPFDG-SNFKRLVKQISNG 251
+ P+ G + K I G
Sbjct: 245 SSPYPGMPVDSKFYKMIKEG 264
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ I +G+G+YG V L +K T + VAIK + + E D RI REI I++ ++
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKS 84
Query: 96 PNIIHIYEVF--ENREKMV---LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
II +Y++ ++ K +V+E A +L LTEE + I +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL---------- 200
+ H+ I HRDLK N LL+++ + K+ DFGL+ + +
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 201 -------------YASPEIVKGIPYHGPEVDCWSLG 223
Y +PE++ + +D WS G
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 13/238 (5%)
Query: 13 NNIMGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKC 72
++ M + G + + R+ + +G+G YG V + VAIK I
Sbjct: 4 HHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP- 62
Query: 73 KIETEADLIRIRREIQIMSSVRHPNIIHIYEVF-----ENREKMVLVMEYAAGGELYDFL 127
E + R REI+I+ RH NII I ++ E + + +V + +LY L
Sbjct: 63 -FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL 120
Query: 128 DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL----S 183
+ + L+ + QI + Y H + HRDLK N+LL+ + KI DFGL
Sbjct: 121 -KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 184 NVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF 241
+ FL+ + + Y +PEI+ + +D WS+G +L ++ F G ++
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 26/233 (11%)
Query: 40 IVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKK-CKIETEADLIRIRREIQIMSSV 93
++R LG G +G+V G N + +VA+KT+ + C + E D + E I+S
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKF 90
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-------DQKKVLTEEEARRIFRQIA 146
H NI+ V ++ME AGG+L FL Q L + + R IA
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGN---AKIADFGLSNVFTESRFLSTFCGSPL--- 200
Y ++ HRD+ N LL G AKI DFG++ + + + L
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 201 YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ PE ++GI + D WS GVLL+ + G MP+ + + +++ +++G
Sbjct: 211 WMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 69/263 (26%), Positives = 110/263 (41%), Gaps = 58/263 (22%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
R+ L + + LG+G +GKV + VA+K +K+ + ++L +
Sbjct: 22 RKNLV----LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLS 75
Query: 86 EIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL------------------ 127
E ++ V HP++I +Y ++L++EYA G L FL
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 128 ------DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFG 181
++ LT + QI+ + Y + K+ HRDL NIL+ E KI+DFG
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 182 LS-NVFTESRFLSTFCGS-PLYASPEIVKGIPYHGPEV----------DCWSLGVLLYTL 229
LS +V+ E ++ G P VK + E D WS GVLL+ +
Sbjct: 196 LSRDVYEEDSYVKRSQGRIP-------VKWMA---IESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 230 V-YGAMPFDGSNFKRLVKQISNG 251
V G P+ G +RL + G
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKTG 268
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 67/285 (23%), Positives = 131/285 (45%), Gaps = 45/285 (15%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ ++ +G G YG V ++ TG +VAIK + + ++E R RE++++ +RH
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRH 83
Query: 96 PNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149
N+I + +VF ++ LVM + G +L + + + L E+ + + Q+ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGL 141
Query: 150 YYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
Y H I HRDLK N+ ++E+ KI DFGL+ ++ + + Y +PE++
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAPEVILN 199
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF---------------KRLVKQISNGD-- 252
+ VD WS+G ++ ++ G F GS+ V+++ + +
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 253 -------YFEPKNQST----ASP----LIAEMLNINPSSRADISV 282
E K+ ++ ASP L+ +ML ++ R ++
Sbjct: 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR--VTA 302
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-33
Identities = 51/231 (22%), Positives = 91/231 (39%), Gaps = 51/231 (22%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+++ + + LG G++G V + E+G+ A+K K+ + RE+ IM + H
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQDP--RYKNRELDIMKVLDH 59
Query: 96 PNIIHIYEVFENREKMV--------------------------------------LVMEY 117
NII + + F ++MEY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 118 AAGGELYDFLD----QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD-EN 172
L+ L + + Q+ AV + H ICHRD+K +N+L++ ++
Sbjct: 120 V-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 173 GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLG 223
K+ DFG + S + S Y +PE++ G + P +D WS+G
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 34/247 (13%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
++ + +LG+ +GKV G E Q VAIKT+K R
Sbjct: 8 LSAVR----FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRH 61
Query: 86 EIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL----------------DQ 129
E + + ++HPN++ + V + + ++ Y + G+L++FL
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 130 KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189
K L + + QIA + Y H + H+DL N+L+ + N KI+D GL +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 190 RFLSTFCGSPL---YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRL 244
+ S L + +PE I+ G + D WS GV+L+ + YG P+ G + + +
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSI--DSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 245 VKQISNG 251
V+ I N
Sbjct: 240 VEMIRNR 246
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 66/251 (26%), Positives = 104/251 (41%), Gaps = 47/251 (18%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI--NKETGQEVAIKTIKKCKIETEADLIRIRREIQ 88
+K +G+GN+G+V + AIK +K+ ++ D E++
Sbjct: 24 WNDIK----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELE 77
Query: 89 IMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL----------------DQKK 131
++ + HPNII++ E+R + L +EYA G L DFL
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 132 VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191
L+ ++ +A + Y + + HRDL NIL+ EN AKIADFGL SR
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL------SRG 191
Query: 192 LSTFCGSPLYASPEIVKGIPYHGPEV----------DCWSLGVLLYTLV-YGAMPFDGSN 240
+ + P V+ + E D WS GVLL+ +V G P+ G
Sbjct: 192 QEVYVKKTMGRLP--VRWMA---IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 241 FKRLVKQISNG 251
L +++ G
Sbjct: 247 CAELYEKLPQG 257
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 26/233 (11%)
Query: 40 IVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKK-CKIETEADLIRIRREIQIMSSV 93
++R LG G +G+V G N + +VA+KT+ + C + E D + E I+S
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKF 131
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-------DQKKVLTEEEARRIFRQIA 146
H NI+ V +++E AGG+L FL Q L + + R IA
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 147 TAVYYCHKHKICHRDLKLENILLDENGN---AKIADFGLSNVFTESRFLSTFCGSPL--- 200
Y ++ HRD+ N LL G AKI DFG++ + + + L
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 201 YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
+ PE ++GI + D WS GVLL+ + G MP+ + + +++ +++G
Sbjct: 252 WMPPEAFMEGI--FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 55/259 (21%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI-------NKETGQEVAIKTIKK-CKIETEADLIR 82
R KL + + LG+G +G+V + + VA+K +K + +DL+
Sbjct: 80 RDKLT----LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 135
Query: 83 IRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-------------- 127
E+++M + +H NII++ + +++EYA+ G L ++L
Sbjct: 136 ---EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 128 --DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-N 184
++ +T ++ Q+A + Y K HRDL N+L+ EN KIADFGL+ +
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 185 VFTESRFLSTFCGS-PLYASPEIVKGIPYHGPEV----------DCWSLGVLLYTLV-YG 232
+ + T G P VK + PE D WS GVL++ + G
Sbjct: 253 INNIDYYKKTTNGRLP-------VKWMA---PEALFDRVYTHQSDVWSFGVLMWEIFTLG 302
Query: 233 AMPFDGSNFKRLVKQISNG 251
P+ G + L K + G
Sbjct: 303 GSPYPGIPVEELFKLLKEG 321
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 69/266 (25%), Positives = 116/266 (43%), Gaps = 69/266 (25%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKV----QLGINKETGQE---VAIKTIKK-CKIETEADLIR 82
R KL + + LG+G +G+V +GI+K+ +E VA+K +K + +DL+
Sbjct: 34 RDKLT----LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 89
Query: 83 IRREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-------------- 127
E+++M + +H NII++ + +++EYA+ G L ++L
Sbjct: 90 ---EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 128 --DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-N 184
++ +T ++ Q+A + Y K HRDL N+L+ EN KIADFGL+ +
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 185 VF--------TESRFLSTFCGSPLYASPEIVKGIPYHGPEV----------DCWSLGVLL 226
+ T R P VK + PE D WS GVL+
Sbjct: 207 INNIDYYKKTTNGRL-------P-------VKWMA---PEALFDRVYTHQSDVWSFGVLM 249
Query: 227 YTLV-YGAMPFDGSNFKRLVKQISNG 251
+ + G P+ G + L K + G
Sbjct: 250 WEIFTLGGSPYPGIPVEELFKLLKEG 275
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 62/249 (24%), Positives = 110/249 (44%), Gaps = 38/249 (15%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKV----QLGINKETGQ-EVAIKTIKKCKIETE-ADLIRIR 84
R L+ + LG G +GKV G+ KE +VA+K +K E L+
Sbjct: 45 RNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS-- 98
Query: 85 REIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--------------DQ 129
E++IMS + +H NI+++ + ++++ EY G+L +FL
Sbjct: 99 -ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 130 KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVFTE 188
+ + Q+A + + HRD+ N+LL AKI DFGL+ ++ +
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 189 SRFLSTFCGS-PL-YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDG--SNFK 242
S ++ P+ + +PE I + + + D WS G+LL+ + G P+ G N
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGLNPYPGILVN-S 274
Query: 243 RLVKQISNG 251
+ K + +G
Sbjct: 275 KFYKLVKDG 283
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 32/234 (13%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-- 94
R+ +VRKLG G++ V L + VA+K ++ K+ TEA EI+++ V
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDA 75
Query: 95 ---------HPNIIHIYEVFE----NREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEAR 139
+I+ + + F N +V+V E G L + + + + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 140 RIFRQIATAVYYCHKH-KICHRDLKLENILLDE------NGNAKIADFGLSNVFTESRFL 192
+I +Q+ + Y H+ I H D+K EN+L++ KIAD G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC--WYDEHY 192
Query: 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVK 246
+ + Y SPE++ G P+ G D WS L++ L+ G F+ K
Sbjct: 193 TNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 67/258 (25%), Positives = 112/258 (43%), Gaps = 53/258 (20%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI-------NKETGQEVAIKTIKKCKIETEADLIRI 83
R +L + + LG+G +G+V L +VA+K +K TE DL +
Sbjct: 68 RDRLV----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDL 121
Query: 84 RREIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL--------------- 127
E+++M + +H NII++ + +++EYA+ G L ++L
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 128 -DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NV 185
+ ++ L+ ++ Q+A + Y K HRDL N+L+ E+ KIADFGL+ ++
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 186 FTESRFLSTFCGS-PLYASPEIVKGIPYHGPEV----------DCWSLGVLLYTLV-YGA 233
+ T G P VK + PE D WS GVLL+ + G
Sbjct: 242 HHIDYYKKTTNGRLP-------VKWMA---PEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 234 MPFDGSNFKRLVKQISNG 251
P+ G + L K + G
Sbjct: 292 SPYPGVPVEELFKLLKEG 309
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 60/258 (23%), Positives = 108/258 (41%), Gaps = 53/258 (20%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
R +LK + + LG+G +G+V T + VA+K +K+ T ++ +
Sbjct: 26 RDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMS 79
Query: 86 EIQIMSSV-RHPNIIHIYEV-FENREKMVLVMEYAAGGELYDFL---------------- 127
E++I+ + H N++++ + +++++E+ G L +L
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 128 DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS-NVF 186
K LT E Q+A + + K HRDL NILL E KI DFGL+ +++
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 187 TESRFLSTFCGS-PLYASPEIVKGIPYHGPEV----------DCWSLGVLLYTLV-YGAM 234
+ ++ P +K + PE D WS GVLL+ + GA
Sbjct: 200 KDPDYVRKGDARLP-------LKWMA---PETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 235 PFDG-SNFKRLVKQISNG 251
P+ G + +++ G
Sbjct: 250 PYPGVKIDEEFCRRLKEG 267
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-32
Identities = 67/270 (24%), Positives = 107/270 (39%), Gaps = 72/270 (26%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRR 85
R ++ VR +G+G +G+V E VA+K +K+ + +R
Sbjct: 46 RNNIE----YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQR 99
Query: 86 EIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL------------------ 127
E +M+ +PNI+ + V + M L+ EY A G+L +FL
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 128 ------DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFG 181
L+ E I RQ+A + Y + K HRDL N L+ EN KIADFG
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 182 LS-NVF--------TESRFLSTFCGSPLYASPEIVKGIPYHGPEV----------DCWSL 222
LS N++ P ++ +P PE D W+
Sbjct: 220 LSRNIYSADYYKADGNDAI-------P-------IRWMP---PESIFYNRYTTESDVWAY 262
Query: 223 GVLLYTLV-YGAMPFDGSNFKRLVKQISNG 251
GV+L+ + YG P+ G + ++ + +G
Sbjct: 263 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 292
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 57/248 (22%), Positives = 100/248 (40%), Gaps = 43/248 (17%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
+ L F ++RK+G G +G+V L + + + A+K ++ K T + I
Sbjct: 27 WKKGML---LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI--- 80
Query: 85 REIQIMSSVRH-----PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV--LTEEE 137
E I+ +++ NI+ + F + M L+ E G LY+ + + E+
Sbjct: 81 -EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIED 138
Query: 138 ARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA---------------------- 175
+ +I A+ Y K + H DLK ENILLD+
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 176 ---KIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG 232
K+ DFG F +S + + + Y +PE++ + + D WS G +L L G
Sbjct: 199 TGIKLIDFG-CATF-KSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTG 255
Query: 233 AMPFDGSN 240
++ F
Sbjct: 256 SLLFRTHE 263
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 62/257 (24%), Positives = 109/257 (42%), Gaps = 45/257 (17%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETE-ADLIRIR 84
R L+ + LG G +GKV +VA+K +K+ +E L+
Sbjct: 44 RENLE----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS-- 97
Query: 85 REIQIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL---------------- 127
E+++M+ + H NI+++ + L+ EY G+L ++L
Sbjct: 98 -ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 128 -------DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180
+ VLT E+ Q+A + + HRDL N+L+ KI DF
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 181 GLS-NVFTESRFLSTFCGS-PL-YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMP 235
GL+ ++ ++S ++ P+ + +PE + +GI + + D WS G+LL+ + G P
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNP 274
Query: 236 FDG-SNFKRLVKQISNG 251
+ G K I NG
Sbjct: 275 YPGIPVDANFYKLIQNG 291
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR- 94
+++++V+KLG+G YG V I++ TG+ VA+K I + D R REI I++ +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSG 67
Query: 95 HPNIIHIYEVF--ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
H NI+++ V +N + LV +Y +L+ + + +L + + Q+ + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI-RANILEPVHKQYVVYQLIKVIKYL 125
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPL------------ 200
H + HRD+K NILL+ + K+ADFGLS F R ++ +
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 201 ----------YASPEIVKGIPYHGPEVDCWSLG 223
Y +PEI+ G + +D WSLG
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 23/228 (10%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
V+ R++I +G+G++G+V ++ + VAIK IK K I
Sbjct: 46 VKNGEK---WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI--- 99
Query: 85 REIQIMSSVRHP------NIIHIYEVFENREKMVLVMEYAAGGELYDFL--DQKKVLTEE 136
E++++ + I+H+ F R + LV E LYD L + ++
Sbjct: 100 -EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM-LSYNLYDLLRNTNFRGVSLN 157
Query: 137 EARRIFRQIATAVYYCHKHK--ICHRDLKLENILLDENGNA--KIADFGLSNVFTESRFL 192
R+ +Q+ TA+ + + I H DLK ENILL + KI DFG S+ + +
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQ-LGQRI 215
Query: 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
+ S Y SPE++ G+PY +D WSLG +L + G F G+N
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGAN 262
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 39/244 (15%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQE-VAIKTIKKCKIETEADLIRI 83
+ + L R++IV LG+G +GKV I+ + G VA+K +K EA
Sbjct: 6 CQSGDV---LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-- 60
Query: 84 RREIQIMSSVRHP------NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV--LTE 135
EIQ++ + + + E FE+ + +V E G YDF+ +
Sbjct: 61 --EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRL 117
Query: 136 EEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA-------------------K 176
+ R++ QI +V + H +K+ H DLK ENIL ++ K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 177 IADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
+ DFG S + + ST + Y +PE++ + + P D WS+G +L G F
Sbjct: 178 VVDFG-SATY-DDEHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVF 234
Query: 237 DGSN 240
+
Sbjct: 235 PTHD 238
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 56/244 (22%), Positives = 102/244 (41%), Gaps = 39/244 (15%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQE-VAIKTIKKCKIETEADLIRI 83
R+ + L++R++IV LG+G +GKV ++ G+ VA+K I+ EA +
Sbjct: 11 CRIGDW---LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-- 65
Query: 84 RREIQIMSSVRHP------NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV--LTE 135
EI ++ ++ + + + F M + E G ++FL +
Sbjct: 66 --EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPL 122
Query: 136 EEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA-------------------K 176
R + Q+ A+ + H++++ H DLK ENIL + +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 177 IADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236
+ADFG S F + +T + Y PE++ + + P D WS+G +L+ G F
Sbjct: 183 VADFG-SATF-DHEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 239
Query: 237 DGSN 240
Sbjct: 240 QTHE 243
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 58/271 (21%), Positives = 100/271 (36%), Gaps = 72/271 (26%)
Query: 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93
R+ ++RKLG G++ V L + + + VA+K +K + TE EI+++ SV
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA----LDEIRLLKSV 90
Query: 94 R-----HPN---IIHIYEVFE----NREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEAR 139
R PN ++ + + F+ N + +V E G L ++ + + L +
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 140 RIFRQIATAVYYCHKH-KICHRDLKLENILL----------------------------- 169
+I +Q+ + Y H +I H D+K ENILL
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 170 --------------------DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG 209
E KIAD G + + + + Y S E++ G
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEVLIG 267
Query: 210 IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240
Y D WS + + L G F+ +
Sbjct: 268 SGY-NTPADIWSTACMAFELATGDYLFEPHS 297
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-23
Identities = 58/177 (32%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI--ETEADLIRIRREIQIMSSVRH 95
FD +G G +GKV G+ ++ G +VA+K E EI+ +S RH
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEE-----FETEIETLSFCRH 94
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL----DQKKVLTEEEARRIFRQIATAVYY 151
P+++ + + R +M+L+ +Y G L L ++ E+ I A ++Y
Sbjct: 95 PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--LSTFC-GSPLYASPE 205
H I HRD+K NILLDEN KI DFG+S TE LST G+ Y PE
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 43/227 (18%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCK---IETEADLIRIRREIQIMSSVR 94
F LG+G +GKV G G VA+K +K+ + E + + E++++S
Sbjct: 32 FSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQ-----FQTEVEMISMAV 85
Query: 95 HPNIIHIYEV-FENREKMVLVMEYAAGGELYDFL----DQKKVLTEEEARRIFRQIATAV 149
H N++ + E++ LV Y A G + L + + L + +RI A +
Sbjct: 86 HRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 144
Query: 150 YYCHKH---KICHRDLKLENILLDENGNAKIADFGL--------SNVFTESRFLSTFCGS 198
Y H H KI HRD+K NILLDE A + DFGL ++V T T
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT--AVRGTIG-- 200
Query: 199 PLYASPEIVKGIPY--HG---PEVDCWSLGVLLYTLVYGAMPFDGSN 240
+ +PE Y G + D + GV+L L+ G FD +
Sbjct: 201 --HIAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-21
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 43 KLGQGNYGKVQLG-INKETGQEVAIKTIKKCKIETEADLIR-IRREIQIMSSVRHPNIIH 100
K+G+G +G V G +N VA+K + T +L + +EI++M+ +H N+
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL-- 92
Query: 101 IYEV------FENREKMVLVMEYAAGGELYDFL---DQKKVLTEEEARRIFRQIATAVYY 151
V + + LV Y G L D L D L+ +I + A + +
Sbjct: 93 ---VELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF 148
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-------SRFLSTFCGSPLYASP 204
H++ HRD+K NILLDE AKI+DFGL+ + SR + T Y +P
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT-A---YMAP 204
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS 239
E ++G P+ D +S GV+L ++ G D
Sbjct: 205 EALRGEIT--PKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-21
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 26/218 (11%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH- 95
R+ + RK+G G++G + LG + G+EVAIK + ++ E +I ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 64
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYD-FLDQKKVLTEEEARRIFRQIATAVYYCHK 154
I I + V+VME G L D F + + + + Q+ + + Y H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMEL-LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 155 HKICHRDLKLENILLDENGNAK---IADFGLSNVFTESRFLS--------TFCGSPLYAS 203
HRD+K +N L+ I DFGL+ + ++R G+ YAS
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVY---GAMPFDG 238
GI D SLG Y L+Y G++P+ G
Sbjct: 184 INTHLGIE-QSRRDDLESLG---YVLMYFNLGSLPWQG 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 89.2 bits (220), Expect = 3e-20
Identities = 35/198 (17%), Positives = 63/198 (31%), Gaps = 48/198 (24%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTI-----KKCKIETEADLIRIRREIQI 89
++ K+G+G +G+V I VAIK I + I EI I
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 90 MSSV---------RHPNIIHIYEVF------------------------------ENREK 110
+ R I + V ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILL 169
+ +V+E+ GG + + + K+ + A+ I Q+ ++ + HRDL N+LL
Sbjct: 137 LFIVLEFEFGGIDLEQM-RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 170 DENGNAKIADFGLSNVFT 187
+ K+ T
Sbjct: 196 KKTSLKKLHYTLNGKSST 213
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-H 95
+F + RK+G G++G++ LG N +T +EVAIK + ++ E +I ++
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRILQGG 62
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHK 154
I ++ + VLVM+ G L D + + L+ + + Q+ V + H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 155 HKICHRDLKLENILLDENGNAK---IADFGLSNVFTESRFLS--------TFCGSPLYAS 203
HRD+K +N L+ A I DFGL+ + ++ G+ YAS
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVY---GAMP 235
GI D SLG Y L+Y G++P
Sbjct: 182 VNTHLGIE-QSRRDDLESLG---YVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 30/221 (13%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-TEADLIRIRREIQIMSSVRH 95
F + +K+G GN+G+++LG N T + VAI K+E ++ ++ E + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAI------KLEPMKSRAPQLHLEYRFYKQLGS 63
Query: 96 -PNIIHIYEVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCH 153
I +Y + +V+E G L D D + + + I Q+ + + Y H
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 154 KHKICHRDLKLENILLDENGNAK-----IADFGLSNVFTESRFLS--------TFCGSPL 200
+ +RD+K EN L+ GN I DF L+ + + + G+
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLVY---GAMPFDG 238
Y S G D +LG + +Y G++P+ G
Sbjct: 183 YMSINTHLGKE-QSRRDDLEALG---HMFMYFLRGSLPWQG 219
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 45/217 (20%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH- 95
+ + R++G+G++G + G N Q+VAIK +D ++R E + +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGC 65
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHK 154
I ++Y + VLV++ G L D LD + + + +Q+ V H+
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 155 HKICHRDLKLENILLDENGNAK-----IADFGLSNVFTESRFLS--------TFCGSPLY 201
+ +RD+K +N L+ + + DFG+ + + G+ Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVY---GAMP 235
S G D +LG + +Y G++P
Sbjct: 185 MSINTHLGRE-QSRRDDLEALG---HVFMYFLRGSLP 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 41/232 (17%), Positives = 81/232 (34%), Gaps = 39/232 (16%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKK-----------CKIETEADLIRI 83
++ + +K+G G +G + L ++ A +K K
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 84 RREIQIMSSVRHPNIIHIY----EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEAR 139
++ + + I Y F+ R +VME G +L Q +
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER-LGIDLQKISGQNGTFKKSTVL 154
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKI--ADFGLSNVFTES-------- 189
++ ++ + Y H+++ H D+K N+LL ++ AD+GLS + +
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 190 RFLSTFCGSPLYASPEIVKGIPYH-GPEV----DCWSLG-VLLYTLVYGAMP 235
G+ + S + H G + D LG +L + G +P
Sbjct: 215 NPRKGHNGTIEFTS------LDAHKGVALSRRSDVEILGYCMLR-WLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-15
Identities = 43/232 (18%), Positives = 86/232 (37%), Gaps = 43/232 (18%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETG--------QEVAIKT-IKKCKIETEAD-LIR 82
K +++ + + N G + T Q+ ++K K ++ E + R
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR 98
Query: 83 IRREIQI-----MSSVRHPNIIHIYEVFENREKM-VLVMEYAAGGELYDFLDQ--KKVLT 134
+ +Q+ + S I +++K LV+ G L LD K VL+
Sbjct: 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-LGRSLQSALDVSPKHVLS 157
Query: 135 EEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKI--ADFGLSNVFTES--- 189
E ++ ++ A+ + H+++ H ++ ENI +D +++ A +G + + S
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 190 -----RFLSTFCGSPLYASPEIVKGIPYH-GPEV----DCWSLGVLLYTLVY 231
S G + S + H G D SLG Y ++
Sbjct: 218 VAYVEGSRSPHEGDLEFIS------MDLHKGCGPSRRSDLQSLG---YCMLK 260
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 33/230 (14%), Positives = 78/230 (33%), Gaps = 32/230 (13%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKK--------CKIETEADLI 81
+ + +GQG +G + L + + +K K A
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP 93
Query: 82 RIRREIQIMSSVRHPNIIHIY----EVFENREKMVLVMEYAAGGELYDFLD-QKKVLTEE 136
++ +++ + + + ++M+ G +L + K + +
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRK 152
Query: 137 EARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKI--ADFGLSNVFTES----- 189
++ +I + Y H+H+ H D+K N+LL+ ++ D+GL+ +
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 190 ---RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLG-VLLYTLVYGAMP 235
G+ + S + G+ D LG ++ + G +P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQ-WLTGHLP 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 124 YDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
K LT E Q+A + + K HRDL NILL E KI DFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 184 -NVFTESRFLSTFCGS-PL-YASPE-IVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDG 238
+++ + ++ PL + +PE I + + + D WS GVLL+ + GA P+ G
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPG 298
Query: 239 -SNFKRLVKQISNGDYFE-PKNQSTASPLIAE-ML---NINPSSRADISVICSH 286
+ +++ G P +P + + ML + PS R S + H
Sbjct: 299 VKIDEEFCRRLKEGTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 9e-11
Identities = 29/161 (18%), Positives = 65/161 (40%), Gaps = 17/161 (10%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLG-----INKETGQEVAIKTIKKCKIETEADLIRIRR 85
R +LK + + LG+G +G+V T + VA+K +K+ T ++ +
Sbjct: 21 RDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMS 74
Query: 86 EIQIMSSV-RHPNIIHIY-EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
E++I+ + H N++++ + +++++E+ G L +L K+ + R
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184
Y DLK + + ++ + F
Sbjct: 135 FRQGKDYVG----AIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 14/104 (13%)
Query: 82 RIRREIQIMSSVRHPNII--HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEAR 139
R RE + ++ V+ I +I++V + + ++M Y G D ++ + A
Sbjct: 385 RTAREARYLALVKDFGIPAPYIFDV--DLDNKRIMMSYINGKLAKDVIED----NLDIAY 438
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
+I + HK+ + H DL N + D + I DFGL
Sbjct: 439 KIGEIVGK----LHKNDVIHNDLTTSNFIFD--KDLYIIDFGLG 476
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 28/158 (17%), Positives = 53/158 (33%), Gaps = 28/158 (17%)
Query: 39 DIVRKLGQGNYGKVQLGINKETGQEVAIK----------TIKKCKIETEADLIRI----- 83
I + +G+G V +++ E +K +K+ + + +
Sbjct: 93 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151
Query: 84 RREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFR 143
R E + + ++ + +Y N ++ME ELY + E +
Sbjct: 152 RNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYR-------VRVENPDEVLD 200
Query: 144 QIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFG 181
I V + I H DL N+L+ I DF
Sbjct: 201 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 2e-04
Identities = 34/296 (11%), Positives = 81/296 (27%), Gaps = 114/296 (38%)
Query: 73 KIETEADLIRIRREIQ---------IMSSVRHPNIIHIYEVFENREKMVL------VMEY 117
K+ + +RR ++ ++ +V++ F K++L V ++
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW---NAFNLSCKILLTTRFKQVTDF 280
Query: 118 AAGGELYDFL--DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA 175
+ LT +E + + + +
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYL---------------------------DC 313
Query: 176 KIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMP 235
+ D P E++ P +++
Sbjct: 314 RPQDL------------------P----REVLTTNP-------------RRLSII-AESI 337
Query: 236 FDG---------SNFKRLVKQISNG-DYFEPKNQSTASPLIAEMLNINPSSRADIS--VI 283
DG N +L I + + EP + + L++ P S A I ++
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK----MFDRLSVFPPS-AHIPTILL 392
Query: 284 CSHWW----------IDKDHSVACLEEAEELANQTPVRL-DLLLSLAPSPSTDKIL 328
W+ ++K H + +E+ ++ + + + L L + L
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQ---PKESTISIPSIYLELKVKLENEYAL 445
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 335 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.45 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.99 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.74 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.51 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.36 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.2 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.05 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.68 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.14 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.75 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 86.2 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 82.89 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-63 Score=434.08 Aligned_cols=256 Identities=48% Similarity=0.827 Sum_probs=218.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999998765555566678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||+ +|+|.+++.+++++++..+..++.||+.||+|||++||+||||||+||+++.++++||+|||++............
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 999 6799999999999999999999999999999999999999999999999999999999999999887766666678
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp 274 (335)
+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+..++...+..+.... ...++++.++|++||+.||
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 251 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 251 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSG
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 899999999999998876789999999999999999999999999999888888776543 4467899999999999999
Q ss_pred CCCCCHHHHhcCCCcCCC
Q psy2306 275 SSRADISVICSHWWIDKD 292 (335)
Q Consensus 275 ~~Rps~~~ll~~~~~~~~ 292 (335)
++|||++|+++||||+..
T Consensus 252 ~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 252 LNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp GGSCCHHHHHHCHHHHTT
T ss_pred hHCcCHHHHHcCcccccC
Confidence 999999999999999754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-63 Score=439.50 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=234.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
-++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++++.++||||++++++|.+.+.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999864433344567889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC---cc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES---RF 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~---~~ 191 (335)
|||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++...... ..
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999999876432 23
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhc
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEML 270 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l 270 (335)
....+||+.|||||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+...... +...++++.+||++||
T Consensus 191 ~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL 269 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLL 269 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHS
T ss_pred ccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHc
Confidence 456789999999999998877 89999999999999999999999999999998888877653 4456789999999999
Q ss_pred ccCCCCCCCHHH------HhcCCCcCCCCc
Q psy2306 271 NINPSSRADISV------ICSHWWIDKDHS 294 (335)
Q Consensus 271 ~~dp~~Rps~~~------ll~~~~~~~~~~ 294 (335)
+.||++|||++| |++||||+...+
T Consensus 270 ~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 270 VLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred cCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 999999999988 589999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-62 Score=439.41 Aligned_cols=256 Identities=30% Similarity=0.591 Sum_probs=225.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 589999999999999999999999999999999987543 4456778999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 116 EYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
||++||+|.+++..+ ..+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 999999999999754 457999999999999999999999999999999999999999999999999998765432 23
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC--CCCCCCchHHHHHHhc
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF--EPKNQSTASPLIAEML 270 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l 270 (335)
...+||+.|||||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+..+... ....++++.+||.+||
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L 261 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 45689999999999998877 89999999999999999999999999999988888877653 3456789999999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 271 NINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
+.||.+|||++|+|+||||++..
T Consensus 262 ~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 262 KRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp CSSGGGSCCHHHHHTSHHHHTTG
T ss_pred cCChhHCcCHHHHhcCHHhhcCC
Confidence 99999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=434.79 Aligned_cols=259 Identities=26% Similarity=0.488 Sum_probs=231.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+.|++.++||+|+||+||+|.++.+|+.||+|++....... .+.+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457999999999999999999999999999999997644332 34578999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
|||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++...... ....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 999999999999976 46999999999999999999999999999999999999999999999999999876543 3455
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC----CCCCCchHHHHHHh
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE----PKNQSTASPLIAEM 269 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~ 269 (335)
..+||+.|||||++.+..+ +.++|||||||++|||++|..||.+.+..+....+....... ...++++.+||.+|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 7789999999999988887 999999999999999999999999999888888877653322 23577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCCcchhh
Q psy2306 270 LNINPSSRADISVICSHWWIDKDHSVACL 298 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 298 (335)
|+.||++|||++|+|+||||++...++.+
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~~~~p~~l 336 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAKAGPPASI 336 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCCCGGGT
T ss_pred cCCChhHCcCHHHHhcCHhhcCCCCCccc
Confidence 99999999999999999999977655443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=438.05 Aligned_cols=259 Identities=26% Similarity=0.484 Sum_probs=231.8
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+.|++.+.||+|+||.||+|.++.+|+.||+|++....... .+.+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998644332 34678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
||||+||+|.+++.. ..+++.++..++.||+.||+|||++||+||||||+|||++.+|++||+|||++...... ....
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 999999999999975 45999999999999999999999999999999999999999999999999999876543 3455
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCchHHHHHHh
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTASPLIAEM 269 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~ 269 (335)
..+||+.|||||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+...... ....++++.+||.+|
T Consensus 306 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 7789999999999998887 99999999999999999999999999988888887765332 234577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCCcchhh
Q psy2306 270 LNINPSSRADISVICSHWWIDKDHSVACL 298 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 298 (335)
|+.||.+|||++|+|+||||++....+++
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~~~~p~~l 413 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAKAGPPASI 413 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCCCGGGT
T ss_pred cCCChhHCcCHHHHhcCHHhcCCCCCccc
Confidence 99999999999999999999987665544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-60 Score=416.54 Aligned_cols=256 Identities=26% Similarity=0.495 Sum_probs=220.7
Q ss_pred hhccce-eEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe----
Q psy2306 33 KLKQRF-DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN---- 107 (335)
Q Consensus 33 ~~~~~y-~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 107 (335)
...++| ++.++||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+++.++||||++++++|.+
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 345566 788899999999999999999999999999986443 44556789999999999999999999999865
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEcc-CCCeEEeeccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLDE-NGNAKIADFGLSN 184 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~~-~~~~kL~df~~~~ 184 (335)
.+.+|+||||++||+|.+++.+.+++++..+..++.|++.||+|||++| |+||||||+|||++. ++.+||+|||++.
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 4568999999999999999999889999999999999999999999998 999999999999974 7899999999997
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhcCCCC---CCCCCC
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS-NFKRLVKQISNGDYF---EPKNQS 260 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~-~~~~~~~~~~~~~~~---~~~~~~ 260 (335)
.... ......+||+.|||||++.+ ++ +.++|||||||++|+|+||..||.+. +...+...+..+... +...++
T Consensus 181 ~~~~-~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 181 LKRA-SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred eCCC-CccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 6543 33456789999999999875 45 99999999999999999999999764 455666666655332 233466
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 89999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-61 Score=423.03 Aligned_cols=255 Identities=31% Similarity=0.545 Sum_probs=221.1
Q ss_pred cceeEEeeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
++|++.+.||+|+||+||+|++. .+++.||+|++....... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 47999999999999999999874 468899999997643222 12335778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-Ccc
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~ 191 (335)
+||||++||+|.+++.+.+++++.++..++.|++.||+|||++||+||||||+|||++.+|++||+|||++..... ...
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999976543 334
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhc
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEML 270 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l 270 (335)
....+||+.|||||++.+..+ +.++|||||||++|+|+||..||.+.+..++...+...... +...++++.+||++||
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 261 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 261 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence 456789999999999998887 89999999999999999999999999999988888877654 3446889999999999
Q ss_pred ccCCCCCCC-----HHHHhcCCCcCCC
Q psy2306 271 NINPSSRAD-----ISVICSHWWIDKD 292 (335)
Q Consensus 271 ~~dp~~Rps-----~~~ll~~~~~~~~ 292 (335)
+.||++||| ++|+++||||+..
T Consensus 262 ~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 262 KRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp CSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 999999998 4799999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=419.47 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=219.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+.|++.++||+|+||.||+|+++.+|+.||+|+++..... .+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999999864322 36899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-CeEEeeccccccccCCcc---
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-NAKIADFGLSNVFTESRF--- 191 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-~~kL~df~~~~~~~~~~~--- 191 (335)
||++||+|.+++++.+++++..+..++.|++.||+|||++||+||||||+|||++.+| ++||+|||++........
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999999999999888999999999999999999999999999999999999999887 699999999987654321
Q ss_pred ---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHH
Q psy2306 192 ---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASP 264 (335)
Q Consensus 192 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~ 264 (335)
....+||+.|||||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+..... .++..++++.+
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 288 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred eecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence 223579999999999998877 8999999999999999999999988776666666665543 34566789999
Q ss_pred HHHHhcccCCCCCCCHHHH-------------hcCCCcCCCCcc
Q psy2306 265 LIAEMLNINPSSRADISVI-------------CSHWWIDKDHSV 295 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~l-------------l~~~~~~~~~~~ 295 (335)
+|.+||+.||.+|||+.|+ |+|||+.+...+
T Consensus 289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 9999999999999999998 578998765443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=418.16 Aligned_cols=261 Identities=27% Similarity=0.466 Sum_probs=225.9
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-----
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN----- 107 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 107 (335)
.+.++|++.+.||+|+||+||+|+++.+|+.||+|++.... ......+.+.+|+.+|+.++||||+++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 35578999999999999999999999999999999997643 344556788899999999999999999999754
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 108 -REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 108 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
.+.+|+||||++ |+|.+++.+++++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 367899999995 689999998899999999999999999999999999999999999999999999999999999765
Q ss_pred cCC-----ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-------
Q psy2306 187 TES-----RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF------- 254 (335)
Q Consensus 187 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~------- 254 (335)
... ......+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+..+....+......
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 432 23446789999999999988777799999999999999999999999998887776665431100
Q ss_pred -------------------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 255 -------------------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 255 -------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.+..++++.+||.+||..||.+|||++|+|+||||++...+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 12346688999999999999999999999999999976544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=396.50 Aligned_cols=246 Identities=27% Similarity=0.432 Sum_probs=215.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.++|.+.+.||+|+||+||+|.+. .++..||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 358999999999999999999865 35788999999753 4556778999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhC-------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 110 KMVLVMEYAAGGELYDFLDQK-------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
..++||||+++|+|.+++.+. ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 999999999999999999753 3699999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCC
Q psy2306 177 IADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGD 252 (335)
Q Consensus 177 L~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 252 (335)
|+|||+++....... .....||+.|||||++.+..+ +.++||||||+++|||+| |..||.+.+..++...+..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999976544322 223568999999999998887 999999999999999998 899999999999888888765
Q ss_pred C--CCCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 253 Y--FEPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 253 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
. .+...++++.+++.+||+.||++|||+++|+
T Consensus 248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 3 3445678999999999999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=396.95 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=203.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE---- 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 109 (335)
+-++|++.+.||+|+||+||+|+++.+|+.||+|++.... .....+.+.+|+.+++.++||||++++++|.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 3457999999999999999999999999999999997633 4556678999999999999999999999997544
Q ss_pred --------eEEEEEecCCCCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEe
Q psy2306 110 --------KMVLVMEYAAGGELYDFLDQKKV---LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIA 178 (335)
Q Consensus 110 --------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~ 178 (335)
.+|++|||+++++|.+++..+.. .++..++.++.|+++||+|||++||+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999987654 4556788999999999999999999999999999999999999999
Q ss_pred eccccccccCCcc-------------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHH
Q psy2306 179 DFGLSNVFTESRF-------------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-KRL 244 (335)
Q Consensus 179 df~~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-~~~ 244 (335)
|||+++....... ....+||+.|||||++.+..+ +.++|||||||++|||++ ||..... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 9999987643221 234579999999999998877 999999999999999996 7765332 233
Q ss_pred HHHHhcCCCCC--CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 245 VKQISNGDYFE--PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 245 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
...+.....++ ....+.+.++|++||+.||.+|||+.|+++||||++..
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 34444433321 12244678899999999999999999999999998653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=393.85 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=211.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.++|.+.++||+|+||+||+|.+. .++..||+|+++. ......+.+.+|+.++++++||||++++++|.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC---CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 458999999999999999999865 3688999999975 34556778999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQK---------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
..++||||+++|+|.+++... .++++.++..++.|++.||+|||+.+|+||||||+|||++.++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 999999999999999999753 35999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy2306 175 AKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISN 250 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~ 250 (335)
+||+|||+++....... .....||+.|||||++.+..+ +.++||||||+++|||+| |..||...+..+....+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987643322 234678999999999998887 999999999999999998 8999999998888888876
Q ss_pred CCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 251 GDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 251 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+.. .+...++++.+++.+||+.||++|||+.||++
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 543 34456789999999999999999999999983
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=397.62 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=208.7
Q ss_pred hhccceeEEeeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeC
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENR 108 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 108 (335)
.+.++|++.+.||+|+||+||+|.++ .+++.||+|.+.... ....+.+|+.+++.+ +||||++++++|.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 57789999999999999999999875 457899999986532 234677899999988 599999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-CCeEEeecccccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-GNAKIADFGLSNVFT 187 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~-~~~kL~df~~~~~~~ 187 (335)
+++|+||||+++++|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999999984 48999999999999999999999999999999999999876 799999999997543
Q ss_pred CCc-----------------------------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy2306 188 ESR-----------------------------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG 238 (335)
Q Consensus 188 ~~~-----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~ 238 (335)
... .....+||+.|+|||++.+.+.++.++||||+||++|+|++|..||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 221 123457999999999998877669999999999999999999999954
Q ss_pred C-cHHHHHHHHhc--------------------------------------CC-----------------CCCCCCCCch
Q psy2306 239 S-NFKRLVKQISN--------------------------------------GD-----------------YFEPKNQSTA 262 (335)
Q Consensus 239 ~-~~~~~~~~~~~--------------------------------------~~-----------------~~~~~~~~~l 262 (335)
. +..+....+.. .. ......++++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 3 33222222110 00 0112346688
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+||++||+.||.+|+|++|+|+||||++.
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=417.51 Aligned_cols=259 Identities=30% Similarity=0.561 Sum_probs=234.8
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
.+-++|++.+.||+|+||.||+|+++.+|+.||+|++... .....+.+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3456899999999999999999999999999999999763 3445677889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC--CCeEEeeccccccccCC
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN--GNAKIADFGLSNVFTES 189 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~--~~~kL~df~~~~~~~~~ 189 (335)
++|||++||+|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999999999864 5679999999999999999999999999999999999999854 89999999999988777
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCCchHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQSTASP 264 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~ 264 (335)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....... ...++++.+
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred CceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 77777889999999999999887 899999999999999999999999999999988888765432 245778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
||++||+.||.+|||+.|+|+||||+.....
T Consensus 390 li~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 9999999999999999999999999976543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=389.40 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=217.0
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
..++++.++||+|+||+||+|... .+++.||+|.++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 357899999999999999999853 467889999987532 2334567999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQK----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG 173 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~ 173 (335)
..++||||+++|+|.+++..+ ..+++..+..++.|++.||+|||+++++||||||+|||++.++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 999999999999999999643 3589999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccCCc---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q psy2306 174 NAKIADFGLSNVFTESR---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQIS 249 (335)
Q Consensus 174 ~~kL~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 249 (335)
.+||+|||+++...... ......||+.|||||++.+..+ +.++||||||+++|||+| |..||.+.+..++...+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999997654322 2345678999999999988877 999999999999999998 899999999999988888
Q ss_pred cCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 250 NGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 250 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+.. .+...+.++.+++.+||+.||.+|||+.||+++
T Consensus 262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7654 344567799999999999999999999999854
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-55 Score=418.41 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=223.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc---CCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+... .........+.++.+++.++||||++++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 479999999999999999999999999999999975332 22223333445567778889999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++....... .
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-~ 347 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-P 347 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-C
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-C
Confidence 999999999999999998999999999999999999999999999999999999999999999999999998765443 3
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhcCCC-CCCCCCCchHHHHHH
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---NFKRLVKQISNGDY-FEPKNQSTASPLIAE 268 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---~~~~~~~~~~~~~~-~~~~~~~~l~~li~~ 268 (335)
...+||+.|||||++.+...++.++|||||||++|+|++|..||.+. +..++...+..... .+...++++.+||.+
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~ 427 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHH
Confidence 45789999999999976554599999999999999999999999753 44455555555443 445678899999999
Q ss_pred hcccCCCCCCC-----HHHHhcCCCcCCCCcc
Q psy2306 269 MLNINPSSRAD-----ISVICSHWWIDKDHSV 295 (335)
Q Consensus 269 ~l~~dp~~Rps-----~~~ll~~~~~~~~~~~ 295 (335)
||+.||.+|++ ++||++||||+...+.
T Consensus 428 lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 428 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp HTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred HccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence 99999999998 7999999999875443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=385.06 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=203.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+++++.+.||+|+||+||+|+... .||+|+++... ......+.+.+|+.++++++||||+++++++.+ +.+++|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 3588999999999999999997653 59999987543 345667889999999999999999999998754 568999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC---c
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES---R 190 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~---~ 190 (335)
|||+++|+|.+++.. ..++++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 999999999999975 467999999999999999999999999999999999999999999999999999775432 2
Q ss_pred cccccccCCccCChhhhcCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcCCC------CCCCCCCc
Q psy2306 191 FLSTFCGSPLYASPEIVKGIP--YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNGDY------FEPKNQST 261 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~------~~~~~~~~ 261 (335)
......||+.|||||++.+.. .++.++|||||||++|||+||..||.+.+.. .....+..+.. .....+++
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 234568999999999996432 2488999999999999999999999876544 44444443322 12345678
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 262 ASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+++.+||+.||.+|||+.||++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=382.19 Aligned_cols=261 Identities=45% Similarity=0.813 Sum_probs=238.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 355699999999999999999999999999999999986433 4556778899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+||||+++++|.+++..++++++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999877766666
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCchHHHHHHhcc
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTASPLIAEMLN 271 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~ 271 (335)
...+|++.|+|||++.+..+.+.++||||||+++|+|++|..||.+.+..+....+..+.... ...++++.+++++||+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLV 250 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCC
Confidence 777899999999999988876789999999999999999999999999999888888776543 3457799999999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 272 INPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
.||.+|||++|+++||||+....
T Consensus 251 ~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 251 LNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp SSTTTSCCHHHHTTCTTTTTTCT
T ss_pred CChhHCcCHHHHhcCHhhcCCCc
Confidence 99999999999999999986543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=377.26 Aligned_cols=261 Identities=38% Similarity=0.589 Sum_probs=234.7
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH---HHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE---ADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
..+.++|++.+.||+|+||.||+|.++.+|..||+|++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 4678899999999999999999999999999999999986443221 2346788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC----CeEEeeccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG----NAKIADFGLSN 184 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~----~~kL~df~~~~ 184 (335)
+..++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999999888899999999999999999999999999999999999998776 79999999998
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCC
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQ 259 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~ 259 (335)
............|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+....... ...+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred EcCCCCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 8766655566789999999999988776 899999999999999999999999999888888888765533 3457
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 260 STASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
..+.+||++||..||.+|||+.++++||||+...
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 7899999999999999999999999999998643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-53 Score=380.67 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=211.8
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCC-----CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC-CcccceeEEEEe-
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKET-----GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH-PNIIHIYEVFEN- 107 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~- 107 (335)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+.+.+|+.++.+++| |||++++++|.+
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 46899999999999999999987643 4679999987633 44556789999999999965 899999999965
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQK----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE 171 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~ 171 (335)
.+.+++|||||++|+|.++|+.. ..+++..+..++.|++.||+|||+++++||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 45789999999999999999752 34899999999999999999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc-HHHHHH
Q psy2306 172 NGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSN-FKRLVK 246 (335)
Q Consensus 172 ~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~-~~~~~~ 246 (335)
++.+||+|||+++....... .....||+.|||||++.+..+ +.++|||||||++|||+| |..||.+.+ .+.+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987643322 234678999999999998777 999999999999999998 999998755 344555
Q ss_pred HHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 247 QISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 247 ~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+..+.. .+...++++.+++.+||+.||.+|||+.+|++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5554432 344567799999999999999999999999976
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=373.34 Aligned_cols=258 Identities=34% Similarity=0.618 Sum_probs=230.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.++.+|+.||+|++.............+.+|..+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 58999999999999999999999999999999997643222334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~~ 194 (335)
||+++++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.+|++||+|||++.... .......
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~ 164 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999987643 3334456
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~d 273 (335)
.+|++.|+|||++.+..+ +.++|+||||+++|+|++|..||.+.+..+....+..... .+...++++.++|.+||+.|
T Consensus 165 ~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~d 243 (337)
T 1o6l_A 165 FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp CEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 789999999999988777 8999999999999999999999999988888877776654 34456789999999999999
Q ss_pred CCCCC-----CHHHHhcCCCcCCCCc
Q psy2306 274 PSSRA-----DISVICSHWWIDKDHS 294 (335)
Q Consensus 274 p~~Rp-----s~~~ll~~~~~~~~~~ 294 (335)
|.+|| +++++++||||+...+
T Consensus 244 P~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 244 PKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp TTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 99999 9999999999986543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=378.43 Aligned_cols=263 Identities=33% Similarity=0.586 Sum_probs=227.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCC
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENRE 109 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 109 (335)
...--++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 334456999999999999999999999999999999999864333444566788999999988 6999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-C
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-E 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~ 188 (335)
..|+||||+++++|.+++.....+++..++.++.||+.||+|||++|++||||||+||+++.++++||+|||++.... .
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999999999988889999999999999999999999999999999999999999999999999987543 2
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-CCCCchHHHHH
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-KNQSTASPLIA 267 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~ 267 (335)
.......+|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+.......+ ..+.++.++|+
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK 256 (353)
T ss_dssp --------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 333456689999999999987776 8999999999999999999999999999998888887765443 46779999999
Q ss_pred HhcccCCCCCCCH------HHHhcCCCcCCCCc
Q psy2306 268 EMLNINPSSRADI------SVICSHWWIDKDHS 294 (335)
Q Consensus 268 ~~l~~dp~~Rps~------~~ll~~~~~~~~~~ 294 (335)
+||+.||.+||++ +++++||||+...+
T Consensus 257 ~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp HHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred HHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 9999999999999 89999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=367.88 Aligned_cols=262 Identities=36% Similarity=0.609 Sum_probs=232.8
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC---HHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET---EADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
..+.++|++.+.||+|+||.||+|.+..+|..||+|++....... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 456789999999999999999999999999999999998643321 12356788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC----CeEEeeccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG----NAKIADFGLSN 184 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~----~~kL~df~~~~ 184 (335)
+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999999999888899999999999999999999999999999999999998877 89999999998
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCC
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQ 259 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~ 259 (335)
............|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+....... ...+
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ECCCCCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 7765555566779999999999988776 899999999999999999999999988887777776654432 3457
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 260 STASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
..+.++|++||+.||.+|||+.++|+||||+....
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 78999999999999999999999999999987643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=370.25 Aligned_cols=255 Identities=26% Similarity=0.483 Sum_probs=230.8
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
.+.++|++.+.||+|+||.||+|.+..+++.+++|.+... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 4678999999999999999999999999999999998742 234557889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc--CCCeEEeeccccccccCC
Q psy2306 113 LVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE--NGNAKIADFGLSNVFTES 189 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~--~~~~kL~df~~~~~~~~~ 189 (335)
++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.+||+|||.+......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999999999765 47999999999999999999999999999999999999987 789999999999887766
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-----CCCCchHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-----KNQSTASP 264 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~ 264 (335)
.......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+.......+ ..+.++.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 66666789999999999988766 8899999999999999999999999998888888877665432 46779999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
+|.+||+.||.+|||+.|+|+||||++.
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=363.66 Aligned_cols=267 Identities=28% Similarity=0.485 Sum_probs=231.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||+||+|.+..+|+.||+|.+....... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 5679999999999999999999999999999999997644333 4567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~ 192 (335)
||||+++++|.+++... .+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 99999999999999865 59999999999999999999999999999999999999999999999999987665432 33
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHHHHHH
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASPLIAE 268 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~ 268 (335)
....|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..... .+...+..+.++|.+
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred CCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 45678999999999998877 8999999999999999999999998877666555543322 233456689999999
Q ss_pred hcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHh
Q psy2306 269 MLNINPSSRADISVICSHWWIDKDHSVACLEEAEELA 305 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~ 305 (335)
||+.||.+|||++++++||||+..............+
T Consensus 253 ~l~~dp~~Rps~~ell~h~~~~~~~~~~~~~p~~~~~ 289 (297)
T 3fxz_A 253 CLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAA 289 (297)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCCGGGGHHHHHHH
T ss_pred HccCChhHCcCHHHHhhChhhcccCcccccchHHHHH
Confidence 9999999999999999999999877766655444433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=374.25 Aligned_cols=266 Identities=34% Similarity=0.586 Sum_probs=234.1
Q ss_pred CccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeE
Q psy2306 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103 (335)
Q Consensus 24 ~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 103 (335)
+.........+.++|++.+.||+|+||.||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||+++++
T Consensus 17 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~ 95 (362)
T 2bdw_A 17 SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHD 95 (362)
T ss_dssp -------CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceEeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 334455667788999999999999999999999999999999999986443 4455678899999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC---CeEEeec
Q psy2306 104 VFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG---NAKIADF 180 (335)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~---~~kL~df 180 (335)
++.+.+..++||||+++++|.+.+..+..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+||
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 9999999999999999999999998888899999999999999999999999999999999999997654 5999999
Q ss_pred cccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC----
Q psy2306 181 GLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP---- 256 (335)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 256 (335)
|++.............|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+..+....+
T Consensus 176 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 254 (362)
T 2bdw_A 176 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 254 (362)
T ss_dssp TTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG
T ss_pred CcceEecCCcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 99987766555566789999999999988776 8999999999999999999999999988888888877654332
Q ss_pred -CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 257 -KNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 257 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
..++++.++|.+||+.||.+|||+.++|+||||..
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 34678999999999999999999999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=366.34 Aligned_cols=256 Identities=32% Similarity=0.592 Sum_probs=229.6
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 58999999999999999999999999999999997643222234567789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.+|++||+|||++...... ....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~ 163 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTL 163 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCC
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--cccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999765443 3456
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp 274 (335)
+|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+..+....+..... .+...+.++.++|.+||+.||
T Consensus 164 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp 242 (318)
T 1fot_A 164 CGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 242 (318)
T ss_dssp CSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCT
T ss_pred cCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCH
Confidence 78999999999988776 8999999999999999999999999888888777776654 344567899999999999999
Q ss_pred CCCC-----CHHHHhcCCCcCCCCc
Q psy2306 275 SSRA-----DISVICSHWWIDKDHS 294 (335)
Q Consensus 275 ~~Rp-----s~~~ll~~~~~~~~~~ 294 (335)
.+|| +++++++||||+...+
T Consensus 243 ~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 243 SQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp TTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HHcCCCcCCCHHHHhcCccccCCCH
Confidence 9999 9999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=378.71 Aligned_cols=261 Identities=43% Similarity=0.775 Sum_probs=228.1
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34567999999999999999999999999999999998753322223345788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
++||||+ +++|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9999999 679999998888899999999999999999999999999999999999999999999999999988776666
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhc
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEML 270 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l 270 (335)
....+|++.|+|||++.+..+.+.++||||||+++|+|++|..||...........+..... .+...++++.++|++||
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTS
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHc
Confidence 66778999999999998877767899999999999999999999987665544444444333 23345778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 271 NINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
+.||.+|||++|+++||||+...
T Consensus 244 ~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 244 VADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp CSSGGGSCCHHHHTTCHHHHTTC
T ss_pred CCChhHCcCHHHHHhChhhccCC
Confidence 99999999999999999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=356.03 Aligned_cols=263 Identities=34% Similarity=0.592 Sum_probs=235.9
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
.+.++|++.+.||+|+||.||+|.+..+|..|++|++..... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 578899999999999999999999999999999999976443 4455678889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC---eEEeeccccccccCC
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN---AKIADFGLSNVFTES 189 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~---~kL~df~~~~~~~~~ 189 (335)
++|||+++++|.+.+..+..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999999999988888999999999999999999999999999999999999986655 999999999877766
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCCchHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQSTASP 264 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~ 264 (335)
.......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+....... ...++++.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred ccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 65566788999999999988877 899999999999999999999999998888888777665422 245678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCCcchh
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVAC 297 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 297 (335)
++.+||+.||.+|||+.++++||||+.......
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRERVAS 273 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence 999999999999999999999999987655543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=378.68 Aligned_cols=260 Identities=33% Similarity=0.570 Sum_probs=230.6
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
+..+.++|++.+.||+|+||+||+|.+..+|+.+++|++..... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 45688899999999999999999999999999999999986443 34456778999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc---cCCCeEEeecccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD---ENGNAKIADFGLSNVFT 187 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~---~~~~~kL~df~~~~~~~ 187 (335)
.++||||+++++|.+.+..++.+++..+..++.||+.||.|||+.|++||||||+||+++ .++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999999888999999999999999999999999999999999999998 45789999999997765
Q ss_pred CCc-cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCCc
Q psy2306 188 ESR-FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQST 261 (335)
Q Consensus 188 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 261 (335)
... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+..+.... ...+++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 433 2345679999999999988777 899999999999999999999999999888888888765432 245778
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 262 ASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
+.++|.+||+.||.+|||+.|+|+||||+..
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999743
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=366.13 Aligned_cols=258 Identities=32% Similarity=0.561 Sum_probs=227.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 114 (335)
++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|..+++.+ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5899999999999999999999999999999999876666677778889999999888 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCcccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~~~ 193 (335)
|||+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++++||+|||++.... ......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~ 168 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCccc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999997643 333345
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC---------CcHHHHHHHHhcCCC-CCCCCCCchH
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG---------SNFKRLVKQISNGDY-FEPKNQSTAS 263 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~---------~~~~~~~~~~~~~~~-~~~~~~~~l~ 263 (335)
..+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.. .........+..... .+...+.++.
T Consensus 169 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 247 (345)
T 3a8x_A 169 TFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 6689999999999998777 8999999999999999999999965 233444555554443 3445678999
Q ss_pred HHHHHhcccCCCCCCCH------HHHhcCCCcCCCCc
Q psy2306 264 PLIAEMLNINPSSRADI------SVICSHWWIDKDHS 294 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~------~~ll~~~~~~~~~~ 294 (335)
++|++||+.||.+||++ +++++||||+...+
T Consensus 248 ~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp HHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred HHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 99999999999999995 89999999986543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=370.87 Aligned_cols=260 Identities=33% Similarity=0.523 Sum_probs=229.5
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 112 (335)
-.++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 446999999999999999999999999999999999864322223455677888888876 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCcc
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~ 191 (335)
+||||+++++|.+++.....+++..++.++.|++.||+|||++|++||||||+||+++.+|++||+|||++.... ....
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987643 2333
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhc
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEML 270 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l 270 (335)
....+|++.|+|||++.+..+ +.++|+||||+++|+|++|..||.+.+..+....+...... +...+.++.++|.+||
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 253 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred ccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHh
Confidence 456789999999999988776 89999999999999999999999999988888888776543 3446779999999999
Q ss_pred ccCCCCCCCHH-HHhcCCCcCCCCc
Q psy2306 271 NINPSSRADIS-VICSHWWIDKDHS 294 (335)
Q Consensus 271 ~~dp~~Rps~~-~ll~~~~~~~~~~ 294 (335)
+.||.+||++. ++++||||+...+
T Consensus 254 ~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 254 VREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp CSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred cCCHhHcCCChHHHHcCccccCCCH
Confidence 99999999998 9999999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=373.84 Aligned_cols=259 Identities=32% Similarity=0.554 Sum_probs=224.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 113 (335)
-++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35899999999999999999999999999999999876555555566788899999877 79999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc-cCCccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~-~~~~~~ 192 (335)
||||+++++|..++.+...+++..++.++.||+.||+|||++||+||||||+||+++.++++||+|||++... ......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 210 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999763 334445
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------cHHHHHHHHhcCCC-CCCCCCCch
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---------NFKRLVKQISNGDY-FEPKNQSTA 262 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---------~~~~~~~~~~~~~~-~~~~~~~~l 262 (335)
...+|++.|+|||++.+..+ +.++||||||+++|+|++|..||... ....+.+.+..... .+...+.++
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 289 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred ccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHH
Confidence 56789999999999998877 89999999999999999999999532 23345555555443 445567899
Q ss_pred HHHHHHhcccCCCCCCCH------HHHhcCCCcCCCCc
Q psy2306 263 SPLIAEMLNINPSSRADI------SVICSHWWIDKDHS 294 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~------~~ll~~~~~~~~~~ 294 (335)
.++|++||+.||.+||++ ++|++||||+...+
T Consensus 290 ~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp HHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred HHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 999999999999999985 79999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=369.23 Aligned_cols=258 Identities=29% Similarity=0.518 Sum_probs=231.8
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
.-++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|..+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 44699999999999999999999999999999999976433233345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++++||+|||++...... ..
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~ 196 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TW 196 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BC
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--cc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999876543 23
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhccc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNI 272 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~ 272 (335)
...|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..+... +...+.++.++|++||+.
T Consensus 197 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~ 275 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred cccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 5678999999999988776 89999999999999999999999999988888888776543 445688999999999999
Q ss_pred CCCCCCC-----HHHHhcCCCcCCCCc
Q psy2306 273 NPSSRAD-----ISVICSHWWIDKDHS 294 (335)
Q Consensus 273 dp~~Rps-----~~~ll~~~~~~~~~~ 294 (335)
||.+||+ +++|++||||+...+
T Consensus 276 dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 276 DLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred CHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 9999998 999999999986544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=385.22 Aligned_cols=262 Identities=44% Similarity=0.808 Sum_probs=236.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
+....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 44556799999999999999999999999999999999976432223345678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
.++||||+++++|.+++..++.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998876665
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-CCCCchHHHHHHh
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-KNQSTASPLIAEM 269 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~ 269 (335)
.....+|++.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+..+....+ ..++++.++|++|
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 250 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHM 250 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHH
Confidence 566678999999999999887767899999999999999999999999888888888877765433 4677999999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCC
Q psy2306 270 LNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
|+.||.+|||+.++++||||++.
T Consensus 251 L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 251 LQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TCSSTTTSCCHHHHHTCHHHHTT
T ss_pred cCCCchhCcCHHHHHhCHHhhhc
Confidence 99999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=355.88 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=216.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 589999999999999999999999999999999986442 3344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~~ 194 (335)
||++++.+..+...++.+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.+...... .....
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 99976444444444678999999999999999999999999999999999999999999999999999776533 23345
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHhcC--C-------------------
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMP-FDGSNFKRLVKQISNG--D------------------- 252 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p-~~~~~~~~~~~~~~~~--~------------------- 252 (335)
..+++.|+|||++.+...++.++||||||+++|+|++|..| |...+..+....+... .
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 67899999999998877569999999999999999988777 5556655555544321 0
Q ss_pred ---------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 253 ---------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 253 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
...+..+.++.++|++||+.||.+|||++|+++||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 01123456789999999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=370.00 Aligned_cols=262 Identities=32% Similarity=0.537 Sum_probs=222.9
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHH-HHcCCCCcccceeEEEEeCCeE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI-MSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+..|... ++.++||||+++++++.+.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 344689999999999999999999999999999999987655444455566667666 4678999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCc
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~ 190 (335)
|+||||++|++|.+++.+...+++..++.++.||+.||+|||++|++||||||+||+++.+|++||+|||++.... ...
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999997643 333
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHh
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEM 269 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~ 269 (335)
.....+|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+..+....+..... .+...+.++.++|++|
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~l 273 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 273 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHH
T ss_pred ccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Confidence 4456789999999999988776 8999999999999999999999999998888888776654 3455778999999999
Q ss_pred cccCCCCCCCH----HHHhcCCCcCCCCcc
Q psy2306 270 LNINPSSRADI----SVICSHWWIDKDHSV 295 (335)
Q Consensus 270 l~~dp~~Rps~----~~ll~~~~~~~~~~~ 295 (335)
|+.||.+||++ .++++||||+...+.
T Consensus 274 L~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp TCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred cccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 99999999987 699999999875443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=368.56 Aligned_cols=260 Identities=30% Similarity=0.505 Sum_probs=229.8
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 112 (335)
-.++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 346899999999999999999999999999999999864322233456778899999888 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCcc
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~ 191 (335)
+||||++|++|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.+|++||+|||++.... ....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 999999999999999988889999999999999999999999999999999999999999999999999997643 2333
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhc
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEML 270 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l 270 (335)
....+|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..++...+...... +...+.++.++|++||
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 256 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 256 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 456789999999999988777 89999999999999999999999999988888888776543 4456789999999999
Q ss_pred ccCCCCCCC-----HHHHhcCCCcCCCCc
Q psy2306 271 NINPSSRAD-----ISVICSHWWIDKDHS 294 (335)
Q Consensus 271 ~~dp~~Rps-----~~~ll~~~~~~~~~~ 294 (335)
+.||.+||+ +++|++||||+...+
T Consensus 257 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 257 TKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp CSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred hcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 999999994 699999999986533
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=370.14 Aligned_cols=259 Identities=31% Similarity=0.544 Sum_probs=229.6
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
..+.++|++.+.||+|+||.||+|.+..+|+.|++|++... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 34667999999999999999999999999999999998753 234456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc--CCCeEEeeccccccccC
Q psy2306 112 VLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE--NGNAKIADFGLSNVFTE 188 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~--~~~~kL~df~~~~~~~~ 188 (335)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++. .+.+||+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999999999764 37999999999999999999999999999999999999974 46899999999988766
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-----CCCCCCchH
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-----EPKNQSTAS 263 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~ 263 (335)
........|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+...... ....++++.
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 655566789999999999988776 88999999999999999999999998887777777665432 224577899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
++|.+||+.||.+|||+.++|+||||+....
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999999999999999999986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=368.93 Aligned_cols=258 Identities=36% Similarity=0.635 Sum_probs=213.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||+||+|.+..+++.||+|++....... +.+.+|+..++.++||||+++++++.+.+..++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4569999999999999999999999999999999997643322 357789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC--eEEeeccccccccCCcc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN--AKIADFGLSNVFTESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~--~kL~df~~~~~~~~~~~ 191 (335)
||||+++++|.+++...+++++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++........
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 9999999999999988888999999999999999999999999999999999999987665 99999999876554444
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcCCCCCC---CCCCchHH
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS----NFKRLVKQISNGDYFEP---KNQSTASP 264 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~----~~~~~~~~~~~~~~~~~---~~~~~l~~ 264 (335)
.....|++.|+|||++.+..+.+.++||||||+++|+|++|..||... ........+.......+ ..++++.+
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 253 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence 556679999999999988877555699999999999999999999764 34455555555443222 35778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
+|.+||+.||.+|||+.++++||||.+....
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 284 (361)
T 3uc3_A 254 LISRIFVADPATRISIPEIKTHSWFLKNLPA 284 (361)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred HHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence 9999999999999999999999999765443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=370.18 Aligned_cols=262 Identities=27% Similarity=0.485 Sum_probs=229.8
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34699999999999999999999999999999999976433333445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
||||+.+++|.+++..+..+++..++.++.|++.||.|||+.|++||||||+||+++.+|+++|+|||++..........
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 172 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCcee
Confidence 99999999999999988899999999999999999999999999999999999999999999999999998877666667
Q ss_pred ccccCCccCChhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHhcCCC-CCCCCCCchHHHHH
Q psy2306 194 TFCGSPLYASPEIVKGI--PYHGPEVDCWSLGVLLYTLVYGAMPFDG---SNFKRLVKQISNGDY-FEPKNQSTASPLIA 267 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~tg~~p~~~---~~~~~~~~~~~~~~~-~~~~~~~~l~~li~ 267 (335)
..+|++.|+|||++... ..++.++||||||+++|+|++|..||.. ....+....+..... .+...+.++.++|.
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~ 252 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLK 252 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHH
Confidence 78899999999998643 2248899999999999999999999964 344555555554433 44567889999999
Q ss_pred HhcccCCCCCCC-HHHHhcCCCcCCCCcc
Q psy2306 268 EMLNINPSSRAD-ISVICSHWWIDKDHSV 295 (335)
Q Consensus 268 ~~l~~dp~~Rps-~~~ll~~~~~~~~~~~ 295 (335)
+||+.||.+||+ ++++++||||+...+.
T Consensus 253 ~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 253 KLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp HHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred HHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 999999999998 8999999999876443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=359.21 Aligned_cols=263 Identities=37% Similarity=0.576 Sum_probs=234.4
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH---HHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE---ADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
..+.++|++.+.||+|+||.||+|.+..+|+.|++|.+........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4577899999999999999999999999999999999986443221 1356788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC----CeEEeeccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG----NAKIADFGLSN 184 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~----~~kL~df~~~~ 184 (335)
+..+++|||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999999888899999999999999999999999999999999999999887 79999999998
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCC
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQ 259 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~ 259 (335)
............|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+....... ...+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred ecCccccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 7766555566678999999999988776 899999999999999999999999988888888777665432 3457
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 260 STASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
..+.++|.+||+.||.+|||+.++++||||......
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence 789999999999999999999999999999875443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=352.07 Aligned_cols=257 Identities=37% Similarity=0.711 Sum_probs=231.2
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
...+.++|++.+.||+|+||.||+|.+..++..+++|.+...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 346788999999999999999999999999999999999864332 24578899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE---ccCCCeEEeecccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFT 187 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili---~~~~~~kL~df~~~~~~~ 187 (335)
.+++|||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999888889999999999999999999999999999999999999 778899999999998776
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-----CCCCch
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-----KNQSTA 262 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~l 262 (335)
.........+++.|+|||++.+. + +.++||||||+++|+|++|..||...+..+....+.......+ ..++.+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred CccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 66666677899999999998764 4 8999999999999999999999999988888888877765443 467899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.++|.+||+.||.+|||+.++++||||++.
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=356.87 Aligned_cols=264 Identities=44% Similarity=0.784 Sum_probs=224.9
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
+....++|++.+.||+|+||.||+|.+..+|+.|++|.+...........+.+.+|+..++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 44566799999999999999999999999999999999876332223345678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
.+++|||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998776555
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHh
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEM 269 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~ 269 (335)
......+++.|+|||.+.+..+.+.++||||||+++|+|++|..||...+.......+...... +...+..+.+++.+|
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 245 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHM 245 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHH
Confidence 4556678999999999988776578999999999999999999999998888888777766543 344577999999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 270 LNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
|+.||.+|||++++++||||++...
T Consensus 246 l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 246 LQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp TCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred ccCChhhCCCHHHHHhChhhccCch
Confidence 9999999999999999999987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=361.22 Aligned_cols=266 Identities=27% Similarity=0.449 Sum_probs=216.0
Q ss_pred CccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeE
Q psy2306 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103 (335)
Q Consensus 24 ~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 103 (335)
+...+...+.+.++|++.+.||+|+||+||+|.+. +|+.||+|++.... ........+.+|+.+++.++||||+++++
T Consensus 9 ~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 86 (311)
T 3niz_A 9 SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLID 86 (311)
T ss_dssp ------CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeee
Confidence 33444567789999999999999999999999986 48999999987532 23334567889999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 104 VFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
++.+.+..++||||+++ +|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 87 VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp EECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcC
Confidence 99999999999999975 78777765 44599999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---C-CC----
Q psy2306 183 SNVFTES-RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---G-DY---- 253 (335)
Q Consensus 183 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---~-~~---- 253 (335)
+...... .......+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+.. . ..
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 9876533 2334557899999999998766559999999999999999999999987655444333322 0 00
Q ss_pred -----------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 -----------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
..+..++++.++|.+||+.||.+|||++|+|+||||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 012245678899999999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=360.55 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=192.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE---- 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 109 (335)
+.++|.+.+.||+|+||+||+|.+ +|+.||+|++.... ........|+..+..++||||+++++++.+.+
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 356899999999999999999987 48899999986521 11222334566667789999999999997654
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC--------CcEecCCCCCCEEEccCCCeEEeecc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH--------KICHRDLKLENILLDENGNAKIADFG 181 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~--------givH~di~p~nili~~~~~~kL~df~ 181 (335)
.+|+||||+++|+|.++++.. ++++..+..++.|++.||+|||++ ||+||||||+|||++.++++||+|||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 689999999999999999864 589999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCcc-----ccccccCCccCChhhhcCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCC-------------
Q psy2306 182 LSNVFTESRF-----LSTFCGSPLYASPEIVKGIP-----YHGPEVDCWSLGVLLYTLVYGAMPFDG------------- 238 (335)
Q Consensus 182 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~-----~~~~~~Dv~slG~~l~~l~tg~~p~~~------------- 238 (335)
++........ .....||+.|||||++.+.. .++.++|||||||++|||+||..||..
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 9977654322 22457999999999997642 126789999999999999999766532
Q ss_pred --CcHHHHHHHHhcCCCCCCCCC---------CchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 239 --SNFKRLVKQISNGDYFEPKNQ---------STASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 239 --~~~~~~~~~~~~~~~~~~~~~---------~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
...+.+...+...... +..+ ..+.+++.+||+.||.+|||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~r-p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHTTSCCC-CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHhcccCC-CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1334454444443322 2221 25778999999999999999999984
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=361.78 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=217.6
Q ss_pred CCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHc-CCCCccc
Q psy2306 21 STGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS-VRHPNII 99 (335)
Q Consensus 21 ~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~ 99 (335)
.+.++.+..++..+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... .........|+..+.. .+|+||+
T Consensus 42 ~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv 120 (311)
T 3p1a_A 42 QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCV 120 (311)
T ss_dssp CCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEE
Confidence 4567778888899999999999999999999999999999999999998654333 3333444455555544 4899999
Q ss_pred ceeEEEEeCCeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEe
Q psy2306 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIA 178 (335)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~ 178 (335)
++++++.+.+..++|||++ +++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+
T Consensus 121 ~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 121 RLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEEC
T ss_pred EEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEc
Confidence 9999999999999999999 6688888765 4569999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CC
Q psy2306 179 DFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FE 255 (335)
Q Consensus 179 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~ 255 (335)
|||++.............|++.|+|||++.+ .+ +.++||||||+++|+|++|..|+...... ..+..... ..
T Consensus 200 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~ 274 (311)
T 3p1a_A 200 DFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFT 274 (311)
T ss_dssp CCTTCEECC------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHH
T ss_pred cceeeeecccCCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccc
Confidence 9999987766555556678999999999886 44 89999999999999999997776543322 22222221 23
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
...++++.++|.+||+.||.+|||++++++||||++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 446779999999999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=366.84 Aligned_cols=265 Identities=30% Similarity=0.571 Sum_probs=222.2
Q ss_pred cchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC--CHHHHHHHHHHHHHHHcCCCCcccceeE
Q psy2306 26 RLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE--TEADLIRIRREIQIMSSVRHPNIIHIYE 103 (335)
Q Consensus 26 ~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 103 (335)
.+......+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+++.++||||+++++
T Consensus 14 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp ------CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCCCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 34445667888999999999999999999999999999999998742211 1113467889999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC---eE
Q psy2306 104 VFENREKMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN---AK 176 (335)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~---~k 176 (335)
++.+.+..++||||+++++|.+.+.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++. +|
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEE
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEE
Confidence 99999999999999999999887754 335899999999999999999999999999999999999987654 99
Q ss_pred EeeccccccccCCcc-ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC
Q psy2306 177 IADFGLSNVFTESRF-LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE 255 (335)
Q Consensus 177 L~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 255 (335)
|+|||++........ .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.... .+....+.......
T Consensus 174 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 174 LGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp ECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred EecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 999999977655433 345678999999999988777 899999999999999999999998764 34455554444322
Q ss_pred -----CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 256 -----PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 256 -----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
...+.++.++|++||+.||.+|||+.++|+||||+..
T Consensus 252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 3457789999999999999999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=356.67 Aligned_cols=261 Identities=28% Similarity=0.481 Sum_probs=217.8
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
-++|++.+.||+|+||+||+|.+..+|+.|++|.+.... ......+.+.+|+..++.++||||+++++++.+.+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999987643 3445567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
|||+++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 999999999999988888999999999999999999999999999999999999999999999999999776533 2334
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---------------------C
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---------------------D 252 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---------------------~ 252 (335)
...+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+... .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 5678999999999987555599999999999999999999999888766554443221 0
Q ss_pred CC-----------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 253 YF-----------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 253 ~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
.. .+..+.++.+++.+||+.||.+|||++++++||||+......
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 00 123466789999999999999999999999999999765443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=364.36 Aligned_cols=268 Identities=34% Similarity=0.561 Sum_probs=233.3
Q ss_pred CccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-----CHHHHHHHHHHHHHHHcC-CCCc
Q psy2306 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-----TEADLIRIRREIQIMSSV-RHPN 97 (335)
Q Consensus 24 ~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~~~~ 97 (335)
+.........+.++|++.+.||+|++|.||+|.+..+|+.||+|++...... .....+.+.+|+.+++.+ +|||
T Consensus 82 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 161 (365)
T 2y7j_A 82 ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161 (365)
T ss_dssp CBCHHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hcccchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3344445677888999999999999999999999999999999998764311 123356778999999999 7999
Q ss_pred ccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEE
Q psy2306 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKI 177 (335)
Q Consensus 98 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL 177 (335)
|+++++++...+..++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|
T Consensus 162 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp BCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred EeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999998888999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCccccccccCCccCChhhhcCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC
Q psy2306 178 ADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI-----PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD 252 (335)
Q Consensus 178 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~ 252 (335)
+|||++.............|++.|+|||++.+. ..++.++||||||+++|+|++|..||...+.......+....
T Consensus 242 ~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 242 SDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321 (365)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred EecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 999999877666556667899999999998632 224889999999999999999999999888877777776655
Q ss_pred CCC-----CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 253 YFE-----PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 253 ~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
... ...+..+.++|.+||+.||.+|||++++++||||++
T Consensus 322 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 322 YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 432 245668999999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=352.80 Aligned_cols=264 Identities=29% Similarity=0.485 Sum_probs=235.8
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
+....++|++.+.||+|+||.||+|.+..+++.+++|++...........+.+.+|+..++.++|+||+++++++.+.+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 89 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 89 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence 34566799999999999999999999999999999999987655566777889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES- 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~- 189 (335)
.+++|||+++++|.+++.....+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999999776432
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAE 268 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~ 268 (335)
.......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+..... .+...+..+.+++.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 22344568999999999988776 8999999999999999999999999888777777766554 344567789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 269 MLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
||+.||.+|||++++++||||......
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HcccChhhCcCHHHHhhChheecCCcC
Confidence 999999999999999999999866443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=361.64 Aligned_cols=258 Identities=34% Similarity=0.602 Sum_probs=219.1
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 56799999999999999999999999999999999875332 2234567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC---c
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES---R 190 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~---~ 190 (335)
+|||+++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++...... .
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999765322 2
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcC-CCC--CCCCCCchHHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNG-DYF--EPKNQSTASPLI 266 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~-~~~--~~~~~~~l~~li 266 (335)
......|++.|+|||++.+..+++.++||||||+++|+|++|..||...... ......... ... ....+..+.++|
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 2345678999999999988777678999999999999999999999765432 222222222 221 134577899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.+||+.||.+|||+.|+++||||++..
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999998643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=382.77 Aligned_cols=262 Identities=39% Similarity=0.658 Sum_probs=236.1
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
.....+.++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK 98 (484)
T ss_dssp CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34556888999999999999999999999999999999999875544445567889999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE---ccCCCeEEeecccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNV 185 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili---~~~~~~kL~df~~~~~ 185 (335)
+..++|+||+.+++|.+.+..+..+++..++.++.|++.||.|||++|++||||||+||++ +.++.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999999999988899999999999999999999999999999999999999 4678999999999987
Q ss_pred ccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCC
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQS 260 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~ 260 (335)
...........|++.|+|||++.+ .+ +.++||||||+++|+|++|..||...+..+....+..+.... ...++
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred cccccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 776666667789999999999977 44 899999999999999999999999999988888888775432 23567
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
++.++|++||+.||.+|||+.++|+||||+..
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 89999999999999999999999999999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=354.62 Aligned_cols=257 Identities=35% Similarity=0.621 Sum_probs=225.8
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
-++|++.+.||+|+||.||+|.+..++..|++|++.............+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 45899999999999999999999999999999998764333334456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
|||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~ 166 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTD 166 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-ccc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999886544332 345
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~d 273 (335)
..+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..+....+...... +...+..+.++|.+||+.|
T Consensus 167 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 245 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245 (279)
T ss_dssp -CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSS
T ss_pred cCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccC
Confidence 578999999999988776 88999999999999999999999999988888777766543 3446778999999999999
Q ss_pred CCCCCCHHHHhcCCCcCCCC
Q psy2306 274 PSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 274 p~~Rps~~~ll~~~~~~~~~ 293 (335)
|.+|||++++++||||+...
T Consensus 246 p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 246 PSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp GGGSCCHHHHHHCHHHHHHC
T ss_pred hhhCCCHHHHhhCccccCCc
Confidence 99999999999999998543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=377.48 Aligned_cols=258 Identities=33% Similarity=0.611 Sum_probs=220.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 44689999999999999999999999999999999986443344455677889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeecccccccc-CCcc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~ 191 (335)
||||+++++|.+++.....+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.... ....
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence 99999999999999988889999999999999999999998 999999999999999999999999999987643 2333
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhc
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEML 270 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l 270 (335)
.....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..... .+...++++.++|.+||
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 384 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 456789999999999988777 9999999999999999999999999998888887776654 34456789999999999
Q ss_pred ccCCCCCC-----CHHHHhcCCCcCCC
Q psy2306 271 NINPSSRA-----DISVICSHWWIDKD 292 (335)
Q Consensus 271 ~~dp~~Rp-----s~~~ll~~~~~~~~ 292 (335)
+.||.+|| +++++++||||+..
T Consensus 385 ~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 385 KKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999 99999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=352.04 Aligned_cols=256 Identities=33% Similarity=0.591 Sum_probs=219.0
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
..+.++|++.+.||+|+||.||+|.+..++..+++|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 4677899999999999999999999999999999999986432 22356788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE---ccCCCeEEeeccccc
Q psy2306 112 VLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSN 184 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili---~~~~~~kL~df~~~~ 184 (335)
++||||+++++|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999998854 4679999999999999999999999999999999999999 445789999999998
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC----CCCCC
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE----PKNQS 260 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~ 260 (335)
............+++.|+|||++.+ .+ +.++||||||+++|+|++|..||...+..+............ ...++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP 253 (285)
T ss_dssp C----------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred ecCCcccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence 7766555566778999999999864 44 889999999999999999999999988887777666543322 23567
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
++.+++.+||+.||.+|||+.|+|+||||++
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 8999999999999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=362.45 Aligned_cols=258 Identities=35% Similarity=0.610 Sum_probs=210.1
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 122 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence 4567889999999999999999999999999999999987532 23467789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CCCeEEeecccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NGNAKIADFGLSNVFT 187 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~~~kL~df~~~~~~~ 187 (335)
.+++|||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.+||+|||++....
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999999999998888999999999999999999999999999999999999975 7899999999998776
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcCCCCC-----CCCCCc
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNGDYFE-----PKNQST 261 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~-----~~~~~~ 261 (335)
.........|++.|+|||++.+..+ +.++||||||+++|+|++|..||...... .....+....... ...+.+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp ----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred cccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 5555556778999999999988776 89999999999999999999999765543 3555555543321 345678
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 262 ASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
+.++|++||+.||.+|||+.++++||||.....
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 999999999999999999999999999986544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=358.44 Aligned_cols=265 Identities=29% Similarity=0.486 Sum_probs=236.5
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
.....++|++.+.||+|+||.||++.+..+++.|++|++...........+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 115 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence 34566799999999999999999999999999999999987655566777889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES- 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~- 189 (335)
.+++|||+++++|.+++..+..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999999776432
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAE 268 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~ 268 (335)
.......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+..... .+...+..+.++|++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 22345678999999999988776 8999999999999999999999999887777666665544 344567789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 269 MLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
||+.||.+|||++++++||||.......
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999998765543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=356.51 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=212.8
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC--CHHHHHHHHHHHHHHHcC---CCCcccceeEEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE--TEADLIRIRREIQIMSSV---RHPNIIHIYEVF 105 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~ 105 (335)
+..+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+..++.+ +||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 456788999999999999999999999999999999998743211 111122444566666555 599999999999
Q ss_pred EeCC-----eEEEEEecCCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEe
Q psy2306 106 ENRE-----KMVLVMEYAAGGELYDFLDQKKV--LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIA 178 (335)
Q Consensus 106 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~ 178 (335)
.... ..+++||+++ ++|.+++..... +++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 7755 5899999996 599999987554 9999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-----
Q psy2306 179 DFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----- 253 (335)
Q Consensus 179 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----- 253 (335)
|||.+.............+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+.....
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9999987776666667789999999999988776 8999999999999999999999998887776665543100
Q ss_pred -----------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 -----------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
..+..++.+.++|.+||+.||.+|||+.|+|+||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 012345678899999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=359.10 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=206.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 3589999999999999999999999999999999976432 22334677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 115 MEYAAGGELYDFLDQK------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
|||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999988653 3589999999999999999999999999999999999999999999999999977653
Q ss_pred C-ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--C-------------
Q psy2306 189 S-RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--D------------- 252 (335)
Q Consensus 189 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--~------------- 252 (335)
. .......+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+... .
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 2 23345678999999999987655589999999999999999999999988877666555321 0
Q ss_pred --------------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchh
Q psy2306 253 --------------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVAC 297 (335)
Q Consensus 253 --------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 297 (335)
......+.++.++|.+||+.||.+|||++|+|+||||++....+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence 001134568899999999999999999999999999997665543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=364.65 Aligned_cols=261 Identities=34% Similarity=0.590 Sum_probs=226.8
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH-----HHHHHHHHHHHHHHcCCCCcccceeEEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE-----ADLIRIRREIQIMSSVRHPNIIHIYEVF 105 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 105 (335)
...+.++|++.+.||+|+||.||+|.+..+++.|++|++........ .....+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45678899999999999999999999999999999999986432211 1233566799999999999999999999
Q ss_pred EeCCeEEEEEecCCCC-CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 106 ENREKMVLVMEYAAGG-ELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 106 ~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.+.+..+++||++.++ +|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+.
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999998766 999999988899999999999999999999999999999999999999999999999999998
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCchHH
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 264 (335)
............|++.|+|||++.+..+.+.++||||||+++|+|++|..||..... ........+...++++.+
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----TVEAAIHPPYLVSKELMS 253 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----GTTTCCCCSSCCCHHHHH
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----HHhhccCCCcccCHHHHH
Confidence 877666666778999999999999888768899999999999999999999976321 122222334456789999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
+|.+||+.||.+|||++++++||||++.....
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 285 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVNLA 285 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCCCCGG
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCCcccc
Confidence 99999999999999999999999998765443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=376.64 Aligned_cols=266 Identities=36% Similarity=0.629 Sum_probs=233.6
Q ss_pred chhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH----------HHHHHHHHHHHHHHcCCCC
Q psy2306 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE----------ADLIRIRREIQIMSSVRHP 96 (335)
Q Consensus 27 ~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~ 96 (335)
.......+.++|++.+.||+|+||+||+|.+..++..||+|++........ ...+.+.+|+.+++.++||
T Consensus 27 ~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 106 (504)
T 3q5i_A 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106 (504)
T ss_dssp CCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCT
T ss_pred eeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCC
Confidence 444566788999999999999999999999999999999999986432211 3356788999999999999
Q ss_pred cccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC---
Q psy2306 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG--- 173 (335)
Q Consensus 97 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~--- 173 (335)
||+++++++.+.+..++||||+++++|.+.+.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++
T Consensus 107 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred CCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999999999998888899999999999999999999999999999999999998776
Q ss_pred CeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC
Q psy2306 174 NAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY 253 (335)
Q Consensus 174 ~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~ 253 (335)
.+||+|||++.............|++.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.+..+....+..+..
T Consensus 187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 699999999988776666667789999999999875 44 8999999999999999999999999999999888888765
Q ss_pred CC-----CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 254 FE-----PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 254 ~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
.. ...++++.++|++||+.||.+|||++++|+||||++...
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 43 346789999999999999999999999999999986543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=357.78 Aligned_cols=261 Identities=33% Similarity=0.544 Sum_probs=218.8
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCcC-CHHHHHHHHHHHHHHHcCCCCcccceeEEEEe
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKIE-TEADLIRIRREIQIMSSVRHPNIIHIYEVFEN 107 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 107 (335)
....++|++.+.||+|+||.||+|.+. .+|+.||+|++...... .......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 345579999999999999999999985 67999999999764321 23345567889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
.+..++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999987543
Q ss_pred C-CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHH
Q psy2306 188 E-SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPL 265 (335)
Q Consensus 188 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 265 (335)
. ........|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..... .+...+.++.++
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 251 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDL 251 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred cCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 2 223345678999999999988776 8999999999999999999999999888887777776554 344567899999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCCcCCCC
Q psy2306 266 IAEMLNINPSSRA-----DISVICSHWWIDKDH 293 (335)
Q Consensus 266 i~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~ 293 (335)
|.+||+.||.+|| +++++++||||+...
T Consensus 252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 9999999999999 899999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=361.12 Aligned_cols=271 Identities=25% Similarity=0.410 Sum_probs=212.5
Q ss_pred CCCCccchh-hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCccc
Q psy2306 21 STGGVRLHN-HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99 (335)
Q Consensus 21 ~~~~~~~~~-~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 99 (335)
++++..... +.....++|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+
T Consensus 18 Gp~s~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv 96 (329)
T 3gbz_A 18 GPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNII 96 (329)
T ss_dssp --------------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBC
T ss_pred CCCcceeccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcc
Confidence 333433333 35667779999999999999999999999999999999997543 2333455677999999999999999
Q ss_pred ceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-----CCC
Q psy2306 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-----NGN 174 (335)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-----~~~ 174 (335)
++++++.+.+..++||||+++ +|.+++.....+++..++.++.|++.||.|||++|++|+||||+||+++. ++.
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp CEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCE
T ss_pred eEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccce
Confidence 999999999999999999975 99999998888999999999999999999999999999999999999954 445
Q ss_pred eEEeeccccccccCC-ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC
Q psy2306 175 AKIADFGLSNVFTES-RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY 253 (335)
Q Consensus 175 ~kL~df~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~ 253 (335)
+||+|||.+...... .......+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255 (329)
T ss_dssp EEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence 999999999766432 2334556799999999998866559999999999999999999999998877666555432100
Q ss_pred CC-------------------------------CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 254 FE-------------------------------PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 254 ~~-------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.+ ...+.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 00 01356788999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=366.18 Aligned_cols=262 Identities=29% Similarity=0.493 Sum_probs=213.5
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCC
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENRE 109 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 109 (335)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++... .........+.+|+..++.+. ||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 466788999999999999999999999999999999998653 345566778889999999997 999999999997544
Q ss_pred --eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 110 --KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 110 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
.+|+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 7899999996 589999876 469999999999999999999999999999999999999999999999999997653
Q ss_pred C----------------------CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q psy2306 188 E----------------------SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV 245 (335)
Q Consensus 188 ~----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~ 245 (335)
. ........|+++|+|||++.+...++.++|||||||++|+|++|..||.+.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 112234578999999999987555599999999999999999999999988776655
Q ss_pred HHHhcCCC------------------------------------------------CCCCCCCchHHHHHHhcccCCCCC
Q psy2306 246 KQISNGDY------------------------------------------------FEPKNQSTASPLIAEMLNINPSSR 277 (335)
Q Consensus 246 ~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~dp~~R 277 (335)
..+..... .....++++.+||.+||+.||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 55432100 011456789999999999999999
Q ss_pred CCHHHHhcCCCcCCCCcc
Q psy2306 278 ADISVICSHWWIDKDHSV 295 (335)
Q Consensus 278 ps~~~ll~~~~~~~~~~~ 295 (335)
||++|+|+||||+.....
T Consensus 321 ~t~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 321 ISANDALKHPFVSIFHNP 338 (388)
T ss_dssp CCHHHHTTSTTTTTTCCG
T ss_pred CCHHHHhCCHHHHHhcCC
Confidence 999999999999876544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=352.81 Aligned_cols=264 Identities=27% Similarity=0.461 Sum_probs=230.9
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEe
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVME 116 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 116 (335)
.|+..+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+..++.++||||+++++++...+..+++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58899999999999999999999999999999976432 234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccccc
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTF 195 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~~ 195 (335)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 9999999999874 569999999999999999999999999999999999999999999999999987664432 23456
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC----CCCCCchHHHHHHhcc
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE----PKNQSTASPLIAEMLN 271 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~ 271 (335)
.|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+....... ...++.+.+++.+||+
T Consensus 202 ~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 280 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280 (321)
T ss_dssp CSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred cCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHcc
Confidence 78999999999988776 899999999999999999999999888877777666543321 2346689999999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHh
Q psy2306 272 INPSSRADISVICSHWWIDKDHSVACLEEAEELA 305 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~ 305 (335)
.||.+|||+.++++||||.+.....+...+.+..
T Consensus 281 ~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~ 314 (321)
T 2c30_A 281 RDPQERATAQELLDHPFLLQTGLPECLVPLIQLY 314 (321)
T ss_dssp SSTTTSCCHHHHHTSGGGGGCCCGGGGHHHHHHC
T ss_pred CChhhCcCHHHHhcChhhccCCCcccchHHHHHH
Confidence 9999999999999999999888777777665544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=364.40 Aligned_cols=260 Identities=19% Similarity=0.306 Sum_probs=216.8
Q ss_pred hccceeEEeeeecc--CCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 34 LKQRFDIVRKLGQG--NYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 34 ~~~~y~~~~~ig~g--~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
-.++|++.+.||+| +||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 34599999999999 99999999999999999999998643 3455677888999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 112 VLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999999875 67999999999999999999999999999999999999999999999999987544221
Q ss_pred --------ccccccccCCccCChhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-------
Q psy2306 190 --------RFLSTFCGSPLYASPEIVKGI-PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY------- 253 (335)
Q Consensus 190 --------~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~------- 253 (335)
.......|++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 112234678899999999873 2238999999999999999999999977544333332221110
Q ss_pred ----------------------------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 254 ----------------------------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 254 ----------------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.....++++.+||++||+.||.+|||++|+|+||||++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 1223466799999999999999999999999999998764
Q ss_pred c
Q psy2306 294 S 294 (335)
Q Consensus 294 ~ 294 (335)
.
T Consensus 342 ~ 342 (389)
T 3gni_B 342 R 342 (389)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=370.31 Aligned_cols=261 Identities=29% Similarity=0.492 Sum_probs=225.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|..+++.++||||+++++++.+.+..|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999875322111223357789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-- 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-- 191 (335)
||||++|++|.+++... .+++..++.++.|++.||.|||+.|++||||||+||+++.++++||+|||++........
T Consensus 147 V~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp EECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred EEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 99999999999999764 589999999999999999999999999999999999999999999999999977654432
Q ss_pred ccccccCCccCChhhhcCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC----CC-CCCCCCchH
Q psy2306 192 LSTFCGSPLYASPEIVKGIP---YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD----YF-EPKNQSTAS 263 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----~~-~~~~~~~l~ 263 (335)
....+|++.|+|||++.+.. .++.++||||||+++|+|++|..||...+.......+.... +. ....+.++.
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 305 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHH
Confidence 33567999999999997654 13789999999999999999999999999888888776532 21 235678999
Q ss_pred HHHHHhcccCCCC--CCCHHHHhcCCCcCCCCcc
Q psy2306 264 PLIAEMLNINPSS--RADISVICSHWWIDKDHSV 295 (335)
Q Consensus 264 ~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~~~ 295 (335)
++|++||+.+|.+ ||++++|++||||+...+.
T Consensus 306 ~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 306 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp HHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred HHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 9999999999998 9999999999999976443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=354.31 Aligned_cols=257 Identities=32% Similarity=0.578 Sum_probs=217.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC-----------------------HHHHHHHHHHHHHH
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET-----------------------EADLIRIRREIQIM 90 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~-----------------------~~~~~~~~~e~~~l 90 (335)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4569999999999999999999999999999999997643211 12245688999999
Q ss_pred HcCCCCcccceeEEEEe--CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEE
Q psy2306 91 SSVRHPNIIHIYEVFEN--REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENIL 168 (335)
Q Consensus 91 ~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nil 168 (335)
+.++||||+++++++.+ .+..+++|||+++++|.+++. ..++++..++.++.|++.||+|||+.|++|+||||+||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999986 678999999999999988654 457999999999999999999999999999999999999
Q ss_pred EccCCCeEEeeccccccccCCc-cccccccCCccCChhhhcCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q psy2306 169 LDENGNAKIADFGLSNVFTESR-FLSTFCGSPLYASPEIVKGIPY--HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV 245 (335)
Q Consensus 169 i~~~~~~kL~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~ 245 (335)
++.++.+||+|||++....... ......|++.|+|||++.+... .+.++||||||+++|+|++|..||...+.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 9999999999999997765432 2345678999999999976542 367899999999999999999999998887777
Q ss_pred HHHhcCCCCC---CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 246 KQISNGDYFE---PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 246 ~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
..+....... +..++++.++|.+||+.||.+|||+.++++||||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 7766654322 346778999999999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=349.48 Aligned_cols=265 Identities=32% Similarity=0.526 Sum_probs=228.9
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC------CHHHHHHHHHHHHHHHcCC-CCcccce
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE------TEADLIRIRREIQIMSSVR-HPNIIHI 101 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-~~~i~~~ 101 (335)
.....+.++|++.+.||+|++|.||+|.+..+|+.|++|++...... .....+.+.+|+.+++.+. ||||+++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 33456778999999999999999999999999999999999764311 1234567889999999996 9999999
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecc
Q psy2306 102 YEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFG 181 (335)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~ 181 (335)
++++.+.+..+++|||+++++|.+++..+..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999999999988889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccccccCCccCChhhhc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-
Q psy2306 182 LSNVFTESRFLSTFCGSPLYASPEIVK-----GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE- 255 (335)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~- 255 (335)
.+.............+++.|+|||++. ....++.++||||||+++|+|++|..||...+.......+.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 998776655556677899999999985 22334889999999999999999999999988887777776654432
Q ss_pred ----CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 256 ----PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 256 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
...+..+.+++.+||+.||.+|||+.++++||||++..
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 23466899999999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=348.21 Aligned_cols=259 Identities=36% Similarity=0.622 Sum_probs=225.3
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC---HHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET---EADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.+.++|++.+.||+|+||.||+|.+..+|+.|++|.+....... ....+.+.+|+..++.++||||+++++++.+.+
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 35679999999999999999999999999999999997643322 123567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC----CeEEeecccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG----NAKIADFGLSNV 185 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~----~~kL~df~~~~~ 185 (335)
..+++|||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999998888899999999999999999999999999999999999998876 899999999987
Q ss_pred ccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCC
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQS 260 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~ 260 (335)
...........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+....... ...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 765555556678999999999988776 899999999999999999999999988888777776654422 34577
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+.+++.+||+.||.+|||+.++++||||+..
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 89999999999999999999999999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=351.49 Aligned_cols=254 Identities=28% Similarity=0.494 Sum_probs=211.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.+ .+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5899999999999999999998 5789999999875432 2223356779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
||+++ +|.+++.. .+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+...... ....
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 99975 99998876 367999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--CC------------------
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--DY------------------ 253 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--~~------------------ 253 (335)
...+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+... ..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 4578999999999987665599999999999999999999999887766555444320 00
Q ss_pred ----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 ----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.....++++.++|++||+.||.+|||++|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 012346678899999999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=375.96 Aligned_cols=261 Identities=34% Similarity=0.622 Sum_probs=227.8
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
.....+.++|++.+.||+|+||+||+|.++.++..||+|++...... ......+.+|+.+++.++||||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 108 (494)
T 3lij_A 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK 108 (494)
T ss_dssp CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 34556788999999999999999999999999999999999864322 22345788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC---CCeEEeecccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN---GNAKIADFGLSNV 185 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~---~~~kL~df~~~~~ 185 (335)
+.+++||||+++++|.+.+....++++..++.++.|++.||.|||+.|++||||||+||+++.. +.+||+|||++..
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999999999999888889999999999999999999999999999999999999764 4599999999988
Q ss_pred ccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCC
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQS 260 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~ 260 (335)
...........|++.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.+..+....+....... ...++
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred CCCCccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 776666667789999999999874 44 899999999999999999999999999998888888765532 23567
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+.++|++||+.||.+|||+.++|+||||++.
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 89999999999999999999999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=371.61 Aligned_cols=262 Identities=29% Similarity=0.488 Sum_probs=225.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||.||+|.++.+++.||+|++.............+.+|..++..++||||+++++++.+.+..|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 46999999999999999999999999999999999753222222233477899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-- 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-- 191 (335)
|||+++++|.+++.+ ...+++..++.++.|++.||.|||+.|++||||||+||+++.++++||+|||++........
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 999999999999987 57899999999999999999999999999999999999999999999999999976644332
Q ss_pred ccccccCCccCChhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC--C-CC---CCCCCc
Q psy2306 192 LSTFCGSPLYASPEIVK----GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--Y-FE---PKNQST 261 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~----~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~-~~---~~~~~~ 261 (335)
....+|++.|+|||++. +...++.++||||||+++|+|++|..||.+.+..+....+.... . .+ ...+++
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 312 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN 312 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHH
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHH
Confidence 23467999999999986 23334899999999999999999999999998888877775421 1 11 236779
Q ss_pred hHHHHHHhcccCCCC--CCCHHHHhcCCCcCCCCcch
Q psy2306 262 ASPLIAEMLNINPSS--RADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 262 l~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~~~~ 296 (335)
+.++|++||..+|++ ||+++++++||||+...+..
T Consensus 313 ~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 313 AKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp HHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred HHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 999999999998888 99999999999999765543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=373.44 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=213.0
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC----
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR---- 108 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 108 (335)
.+.++|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 5678999999999999999999999999999999999764 33556677889999999999999999999999654
Q ss_pred --CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 109 --EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 109 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
...|+||||+++ +|.+.+.. .+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 467999999965 57676653 4899999999999999999999999999999999999999999999999999887
Q ss_pred cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---------------
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--------------- 251 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 251 (335)
..........|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 76656667889999999999998876 89999999999999999999999988766555444321
Q ss_pred -------CCCCCCC---------------------CCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 252 -------DYFEPKN---------------------QSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 252 -------~~~~~~~---------------------~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
....... ++++.+||++||+.||.+|||++|+|+||||+....
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 0000000 235789999999999999999999999999986543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=350.03 Aligned_cols=257 Identities=36% Similarity=0.617 Sum_probs=198.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+..+|+.|++|.+...........+.+.+|+..++.++||||+++++++.+.+..++++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 57999999999999999999999999999999987533222233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-ccc
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~ 193 (335)
||+++++|.+++... .++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 170 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence 999999999999865 679999999999999999999999999999999999999999999999999987764322 223
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhccc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNI 272 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~ 272 (335)
...+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..... .+...+.++.++|.+||+.
T Consensus 171 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 249 (278)
T 3cok_A 171 TLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCS
T ss_pred eccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHccc
Confidence 4568899999999987766 8899999999999999999999987665555444443333 2344577899999999999
Q ss_pred CCCCCCCHHHHhcCCCcCCCC
Q psy2306 273 NPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 273 dp~~Rps~~~ll~~~~~~~~~ 293 (335)
||.+|||++++++||||.+..
T Consensus 250 dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 250 NPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp SGGGSCCHHHHTTSTTTC---
T ss_pred CHhhCCCHHHHhcCccccCCC
Confidence 999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=348.66 Aligned_cols=256 Identities=36% Similarity=0.641 Sum_probs=227.1
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||+|.+..++..|++|++.............+.+|+..++.++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 34689999999999999999999999999999999875332223334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
+|||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 170 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-RR 170 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-BC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-cc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999986654332 23
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhccc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNI 272 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~ 272 (335)
...+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..... .+...+.++.++|.+||+.
T Consensus 171 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 249 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 249 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCS
T ss_pred cccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhc
Confidence 4568999999999988776 8999999999999999999999998888777777766544 3445678999999999999
Q ss_pred CCCCCCCHHHHhcCCCcCC
Q psy2306 273 NPSSRADISVICSHWWIDK 291 (335)
Q Consensus 273 dp~~Rps~~~ll~~~~~~~ 291 (335)
||.+|||++++++||||+.
T Consensus 250 ~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 250 HPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp SGGGSCCHHHHHTCHHHHH
T ss_pred CHhhCCCHHHHhhCHHHHh
Confidence 9999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=354.84 Aligned_cols=265 Identities=31% Similarity=0.530 Sum_probs=225.5
Q ss_pred hhhhhhccceeEE-eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEE
Q psy2306 29 NHRRKLKQRFDIV-RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFE 106 (335)
Q Consensus 29 ~~~~~~~~~y~~~-~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 106 (335)
...+.+.++|.+. +.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+..++.++ ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 3457899999998 899999999999999999999999999976432 2234567889999999995 699999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CCCeEEeecc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NGNAKIADFG 181 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~~~kL~df~ 181 (335)
+.+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++. ++.++|+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999999999864 367999999999999999999999999999999999999987 7899999999
Q ss_pred ccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-----CC
Q psy2306 182 LSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-----EP 256 (335)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~~ 256 (335)
.+.............+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+...... ..
T Consensus 180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 180 MSRKIGHACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp GCEEC---------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred cccccCCccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 9988766655566789999999999988776 89999999999999999999999998887776666554321 23
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
..+..+.++|.+||+.||.+|||++++|+||||+.....
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 456789999999999999999999999999999876444
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=360.91 Aligned_cols=256 Identities=31% Similarity=0.483 Sum_probs=220.2
Q ss_pred hhccceeE--EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 33 KLKQRFDI--VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 33 ~~~~~y~~--~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
.+...|++ .+.||+|+||.||+|.+..+|..|++|++... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 84 ~~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND 160 (373)
T ss_dssp CGGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34555666 67899999999999999999999999999863 23456688999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE--ccCCCeEEeecccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL--DENGNAKIADFGLSNVFT 187 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili--~~~~~~kL~df~~~~~~~ 187 (335)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.+||+|||++....
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 99999999999999888653 469999999999999999999999999999999999999 456789999999998876
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCCch
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQSTA 262 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~l 262 (335)
.........|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+....... ...++++
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 6655566679999999999987665 889999999999999999999999988887777776654322 3457799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.++|.+||+.||.+|||+.++|+||||++.
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=357.44 Aligned_cols=253 Identities=23% Similarity=0.403 Sum_probs=218.1
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-----CCcccceeEE
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-----HPNIIHIYEV 104 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~ 104 (335)
.+..+.++|++.+.||+|+||+||+|.+..+++.||+|++.. ..........|..+++.++ ||||++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 567788999999999999999999999999999999999864 3344556778999999986 9999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-----------
Q psy2306 105 FENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE----------- 171 (335)
Q Consensus 105 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~----------- 171 (335)
+...+..++|||++ +++|.+++.... .+++..++.++.||+.||+|||+.|++||||||+||+++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 99999999999999 889999998654 5999999999999999999999999999999999999975
Q ss_pred --------------CCCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy2306 172 --------------NGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFD 237 (335)
Q Consensus 172 --------------~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~ 237 (335)
++.+||+|||++...... .....|++.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCCC
Confidence 789999999999765432 245678999999999998876 899999999999999999999998
Q ss_pred CCcHHHHHHHHhcCCCCCC-----------------------------------------------CCCCchHHHHHHhc
Q psy2306 238 GSNFKRLVKQISNGDYFEP-----------------------------------------------KNQSTASPLIAEML 270 (335)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~l~~li~~~l 270 (335)
..+..+....+.......+ ..++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 8877666555443211110 01245679999999
Q ss_pred ccCCCCCCCHHHHhcCCCcC
Q psy2306 271 NINPSSRADISVICSHWWID 290 (335)
Q Consensus 271 ~~dp~~Rps~~~ll~~~~~~ 290 (335)
+.||.+|||++|+|+||||+
T Consensus 341 ~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGC
T ss_pred cCChhhCCCHHHHhcCcccC
Confidence 99999999999999999995
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=365.48 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=224.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|..++..++||||+++++++.+.+..|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 35699999999999999999999999999999999976332233334557889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-
Q psy2306 114 VMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~- 191 (335)
||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++++||+|||++........
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999999999864 4799999999999999999999999999999999999999999999999999977654432
Q ss_pred -ccccccCCccCChhhhcC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC----CC--CCCC
Q psy2306 192 -LSTFCGSPLYASPEIVKG------IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD----YF--EPKN 258 (335)
Q Consensus 192 -~~~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----~~--~~~~ 258 (335)
....+|++.|+|||++.. ...++.++||||||+++|+|++|..||...+..+....+.... .. ....
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 298 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCC
Confidence 234579999999999872 2234899999999999999999999999988888777766421 11 2357
Q ss_pred CCchHHHHHHhcccCCCCC---CCHHHHhcCCCcCCCCcch
Q psy2306 259 QSTASPLIAEMLNINPSSR---ADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 259 ~~~l~~li~~~l~~dp~~R---ps~~~ll~~~~~~~~~~~~ 296 (335)
++++.++|++||. +|.+| |+++++++||||+...+..
T Consensus 299 s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 8899999999999 99998 6999999999998765543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=375.30 Aligned_cols=261 Identities=37% Similarity=0.653 Sum_probs=229.0
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
...+.++|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 346888999999999999999999999999999999998753221 1234578899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc---cCCCeEEeecccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD---ENGNAKIADFGLSNVFT 187 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~---~~~~~kL~df~~~~~~~ 187 (335)
+++||||+.+++|.+.+.....+++..++.++.|++.||.|||++|++||||||+||+++ .++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999998888899999999999999999999999999999999999995 45679999999998776
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCCch
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQSTA 262 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~l 262 (335)
.........|++.|+|||++.+. + +.++||||||+++|+|++|..||.+.+..+....+..+.... ...++++
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred CCCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 66556667899999999999864 4 889999999999999999999999999988888888765432 2346789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
.++|++||+.||.+|||+.++|+||||+....
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=346.43 Aligned_cols=259 Identities=28% Similarity=0.406 Sum_probs=222.4
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.+..+.++|++.+.||+|+||.||+|.+..++..|++|.+...........+.+.+|+..++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 35678899999999999999999999999999999999998766667777889999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
..+++|||+++++|.+++...+++++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999776443
Q ss_pred c--cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC------CCCCCCCc
Q psy2306 190 R--FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY------FEPKNQST 261 (335)
Q Consensus 190 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~ 261 (335)
. ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+............. .....++.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp ----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred cccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 2 2234568999999999988776 8999999999999999999999998887665555444432 23456788
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 262 ASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
+.++|.+||+.||.+||+..+.+.+.|.
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 9999999999999999965555555443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=354.63 Aligned_cols=264 Identities=26% Similarity=0.447 Sum_probs=227.7
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||+||+|.+..+|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 34567999999999999999999999999999999998755555666778999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+||||+. ++|.+++. ...++++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9999996 57877775 4677999999999999999999999999999999999999999999999999999766443
Q ss_pred ccccccCCccCChhhhc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHH
Q psy2306 192 LSTFCGSPLYASPEIVK---GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPL 265 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~---~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 265 (335)
....|++.|+|||++. ...+ +.++||||||+++|+|++|..||...+.......+..... .....+..+.++
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred -CcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 3457899999999985 3344 8899999999999999999999988877666555554432 233467789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHH
Q psy2306 266 IAEMLNINPSSRADISVICSHWWIDKDHSVACLEEA 301 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~ 301 (335)
|.+||+.||.+|||++++++||||..........+.
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~~~ 321 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 321 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHH
T ss_pred HHHHcccChhhCcCHHHHhhChhhhccCCcchhhHH
Confidence 999999999999999999999999877665544433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=358.27 Aligned_cols=269 Identities=36% Similarity=0.571 Sum_probs=224.1
Q ss_pred ccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc--CCHHHHHHHHHHHHHHHcCCCCccccee
Q psy2306 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI--ETEADLIRIRREIQIMSSVRHPNIIHIY 102 (335)
Q Consensus 25 ~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 102 (335)
+-..+....+.++|++.+.||+|+||.||+|.+..++..|++|++..... ......+.+.+|+.+++.++||||++++
T Consensus 15 ~~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 94 (345)
T 3hko_A 15 YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY 94 (345)
T ss_dssp CCCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence 33344456788999999999999999999999999999999999875321 1234567889999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhh----------------------------------------CCCCCHHHHHHHH
Q psy2306 103 EVFENREKMVLVMEYAAGGELYDFLDQ----------------------------------------KKVLTEEEARRIF 142 (335)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~i~ 142 (335)
+++.+.+..++||||+++++|.+++.. ...+++..++.++
T Consensus 95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 999999999999999999999999852 1124678899999
Q ss_pred HHHHHHHHHhHHCCcEecCCCCCCEEEccCC--CeEEeeccccccccCCc-----cccccccCCccCChhhhcCC-CCCC
Q psy2306 143 RQIATAVYYCHKHKICHRDLKLENILLDENG--NAKIADFGLSNVFTESR-----FLSTFCGSPLYASPEIVKGI-PYHG 214 (335)
Q Consensus 143 ~~l~~~l~~LH~~givH~di~p~nili~~~~--~~kL~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~ 214 (335)
.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||.+....... ......|++.|+|||++.+. ..++
T Consensus 175 ~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 175 RQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 9999999999999999999999999998766 89999999997653211 13456789999999999752 3348
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-----CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-----KNQSTASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 215 ~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
.++||||||+++|+|++|..||...+..+....+........ ..++.+.++|.+||+.||.+|||+.++++||||
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 899999999999999999999999888877777776654332 256789999999999999999999999999999
Q ss_pred CCCC
Q psy2306 290 DKDH 293 (335)
Q Consensus 290 ~~~~ 293 (335)
++..
T Consensus 335 ~~~~ 338 (345)
T 3hko_A 335 SQFS 338 (345)
T ss_dssp HTTS
T ss_pred ccCh
Confidence 8653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=357.56 Aligned_cols=254 Identities=31% Similarity=0.578 Sum_probs=219.1
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENR 108 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 108 (335)
....+.++|++.+.||+|+||.||+|.++.+|+.||+|++...... ..+|++.+.++ +||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 3456788999999999999999999999999999999999864432 23577777777 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-C---CeEEeeccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-G---NAKIADFGLSN 184 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~-~---~~kL~df~~~~ 184 (335)
+..|+||||+++++|.+.+...+.+++..+..++.|++.||.|||++|++||||||+||++..+ + .+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999999999988889999999999999999999999999999999999998543 3 59999999998
Q ss_pred cccCC-ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHhcCCCCC-----
Q psy2306 185 VFTES-RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG---SNFKRLVKQISNGDYFE----- 255 (335)
Q Consensus 185 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~---~~~~~~~~~~~~~~~~~----- 255 (335)
..... ......++++.|+|||++.+..+ +.++||||||+++|+|++|..||.. .+..++...+..+....
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 66433 33445678999999999987665 8899999999999999999999975 46677777777665532
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
...++++.++|++||..||.+|||+.++++||||..
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 345779999999999999999999999999999965
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=369.54 Aligned_cols=264 Identities=25% Similarity=0.409 Sum_probs=204.5
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe---
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--- 107 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 107 (335)
...+.++|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+.+|+.+++.++|+||+++++++..
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 48 DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 345678999999999999999999999999999999998653 3455667789999999999999999999999843
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 108 --REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 108 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
...+|+|||++ +++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 35799999998 569999999888899999999999999999999999999999999999999999999999999977
Q ss_pred ccCCc----------------------------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh------
Q psy2306 186 FTESR----------------------------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY------ 231 (335)
Q Consensus 186 ~~~~~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t------ 231 (335)
..... .....+||++|+|||++.....++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 54221 23445789999999987655545999999999999999998
Q ss_pred -----CCCCCCCCcH--------------------HHHHHHHh---cC-----------------------------CCC
Q psy2306 232 -----GAMPFDGSNF--------------------KRLVKQIS---NG-----------------------------DYF 254 (335)
Q Consensus 232 -----g~~p~~~~~~--------------------~~~~~~~~---~~-----------------------------~~~ 254 (335)
|.++|.+.+. ......+. .. ...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 6666755431 11111110 00 001
Q ss_pred CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 255 EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
.+..++++.+||++||..||.+|||++|+|+||||+......
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 234467899999999999999999999999999999875543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=357.06 Aligned_cols=270 Identities=26% Similarity=0.425 Sum_probs=222.3
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe------
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN------ 107 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 107 (335)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 34699999999999999999999999999999999865432 22233466789999999999999999999976
Q ss_pred --CCeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 108 --REKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 108 --~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.+..++||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.+.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4578999999975 77666654 4679999999999999999999999999999999999999999999999999997
Q ss_pred cccC-----CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--CCCCCC
Q psy2306 185 VFTE-----SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--DYFEPK 257 (335)
Q Consensus 185 ~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~~ 257 (335)
.... ........+++.|+|||++.+...++.++||||||+++|+|++|..||...+.......+... ......
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 6542 222344567999999999987665599999999999999999999999998877666555431 111100
Q ss_pred -------------------------------CCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHh
Q psy2306 258 -------------------------------NQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELA 305 (335)
Q Consensus 258 -------------------------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~ 305 (335)
.++.+.++|.+||+.||.+|||++|+|+||||.............+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~ 331 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTH 331 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHHHHHSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccccccccCcc
Confidence 144588999999999999999999999999999877776655444443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=375.28 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=227.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
.-.++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|..+++.++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34568999999999999999999999999999999997643323334556789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 113 LVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.+|++||+|||++.......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999998654 49999999999999999999999999999999999999999999999999998876655
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcCC-CCCCCCCCchHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS----NFKRLVKQISNGD-YFEPKNQSTASPL 265 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~----~~~~~~~~~~~~~-~~~~~~~~~l~~l 265 (335)
......|++.|+|||++.+..+ +.++||||||+++|+|++|..||... ....+...+.... ..+...++++.++
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 5566789999999999988776 89999999999999999999999775 3455555555443 2345578899999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCCcCCCC
Q psy2306 266 IAEMLNINPSSRA-----DISVICSHWWIDKDH 293 (335)
Q Consensus 266 i~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~ 293 (335)
|++||+.||.+|| +++++++||||+...
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 9999999999999 899999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=362.21 Aligned_cols=264 Identities=27% Similarity=0.434 Sum_probs=215.8
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR-- 108 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 108 (335)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+.+|+.+++.++|+||+++++++...
T Consensus 21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 455788999999999999999999999999999999999753 34556677899999999999999999999999766
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 109 ---EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 109 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
+..|+|||+++ ++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 57999999995 59999999888899999999999999999999999999999999999999999999999999977
Q ss_pred ccCCc-----------------------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCC--------
Q psy2306 186 FTESR-----------------------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAM-------- 234 (335)
Q Consensus 186 ~~~~~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~-------- 234 (335)
..... ......|+++|+|||++.....++.++|||||||++|+|++|..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 64322 23566789999999997655555999999999999999998543
Q ss_pred ---CCCCCcH-----------------HH------------------------HHHHHhcCCC--------CCCCCCCch
Q psy2306 235 ---PFDGSNF-----------------KR------------------------LVKQISNGDY--------FEPKNQSTA 262 (335)
Q Consensus 235 ---p~~~~~~-----------------~~------------------------~~~~~~~~~~--------~~~~~~~~l 262 (335)
+|.+.+. .. ....+..... ..+..++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 3433220 01 1111111110 013467789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
.+||++||+.||.+|||++|+|+||||++.....
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 9999999999999999999999999999876554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=353.17 Aligned_cols=253 Identities=33% Similarity=0.580 Sum_probs=202.8
Q ss_pred hccceeEE---eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCC
Q psy2306 34 LKQRFDIV---RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENRE 109 (335)
Q Consensus 34 ~~~~y~~~---~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 109 (335)
+.++|.+. +.||+|+||.||+|.+..+|+.||+|++... ......+|+..++.+. ||||+++++++.+.+
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 45678886 7899999999999999999999999998752 2346678999999997 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC---CeEEeeccccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG---NAKIADFGLSNVF 186 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~---~~kL~df~~~~~~ 186 (335)
..++||||+++++|.+++..+..+++..++.++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999988999999999999999999999999999999999999998765 7999999999765
Q ss_pred cCC-ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHHhcCCCCCC--
Q psy2306 187 TES-RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-------FKRLVKQISNGDYFEP-- 256 (335)
Q Consensus 187 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-------~~~~~~~~~~~~~~~~-- 256 (335)
... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+ ..+....+..+.....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp CC----------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 433 22345667999999999988776 899999999999999999999997643 3566677766655333
Q ss_pred ---CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 257 ---KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 257 ---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
..++++.++|++||+.||.+|||++++++||||+...
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 3577899999999999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=351.35 Aligned_cols=257 Identities=32% Similarity=0.521 Sum_probs=213.4
Q ss_pred hhhccceeEE-eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCC
Q psy2306 32 RKLKQRFDIV-RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENRE 109 (335)
Q Consensus 32 ~~~~~~y~~~-~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 109 (335)
..+.++|++. +.||+|+||.||+|.+..+++.||+|++..... .....+.+|+..+.++ +||||+++++++.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 4577899995 789999999999999999999999999976432 2345778999999885 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC---eEEeeccccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN---AKIADFGLSNVF 186 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~---~kL~df~~~~~~ 186 (335)
..++||||+++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999998888999999999999999999999999999999999999988765 999999998765
Q ss_pred cCCc--------cccccccCCccCChhhhcC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-------------
Q psy2306 187 TESR--------FLSTFCGSPLYASPEIVKG-----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN------------- 240 (335)
Q Consensus 187 ~~~~--------~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~------------- 240 (335)
.... ......|++.|+|||++.+ ..+ +.++||||||+++|+|++|..||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 3211 1223458999999999865 233 789999999999999999999997653
Q ss_pred --HHHHHHHHhcCCCCCC-----CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 241 --FKRLVKQISNGDYFEP-----KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 241 --~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.......+.......+ ..+.++.++|++||+.||.+|||++++++||||+..
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2334555555444322 457789999999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=353.53 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=219.3
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
.-++|++.+.||+|+||.||+|.+..+|+.|++|.+.... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 4569999999999999999999999999999999987643 345556678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-ccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~ 192 (335)
||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence 9999999999998887788999999999999999999999999999999999999999999999999999765432 233
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------------CC
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------------------DY 253 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------~~ 253 (335)
....+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+... ..
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 45678999999999987655589999999999999999999999887765554443210 00
Q ss_pred -------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 254 -------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 254 -------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
..+..++.+.++|.+||+.||.+|||++|+|+||||+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 315 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCCh
Confidence 01234678999999999999999999999999999987533
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=356.68 Aligned_cols=259 Identities=25% Similarity=0.418 Sum_probs=222.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE- 109 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 109 (335)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+..++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 3567889999999999999999999999999999999998766666677788999999999999999999999987654
Q ss_pred ---eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 110 ---KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 110 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
..++||||+++++|.+++...+++++..++.++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 34999999999999999998888999999999999999999999999999999999999999999999999999765
Q ss_pred cCCc----cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CC
Q psy2306 187 TESR----FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PK 257 (335)
Q Consensus 187 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~ 257 (335)
.... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..............+ ..
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred cccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 4332 1234568999999999988776 889999999999999999999999988877766665554432 34
Q ss_pred CCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 258 NQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
.+.++.++|.+||+.||.+||++.+++.|+|++
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 677899999999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=348.22 Aligned_cols=258 Identities=34% Similarity=0.613 Sum_probs=225.8
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
..+.++|++.+.||+|+||.||+|.+..+|+.|++|.+..... ...+.+.+|+..++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 4577899999999999999999999999999999999986332 2334678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE---ccCCCeEEeeccccccccC
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili---~~~~~~kL~df~~~~~~~~ 188 (335)
+++|||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999999999888889999999999999999999999999999999999999 6788999999999876543
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-----CCCCCCchH
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-----EPKNQSTAS 263 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~ 263 (335)
. ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+... ....+.++.
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 162 G-IMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp B-TTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred C-ccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 2 2344568999999999988776 88999999999999999999999998888887777765432 234577899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
++|.+||+.||.+|||+.++++||||.....
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 9999999999999999999999999987544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=358.23 Aligned_cols=262 Identities=25% Similarity=0.440 Sum_probs=217.0
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
+....+.++|++.+.||+|+||.||+|.+..+|+.||+|.+... .......+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 18 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp SSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred CceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 34456788999999999999999999999999999999998653 34555677889999999999999999999999765
Q ss_pred ------CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 109 ------EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 109 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
..+|+||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 3469999999 7899999986 5699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC----------
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD---------- 252 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---------- 252 (335)
+...... .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 175 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 175 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9775433 3456789999999999874445999999999999999999999999887665554443210
Q ss_pred ----------------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 253 ----------------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 253 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
...+..++.+.+++.+||+.||.+|||++++|+||||+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 0123456789999999999999999999999999999876544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=352.83 Aligned_cols=268 Identities=33% Similarity=0.601 Sum_probs=219.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-----CHHHHHHHHHHHHHHHcCCCCcccceeEEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-----TEADLIRIRREIQIMSSVRHPNIIHIYEVF 105 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 105 (335)
...+.++|++.+.||+|+||.||+|.+..+++.|++|++...... .......+.+|+.+++.++||||+++++++
T Consensus 5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 356778999999999999999999999999999999998753321 122344578999999999999999999998
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC---eEEeeccc
Q psy2306 106 ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN---AKIADFGL 182 (335)
Q Consensus 106 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~---~kL~df~~ 182 (335)
...+ .+++|||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++. +||+|||.
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7655 8999999999999999988888999999999999999999999999999999999999987654 99999999
Q ss_pred cccccCCccccccccCCccCChhhhc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcCCCCC----
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVK--GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNGDYFE---- 255 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~---- 255 (335)
+.............+++.|+|||++. +...++.++||||||+++|+|++|..||...... .....+.......
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 98776655455667899999999974 2333488999999999999999999999764322 2333333333221
Q ss_pred -CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhH
Q psy2306 256 -PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLE 299 (335)
Q Consensus 256 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~ 299 (335)
...+..+.++|.+||+.||.+|||+.++++||||+.........
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~~~~ 288 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHHHHH
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHHHHH
Confidence 34577899999999999999999999999999998754443333
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=341.38 Aligned_cols=259 Identities=34% Similarity=0.588 Sum_probs=221.8
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
+.++|++.+.||+|+||.||+|.+..+++.|++|++..... ....+.+.+|+..++.++||||+++++++.+.+..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 55799999999999999999999999999999999975432 2345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC---c
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES---R 190 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~---~ 190 (335)
++||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998765422 1
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcCCC-C--CCCCCCchHHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNGDY-F--EPKNQSTASPLI 266 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~-~--~~~~~~~l~~li 266 (335)
......+++.|+|||++.+..+.+.++||||||+++|+|++|..||...... ........... . ....+..+.++|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2345568999999999988776678899999999999999999999765432 22222222221 1 224577899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
.+||+.||.+|||++++++||||++...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=355.54 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=210.2
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC---
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE--- 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 109 (335)
++.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 46679999999999999999999999999999999997643 3345678899999999999999999999986543
Q ss_pred ------------------------------------------------------eEEEEEecCCCCCHHHHHhhCCC---
Q psy2306 110 ------------------------------------------------------KMVLVMEYAAGGELYDFLDQKKV--- 132 (335)
Q Consensus 110 ------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~--- 132 (335)
..+++|||+++++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987543
Q ss_pred CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-------------cccccccCC
Q psy2306 133 LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-------------FLSTFCGSP 199 (335)
Q Consensus 133 ~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-------------~~~~~~~~~ 199 (335)
.++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||.+....... ......|++
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 5666789999999999999999999999999999999999999999999997765432 223456899
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC--CCCCCchHHHHHHhcccCCCCC
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE--PKNQSTASPLIAEMLNINPSSR 277 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~R 277 (335)
.|+|||++.+..+ +.++||||||+++|+|++|..|+.. .......+....... ...++++.++|.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999999988776 9999999999999999998776422 222333333332211 2235678899999999999999
Q ss_pred CCHHHHhcCCCcCC
Q psy2306 278 ADISVICSHWWIDK 291 (335)
Q Consensus 278 ps~~~ll~~~~~~~ 291 (335)
||++++++||||++
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=342.37 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=215.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCC
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENRE 109 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 109 (335)
..++.++|++.+.||+|+||+||+|.+..+++.|++|.+...... ......+.+|+..+..+ +||||+++++++.+.+
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 356778999999999999999999999999999999999864433 33456777889999888 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-------------
Q psy2306 110 KMVLVMEYAAGGELYDFLDQK----KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN------------- 172 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~------------- 172 (335)
..+++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999999764 679999999999999999999999999999999999999844
Q ss_pred ------CCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy2306 173 ------GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVK 246 (335)
Q Consensus 173 ------~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~ 246 (335)
..++|+|||.+....... ...+++.|+|||++.+...++.++||||||+++|+|++|..++.......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--- 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH--- 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---
T ss_pred cccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---
Confidence 479999999987765443 34589999999999876555789999999999999999998876554322
Q ss_pred HHhcCC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 247 QISNGD--YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 247 ~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+.... ..+...++++.++|.+||+.||.+|||+.++++||||.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 222222 2344567899999999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=356.90 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=209.3
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC---
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE--- 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 109 (335)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 56789999999999999999999999999999999997633 34556678889999999999999999999997654
Q ss_pred ---eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 110 ---KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 110 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 78999999965 7888886 34899999999999999999999999999999999999999999999999999877
Q ss_pred cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----------
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE----------- 255 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 255 (335)
..........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+......+
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp ------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 65555556788999999999988776 899999999999999999999999887766655554321100
Q ss_pred -------------------------CC-------CCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 256 -------------------------PK-------NQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 256 -------------------------~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
+. .+.++.+||++||+.||.+|||++++|+||||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 00 0346789999999999999999999999999986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=356.10 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=221.8
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
+....++|++.+.||+|+||.||+|.+..++..|++|++... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 455677999999999999999999999999999999999863 245566788999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999999999999888899999999999999999999985 9999999999999999999999999998655322
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH---------------------
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQI--------------------- 248 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~--------------------- 248 (335)
......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2234578999999999988776 89999999999999999999999877665443222
Q ss_pred ---------------------hcCC---CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 249 ---------------------SNGD---YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 249 ---------------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.... ......+.++.+||++||+.||.+|||++++|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 1111 1112346689999999999999999999999999999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=344.43 Aligned_cols=261 Identities=36% Similarity=0.645 Sum_probs=229.8
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
.....+.++|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+..++.++||||+++++++.+.
T Consensus 15 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 34567888999999999999999999999999999999999764322 23456788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC---CCeEEeecccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN---GNAKIADFGLSNV 185 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~---~~~kL~df~~~~~ 185 (335)
+..++++|++++++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999999999999887889999999999999999999999999999999999999754 4799999999987
Q ss_pred ccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCC
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQS 260 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~ 260 (335)
...........+++.|+|||++.+. + +.++||||||+++|+|++|..||...+..+....+..+.... ...+.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 174 FQQNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp BCCCSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred ecCCCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 6655544556688899999998764 4 889999999999999999999999998888888777665422 34577
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
++.++|++||+.||.+|||+.++++||||++.
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 89999999999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=354.01 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=209.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 589999999999999999999999999999999875321 111223457899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+...... ....
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 9996 5888888764 46999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC--C------------------
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--Y------------------ 253 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~------------------ 253 (335)
...+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+.... .
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 55779999999999875555999999999999999999999999988776665554310 0
Q ss_pred -----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 -----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
..+..++++.+||.+||+.||.+|||++|+|+||||.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 012345678899999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=381.13 Aligned_cols=261 Identities=30% Similarity=0.503 Sum_probs=232.0
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 112 (335)
-.++|++.+.||+|+||.||+|.++.+++.||+|++...........+.+..|..++..+ +|++|+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 346899999999999999999999999999999999864322333456777899999887 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc-CCcc
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~-~~~~ 191 (335)
+||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++++||+|||++.... ....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence 999999999999999988889999999999999999999999999999999999999999999999999997643 3334
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhc
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEML 270 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l 270 (335)
.....||+.|+|||++.+..+ +.++||||||+++|||++|..||.+.+..++...+...... +...++++.+||++||
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 577 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLM 577 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHS
T ss_pred cccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHc
Confidence 456789999999999988887 99999999999999999999999999999999888887653 4456789999999999
Q ss_pred ccCCCCCCCH-----HHHhcCCCcCCCCcc
Q psy2306 271 NINPSSRADI-----SVICSHWWIDKDHSV 295 (335)
Q Consensus 271 ~~dp~~Rps~-----~~ll~~~~~~~~~~~ 295 (335)
+.||.+||++ ++|++||||+...+.
T Consensus 578 ~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 578 TKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp CSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred cCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 9999999997 999999999875443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=369.20 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=225.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.............+.+|..+++.++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 46899999999999999999999999999999999764332333456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 115 MEYAAGGELYDFLDQK----KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
|||++|++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.+|++||+|||++.......
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999999999753 469999999999999999999999999999999999999999999999999998765443
Q ss_pred c-ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcCCC-CCCCCCCchHH
Q psy2306 191 F-LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS----NFKRLVKQISNGDY-FEPKNQSTASP 264 (335)
Q Consensus 191 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~----~~~~~~~~~~~~~~-~~~~~~~~l~~ 264 (335)
. ....+|++.|+|||++.+..+ +.++|||||||++|+|++|..||... ...++...+..... .+...+.++.+
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 422 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred cccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHH
Confidence 3 334589999999999998776 89999999999999999999999764 44566666655443 44567889999
Q ss_pred HHHHhcccCCCCCCC-----HHHHhcCCCcCCCCc
Q psy2306 265 LIAEMLNINPSSRAD-----ISVICSHWWIDKDHS 294 (335)
Q Consensus 265 li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 294 (335)
+|++||+.||.+||+ +++|++||||+...+
T Consensus 423 li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp HHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred HHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 999999999999995 589999999987543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=357.85 Aligned_cols=271 Identities=24% Similarity=0.420 Sum_probs=211.1
Q ss_pred CCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccc
Q psy2306 21 STGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100 (335)
Q Consensus 21 ~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 100 (335)
++..+.+.+....+.++|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~ 92 (367)
T 2fst_X 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 92 (367)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcceEeecCcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 3444556666777889999999999999999999999999999999998753 234556778889999999999999999
Q ss_pred eeEEEEeC------CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 101 IYEVFENR------EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 101 ~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
+++++... ...++++|++ +++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 93 LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp CSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred EEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC
Confidence 99999654 5689999999 7799998875 56999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---
Q psy2306 175 AKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--- 251 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--- 251 (335)
+||+|||++...... .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 171 ~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 248 (367)
T 2fst_X 171 LKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248 (367)
T ss_dssp EEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred EEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999999765432 345678999999999987555599999999999999999999999988766554443320
Q ss_pred ----------------------CC-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 252 ----------------------DY-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 252 ----------------------~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
.. ..+..++.+.+||.+||+.||.+|||+.++|+||||++.....
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 00 0123466789999999999999999999999999999765543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=338.70 Aligned_cols=254 Identities=26% Similarity=0.503 Sum_probs=217.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe----CCe
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN----REK 110 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 110 (335)
.+.|++.+.||+|+||.||+|.+..++..|++|.+..... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3468999999999999999999999999999999986433 45567788999999999999999999999865 456
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEc-cCCCeEEeecccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLD-ENGNAKIADFGLSNVFT 187 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~-~~~~~kL~df~~~~~~~ 187 (335)
.++||||+++++|.+++.....+++..++.++.|++.||.|||+.| ++|+||+|+||+++ .++.++|+|||.+....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999998888999999999999999999999999 99999999999997 78899999999986554
Q ss_pred CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcCCC---CCCCCCCchH
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDY---FEPKNQSTAS 263 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~ 263 (335)
.. ......+++.|+|||++.+. + +.++||||||+++|+|++|..||.. .........+..... .....++++.
T Consensus 184 ~~-~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 260 (290)
T 1t4h_A 184 AS-FAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp TT-SBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred cc-ccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence 33 23455789999999998753 4 8999999999999999999999987 444555555554432 2233456899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
++|.+||+.||.+|||++++++||||++.
T Consensus 261 ~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 99999999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=360.58 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=215.0
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC------CCCcccceeE
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV------RHPNIIHIYE 103 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~ 103 (335)
+.+.+..+|++.+.||+|+||+||+|.+..+++.||+|++.. .......+.+|+.+++.+ .|+||+++++
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 466788899999999999999999999999999999999875 234445667787777776 4679999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC--eEEee
Q psy2306 104 VFENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN--AKIAD 179 (335)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~--~kL~d 179 (335)
.+...+..+++||++. ++|.+++.... .+++..++.++.||+.||+|||+.|++||||||+||+++.++. +||+|
T Consensus 167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 9999999999999995 69999987653 4999999999999999999999999999999999999999887 99999
Q ss_pred ccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC------
Q psy2306 180 FGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY------ 253 (335)
Q Consensus 180 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~------ 253 (335)
||++...... .....+++.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+.....
T Consensus 246 FG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 246 FGSSCYEHQR--VYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CTTCEETTCC--CCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccceecCCc--ccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 9999765432 335578999999999998877 9999999999999999999999998877665544432100
Q ss_pred ------------------------------------------------------CCCCCCCchHHHHHHhcccCCCCCCC
Q psy2306 254 ------------------------------------------------------FEPKNQSTASPLIAEMLNINPSSRAD 279 (335)
Q Consensus 254 ------------------------------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps 279 (335)
.....++.+.+||++||+.||.+|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 00112456889999999999999999
Q ss_pred HHHHhcCCCcCCCCc
Q psy2306 280 ISVICSHWWIDKDHS 294 (335)
Q Consensus 280 ~~~ll~~~~~~~~~~ 294 (335)
++|+|+||||++...
T Consensus 403 a~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 403 PGQALRHPWLRRRLP 417 (429)
T ss_dssp HHHHHTSTTTC----
T ss_pred HHHHhCChhhccCCC
Confidence 999999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=364.65 Aligned_cols=262 Identities=34% Similarity=0.601 Sum_probs=211.2
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-----CHHHHHHHHHHHHHHHcCCCCcccceeEEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-----TEADLIRIRREIQIMSSVRHPNIIHIYEVF 105 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 105 (335)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++
T Consensus 130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 356788999999999999999999999999999999999764321 122233578999999999999999999998
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC---CeEEeeccc
Q psy2306 106 ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG---NAKIADFGL 182 (335)
Q Consensus 106 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~---~~kL~df~~ 182 (335)
. .+..++||||+++++|.+++.....+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||+
T Consensus 210 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 210 D-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp E-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred e-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 5 456899999999999999998888999999999999999999999999999999999999997544 599999999
Q ss_pred cccccCCccccccccCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhcCCCCC----
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-KRLVKQISNGDYFE---- 255 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~---- 255 (335)
+.............|++.|+|||++.+ ...++.++||||||+++|+|++|..||..... ......+.......
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 988776655566789999999999864 23337899999999999999999999976432 23344444443322
Q ss_pred -CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 256 -PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 256 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
...+..+.++|.+||+.||.+|||++++|+||||+...
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 34577899999999999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=344.72 Aligned_cols=271 Identities=28% Similarity=0.459 Sum_probs=224.8
Q ss_pred chhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE
Q psy2306 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE 106 (335)
Q Consensus 27 ~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 106 (335)
.........++|++.+.||+|+||.||+|.+..+++.|++|++.... ....+.+.+|+..++.++||||+++++++.
T Consensus 10 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 33344567789999999999999999999999999999999987532 234567889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
+.+..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999999998875 56799999999999999999999999999999999999999999999999998754
Q ss_pred ccC-CccccccccCCccCChhhhc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----C
Q psy2306 186 FTE-SRFLSTFCGSPLYASPEIVK-----GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----E 255 (335)
Q Consensus 186 ~~~-~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~ 255 (335)
... ........+++.|+|||++. ...+ +.++||||||+++|+|++|..||...+.......+...... +
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T 2j7t_A 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245 (302)
T ss_dssp HHHHHHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred ccccccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc
Confidence 321 11223456889999999984 4444 88999999999999999999999988877766666554332 2
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHH
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEA 301 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~ 301 (335)
...+..+.++|.+||+.||.+|||+.++++||||+.........+.
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~ 291 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALREL 291 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHHHH
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhHHHH
Confidence 3456689999999999999999999999999999987766544433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=353.24 Aligned_cols=269 Identities=26% Similarity=0.422 Sum_probs=222.0
Q ss_pred CCCccchhhhhhhc--cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCccc
Q psy2306 22 TGGVRLHNHRRKLK--QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99 (335)
Q Consensus 22 ~~~~~~~~~~~~~~--~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 99 (335)
+++++....++.+. ++|++.+.||+|+||.||+|.+..++..||+|++... ........+.+|+.+++.++||||+
T Consensus 11 ~~~~~~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv 88 (364)
T 3qyz_A 11 AAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENII 88 (364)
T ss_dssp ----CCBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhcceEEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCc
Confidence 44444444555554 7999999999999999999999999999999998752 3455567889999999999999999
Q ss_pred ceeEEEEeC-----CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 100 HIYEVFENR-----EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 100 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
++++++... ...++++|+++ ++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~ 166 (364)
T 3qyz_A 89 GINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166 (364)
T ss_dssp CCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred cceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC
Confidence 999999655 47899999996 599999875 45999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc
Q psy2306 175 AKIADFGLSNVFTESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN 250 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 250 (335)
++|+|||.+........ .....|++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 99999999976643322 23457899999999987666559999999999999999999999988765554444321
Q ss_pred C---------------------------CC-----CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 251 G---------------------------DY-----FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 251 ~---------------------------~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
. .. ..+..++++.++|.+||+.||.+|||++++|+||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 0 00 11345678999999999999999999999999999997644
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=342.71 Aligned_cols=259 Identities=30% Similarity=0.536 Sum_probs=227.8
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
.....++|++.+.||+|+||.||+|.+..+++.|++|++..... ....+.+.+|+..++.++||||+++++++.+.+.
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 17 KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK 94 (303)
T ss_dssp EECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 45567789999999999999999999999999999999986432 2345678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
.+++|||+++++|.+++.. .++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 95 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999999999875 569999999999999999999999999999999999999999999999999997765432
Q ss_pred -cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 191 -FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 191 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..... .....+..+.+++.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred cccCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence 2345568899999999988776 8899999999999999999999998887777666654432 33456778999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 268 EMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
+||+.||.+|||+.++++||||....
T Consensus 253 ~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 253 ACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHcCCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999999999997543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=341.22 Aligned_cols=271 Identities=30% Similarity=0.504 Sum_probs=224.4
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
.......++|++.+.||+|+||.||+|.+..+|+.|++|.+.... ..+.+.+|+..++.++||||+++++++...
T Consensus 22 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (314)
T 3com_A 22 SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96 (314)
T ss_dssp --------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred hhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 345667889999999999999999999999999999999997632 234678899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
+..+++|||+++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 99999999999999999997 46679999999999999999999999999999999999999999999999999997664
Q ss_pred CCc-cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCch
Q psy2306 188 ESR-FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTA 262 (335)
Q Consensus 188 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l 262 (335)
... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+...... +...+..+
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred hhccccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence 432 2344568899999999988776 89999999999999999999999887776655555443321 22346789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHHHh
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKDHSVACLEEAEELA 305 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~ 305 (335)
.++|.+||+.||.+|||+.++++||||+...............
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~ 298 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEA 298 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHHHHHhhhh
Confidence 9999999999999999999999999999887777666554433
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=356.10 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=211.8
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-----
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN----- 107 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 107 (335)
...++|++.+.||+|+||+||+|.+..+|+.||+|.+...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3567999999999999999999999999999999998754322 2368999999999999999999843
Q ss_pred ---------------------------------CCeEEEEEecCCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHH
Q psy2306 108 ---------------------------------REKMVLVMEYAAGGELYDFLD----QKKVLTEEEARRIFRQIATAVY 150 (335)
Q Consensus 108 ---------------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~ 150 (335)
....++||||+++ +|.+.+. .+..+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348999999975 7766654 4678999999999999999999
Q ss_pred HhHHCCcEecCCCCCCEEEc-cCCCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHH
Q psy2306 151 YCHKHKICHRDLKLENILLD-ENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTL 229 (335)
Q Consensus 151 ~LH~~givH~di~p~nili~-~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l 229 (335)
|||+.|++||||||+||+++ .++.+||+|||.+.............+++.|+|||++.+...++.++|||||||++|+|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 99999999999999999997 57899999999998776666666778899999999998766559999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcC--------------C-----C-----------CCCCCCCchHHHHHHhcccCCCCCCC
Q psy2306 230 VYGAMPFDGSNFKRLVKQISNG--------------D-----Y-----------FEPKNQSTASPLIAEMLNINPSSRAD 279 (335)
Q Consensus 230 ~tg~~p~~~~~~~~~~~~~~~~--------------~-----~-----------~~~~~~~~l~~li~~~l~~dp~~Rps 279 (335)
++|..||.+.+..+....+... . + .+...++++.++|.+||+.||.+|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999988766655544320 0 0 12335667999999999999999999
Q ss_pred HHHHhcCCCcCCC
Q psy2306 280 ISVICSHWWIDKD 292 (335)
Q Consensus 280 ~~~ll~~~~~~~~ 292 (335)
+.|+++||||++.
T Consensus 316 ~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 316 PYEAMAHPFFDHL 328 (383)
T ss_dssp HHHHHTSGGGHHH
T ss_pred HHHHhcCHHHHHH
Confidence 9999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=351.57 Aligned_cols=261 Identities=27% Similarity=0.414 Sum_probs=212.7
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC--HHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET--EADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
...++|++.+.||+|+||.||+|.+..+|+.|++|.+....... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 35679999999999999999999999999999999987533211 1123467799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.++||||+++ +|.+++..+ ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999976 888888754 46899999999999999999999999999999999999999999999999999776433
Q ss_pred -ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--CC----C--------
Q psy2306 190 -RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--DY----F-------- 254 (335)
Q Consensus 190 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--~~----~-------- 254 (335)
.......+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+... .. +
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 23345678999999999987665588999999999999999999999988776665554321 00 0
Q ss_pred ---------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 255 ---------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 255 ---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
....+.++.++|++||+.||.+|||+.|+|+||||+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 0233567899999999999999999999999999986543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=357.00 Aligned_cols=252 Identities=33% Similarity=0.586 Sum_probs=204.1
Q ss_pred hhccceeEE-eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHH-HcCCCCcccceeEEEEe---
Q psy2306 33 KLKQRFDIV-RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM-SSVRHPNIIHIYEVFEN--- 107 (335)
Q Consensus 33 ~~~~~y~~~-~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~--- 107 (335)
.+.++|.+. +.||+|+||+||+|.+..+|+.||+|++... ..+.+|+..+ +..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 344567776 7899999999999999999999999998642 2455777776 44589999999999875
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CCCeEEeecc
Q psy2306 108 -REKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NGNAKIADFG 181 (335)
Q Consensus 108 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~~~kL~df~ 181 (335)
.+.+|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 667899999999999999998643 5999999999999999999999999999999999999987 7899999999
Q ss_pred ccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHHhcCCCCC--
Q psy2306 182 LSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK----RLVKQISNGDYFE-- 255 (335)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~-- 255 (335)
++............+|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.. .....+..+....
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 9987765555566788999999999988776 89999999999999999999999765421 1233333333211
Q ss_pred ---CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 256 ---PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 256 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
...+.++.++|++||+.||.+|||+.++++||||.+..
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 34577899999999999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=340.83 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=202.0
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.++...++.++||||+++++++.+.+..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 4579999999999999999999999999999999987632 233344455566666788899999999999999999999
Q ss_pred EEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 114 VMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
+|||+++ +|.+++.. ...+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9999965 88777653 56799999999999999999999998 999999999999999999999999999987766
Q ss_pred CccccccccCCccCChhhhc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcH-HHHHHHHhcCCC--CCCCCCCc
Q psy2306 189 SRFLSTFCGSPLYASPEIVK---GIPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNF-KRLVKQISNGDY--FEPKNQST 261 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~-~~~-~~~~~~~~~~~~--~~~~~~~~ 261 (335)
........+++.|+|||++. ....++.++||||||+++|+|++|..||.. ... ......+..... .....+++
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (290)
T 3fme_A 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE 242 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHH
T ss_pred cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHH
Confidence 55555567899999999973 233348899999999999999999999985 333 333333333322 22346778
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 262 ASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
+.+++.+||+.||.+|||+.++++||||+..
T Consensus 243 ~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 243 FVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 9999999999999999999999999999743
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=350.38 Aligned_cols=274 Identities=24% Similarity=0.424 Sum_probs=222.9
Q ss_pred cccccCCCCccch--hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC
Q psy2306 16 MGGIESTGGVRLH--NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93 (335)
Q Consensus 16 ~~~~~~~~~~~~~--~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l 93 (335)
|...+..+-++.. .....+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+
T Consensus 20 m~~~~~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l 98 (371)
T 4exu_A 20 MSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM 98 (371)
T ss_dssp -CCSSCTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHC
T ss_pred eeeeccccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhc
Confidence 4444444433332 234567889999999999999999999999999999999997633 3455677888999999999
Q ss_pred CCCcccceeEEEEeCCeE------EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCE
Q psy2306 94 RHPNIIHIYEVFENREKM------VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENI 167 (335)
Q Consensus 94 ~~~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ni 167 (335)
+||||+++++++...+.. +++|||+. ++|.+++. ..+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 99 ~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 175 (371)
T 4exu_A 99 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 175 (371)
T ss_dssp CCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHe
Confidence 999999999999876654 99999996 58888874 3499999999999999999999999999999999999
Q ss_pred EEccCCCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q psy2306 168 LLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQ 247 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~ 247 (335)
+++.++.++|+|||.+...... .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....
T Consensus 176 ll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 253 (371)
T 4exu_A 176 AVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 253 (371)
T ss_dssp EECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999999999765433 34457899999999998754459999999999999999999999998876665555
Q ss_pred HhcCC-------------------------C-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 248 ISNGD-------------------------Y-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 248 ~~~~~-------------------------~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
+.... . ..+..++.+.+||++||+.||.+|||++|+|+||||+.....
T Consensus 254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 43210 0 113457789999999999999999999999999999865433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=345.34 Aligned_cols=262 Identities=34% Similarity=0.593 Sum_probs=220.4
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-CHHHHHHHHHHHHHHHcCCCCcccceeEEE--EeCC
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-TEADLIRIRREIQIMSSVRHPNIIHIYEVF--ENRE 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~ 109 (335)
++.++|++.+.||+|+||.||+|.+..++..|++|++...... .....+.+.+|+..++.++|+||+++++++ .+.+
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 4568999999999999999999999999999999998753211 123456789999999999999999999998 4456
Q ss_pred eEEEEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
..+++|||++++ |.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 889999999775 7777765 4569999999999999999999999999999999999999999999999999997654
Q ss_pred C---CccccccccCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCch
Q psy2306 188 E---SRFLSTFCGSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTA 262 (335)
Q Consensus 188 ~---~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l 262 (335)
. ........+++.|+|||++.+.. ..+.++||||||+++|+|++|..||...+..+....+...... +...+..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 3 22233456899999999997643 2367899999999999999999999998888888777766543 44567799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 263 SPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.+++.+||+.||.+|||++++++||||++....
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 999999999999999999999999999876554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=342.09 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=212.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEe--CCe
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFEN--REK 110 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~ 110 (335)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 4579999999999999999999999999999999987422 346789999999997 9999999999987 678
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-CeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-NAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-~~kL~df~~~~~~~~~ 189 (335)
.+++|||+++++|.+++.. +++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||.+......
T Consensus 108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999999999854 89999999999999999999999999999999999999777 8999999999877666
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHH-------------HhcCCC--
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQ-------------ISNGDY-- 253 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~-------------~~~~~~-- 253 (335)
.......+++.|+|||++.+...++.++||||||+++|+|++|..||.... ..+.... +.....
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 556667889999999999875555999999999999999999999995432 2111111 111110
Q ss_pred -----------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 254 -----------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 254 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.....++++.++|.+||+.||.+|||++|+|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0111477899999999999999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=349.49 Aligned_cols=269 Identities=30% Similarity=0.554 Sum_probs=221.3
Q ss_pred CCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH---HHHHHHHHHHHHHHcCC--C
Q psy2306 21 STGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE---ADLIRIRREIQIMSSVR--H 95 (335)
Q Consensus 21 ~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--~ 95 (335)
....+........+.++|++.+.||+|+||.||+|.+..+++.|++|.+........ .....+.+|+.+++.++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 107 (320)
T 3a99_A 28 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107 (320)
T ss_dssp ------------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSS
T ss_pred hhhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCC
Confidence 334556667788899999999999999999999999999999999999976432221 11234567889999986 5
Q ss_pred CcccceeEEEEeCCeEEEEEecCCC-CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc-cCC
Q psy2306 96 PNIIHIYEVFENREKMVLVMEYAAG-GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD-ENG 173 (335)
Q Consensus 96 ~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~-~~~ 173 (335)
+||+++++++.+.+..++++|++.+ ++|.+++..+..+++..++.++.|++.||+|||+.|++|+||+|+||+++ .++
T Consensus 108 ~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp CSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT
T ss_pred CCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC
Confidence 9999999999999999999999976 89999999888899999999999999999999999999999999999998 678
Q ss_pred CeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC
Q psy2306 174 NAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY 253 (335)
Q Consensus 174 ~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~ 253 (335)
.+||+|||.+....... .....+++.|+|||++.+..+.+.++||||||+++|+|++|..||..... .......
T Consensus 188 ~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~ 261 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIRGQVF 261 (320)
T ss_dssp EEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHHCCCC
T ss_pred CEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hhccccc
Confidence 99999999987765432 33456899999999998777667889999999999999999999975421 2233334
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.....++++.++|++||+.||.+|||++++++||||++....
T Consensus 262 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 556678899999999999999999999999999999987554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=355.28 Aligned_cols=263 Identities=25% Similarity=0.429 Sum_probs=215.1
Q ss_pred CCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC------
Q psy2306 21 STGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR------ 94 (335)
Q Consensus 21 ~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~------ 94 (335)
.+++++....++.+.++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+.+|+.+++.++
T Consensus 22 ~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~ 97 (397)
T 1wak_A 22 CKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPND 97 (397)
T ss_dssp CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHSCTTC
T ss_pred CCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec----CCcchHHHHHHHHHHHHHhhcCCCC
Confidence 567788889999999999999999999999999999999999999999874 3445667889999998885
Q ss_pred --CCcccceeEEEE----eCCeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCC
Q psy2306 95 --HPNIIHIYEVFE----NREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLE 165 (335)
Q Consensus 95 --~~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~ 165 (335)
|+||+++++++. .....++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ |++||||||+
T Consensus 98 ~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~ 176 (397)
T 1wak_A 98 PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE 176 (397)
T ss_dssp GGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGG
T ss_pred CCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 788999999987 556899999999 55666666543 5699999999999999999999998 9999999999
Q ss_pred CEEEccCC-------------------------------------------------CeEEeeccccccccCCccccccc
Q psy2306 166 NILLDENG-------------------------------------------------NAKIADFGLSNVFTESRFLSTFC 196 (335)
Q Consensus 166 nili~~~~-------------------------------------------------~~kL~df~~~~~~~~~~~~~~~~ 196 (335)
||+++.++ .++|+|||.+...... .....
T Consensus 177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~ 254 (397)
T 1wak_A 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDI 254 (397)
T ss_dssp GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCC
T ss_pred HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCC
Confidence 99998765 7999999999776543 34457
Q ss_pred cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHHhc---C---------CC-----
Q psy2306 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN------FKRLVKQISN---G---------DY----- 253 (335)
Q Consensus 197 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~------~~~~~~~~~~---~---------~~----- 253 (335)
|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+ .......+.. . ..
T Consensus 255 gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 333 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333 (397)
T ss_dssp SCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred CCCcccCChhhcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence 8999999999998876 899999999999999999999997543 1111111111 0 00
Q ss_pred --------------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 254 --------------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 254 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
.....+..+.+||.+||+.||.+|||++|+|+||||++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00111235779999999999999999999999999963
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=350.34 Aligned_cols=263 Identities=24% Similarity=0.432 Sum_probs=225.0
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHH--------------HHHHHHHHHHHHHcCCCC
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEA--------------DLIRIRREIQIMSSVRHP 96 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~--------------~~~~~~~e~~~l~~l~~~ 96 (335)
...+.++|++.+.||+|+||.||+|.+ +|+.|++|.+......... ..+.+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 455668999999999999999999998 7999999998753322111 126788999999999999
Q ss_pred cccceeEEEEeCCeEEEEEecCCCCCHHHH------Hhh--CCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCE
Q psy2306 97 NIIHIYEVFENREKMVLVMEYAAGGELYDF------LDQ--KKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENI 167 (335)
Q Consensus 97 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~ni 167 (335)
||+++++++.+.+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 665 5779999999999999999999999 9999999999999
Q ss_pred EEccCCCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCcH-HHHH
Q psy2306 168 LLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP-EVDCWSLGVLLYTLVYGAMPFDGSNF-KRLV 245 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Dv~slG~~l~~l~tg~~p~~~~~~-~~~~ 245 (335)
+++.++.++|+|||.+...... ......+++.|+|||++.+...++. ++||||||+++|+|++|..||...+. .+..
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999999999999999776443 3445678999999999988733244 89999999999999999999988766 6677
Q ss_pred HHHhcCCCCC--------------------CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 246 KQISNGDYFE--------------------PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 246 ~~~~~~~~~~--------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
..+....... ...+.++.+++.+||+.||.+|||+.++++||||++.....
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~ 333 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED 333 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHH
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHH
Confidence 7766654322 34577899999999999999999999999999999765443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=347.42 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=212.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE- 109 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 109 (335)
...+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 34577899999999999999999999999999999999975332 223456789999999999999999999998765
Q ss_pred -eEEEEEecCCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE----ccCCCeEEeecc
Q psy2306 110 -KMVLVMEYAAGGELYDFLDQKK---VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL----DENGNAKIADFG 181 (335)
Q Consensus 110 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili----~~~~~~kL~df~ 181 (335)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||||+||++ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 7899999999999999998643 39999999999999999999999999999999999999 677789999999
Q ss_pred ccccccCCccccccccCCccCChhhhc--------CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHh
Q psy2306 182 LSNVFTESRFLSTFCGSPLYASPEIVK--------GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS----NFKRLVKQIS 249 (335)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~----~~~~~~~~~~ 249 (335)
.+.............+++.|+|||++. +..+ +.++||||||+++|+|++|..||... ...+....+.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 998877666666677999999999986 3444 89999999999999999999999642 2233333333
Q ss_pred cCCCC--------------------C------CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy2306 250 NGDYF--------------------E------PKNQSTASPLIAEMLNINPSSRADISVICSHWW 288 (335)
Q Consensus 250 ~~~~~--------------------~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 288 (335)
.+... + ...+..+.+++++||+.||.+|||++|+|+||-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 32210 0 011336788999999999999999999998874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=346.20 Aligned_cols=262 Identities=26% Similarity=0.443 Sum_probs=218.8
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC-
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR- 108 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 108 (335)
....+.++|++.+.||+|+||.||+|.+..+|+.|++|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 3456788999999999999999999999999999999998652 3455667788999999999999999999988654
Q ss_pred ----CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 109 ----EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 109 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
...++++|+++ ++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 67999999996 599999876 469999999999999999999999999999999999999999999999999997
Q ss_pred cccCCcc-----------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--
Q psy2306 185 VFTESRF-----------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-- 251 (335)
Q Consensus 185 ~~~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-- 251 (335)
....... .....|++.|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 6543211 123467899999999876544589999999999999999999999988765544433210
Q ss_pred -C-----------------------C-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 252 -D-----------------------Y-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 252 -~-----------------------~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
. . ..+..++++.++|++||+.||.+|||++++++||||+.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 0 0 013456788999999999999999999999999999875443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=363.37 Aligned_cols=249 Identities=12% Similarity=0.132 Sum_probs=204.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHH---HHHcCCCCccccee-------EE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ---IMSSVRHPNIIHIY-------EV 104 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~---~l~~l~~~~i~~~~-------~~ 104 (335)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999899999999998655555566778889994 45555799999998 77
Q ss_pred EEeCC-----------------eEEEEEecCCCCCHHHHHhhCCCCCH-------HHHHHHHHHHHHHHHHhHHCCcEec
Q psy2306 105 FENRE-----------------KMVLVMEYAAGGELYDFLDQKKVLTE-------EEARRIFRQIATAVYYCHKHKICHR 160 (335)
Q Consensus 105 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~i~~~l~~~l~~LH~~givH~ 160 (335)
+.+.+ ..+++|||+ +|+|.+++...+.+++ ..++.++.|++.||+|||++|++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66554 389999999 6799999986544554 8888999999999999999999999
Q ss_pred CCCCCCEEEccCCCeEEeeccccccccCCccccccccCCccCChhhhcCC-----------CCCCCcchHHHHHHHHHHH
Q psy2306 161 DLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI-----------PYHGPEVDCWSLGVLLYTL 229 (335)
Q Consensus 161 di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Dv~slG~~l~~l 229 (335)
||||+||+++.++.+||+|||++..... ......| +.|+|||++.+. .+ +.++||||||+++|+|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHHHH
Confidence 9999999999999999999999976433 2344566 999999999876 45 8999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 230 VYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 230 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
++|..||...+.......+... ....++++.++|.+||+.||.+|||+.++++||||++
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIFRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHSSCCC------CCSGGGGSS---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHCCCCCcccccccchhhhhhh---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999776544433333222 2466789999999999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=342.18 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=213.6
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE---
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE--- 106 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 106 (335)
.+..+.++|++.+.||+|+||.||+|.+..+|+.|++|.+... .....+.+.+|+..++.++||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 4567889999999999999999999999999999999998753 4556778899999999999999999999873
Q ss_pred -----------eCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc-cCCC
Q psy2306 107 -----------NREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD-ENGN 174 (335)
Q Consensus 107 -----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~-~~~~ 174 (335)
+.+..+++|||++ ++|.+++.. +++++..++.++.|++.||+|||+.|++|+||+|+||+++ .++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence 4468899999997 599999874 5699999999999999999999999999999999999997 4678
Q ss_pred eEEeeccccccccCC----ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc
Q psy2306 175 AKIADFGLSNVFTES----RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN 250 (335)
Q Consensus 175 ~kL~df~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 250 (335)
+||+|||.+...... .......+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999765432 2233456788999999987644458999999999999999999999998876655544432
Q ss_pred CCC-------------------------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 251 GDY-------------------------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 251 ~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
... ..+..+.++.++|++||+.||.+|||++++++||||+....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 211 113467789999999999999999999999999999865433
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=336.32 Aligned_cols=257 Identities=30% Similarity=0.560 Sum_probs=223.0
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--CCeE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--REKM 111 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 111 (335)
..++|++.+.||+|+||.||+|.+..+|+.|++|.+..... .....+.+.+|+..++.++||||+++++++.+ .+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34699999999999999999999999999999999986433 44567789999999999999999999998854 6789
Q ss_pred EEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCC-----cEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 112 VLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHK-----ICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~g-----ivH~di~p~nili~~~~~~kL~df~~ 182 (335)
+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999999975 345999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcc-ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCC
Q psy2306 183 SNVFTESRF-LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQ 259 (335)
Q Consensus 183 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 259 (335)
+........ .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+..+.. .+...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred heeeccccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccC
Confidence 876654322 234568999999999988776 8999999999999999999999999888887777776654 334567
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 260 STASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.++.++|.+||+.||.+|||+.++++|+|+.+.
T Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 242 DELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 899999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=343.65 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=217.1
Q ss_pred chhhhhhhccceeEEeeeeccCCeEEEEEEE-CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCC------ccc
Q psy2306 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGIN-KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP------NII 99 (335)
Q Consensus 27 ~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~-~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~ 99 (335)
....++.+.++|++.+.||+|+||.||+|.+ ..+++.||+|++.. .....+.+.+|+.+++.++|+ +++
T Consensus 5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----CCchhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 3456788899999999999999999999998 56789999999864 234556788899999888654 599
Q ss_pred ceeEEEEeCCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc------
Q psy2306 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE------ 171 (335)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~------ 171 (335)
++++++.+.+..++||||+ +++|.+++.... ++++..++.++.|++.||+|||++|++|+||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred -------------CCCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy2306 172 -------------NGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG 238 (335)
Q Consensus 172 -------------~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~ 238 (335)
++.++|+|||.+...... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCC
Confidence 668999999998765433 234578999999999988776 8999999999999999999999988
Q ss_pred CcHHHHHHHHhcCCC---------------------------------------------CCCCCCCchHHHHHHhcccC
Q psy2306 239 SNFKRLVKQISNGDY---------------------------------------------FEPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 239 ~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~l~~li~~~l~~d 273 (335)
.+..+....+..... .....++++.++|.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 776655443322100 00111346789999999999
Q ss_pred CCCCCCHHHHhcCCCcCCC
Q psy2306 274 PSSRADISVICSHWWIDKD 292 (335)
Q Consensus 274 p~~Rps~~~ll~~~~~~~~ 292 (335)
|.+|||+.|+++||||+..
T Consensus 317 P~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 317 PAKRITLREALKHPFFDLL 335 (339)
T ss_dssp TTTSCCHHHHTTSGGGGGG
T ss_pred cccccCHHHHhcCHHHHHH
Confidence 9999999999999999853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=353.03 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=211.3
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.+.....+|++.+.||+|+||+||+|.+..++. +++|.+...... ..+|+.+++.++||||+++++++...+
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 355667799999999999999999999987665 888877643221 126899999999999999999995433
Q ss_pred ------eEEEEEecCCCCCHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc-cCCCeEEee
Q psy2306 110 ------KMVLVMEYAAGGELYDFL---DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD-ENGNAKIAD 179 (335)
Q Consensus 110 ------~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~-~~~~~kL~d 179 (335)
..++||||++++.+..+. .....+++..++.++.|++.||+|||+.|++||||||+||+++ .++.+||+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 388999999764333322 2366799999999999999999999999999999999999998 789999999
Q ss_pred ccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--------
Q psy2306 180 FGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------- 251 (335)
Q Consensus 180 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------- 251 (335)
||.+.............+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 186 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987766555566778999999999987665699999999999999999999999988765554443320
Q ss_pred -----------C-----------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 252 -----------D-----------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 252 -----------~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
. ......++++.++|.+||+.||.+|||+.++++||||++...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0 012235678999999999999999999999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=338.74 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=209.3
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||+||+|.+ +|..||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 4456999999999999999999976 47899999987643 34555678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 113 LVMEYAAGGELYDFLDQKKV---LTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
+||||+++++|.+++..... +++..++.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999987553 999999999999999999999999 9999999999999999999999999987654
Q ss_pred CCc-cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---CCCCCCCCCchH
Q psy2306 188 ESR-FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---DYFEPKNQSTAS 263 (335)
Q Consensus 188 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 263 (335)
... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+... ...+...++++.
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269 (309)
T ss_dssp -----------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred ccccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 332 2345678999999999988776 89999999999999999999999998888777666422 223455678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy2306 264 PLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~ 285 (335)
++|.+||+.||.+|||+.++++
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=347.20 Aligned_cols=266 Identities=26% Similarity=0.406 Sum_probs=212.8
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc--------CCHHHHHHHHHHHHHHHcCCCCcccc
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI--------ETEADLIRIRREIQIMSSVRHPNIIH 100 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~i~~ 100 (335)
.....+.++|++.+.||+|+||.||+|.+.. |..||+|.+..... ......+.+.+|+.+++.++||||++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 3456788999999999999999999999865 89999999865322 23344578899999999999999999
Q ss_pred eeEEEEe-----CCeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 101 IYEVFEN-----REKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 101 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
+++++.. ....++||||++ ++|.+.+.. +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 9999843 347899999997 578777765 447999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC---
Q psy2306 175 AKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--- 251 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--- 251 (335)
++|+|||.+.............+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+...
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999999987665555566778999999999987554599999999999999999999999988766655554320
Q ss_pred --------------------CC----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 252 --------------------DY----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 252 --------------------~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
.. ..+..++.+.++|.+||+.||.+|||+.++++||||+......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 327 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL 327 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence 00 1123466789999999999999999999999999999865543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=341.37 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=214.4
Q ss_pred hhccceeEEeeeeccCCeEEEEEEEC-CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC---CCCcccceeEEEE--
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINK-ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV---RHPNIIHIYEVFE-- 106 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-- 106 (335)
...++|++.+.||+|+||.||+|.+. .+|+.|++|++....... .....+.+|+..++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 35579999999999999999999995 678999999987533211 1112344555555554 8999999999987
Q ss_pred ---eCCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecc
Q psy2306 107 ---NREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFG 181 (335)
Q Consensus 107 ---~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~ 181 (335)
.....++++||++ ++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5668999999997 59999998643 49999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC---------
Q psy2306 182 LSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--------- 252 (335)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--------- 252 (335)
.+.............+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred ccccccCCCCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 9987665555556778999999999988776 899999999999999999999999887766655543210
Q ss_pred -------------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 253 -------------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 253 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
......+..+.++|.+||+.||.+|||+.++++||||++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 012345667899999999999999999999999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=344.86 Aligned_cols=265 Identities=23% Similarity=0.404 Sum_probs=220.9
Q ss_pred cCCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCC-cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc-
Q psy2306 20 ESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETG-QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN- 97 (335)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~-~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~- 97 (335)
+.+++......++.+.++|++.+.||+|+||.||+|.+..++ ..||+|++.. .....+.+.+|+.+++.++|++
T Consensus 3 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~ 78 (355)
T 2eu9_A 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIKEKDK 78 (355)
T ss_dssp BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHHCT
T ss_pred cccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----cccchhHHHHHHHHHHHHhhcCC
Confidence 456677777889999999999999999999999999998776 6899999874 2345567788999998887654
Q ss_pred -----ccceeEEEEeCCeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE-
Q psy2306 98 -----IIHIYEVFENREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL- 169 (335)
Q Consensus 98 -----i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili- 169 (335)
++.+++++...+..+++||++ ++++.+.+... .++++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~ 157 (355)
T 2eu9_A 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFV 157 (355)
T ss_dssp TSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEES
T ss_pred CCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 899999999999999999999 56777776654 469999999999999999999999999999999999999
Q ss_pred ------------------ccCCCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh
Q psy2306 170 ------------------DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY 231 (335)
Q Consensus 170 ------------------~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t 231 (335)
+.++.+||+|||.+...... .....|++.|+|||++.+..+ +.++||||||+++|+|++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHh
Confidence 56789999999999765433 234578999999999988776 899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCC---------------------------------------------CCCCCCchHHHH
Q psy2306 232 GAMPFDGSNFKRLVKQISNGDYF---------------------------------------------EPKNQSTASPLI 266 (335)
Q Consensus 232 g~~p~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~l~~li 266 (335)
|..||...+..+....+...... ....+.++.++|
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence 99999887766544433221000 000123678999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
++||+.||.+|||++++++||||+..
T Consensus 315 ~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 315 RRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HHHhcCChhhCcCHHHHhcChhhcCC
Confidence 99999999999999999999999865
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=343.01 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=210.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC--CcccceeEEEEeCCe
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH--PNIIHIYEVFENREK 110 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~ 110 (335)
...++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+.+|+.+++.++| +||+++++++.+.+.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34668999999999999999999875 58899999997643 345566788999999999976 999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
.++|||+ .+++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++ ++.+||+|||++.......
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9999995 4789999999989999999999999999999999999999999999999996 6789999999997764332
Q ss_pred c---ccccccCCccCChhhhcC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcCC---C
Q psy2306 191 F---LSTFCGSPLYASPEIVKG----------IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQISNGD---Y 253 (335)
Q Consensus 191 ~---~~~~~~~~~~~aPE~~~~----------~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~~~~~~---~ 253 (335)
. .....|++.|+|||++.+ ...++.++||||||+++|+|++|..||.... .......+.... .
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 2 235678999999999864 1234889999999999999999999997643 223333333221 1
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.+...+.++.+++.+||+.||.+|||+.++++||||+...
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 2333456899999999999999999999999999998543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=343.20 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=196.0
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
....++|++.+.||+|+||.||+|.+..+++.|++|.+.... .....+.+.+|+..++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 445679999999999999999999998899999999986532 223455778999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 112 VLVMEYAAGGELYDFLDQ--------KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999974 456999999999999999999999999999999999999999999999999988
Q ss_pred ccccCCc------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----
Q psy2306 184 NVFTESR------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---- 253 (335)
Q Consensus 184 ~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---- 253 (335)
....... ......+++.|+|||++.+...++.++||||||+++|+|++|..||.................
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 6654321 123456899999999987533348899999999999999999999987665444433332221
Q ss_pred -------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 254 -------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 254 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
.....+.++.+++.+||+.||.+|||+.++++||||++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 11334668999999999999999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=338.78 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=214.9
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEe----
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFEN---- 107 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---- 107 (335)
...++|++.+.||+|+||.||+|.+..+|+.|++|++..... ..+.+.+|+..++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 356799999999999999999999999999999999976432 234677899999998 79999999999976
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 108 --REKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 108 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
.+..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 56899999999999999999864 56999999999999999999999999999999999999999999999999998
Q ss_pred ccccCC-ccccccccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CC
Q psy2306 184 NVFTES-RFLSTFCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FE 255 (335)
Q Consensus 184 ~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~ 255 (335)
...... .......+++.|+|||++.. ...++.++||||||+++|+|++|..||...+.......+..... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence 765432 22344568999999999862 22348899999999999999999999988877666655544332 23
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
...+..+.++|.+||+.||.+||+++++++||||++....
T Consensus 257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296 (326)
T ss_dssp SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTH
T ss_pred cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccc
Confidence 4567799999999999999999999999999999976544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=342.69 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=216.5
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
....+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 18 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 34557789999999999999999999999999999999987532 34556678889999999999999999999997765
Q ss_pred e------EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 110 K------MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 110 ~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
. ++++|||++ ++|.+++.. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred ccccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 3 599999996 588887753 4899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC------------
Q psy2306 184 NVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG------------ 251 (335)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------------ 251 (335)
...... .....+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 765433 234578999999999987544589999999999999999999999887765554443220
Q ss_pred --------------------CCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 252 --------------------DYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 252 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
....+..++++.++|.+||+.||.+|||++++++||||+.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 01123457789999999999999999999999999999865443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=345.03 Aligned_cols=259 Identities=28% Similarity=0.415 Sum_probs=205.2
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
....-++|++.+.||+|+||.||+|.+..+|+.||+|.+....... ....+++..+..++||||+++++++...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 4455679999999999999999999999999999999986543222 245567788888999999999999965433
Q ss_pred -------EEEEEecCCCCCHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhH--HCCcEecCCCCCCEEEcc-CCCeE
Q psy2306 111 -------MVLVMEYAAGGELYDFL----DQKKVLTEEEARRIFRQIATAVYYCH--KHKICHRDLKLENILLDE-NGNAK 176 (335)
Q Consensus 111 -------~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~~l~~~l~~LH--~~givH~di~p~nili~~-~~~~k 176 (335)
.+++|||+++ +|...+ .....+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 8899999976 544333 35677999999999999999999999 999999999999999997 89999
Q ss_pred EeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC----
Q psy2306 177 IADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD---- 252 (335)
Q Consensus 177 L~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---- 252 (335)
|+|||++.............+++.|+|||++.+...++.++||||||+++|+|++|..||...+.......+....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999999887766655667789999999999776655999999999999999999999999887766665554210
Q ss_pred -----------------------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 253 -----------------------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 253 -----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
......+.++.++|.+||+.||.+|||+.|+|+||||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 001113457899999999999999999999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=335.93 Aligned_cols=246 Identities=23% Similarity=0.429 Sum_probs=210.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||+||+|.+..+++.|++|.+.. ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 3699999999999999999999999999999999854 3456677899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc-
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL- 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~- 192 (335)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||.+.........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999999987 567999999999999999999999999999999999999999999999999999766433221
Q ss_pred --------------cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHHhcCCC
Q psy2306 193 --------------STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR-----LVKQISNGDY 253 (335)
Q Consensus 193 --------------~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~-----~~~~~~~~~~ 253 (335)
....|++.|+|||++.+..+ +.++||||||+++|+|++|..||....... ...... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-~~~ 243 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-DRY 243 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-HHT
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-ccc
Confidence 14568999999999988776 899999999999999999999986532110 000000 012
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+...++.+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 35667889999999999999999999999984
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=332.41 Aligned_cols=257 Identities=28% Similarity=0.528 Sum_probs=209.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-----
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN----- 107 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 107 (335)
++.++|++.+.||+|+||.||+|.+..+|+.|++|.+.. .....+.+.+|+..++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 467799999999999999999999999999999999864 34556788899999999999999999998854
Q ss_pred --------CCeEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEe
Q psy2306 108 --------REKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIA 178 (335)
Q Consensus 108 --------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~ 178 (335)
.+..+++|||+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence 45789999999999999999854 358899999999999999999999999999999999999999999999
Q ss_pred eccccccccCC---------------ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHH
Q psy2306 179 DFGLSNVFTES---------------RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFK 242 (335)
Q Consensus 179 df~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~-~~~~ 242 (335)
|||.+...... .......+++.|+|||++.+...++.++||||||+++|+|++ ||.. .+..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99998765421 122345688999999999876545899999999999999998 5543 2334
Q ss_pred HHHHHHhcCCCC-C----CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcch
Q psy2306 243 RLVKQISNGDYF-E----PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSVA 296 (335)
Q Consensus 243 ~~~~~~~~~~~~-~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 296 (335)
.....+...... + ...+..+.+++++||+.||.+|||++++++||||.......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHH
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHH
Confidence 444555443321 2 22344689999999999999999999999999998764443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=338.63 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=216.9
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCc---EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQ---EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN 107 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 107 (335)
.....++|++.+.||+|+||.||+|.+..++. .|++|.+... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34556799999999999999999999986554 5999998753 245566788999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999754 57999999999999999999999999999999999999999999999999999776
Q ss_pred cCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCC
Q psy2306 187 TESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQ 259 (335)
Q Consensus 187 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 259 (335)
..... .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...+
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 43321 123345678999999987776 889999999999999998 9999999998888888777643 334567
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 260 STASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
..+.+++.+||+.||.+|||+.++++
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 79999999999999999999999983
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=345.60 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=212.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC--CCcccceeEEEEeCCeE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR--HPNIIHIYEVFENREKM 111 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~ 111 (335)
..++|++.+.||+|+||.||+|.+.. +..||+|++..... .....+.+.+|+.+++.++ |+||+++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34579999999999999999998875 89999999976432 4556778999999999996 59999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR- 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~- 190 (335)
++||| +.+++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++ ++.+||+|||++.......
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 45789999999888999999999999999999999999999999999999995 6899999999998764332
Q ss_pred --cccccccCCccCChhhhcCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcCCC---C
Q psy2306 191 --FLSTFCGSPLYASPEIVKGI----------PYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQISNGDY---F 254 (335)
Q Consensus 191 --~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~~~~~~~---~ 254 (335)
......|++.|+|||++.+. ..++.++||||||+++|+|++|..||.... .......+..... .
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 12356789999999998752 234889999999999999999999997643 3333344433322 2
Q ss_pred CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 255 EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
+...+.++.++|.+||+.||.+|||+.++|+||||+...
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 233456899999999999999999999999999998553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.50 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=208.9
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC----
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR---- 108 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 108 (335)
....+|++.+.||+|+||.||+|.+..+|+.||+|.+..... ...+|+.+++.++|+||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 345589999999999999999999999999999999875321 223689999999999999999998432
Q ss_pred --CeEEEEEecCCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-CCeEEeecc
Q psy2306 109 --EKMVLVMEYAAGGELYDFLD----QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-GNAKIADFG 181 (335)
Q Consensus 109 --~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~-~~~kL~df~ 181 (335)
..+++||||+++ ++.+.+. ....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 246799999975 6666554 35679999999999999999999999999999999999999965 568999999
Q ss_pred ccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-----------
Q psy2306 182 LSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN----------- 250 (335)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~----------- 250 (335)
++.............+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 998766555555677899999999998765559999999999999999999999988775544433321
Q ss_pred ---C---CC-------------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 251 ---G---DY-------------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 251 ---~---~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
. .+ ..+..++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0 00 122346789999999999999999999999999999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=345.23 Aligned_cols=257 Identities=35% Similarity=0.584 Sum_probs=215.6
Q ss_pred cceeEEeeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCc-CCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCe
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKI-ETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREK 110 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 110 (335)
++|++.+.||+|+||.||+|.+. .+|+.||+|++..... ......+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 69999999999999999999984 4799999999865321 1112233566788999999 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES- 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~- 189 (335)
.++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence 9999999999999999998888999999999999999999999999999999999999999999999999998765322
Q ss_pred -ccccccccCCccCChhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcC-CCCCCCCCCch
Q psy2306 190 -RFLSTFCGSPLYASPEIVKGI-PYHGPEVDCWSLGVLLYTLVYGAMPFDGS----NFKRLVKQISNG-DYFEPKNQSTA 262 (335)
Q Consensus 190 -~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~tg~~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~l 262 (335)
.......|++.|+|||++.+. ..++.++||||||+++|+|++|..||... ....+...+... ...+...+..+
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHH
Confidence 223345789999999999863 23488999999999999999999999642 344444444433 33445567789
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCCCcCCC
Q psy2306 263 SPLIAEMLNINPSSRA-----DISVICSHWWIDKD 292 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~ 292 (335)
.++|.+||+.||.+|| +++++++||||+..
T Consensus 294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 9999999999999999 99999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=352.16 Aligned_cols=263 Identities=26% Similarity=0.448 Sum_probs=200.0
Q ss_pred cchhhhhhhccceeE-EeeeeccCCeEEEEEEEC--CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCccccee
Q psy2306 26 RLHNHRRKLKQRFDI-VRKLGQGNYGKVQLGINK--ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIY 102 (335)
Q Consensus 26 ~~~~~~~~~~~~y~~-~~~ig~g~~g~Vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 102 (335)
++.....++.+.|.+ .++||+|+||+||+|.+. .+++.||+|.+..... ...+.+|+.+++.++||||++++
T Consensus 10 ~~~~~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~ 84 (405)
T 3rgf_A 10 KLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQ 84 (405)
T ss_dssp HHHHHCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCC
T ss_pred chhhhhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEe
Confidence 444566778889998 458999999999999965 5688999999875332 12567899999999999999999
Q ss_pred EEEEe--CCeEEEEEecCCCCCHHHHHhh---------CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE--
Q psy2306 103 EVFEN--REKMVLVMEYAAGGELYDFLDQ---------KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL-- 169 (335)
Q Consensus 103 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili-- 169 (335)
+++.. ....++||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~ 163 (405)
T 3rgf_A 85 KVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMG 163 (405)
T ss_dssp EEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECC
T ss_pred eEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEec
Confidence 99954 778999999996 588887753 1249999999999999999999999999999999999999
Q ss_pred --ccCCCeEEeeccccccccCC----ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-
Q psy2306 170 --DENGNAKIADFGLSNVFTES----RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK- 242 (335)
Q Consensus 170 --~~~~~~kL~df~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~- 242 (335)
+.++.+||+|||++...... .......|++.|+|||++.+...++.++|||||||++|+|++|..||......
T Consensus 164 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 243 (405)
T 3rgf_A 164 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243 (405)
T ss_dssp SSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred CCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccc
Confidence 67789999999999876532 22345678999999999988665599999999999999999999999764431
Q ss_pred --------HHHHHHhc-CCC--------------------------------------CCCCCCCchHHHHHHhcccCCC
Q psy2306 243 --------RLVKQISN-GDY--------------------------------------FEPKNQSTASPLIAEMLNINPS 275 (335)
Q Consensus 243 --------~~~~~~~~-~~~--------------------------------------~~~~~~~~l~~li~~~l~~dp~ 275 (335)
+....+.. -.. .....+..+.+||++||+.||.
T Consensus 244 ~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~ 323 (405)
T 3rgf_A 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323 (405)
T ss_dssp ---CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG
T ss_pred cccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc
Confidence 11111110 000 0112266788999999999999
Q ss_pred CCCCHHHHhcCCCcCCCCc
Q psy2306 276 SRADISVICSHWWIDKDHS 294 (335)
Q Consensus 276 ~Rps~~~ll~~~~~~~~~~ 294 (335)
+|||++|+|+||||.+...
T Consensus 324 ~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 324 KRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp GSCCHHHHHTSGGGTSSSC
T ss_pred cCCCHHHHhcChhhccCCC
Confidence 9999999999999987543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=344.09 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=215.6
Q ss_pred chhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CC-----cccc
Q psy2306 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HP-----NIIH 100 (335)
Q Consensus 27 ~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~ 100 (335)
....+..+.++|++.+.||+|+||+||+|.+..+++.||+|++.. .......+..|+.+++.++ |+ ++++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 345677888999999999999999999999999999999999874 2344556778888888774 44 5999
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhH--HCCcEecCCCCCCEEEc--cCCC
Q psy2306 101 IYEVFENREKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCH--KHKICHRDLKLENILLD--ENGN 174 (335)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH--~~givH~di~p~nili~--~~~~ 174 (335)
+++++...+..++|||+++ ++|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++ .++.
T Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence 9999999999999999995 5999999865 46999999999999999999999 57999999999999995 4678
Q ss_pred eEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC
Q psy2306 175 AKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF 254 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 254 (335)
+||+|||++...... .....+++.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+......
T Consensus 200 ~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp EEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEeccCceecccc--cccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999999776433 345678999999999998876 89999999999999999999999988776665554321000
Q ss_pred -------------------------------------CCCC----------------------------CCchHHHHHHh
Q psy2306 255 -------------------------------------EPKN----------------------------QSTASPLIAEM 269 (335)
Q Consensus 255 -------------------------------------~~~~----------------------------~~~l~~li~~~ 269 (335)
.+.. .+++.+||++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 0000 02578999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCC
Q psy2306 270 LNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
|+.||.+|||++|+|+||||++.
T Consensus 357 L~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=342.85 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=216.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEEC-------CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINK-------ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVF 105 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 105 (335)
..++|++.+.||+|+||.||+|.+. .++..||+|++... ......+.+.+|+.+++.+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3579999999999999999999874 34567999998763 3455677899999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE
Q psy2306 106 ENREKMVLVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL 169 (335)
Q Consensus 106 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili 169 (335)
.+.+..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999998643 47999999999999999999999999999999999999
Q ss_pred ccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q psy2306 170 DENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLV 245 (335)
Q Consensus 170 ~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~ 245 (335)
+.++.+||+|||++........ .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999976543322 233456788999999988776 899999999999999998 99999988887777
Q ss_pred HHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 246 KQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 246 ~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
..+..+.. .+...+.++.+++.+||+.||.+||++.++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 77766543 33456779999999999999999999999994
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=331.35 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=211.2
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
...-++|++.+.||+|+||.||+|.+..+++.|++|++...........+.+.+|+..++.++||||+++++++.+.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 34457999999999999999999999999999999999875555566678899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR- 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~- 190 (335)
++++||+++++|.+++....++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999987664432
Q ss_pred -cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC----CCCCCCCchHHH
Q psy2306 191 -FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY----FEPKNQSTASPL 265 (335)
Q Consensus 191 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l 265 (335)
......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..... ..+..+.++.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 2234568899999999988776 8899999999999999999999998887766555554432 234568899999
Q ss_pred HHHhcccCCCCCC-CHHHHhc
Q psy2306 266 IAEMLNINPSSRA-DISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rp-s~~~ll~ 285 (335)
|.+||+.||.+|| ++++++.
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999 8888773
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=325.78 Aligned_cols=246 Identities=24% Similarity=0.448 Sum_probs=214.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||.||+|.+. ++..|++|++...... .+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 358999999999999999999987 4778999999764322 24688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-- 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-- 191 (335)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 999999999999965 45689999999999999999999999999999999999999999999999999976543321
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHH
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAE 268 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 268 (335)
.....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...+..+.+++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence 223445678999999987776 899999999999999999 9999999998888888877533 334457789999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q psy2306 269 MLNINPSSRADISVICSH 286 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~~ 286 (335)
||+.||.+|||+.+++++
T Consensus 243 ~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCcccCcCHHHHHHH
Confidence 999999999999999954
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=339.36 Aligned_cols=259 Identities=30% Similarity=0.553 Sum_probs=207.8
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH---HHHHHHHHHHHHHHcC----CCCcccce
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE---ADLIRIRREIQIMSSV----RHPNIIHI 101 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~~~~i~~~ 101 (335)
.....+.++|++.+.||+|+||.||+|.+..+++.|++|++........ .....+.+|+..+..+ +|+||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3467788999999999999999999999999999999999976432221 1233455788888888 89999999
Q ss_pred eEEEEeCCeEEEEEec-CCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc-cCCCeEEee
Q psy2306 102 YEVFENREKMVLVMEY-AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD-ENGNAKIAD 179 (335)
Q Consensus 102 ~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~-~~~~~kL~d 179 (335)
++++.+.+..++++|+ +.+++|.+++..+.++++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999999 78899999999888899999999999999999999999999999999999998 788999999
Q ss_pred ccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCC
Q psy2306 180 FGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ 259 (335)
Q Consensus 180 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 259 (335)
||.+....... .....+++.|+|||++.+..+.+.++||||||+++|+|++|..||..... ............+
T Consensus 184 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 184 FGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----ILEAELHFPAHVS 257 (312)
T ss_dssp CSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHHTCCCCCTTSC
T ss_pred cchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----HhhhccCCcccCC
Confidence 99987765432 34556899999999998777656689999999999999999999975321 2223333455678
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 260 STASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
..+.++|.+||+.||.+|||++++++||||+...
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 8999999999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=344.30 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=220.6
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEE-----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEE
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEV 104 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~-----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 104 (335)
......++|++.+.||+|+||.||+|. +..++..||+|.+... ........+.+|+.+++.++||||++++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345567899999999999999999999 4456789999998652 345556678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC---C
Q psy2306 105 FENREKMVLVMEYAAGGELYDFLDQK-------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG---N 174 (335)
Q Consensus 105 ~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~---~ 174 (335)
+.+.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 99999999999999999999999763 3589999999999999999999999999999999999998555 5
Q ss_pred eEEeeccccccccC---CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy2306 175 AKIADFGLSNVFTE---SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISN 250 (335)
Q Consensus 175 ~kL~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~ 250 (335)
+||+|||++..... ........+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999875422 222334567889999999987776 899999999999999998 9999999999888888887
Q ss_pred CCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 251 GDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 251 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
... .+...+..+.+++.+||+.||.+|||+.+|+++.++.
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 653 3344677899999999999999999999999887753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=349.79 Aligned_cols=255 Identities=14% Similarity=0.123 Sum_probs=195.3
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC--CCCccccee-------EE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV--RHPNIIHIY-------EV 104 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~ 104 (335)
....|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+..++.+ +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 345699999999999999999999999999999999986554556677788885444444 699987754 55
Q ss_pred EEeC-----------------CeEEEEEecCCCCCHHHHHhhC-CCCCHHHH------HHHHHHHHHHHHHhHHCCcEec
Q psy2306 105 FENR-----------------EKMVLVMEYAAGGELYDFLDQK-KVLTEEEA------RRIFRQIATAVYYCHKHKICHR 160 (335)
Q Consensus 105 ~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~------~~i~~~l~~~l~~LH~~givH~ 160 (335)
+... ..+++||||++ ++|.+++... ..++...+ ..++.|++.||+|||++|++||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 5433 34899999998 7999999863 33455555 6778999999999999999999
Q ss_pred CCCCCCEEEccCCCeEEeeccccccccCCccccccccCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy2306 161 DLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPFDG 238 (335)
Q Consensus 161 di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~~~ 238 (335)
||||+||+++.++.+||+|||++....... ....+++.|+|||++.+ ..+ +.++||||||+++|+|++|..||..
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998664332 24456699999999976 445 8999999999999999999999977
Q ss_pred CcHHHHHHH-------HhcCCC---CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 239 SNFKRLVKQ-------ISNGDY---FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 239 ~~~~~~~~~-------~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
......... ...... .....++.+.++|.+||+.||.+|||+.++++||||++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 643211000 000111 113457789999999999999999999999999999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=330.40 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=215.3
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCC-------cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETG-------QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVF 105 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~-------~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 105 (335)
...++|++.+.||+|+||+||+|.+..++ ..|++|.+... .....+.+.+|+..++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34579999999999999999999988776 47999998653 234456788999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC--------eE
Q psy2306 106 ENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN--------AK 176 (335)
Q Consensus 106 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~--------~k 176 (335)
.+.+..+++|||+++++|.+++..... +++..++.++.|++.||.|||++|++|+||||+||+++.++. ++
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 999999999999999999999999999999999999998887 99
Q ss_pred EeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCC
Q psy2306 177 IADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYFE 255 (335)
Q Consensus 177 L~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 255 (335)
|+|||.+...... ....+++.|+|||++.+...++.++||||||+++|+|++ |..||...+..............+
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP 238 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence 9999998655433 234578899999999874445899999999999999999 566677777766666666666666
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
...+.++.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7778899999999999999999999999965
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=337.11 Aligned_cols=258 Identities=23% Similarity=0.368 Sum_probs=199.8
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCc---EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQ---EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
...++|++.+.||+|+||.||+|.+..++. .||+|++..... .....+.+.+|+..++.++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 445689999999999999999999887665 899999876432 3344678899999999999999999999998766
Q ss_pred eE------EEEEecCCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEE
Q psy2306 110 KM------VLVMEYAAGGELYDFLDQKK------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKI 177 (335)
Q Consensus 110 ~~------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL 177 (335)
.. ++++||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 55 99999999999999996432 5999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC
Q psy2306 178 ADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY 253 (335)
Q Consensus 178 ~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 253 (335)
+|||.+........ .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 99999976644322 223445678999999988776 899999999999999999 9999998887777777666542
Q ss_pred --CCCCCCCchHHHHHHhcccCCCCCCC-------HHHHhcCCCcCCC
Q psy2306 254 --FEPKNQSTASPLIAEMLNINPSSRAD-------ISVICSHWWIDKD 292 (335)
Q Consensus 254 --~~~~~~~~l~~li~~~l~~dp~~Rps-------~~~ll~~~~~~~~ 292 (335)
.+...+.++.+++.+||+.||.+||| +++++.|||+...
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 34556779999999999999999999 8889999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=337.56 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=218.7
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE 106 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 106 (335)
....++|++.+.||+|+||.||+|.+. .+++.|++|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 445679999999999999999999987 355889999987532 4556678899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhC------------------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCC
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQK------------------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDL 162 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di 162 (335)
+.+..+++|||+++++|.+++... .++++..++.++.|++.||.|||++|++|+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999763 56999999999999999999999999999999
Q ss_pred CCCCEEEccCCCeEEeeccccccccCCc---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy2306 163 KLENILLDENGNAKIADFGLSNVFTESR---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDG 238 (335)
Q Consensus 163 ~p~nili~~~~~~kL~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~ 238 (335)
+|+||+++.++.+||+|||.+....... ......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCC
Confidence 9999999999999999999987654322 2234557888999999987776 899999999999999998 9999999
Q ss_pred CcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 239 SNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 239 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+..+....+..+.. .+...+..+.+++++||+.||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 988888888777654 34456779999999999999999999999984
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=339.42 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=220.4
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECC-------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCccccee
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKE-------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIY 102 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~ 102 (335)
.....++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 34556799999999999999999998753 3357999998763 3455667889999999999 899999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCC
Q psy2306 103 EVFENREKMVLVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLEN 166 (335)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~n 166 (335)
+++.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998653 49999999999999999999999999999999999
Q ss_pred EEEccCCCeEEeeccccccccCCc---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH
Q psy2306 167 ILLDENGNAKIADFGLSNVFTESR---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFK 242 (335)
Q Consensus 167 ili~~~~~~kL~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~ 242 (335)
|+++.++.+||+|||++....... ......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999997665432 2234456788999999988776 899999999999999999 99999999988
Q ss_pred HHHHHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 243 RLVKQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 243 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+....+..... .+...+.++.+++.+||+.||.+|||+.+++++
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88888877643 344567799999999999999999999999953
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=324.11 Aligned_cols=247 Identities=23% Similarity=0.438 Sum_probs=214.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||.||+|.+. ++..|++|.+...... .+.+.+|+..++.++||||+++++++.+.+..++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 4569999999999999999999876 4678999999764322 3467899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 114 VMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+|||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999999999764 45999999999999999999999999999999999999999999999999999766544322
Q ss_pred --cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 193 --STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 193 --~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...++.+.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMY 239 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHH
Confidence 23345667999999987776 889999999999999998 9999999888887777776543 23345778999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q psy2306 268 EMLNINPSSRADISVICSH 286 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~ 286 (335)
+||+.||.+|||+.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 240 SCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999965
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=327.17 Aligned_cols=249 Identities=19% Similarity=0.282 Sum_probs=210.0
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEe
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFEN 107 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 107 (335)
+.+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+|+..++.+ +|++++++++++.+
T Consensus 3 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 3 GQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp ---CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CcCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 34566888999999999999999999999999999999998753322 2467899999999 79999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC-----eEEeecc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN-----AKIADFG 181 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~-----~kL~df~ 181 (335)
....+++|||+ +++|.+++... .++++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99999999999 89999999864 45999999999999999999999999999999999999987765 9999999
Q ss_pred ccccccCCcc--------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhc
Q psy2306 182 LSNVFTESRF--------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---NFKRLVKQISN 250 (335)
Q Consensus 182 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---~~~~~~~~~~~ 250 (335)
.+........ .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||... ...+....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 9977654322 345568999999999988776 89999999999999999999999773 33333333322
Q ss_pred CCC------CCCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 251 GDY------FEPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 251 ~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
... .....++++.+++.+||+.||.+||++++|+
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~ 275 (298)
T 1csn_A 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 275 (298)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 211 1235678999999999999999999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=332.45 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=216.8
Q ss_pred hccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
..++|++.+.||+|+||.||+|.+. .++..|++|.+... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 3569999999999999999999873 45688999998753 3456677899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCC------------------------CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCC
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKV------------------------LTEEEARRIFRQIATAVYYCHKHKICHRDLKL 164 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~i~~~l~~~l~~LH~~givH~di~p 164 (335)
+..+++|||+++++|.+++..... +++..++.++.|++.||.|||++|++|+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 999999999999999999986543 89999999999999999999999999999999
Q ss_pred CCEEEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc
Q psy2306 165 ENILLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSN 240 (335)
Q Consensus 165 ~nili~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~ 240 (335)
+||+++.++.++|+|||++........ .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999976643322 223456778999999987766 889999999999999999 999999888
Q ss_pred HHHHHHHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 241 FKRLVKQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 241 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..+....+..... .+...++++.+++.+||+.||.+||++.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777777766543 344567799999999999999999999999854
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=342.36 Aligned_cols=266 Identities=26% Similarity=0.451 Sum_probs=212.0
Q ss_pred CCCccchhhhhhhc-cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC------
Q psy2306 22 TGGVRLHNHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR------ 94 (335)
Q Consensus 22 ~~~~~~~~~~~~~~-~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~------ 94 (335)
++++++.-.++.+. ++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+.+|+..++.++
T Consensus 4 ~~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~ 79 (373)
T 1q8y_A 4 PGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTK 79 (373)
T ss_dssp ---CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSH
T ss_pred CCCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccc
Confidence 45666666666654 599999999999999999999999999999999874 3344566778888888876
Q ss_pred -----CCcccceeEEEEeCC----eEEEEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCC
Q psy2306 95 -----HPNIIHIYEVFENRE----KMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKH-KICHRDL 162 (335)
Q Consensus 95 -----~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di 162 (335)
|+||+++++++...+ ..+++||++ +++|.+++.. ...+++..++.++.||+.||.|||++ |++|+||
T Consensus 80 ~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Di 158 (373)
T 1q8y_A 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDI 158 (373)
T ss_dssp HHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCC
T ss_pred hhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCC
Confidence 789999999997654 789999999 8899999976 34599999999999999999999998 9999999
Q ss_pred CCCCEEEccC------CCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy2306 163 KLENILLDEN------GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236 (335)
Q Consensus 163 ~p~nili~~~------~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~ 236 (335)
||+||+++.+ +.+||+|||++...... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||
T Consensus 159 kp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 159 KPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCC
Confidence 9999999543 37999999999766543 234578999999999998876 89999999999999999999999
Q ss_pred CCCcH------HHHHHHHhc-------------------------------------------CCCCCCCCCCchHHHHH
Q psy2306 237 DGSNF------KRLVKQISN-------------------------------------------GDYFEPKNQSTASPLIA 267 (335)
Q Consensus 237 ~~~~~------~~~~~~~~~-------------------------------------------~~~~~~~~~~~l~~li~ 267 (335)
...+. ......+.. ........+.++.+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 76431 111111110 00011122457789999
Q ss_pred HhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 268 EMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
+||+.||.+|||++++|+||||++....
T Consensus 316 ~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred HHhccCccccCCHHHHhhChhhhcccCc
Confidence 9999999999999999999999976444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=333.38 Aligned_cols=267 Identities=24% Similarity=0.397 Sum_probs=220.5
Q ss_pred cccccCCCCccchhhhhhhccceeEEeeeeccCCeEEEEEEEC-------CCCcEEEEEEeecCCcCCHHHHHHHHHHHH
Q psy2306 16 MGGIESTGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINK-------ETGQEVAIKTIKKCKIETEADLIRIRREIQ 88 (335)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~e~~ 88 (335)
|..+.+...+.-...-....++|++.+.||+|+||.||+|.+. .++..|++|++... ......+.+.+|+.
T Consensus 15 ~~~~~s~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~ 92 (334)
T 2pvf_A 15 MLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92 (334)
T ss_dssp --------CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHH
T ss_pred hhcccccccCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHH
Confidence 4445555555544444555689999999999999999999875 45778999998753 24556778899999
Q ss_pred HHHcC-CCCcccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHH
Q psy2306 89 IMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYY 151 (335)
Q Consensus 89 ~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~ 151 (335)
+++.+ +||||+++++++.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.|
T Consensus 93 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 172 (334)
T 2pvf_A 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172 (334)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 99999 89999999999999999999999999999999998643 38999999999999999999
Q ss_pred hHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHH
Q psy2306 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYT 228 (335)
Q Consensus 152 LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~ 228 (335)
||+.|++|+||+|+||+++.++.+||+|||.+........ .....+++.|+|||++.+..+ +.++||||||+++|+
T Consensus 173 LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e 251 (334)
T 2pvf_A 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWE 251 (334)
T ss_dssp HHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHH
T ss_pred HHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999976654322 223445778999999987666 889999999999999
Q ss_pred HHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 229 LVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 229 l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
|++ |..||......+....+..... .+...+.++.+++.+||+.||.+|||+.++++
T Consensus 252 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 252 IFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999 9999999888887777766532 34456779999999999999999999999994
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=329.58 Aligned_cols=256 Identities=21% Similarity=0.365 Sum_probs=197.3
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
-++|++.+.||+|+||.||+|.+..+|+.|++|.+.... ......+.+.++...++.++||||+++++++.+.+..+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 458999999999999999999999999999999998643 2233344555566678888999999999999999999999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
|||+ ++.+..+... ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||.+.........
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence 9999 5566666654 56799999999999999999999995 9999999999999999999999999999776555445
Q ss_pred cccccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcCCCC-C---CCCCCchH
Q psy2306 193 STFCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDYF-E---PKNQSTAS 263 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~~~~-~---~~~~~~l~ 263 (335)
....+++.|+|||++.. ...++.++||||||+++|+|++|..||.. ....+....+...... . ...+.++.
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 261 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHH
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHH
Confidence 55678999999999952 23348899999999999999999999986 3444444444443321 1 23577899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
+++.+||+.||.+||+++++++||||+..
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 262 SFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 99999999999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=327.83 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=207.4
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
|.....||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+..++.++||||+++++++.+.+..+++|||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 333448999999999999999999999999987643 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-CCCeEEeeccccccccCCc-cc
Q psy2306 118 AAGGELYDFLDQK---KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-NGNAKIADFGLSNVFTESR-FL 192 (335)
Q Consensus 118 ~~~~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-~~~~kL~df~~~~~~~~~~-~~ 192 (335)
+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+....... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 9999999999864 24679999999999999999999999999999999999987 8999999999997664322 23
Q ss_pred cccccCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCcH-HHH-HHH-H-hcCCCCCCCCCCchHHHHH
Q psy2306 193 STFCGSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-KRL-VKQ-I-SNGDYFEPKNQSTASPLIA 267 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-~~~-~~~-~-~~~~~~~~~~~~~l~~li~ 267 (335)
....+++.|+|||++.+.. .++.++||||||+++|+|++|..||..... ... ... . ......+...+.++.+++.
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 260 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHH
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHH
Confidence 3456889999999987543 237899999999999999999999965432 221 111 1 1122334556789999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 268 EMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
+||+.||.+||+++++++||||+..
T Consensus 261 ~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 261 KCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHccCChhhCCCHHHHhcChhhhhc
Confidence 9999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=341.87 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=215.3
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||.||+|.+..++..||+|.+... ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 46899999999999999999999989999999998753 2345556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccc
Q psy2306 115 MEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~ 193 (335)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++..........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999999999764 469999999999999999999999999999999999999999999999999987654332211
Q ss_pred ---ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 194 ---TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 194 ---~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
...++..|+|||++.+..+ +.++||||||+++|||++ |..||...+..+....+..+.. .+...+.++.+++.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1234667999999987776 889999999999999998 9999999888888777766543 23345778999999
Q ss_pred HhcccCCCCCCCHHHHh
Q psy2306 268 EMLNINPSSRADISVIC 284 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll 284 (335)
+||+.||.+|||+++++
T Consensus 350 ~cl~~dP~~Rps~~~i~ 366 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIY 366 (377)
T ss_dssp HHTCSSGGGSCCHHHHH
T ss_pred HHcCCCchhCcCHHHHH
Confidence 99999999999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=333.98 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=212.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEE--EEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEV--AIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKM 111 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~v--alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 111 (335)
.++|++.+.||+|+||.||+|.+..+|..+ ++|.+... ......+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 368999999999999999999998888765 99988752 2334456788999999999 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCC----------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCe
Q psy2306 112 VLVMEYAAGGELYDFLDQKK----------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNA 175 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~ 175 (335)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 99999999999999997654 69999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC-
Q psy2306 176 KIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY- 253 (335)
Q Consensus 176 kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~- 253 (335)
+|+|||++.............+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+.....
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 260 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 260 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC
Confidence 9999999875443333344556788999999987766 889999999999999998 9999999998888887776532
Q ss_pred -CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 254 -FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 254 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+...++++.++|.+||+.||.+|||+++++++
T Consensus 261 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 334457799999999999999999999999954
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=325.09 Aligned_cols=247 Identities=21% Similarity=0.423 Sum_probs=212.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
-.++|++.+.||+|+||+||+|.+. ++..|++|++...... .+.+.+|+..++.++|+||+++++++.+.+..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 3469999999999999999999877 5778999999864322 2467899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-
Q psy2306 114 VMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~- 191 (335)
+|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999999999976 56799999999999999999999999999999999999999999999999999976643321
Q ss_pred -ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 192 -LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 192 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
.....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...++.+.+++.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHH
Confidence 223345678999999987776 899999999999999998 9999999888888887776633 33445778999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q psy2306 268 EMLNINPSSRADISVICSH 286 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~ 286 (335)
+||+.||.+|||+.++++|
T Consensus 256 ~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 256 SCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhHCcCHHHHHHH
Confidence 9999999999999999965
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=324.13 Aligned_cols=254 Identities=27% Similarity=0.510 Sum_probs=208.0
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
+....++|++.+.||+|+||.||+|.+..+|+.|++|.+...........+.+.+|+..++.++||||+++++++.+.+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 34455689999999999999999999999999999999987555566777889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
.+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999999864 567999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc-cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHHhcCCCC---CCCCCC
Q psy2306 187 TESR-FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS--NFKRLVKQISNGDYF---EPKNQS 260 (335)
Q Consensus 187 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~--~~~~~~~~~~~~~~~---~~~~~~ 260 (335)
.... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||... ........+...... ....+.
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 4332 2234568899999999988776 88999999999999999999999653 344555555554432 234577
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 261 TASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
++.+++.+||+.||.+|||+.++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8999999999999999999999983
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=326.11 Aligned_cols=249 Identities=27% Similarity=0.473 Sum_probs=203.9
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
...++|++.+.||+|+||.||+|.+..+ +..|++|.+... ......+.+.+|+..++.++||||+++++++. .+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 4567999999999999999999998653 456999998653 34556778899999999999999999999984 56
Q ss_pred eEEEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 7899999999999999998654 699999999999999999999999999999999999999999999999999977654
Q ss_pred Ccc--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchH
Q psy2306 189 SRF--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTAS 263 (335)
Q Consensus 189 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 263 (335)
... .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...++.+.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 247 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 247 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 322 223445678999999987776 889999999999999996 9999988877777777665532 3455678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy2306 264 PLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+++.+||+.||.+|||+.++++
T Consensus 248 ~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 248 SLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999984
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=327.90 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=205.3
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEE----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE 106 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 106 (335)
.....++|++.+.||+|+||+||+|. +..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34567799999999999999999998 5668999999998752 4556678899999999999999999999985
Q ss_pred e--CCeEEEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 107 N--REKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 107 ~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
. ....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4 456899999999999999998754 5999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----------------H
Q psy2306 184 NVFTESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK----------------R 243 (335)
Q Consensus 184 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~----------------~ 243 (335)
........ .....++..|+|||++.+..+ +.++||||||+++|+|++|..|+...... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 87644321 223345667999999988776 89999999999999999999998653221 2
Q ss_pred HHHHHhcCC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 244 LVKQISNGD--YFEPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 244 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
....+.... ..+...++++.+++.+||+.||.+|||+.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~ 283 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 222233222 23445677999999999999999999999998
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=325.22 Aligned_cols=250 Identities=25% Similarity=0.435 Sum_probs=215.9
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe---
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--- 107 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 107 (335)
+..+.++|++.+.||+|+||.||+|.+..+|+.|++|.+.... +.+.+|+..++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 4678889999999999999999999999999999999997632 145689999999999999999999854
Q ss_pred -------------CCeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC
Q psy2306 108 -------------REKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN 172 (335)
Q Consensus 108 -------------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~ 172 (335)
....+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 45689999999999999999753 579999999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC
Q psy2306 173 GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD 252 (335)
Q Consensus 173 ~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~ 252 (335)
+.++|+|||.+.............+++.|+|||++.+..+ +.++||||||+++|+|++|..|+... ......+...
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~- 234 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG- 234 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT-
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc-
Confidence 9999999999987766555556678999999999988776 89999999999999999999887432 2333333333
Q ss_pred CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 253 YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
......+..+.+++.+||+.||.+|||+.+++++.+.-.
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 334567889999999999999999999999999877654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=329.52 Aligned_cols=255 Identities=23% Similarity=0.388 Sum_probs=220.7
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeE
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 103 (335)
..-....++|++.+.||+|+||.||+|.+. .++..|++|.+... ........+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 344566789999999999999999999876 35788999998753 34455667889999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC
Q psy2306 104 VFENREKMVLVMEYAAGGELYDFLDQK----------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG 173 (335)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~ 173 (335)
++.+.+..+++|||+++++|.+++... .++++..++.++.|++.||.|||++|++|+||+|+||+++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999999752 4579999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q psy2306 174 NAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQIS 249 (335)
Q Consensus 174 ~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 249 (335)
.++|+|||.+........ .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 999999999876543322 223456788999999987776 889999999999999999 899999988888888777
Q ss_pred cCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 250 NGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 250 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.... .+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6543 344567789999999999999999999999976
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=339.22 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=210.2
Q ss_pred hhccceeEEeeeeccCCeEEEEEE-----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE 106 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~-----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 106 (335)
...++|++.+.||+|+||.||+|. +..+++.||+|.+... ......+.+.+|+.++..+ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 345799999999999999999998 4556789999999753 3445567889999999999 7899999999997
Q ss_pred eCC-eEEEEEecCCCCCHHHHHhhCCC-----------------------------------------------------
Q psy2306 107 NRE-KMVLVMEYAAGGELYDFLDQKKV----------------------------------------------------- 132 (335)
Q Consensus 107 ~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 132 (335)
+.+ ..+++|||+++++|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 48999999999999999976432
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc---cccccc
Q psy2306 133 -------------LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR---FLSTFC 196 (335)
Q Consensus 133 -------------~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~---~~~~~~ 196 (335)
+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+....... ......
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 8999999999999999999999999999999999999999999999999997654322 223456
Q ss_pred cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcH-HHHHHHHhcCC--CCCCCCCCchHHHHHHhccc
Q psy2306 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNF-KRLVKQISNGD--YFEPKNQSTASPLIAEMLNI 272 (335)
Q Consensus 197 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~-~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~ 272 (335)
+++.|+|||++.+..+ +.++||||||+++|+|++ |..||..... ......+.... ..+...++++.+++.+||+.
T Consensus 257 ~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp ECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 7889999999987776 899999999999999998 9999987653 33333333332 23444677999999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy2306 273 NPSSRADISVICSH 286 (335)
Q Consensus 273 dp~~Rps~~~ll~~ 286 (335)
||.+|||+.++++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999955
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=321.68 Aligned_cols=247 Identities=29% Similarity=0.466 Sum_probs=201.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC-HHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET-EADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
.++|++.+.||+|+||.||+|.+. |..|++|++....... ....+.+.+|+..++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 458999999999999999999875 7899999987543222 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCC---cEecCCCCCCEEEcc--------CCCeEEeeccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK---ICHRDLKLENILLDE--------NGNAKIADFGL 182 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~g---ivH~di~p~nili~~--------~~~~kL~df~~ 182 (335)
+|||+++++|.+++. +.++++..++.++.|++.||.|||+.| ++|+||+|+||+++. ++.++|+|||.
T Consensus 84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999999986 457999999999999999999999999 899999999999986 67899999999
Q ss_pred cccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCC
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQ 259 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 259 (335)
+........ ....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..... .+...+
T Consensus 163 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3dtc_A 163 AREWHRTTK-MSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccccccccc-cCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccC
Confidence 976554332 34568999999999987776 8999999999999999999999999887777666665543 234557
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 260 STASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+.+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 241 EPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 789999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=335.51 Aligned_cols=254 Identities=31% Similarity=0.563 Sum_probs=185.6
Q ss_pred hhhhhccceeEEe-eeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-
Q psy2306 30 HRRKLKQRFDIVR-KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN- 107 (335)
Q Consensus 30 ~~~~~~~~y~~~~-~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 107 (335)
....+.++|.+.+ .||+|+||.||+|.+..+|+.||+|++... ... ..+....++.++|+||+++++++..
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKA---RQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHH---HHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHH---HHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 3456888999965 699999999999999999999999998652 221 1223334567789999999999976
Q ss_pred ---CCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CCCeEEee
Q psy2306 108 ---REKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NGNAKIAD 179 (335)
Q Consensus 108 ---~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~~~kL~d 179 (335)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++. ++.++|+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 456899999999999999998653 6999999999999999999999999999999999999976 44599999
Q ss_pred ccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH----HHHhcCCC--
Q psy2306 180 FGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV----KQISNGDY-- 253 (335)
Q Consensus 180 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~----~~~~~~~~-- 253 (335)
||++...... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......... ..+.....
T Consensus 175 fg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 175 FGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CTTCEEC-----------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred cccceecccc-ccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 9999765433 2334567999999999977766 88999999999999999999999776544331 11221111
Q ss_pred ---CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 ---FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.....+.++.++|.+||+.||.+|||++++++||||++.
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 113457789999999999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=333.74 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=190.2
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHH-HHHcCCCCcccceeEEEEeCCeE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQ-IMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.-.++|++.+.||+|+||.||+|.+..+|+.|++|.+.... .......+..|.. .++.++||||+++++++.+.+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 34579999999999999999999999999999999997632 2333445555555 67778999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhHHC-CcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-----KKVLTEEEARRIFRQIATAVYYCHKH-KICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~-givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
+++|||+++ +|.+++.. ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.+||+|||.+..
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999999975 88887763 56799999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCccccccccCCccCChhhhc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcCCCC------
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVK----GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNGDYF------ 254 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~------ 254 (335)
...........|++.|+|||++. +..+ +.++||||||+++|+|++|..||...... +....+..+...
T Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3aln_A 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254 (327)
T ss_dssp ------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred cccccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence 66554445557899999999983 3344 88999999999999999999999764321 222222222111
Q ss_pred CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 255 EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
....+..+.+++.+||+.||.+|||+.++++||||..
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 1235678999999999999999999999999999974
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=331.86 Aligned_cols=245 Identities=21% Similarity=0.321 Sum_probs=207.7
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKM 111 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 111 (335)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+|+.+++.+ +|+||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 3567999999999999999999999999999999998754322 2577899999999 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC-----eEEeecccccc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN-----AKIADFGLSNV 185 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~-----~kL~df~~~~~ 185 (335)
++||||+ +++|.+++.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 8999999986 467999999999999999999999999999999999999988876 99999999987
Q ss_pred ccCCcc--------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhcCCC-
Q psy2306 186 FTESRF--------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---NFKRLVKQISNGDY- 253 (335)
Q Consensus 186 ~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---~~~~~~~~~~~~~~- 253 (335)
...... .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||... +..+....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 543322 245678999999999998776 89999999999999999999999873 33344443322211
Q ss_pred -----CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 254 -----FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 254 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.....+ ++.+++..||+.||.+||++++|++
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 112234 8999999999999999999999884
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=325.31 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=217.7
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||.||+|.+..++..|++|.+... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 4566999999999999999999999999999999998752 234567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 113 LVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999999986 3459999999999999999999999999999999999999999999999999997765433
Q ss_pred c--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 F--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
. .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..... .+...++.+.++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 244 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 2 233456778999999987776 899999999999999999 9999998887777766665532 344567789999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+++||+.||.+|||++++++
T Consensus 245 i~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 245 MRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999984
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=322.67 Aligned_cols=247 Identities=23% Similarity=0.397 Sum_probs=211.9
Q ss_pred ccceeEEe-eeeccCCeEEEEEEE--CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 35 KQRFDIVR-KLGQGNYGKVQLGIN--KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 35 ~~~y~~~~-~ig~g~~g~Vy~~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.++|++.+ .||+|+||.||+|.+ ..+++.|++|++.... ......+.+.+|+..++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 35899998 999999999999954 5668899999997643 2334467889999999999999999999999 56778
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+++|||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999977644322
Q ss_pred c----cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHH
Q psy2306 192 L----STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASP 264 (335)
Q Consensus 192 ~----~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 264 (335)
. ....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...+..+.+
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 251 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 22335678999999987766 889999999999999999 9999999888888777776543 33456779999
Q ss_pred HHHHhcccCCCCCCCHHHHh
Q psy2306 265 LIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll 284 (335)
++.+||+.||.+||++.+++
T Consensus 252 li~~~l~~dp~~Rps~~~l~ 271 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVE 271 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHH
Confidence 99999999999999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=331.88 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=217.2
Q ss_pred hhhhhhccceeEEeeeeccCCeEEEEEE-----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeE
Q psy2306 29 NHRRKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103 (335)
Q Consensus 29 ~~~~~~~~~y~~~~~ig~g~~g~Vy~~~-----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 103 (335)
.......++|++.+.||+|+||.||+|. +..++..|++|.+... ........+.+|+.+++.++||||+++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 3455667899999999999999999998 5567889999998742 34555668889999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CC
Q psy2306 104 VFENREKMVLVMEYAAGGELYDFLDQK-------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NG 173 (335)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~ 173 (335)
++.+.+..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 999999999999999999999999865 34899999999999999999999999999999999999984 44
Q ss_pred CeEEeeccccccccCCc---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q psy2306 174 NAKIADFGLSNVFTESR---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQIS 249 (335)
Q Consensus 174 ~~kL~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 249 (335)
.++|+|||.+....... ......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 69999999987553322 2234567889999999987776 899999999999999998 999999988888877777
Q ss_pred cCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 250 NGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 250 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
.... .+...+..+.+++.+||+.||.+||++.+++++.|+.
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 6543 3345677899999999999999999999999987753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=328.48 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=213.0
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEE-----CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGIN-----KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEV 104 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 104 (335)
-....++|++.+.||+|+||.||+|.+ ..++..|++|.+.... .....+.+.+|+..++.+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 344557999999999999999999985 4567899999997633 345567889999999999 89999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhCC------------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCC
Q psy2306 105 FENREKMVLVMEYAAGGELYDFLDQKK------------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLEN 166 (335)
Q Consensus 105 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~n 166 (335)
+.+.+..+++|||+++++|.+++.... ++++..++.++.|++.||.|||++|++|+||+|+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999998643 48999999999999999999999999999999999
Q ss_pred EEEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH
Q psy2306 167 ILLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFK 242 (335)
Q Consensus 167 ili~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~ 242 (335)
|+++.++.++|+|||.+........ .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 9999999999999999977654332 223456778999999987776 899999999999999998 99999876533
Q ss_pred H-HHHHHhcC--CCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 243 R-LVKQISNG--DYFEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 243 ~-~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
. ....+... ...+...+.++.+++.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3 22222222 22344567799999999999999999999999943
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=331.24 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=205.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEE----EEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEV----AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~v----alK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
..++|++.+.||+|+||+||+|.+..++..+ ++|.+... ......+.+.+|+.+++.++||||+++++++.+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3468999999999999999999988777654 77776542 23344567889999999999999999999998755
Q ss_pred eEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
.+++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 7789999999999999976 46799999999999999999999999999999999999999999999999999977644
Q ss_pred Ccc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCch
Q psy2306 189 SRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTA 262 (335)
Q Consensus 189 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l 262 (335)
... .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..... .+...+.++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred CcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 322 223445778999999988776 899999999999999999 9999998877777766665543 344467789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 263 SPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+++.+||+.||.+||++.+++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999964
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=324.78 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=209.7
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC--CCcccceeEEEEeCC
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR--HPNIIHIYEVFENRE 109 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 109 (335)
....++|++.+.||+|+||.||+|.+. +++.|++|++.... ......+.+.+|+..++.++ |+||+++++++.+.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 345568999999999999999999886 48899999997643 34556778899999999997 599999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
..+++|| +.+++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++ ++.+||+|||.+......
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9999999 45789999999888999999999999999999999999999999999999995 589999999999776433
Q ss_pred cc---ccccccCCccCChhhhcCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcCC---
Q psy2306 190 RF---LSTFCGSPLYASPEIVKGI----------PYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQISNGD--- 252 (335)
Q Consensus 190 ~~---~~~~~~~~~~~aPE~~~~~----------~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~~~~~~--- 252 (335)
.. .....+++.|+|||++.+. ..++.++||||||+++|+|++|..||.... .......+....
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 22 2345689999999998752 234789999999999999999999997643 223333333322
Q ss_pred CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 253 YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
..+...+.++.+++.+||+.||.+||++.++++||||+...
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 12333466899999999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=332.89 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=209.0
Q ss_pred hhccceeEEeeeeccCCeEEEEEEE-----CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGIN-----KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE 106 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 106 (335)
.-.++|++.+.||+|+||.||+|.+ ..++..|++|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3457999999999999999999997 3456789999997532 334456788999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCC-----------------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCC
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQKK-----------------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLK 163 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~ 163 (335)
+.+..+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997643 37999999999999999999999999999999
Q ss_pred CCCEEEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy2306 164 LENILLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGS 239 (335)
Q Consensus 164 p~nili~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~ 239 (335)
|+||+++.++.++|+|||.+........ .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999976643322 234456788999999987776 899999999999999998 99999876
Q ss_pred cHHH-HHHHHhcCC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCC
Q psy2306 240 NFKR-LVKQISNGD--YFEPKNQSTASPLIAEMLNINPSSRADISVICSHW 287 (335)
Q Consensus 240 ~~~~-~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 287 (335)
.... ....+.... ..+...++++.+++.+||+.||.+|||+.+++++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 5433 333333332 23344677999999999999999999999999664
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=318.66 Aligned_cols=244 Identities=25% Similarity=0.446 Sum_probs=213.3
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+. ++..|++|.+...... .+.+.+|+..++.++||||+++++++.+.+..+++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 58999999999999999999987 5778999999864322 246889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--c
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--L 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--~ 192 (335)
||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999999999864 5689999999999999999999999999999999999999999999999999876543221 2
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...+..+.+++.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 241 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 241 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHH
Confidence 23455678999999987776 889999999999999999 8999999888888887776533 3344577899999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy2306 270 LNINPSSRADISVICS 285 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~ 285 (335)
|+.||.+|||+.++++
T Consensus 242 l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 242 WRERPEDRPAFSRLLR 257 (267)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhhCcCHHHHHH
Confidence 9999999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.13 Aligned_cols=248 Identities=22% Similarity=0.379 Sum_probs=208.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcE----EEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQE----VAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~----valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
.++|++.+.||+|+||.||+|.+..++.. |++|.+.... .......+.+|+..++.++||||+++++++. .+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 45999999999999999999999888776 7777765322 1222335668899999999999999999986 466
Q ss_pred EEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.++++||+.+++|.+++... +.+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 88999999999999999764 57999999999999999999999999999999999999999999999999999876433
Q ss_pred c---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchH
Q psy2306 190 R---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTAS 263 (335)
Q Consensus 190 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 263 (335)
. ......++..|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..... .+...+.++.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY 247 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTT
T ss_pred cccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHH
Confidence 2 2234567778999999987776 899999999999999999 9999998877777777766533 3344677999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q psy2306 264 PLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+++.+||+.||.+|||+.+++++
T Consensus 248 ~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 248 MVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999976
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=321.18 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=207.4
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHH----HHHHHHHHHHHcCCCCcccceeEEEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL----IRIRREIQIMSSVRHPNIIHIYEVFE 106 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~ 106 (335)
.....++|++.+.||+|+||.||+|.+..+++.|++|.+........... +.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 34566799999999999999999999999999999999876443332221 67889999999999999999999997
Q ss_pred eCCeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEccCCC-----eEEe
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLDENGN-----AKIA 178 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~~~~~-----~kL~ 178 (335)
+.. +++|||+++++|.+.+.. ..++++..++.++.|++.||+|||+.| ++|+||+|+||+++.++. ++|+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 655 699999999999888764 457999999999999999999999999 999999999999988776 9999
Q ss_pred eccccccccCCccccccccCCccCChhhhcCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHHhcCC---
Q psy2306 179 DFGLSNVFTESRFLSTFCGSPLYASPEIVKGI-PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR--LVKQISNGD--- 252 (335)
Q Consensus 179 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~--~~~~~~~~~--- 252 (335)
|||.+..... ......+++.|+|||++... ..++.++||||||+++|+|++|..||....... ....+....
T Consensus 172 Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 172 DFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 9999875443 23456789999999998432 223789999999999999999999997654322 233333222
Q ss_pred CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 253 YFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
..+...++++.+++.+||+.||.+|||++++++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 234456778999999999999999999999984
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=335.40 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=205.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEEC---CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
..++|++.+.||+|+||.||+|.+. .++..|++|.+... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 3458999999999999999999876 45778999998753 245566789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999999865 36999999999999999999999999999999999999999999999999999776433
Q ss_pred cc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCch
Q psy2306 190 RF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTA 262 (335)
Q Consensus 190 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l 262 (335)
.. .....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...+..+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 279 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279 (373)
T ss_dssp -------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 21 112234678999999987776 889999999999999997 9999999888888877766532 234456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy2306 263 SPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+++.+||+.||.+||++.++++
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=325.36 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=210.3
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCC----cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETG----QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN 107 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 107 (335)
....++|++.+.||+|+||.||+|.+..++ ..|++|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 334569999999999999999999876543 459999987532 44556678999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999764 67999999999999999999999999999999999999999999999999999776
Q ss_pred cCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCC
Q psy2306 187 TESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQ 259 (335)
Q Consensus 187 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 259 (335)
..... .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..+.. .+...+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred ccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence 43321 122345678999999988776 889999999999999998 9999999888888877776533 234456
Q ss_pred CchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 260 STASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 260 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..+.+++.+||+.||.+||++.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999843
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=322.91 Aligned_cols=253 Identities=24% Similarity=0.418 Sum_probs=208.7
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEE----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEE
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVF 105 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 105 (335)
+.....++|++.+.||+|+||.||+|. +..+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 344556789999999999999999998 56789999999987533 233456788999999999999999999999
Q ss_pred EeC--CeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 106 ENR--EKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 106 ~~~--~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
.+. +..+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 876 678999999999999999954 56799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------------cHHH
Q psy2306 183 SNVFTESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---------------NFKR 243 (335)
Q Consensus 183 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---------------~~~~ 243 (335)
+........ .....++..|+|||++.+..+ +.++||||||+++|+|++|..|+... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 977654432 234456778999999988776 78999999999999999999876322 2233
Q ss_pred HHHHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 244 LVKQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 244 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
....+..... .+...++++.+++.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 3344443322 34456789999999999999999999999984
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=319.48 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=214.2
Q ss_pred ccceeEEe-eeeccCCeEEEEEEEC--CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 35 KQRFDIVR-KLGQGNYGKVQLGINK--ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 35 ~~~y~~~~-~ig~g~~g~Vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.++|.+.+ .||+|+||.||+|.+. .++..|++|++... ......+.+.+|+..++.++||||+++++++ ..+..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 45788877 9999999999999864 46788999999763 3456677899999999999999999999999 55678
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+++||++++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999999964 4569999999999999999999999999999999999999999999999999997764332
Q ss_pred c----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchH
Q psy2306 191 F----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTAS 263 (335)
Q Consensus 191 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 263 (335)
. .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...++++.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 243 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHH
Confidence 2 123345788999999987666 889999999999999998 9999998887777777766542 3456688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCC
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWW 288 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~ 288 (335)
+++.+||+.||.+||++.+++++.+
T Consensus 244 ~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 244 ALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999996543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=342.84 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=208.6
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE- 109 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 109 (335)
...+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 34577899999999999999999999999999999999975332 223456779999999999999999999998765
Q ss_pred -eEEEEEecCCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE----ccCCCeEEeecc
Q psy2306 110 -KMVLVMEYAAGGELYDFLDQKK---VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL----DENGNAKIADFG 181 (335)
Q Consensus 110 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili----~~~~~~kL~df~ 181 (335)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||++ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 7899999999999999997643 39999999999999999999999999999999999999 667789999999
Q ss_pred ccccccCCccccccccCCccCChhhhcC--------CCCCCCcchHHHHHHHHHHHHhCCCCCCC----CcHHHHHHHHh
Q psy2306 182 LSNVFTESRFLSTFCGSPLYASPEIVKG--------IPYHGPEVDCWSLGVLLYTLVYGAMPFDG----SNFKRLVKQIS 249 (335)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Dv~slG~~l~~l~tg~~p~~~----~~~~~~~~~~~ 249 (335)
.+.............|++.|+|||++.+ ..+ +.++||||||+++|+|++|..||.. ....+....+.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 9988766655566779999999999864 233 6789999999999999999999963 22233444443
Q ss_pred cCCCCC--------------------------CCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 250 NGDYFE--------------------------PKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 250 ~~~~~~--------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+.... ...+..+.+++++||+.||++||++.++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 332110 011236778999999999999999999854
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=316.20 Aligned_cols=245 Identities=20% Similarity=0.347 Sum_probs=210.8
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC--CeE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR--EKM 111 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 111 (335)
-.++|++.+.||+|+||.||+|.+. +..|++|++.... ......+.+.+|+..++.++||||+++++++.+. +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 3459999999999999999999875 7899999998643 3445567899999999999999999999999877 788
Q ss_pred EEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 112 VLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+||++.....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999999998755 5899999999999999999999999 9999999999999999999999998875433
Q ss_pred CCccccccccCCccCChhhhcCCCCC--CCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCch
Q psy2306 188 ESRFLSTFCGSPLYASPEIVKGIPYH--GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTA 262 (335)
Q Consensus 188 ~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l 262 (335)
. ....+++.|+|||++.+.... +.++||||||+++|+|++|..||...+..+....+..... .+...++++
T Consensus 165 ~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3kmu_A 165 S----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240 (271)
T ss_dssp C----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred c----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 2 234678999999999876552 2379999999999999999999998887776655554322 344567799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy2306 263 SPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+++.+||+.||.+|||++++++
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 241 SKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=322.88 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=203.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC---CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC--
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE---TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE-- 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 109 (335)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ......+.+.+|+..++.++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4699999999999999999998765 45689999987643 34455678899999999999999999999997655
Q ss_pred ---eEEEEEecCCCCCHHHHHh------hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeec
Q psy2306 110 ---KMVLVMEYAAGGELYDFLD------QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180 (335)
Q Consensus 110 ---~~~lv~e~~~~~~L~~~l~------~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df 180 (335)
..++++||+++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3599999999999999984 3456999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCc---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--C
Q psy2306 181 GLSNVFTESR---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--F 254 (335)
Q Consensus 181 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~ 254 (335)
|.+....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..... .
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence 9987654332 1223456778999999988776 899999999999999999 8999988877777666665532 3
Q ss_pred CCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 255 EPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+...++.+.+++.+||+.||.+|||+.++++
T Consensus 271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4456778999999999999999999999984
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=320.91 Aligned_cols=250 Identities=26% Similarity=0.480 Sum_probs=199.0
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
+.+...++|++.+.||+|+||+||+|.+.. .+++|++.... ......+.+.+|+..++.++|+||+++++++ ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 356778899999999999999999997553 59999987643 3456677899999999999999999999965 556
Q ss_pred eEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 78999999999999999964 45699999999999999999999999999999999999999999999999999876542
Q ss_pred ---CccccccccCCccCChhhhc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcCCCC------C
Q psy2306 189 ---SRFLSTFCGSPLYASPEIVK---GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKRLVKQISNGDYF------E 255 (335)
Q Consensus 189 ---~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~~~~~~~~~~~~------~ 255 (335)
........|++.|+|||++. +..+ +.++||||||+++|+|++|..||.... .......+...... .
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred ccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 22234457899999999986 3344 789999999999999999999998744 44444444443322 2
Q ss_pred CCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 256 PKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 256 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
...++.+.+++.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 245678999999999999999999999984
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=327.62 Aligned_cols=255 Identities=22% Similarity=0.394 Sum_probs=212.3
Q ss_pred hhhhhhhccceeEEeeeeccCCeEEEEEEECCCCc-----EEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccce
Q psy2306 28 HNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQ-----EVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHI 101 (335)
Q Consensus 28 ~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~ 101 (335)
........++|++.+.||+|+||.||+|.+..++. .|++|.+.... .....+.+.+|+.+++.+ +||||+++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 33444556799999999999999999999876654 79999987632 445567889999999999 89999999
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhh--------------CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCE
Q psy2306 102 YEVFENREKMVLVMEYAAGGELYDFLDQ--------------KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENI 167 (335)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ni 167 (335)
++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI 195 (333)
T 2i1m_A 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195 (333)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence 9999999999999999999999999974 24589999999999999999999999999999999999
Q ss_pred EEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHH
Q psy2306 168 LLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKR 243 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~ 243 (335)
+++.++.++|+|||++........ .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.......
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 999999999999999976543322 223456778999999987776 899999999999999998 999998755433
Q ss_pred HHHHH-hcC--CCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 244 LVKQI-SNG--DYFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 244 ~~~~~-~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
....+ ... ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 32222 222 1233445778999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=325.02 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=209.5
Q ss_pred ccceeEEeeeeccCCeEEEEEE----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE--eC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE--NR 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~ 108 (335)
.++|++.+.||+|+||.||+|. +..++..|++|.+... .....+.+.+|+.+++.++|+||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 3599999999999999999998 5678999999998753 4555677899999999999999999999986 55
Q ss_pred CeEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 679999999999999999976 4569999999999999999999999999999999999999999999999999998765
Q ss_pred CCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH---------------HHHHHHH
Q psy2306 188 ESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF---------------KRLVKQI 248 (335)
Q Consensus 188 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~---------------~~~~~~~ 248 (335)
.... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||..... ......+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 4322 223456778999999988776 8899999999999999999999865432 2233333
Q ss_pred hcCC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 249 SNGD--YFEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 249 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.... ..+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3332 2344567799999999999999999999999744
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=319.85 Aligned_cols=242 Identities=24% Similarity=0.445 Sum_probs=201.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC-CeEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR-EKMV 112 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~ 112 (335)
-.++|++.+.||+|+||.||+|.+. |..|++|.+.... ..+.+.+|+..++.++||||+++++++... +..+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 3469999999999999999999775 7899999987532 345788999999999999999999997544 5789
Q ss_pred EEEecCCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 113 LVMEYAAGGELYDFLDQKKV--LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
++|||+++++|.+++..... +++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999999999986543 8999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..... .+...++.+.+++.
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 248 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 248 (278)
T ss_dssp ------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred --cCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence 23356788999999987776 889999999999999998 9999998877777777665532 33456779999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q psy2306 268 EMLNINPSSRADISVICS 285 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~ 285 (335)
+||+.||.+|||+.++++
T Consensus 249 ~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 249 NCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHhcCChhhCCCHHHHHH
Confidence 999999999999999983
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=324.28 Aligned_cols=242 Identities=22% Similarity=0.340 Sum_probs=197.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC----eE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE----KM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~ 111 (335)
++|++.+.||+|+||+||+|.+. ++.||+|++... .........|+..++.++||||+++++++.+.. .+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 59999999999999999999876 789999998652 233345566888899999999999999997743 47
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC----------CcEecCCCCCCEEEccCCCeEEeecc
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH----------KICHRDLKLENILLDENGNAKIADFG 181 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~----------givH~di~p~nili~~~~~~kL~df~ 181 (335)
++||||+++++|.+++..+ .+++..++.++.|++.||+|||+. |++|+||||+||+++.++.+||+|||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999999864 499999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcc---ccccccCCccCChhhhcCCCC----CCCcchHHHHHHHHHHHHhCCCCCCCC---------------
Q psy2306 182 LSNVFTESRF---LSTFCGSPLYASPEIVKGIPY----HGPEVDCWSLGVLLYTLVYGAMPFDGS--------------- 239 (335)
Q Consensus 182 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~----~~~~~Dv~slG~~l~~l~tg~~p~~~~--------------- 239 (335)
.+........ .....|++.|+|||++.+... ++.++||||||+++|+|++|..||.+.
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9976644322 234578999999999986422 256789999999999999999999653
Q ss_pred -cHHHHHHHHhcCCCCCCCC--------CCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 240 -NFKRLVKQISNGDYFEPKN--------QSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 240 -~~~~~~~~~~~~~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
........+......+... +.++.++|.+||+.||.+|||+.+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 310 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence 2333444333332221111 12389999999999999999999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=317.29 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=207.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECC---CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKE---TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+... ......+.+.+|+..++.++||||+++++++.+ +.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 34699999999999999999998654 3446999998763 244566788999999999999999999999865 45
Q ss_pred EEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.+++||++++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 68999999999999999764 46999999999999999999999999999999999999999999999999998766543
Q ss_pred cc--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHH
Q psy2306 190 RF--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASP 264 (335)
Q Consensus 190 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 264 (335)
.. .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..... .+...++.+.+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT 245 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 22 233456778999999987776 889999999999999998 9999987666655555554432 33446778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q psy2306 265 LIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~ 286 (335)
++.+||+.||.+|||+.+++++
T Consensus 246 li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 246 LMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999954
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=320.55 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=204.3
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE----eCC
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE----NRE 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~ 109 (335)
-.++|++.+.||+|+||.||+|.+..+|+.||+|.+.. ......+.+.+|+.+++.++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC---HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE---SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec---CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 35699999999999999999999999999999999875 24556778899999999999999999999986 345
Q ss_pred eEEEEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
..++++||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999999999999875 56799999999999999999999999999999999999999999999999998865
Q ss_pred ccCCcc----------ccccccCCccCChhhhcCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHhcC
Q psy2306 186 FTESRF----------LSTFCGSPLYASPEIVKGIPY--HGPEVDCWSLGVLLYTLVYGAMPFDGSNF--KRLVKQISNG 251 (335)
Q Consensus 186 ~~~~~~----------~~~~~~~~~~~aPE~~~~~~~--~~~~~Dv~slG~~l~~l~tg~~p~~~~~~--~~~~~~~~~~ 251 (335)
...... .....|++.|+|||++.+... ++.++||||||+++|+|++|..||..... ......+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 432111 123456899999999876541 37899999999999999999999953110 0111122221
Q ss_pred --CCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 252 --DYFEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 252 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.......+.++.++|.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 11234567799999999999999999999999954
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=325.11 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=205.3
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEE----EEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEV----AIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~v----alK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
..++|++.+.||+|+||.||+|.+..+++.+ ++|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3569999999999999999999998887765 666665322 2334567889999999999999999999998765
Q ss_pred eEEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
.+++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+.....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 7888999999999999976 45799999999999999999999999999999999999999999999999999977643
Q ss_pred Ccc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCch
Q psy2306 189 SRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTA 262 (335)
Q Consensus 189 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l 262 (335)
... .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..... .+...+.++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred ccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 322 223445778999999988776 899999999999999999 9999998887777777766543 334467789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy2306 263 SPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+++++||+.||.+||++.++++
T Consensus 249 ~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999995
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=336.06 Aligned_cols=240 Identities=24% Similarity=0.466 Sum_probs=207.3
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC-eEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE-KMVL 113 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~l 113 (335)
.++|++.+.||+|+||.||+|.+. |..||+|.++... ..+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 468999999999999999999875 7799999987532 3457889999999999999999999987655 7999
Q ss_pred EEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 114 VMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 999999999999998654 37999999999999999999999999999999999999999999999999987544322
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHH
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAE 268 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 268 (335)
....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..+.. .+...++++.++|.+
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred -cCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 22356788999999988776 899999999999999998 9999998777777777766532 344567899999999
Q ss_pred hcccCCCCCCCHHHHh
Q psy2306 269 MLNINPSSRADISVIC 284 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll 284 (335)
||+.||.+|||+.+++
T Consensus 422 cl~~dp~~Rpt~~~l~ 437 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLR 437 (450)
T ss_dssp HTCSSGGGSCCHHHHH
T ss_pred HcCCChhHCcCHHHHH
Confidence 9999999999999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.22 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=210.6
Q ss_pred hhccceeEEeeeeccCCeEEEEEEE-----CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGIN-----KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE 106 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 106 (335)
...++|++.+.||+|+||.||+|.+ ..+++.|++|.+... ......+.+.+|+..++.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 3457999999999999999999985 356789999999763 2445566889999999999 6899999999987
Q ss_pred eCC-eEEEEEecCCCCCHHHHHhhCCC----------------CCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE
Q psy2306 107 NRE-KMVLVMEYAAGGELYDFLDQKKV----------------LTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL 169 (335)
Q Consensus 107 ~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili 169 (335)
..+ ..+++|||+++++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 58999999999999999986543 8999999999999999999999999999999999999
Q ss_pred ccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcH-HHH
Q psy2306 170 DENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNF-KRL 244 (335)
Q Consensus 170 ~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~-~~~ 244 (335)
+.++.++|+|||.+........ .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||..... ...
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 9999999999999976543322 234556888999999987776 899999999999999998 9999977543 333
Q ss_pred HHHHhcCC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 245 VKQISNGD--YFEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 245 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
...+.... ..+...++++.+++.+||+.||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34444332 2334467799999999999999999999999965
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=327.79 Aligned_cols=251 Identities=15% Similarity=0.180 Sum_probs=199.7
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECC---CCcEEEEEEeecCCcCCHH--------HHHHHHHHHHHHHcCCCCcccce
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKE---TGQEVAIKTIKKCKIETEA--------DLIRIRREIQIMSSVRHPNIIHI 101 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~---~~~~valK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~ 101 (335)
...++|++.+.||+|+||.||+|.+.. ++..+++|.+......... ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345699999999999999999999987 7889999998764321111 11235678888999999999999
Q ss_pred eEEEEe----CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC--Ce
Q psy2306 102 YEVFEN----REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG--NA 175 (335)
Q Consensus 102 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~--~~ 175 (335)
++++.. ....+++|||+ +++|.+++...+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999987 78899999999 999999998877899999999999999999999999999999999999998877 99
Q ss_pred EEeeccccccccCCc--------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC--CcHHHHH
Q psy2306 176 KIADFGLSNVFTESR--------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG--SNFKRLV 245 (335)
Q Consensus 176 kL~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~--~~~~~~~ 245 (335)
||+|||++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.. .+.....
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999997653221 1234578999999999998776 8999999999999999999999954 2322222
Q ss_pred HHHh---cCCC-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 246 KQIS---NGDY-------FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 246 ~~~~---~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.... .... .....+.++.+++.+||+.||.+||++++|++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1111 1110 11256779999999999999999999999984
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=315.21 Aligned_cols=246 Identities=24% Similarity=0.446 Sum_probs=211.0
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||.||+|.+. ++..|++|.+..... ..+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 34579999999999999999999876 467899999875332 2457889999999999999999999986 45689
Q ss_pred EEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 113 LVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999999997543 69999999999999999999999999999999999999999999999999997765433
Q ss_pred c--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 F--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
. .....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .+...+.++.++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence 2 223445778999999987666 889999999999999999 9999999888888777766532 334567799999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+||+.||.+|||+.++++
T Consensus 243 i~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHH
Confidence 99999999999999999983
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=316.66 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=203.8
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEE-EeCCe
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVF-ENREK 110 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~ 110 (335)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+|+.+++.++|++++..+..+ ...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 34678999999999999999999999999999999998764322 2577899999999987766555554 67788
Q ss_pred EEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc---cCCCeEEeeccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD---ENGNAKIADFGLSNVF 186 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~---~~~~~kL~df~~~~~~ 186 (335)
.+++|||+ +++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++ .++.+||+|||.+...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999999 8899999974 56799999999999999999999999999999999999994 7889999999999776
Q ss_pred cCCcc--------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhc----C
Q psy2306 187 TESRF--------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN---FKRLVKQISN----G 251 (335)
Q Consensus 187 ~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~---~~~~~~~~~~----~ 251 (335)
..... .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.... ..+....+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 54322 245578999999999998776 899999999999999999999997632 1111111111 1
Q ss_pred C--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 252 D--YFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 252 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
. ......++++.+++.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1 112456789999999999999999999999983
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=331.11 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=205.3
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||.||+|.+. +|..|++|.+.... ....+.+.+|+..++.++||||+++++++.+.+..+
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 35679999999999999999999865 68999999987532 334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 113 LVMEYAAGGELYDFLDQKK----VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
++|||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999997543 589999999999999999999999999999999999999999999999999876432
Q ss_pred C---ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH------H-HHHHhcCCC---CC
Q psy2306 189 S---RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR------L-VKQISNGDY---FE 255 (335)
Q Consensus 189 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~------~-~~~~~~~~~---~~ 255 (335)
. .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||......+ . ......... ..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 2 12234568899999999987776 899999999999999999999997543211 1 111111111 01
Q ss_pred --------CCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 256 --------PKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 256 --------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+..+..+.+++.+||+.||.+|||+.+++++
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1113367889999999999999999999954
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=316.51 Aligned_cols=247 Identities=22% Similarity=0.349 Sum_probs=206.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEE-EeCCeE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVF-ENREKM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 111 (335)
.+|++.+.||+|+||+||+|.+..+ +..+++|.+.. .......+.+.+|+.+++.++||||+++++++ ...+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc--CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 4899999999999999999987543 34588998875 33556677889999999999999999999986 456688
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999999999999975 4568999999999999999999999999999999999999999999999999997654322
Q ss_pred c-----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCch
Q psy2306 191 F-----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTA 262 (335)
Q Consensus 191 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l 262 (335)
. .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+..+....+..... .+...+..+
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 261 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred hhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHH
Confidence 1 233456778999999988776 889999999999999999 6777777666555555555433 344467789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy2306 263 SPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+++.+||+.||.+|||+.++++
T Consensus 262 ~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 262 YEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=315.08 Aligned_cols=245 Identities=24% Similarity=0.383 Sum_probs=207.7
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCc---EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE-E
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQ---EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM-V 112 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~ 112 (335)
+|++.+.||+|+||+||+|.+..++. .+++|.+.. .......+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc--cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 77888999999999999998765444 799999875 33556677889999999999999999999999776655 9
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR- 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~- 190 (335)
+++||+.+++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999986 4568999999999999999999999999999999999999999999999999997653322
Q ss_pred ----cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchH
Q psy2306 191 ----FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTAS 263 (335)
Q Consensus 191 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 263 (335)
......+++.|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+.......+..... .+...+..+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 2234456788999999988776 899999999999999999 5556666666666666665543 3344577899
Q ss_pred HHHHHhcccCCCCCCCHHHHh
Q psy2306 264 PLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll 284 (335)
+++.+||+.||.+|||+.+++
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll 279 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLV 279 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHH
Confidence 999999999999999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=342.67 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=215.8
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
-.++|++.+.||+|+||.||+|.+..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34689999999999999999999998899999999875332 24578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 114 VMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++........
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999999999863 4589999999999999999999999999999999999999999999999999987644322
Q ss_pred c--cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHH
Q psy2306 192 L--STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLI 266 (335)
Q Consensus 192 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 266 (335)
. ....++..|+|||++....+ +.++||||||+++|+|++ |..||...+..+....+..... .+...+.++.++|
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 452 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1 23345678999999987776 889999999999999998 9999998887777776665532 2345677999999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q psy2306 267 AEMLNINPSSRADISVICSH 286 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+||+.||.+|||+.+|++.
T Consensus 453 ~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 453 RACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCcChhHCcCHHHHHHH
Confidence 99999999999999999853
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=322.78 Aligned_cols=247 Identities=30% Similarity=0.499 Sum_probs=187.9
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEE------
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFE------ 106 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~------ 106 (335)
...+|++.+.||+|+||.||+|.+..+++.|++|.+... .....+.+.+|+..++.+. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 345999999999999999999999999999999998653 4555677889999999996 999999999984
Q ss_pred --eCCeEEEEEecCCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEccCCCeEEee
Q psy2306 107 --NREKMVLVMEYAAGGELYDFLDQ---KKVLTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLDENGNAKIAD 179 (335)
Q Consensus 107 --~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~~~~~~kL~d 179 (335)
....+++++||++ ++|.+++.. .+++++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 3456899999995 689888864 567999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCccc-------------cccccCCccCChhhhc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy2306 180 FGLSNVFTESRFL-------------STFCGSPLYASPEIVK---GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKR 243 (335)
Q Consensus 180 f~~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~---~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~ 243 (335)
||.+......... ....+++.|+|||++. +..+ +.++||||||+++|+|++|..||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 9999776543221 1345889999999983 4344 889999999999999999999997765544
Q ss_pred HHHHHhcCCCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 244 LVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
....... .......+..+.+++++||+.||.+|||+.+++++
T Consensus 261 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 261 IVNGKYS-IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp -----CC-CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCccc-CCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3332222 12234456689999999999999999999999966
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=320.95 Aligned_cols=249 Identities=28% Similarity=0.412 Sum_probs=207.5
Q ss_pred hhhccce-eEEeeeeccCCeEEEEEEE----CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE
Q psy2306 32 RKLKQRF-DIVRKLGQGNYGKVQLGIN----KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE 106 (335)
Q Consensus 32 ~~~~~~y-~~~~~ig~g~~g~Vy~~~~----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 106 (335)
..+.++| ++.+.||+|+||+||++.. ..+++.||+|++... ......+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 4477777 9999999999999988753 457899999999763 34556778999999999999999999999998
Q ss_pred e--CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 107 N--REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 107 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
+ ....+++|||+++++|.+++.... +++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 7 468899999999999999998654 9999999999999999999999999999999999999999999999999998
Q ss_pred cccCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH---------------HHH
Q psy2306 185 VFTESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK---------------RLV 245 (335)
Q Consensus 185 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~---------------~~~ 245 (335)
....... .....++..|+|||++.+..+ +.++||||||+++|+|++|..||...... ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 7654322 233456778999999988776 88999999999999999999998653221 222
Q ss_pred HHHhcCC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 246 KQISNGD--YFEPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 246 ~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
..+.... ..+...+.++.++|++||+.||.+|||+.+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 302 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI 302 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 3333322 23445677999999999999999999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=318.61 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=203.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECC-CCc--EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCe
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKE-TGQ--EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREK 110 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~-~~~--~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 110 (335)
..++|++.+.||+|+||+||+|.+.. ++. .|++|.+...........+.+.+|+..++.++||||+++++++.+..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 45699999999999999999998643 333 68999987654445566778999999999999999999999998765
Q ss_pred EEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~ 189 (335)
.++++|++++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 8899999999999999976 356999999999999999999999999999999999999999999999999998776443
Q ss_pred cc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC---CCCCCCCc
Q psy2306 190 RF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY---FEPKNQST 261 (335)
Q Consensus 190 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 261 (335)
.. .....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..... .....+.+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred ccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence 22 123456778999999987766 889999999999999999 9999999888888877765433 23346778
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 262 ASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+++.+||+.||.+|||+.++++
T Consensus 254 l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 254 IYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999995
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=315.83 Aligned_cols=245 Identities=29% Similarity=0.451 Sum_probs=196.5
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHc--CCCCcccceeEEEEe-
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS--VRHPNIIHIYEVFEN- 107 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~- 107 (335)
.+.+.++|++.+.||+|+||+||+|.+ +|+.||+|++... ......+|.+++.. ++||||+++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 356788999999999999999999977 5889999998652 22344556666666 789999999998654
Q ss_pred ---CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhH--------HCCcEecCCCCCCEEEccCCCeE
Q psy2306 108 ---REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH--------KHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 108 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH--------~~givH~di~p~nili~~~~~~k 176 (335)
....+++|||+++++|.++++. ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+|
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 3568999999999999999964 56999999999999999999999 99999999999999999999999
Q ss_pred EeeccccccccCCccc-----cccccCCccCChhhhcCCCC-----CCCcchHHHHHHHHHHHHhC----------CCCC
Q psy2306 177 IADFGLSNVFTESRFL-----STFCGSPLYASPEIVKGIPY-----HGPEVDCWSLGVLLYTLVYG----------AMPF 236 (335)
Q Consensus 177 L~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~-----~~~~~Dv~slG~~l~~l~tg----------~~p~ 236 (335)
|+|||++......... ....|++.|+|||++.+... .+.++||||||+++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999998765443221 23478999999999987632 14689999999999999999 8888
Q ss_pred CCC-----cHHHHHHHHhcCCCCCCCC---------CCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 237 DGS-----NFKRLVKQISNGDYFEPKN---------QSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 237 ~~~-----~~~~~~~~~~~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
... .............. .+.. +.++.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQ-RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCC-CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCC-CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 542 23333333332222 2222 246889999999999999999999984
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=327.92 Aligned_cols=251 Identities=13% Similarity=0.203 Sum_probs=199.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCC-----CcEEEEEEeecCCcCCHHHH--------HHHHHHHHHHHcCCCCccc
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKET-----GQEVAIKTIKKCKIETEADL--------IRIRREIQIMSSVRHPNII 99 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~-----~~~valK~~~~~~~~~~~~~--------~~~~~e~~~l~~l~~~~i~ 99 (335)
...++|++.+.||+|+||.||+|.+..+ ++.||+|++........... .....|+..++.++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4455999999999999999999998764 58899999876432111111 1233455667778899999
Q ss_pred ceeEEEEeC----CeEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc--cC
Q psy2306 100 HIYEVFENR----EKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD--EN 172 (335)
Q Consensus 100 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~--~~ 172 (335)
++++++... ...++||||+ +++|.+++... ..+++..++.++.|++.||+|||+.|++||||||+||+++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 5689999999 99999999875 6799999999999999999999999999999999999999 88
Q ss_pred CCeEEeeccccccccCCcc--------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc-HHH
Q psy2306 173 GNAKIADFGLSNVFTESRF--------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN-FKR 243 (335)
Q Consensus 173 ~~~kL~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~-~~~ 243 (335)
+.+||+|||++........ .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.. ...
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 9999999999976543221 123458999999999988776 899999999999999999999997532 111
Q ss_pred HHH-----------HHhcCCCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 244 LVK-----------QISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 244 ~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
... .+..........+.++.+++..||+.||.+||++.+|++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 111 111111223566889999999999999999999999884
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=332.54 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=197.3
Q ss_pred hhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE
Q psy2306 28 HNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE 106 (335)
Q Consensus 28 ~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 106 (335)
......+.+.|.+.+.||+|+||+||.+ ...+|+.||+|.+... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 7 p~~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp -CCSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 3445667889999999999999999875 3457999999998752 133567899999876 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCC-------CHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-------
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQKKVL-------TEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN------- 172 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~------- 172 (335)
+.+..+++|||++ ++|.+++...... ++..++.++.|++.||+|||+.|++||||||+||+++.+
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999999995 5999999865432 223457899999999999999999999999999999754
Q ss_pred ------CCeEEeeccccccccCCcc-----ccccccCCccCChhhhcC------CCCCCCcchHHHHHHHHHHHHh-CCC
Q psy2306 173 ------GNAKIADFGLSNVFTESRF-----LSTFCGSPLYASPEIVKG------IPYHGPEVDCWSLGVLLYTLVY-GAM 234 (335)
Q Consensus 173 ------~~~kL~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~t-g~~ 234 (335)
+.+||+|||++........ .....|++.|+|||++.+ ...++.++|||||||++|+|++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 3799999999987654321 234578999999999975 1334899999999999999998 999
Q ss_pred CCCCCcHHHHHHHHhcCCCCCCC--------CCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 235 PFDGSNFKRLVKQISNGDYFEPK--------NQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 235 p~~~~~~~~~~~~~~~~~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
||........ .+.......+. .+.++.++|.+||+.||.+|||+.++++||||...
T Consensus 239 Pf~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 239 PFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred CCCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 9976544332 22222111111 13578999999999999999999999999999753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=313.65 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=198.4
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEE-EeCCe
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVF-ENREK 110 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~ 110 (335)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++|++++..+..+ ...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 35678999999999999999999999999999999987653322 2467899999999887766665554 77888
Q ss_pred EEEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE---ccCCCeEEeeccccccc
Q psy2306 111 MVLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVF 186 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili---~~~~~~kL~df~~~~~~ 186 (335)
.+++|||+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.+||+|||.+...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 8899999984 5679999999999999999999999999999999999999 78899999999999776
Q ss_pred cCCcc--------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHHhcC
Q psy2306 187 TESRF--------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNF-------KRLVKQISNG 251 (335)
Q Consensus 187 ~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~-------~~~~~~~~~~ 251 (335)
..... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+. ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 54322 235578999999999998776 8999999999999999999999976321 1111111111
Q ss_pred C--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 252 D--YFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 252 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
. ......++++.+++.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1 112456789999999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.00 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=208.6
Q ss_pred CccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeE
Q psy2306 24 GVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYE 103 (335)
Q Consensus 24 ~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 103 (335)
++++.-++..+ ++|++.+.||+|+||.||+|.+..+|..||+|++... ......+.+.+|+.+++.++||||+++++
T Consensus 3 G~~p~~pg~~~-grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~ 79 (676)
T 3qa8_A 3 GRSPSLPTQTC-GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSARE 79 (676)
T ss_dssp ---------------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred CCCCCCCCCCC-CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceee
Confidence 34444444444 8999999999999999999999999999999998753 34556778899999999999999999999
Q ss_pred EEEe------CCeEEEEEecCCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 104 VFEN------REKMVLVMEYAAGGELYDFLDQKK---VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 104 ~~~~------~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
++.. .+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.
T Consensus 80 v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~ 159 (676)
T 3qa8_A 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159 (676)
T ss_dssp CCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSS
T ss_pred eecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCC
Confidence 8755 677899999999999999998644 5899999999999999999999999999999999999997765
Q ss_pred ---eEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH------
Q psy2306 175 ---AKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV------ 245 (335)
Q Consensus 175 ---~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~------ 245 (335)
++|+|||.+.............+++.|+|||++.+..+ +.++||||||+++|+|++|..||.........
T Consensus 160 ~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~ 238 (676)
T 3qa8_A 160 RLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238 (676)
T ss_dssp SCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred ceeEEEcccccccccccccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence 89999999988776666667789999999999988776 89999999999999999999999764322110
Q ss_pred ---HHHh-----cCCC-----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 246 ---KQIS-----NGDY-----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 246 ---~~~~-----~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
.... .+.. .....++.+.++|.+||+.||.+|||+.++++||||+.
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000 0000 00112346889999999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=334.74 Aligned_cols=246 Identities=24% Similarity=0.413 Sum_probs=211.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred echHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 345689999999999999999998864 6789999997633 23557889999999999999999999986 66789
Q ss_pred EEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 113 LVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+||||+++++|.+++... ..++...+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999999753 368999999999999999999999999999999999999999999999999997764322
Q ss_pred c--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 F--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
. .....++..|+|||++....+ +.++||||||+++|+|++ |..||.+.+..+....+..+.. .+...++++.++
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred eeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 123345678999999987776 899999999999999999 9999999888888777766533 234467799999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+||+.||.+|||+++|++
T Consensus 418 i~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHH
Confidence 99999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=323.26 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=206.1
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
......++|++.+.||+|+||.||+|.+. +|..||+|.+..... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 34567789999999999999999999754 588999999875332 122235789999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhHHC---CcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKK----VLTEEEARRIFRQIATAVYYCHKH---KICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~LH~~---givH~di~p~nili~~~~~~kL~df~~ 182 (335)
..+++|||+++++|.+++.... ++++..++.++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 9999999999999999998643 499999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC--ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHhcCC
Q psy2306 183 SNVFTES--RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS--------NFKRLVKQISNGD 252 (335)
Q Consensus 183 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~--------~~~~~~~~~~~~~ 252 (335)
+...... .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||... .............
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 9776432 22334558999999999987776 89999999999999999999999521 1111111111111
Q ss_pred CCC--------CC----CCCchHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy2306 253 YFE--------PK----NQSTASPLIAEMLNINPSSRADISVICSHWW 288 (335)
Q Consensus 253 ~~~--------~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 288 (335)
... .. .+..+.+++.+||+.||.+|||+.++++|..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 100 01 1246889999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=324.25 Aligned_cols=240 Identities=18% Similarity=0.253 Sum_probs=200.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC--------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccc------
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE--------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH------ 100 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~--------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~------ 100 (335)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 5799999999999999999999987 4889999998753 25678999999999999887
Q ss_pred ---------eeEEEEe-CCeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEE
Q psy2306 101 ---------IYEVFEN-REKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENIL 168 (335)
Q Consensus 101 ---------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nil 168 (335)
+++++.. .+..++||||+ +++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6677765 78899999999 99999999876 78999999999999999999999999999999999999
Q ss_pred EccCC--CeEEeeccccccccCCc--------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy2306 169 LDENG--NAKIADFGLSNVFTESR--------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG 238 (335)
Q Consensus 169 i~~~~--~~kL~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~ 238 (335)
++.++ .++|+|||++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 89999999997654322 1234478999999999988776 8999999999999999999999976
Q ss_pred C--cHHHHHHHHh---cCCC-CC------CCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 239 S--NFKRLVKQIS---NGDY-FE------PKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 239 ~--~~~~~~~~~~---~~~~-~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
. .......... .... .. ...+.++.+++.+||+.||.+|||+++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 328 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLR 328 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence 5 3333332222 1111 11 13478999999999999999999999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=332.26 Aligned_cols=246 Identities=28% Similarity=0.464 Sum_probs=207.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 345689999999999999999999875 46799999876432 23468899999999999999999999876 6789
Q ss_pred EEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 113 LVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999999974 3569999999999999999999999999999999999999999999999999997764322
Q ss_pred c--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 F--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
. .....++..|+|||++....+ +.++||||||+++|+|++ |..||.+....+....+..+.. .+...++.+.++
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp --------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 223445678999999987776 899999999999999999 9999999888888887776533 234567789999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q psy2306 266 IAEMLNINPSSRADISVICS 285 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~ 285 (335)
+.+||+.||.+|||+++|++
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=326.68 Aligned_cols=246 Identities=22% Similarity=0.349 Sum_probs=198.0
Q ss_pred ceeEEeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE-eCCeEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE-NREKMV 112 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~ 112 (335)
+|++.+.||+|+||.||+|.+..+ +..|++|.+.. .......+.+.+|+.+++.++||||+++++++. ..+..+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS--CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC--CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 689999999999999999987543 24589998865 234455678899999999999999999999874 456889
Q ss_pred EEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999999764 4589999999999999999999999999999999999999999999999999976543221
Q ss_pred -----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchH
Q psy2306 192 -----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTAS 263 (335)
Q Consensus 192 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 263 (335)
.....+++.|+|||++.+..+ +.++||||||+++|+|++ |.+||...+..+....+..+.. .+...+..+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 123456778999999987776 899999999999999999 7888877665555555554433 3344677999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy2306 264 PLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+++.+||+.||.+|||+.++++
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999984
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=312.91 Aligned_cols=232 Identities=32% Similarity=0.571 Sum_probs=189.9
Q ss_pred hhhccceeEE-eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHH-HcCCCCcccceeEEEEe--
Q psy2306 32 RKLKQRFDIV-RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM-SSVRHPNIIHIYEVFEN-- 107 (335)
Q Consensus 32 ~~~~~~y~~~-~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~-- 107 (335)
..+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+..+ +..+||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3455677777 7899999999999999999999999998641 2455777777 66689999999999987
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CCCeEEeec
Q psy2306 108 --REKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NGNAKIADF 180 (335)
Q Consensus 108 --~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~~~kL~df 180 (335)
....+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 778999999999999999998754 6999999999999999999999999999999999999988 788999999
Q ss_pred cccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC----CCC-C
Q psy2306 181 GLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG----DYF-E 255 (335)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~----~~~-~ 255 (335)
|++..... ..+ +.++||||||+++|+|++|..||...+.......+... ... +
T Consensus 165 g~a~~~~~---------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 165 GFAKETTG---------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp TTCEECTT---------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred cccccccc---------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence 98854332 122 77899999999999999999999776554332222111 111 1
Q ss_pred ----CCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 256 ----PKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 256 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
...++++.++|.+||+.||.+|||+.++++||||.+..
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 34577899999999999999999999999999998653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=328.18 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=195.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 114 (335)
.+|++.+.||+|+||+|+. ....+|+.||+|++...... .+.+|+.+++.+ +||||+++++++.+.+..|++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3799999999999999764 33557899999998653321 245789999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-----CCCeEEeeccccccccC
Q psy2306 115 MEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-----NGNAKIADFGLSNVFTE 188 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-----~~~~kL~df~~~~~~~~ 188 (335)
||+++ ++|.+++.... ..++..++.++.|++.||.|||+.|++||||||+||+++. ...++|+|||++.....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99995 59999997643 4566677899999999999999999999999999999953 23688999999977653
Q ss_pred C----ccccccccCCccCChhhhcCC--CCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCCCCC----
Q psy2306 189 S----RFLSTFCGSPLYASPEIVKGI--PYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYFEPK---- 257 (335)
Q Consensus 189 ~----~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~---- 257 (335)
. .......|++.|+|||++.+. ..++.++|||||||++|+|++ |..||.....................
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 3 223456789999999999742 223779999999999999999 99999766555444433332221111
Q ss_pred CCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 258 NQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
.+..+.++|.+||+.||.+|||+.++++||||...
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 12347899999999999999999999999999753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=312.70 Aligned_cols=238 Identities=29% Similarity=0.492 Sum_probs=195.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.+. ++.|++|.+.. ....+.+.+|+..++.++||||+++++++. +..++||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~ 78 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM 78 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence 58999999999999999999875 78899999864 234567889999999999999999999886 3478999
Q ss_pred ecCCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhHH---CCcEecCCCCCCEEEccCCC-eEEeeccccccccC
Q psy2306 116 EYAAGGELYDFLDQKK---VLTEEEARRIFRQIATAVYYCHK---HKICHRDLKLENILLDENGN-AKIADFGLSNVFTE 188 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~LH~---~givH~di~p~nili~~~~~-~kL~df~~~~~~~~ 188 (335)
||+++++|.+++.... .++...++.++.|++.||.|||+ +|++|+||+|+||+++.++. +||+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999999998654 37899999999999999999999 89999999999999998887 79999999876543
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHHhcCC--CCCCCCCCchHH
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS--NFKRLVKQISNGD--YFEPKNQSTASP 264 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~--~~~~~~~~~~~~~--~~~~~~~~~l~~ 264 (335)
. .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||... ........+.... ......+..+.+
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 159 H--MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp --------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred c--cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence 2 234468999999999988776 89999999999999999999999753 2333333333332 233456779999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q psy2306 265 LIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~ 285 (335)
++.+||+.||.+|||++++++
T Consensus 236 li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=324.70 Aligned_cols=244 Identities=16% Similarity=0.238 Sum_probs=197.5
Q ss_pred hhhccceeEEeeeeccCCeEEEEEE-----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC---CCcccceeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR---HPNIIHIYE 103 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~-----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~ 103 (335)
..-.++|++.+.||+|+||+||+|. +..+++.||+|++.... ...+..|...++.++ |+||+.+++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3445789999999999999999994 66789999999987532 224566777777776 899999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-------
Q psy2306 104 VFENREKMVLVMEYAAGGELYDFLDQ-----KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE------- 171 (335)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~------- 171 (335)
++...+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999999973 567999999999999999999999999999999999999988
Q ss_pred ----CCCeEEeecccccccc---CCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHH
Q psy2306 172 ----NGNAKIADFGLSNVFT---ESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRL 244 (335)
Q Consensus 172 ----~~~~kL~df~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~ 244 (335)
++.+||+|||++.... .........|++.|+|||++.+..+ +.++||||||+++|+|++|..||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 8999999999996543 3334456679999999999998886 9999999999999999999999854332110
Q ss_pred HHHHhcCCCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 245 VKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
. ..........++.+.+++..||+.+|.+|++..+.+.
T Consensus 294 ~---~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 294 K---PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp E---ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred e---echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 0 0111112223457889999999999999965544443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.76 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=199.8
Q ss_pred ccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC--CCCccccee
Q psy2306 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV--RHPNIIHIY 102 (335)
Q Consensus 25 ~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~ 102 (335)
.........+.++|++.+.||+|+||.||+|.+. |+.||+|++.... ......|.+++..+ +||||++++
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~ 97 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFI 97 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEE
Confidence 3344567888899999999999999999999876 8899999986421 22334455555554 899999999
Q ss_pred EEEEeC----CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC--------CcEecCCCCCCEEEc
Q psy2306 103 EVFENR----EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH--------KICHRDLKLENILLD 170 (335)
Q Consensus 103 ~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~--------givH~di~p~nili~ 170 (335)
+++... ...+++|||+++++|.++++.. .+++..++.++.|++.||.|||+. |++|+||||+||+++
T Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred EEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 999877 7899999999999999999764 599999999999999999999998 999999999999999
Q ss_pred cCCCeEEeeccccccccCCccc-----cccccCCccCChhhhcCCCCCCCc------chHHHHHHHHHHHHhC-------
Q psy2306 171 ENGNAKIADFGLSNVFTESRFL-----STFCGSPLYASPEIVKGIPYHGPE------VDCWSLGVLLYTLVYG------- 232 (335)
Q Consensus 171 ~~~~~kL~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~------~Dv~slG~~l~~l~tg------- 232 (335)
.++.+||+|||.+......... ....|++.|+|||++.+... +.. +||||||+++|+|++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN-RNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCC-TTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccC-CccccCccccchHHHHHHHHHHHhccCccccc
Confidence 9999999999999765433221 24578999999999987665 443 8999999999999999
Q ss_pred ---CCCCCCC-----cHHHHHHHHhcCCCCCC--------CCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 233 ---AMPFDGS-----NFKRLVKQISNGDYFEP--------KNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 233 ---~~p~~~~-----~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..||... ........+......+. ..+.++.+++.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 6777542 23333333333222111 112358899999999999999999999943
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=316.29 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=207.1
Q ss_pred hhhhccceeEEeeeeccCCeEEEEEE----ECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEE
Q psy2306 31 RRKLKQRFDIVRKLGQGNYGKVQLGI----NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFE 106 (335)
Q Consensus 31 ~~~~~~~y~~~~~ig~g~~g~Vy~~~----~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 106 (335)
.....++|++.+.||+|+||.||+|. +..+|+.|++|.+... .....+.+.+|+..++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 34456689999999999999999998 4568999999998753 3455678899999999999999999999986
Q ss_pred eCC--eEEEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 107 NRE--KMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 107 ~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
..+ ..+++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 544 789999999999999999875 46999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcc----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----------------H
Q psy2306 184 NVFTESRF----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK----------------R 243 (335)
Q Consensus 184 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~----------------~ 243 (335)
........ .....++..|+|||++.+..+ +.++||||||+++|+|++|..||...... .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 87654332 123345677999999987766 88999999999999999999998643111 1
Q ss_pred HHHHHhcCC--CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 244 LVKQISNGD--YFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 244 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+...+.... ..+...+.++.++|++||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222333222 233456779999999999999999999999983
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=340.52 Aligned_cols=245 Identities=24% Similarity=0.400 Sum_probs=208.3
Q ss_pred eeE-EeeeeccCCeEEEEEEE--CCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 38 FDI-VRKLGQGNYGKVQLGIN--KETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 38 y~~-~~~ig~g~~g~Vy~~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
+.+ .+.||+|+||.||+|.+ +.+++.||+|+++... ......+.+.+|+.+++.++||||+++++++.. +..++|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 444 34899999999999955 4567899999997632 233456789999999999999999999999964 558899
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--- 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--- 191 (335)
|||+++++|.+++..+..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999976643321
Q ss_pred -ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 192 -LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 192 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
.....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..+....+..+.. .+...+.++.++|.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 223345678999999988776 899999999999999998 9999999998888888877643 34456789999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q psy2306 268 EMLNINPSSRADISVICS 285 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~ 285 (335)
+||+.||.+||++++|++
T Consensus 607 ~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHTCSSTTTSCCHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHH
Confidence 999999999999999983
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.39 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=208.9
Q ss_pred CCCccchhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHc--CCCCccc
Q psy2306 22 TGGVRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS--VRHPNII 99 (335)
Q Consensus 22 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~ 99 (335)
.+..........+.++|++.+.||+|+||.||+|.+ +|+.||+|.+... ....+.+|.+++.. ++||||+
T Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~ 99 (342)
T 1b6c_B 28 SGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENIL 99 (342)
T ss_dssp CCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBC
T ss_pred CCCCCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEE
Confidence 344455556788999999999999999999999987 4889999998642 23456678888877 6899999
Q ss_pred ceeEEEEeCC----eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhH--------HCCcEecCCCCCCE
Q psy2306 100 HIYEVFENRE----KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH--------KHKICHRDLKLENI 167 (335)
Q Consensus 100 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH--------~~givH~di~p~ni 167 (335)
++++++.... ..+++|||+++++|.+++.+. .+++..++.++.|++.||.||| +.|++|+||+|+||
T Consensus 100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI 178 (342)
T 1b6c_B 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178 (342)
T ss_dssp CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred EEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence 9999998776 899999999999999999764 5899999999999999999999 89999999999999
Q ss_pred EEccCCCeEEeeccccccccCCcc-----ccccccCCccCChhhhcCCCCC-----CCcchHHHHHHHHHHHHhC-----
Q psy2306 168 LLDENGNAKIADFGLSNVFTESRF-----LSTFCGSPLYASPEIVKGIPYH-----GPEVDCWSLGVLLYTLVYG----- 232 (335)
Q Consensus 168 li~~~~~~kL~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~-----~~~~Dv~slG~~l~~l~tg----- 232 (335)
+++.++.+||+|||++........ .....+++.|+|||++.+.... +.++||||||+++|+|++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 999999999999999977654332 2345689999999999775321 2689999999999999999
Q ss_pred -----CCCCCCC-----cHHHHHHHHhcCCCCCCCC---------CCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 233 -----AMPFDGS-----NFKRLVKQISNGDYFEPKN---------QSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 233 -----~~p~~~~-----~~~~~~~~~~~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
..||... ........+...... +.. +..+.+++.+||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccccccCccccCcCcccHHHHHHHHHHHHhC-CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 7888653 344555554443322 222 2368899999999999999999999954
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=316.40 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=206.7
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
....++|++.+.||+|+||.||+|.+.. .+++|.+..... .....+.+.+|+..++.++|+||+++++++.+.+..
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3445799999999999999999998764 499999875332 222234566899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC--
Q psy2306 112 VLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-- 188 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-- 188 (335)
++++||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||++.....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999999998754 699999999999999999999999999999999999997 78999999998765431
Q ss_pred ----CccccccccCCccCChhhhcCC--------CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC--
Q psy2306 189 ----SRFLSTFCGSPLYASPEIVKGI--------PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-- 254 (335)
Q Consensus 189 ----~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-- 254 (335)
........|++.|+|||++.+. ..++.++||||||+++|+|++|..||...........+......
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 1222344578899999998752 22478999999999999999999999998888887777665432
Q ss_pred -CCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 255 -EPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 255 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
....+.++.+++.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2246789999999999999999999999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=332.29 Aligned_cols=249 Identities=15% Similarity=0.130 Sum_probs=196.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC-Ccc---------cceeEE-
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH-PNI---------IHIYEV- 104 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i---------~~~~~~- 104 (335)
..|+..+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+..++.++| .+. +...+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 358999999999999999999999999999999885544444556788899999999976 211 111111
Q ss_pred -----------EEe-----CCeEEEEEecCCCCCHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecC
Q psy2306 105 -----------FEN-----REKMVLVMEYAAGGELYDFLDQ-------KKVLTEEEARRIFRQIATAVYYCHKHKICHRD 161 (335)
Q Consensus 105 -----------~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~~l~~~l~~LH~~givH~d 161 (335)
+.. ...++++|+.+ +++|.++++. +.++++..+..++.|++.||+|||++|++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111 22467788877 6799988841 34578889999999999999999999999999
Q ss_pred CCCCCEEEccCCCeEEeeccccccccCCccccccccCCccCChhhh----------cCCCCCCCcchHHHHHHHHHHHHh
Q psy2306 162 LKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV----------KGIPYHGPEVDCWSLGVLLYTLVY 231 (335)
Q Consensus 162 i~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~~Dv~slG~~l~~l~t 231 (335)
|||+||+++.++.+||+|||++...... .....| +.|+|||++ ....+ +.++||||||+++|+|++
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHH
Confidence 9999999999999999999998765443 344566 999999999 33334 789999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 232 GAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 232 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
|..||...+..+....+... ....++++.++|.+||+.||.+||++.++++||||++.
T Consensus 313 g~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWIFRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp SSCCCCTTGGGSCSGGGGSS---CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCCCCcchhhhHHHHHhh---cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 99999876654433333222 23567899999999999999999999999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=336.52 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=206.4
Q ss_pred cceeEEe-eeeccCCeEEEEEEEC--CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVR-KLGQGNYGKVQLGINK--ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~-~ig~g~~g~Vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
+++.+.+ .||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 4566666 8999999999999875 356679999997642 23345678899999999999999999999976 5689
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999999975 45699999999999999999999999999999999999999999999999999977643221
Q ss_pred ----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHH
Q psy2306 192 ----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASP 264 (335)
Q Consensus 192 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 264 (335)
.....+++.|+|||++.+..+ +.++||||||+++|||++ |..||...+..+....+..+.. .+...++++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 112334578999999987776 899999999999999998 9999999888888887776643 34456789999
Q ss_pred HHHHhcccCCCCCCCHHHHh
Q psy2306 265 LIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll 284 (335)
++.+||+.||.+||++.+|+
T Consensus 571 li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=334.72 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=212.1
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.+++.++|+||+++++++.+ +..+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 345689999999999999999999875 46799999976432 23468899999999999999999999876 6789
Q ss_pred EEEecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 113 LVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999999974 3569999999999999999999999999999999999999999999999999997664322
Q ss_pred c--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 F--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
. .....++..|+|||++....+ +.++||||||+++|+|++ |..||.+....+....+..+.. .+...+..+.++
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 123345678999999987776 899999999999999999 9999999888888888776543 234567789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q psy2306 266 IAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~ 286 (335)
|.+||+.||.+|||+++|++.
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999853
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=325.37 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=205.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC-CcccceeEEEEeCCeE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH-PNIIHIYEVFENREKM 111 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~ 111 (335)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+|+.+++.++| +++..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 56789999999999999999999999999999999987543322 46789999999986 6666677777888899
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEE---ccCCCeEEeecccccccc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILL---DENGNAKIADFGLSNVFT 187 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili---~~~~~~kL~df~~~~~~~ 187 (335)
+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999985 5679999999999999999999999999999999999999 578999999999997765
Q ss_pred CCcc--------ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhcCC----
Q psy2306 188 ESRF--------LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN---FKRLVKQISNGD---- 252 (335)
Q Consensus 188 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~---~~~~~~~~~~~~---- 252 (335)
.... .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.... ..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 4322 225678999999999998877 899999999999999999999997643 222222222211
Q ss_pred --CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 253 --YFEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 253 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
......+.++.+++..||+.||.+||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 112456789999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=313.12 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=200.4
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCC-cCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCK-IETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
.|...+.||+|+||.||+|.+ ++..|++|.+.... .......+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 344559999999999999975 57899999987533 233455678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-
Q psy2306 116 EYAAGGELYDFLDQ---KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 116 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~- 191 (335)
||+++++|.+++.. ..++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999999873 45699999999999999999999999999999999999999999999999999876543221
Q ss_pred --ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHHhcCCC------------
Q psy2306 192 --LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK----RLVKQISNGDY------------ 253 (335)
Q Consensus 192 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~----~~~~~~~~~~~------------ 253 (335)
.....|++.|+|||++.+. + +.++||||||+++|+|++|..||...... .....+.....
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 2345689999999998763 4 88999999999999999999999764322 22222222111
Q ss_pred CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 254 FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.....+..+.+++.+||+.||.+|||+.++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01112346888999999999999999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=313.77 Aligned_cols=240 Identities=24% Similarity=0.379 Sum_probs=186.1
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHH--HHcCCCCcccceeEEEEe-----
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI--MSSVRHPNIIHIYEVFEN----- 107 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~----- 107 (335)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+..|.++ +..++|+||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 45999999999999999999966 58899999987522 1223334444 445789999999986542
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC---------CcEecCCCCCCEEEccCCCeEEe
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH---------KICHRDLKLENILLDENGNAKIA 178 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~---------givH~di~p~nili~~~~~~kL~ 178 (335)
...+++||||+++++|.+++.... .++..++.++.|++.||.|||+. |++|+||||+||+++.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 336799999999999999997654 58999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCc---------cccccccCCccCChhhhcCCC------CCCCcchHHHHHHHHHHHHhCCCCCCCC----
Q psy2306 179 DFGLSNVFTESR---------FLSTFCGSPLYASPEIVKGIP------YHGPEVDCWSLGVLLYTLVYGAMPFDGS---- 239 (335)
Q Consensus 179 df~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~~------~~~~~~Dv~slG~~l~~l~tg~~p~~~~---- 239 (335)
|||++....... ......|++.|+|||++.+.. .++.++||||||+++|+|++|..||...
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999997664321 122456899999999997631 2256899999999999999997765321
Q ss_pred --------------cHHHHHHHHhcCCCCCCCCC----------CchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 240 --------------NFKRLVKQISNGDYFEPKNQ----------STASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 240 --------------~~~~~~~~~~~~~~~~~~~~----------~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
........+..... .+..+ +++.++|.+||+.||.+|||+.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l 310 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQ-RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCC-CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhccccc-CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence 12222222222211 11211 2589999999999999999999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=334.04 Aligned_cols=250 Identities=27% Similarity=0.473 Sum_probs=212.1
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
....++|++.+.||+|+||.||+|.+..+ +..|++|.+... ......+.+.+|+..++.++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34557899999999999999999998643 467999987652 34556678999999999999999999999985 5
Q ss_pred CeEEEEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
+..++||||+++++|.+++..+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 66899999999999999998654 69999999999999999999999999999999999999999999999999997765
Q ss_pred CCcc--ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCch
Q psy2306 188 ESRF--LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTA 262 (335)
Q Consensus 188 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l 262 (335)
.... .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..+....+..... .+...++.+
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 4322 223445678999999987766 889999999999999997 9999999888888777766543 345567899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q psy2306 263 SPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+++.+||+.||.+|||+.++++
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999983
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=302.47 Aligned_cols=226 Identities=15% Similarity=0.192 Sum_probs=191.3
Q ss_pred hhh-hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 30 HRR-KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 30 ~~~-~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
++. .+.++|++.+.||+|+||.||+|.+..+|+.|++|++...........+.+.+|+..+..++||||+++++++.+.
T Consensus 24 ~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 24 PGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp TTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 445 6788999999999999999999999999999999999876655666778899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
+..|+||||++|++|.++++.+ ....++..++.|++.||.|||++|++|+||||+||+++.++.++|++++
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999999999653 4666789999999999999999999999999999999999999998443
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---HHhcCCC-----CCCCCCC
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVK---QISNGDY-----FEPKNQS 260 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~---~~~~~~~-----~~~~~~~ 260 (335)
|++| .+.++||||||+++|+|++|..||...+...... ....... .....++
T Consensus 175 ------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T 3uqc_A 175 ------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234 (286)
T ss_dssp ------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCH
T ss_pred ------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCH
Confidence 3332 3889999999999999999999998754322110 0001111 1245677
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 261 TASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
++.++|.+||+.||.+| |+.++++
T Consensus 235 ~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 235 QISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHHHHHcccCCccC-CHHHHHH
Confidence 89999999999999999 9999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.94 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=203.4
Q ss_pred hhhhhccceeEEeeeeccCCeEEEEEEECC-CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 30 HRRKLKQRFDIVRKLGQGNYGKVQLGINKE-TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 30 ~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
++..+.++|++.+.||+|+||+||+|.+.. +|+.|++|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 456788999999999999999999999976 7899999998653 3455667788999999999999999999999876
Q ss_pred Ce-----EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 109 EK-----MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 109 ~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
+. .|+||||+++++|.+++.. ++++..++.++.|++.||.|||++||+|+||||+||+++.+ .+||+|||++
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccc
Confidence 55 7999999999999988764 69999999999999999999999999999999999999875 9999999999
Q ss_pred ccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCchH
Q psy2306 184 NVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTAS 263 (335)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 263 (335)
...... ....|++.|+|||++.+.. +.++||||||+++|+|++|..||........ .........++.+.
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----~~~~~~~~~~~~l~ 298 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----PEDDPVLKTYDSYG 298 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----CTTCHHHHHCHHHH
T ss_pred hhcccC---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc-----cccccccccCHHHH
Confidence 776543 4556899999999987653 7899999999999999999988865221000 00000001245788
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
++|.+||+.||.+||+..+.+.|+|+.
T Consensus 299 ~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 299 RLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999999998874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=313.18 Aligned_cols=243 Identities=19% Similarity=0.264 Sum_probs=191.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-----CHHHHHHHHHHHHHHHcCC---------CCccc
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-----TEADLIRIRREIQIMSSVR---------HPNII 99 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------~~~i~ 99 (335)
..++|++.+.||+|+||+||+|++ +|+.||+|++...... .....+.+.+|+.+++.++ |+||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346899999999999999999987 5899999999865321 2233457788888888875 66776
Q ss_pred ceeEEEE-----------------e-------------CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHH
Q psy2306 100 HIYEVFE-----------------N-------------REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAV 149 (335)
Q Consensus 100 ~~~~~~~-----------------~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l 149 (335)
++.+++. + .+..|+||||+++|++.+.+.+ ..+++..++.++.|++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 6666542 2 6889999999999976666643 5689999999999999999
Q ss_pred HHhH-HCCcEecCCCCCCEEEccCC--------------------CeEEeeccccccccCCccccccccCCccCChhhhc
Q psy2306 150 YYCH-KHKICHRDLKLENILLDENG--------------------NAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK 208 (335)
Q Consensus 150 ~~LH-~~givH~di~p~nili~~~~--------------------~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 208 (335)
.||| +.||+||||||+|||++.++ .+||+|||++...... ...|++.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999999887 8999999999876543 347899999999998
Q ss_pred CCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCcH-HHHHHHHhcC-CCC---CC----CCCCchHHHHHHhcccCCCCCC
Q psy2306 209 GIPYHGPEVDCWSLGVL-LYTLVYGAMPFDGSNF-KRLVKQISNG-DYF---EP----KNQSTASPLIAEMLNINPSSRA 278 (335)
Q Consensus 209 ~~~~~~~~~Dv~slG~~-l~~l~tg~~p~~~~~~-~~~~~~~~~~-~~~---~~----~~~~~l~~li~~~l~~dp~~Rp 278 (335)
+.. +.++||||||++ .+++++|..||.+... ......+... ... .. ..++++.+||++||+.|
T Consensus 251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred CCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 765 789999998777 7778889999854322 2222233211 111 11 23557899999999977
Q ss_pred CHHHHh-cCCCcC
Q psy2306 279 DISVIC-SHWWID 290 (335)
Q Consensus 279 s~~~ll-~~~~~~ 290 (335)
|++|+| +||||+
T Consensus 324 sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHCGGGC
T ss_pred CHHHHHhcCCCcC
Confidence 999999 999995
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-34 Score=273.45 Aligned_cols=186 Identities=17% Similarity=0.114 Sum_probs=136.9
Q ss_pred eeeccCCeEEEEEEECCCCcEEEEEEeecCCcC-------CHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEEEE
Q psy2306 43 KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE-------TEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 43 ~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~-------~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 114 (335)
..+.|+.|.+..++....|+.+++|++...... .+...+.+.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 345677777777777778999999999764321 234557799999999999 699999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
|||++|++|.++|.+++++++. +|+.||+.||+|+|++|||||||||+|||++.+|++||+|||+++..... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 9999999999999999888875 47899999999999999999999999999999999999999999776543 3345
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCC
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGA 233 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~ 233 (335)
..+||+.|+|||++.+.. ..++|+|++|++++++.++.
T Consensus 398 t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 398 NLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred CceechhhccHHHhCCCC--CCcccccccccchhhhcccc
Confidence 678999999999998753 56899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=228.53 Aligned_cols=185 Identities=21% Similarity=0.216 Sum_probs=144.9
Q ss_pred eEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH-----HHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE-----ADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 39 ~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
...+.||+|+||.||+| ...+..+++|.......... ...+.+.+|+.+++.++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999 44578899998754332222 224568999999999999999966666667778899
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-- 191 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-- 191 (335)
||||+++++|.+++.. +..++.|+++||.|||++|++||||||+||+++. ++||+|||++........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999975 6689999999999999999999999999999988 999999999988755322
Q ss_pred ------ccccccCCccCChhhhcC--CCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy2306 192 ------LSTFCGSPLYASPEIVKG--IPYHGPEVDCWSLGVLLYTLVYGAMPF 236 (335)
Q Consensus 192 ------~~~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~tg~~p~ 236 (335)
.....||+.|+|||++.. ..| +..+|+|+..+-..+-..++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhcccc
Confidence 135678999999999976 334 66789999998888887776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=191.75 Aligned_cols=148 Identities=22% Similarity=0.221 Sum_probs=118.3
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH---------------HHHHHHHHHHHHHHcCCCCcccc
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE---------------ADLIRIRREIQIMSSVRHPNIIH 100 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~~~~i~~ 100 (335)
..|.+.+.||+|+||.||+|.+ .+|+.||+|.+........ .....+.+|+.+++.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3566669999999999999999 7899999999864321111 24567889999999999 4 66
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeec
Q psy2306 101 IYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADF 180 (335)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df 180 (335)
+.+++.. +..++||||++|++|.+ +.. .....++.|++.||.+||+.|++|+||||+||+++ ++.++|+||
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 6665544 55699999999999988 432 23557999999999999999999999999999999 999999999
Q ss_pred cccccccCCccccccccCCccCChhhhc
Q psy2306 181 GLSNVFTESRFLSTFCGSPLYASPEIVK 208 (335)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 208 (335)
|.+.. +..++|||.+.
T Consensus 237 G~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE------------TTSTTHHHHHH
T ss_pred CCCeE------------CCCCCHHHHHH
Confidence 99853 33467888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.8e-21 Score=166.18 Aligned_cols=142 Identities=20% Similarity=0.249 Sum_probs=110.2
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcE--EEEEEeecCCcCC---------------------HHHHHHHHHHHHHHHcC
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQE--VAIKTIKKCKIET---------------------EADLIRIRREIQIMSSV 93 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~--valK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l 93 (335)
.|.+.+.||+|+||.||+|.+..+|.. ||+|++....... ......+.+|+..+..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998677889 9999976432110 11224678899999999
Q ss_pred CCCcc--cceeEEEEeCCeEEEEEecCCC-C----CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhH-HCCcEecCCCCC
Q psy2306 94 RHPNI--IHIYEVFENREKMVLVMEYAAG-G----ELYDFLDQKKVLTEEEARRIFRQIATAVYYCH-KHKICHRDLKLE 165 (335)
Q Consensus 94 ~~~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH-~~givH~di~p~ 165 (335)
.|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.+|.+|| +.|++||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 87754 334432 356899999942 3 77776543 234567889999999999999 999999999999
Q ss_pred CEEEccCCCeEEeecccccccc
Q psy2306 166 NILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 166 nili~~~~~~kL~df~~~~~~~ 187 (335)
|||++. .++|+|||++....
T Consensus 201 NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SEEESS--SEEECCCTTCEETT
T ss_pred HEEEcC--cEEEEECcccccCC
Confidence 999987 99999999996543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.5e-18 Score=155.58 Aligned_cols=142 Identities=13% Similarity=0.239 Sum_probs=102.5
Q ss_pred ceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC--------------CH-----HHHHHHHHHHHHHHcCCCCc
Q psy2306 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE--------------TE-----ADLIRIRREIQIMSSVRHPN 97 (335)
Q Consensus 37 ~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~--------------~~-----~~~~~~~~e~~~l~~l~~~~ 97 (335)
-|++.+.||.|++|.||+|.+. +|+.||+|+++..... .. ........|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999876 5899999997542110 00 01112245677777775444
Q ss_pred ccceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC---
Q psy2306 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN--- 174 (335)
Q Consensus 98 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~--- 174 (335)
+....-+... ..++||||++|.+|.++... .....++.|++.+|.+||+.|+|||||||.|||++.++.
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 3222222122 23799999999888765431 234678899999999999999999999999999987763
Q ss_pred -------eEEeecccccccc
Q psy2306 175 -------AKIADFGLSNVFT 187 (335)
Q Consensus 175 -------~kL~df~~~~~~~ 187 (335)
+.++||+.+....
T Consensus 247 ~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECCCTTCEETT
T ss_pred ccccccceEEEEeCCcccCC
Confidence 8999999875543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=4.2e-12 Score=109.79 Aligned_cols=139 Identities=17% Similarity=0.189 Sum_probs=110.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 114 (335)
+.|++...++.|+.+.||++... +..+++|......... ...+.+|+..++.+. +..++++++++.+.+..|++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 46899999999999999999643 6789999987522111 124778888898885 66788999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH----------------------------------------
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK---------------------------------------- 154 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~---------------------------------------- 154 (335)
||+++|.+|.+.+. +......++.++..+|+.||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999987642 122345788899999999998
Q ss_pred -------------------CCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 155 -------------------HKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 155 -------------------~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
..++|||++|.||+++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999765556799998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=2.6e-11 Score=104.41 Aligned_cols=134 Identities=16% Similarity=0.141 Sum_probs=97.7
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc--ccceeEEEEeCCeEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN--IIHIYEVFENREKMVL 113 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~l 113 (335)
..|.+....+.|..+.||++.. .+|..+++|...... ...+.+|+..++.+.+.+ +++++++....+..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 3566655555666799999954 457789999976531 124667888888875433 5668888888888999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCC-------------------------------------
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK------------------------------------- 156 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~g------------------------------------- 156 (335)
+||+++|.++. ... .+ ...++.++...|..||+..
T Consensus 93 v~e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999998884 211 12 2356677777777777643
Q ss_pred ---------------------cEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 157 ---------------------ICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 157 ---------------------ivH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
++|||++|.||+++.++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999776556799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=6.5e-11 Score=107.14 Aligned_cols=141 Identities=20% Similarity=0.359 Sum_probs=105.4
Q ss_pred eEEeeeeccCCeEEEEEEECCCCcEEEEEEee--cCCcCCHHHHHHHHHHHHHHHcCC--CCcccceeEEEEeC---CeE
Q psy2306 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIK--KCKIETEADLIRIRREIQIMSSVR--HPNIIHIYEVFENR---EKM 111 (335)
Q Consensus 39 ~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~--~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~---~~~ 111 (335)
...+.|+.|.++.+|++... +..+++|+.. .... ......+.+|..+++.+. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 35678899999999998654 4689999876 3221 112346778999998886 34578888888766 458
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-------------------------------------
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK------------------------------------- 154 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~------------------------------------- 154 (335)
|++||+++|.++.+.. -..++......++.++..+|+.||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999988774321 2236788888999999999999997
Q ss_pred ---------------------CCcEecCCCCCCEEEccCCC--eEEeecccccc
Q psy2306 155 ---------------------HKICHRDLKLENILLDENGN--AKIADFGLSNV 185 (335)
Q Consensus 155 ---------------------~givH~di~p~nili~~~~~--~kL~df~~~~~ 185 (335)
.+++|||++|.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999987753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.8e-10 Score=101.74 Aligned_cols=181 Identities=18% Similarity=0.199 Sum_probs=120.1
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCc--ccceeEEEEeCC---eEEEE
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPN--IIHIYEVFENRE---KMVLV 114 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv 114 (335)
.+.++.|....||++ +..+++|+... ......+.+|...++.+. +.. +++++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v-----~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI-----NRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEES-----TTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEE-----CCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 355899999999987 25699998543 244567889999998873 332 444554443333 34889
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH----------------------------------------
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK---------------------------------------- 154 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~---------------------------------------- 154 (335)
|++++|.++.+... ..++..+...++.++...++.||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865432 236777777888888888888885
Q ss_pred ------------------CCcEecCCCCCCEEEcc--CCCeEEeeccccccccCCccccccccCCccCChh---------
Q psy2306 155 ------------------HKICHRDLKLENILLDE--NGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE--------- 205 (335)
Q Consensus 155 ------------------~givH~di~p~nili~~--~~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE--------- 205 (335)
..++|||++|.||+++. .+.+.++||+.+.................-..|+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 13799999999999988 4567899999876543221111000000002222
Q ss_pred -------hhcCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy2306 206 -------IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236 (335)
Q Consensus 206 -------~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~ 236 (335)
..... ..-.+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~---~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKY---RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHH---HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHH---HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22111 11258999999999999998775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=1.7e-08 Score=87.38 Aligned_cols=133 Identities=17% Similarity=0.224 Sum_probs=98.6
Q ss_pred eeeccCCe-EEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEEEEEecCCC
Q psy2306 43 KLGQGNYG-KVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMVLVMEYAAG 120 (335)
Q Consensus 43 ~ig~g~~g-~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 120 (335)
.+..|..+ .||+......+..+++|.... .....+.+|...|+.+. +--+.+++.++.+.+..+++||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445554 689987777788899998654 22446778898888875 33477889999999999999999999
Q ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCC--------------------------------------------
Q psy2306 121 GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK-------------------------------------------- 156 (335)
Q Consensus 121 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~g-------------------------------------------- 156 (335)
.++.+..... ......+..++...|..||+..
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8887766432 1233455666777777777421
Q ss_pred --------------cEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 157 --------------ICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 157 --------------ivH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
++|||+++.||+++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 79999999999998776677999998743
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=2.3e-07 Score=81.91 Aligned_cols=135 Identities=19% Similarity=0.184 Sum_probs=93.9
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCC---cccceeEEEE-eCCeEEEEEe
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP---NIIHIYEVFE-NREKMVLVME 116 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e 116 (335)
.+.++.|....||.. |..+++|+.. .......+.+|...++.+.+. .+++++.+.. ..+..+++|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456788988999998 5678999842 234456788999999998642 3566677664 4556789999
Q ss_pred cCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC-----------------------------------------
Q psy2306 117 YAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH----------------------------------------- 155 (335)
Q Consensus 117 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~----------------------------------------- 155 (335)
+++|.++.+..- ..++..+...++.++...|+.||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988866321 1134444444455555555544432
Q ss_pred -------------------CcEecCCCCCCEEEcc---CCCe-EEeecccccccc
Q psy2306 156 -------------------KICHRDLKLENILLDE---NGNA-KIADFGLSNVFT 187 (335)
Q Consensus 156 -------------------givH~di~p~nili~~---~~~~-kL~df~~~~~~~ 187 (335)
.++|+|++|.||+++. ++.+ .|+||+.+....
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 4599999999999987 4565 799999876543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=4.8e-07 Score=82.76 Aligned_cols=80 Identities=21% Similarity=0.204 Sum_probs=49.8
Q ss_pred EEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc-CCH---HHHHHHHHHHHHHHcCCC--C-cccceeEEEEeCCeEE
Q psy2306 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI-ETE---ADLIRIRREIQIMSSVRH--P-NIIHIYEVFENREKMV 112 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~-~~~---~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~ 112 (335)
..+.||.|.++.||++.+..++..+++|....... ... .....+..|.+.++.+.. + .+++++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35688999999999997666678999998654211 000 122355678888877632 3 34455544 345568
Q ss_pred EEEecCCCC
Q psy2306 113 LVMEYAAGG 121 (335)
Q Consensus 113 lv~e~~~~~ 121 (335)
++||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=1.2e-05 Score=71.59 Aligned_cols=30 Identities=30% Similarity=0.501 Sum_probs=27.2
Q ss_pred CCcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 155 HKICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 155 ~givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.+++|||+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=3e-06 Score=76.14 Aligned_cols=87 Identities=8% Similarity=0.085 Sum_probs=55.1
Q ss_pred eeEEeee-eccCCeEEEEEEEC--C----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-C--CcccceeEEEEe
Q psy2306 38 FDIVRKL-GQGNYGKVQLGINK--E----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-H--PNIIHIYEVFEN 107 (335)
Q Consensus 38 y~~~~~i-g~g~~g~Vy~~~~~--~----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~ 107 (335)
....+.| +.|....+|++... . ++..+++|...............+.+|+..++.+. + -.+++++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3455778 88888999988643 1 15689999865422000000124557777777774 2 356778887765
Q ss_pred C---CeEEEEEecCCCCCHH
Q psy2306 108 R---EKMVLVMEYAAGGELY 124 (335)
Q Consensus 108 ~---~~~~lv~e~~~~~~L~ 124 (335)
. +..+++||+++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999886653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.23 E-value=7.7e-06 Score=67.20 Aligned_cols=135 Identities=17% Similarity=0.144 Sum_probs=89.9
Q ss_pred CHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhH-HCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccccccCC
Q psy2306 122 ELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCH-KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199 (335)
Q Consensus 122 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH-~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~~~ 199 (335)
+|.++|+. +.|++++++|.++.|++.+|..+- +..-...=+.|..|++..+|.|.+.+ ..+. ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence 79999875 678999999999999999988762 12222344567899999999998874 1110 1123
Q ss_pred ccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCchHHHHHHhccc-------
Q psy2306 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLIAEMLNI------- 272 (335)
Q Consensus 200 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~------- 272 (335)
.+.|||.... ..+.+.=|||||+++|..+--..|- ..+...++++.+||..|.+.
T Consensus 102 ~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~e----------------~eE~eLS~~LE~LL~~Mt~~~~d~~~~ 163 (229)
T 2yle_A 102 PPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLKE----------------NEERELSPPLEQLIDHMANTVEADGSN 163 (229)
T ss_dssp -----CCSSS--SSCHHHHHHHHHHHHHHHHTTTCCT----------------TEEECCCHHHHHHHHHHTTCCC-----
T ss_pred CCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCCc----------------ccchhhCHHHHHHHHHHHhcccccccc
Confidence 4678877641 2267889999999999999432221 22455677888888888765
Q ss_pred ------------------CCCCCCCHHHHhcC
Q psy2306 273 ------------------NPSSRADISVICSH 286 (335)
Q Consensus 273 ------------------dp~~Rps~~~ll~~ 286 (335)
.+..|+++++|++.
T Consensus 164 DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 164 DEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp ---------------CCSCCCCCCSHHHHHHH
T ss_pred cccccccccccccccccccccCcCCHHHHHHH
Confidence 24678888888743
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.03 E-value=0.0001 Score=64.85 Aligned_cols=77 Identities=17% Similarity=0.143 Sum_probs=60.4
Q ss_pred eEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC---CCcccceeEEEEeCCeEEEEE
Q psy2306 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR---HPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 39 ~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~ 115 (335)
.-.+.|+.|....+|+... ++..+++|..... ....+..|...|+.+. ...+++++......+..+++|
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 4467889999999999864 4678999987642 2446778888888774 356888898888888999999
Q ss_pred ecCCCCCH
Q psy2306 116 EYAAGGEL 123 (335)
Q Consensus 116 e~~~~~~L 123 (335)
|+++|.++
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.7e-05 Score=70.76 Aligned_cols=78 Identities=9% Similarity=0.031 Sum_probs=44.8
Q ss_pred HHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccccc--CCccCChhhhcCCC--CCCCcchHHHHHHHHHH
Q psy2306 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCG--SPLYASPEIVKGIP--YHGPEVDCWSLGVLLYT 228 (335)
Q Consensus 153 H~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~~~--~~~~~aPE~~~~~~--~~~~~~Dv~slG~~l~~ 228 (335)
+...++|||++|.||+++.++ +.++||+.+..-....-...... ...|++|+...... ......++..+...+++
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 356799999999999998776 99999998865432211111110 12345554443111 00122445566667776
Q ss_pred HHh
Q psy2306 229 LVY 231 (335)
Q Consensus 229 l~t 231 (335)
.++
T Consensus 309 ~y~ 311 (420)
T 2pyw_A 309 LFN 311 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 664
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.91 E-value=2.5e-05 Score=68.43 Aligned_cols=133 Identities=16% Similarity=0.123 Sum_probs=74.3
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc-cceeEEEEeCCeEEEEEecC-
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI-IHIYEVFENREKMVLVMEYA- 118 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~- 118 (335)
.+.|+.|....+|++ ..+++|+....... .....+|...++.+...++ .+++.. +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 678899999999999 46899997652111 1112356666666642222 455554 344457899999
Q ss_pred CCCCHHH--------HH----------hhCC-CC----C-HHHHHHHHH--------------HHHHHHHHhH-------
Q psy2306 119 AGGELYD--------FL----------DQKK-VL----T-EEEARRIFR--------------QIATAVYYCH------- 153 (335)
Q Consensus 119 ~~~~L~~--------~l----------~~~~-~~----~-~~~~~~i~~--------------~l~~~l~~LH------- 153 (335)
+|.++.. .. +... .+ . ...+..+.. .+...+..|.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6654421 01 0001 01 0 111111111 1111111111
Q ss_pred -HCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 154 -KHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 154 -~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
...++|+|+.+.||+ ..++.+.++||+.+...
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 124899999999999 56778999999987543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=0.0003 Score=61.04 Aligned_cols=80 Identities=11% Similarity=0.032 Sum_probs=55.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC---CcccceeEEEEeCCeE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH---PNIIHIYEVFENREKM 111 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~~ 111 (335)
..+..-.+.+|.|..+.||++... +|+.|++|+........ ...+..|+..|+.+.. -.+++++.. +. .
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--R 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--T
T ss_pred CCCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--c
Confidence 346778899999999999999755 68899999876433222 2246678888888742 234455554 22 3
Q ss_pred EEEEecCCCCC
Q psy2306 112 VLVMEYAAGGE 122 (335)
Q Consensus 112 ~lv~e~~~~~~ 122 (335)
+++||++++..
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 68899998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00015 Score=63.89 Aligned_cols=140 Identities=12% Similarity=0.073 Sum_probs=76.2
Q ss_pred eEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc--ccceeEE------EEeCCe
Q psy2306 39 DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN--IIHIYEV------FENREK 110 (335)
Q Consensus 39 ~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~ 110 (335)
.-.+.|+.|....+|++... +..+++|...... . .+.+..|..+++.+...+ +++++.. ....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeC--CccEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 44567788888999998654 3368999987521 1 123445666665553111 2333321 223567
Q ss_pred EEEEEecCCCCCHHH-----------HH---hh---C-C-C----CCHHHHHH---------------HHHHHHHHHHHh
Q psy2306 111 MVLVMEYAAGGELYD-----------FL---DQ---K-K-V----LTEEEARR---------------IFRQIATAVYYC 152 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~-----------~l---~~---~-~-~----~~~~~~~~---------------i~~~l~~~l~~L 152 (335)
.++++++++|.++.. .+ +. . . + ........ +...+...+..+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 899999998864311 11 10 0 0 0 01110000 001133444555
Q ss_pred HH-------CCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 153 HK-------HKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 153 H~-------~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
.. .+++|+|+++.||+++.++.+.++||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 42 4699999999999998765567999987743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=7.8e-05 Score=67.44 Aligned_cols=137 Identities=18% Similarity=0.163 Sum_probs=81.7
Q ss_pred EeeeeccCCeEEEEEEECC-------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeEE
Q psy2306 41 VRKLGQGNYGKVQLGINKE-------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKMV 112 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 112 (335)
.+.|..|-...+|++.... ++..+++|+..... .....+.+|..+++.+. +.-.+++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567778888999987642 35789999964311 12335558888888774 3223566666543 2
Q ss_pred EEEecCCCCCHHH--------------HHh---h-----CCCC--CHHHHHHHHHHHHH-------------------HH
Q psy2306 113 LVMEYAAGGELYD--------------FLD---Q-----KKVL--TEEEARRIFRQIAT-------------------AV 149 (335)
Q Consensus 113 lv~e~~~~~~L~~--------------~l~---~-----~~~~--~~~~~~~i~~~l~~-------------------~l 149 (335)
+|+||++|.+|.. .+. . ..+. -+.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998754321 111 1 1112 24556666554422 23
Q ss_pred HHhH----H----CCcEecCCCCCCEEEccC----CCeEEeecccccc
Q psy2306 150 YYCH----K----HKICHRDLKLENILLDEN----GNAKIADFGLSNV 185 (335)
Q Consensus 150 ~~LH----~----~givH~di~p~nili~~~----~~~kL~df~~~~~ 185 (335)
..|. . ..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 258999999999999876 6899999998743
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00016 Score=64.17 Aligned_cols=137 Identities=14% Similarity=0.142 Sum_probs=70.8
Q ss_pred EeeeeccCCeE-EEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC--CcccceeEEEEeCCeEEEEEec
Q psy2306 41 VRKLGQGNYGK-VQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH--PNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 41 ~~~ig~g~~g~-Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
.+.|+.|+... +|+... .+|..+++|....... ..+..|+.+++.+.. -.+++++.+..+.+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 34566665554 566642 2367788887554210 123345555555532 23556666543333 689999
Q ss_pred CCCCCHHHHHhhC--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHH
Q psy2306 118 AAGGELYDFLDQK--------------------------KVLTEEEAR-------RIF-------------RQIATAVYY 151 (335)
Q Consensus 118 ~~~~~L~~~l~~~--------------------------~~~~~~~~~-------~i~-------------~~l~~~l~~ 151 (335)
+++.++.+.+... ..++..... .+. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776665443211 011221110 000 011122222
Q ss_pred h------HHCCcEecCCCCCCEEEccC----CCeEEeeccccccc
Q psy2306 152 C------HKHKICHRDLKLENILLDEN----GNAKIADFGLSNVF 186 (335)
Q Consensus 152 L------H~~givH~di~p~nili~~~----~~~kL~df~~~~~~ 186 (335)
| +...++|||+++.||+++.+ +.+.++||+.+..-
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3 23479999999999999874 67899999987554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00035 Score=64.35 Aligned_cols=74 Identities=16% Similarity=0.152 Sum_probs=49.0
Q ss_pred EEeeeeccCCeEEEEEEECC-------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc-ccceeEEEEeCCeE
Q psy2306 40 IVRKLGQGNYGKVQLGINKE-------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN-IIHIYEVFENREKM 111 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~ 111 (335)
-.+.|+.|....+|++.... ++..+++|+.... .. .+.+.+|..+++.+...+ .+++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 45678889899999997653 3578999998431 11 123446888888775333 356666553 2
Q ss_pred EEEEecCCCCC
Q psy2306 112 VLVMEYAAGGE 122 (335)
Q Consensus 112 ~lv~e~~~~~~ 122 (335)
.+++||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38899998643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.001 Score=58.66 Aligned_cols=136 Identities=15% Similarity=0.120 Sum_probs=76.1
Q ss_pred eeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCC--cccceeEE-----EEeCCeEEEE
Q psy2306 42 RKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP--NIIHIYEV-----FENREKMVLV 114 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~-----~~~~~~~~lv 114 (335)
..++ |....||.+... +|+.+++|....... . ...+..|...++.+... .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3455 788899987533 466899999864321 2 22455566666666321 13334332 2335677899
Q ss_pred EecCCCCCHH-----H------HH---hh---C------CCCCHHHH----------------------HHHHHHHHHHH
Q psy2306 115 MEYAAGGELY-----D------FL---DQ---K------KVLTEEEA----------------------RRIFRQIATAV 149 (335)
Q Consensus 115 ~e~~~~~~L~-----~------~l---~~---~------~~~~~~~~----------------------~~i~~~l~~~l 149 (335)
+++++|.++. . .+ +. . ...+.... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875321 1 11 00 0 01111111 11112222222
Q ss_pred HHh----HHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 150 YYC----HKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 150 ~~L----H~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
..+ ....++|||+++.||+++ + .+.++||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 234589999999999998 4 899999987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00033 Score=63.13 Aligned_cols=75 Identities=15% Similarity=0.134 Sum_probs=43.8
Q ss_pred EEeeeeccCCeEEEEEEECC--------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc-ccceeEEEEeCCe
Q psy2306 40 IVRKLGQGNYGKVQLGINKE--------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN-IIHIYEVFENREK 110 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~--------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~ 110 (335)
..+.|+.|....+|++.... .+..+++|+..... ........|...++.+...+ .+++++.+ .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 35677888889999987653 13689999876421 11112346777777764333 44666544 22
Q ss_pred EEEEEecCCCCC
Q psy2306 111 MVLVMEYAAGGE 122 (335)
Q Consensus 111 ~~lv~e~~~~~~ 122 (335)
+++++|++|.+
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 68999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0059 Score=54.20 Aligned_cols=32 Identities=22% Similarity=0.424 Sum_probs=27.8
Q ss_pred CCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 155 HKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 155 ~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
..++|+|+++.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999988888999999877543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0055 Score=56.75 Aligned_cols=76 Identities=18% Similarity=0.155 Sum_probs=48.2
Q ss_pred EEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc-cceeEEEEeCCeEEEEEecC
Q psy2306 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI-IHIYEVFENREKMVLVMEYA 118 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~ 118 (335)
-.+.|+.|-...+|++....++..+++|+...... . .....+|..+++.+...++ +++++.+ .+ .+++||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~---~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E---IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S---CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h---hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEee
Confidence 45678889999999997765457899999754211 1 0012478888888864444 5667665 23 2599999
Q ss_pred CCCCH
Q psy2306 119 AGGEL 123 (335)
Q Consensus 119 ~~~~L 123 (335)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.026 Score=51.61 Aligned_cols=137 Identities=13% Similarity=0.157 Sum_probs=82.0
Q ss_pred EEeeeeccCCeEEEEEEECCC-------CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeE
Q psy2306 40 IVRKLGQGNYGKVQLGINKET-------GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKM 111 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 111 (335)
-.+.|..|-...+|++..... +..+++|+..... +......+|..+++.+. +.-.+++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 456677888899999876531 5789999975421 11112346777777764 22245556533 22
Q ss_pred EEEEecCCCCCHHH-----------H---Hh------h-C-------C--CCCHHHHHHHHHHH----------------
Q psy2306 112 VLVMEYAAGGELYD-----------F---LD------Q-K-------K--VLTEEEARRIFRQI---------------- 145 (335)
Q Consensus 112 ~lv~e~~~~~~L~~-----------~---l~------~-~-------~--~~~~~~~~~i~~~l---------------- 145 (335)
+.|++|++|.+|.. + +. . . . +..+.++..+..++
T Consensus 146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~ 225 (424)
T 3mes_A 146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY 225 (424)
T ss_dssp EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence 68899998865311 1 10 0 0 1 11244444444332
Q ss_pred ---HHHHHHhH------------------------HCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 146 ---ATAVYYCH------------------------KHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 146 ---~~~l~~LH------------------------~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
...+.+|. ...++|+|+.+.||+ +.++.+.++||..+..
T Consensus 226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22233332 124899999999999 7788999999998854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.68 E-value=0.034 Score=50.45 Aligned_cols=29 Identities=38% Similarity=0.555 Sum_probs=24.7
Q ss_pred cEecCCCCCCEEEc------cCCCeEEeecccccc
Q psy2306 157 ICHRDLKLENILLD------ENGNAKIADFGLSNV 185 (335)
Q Consensus 157 ivH~di~p~nili~------~~~~~kL~df~~~~~ 185 (335)
++|+|+.+.||++. .++.+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999993 456799999998854
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.14 E-value=0.43 Score=38.97 Aligned_cols=114 Identities=17% Similarity=0.192 Sum_probs=79.2
Q ss_pred CCCcccceeEEEEeCCeEEEEEecCCCC-CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC
Q psy2306 94 RHPNIIHIYEVFENREKMVLVMEYAAGG-ELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN 172 (335)
Q Consensus 94 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~ 172 (335)
.+|++++. .+-.+.+.+.+.++.-+.+ +... ++. .+....++++..|+....+ ...-+|--++|+|++++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~---~~~~eKlr~l~ni~~l~~~--~~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS---FTKNEKLRYLLNIKNLEEV--NRTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG---SCHHHHHHHHHHGGGGGGG--GGSSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh---cCHHHHHHHHHHHHHHHHH--hcCceEEEEecceEEEcCC
Confidence 57888877 5667777887877766533 4444 332 6888999999998887733 3445788999999999999
Q ss_pred CCeEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy2306 173 GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF 236 (335)
Q Consensus 173 ~~~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~ 236 (335)
+.+++.-.|+...+. |. .. +...=+-..=|++..+++++..|
T Consensus 116 ~~p~i~~RGik~~l~----------------P~-----~~-~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 116 GLPIAKTRGLQNVVD----------------PL-----PV-SEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp SCEEESCCEETTTBS----------------CC-----CC-CHHHHHHHHHHHHHHHHCTTCCH
T ss_pred CCEEEEEccCccCCC----------------CC-----CC-CHHHHHHHHHHHHHHHHcCCCCH
Confidence 999998777653322 11 11 22333445668888888887776
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.75 E-value=0.97 Score=36.98 Aligned_cols=85 Identities=12% Similarity=0.092 Sum_probs=62.9
Q ss_pred CCCcccceeEEEEeCCeEEEEEecCCCC-CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC
Q psy2306 94 RHPNIIHIYEVFENREKMVLVMEYAAGG-ELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN 172 (335)
Q Consensus 94 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~ 172 (335)
.+|++ -..+-.+++.+.+.++.-+++ +.. .++ .++....++++..|+.... -|...-+|--++|+|++++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~---~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR---KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH---TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH---hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCC
Confidence 47777 445557788888888877554 444 333 2688999999998887655 123556788999999999999
Q ss_pred CCeEEeecccccc
Q psy2306 173 GNAKIADFGLSNV 185 (335)
Q Consensus 173 ~~~kL~df~~~~~ 185 (335)
+.+++...|+-..
T Consensus 121 ~~p~i~hRGi~~~ 133 (219)
T 4ano_A 121 LEPFFLHVGVKES 133 (219)
T ss_dssp CCEEESCCEETTT
T ss_pred CcEEEEEcCCccc
Confidence 9999998776543
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=86.20 E-value=16 Score=34.67 Aligned_cols=81 Identities=21% Similarity=0.322 Sum_probs=49.8
Q ss_pred cceeEEEEeCCeEEEEEecCCCCCHHHHHhhCC----------C-------CCHHHHHHHHHHHH--HHHHHhHHCCcEe
Q psy2306 99 IHIYEVFENREKMVLVMEYAAGGELYDFLDQKK----------V-------LTEEEARRIFRQIA--TAVYYCHKHKICH 159 (335)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~-------~~~~~~~~i~~~l~--~~l~~LH~~givH 159 (335)
++.+.+........++ |++++.++.+.+...+ + ..+.....++..++ +.+.|+=.-
T Consensus 402 i~~Y~Vipls~~~GlI-E~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi---- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHGFM-QFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV---- 476 (614)
T ss_dssp CCCCCEEESSSSEEEE-ECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred eeccEEEEecCCCceE-EEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec----
Confidence 3455555555555554 7777666666554321 1 12334445554443 234444433
Q ss_pred cCCCCCCEEEccCCCeEEeeccccc
Q psy2306 160 RDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 160 ~di~p~nili~~~~~~kL~df~~~~ 184 (335)
||=+++||+|+.+|++.=+|||++-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 5999999999999999999999873
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=82.89 E-value=27 Score=33.71 Aligned_cols=80 Identities=23% Similarity=0.321 Sum_probs=47.8
Q ss_pred ceeEEEEeCCeEEEEEecCCCCCHHHHHhhCCC---------------C--CHHHHHHHHHHHH--HHHHHhHHCCcEec
Q psy2306 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKKV---------------L--TEEEARRIFRQIA--TAVYYCHKHKICHR 160 (335)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~--~~~~~~~i~~~l~--~~l~~LH~~givH~ 160 (335)
+.+.+........++ |+++..++.+++...+. + .......++..++ +.+.|+=.- |
T Consensus 477 ~~Y~Vipls~~~GLI-E~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YILGl----G 551 (696)
T 2x6h_A 477 TPYKVLATSSKHGFL-QYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLLGV----G 551 (696)
T ss_dssp CCCCEEESSTTCEEE-ECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHHTC----C
T ss_pred eccEEEeccCCCCee-eeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHccC----C
Confidence 344554444444444 66666666666643321 1 1233444444433 334444333 5
Q ss_pred CCCCCCEEEccCCCeEEeeccccc
Q psy2306 161 DLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 161 di~p~nili~~~~~~kL~df~~~~ 184 (335)
|-+++||+|+.+|++.=+|||++-
T Consensus 552 DRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 552 DRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp CCCTTTEEECTTSCEEECCCCSCT
T ss_pred CCCCcceEEeCCCCEEEEeehhhh
Confidence 999999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 335 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-87 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-86 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-84 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-83 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-83 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-82 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-82 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-81 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-81 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-81 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-80 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-77 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-76 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-76 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-75 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-74 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-74 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-73 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-71 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-71 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-71 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-70 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-69 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-68 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-67 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-67 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-65 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-64 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-63 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-63 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-62 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-62 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-61 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-59 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-58 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-56 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-55 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-24 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (669), Expect = 1e-87
Identities = 92/260 (35%), Positives = 146/260 (56%), Gaps = 3/260 (1%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ F+I R LG+G +G V L K++ +A+K + K ++E ++RRE++I S +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
PNI+ +Y F + ++ L++EYA G +Y L + E+ ++A A+ YCH
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
++ HRD+K EN+LL G KIADFG S SR +T CG+ Y PE+++G +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMH-DE 183
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINP 274
+VD WSLGVL Y + G PF+ + ++ K+IS ++ P + A LI+ +L NP
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 243
Query: 275 SSRADISVICSHWWIDKDHS 294
S R + + H WI + S
Sbjct: 244 SQRPMLREVLEHPWITANSS 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 259 bits (663), Expect = 6e-86
Identities = 65/271 (23%), Positives = 117/271 (43%), Gaps = 8/271 (2%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ F +R++G G++G V + + VAIK + ++ I +E++ + +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
HPN I + LVMEY G KK L E E + + Y H
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY-- 212
H + HRD+K NILL E G K+ DFG +++ + ++F G+P + +PE++ +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQ 190
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP---LIAEM 269
+ +VD WSLG+ L P N + I+ + ++ + +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 270 LNINPSSRADISVICSHWWIDKDHSVACLEE 300
L P R V+ H ++ ++ + +
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 255 bits (653), Expect = 6e-84
Identities = 82/272 (30%), Positives = 137/272 (50%), Gaps = 12/272 (4%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM 90
+ + +DI+ +LG G +G V + K TG+ K I D ++ EI IM
Sbjct: 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT---PYPLDKYTVKNEISIM 80
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAV 149
+ + HP +I++++ FE++ +MVL++E+ +GGEL+D + + ++E E RQ +
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140
Query: 150 YYCHKHKICHRDLKLENILLD--ENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIV 207
+ H+H I H D+K ENI+ + + + KI DFGL+ + + +A+PEIV
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP-- 264
P G D W++GVL Y L+ G PF G + ++ + D+ F+ S+ SP
Sbjct: 201 DREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 265 --LIAEMLNINPSSRADISVICSHWWIDKDHS 294
I +L P R + H W+ DHS
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (646), Expect = 1e-83
Identities = 80/267 (29%), Positives = 134/267 (50%), Gaps = 6/267 (2%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM 90
R+K + F + LG+G++ V L T +E AIK ++K I E + + RE +M
Sbjct: 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
S + HP + +Y F++ EK+ + YA GEL ++ + E R +I +A+
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF---TESRFLSTFCGSPLYASPEIV 207
Y H I HRDLK ENILL+E+ + +I DFG + V ++ ++F G+ Y SPE++
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 208 KGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQS-TASPLI 266
D W+LG ++Y LV G PF N + ++I +Y P+ A L+
Sbjct: 183 TEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241
Query: 267 AEMLNINPSSRADISVICSHWWIDKDH 293
++L ++ + R + + + K H
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPL-KAH 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (642), Expect = 4e-83
Identities = 78/268 (29%), Positives = 134/268 (50%), Gaps = 13/268 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
++I+ +LG G +GKV NKET A K I ++E +L EI I++S HP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT---KSEEELEDYMVEIDILASCDHP 69
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKH 155
NI+ + + F + +++E+ AGG + + + ++ LTE + + + +Q A+ Y H +
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLSTFCGSPLYASPEIVKGIPY-- 212
KI HRDLK NIL +G+ K+ADFG+S T + + +F G+P + +PE+V
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 213 --HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP----LI 266
+ + D WSLG+ L + P N R++ +I+ + S S +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249
Query: 267 AEMLNINPSSRADISVICSHWWIDKDHS 294
+ L N +R S + H ++ D +
Sbjct: 250 KKCLEKNVDARWTTSQLLQHPFVTVDSN 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 1e-82
Identities = 86/264 (32%), Positives = 135/264 (51%), Gaps = 9/264 (3%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ +D+V+ LG+G YG+VQL +N+ T + VA+K + + + I++EI I + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNH 62
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
N++ Y L +EY +GGEL+D ++ + E +A+R F Q+ V Y H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVF---TESRFLSTFCGSPLYASPEIVKGIPY 212
I HRD+K EN+LLDE N KI+DFGL+ VF R L+ CG+ Y +PE++K +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP----LIAE 268
H VD WS G++L ++ G +P+D + L+ +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 269 MLNINPSSRADISVICSHWWIDKD 292
+L NPS+R I I W +K
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKP 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 252 bits (644), Expect = 1e-82
Identities = 80/265 (30%), Positives = 139/265 (52%), Gaps = 12/265 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+DI +LG G +G V + TG A K + E+D +R+EIQ MS +RHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHP 83
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKH 155
++++++ FE+ +MV++ E+ +GGEL++ + D+ ++E+EA RQ+ + + H++
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 156 KICHRDLKLENILL--DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
H DLK ENI+ + K+ DFGL+ + + G+ +A+PE+ +G P
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV- 202
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP----LIAE 268
G D WS+GVL Y L+ G PF G N ++ + + D+ + S S I +
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 269 MLNINPSSRADISVICSHWWIDKDH 293
+L +P++R I H W+ +
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPGN 287
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 246 bits (628), Expect = 4e-81
Identities = 88/273 (32%), Positives = 135/273 (49%), Gaps = 17/273 (6%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI------ETEADLIRIRREIQI 89
+ ++ LG+G V+ I+K T +E A+K I E + +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 90 MSSVR-HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATA 148
+ V HPNII + + +E LV + GEL+D+L +K L+E+E R+I R +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVK 208
+ HK I HRDLK ENILLD++ N K+ DFG S L CG+P Y +PEI++
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182
Query: 209 G-----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTA 262
P +G EVD WS GV++YTL+ G+ PF +++ I +G+Y F
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242
Query: 263 SP----LIAEMLNINPSSRADISVICSHWWIDK 291
S L++ L + P R +H + +
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (629), Expect = 5e-81
Identities = 77/269 (28%), Positives = 136/269 (50%), Gaps = 10/269 (3%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
K+++ K+GQG G V ++ TGQEVAI+ + + + I EI +M +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKELIINEILVMRENK 75
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
+PNI++ + + +++ +VMEY AGG L D + + + E + + R+ A+ + H
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHS 134
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPEIVKGIPYH 213
+++ HRD+K +NILL +G+ K+ DFG T E ST G+P + +PE+V Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP----LIAEM 269
GP+VD WSLG++ ++ G P+ N R + I+ E +N S +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 270 LNINPSSRADISVICSHWWIDKDHSVACL 298
L+++ R + H ++ ++ L
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAKPLSSL 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 246 bits (629), Expect = 6e-81
Identities = 93/270 (34%), Positives = 143/270 (52%), Gaps = 11/270 (4%)
Query: 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV 93
++ +D LG G + +V L +K T + VAIK I K +E + + EI ++ +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKI 64
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
+HPNI+ + +++E+ + L+M+ +GGEL+D + +K TE +A R+ Q+ AV Y H
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 154 KHKICHRDLKLENILL---DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI 210
I HRDLK EN+L DE+ I+DFGLS + LST CG+P Y +PE++
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 211 PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP----L 265
PY VDCWS+GV+ Y L+ G PF N +L +QI +Y F+ S
Sbjct: 185 PY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 266 IAEMLNINPSSRADISVICSHWWIDKDHSV 295
I ++ +P R H WI D ++
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTAL 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 4e-80
Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 16/266 (6%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++++ +G G+YG+ Q K G+ + K + + TEA+ + E+ ++ ++HPN
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 64
Query: 98 IIHIYEVFENRE--KMVLVMEYAAGGELYDFLD----QKKVLTEEEARRIFRQIATAVYY 151
I+ Y+ +R + +VMEY GG+L + +++ L EE R+ Q+ A+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 152 CHK-----HKICHRDLKLENILLDENGNAKIADFGLSNVFT-ESRFLSTFCGSPLYASPE 205
CH+ H + HRDLK N+ LD N K+ DFGL+ + ++ F F G+P Y SPE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ--STAS 263
+ + Y + D WSLG LLY L PF + K L +I G + + +
Sbjct: 185 QMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243
Query: 264 PLIAEMLNINPSSRADISVICSHWWI 289
+I MLN+ R + I + I
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 4e-77
Identities = 68/269 (25%), Positives = 129/269 (47%), Gaps = 13/269 (4%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
++L +++ I LG+G +G V + + + K +K D + +++EI I++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILN 56
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKV-LTEEEARRIFRQIATAVY 150
RH NI+H++E FE+ E++V++ E+ +G ++++ ++ L E E Q+ A+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 151 YCHKHKICHRDLKLENILLDENGNA--KIADFGLSNVFTESRFLSTFCGSPLYASPEIVK 208
+ H H I H D++ ENI+ ++ KI +FG + +P Y +PE+ +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 209 GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP--- 264
D WSLG L+Y L+ G PF +++++ I N +Y F+ + S
Sbjct: 177 HDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 265 -LIAEMLNINPSSRADISVICSHWWIDKD 292
+ +L SR S H W+ +
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 5e-76
Identities = 98/268 (36%), Positives = 143/268 (53%), Gaps = 13/268 (4%)
Query: 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI---RIRREIQIM 90
+ +D +LG G + V+ K TG + A K IKK + ++ + I RE+ I+
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 91 SSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVY 150
++HPN+I ++EV+EN+ ++L++E AGGEL+DFL +K+ LTEEEA +QI VY
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 151 YCHKHKICHRDLKLENILLDENG----NAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206
Y H +I H DLK ENI+L + KI DFGL++ G+P + +PEI
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASP- 264
V P G E D WS+GV+ Y L+ GA PF G + + +S +Y FE + S S
Sbjct: 188 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 265 ---LIAEMLNINPSSRADISVICSHWWI 289
I +L +P R I H WI
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 6e-76
Identities = 86/260 (33%), Positives = 133/260 (51%), Gaps = 5/260 (1%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SVR 94
+ F + + LG+G++GKV L K+T Q AIK +KK + + D+ E +++S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK 154
HP + H++ F+ +E + VMEY GG+L + A +I + + H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 155 HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL-STFCGSPLYASPEIVKGIPYH 213
I +RDLKL+NILLD++G+ KIADFG+ +TFCG+P Y +PEI+ G Y
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY- 180
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNI 272
VD WS GVLLY ++ G PF G + + L I + F P+ A L+ ++
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 273 NPSSRADI-SVICSHWWIDK 291
P R + I H +
Sbjct: 241 EPEKRLGVRGDIRQHPLFRE 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 9e-75
Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 50/301 (16%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
F+ + +LG GN G V +K +G +A K I A +I RE+Q++ P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH-KH 155
I+ Y F + ++ + ME+ GG L L + + E+ ++ + + Y KH
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGP 215
KI HRD+K NIL++ G K+ DFG+S +S ++F G+ Y SPE ++G Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHY-SV 182
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQ---ISNGDYFEPKNQSTASP-------- 264
+ D WS+G+ L + G P + K L GD E +
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 265 ----------------------------------LIAEMLNINPSSRADISVICSHWWID 290
+ + L NP+ RAD+ + H +I
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 291 K 291
+
Sbjct: 303 R 303
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 2e-74
Identities = 85/264 (32%), Positives = 132/264 (50%), Gaps = 15/264 (5%)
Query: 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADL---IRIRREIQIM 90
L+ ++ + LG G +G V GI VAIK ++K +I +L R+ E+ ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 91 SSVR--HPNIIHIYEVFENREKMVLVMEYAAGG-ELYDFLDQKKVLTEEEARRIFRQIAT 147
V +I + + FE + VL++E +L+DF+ ++ L EE AR F Q+
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 148 AVYYCHKHKICHRDLKLENILLDEN-GNAKIADFGLSNVFTESRFLSTFCGSPLYASPEI 206
AV +CH + HRD+K ENIL+D N G K+ DFG + + F G+ +Y+ PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEW 180
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPL 265
++ YHG WSLG+LLY +V G +PF+ +I G F + S+ L
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHL 234
Query: 266 IAEMLNINPSSRADISVICSHWWI 289
I L + PS R I +H W+
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (581), Expect = 3e-74
Identities = 63/263 (23%), Positives = 118/263 (44%), Gaps = 15/263 (5%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
++G+G++ V G++ ET EVA ++ K+ T+++ R + E +++ ++HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPN 69
Query: 98 IIHIYEVFE----NREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
I+ Y+ +E ++ +VLV E G L +L + KV+ + R RQI + + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 154 KHK--ICHRDLKLENILL-DENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGI 210
I HRDLK +NI + G+ KI D GL+ + F G+P + +PE+ +
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 211 PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP----LI 266
+ VD ++ G+ + + P+ + + A P +I
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 267 AEMLNINPSSRADISVICSHWWI 289
+ N R I + +H +
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 227 bits (579), Expect = 3e-73
Identities = 80/260 (30%), Positives = 136/260 (52%), Gaps = 9/260 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
F I+R LG G++G+V L ++ G+ A+K +KK + + E ++S V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
II ++ F++ +++ ++M+Y GGEL+ L + + A+ ++ A+ Y H I
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEV 217
+RDLK ENILLD+NG+ KI DFG + + T CG+P Y +PE+V PY +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPY-NKSI 182
Query: 218 DCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPSS 276
D WS G+L+Y ++ G PF SN + ++I N + P + L++ ++ + S
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQ 242
Query: 277 R-----ADISVICSHWWIDK 291
R + +H W +
Sbjct: 243 RLGNLQNGTEDVKNHPWFKE 262
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 2e-71
Identities = 66/263 (25%), Positives = 113/263 (42%), Gaps = 18/263 (6%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ + +++G G++G V G + +VA+K + T L + E+ ++ RH
Sbjct: 9 QITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHV 64
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKH 155
NI+ + ++ +V ++ G LY L + + I RQ A + Y H
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTE---SRFLSTFCGSPLYASPEIVKGIPY 212
I HRDLK NI L E+ KI DFGL+ V + S GS L+ +PE+++
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 213 --HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP------ 264
+ + D ++ G++LY L+ G +P+ N + + + Y P S
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 265 -LIAEMLNINPSSRADISVICSH 286
L+AE L R I +
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 224 bits (571), Expect = 2e-71
Identities = 64/265 (24%), Positives = 123/265 (46%), Gaps = 13/265 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI---ETEADLIRIRREIQIMSSV 93
F + R +G+G +G+V +TG+ A+K + K +I + E + R + ++S+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
P I+ + F +K+ +++ GG+L+ L Q V +E + R +I + + H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 154 KHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYH 213
+ +RDLK NILLDE+G+ +I+D GL+ F++ + G+ Y +PE+++ +
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAY 183
Query: 214 GPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP----LIAEM 269
D +SLG +L+ L+ G PF K + + + SP L+ +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243
Query: 270 LNINPSSR-----ADISVICSHWWI 289
L + + R + +
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 3e-71
Identities = 89/259 (34%), Positives = 149/259 (57%), Gaps = 8/259 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
FD ++ LG+G +GKV L K TG+ A+K ++K I + ++ E +++ + RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
+ + F+ +++ VMEYA GGEL+ L +++V TEE AR +I +A+ Y H +
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 158 CHRDLKLENILLDENGNAKIADFGLS-NVFTESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
+RD+KLEN++LD++G+ KI DFGL ++ + TFCG+P Y +PE+++ Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 185
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPS 275
VD W LGV++Y ++ G +PF + +RL + I + P+ S A L+A +L +P
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 245
Query: 276 SR-----ADISVICSHWWI 289
R +D + H +
Sbjct: 246 QRLGGGPSDAKEVMEHRFF 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 219 bits (558), Expect = 1e-70
Identities = 66/258 (25%), Positives = 115/258 (44%), Gaps = 14/258 (5%)
Query: 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
L R+++ LG G +V L + ++VA+K ++ + +R RRE Q ++
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 93 VRHPNIIHIYEVFENREK----MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATA 148
+ HP I+ +Y+ E +VMEY G L D + + +T + A + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES----RFLSTFCGSPLYASP 204
+ + H++ I HRD+K NI++ K+ DFG++ +S + G+ Y SP
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264
E +G D +SLG +LY ++ G PF G + + Q D P +
Sbjct: 184 EQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 265 -----LIAEMLNINPSSR 277
++ + L NP +R
Sbjct: 243 ADLDAVVLKALAKNPENR 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 3e-69
Identities = 87/285 (30%), Positives = 137/285 (48%), Gaps = 29/285 (10%)
Query: 31 RRKLKQRFDIVRK-LGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+ + + + + LG G GKV NK T ++ A+K ++ C + RRE+++
Sbjct: 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVEL 57
Query: 90 MSSV-RHPNIIHIYEVFEN----REKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIF 142
+ P+I+ I +V+EN R+ +++VME GGEL+ + + + TE EA I
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLD---ENGNAKIADFGLSNVFTESRFLSTFCGSP 199
+ I A+ Y H I HRD+K EN+L N K+ DFG + T L+T C +P
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177
Query: 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN----FKRLVKQISNGDY-F 254
Y +PE++ Y D WSLGV++Y L+ G PF ++ + +I G Y F
Sbjct: 178 YYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 255 EPKNQSTASP----LIAEMLNINPSSRADISVICSHWWIDKDHSV 295
S S LI +L P+ R I+ +H WI + V
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (551), Expect = 1e-68
Identities = 77/259 (29%), Positives = 133/259 (51%), Gaps = 9/259 (3%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+FD ++ LG G++G+V L +KE+G A+K + K K+ + E +I+ +V P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
++ + F++ + +VMEY AGGE++ L + +E AR QI Y H
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPE 216
+ +RDLK EN+L+D+ G ++ DFG + + T CG+P +PEI+ Y
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKGY-NKA 218
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQST-ASPLIAEMLNINPS 275
VD W+LGVL+Y + G PF ++ ++I +G P + S+ L+ +L ++ +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 276 SR-----ADISVICSHWWI 289
R ++ I +H W
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 6e-68
Identities = 75/286 (26%), Positives = 113/286 (39%), Gaps = 32/286 (11%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLI--RIRREIQIMSSVRHPN 97
+ LG+G + V +K T Q VAIK IK D I REI+++ + HPN
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKI 157
II + + F ++ + LV ++ D VLT + + Y H+H I
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 158 CHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST-FCGSPLYASPEIVKGIPYHGPE 216
HRDLK N+LLDENG K+ADFGL+ F T + Y +PE++ G +G
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 217 VDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ----------------- 259
VD W++G +L L+ G + + +I + Q
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 260 --------STASP----LIAEMLNINPSSRADISVICSHWWIDKDH 293
S A LI + NP +R + +
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-67
Identities = 60/257 (23%), Positives = 120/257 (46%), Gaps = 16/257 (6%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
+ +++ +G+G +G V LG + G +VA+K IK +A E +M+ +RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLRH 59
Query: 96 PNIIHIYEVF-ENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYC 152
N++ + V E + + +V EY A G L D+L + VL + + + A+ Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
+ HRDL N+L+ E+ AK++DFGL+ + ++ T + +PE ++ +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKF 177
Query: 213 HGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQ--STASPLIAEM 269
+ D WS G+LL+ + +G +P+ K +V ++ G + + ++
Sbjct: 178 -STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 236
Query: 270 LNINPSSRADISVICSH 286
+++ + R +
Sbjct: 237 WHLDAAMRPSFLQLREQ 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 9e-67
Identities = 62/261 (23%), Positives = 111/261 (42%), Gaps = 15/261 (5%)
Query: 42 RKLGQGNYGKVQLGI--NKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
++LG GN+G V+ G K+ + VA+K +K + A + E +M + +P I+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIV 71
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICH 159
+ + E E +LVME A G L +L Q + + ++ + Q++ + Y + H
Sbjct: 72 RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 160 RDLKLENILLDENGNAKIADFGLSNVFTESRFL----STFCGSPLYASPEIVKGIPYHGP 215
RDL N+LL AKI+DFGLS + + +PE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189
Query: 216 EVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKNQST-ASPLIAEMLNI 272
+ D WS GVL++ YG P+ G + + G+ P L+
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 273 NPSSRADISVICS---HWWID 290
+ +R + + +++ D
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 2e-65
Identities = 67/303 (22%), Positives = 130/303 (42%), Gaps = 47/303 (15%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+++ + K+GQG +G+V +++TGQ+VA+K + E E I REI+I+ ++H
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHE 69
Query: 97 NIIHIYEVFENRE--------KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATA 148
N++++ E+ + + LV ++ + T E +R+ + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 149 VYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-----FLSTFCGSPLYAS 203
+YY H++KI HRD+K N+L+ +G K+ADFGL+ F+ ++ + + Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 204 PEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ---- 259
PE++ G +GP +D W G ++ + + G+ + + IS
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 260 -----------------------------STASPLIAEMLNINPSSRADISVICSHWWID 290
A LI ++L ++P+ R D +H +
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
Query: 291 KDH 293
D
Sbjct: 310 SDP 312
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-65
Identities = 55/255 (21%), Positives = 115/255 (45%), Gaps = 12/255 (4%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN 97
+++LG G +G V+ G + +VAIK IK+ + + E ++M ++ H
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSED----EFIEEAKVMMNLSHEK 60
Query: 98 IIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHK 156
++ +Y V + + ++ EY A G L ++L + + ++ + + + A+ Y +
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST--FCGSPLYASPEIVKGIPYHG 214
HRDL N L+++ G K++DFGLS + + S+ ++ PE++ +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-S 179
Query: 215 PEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKNQS-TASPLIAEMLN 271
+ D W+ GVL++ + G MP++ + I+ G P S ++ +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239
Query: 272 INPSSRADISVICSH 286
R ++ S+
Sbjct: 240 EKADERPTFKILLSN 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-64
Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 43/297 (14%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R+ + +G+G YG V + VAIK I E + R REI+I+ RH
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHE 66
Query: 97 NIIHIYEVFE----NREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
NII I ++ + K V ++ + G +LY L + L+ + QI + Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR----FLSTFCGSPLYASPEIVK 208
H + HRDLK N+LL+ + KI DFGL+ V FL+ + + Y +PEI+
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 209 GIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ--------- 259
+ +D WS+G +L ++ F G ++ + I +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 260 -------------------STASP----LIAEMLNINPSSRADISVICSHWWIDKDH 293
A L+ +ML NP R ++ +H ++++ +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 9e-64
Identities = 68/262 (25%), Positives = 111/262 (42%), Gaps = 17/262 (6%)
Query: 42 RKLGQGNYGKVQLGINKET--GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNII 99
+LG GN+G V+ G+ + +VAIK +K+ +AD + RE QIM + +P I+
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIV 72
Query: 100 HIYEVFENREKMVLVMEYAAGGELYDFL-DQKKVLTEEEARRIFRQIATAVYYCHKHKIC 158
+ V + ++LVME A GG L+ FL +++ + + Q++ + Y +
Sbjct: 73 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 159 HRDLKLENILLDENGNAKIADFGLSNVFTES----RFLSTFCGSPLYASPEIVKGIPYHG 214
HRDL N+LL AKI+DFGLS S + +PE + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS- 190
Query: 215 PEVDCWSLGVLLY-TLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQST-ASPLIAEMLN 271
D WS GV ++ L YG P+ ++ I G E P L+++
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWI 250
Query: 272 INPSSRADISVICS---HWWID 290
R D + +
Sbjct: 251 YKWEDRPDFLTVEQRMRACYYS 272
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-63
Identities = 70/307 (22%), Positives = 131/307 (42%), Gaps = 43/307 (14%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
+ +++ + ++ +G G YG V ++ TG +VAIK + + ++E R
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAY 65
Query: 85 REIQIMSSVRHPNIIHIYEVFENREKM------VLVMEYAAGGELYDFLDQKKVLTEEEA 138
RE++++ +RH N+I + +VF E + LVM + G L + + L E+
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123
Query: 139 RRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS 198
+ + Q+ + Y H I HRDLK N+ ++E+ KI DFGL+ ++ + +
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVT 181
Query: 199 PLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKN 258
Y +PE++ + VD WS+G ++ ++ G F GS+ +K+I P
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 259 Q----------------------------STASP----LIAEMLNINPSSRADISVICSH 286
+ ASP L+ +ML ++ R +H
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
Query: 287 WWIDKDH 293
+ + H
Sbjct: 302 PYFESLH 308
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-63
Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 47/302 (15%)
Query: 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
R + + + +G G++G V ++G+ VAIK + + D RE+QIM
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMR 68
Query: 92 SVRHPNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLD---QKKVLTEEEARRIF 142
+ H NI+ + F ++ + LV++Y K+ L +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 143 RQIATAVYYCHKHKICHRDLKLENILLDENGNA-KIADFGLSNVFTESRFLSTFCGSPLY 201
Q+ ++ Y H ICHRD+K +N+LLD + K+ DFG + ++ S Y
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 202 ASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG---------- 251
+PE++ G + +D WS G +L L+ G F G + + +I
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 252 --------------------DYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291
F P+ A L + +L P++R C+H + D+
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
Query: 292 DH 293
Sbjct: 309 LR 310
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-63
Identities = 61/260 (23%), Positives = 100/260 (38%), Gaps = 14/260 (5%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSS 92
+ ++ KLG G++G V+ G VA+K +K + + RE+ M S
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 93 VRHPNIIHIYEVFENREKMVLVMEYAAGGELYDF-LDQKKVLTEEEARRIFRQIATAVYY 151
+ H N+I +Y V M +V E A G L D + R Q+A + Y
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES----RFLSTFCGSPLYASPEIV 207
+ HRDL N+LL KI DFGL ++ + +PE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 208 KGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP-- 264
K + D W GV L+ + YG P+ G N +++ +I P+ +
Sbjct: 187 KTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245
Query: 265 -LIAEMLNINPSSRADISVI 283
++ + P R +
Sbjct: 246 NVMVQCWAHKPEDRPTFVAL 265
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 199 bits (507), Expect = 6e-63
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
++ + K+G+G YG V N G+ A+K I+ K E E REI I+ ++H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK 156
NI+ +Y+V ++++VLV E+ + L A+ Q+ + YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 157 ICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPYHGP 215
+ HRDLK +N+L++ G KIADFGL+ F R + + Y +P+++ G +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 216 EVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---------------------- 253
+D WS+G + +V G F G + + +I
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 254 --------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291
F + L+++ML ++P+ R H + +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-63
Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 12/256 (4%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
V+++G G +G V LG +VAIKTI++ + E E ++M + HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEE----DFIEEAEVMMKLSHP 60
Query: 97 NIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVL-TEEEARRIFRQIATAVYYCHKH 155
++ +Y V + + LV E+ G L D+L ++ L E + + + Y +
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST--FCGSPLYASPEIVKGIPYH 213
+ HRDL N L+ EN K++DFG++ + ++ S+ +ASPE+ Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY- 179
Query: 214 GPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKNQST-ASPLIAEML 270
+ D WS GVL++ + G +P++ + +V+ IS G P+ ST ++
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 271 NINPSSRADISVICSH 286
P R S +
Sbjct: 240 KERPEDRPAFSRLLRQ 255
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 8e-63
Identities = 62/258 (24%), Positives = 114/258 (44%), Gaps = 14/258 (5%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ +V +LG G +G+V +G +VA+K++K+ + + E +M ++
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQ 66
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK--VLTEEEARRIFRQIATAVYYC 152
H ++ +Y V E + ++ EY G L DFL LT + + QIA + +
Sbjct: 67 HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--LSTFCGSPLYASPEIVKGI 210
+ HRDL+ NIL+ + + KIADFGL+ + ++ + + +PE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 211 PYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKNQST-ASPLIA 267
+ D WS G+LL +V +G +P+ G +++ + G P N L+
Sbjct: 186 T-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 268 EMLNINPSSRADISVICS 285
P R + S
Sbjct: 245 LCWKERPEDRPTFDYLRS 262
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-62
Identities = 70/290 (24%), Positives = 121/290 (41%), Gaps = 33/290 (11%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH 95
Q+++ + K+G+G YG V N+ET + VA+K ++ + E REI ++ ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKH 60
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
NI+ +++V + +K+ LV E+ F L E + Q+ + +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPYHG 214
+ HRDLK +N+L++ NG K+A+FGL+ F R S + Y P+++ G +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 215 PEVDCWSLGVLLYTLVYGAMP-FDGSNFKRLVKQISNGDY-------------------- 253
+D WS G + L P F G++ +K+I
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 254 ----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293
PK +T L+ +L NP R H +
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (505), Expect = 2e-62
Identities = 65/263 (24%), Positives = 108/263 (41%), Gaps = 16/263 (6%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQE---VAIKTIKKCKIETEADLIRIRREIQIMSSV 93
I + +G G +G+V G K G+ VAIKT+K E + E IM
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQF 84
Query: 94 RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYC 152
HPN+IH+ V ++++ E+ G L FL Q T + + R IA + Y
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF------CGSPLYASPEI 206
HRDL NIL++ N K++DFGLS + T+ + +PE
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQ--STAS 263
++ + D WS G++++ ++ YG P+ + ++ I P S
Sbjct: 205 IQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
Query: 264 PLIAEMLNINPSSRADISVICSH 286
L+ + + + R I +
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 2e-62
Identities = 68/256 (26%), Positives = 119/256 (46%), Gaps = 12/256 (4%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
+ + KLG G YG+V G+ K+ VA+KT+K+ +E E +E +M ++
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIK 71
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYC 152
HPN++ + V ++ E+ G L D+L + ++ ++ + QI++A+ Y
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST--FCGSPLYASPEIVKGI 210
K HRDL N L+ EN K+ADFGLS + T + + + +PE +
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 211 PYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKNQST-ASPLIA 267
+ + D W+ GVLL+ + YG P+ G + ++ + + E P+ L+
Sbjct: 192 KF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250
Query: 268 EMLNINPSSRADISVI 283
NPS R + I
Sbjct: 251 ACWQWNPSDRPSFAEI 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-62
Identities = 70/256 (27%), Positives = 117/256 (45%), Gaps = 14/256 (5%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR 94
++ + KLGQG +G+V +G T VAIKT+K + E +E Q+M +R
Sbjct: 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPE----AFLQEAQVMKKLR 70
Query: 95 HPNIIHIYEVFENREKMVLVMEYAAGGELYDF--LDQKKVLTEEEARRIFRQIATAVYYC 152
H ++ +Y V E + +V EY + G L DF + K L + + QIA+ + Y
Sbjct: 71 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 153 HKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST--FCGSPLYASPEIVKGI 210
+ HRDL+ NIL+ EN K+ADFGL+ + ++ + + + +PE
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 211 PYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKNQS-TASPLIA 267
+ + D WS G+LL L G +P+ G + ++ Q+ G P + L+
Sbjct: 190 RF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248
Query: 268 EMLNINPSSRADISVI 283
+ P R +
Sbjct: 249 QCWRKEPEERPTFEYL 264
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-62
Identities = 100/284 (35%), Positives = 145/284 (51%), Gaps = 19/284 (6%)
Query: 27 LHNHRRKLK-QRFDIVRKLGQGNYGKVQLG---INKETGQEVAIKTIKKCKIETEADLI- 81
L H K+ + F++++ LG G YGKV L +TG+ A+K +KK I +A
Sbjct: 14 LTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE 73
Query: 82 RIRREIQIMSSVRH-PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARR 140
R E Q++ +R P ++ ++ F+ K+ L+++Y GGEL+ L Q++ TE E +
Sbjct: 74 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 133
Query: 141 IFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT--ESRFLSTFCGS 198
+I A+ + HK I +RD+KLENILLD NG+ + DFGLS F E+ FCG+
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 199 PLYASPEIVKGIPY-HGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEP 256
Y +P+IV+G H VD WSLGVL+Y L+ GA PF K +IS EP
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253
Query: 257 KNQSTASP----LIAEMLNINPSSR-----ADISVICSHWWIDK 291
S LI +L +P R D I H + K
Sbjct: 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 8e-62
Identities = 55/288 (19%), Positives = 105/288 (36%), Gaps = 39/288 (13%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKETGQ-----EVAIKTIKKCKIETEADLIRIRREIQI 89
++ + + LG G +GKV + +VA+K +K+ +E + + E+++
Sbjct: 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--ALMSELKM 93
Query: 90 MSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK----------------- 131
M+ + H NI+++ + L+ EY G+L ++L K+
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 132 ------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185
VLT E+ Q+A + + HRDL N+L+ KI DFGL+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 186 FTES---RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNF 241
+ +PE + Y + D WS G+LL+ + G P+ G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 242 KRLVKQISNGDYFEPKNQSTASP---LIAEMLNINPSSRADISVICSH 286
++ + + ++ + R + S
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-61
Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 33/287 (11%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
F V K+G+G YG V NK TG+ VA+K I+ ETE REI ++ + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHP 61
Query: 97 NIIHIYEVFENREKMVLVMEYAA-GGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
NI+ + +V K+ LV E+ + + + + Q+ + +CH H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVF-TESRFLSTFCGSPLYASPEIVKGIPYHG 214
++ HRDLK +N+L++ G K+ADFGL+ F R + + Y +PEI+ G Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 215 PEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ--------------- 259
VD WSLG + +V F G + + +I +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 260 ---------------STASPLIAEMLNINPSSRADISVICSHWWIDK 291
L+++ML+ +P+ R +H +
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-61
Identities = 67/270 (24%), Positives = 109/270 (40%), Gaps = 21/270 (7%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RH 95
+G+GN+G+V K+ G + + + ++ D E++++ + H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFL----------------DQKKVLTEEEAR 139
PNII++ E+R + L +EYA G L DFL L+ ++
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSP 199
+A + Y + + HRDL NIL+ EN AKIADFGLS +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 200 LYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PK 257
+ + E + + D WS GVLL+ +V G P+ G L +++ G E P
Sbjct: 191 RWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249
Query: 258 NQST-ASPLIAEMLNINPSSRADISVICSH 286
N L+ + P R + I
Sbjct: 250 NCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-61
Identities = 53/257 (20%), Positives = 100/257 (38%), Gaps = 9/257 (3%)
Query: 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKC--KIETEADLIRIRREIQIMSSVRH 95
F ++ LG G +G V G+ G++V I K + + I E +M+SV +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 96 PNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
P++ + + ++ G L + K + + QIA + Y
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 156 KICHRDLKLENILLDENGNAKIADFGLSNVFTES---RFLSTFCGSPLYASPEIVKGIPY 212
++ HRDL N+L+ + KI DFGL+ + + + E + Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 213 HGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKNQST-ASPLIAEM 269
+ D WS GV ++ L+ +G+ P+DG + + G+ P + ++ +
Sbjct: 191 -THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 270 LNINPSSRADISVICSH 286
I+ SR +
Sbjct: 250 WMIDADSRPKFRELIIE 266
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 195 bits (496), Expect = 9e-61
Identities = 69/302 (22%), Positives = 130/302 (43%), Gaps = 55/302 (18%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-H 95
+ +VRKLG+G Y +V IN ++V +K +K K + +I+REI+I+ ++R
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK------KIKREIKILENLRGG 89
Query: 96 PNIIHIYEVFENREK--MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCH 153
PNII + ++ ++ LV E+ + + LT+ + R +I A+ YCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 154 KHKICHRDLKLENILLD-ENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPY 212
I HRD+K N+++D E+ ++ D+GL+ + + + S + PE++
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 213 HGPEVDCWSLGVLLYTLVYGAMPFDGSN-------------------------------- 240
+ +D WSLG +L ++++ PF +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 241 FKRLVKQISNGD---YFEPKNQSTASP----LIAEMLNINPSSRADISVICSHWW---ID 290
F ++ + S + +NQ SP + ++L + SR H + +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
Query: 291 KD 292
KD
Sbjct: 327 KD 328
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 2e-60
Identities = 71/282 (25%), Positives = 114/282 (40%), Gaps = 38/282 (13%)
Query: 37 RFDIVRKLGQGNYGKVQLG-----INKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
+ VR +G+G +G+V + E VA+K +K+ +RE +M+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMA 71
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFL------------------------ 127
+PNI+ + V + M L+ EY A G+L +FL
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 128 DQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187
L+ E I RQ+A + Y + K HRDL N L+ EN KIADFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 188 ESRFL---STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKR 243
+ + + PE + Y E D W+ GV+L+ + YG P+ G +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 244 LVKQISNGDYFE-PKNQST-ASPLIAEMLNINPSSRADISVI 283
++ + +G+ P+N L+ + P+ R I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-59
Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 13/261 (4%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINK---ETGQEVAIKTIKKCKIETEADLIRIRREIQIMS 91
++R ++ R +G+G +G V GI VAIKT K C ++ + + +E M
Sbjct: 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEALTMR 63
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVY 150
HP+I+ + V + ++ME GEL FL + L Q++TA+
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL--STFCGSPLYASPEIVK 208
Y + HRD+ N+L+ N K+ DFGLS +S + S + +PE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 209 GIPYHGPEVDCWSLGVLLYT-LVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQS-TASPL 265
+ D W GV ++ L++G PF G ++ +I NG+ P N T L
Sbjct: 183 FRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241
Query: 266 IAEMLNINPSSRADISVICSH 286
+ + +PS R + + +
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQ 262
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-58
Identities = 65/293 (22%), Positives = 126/293 (43%), Gaps = 40/293 (13%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKET-GQEVAIKTIKKCKIETEADLIRIRREIQIM---S 91
Q+++ V ++G+G YGKV + + G+ VA+K ++ + E + RE+ ++
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRHLE 65
Query: 92 SVRHPNIIHIYEVF-----ENREKMVLVMEYAAGGEL-YDFLDQKKVLTEEEARRIFRQI 145
+ HPN++ +++V + K+ LV E+ Y + + E + + Q+
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 146 ATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPE 205
+ + H H++ HRDLK +NIL+ +G K+ADFGL+ +++ L++ + Y +PE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 206 IVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG-------------- 251
++ Y VD WS+G + + F GS+ + +I +
Sbjct: 186 VLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 252 --------------DYFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWID 290
+ F L+ + L NP+ R SH +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-57
Identities = 65/294 (22%), Positives = 127/294 (43%), Gaps = 41/294 (13%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R+ + +G G YG V + +TG VA+K + + ++ R RE++++ ++H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHE 77
Query: 97 NIIHIYEVFENREKM-----VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYY 151
N+I + +VF + V ++ + G +L + + + + LT++ + + QI + Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN-IVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 152 CHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIP 211
H I HRDLK N+ ++E+ KI DFGL+ + + + + Y +PEI+
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 194
Query: 212 YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQ------------ 259
++ VD WS+G ++ L+ G F G++ +K I
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 260 ----------------STASP----LIAEMLNINPSSRADISVICSHWWIDKDH 293
A+P L+ +ML ++ R + +H + + H
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-57
Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 15/262 (5%)
Query: 36 QRFDIVRKLGQGNYGKVQLGINKETGQE----VAIKTIKKCKIETEADLIRIRREIQIMS 91
+ +G G +G+V G+ K + + VAIKT+K TE + E IM
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMG 64
Query: 92 SVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDF-LDQKKVLTEEEARRIFRQIATAVY 150
H NII + V + M+++ EY G L F ++ + + + R IA +
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 151 YCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE----SRFLSTFCGSPLYASPEI 206
Y HRDL NIL++ N K++DFGLS V + + S + +PE
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 207 VKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE-PKNQST-AS 263
+ + D WS G++++ ++ YG P+ + ++K I++G P + +
Sbjct: 185 ISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243
Query: 264 PLIAEMLNINPSSRADISVICS 285
L+ + + R + I S
Sbjct: 244 QLMMQCWQQERARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-56
Identities = 62/273 (22%), Positives = 116/273 (42%), Gaps = 24/273 (8%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+++ + R+LGQG++G V G+ K E VAIKT+ + + + I E +
Sbjct: 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASV 76
Query: 90 MSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK----------VLTEEEAR 139
M +++ + V + +++ME G+L +L + + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 140 RIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES---RFLSTFC 196
++ +IA + Y + +K HRDL N ++ E+ KI DFG++ E+ R
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFE 255
+ SPE +K + D WS GV+L+ + P+ G + +++++ + G +
Sbjct: 197 LPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255
Query: 256 -PKNQST-ASPLIAEMLNINPSSRADISVICSH 286
P N L+ NP R I S
Sbjct: 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 179 bits (455), Expect = 4e-55
Identities = 46/270 (17%), Positives = 96/270 (35%), Gaps = 29/270 (10%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ + R++G+G++G + G N Q+VAIK + +D ++R E + +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 97 NII-HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
I ++Y + VLV++ + + + +Q+ V H+
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 156 KICHRDLKLENILLDE-----NGNAKIADFGLSNVFTES--------RFLSTFCGSPLYA 202
+ +RD+K +N L+ + DFG+ + + R G+ Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 203 SPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK---RLVKQISNGDYFEPKNQ 259
S G D +LG + + G++P+ G + ++I P +
Sbjct: 181 SINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239
Query: 260 STAS------PLIAEMLNINPSSRADISVI 283
A + N+ + D +
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 7e-55
Identities = 69/325 (21%), Positives = 125/325 (38%), Gaps = 54/325 (16%)
Query: 25 VRLHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIR 84
V + + + +R+ ++ +G G G V + + VAIK + + + + R
Sbjct: 6 VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 64
Query: 85 REIQIMSSVRHPNIIHIYEVF------ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEA 138
RE+ +M V H NII + VF E + + LVME + L E
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERM 121
Query: 139 RRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFCGS 198
+ Q+ + + H I HRDLK NI++ + KI DFGL+ S ++ + +
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 199 PLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKN 258
Y +PE++ G+ + VD WS+G ++ +V + F G ++ ++
Sbjct: 182 RYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 259 Q-------------------------------------------STASPLIAEMLNINPS 275
S A L+++ML I+P+
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 276 SRADISVICSHWWIDKDHSVACLEE 300
R + H +I+ + A +E
Sbjct: 301 KRISVDDALQHPYINVWYDPAEVEA 325
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-54
Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 33/282 (11%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGINKET-------GQEVAIKTIKKCKIETEADLIRIRREI 87
+ R + + LG+G +G+V L +VA+K +K TE DL + E+
Sbjct: 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 69
Query: 88 QIMSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK--------------- 131
++M + +H NII++ + +++EYA+ G L ++L ++
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 132 -VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190
L+ ++ Q+A + Y K HRDL N+L+ E+ KIADFGL+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 191 FLST---FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVK 246
+ + +PE + Y + D WS GVLL+ + G P+ G + L K
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 247 QISNGDYFE-PKNQST-ASPLIAEMLNINPSSRADISVICSH 286
+ G + P N + ++ + + PS R +
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-54
Identities = 59/280 (21%), Positives = 104/280 (37%), Gaps = 34/280 (12%)
Query: 35 KQRFDIVRKLGQGNYGKVQLG-----INKETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+ R + LG G +GKV I + VA+K +K TE + + E+++
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSELKV 79
Query: 90 MSSV-RHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKK----------------- 131
+S + H NI+++ +++ EY G+L +FL +K+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 132 -VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190
L E+ Q+A + + HRDL NILL KI DFGL+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 191 FLST---FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVK 246
+ +PE + + E D WS G+ L+ L G+ P+ G
Sbjct: 200 NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 247 QISNGDYFEPKNQSTASP---LIAEMLNINPSSRADISVI 283
++ + + + ++ + +P R I
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 2e-54
Identities = 55/282 (19%), Positives = 101/282 (35%), Gaps = 30/282 (10%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R+ + RK+G G++G + LG + G+EVAIK + ++ E +I ++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 62
Query: 97 NII-HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH 155
I I + V+VME F + + + + Q+ + + Y H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 156 KICHRDLKLENIL---LDENGNAKIADFGLSNVFTESR--------FLSTFCGSPLYASP 204
HRD+K +N L + I DFGL+ + ++R G+ YAS
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 205 EIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASP 264
GI D SLG +L G++P+ G ++ +
Sbjct: 183 NTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 265 ---------LIAEMLNINPSSRADISVI---CSHWWIDKDHS 294
+ ++ + D S + + + + S
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 7e-54
Identities = 59/269 (21%), Positives = 108/269 (40%), Gaps = 18/269 (6%)
Query: 31 RRKLKQRFDIVRKLGQGNYGKVQLGI---NKETGQEVAIKTIKKCKIETEADLIRIRREI 87
L F+ +G+G++G V G N A+K++ + I ++ + E
Sbjct: 24 PSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEG 79
Query: 88 QIMSSVRHPNIIHIYEV-FENREKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQI 145
IM HPN++ + + + ++V+ Y G+L +F+ + T ++ Q+
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 146 ATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTFC-----GSPL 200
A + + K HRDL N +LDE K+ADFGL+ + F S
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 201 YASPEIVKGIPYHGPEVDCWSLGVLLYTLV-YGAMPFDGSNFKRLVKQISNGDYFEPKNQ 259
+ + E ++ + + D WS GVLL+ L+ GA P+ N + + G
Sbjct: 200 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 260 ST--ASPLIAEMLNINPSSRADISVICSH 286
++ + + R S + S
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-51
Identities = 59/292 (20%), Positives = 105/292 (35%), Gaps = 52/292 (17%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
+ +G+G +G+V G K G+EVA+K E EI +RH
Sbjct: 4 TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHE 57
Query: 97 NIIHIYEVFENRE----KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYC 152
NI+ ++ LV +Y G L+D+L++ +T E ++ A+ + +
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHL 116
Query: 153 H--------KHKICHRDLKLENILLDENGNAKIADFGLSNVF-----TESRFLSTFCGSP 199
H K I HRDLK +NIL+ +NG IAD GL+ T + G+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 200 LYASPEIVKGIPYH-----GPEVDCWSLGVLLYTLVYGAMPFDGS--------------- 239
Y +PE++ D +++G++ + +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 240 NFKRLVKQISNGDYFEPKNQSTASP--------LIAEMLNINPSSRADISVI 283
+ + + K + S ++ E N ++R I
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-49
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 33/282 (11%)
Query: 35 KQRFDIVRKLGQGNYGKVQLGI-----NKETGQEVAIKTIKKCKIETEADLIRIRREIQI 89
+ R + + LG+G +G+V T + VA+K +K+ +E + E++I
Sbjct: 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKI 69
Query: 90 MSSVRHPNII--HIYEVFENREKMVLVMEYAAGGELYDFLDQKK---------------- 131
+ + H + + + +++++E+ G L +L K+
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 132 VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-- 189
LT E Q+A + + K HRDL NILL E KI DFGL+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 190 -RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGSNFKR-LVK 246
+ +PE + Y + D WS GVLL+ + A P+ G +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 247 QISNGDYFEPKNQST--ASPLIAEMLNINPSSRADISVICSH 286
++ G + +T + + + PS R S + H
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (346), Expect = 2e-38
Identities = 65/323 (20%), Positives = 110/323 (34%), Gaps = 75/323 (23%)
Query: 37 RFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHP 96
R+ +VRKLG G++ V L + VA+K ++ K+ TE EI+++ V
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----AAEDEIKLLQRVNDA 69
Query: 97 NII---------------HIYEVFENREKMVLVMEYAAGGELYDFLDQKKVL-TEEEARR 140
+ H N +V+V E L + ++
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 141 IFRQIATAVYYC-HKHKICHRDLKLENILLDENGN----AKIADFGLSNVFTESRFLSTF 195
I +Q+ + Y + I H D+K EN+L++ + +I L N +
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQ-------- 247
+ Y SPE++ G P+ G D WS L++ L+ G F+ K
Sbjct: 190 IQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 248 ----------ISNGDY-------------------------------FEPKNQSTASPLI 266
+ NG Y F S +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 267 AEMLNINPSSRADISVICSHWWI 289
+ ML ++P RAD + +H W+
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.8 bits (235), Expect = 6e-24
Identities = 29/159 (18%), Positives = 50/159 (31%), Gaps = 28/159 (17%)
Query: 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE---------------TEADLIRIR 84
I + +G+G V + E E +K K + + R
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 85 REIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQ 144
E + + ++ + +Y N ++ME + + E +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMEL-------IDAKELYRVRVENPDEVLDM 111
Query: 145 IATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183
I V + I H DL N+L+ E G I DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 335 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.06 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-61 Score=420.77 Aligned_cols=255 Identities=35% Similarity=0.628 Sum_probs=231.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999999999999999997644333444667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||+++|+|.+++...+++++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++....... ....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~ 164 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTL 164 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-CEET
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-cccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999997665433 3456
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp 274 (335)
.||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....... ...++++.++|.+||+.||
T Consensus 165 ~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp 243 (263)
T d2j4za1 165 CGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 243 (263)
T ss_dssp TEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCH
Confidence 79999999999998776 899999999999999999999999999999988888776543 4467899999999999999
Q ss_pred CCCCCHHHHhcCCCcCCC
Q psy2306 275 SSRADISVICSHWWIDKD 292 (335)
Q Consensus 275 ~~Rps~~~ll~~~~~~~~ 292 (335)
.+|||++|+|+||||++.
T Consensus 244 ~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 244 SQRPMLREVLEHPWITAN 261 (263)
T ss_dssp GGSCCHHHHHTCHHHHHH
T ss_pred hHCcCHHHHHcCcCcCCc
Confidence 999999999999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-60 Score=416.37 Aligned_cols=257 Identities=34% Similarity=0.595 Sum_probs=220.3
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh--cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 468999999999999999999999999999999997643 223345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC---cc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES---RF 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~---~~ 191 (335)
|||+++++|.+++..+..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999999876432 22
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcCCCC---CCCCCCchHHHHH
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNGDYF---EPKNQSTASPLIA 267 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~ 267 (335)
.....||+.|+|||++.+..+++.++|||||||++|+|++|..||...... ............ ....++++.++|.
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence 345679999999999998887678899999999999999999999765432 222333332222 2345778999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 268 EMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
+||+.||++|||++|+|+||||++..
T Consensus 242 ~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 242 KILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 99999999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-60 Score=414.94 Aligned_cols=264 Identities=28% Similarity=0.491 Sum_probs=230.7
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||+||+|++..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 46899999999999999999999999999999999864332 245788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
|||++|++|.+++.+ .++++.+++.++.||+.||+|||++|++||||||+|||++.++++||+|||++...... ....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 999999999998875 46999999999999999999999999999999999999999999999999999876543 3445
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCchHHHHHHh
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTASPLIAEM 269 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~ 269 (335)
...||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+...... +...++++.+||.+|
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred ccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 6679999999999998877 89999999999999999999999988876666555543222 234577899999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCCcchhhHHHHH
Q psy2306 270 LNINPSSRADISVICSHWWIDKDHSVACLEEAEE 303 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~ 303 (335)
|+.||.+|||++|+|+||||+...+.+.+.++..
T Consensus 254 L~~dP~~R~s~~eil~Hp~~~~~~~~~~l~p~~~ 287 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287 (293)
T ss_dssp TCSSTTTSCCHHHHTTCGGGGGCCCGGGGHHHHH
T ss_pred ccCChhHCcCHHHHhcCHhhCCCCCCCcCCCCCc
Confidence 9999999999999999999987666665554433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-60 Score=416.48 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=228.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.++.+|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997644333445667899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC---ccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES---RFL 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~---~~~ 192 (335)
||+++|+|.+++...+.+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...... ...
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876432 223
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcc
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLN 271 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~ 271 (335)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+...... +...++++.+||++||+
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 246 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSC
T ss_pred ccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence 45679999999999998877 89999999999999999999999999999888888877653 44578899999999999
Q ss_pred cCCCCCCCHHH------HhcCCCcCCC
Q psy2306 272 INPSSRADISV------ICSHWWIDKD 292 (335)
Q Consensus 272 ~dp~~Rps~~~------ll~~~~~~~~ 292 (335)
.||.+|||++| +++||||+..
T Consensus 247 ~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 247 LDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp SSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999998 5889999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-60 Score=417.75 Aligned_cols=259 Identities=35% Similarity=0.607 Sum_probs=215.2
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
+.+.++|++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45778999999999999999999999999999999999864432 2345678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc---cCCCeEEeeccccccccC
Q psy2306 112 VLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD---ENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~---~~~~~kL~df~~~~~~~~ 188 (335)
|+||||++|++|.+++..++++++..+..++.||+.||+|||++|++||||||+||++. .++.+||+|||++.....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999999999888999999999999999999999999999999999999995 478999999999987766
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCCchH
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQSTAS 263 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~ 263 (335)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....... ...++++.
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 666667789999999999998877 899999999999999999999999999888888887765432 34577899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 264 PLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
++|.+||+.||.+|||++|+++||||+...
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999998543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-59 Score=410.70 Aligned_cols=261 Identities=36% Similarity=0.611 Sum_probs=234.0
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC---HHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET---EADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.+.++|++.+.||+|+||+||+|+++.+|+.||+|++.+..... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 46789999999999999999999999999999999997643322 224567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC----CeEEeecccccc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG----NAKIADFGLSNV 185 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~----~~kL~df~~~~~ 185 (335)
.+|+||||+++++|.+++..++++++..++.++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999999999888999999999999999999999999999999999999998776 599999999988
Q ss_pred ccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCC
Q psy2306 186 FTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQS 260 (335)
Q Consensus 186 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~ 260 (335)
...........+++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....... +..++
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 776666667789999999999998776 899999999999999999999999999988888888765432 34677
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
++.+||++||+.||.+|||++|+|+||||+...+
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 8999999999999999999999999999986533
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-59 Score=412.66 Aligned_cols=264 Identities=25% Similarity=0.415 Sum_probs=233.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||+||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 45799999999999999999999999999999999876666667778899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLST 194 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~ 194 (335)
|||+.+++|..++..++++++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... ..
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~ 170 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS 170 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---Cc
Confidence 999999999888888889999999999999999999999999999999999999999999999999999766543 35
Q ss_pred cccCCccCChhhhcCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC---CCCCCCCchHHHHHHh
Q psy2306 195 FCGSPLYASPEIVKGI--PYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY---FEPKNQSTASPLIAEM 269 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~ 269 (335)
..||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+..... .....++++.+||.+|
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 250 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 6799999999998643 2248899999999999999999999998888777766665543 2334577999999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCCCCcchhhHHH
Q psy2306 270 LNINPSSRADISVICSHWWIDKDHSVACLEEA 301 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~ 301 (335)
|+.||.+|||++|+|+||||..........++
T Consensus 251 L~~dP~~Rpt~~ell~Hp~~~~~~~~~~~~~~ 282 (309)
T d1u5ra_ 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282 (309)
T ss_dssp TCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHH
T ss_pred CcCChhHCcCHHHHHhCHHhcCCCCchhhHHH
Confidence 99999999999999999999877665544443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-58 Score=414.75 Aligned_cols=257 Identities=30% Similarity=0.566 Sum_probs=232.3
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
+-++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 446899999999999999999999999999999998753 34556788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc--CCCeEEeeccccccccCCc
Q psy2306 114 VMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE--NGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 114 v~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~--~~~~kL~df~~~~~~~~~~ 190 (335)
||||++||+|.+++. ..+++++..+..++.||+.||.|||++|++||||||+||+++. ++.+||+|||++.......
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999999985 4567999999999999999999999999999999999999964 5789999999998887777
Q ss_pred cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-----CCCCchHHH
Q psy2306 191 FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-----KNQSTASPL 265 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l 265 (335)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+ ..++++.+|
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred ccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 6777889999999999998887 8999999999999999999999999999888888877654322 356789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 266 IAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
|++||+.||.+|||++|+|+||||+....
T Consensus 260 i~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 99999999999999999999999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-58 Score=416.06 Aligned_cols=257 Identities=30% Similarity=0.548 Sum_probs=231.8
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
.+.++|++.+.||+|+||+||+|++..+|+.||+|++... .....+.+.+|+.++++++||||++++++|.+.+.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3556899999999999999999999999999999998763 2344567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc--cCCCeEEeeccccccccCC
Q psy2306 113 LVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD--ENGNAKIADFGLSNVFTES 189 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~--~~~~~kL~df~~~~~~~~~ 189 (335)
+||||++|++|.+.+... .++++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999999999887654 4699999999999999999999999999999999999997 5689999999999988777
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----CCCCCchHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----PKNQSTASP 264 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~ 264 (335)
.......|++.|+|||++.+..+ +.++|||||||++|+|+||..||.+.+..+....+....... ...++++.+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 66777889999999999998887 899999999999999999999999999888888887765432 345778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
||.+||+.||.+|||++|+|+||||+...
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=402.63 Aligned_cols=253 Identities=30% Similarity=0.585 Sum_probs=215.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe--CCeEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN--REKMV 112 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 112 (335)
.++|++.+.||+|+||+||+|+++.+|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 3689999999999999999999999999999999987543 45567788999999999999999999999864 45689
Q ss_pred EEEecCCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhHHCC-----cEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 113 LVMEYAAGGELYDFLDQ----KKVLTEEEARRIFRQIATAVYYCHKHK-----ICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~LH~~g-----ivH~di~p~nili~~~~~~kL~df~~~ 183 (335)
+||||+++|+|.+++.+ +..+++..++.++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999863 567999999999999999999999876 999999999999999999999999999
Q ss_pred ccccCCc-cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC--CCCCCCC
Q psy2306 184 NVFTESR-FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY--FEPKNQS 260 (335)
Q Consensus 184 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 260 (335)
....... ......||+.|+|||++.+..+ +.++|||||||++|+|+||..||...+..++...+..+.. .+...++
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 240 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 8765432 3346788999999999988777 8999999999999999999999999999988888877654 3345688
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCc
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWI 289 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 289 (335)
++.++|++||+.||.+|||++|+++|||+
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-58 Score=411.93 Aligned_cols=256 Identities=34% Similarity=0.603 Sum_probs=233.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 37999999999999999999999999999999998643333344667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-Cccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~~~~ 194 (335)
||++||+|.+++.+...+++..++.++.||+.||+|||++|++||||||+|||++.+|++||+|||++..... ......
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~ 164 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccccc
Confidence 9999999999999989999999999999999999999999999999999999999999999999999986543 444556
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccC
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNIN 273 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~d 273 (335)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+...... +...++++.+||++||++|
T Consensus 165 ~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~d 243 (337)
T d1o6la_ 165 FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp CEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCC
Confidence 789999999999999887 89999999999999999999999999999988888887654 4456889999999999999
Q ss_pred CCCCCC-----HHHHhcCCCcCCC
Q psy2306 274 PSSRAD-----ISVICSHWWIDKD 292 (335)
Q Consensus 274 p~~Rps-----~~~ll~~~~~~~~ 292 (335)
|.+|++ ++++++||||+..
T Consensus 244 P~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 244 PKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred chhhcccccccHHHHHcCcccccC
Confidence 999994 9999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-58 Score=405.03 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=222.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
+.|++.+.||+|+||+||+|+++.+|..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 57999999999999999999999999999999997643 334557889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC-cccc
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES-RFLS 193 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~-~~~~ 193 (335)
||+++|+|.+++.+ ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 99999999998764 567999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred ccccCCccCChhhhcC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC----CCCCCCchHHH
Q psy2306 194 TFCGSPLYASPEIVKG----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF----EPKNQSTASPL 265 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~l 265 (335)
...||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+...... +...++++.+|
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 248 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 5679999999999842 233488999999999999999999999988887777777665432 23457789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 266 IAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
|++||+.||.+|||++|+|+||||+..
T Consensus 249 i~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 249 LKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-58 Score=398.04 Aligned_cols=254 Identities=26% Similarity=0.498 Sum_probs=219.5
Q ss_pred hhccce-eEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe----
Q psy2306 33 KLKQRF-DIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN---- 107 (335)
Q Consensus 33 ~~~~~y-~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 107 (335)
..+++| ++.++||+|+||+||+|.+..++..||+|.+..... .....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 345566 778899999999999999999999999999986443 44556789999999999999999999999865
Q ss_pred CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCC--cEecCCCCCCEEEc-cCCCeEEeeccccc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHK--ICHRDLKLENILLD-ENGNAKIADFGLSN 184 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~g--ivH~di~p~nili~-~~~~~kL~df~~~~ 184 (335)
...+|+||||+++++|.+++.+...+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++.
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 4568999999999999999998889999999999999999999999998 99999999999996 47899999999997
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhcCCCC---CCCCCC
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS-NFKRLVKQISNGDYF---EPKNQS 260 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~-~~~~~~~~~~~~~~~---~~~~~~ 260 (335)
..... ......||+.|+|||++.+ ++ +.++|||||||++|+|++|..||... +...+...+..+... ....++
T Consensus 164 ~~~~~-~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 164 LKRAS-FAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred eccCC-ccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 65433 3346689999999999876 44 89999999999999999999999764 455666666654332 233567
Q ss_pred chHHHHHHhcccCCCCCCCHHHHhcCCCcC
Q psy2306 261 TASPLIAEMLNINPSSRADISVICSHWWID 290 (335)
Q Consensus 261 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 290 (335)
++.++|.+||++||++|||++|+|+||||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 899999999999999999999999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-57 Score=398.60 Aligned_cols=258 Identities=33% Similarity=0.544 Sum_probs=230.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC------HHHHHHHHHHHHHHHcCC-CCcccceeEEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET------EADLIRIRREIQIMSSVR-HPNIIHIYEVFE 106 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 106 (335)
|.++|++.+.||+|+||+||+|++..+|+.||+|++....... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 4579999999999999999999999999999999998644322 223456889999999997 999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVF 186 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~ 186 (335)
+.+..|+||||+++++|.+++..++++++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999887
Q ss_pred cCCccccccccCCccCChhhhcC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-----C
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKG-----IPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-----P 256 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~ 256 (335)
..........|++.|+|||.+.+ ...++.++||||+||++|+|++|..||.+.+.......+..+.... +
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 76666667789999999999852 2334889999999999999999999999999888888777665422 2
Q ss_pred CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 257 KNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
..++++.++|.+||+.||++|||++|+|+||||++
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 45778999999999999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.3e-58 Score=407.59 Aligned_cols=255 Identities=32% Similarity=0.599 Sum_probs=231.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|+++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 37999999999999999999999999999999997643333344677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||++|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...... ....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~ 161 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTL 161 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876543 3456
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDY-FEPKNQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp 274 (335)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+..... .++..++++.+++.+||+.||
T Consensus 162 ~Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp 240 (316)
T d1fota_ 162 CGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 240 (316)
T ss_dssp CSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCT
T ss_pred cCcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCH
Confidence 89999999999998877 8999999999999999999999999999888888877655 345578899999999999999
Q ss_pred CCCC-----CHHHHhcCCCcCCCC
Q psy2306 275 SSRA-----DISVICSHWWIDKDH 293 (335)
Q Consensus 275 ~~Rp-----s~~~ll~~~~~~~~~ 293 (335)
.+|+ |++++++||||++..
T Consensus 241 ~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 241 SQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp TTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HhccccchhhHHHHHcCcccccCC
Confidence 9996 999999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=412.31 Aligned_cols=254 Identities=29% Similarity=0.443 Sum_probs=217.2
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEE
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVL 113 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 113 (335)
..++|++.+.||+|+||+||+|++..+|+.||+|+++... .......+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4679999999999999999999999999999999997643 33445688899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 114 VMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 114 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
||||+++++|.+++.+++.+++..++.++.|++.||.|||+ +||+||||||+|||++.++++||+|||++...... ..
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~ 160 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 160 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-cc
Confidence 99999999999999988889999999999999999999997 59999999999999999999999999999865432 23
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH---------------------------
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV--------------------------- 245 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~--------------------------- 245 (335)
....||+.|+|||++.+.++ +.++||||+||++|||++|+.||.+.+..+..
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred ccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 45689999999999999887 99999999999999999999999765432211
Q ss_pred ---------------HHHhcCCC---CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 246 ---------------KQISNGDY---FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 246 ---------------~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
..+..... .....+.++.+||.+||+.||.+|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 11111111 11123557899999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-57 Score=408.45 Aligned_cols=255 Identities=30% Similarity=0.533 Sum_probs=231.7
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++++.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999999999999999997643333344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcccccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFLSTF 195 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~~~~ 195 (335)
||+.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...... ....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~ 198 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTL 198 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876543 3456
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCchHHHHHHhcccCC
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-EPKNQSTASPLIAEMLNINP 274 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp 274 (335)
.||+.|+|||++.+..+ +.++|||||||++|+|+||..||.+.+.......+...... +...++++.++|++||+.||
T Consensus 199 ~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 277 (350)
T d1rdqe_ 199 CGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp EECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred cCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCH
Confidence 79999999999998877 89999999999999999999999999998888888777653 45578899999999999999
Q ss_pred CCCC-----CHHHHhcCCCcCCCC
Q psy2306 275 SSRA-----DISVICSHWWIDKDH 293 (335)
Q Consensus 275 ~~Rp-----s~~~ll~~~~~~~~~ 293 (335)
.+|+ |++++++||||+...
T Consensus 278 ~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 278 TKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp TTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HhccccccccHHHHHcCccccCCC
Confidence 9994 999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-57 Score=403.55 Aligned_cols=255 Identities=26% Similarity=0.485 Sum_probs=230.5
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
.+-++|++.+.||+|+||+||+|+++.+|+.||+|++.... .....+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 35679999999999999999999999999999999997632 23446789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC--CCeEEeeccccccccCC
Q psy2306 113 LVMEYAAGGELYDFLDQKK-VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN--GNAKIADFGLSNVFTES 189 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~--~~~kL~df~~~~~~~~~ 189 (335)
+||||++|++|.+++..++ ++++.+++.++.||+.||.|||++|++||||||+||+++.+ ..++|+|||++......
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999998654 79999999999999999999999999999999999999854 48999999999887766
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCC-----CCCCchHH
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEP-----KNQSTASP 264 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~ 264 (335)
.......+++.|+|||...+..+ +.++|||||||++|+|++|..||...+..+....+.......+ ..++++.+
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 66667789999999999988776 8999999999999999999999999999998888887765332 46778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 265 LIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
||.+||..||.+|||++|+++||||++.
T Consensus 237 li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-57 Score=400.84 Aligned_cols=256 Identities=33% Similarity=0.529 Sum_probs=227.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHH-HcCCCCcccceeEEEEeCCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIM-SSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
++|++.+.||+|+||+||+|.++.+|+.||+|++.+.........+.+..|...+ +.++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999999999999999999764332333344556666665 468999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-Ccccc
Q psy2306 115 MEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFLS 193 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~~~ 193 (335)
|||+++|+|.+++.....+++.+++.++.||+.||+|||++|++||||||+|||++.++++||+|||.+..... .....
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~ 161 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999976543 33344
Q ss_pred ccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCchHHHHHHhccc
Q psy2306 194 TFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFE-PKNQSTASPLIAEMLNI 272 (335)
Q Consensus 194 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~ 272 (335)
...||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+....... ...++++.+||++||+.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~ 240 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240 (320)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred ccCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhccc
Confidence 5789999999999999887 899999999999999999999999999999888887776544 34688999999999999
Q ss_pred CCCCCCCHH-HHhcCCCcCCC
Q psy2306 273 NPSSRADIS-VICSHWWIDKD 292 (335)
Q Consensus 273 dp~~Rps~~-~ll~~~~~~~~ 292 (335)
||.+||++. ++++||||++.
T Consensus 241 dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 241 EPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp SGGGSBTTBSCGGGSGGGTTC
T ss_pred CCCCCcCHHHHHHhCchhccC
Confidence 999999996 89999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.4e-56 Score=403.72 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=219.0
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC---HHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET---EADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
++|++.+.||+|+||.||+|++..+|+.||+|++.+..... .........++.+++.++||||+++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 47999999999999999999999999999999987533222 222233345577778889999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 113 LVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
+||||++|++|.+++.++..+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++....... .
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~ 162 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-P 162 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-C
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-c
Confidence 999999999999999988899999999999999999999999999999999999999999999999999998765443 3
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhcCCC-CCCCCCCchHHHHHH
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN---FKRLVKQISNGDY-FEPKNQSTASPLIAE 268 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~---~~~~~~~~~~~~~-~~~~~~~~l~~li~~ 268 (335)
....||+.|+|||++.....++.++|||||||++|+|+||..||...+ ............. .+...++++.+||.+
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 242 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHH
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHH
Confidence 456799999999999866655999999999999999999999997643 3334444333333 334578899999999
Q ss_pred hcccCCCCCCC-----HHHHhcCCCcCCC
Q psy2306 269 MLNINPSSRAD-----ISVICSHWWIDKD 292 (335)
Q Consensus 269 ~l~~dp~~Rps-----~~~ll~~~~~~~~ 292 (335)
||+.||.+||| ++++++||||+..
T Consensus 243 ~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 243 LLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999 7999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=390.42 Aligned_cols=256 Identities=32% Similarity=0.590 Sum_probs=219.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCH---HHHHHHHHHHHHHHcCC--CCcccceeEEEEeC
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETE---ADLIRIRREIQIMSSVR--HPNIIHIYEVFENR 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 108 (335)
+.++|++.+.||+|+||+||+|++..+|+.||+|++........ ....++.+|+.+++.++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 46799999999999999999999999999999999975432221 11234568999999886 89999999999999
Q ss_pred CeEEEEEecCCC-CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccC-CCeEEeeccccccc
Q psy2306 109 EKMVLVMEYAAG-GELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDEN-GNAKIADFGLSNVF 186 (335)
Q Consensus 109 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~-~~~kL~df~~~~~~ 186 (335)
+..++|||++.+ +++.+++..+..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 5888899888889999999999999999999999999999999999999854 78999999999765
Q ss_pred cCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCCCCCCCCchHHHH
Q psy2306 187 TESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYFEPKNQSTASPLI 266 (335)
Q Consensus 187 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 266 (335)
... ......||+.|+|||++.+..+++.++|||||||++|+|++|..||...+ + ........+...++++.++|
T Consensus 162 ~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~---i~~~~~~~~~~~s~~~~~li 235 (273)
T d1xwsa_ 162 KDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E---IIRGQVFFRQRVSSECQHLI 235 (273)
T ss_dssp CSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---HHHCCCCCSSCCCHHHHHHH
T ss_pred ccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H---HhhcccCCCCCCCHHHHHHH
Confidence 443 33456799999999999887776788999999999999999999997632 1 22334445667889999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 267 AEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
++||+.||++|||++|+++||||++...+
T Consensus 236 ~~~L~~dp~~R~s~~eil~hp~~~~~~~p 264 (273)
T d1xwsa_ 236 RWCLALRPSDRPTFEEIQNHPWMQDVLLP 264 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence 99999999999999999999999876543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-56 Score=392.34 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=213.8
Q ss_pred EEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCC--HHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEec
Q psy2306 40 IVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIET--EADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEY 117 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 117 (335)
.++.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4688999999999999999999999999987543221 12235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cccccc
Q psy2306 118 AAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLSTFC 196 (335)
Q Consensus 118 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~~~ 196 (335)
+.++++..+...+..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||.+....... ......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 9988888787777889999999999999999999999999999999999999999999999999997765433 334567
Q ss_pred cCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC------CC-----------------
Q psy2306 197 GSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG------DY----------------- 253 (335)
Q Consensus 197 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------~~----------------- 253 (335)
||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 8999999999987766699999999999999999999999988877766554321 00
Q ss_pred ------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 ------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
..+..++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 012345688999999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=382.45 Aligned_cols=255 Identities=30% Similarity=0.502 Sum_probs=214.8
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.+..+|+.||+|+++... ......+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 58999999999999999999999999999999996533 22334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC-Cccc
Q psy2306 116 EYAAGGELYDFLD--QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-SRFL 192 (335)
Q Consensus 116 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-~~~~ 192 (335)
||+.+ .+..++. ....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+..... ....
T Consensus 81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99966 4444443 345699999999999999999999999999999999999999999999999999977654 3334
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC--CC-----------------
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG--DY----------------- 253 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--~~----------------- 253 (335)
....|++.|+|||+.....+.+.++||||||+++|+|++|..||.+.+..+....+... ..
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 56689999999999988887789999999999999999999999988776655544220 00
Q ss_pred -----------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 254 -----------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 254 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
..+..+.++.+|+++||+.||++|||++|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 011335578899999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-54 Score=379.85 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=217.0
Q ss_pred hhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC--
Q psy2306 32 RKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE-- 109 (335)
Q Consensus 32 ~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 109 (335)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|+++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 357789999999999999999999999999999999998766666777788999999999999999999999997654
Q ss_pred --eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccccc
Q psy2306 110 --KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFT 187 (335)
Q Consensus 110 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~ 187 (335)
..|+||||++|++|.+++...+++++.++..++.|++.||+|||++|++||||||+||+++.++..+++|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 489999999999999999988899999999999999999999999999999999999999999999999999886543
Q ss_pred CC----ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC-----CCCC
Q psy2306 188 ES----RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-----EPKN 258 (335)
Q Consensus 188 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~ 258 (335)
.. .......||+.|+|||++.+..+ +.++||||||+++|+|+||..||.+.+..+....+...... ....
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ----------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred cccccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 22 23345678999999999988776 89999999999999999999999998888777666655432 2346
Q ss_pred CCchHHHHHHhcccCCCCCC-CHHHHhcCCCc
Q psy2306 259 QSTASPLIAEMLNINPSSRA-DISVICSHWWI 289 (335)
Q Consensus 259 ~~~l~~li~~~l~~dp~~Rp-s~~~ll~~~~~ 289 (335)
++++.++|++||++||.+|| |+++++ |+|.
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~ 272 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMR-ADLV 272 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHH-HHHH
Confidence 77899999999999999999 555554 4443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=392.98 Aligned_cols=252 Identities=33% Similarity=0.594 Sum_probs=212.5
Q ss_pred hhccceeEEe-eeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHH-cCCCCcccceeEEEEe---
Q psy2306 33 KLKQRFDIVR-KLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMS-SVRHPNIIHIYEVFEN--- 107 (335)
Q Consensus 33 ~~~~~y~~~~-~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~--- 107 (335)
.+-++|.+.+ .||+|+||+||+|.+..+|+.||+|++... ..+.+|+.++. ..+||||++++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 4556899875 599999999999999999999999998752 24667888865 4589999999999976
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CCCeEEeecc
Q psy2306 108 -REKMVLVMEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NGNAKIADFG 181 (335)
Q Consensus 108 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~~~kL~df~ 181 (335)
.+.+|+|||||+||+|.+++..+ .++++.+++.++.|++.||+|||+.|++||||||+||+++. .+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46789999999999999999864 46999999999999999999999999999999999999975 4579999999
Q ss_pred ccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHH----HHHhcCCCCCC-
Q psy2306 182 LSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLV----KQISNGDYFEP- 256 (335)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~----~~~~~~~~~~~- 256 (335)
++.............|++.|+|||++.+..+ +.++|||||||++|+|+||..||.+.+..... ..+.......+
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 9988776666677889999999999988777 89999999999999999999999765533322 22232332222
Q ss_pred ----CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 257 ----KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 257 ----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
..++++.+||++||+.||.+|||+.|+++||||.+..
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 2467899999999999999999999999999997544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-54 Score=380.33 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=216.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.++ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 58999999999999999999986 689999999976432 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-ccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF-LST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~-~~~ 194 (335)
|++.++.+..+...++.+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||.+........ ...
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 9998877777777788899999999999999999999999999999999999999999999999999977654322 345
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC----------------------
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD---------------------- 252 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---------------------- 252 (335)
..+++.|+|||.+.+..+++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 5689999999999887777999999999999999999999999887766655543200
Q ss_pred --------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 253 --------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 253 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
......++++.+||++||+.||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 011233557889999999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-54 Score=379.98 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=212.0
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCC-CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHc---CCCCcccceeEEEEe--
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKET-GQEVAIKTIKKCKIETEADLIRIRREIQIMSS---VRHPNIIHIYEVFEN-- 107 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~---l~~~~i~~~~~~~~~-- 107 (335)
..++|++++.||+|+||+||+|++..+ ++.||+|++....... .....+.+|+..++. ++||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 457999999999999999999999765 6679999987532211 112234456665554 489999999999853
Q ss_pred ---CCeEEEEEecCCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccc
Q psy2306 108 ---REKMVLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLS 183 (335)
Q Consensus 108 ---~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~ 183 (335)
....++++|+++++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 357899999998876654443 3556999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC-----------
Q psy2306 184 NVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD----------- 252 (335)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----------- 252 (335)
.............||+.|+|||++.+.++ +.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 87776666677889999999999998887 899999999999999999999999988777665553210
Q ss_pred -----------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 253 -----------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 253 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
......++.+.+||++||+.||++|||++|+|+||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0122345678999999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-53 Score=374.84 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=206.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCc---EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQ---EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
++|++.+.||+|+||+||+|.++.+++ .|++|.+... ......+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 589999999999999999999887654 5788887652 34556678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+||||+++|+|.+++.. .+.+++.++..++.|++.||+|||++|++||||||+|||++.++++||+|||++........
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 99999999999998876 45699999999999999999999999999999999999999999999999999987653322
Q ss_pred c------cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCch
Q psy2306 192 L------STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTA 262 (335)
Q Consensus 192 ~------~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l 262 (335)
. ....+++.|+|||.+.+..+ +.++|||||||++|||+| |..||.+.+..++...+..+.. .+...+.++
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 262 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL 262 (299)
T ss_dssp ------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHH
Confidence 1 12456889999999988776 899999999999999998 8999999999888888877643 334567799
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 263 SPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+++.+||+.||.+|||+.||+++
T Consensus 263 ~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 263 HQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999843
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=382.59 Aligned_cols=265 Identities=26% Similarity=0.446 Sum_probs=218.7
Q ss_pred Cccchhhhhh---hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccc
Q psy2306 24 GVRLHNHRRK---LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100 (335)
Q Consensus 24 ~~~~~~~~~~---~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 100 (335)
||.....+.. +.++|++++.||+|+||+||+|.+..+|+.||+|++... .......+.+.+|+.+|+.++||||++
T Consensus 3 ~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpniv~ 81 (346)
T d1cm8a_ 3 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIG 81 (346)
T ss_dssp SBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCC
T ss_pred CcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh-hcChHHHHHHHHHHHHHHhcCCCCeeE
Confidence 4444444444 789999999999999999999999999999999999753 345566778899999999999999999
Q ss_pred eeEEEEeCC------eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 101 IYEVFENRE------KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 101 ~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
++++|...+ .+|+||||+ +.+|..+++. .++++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 82 LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp CSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred EEEEeccCccccccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc
Confidence 999997654 579999999 6688887764 56999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC--
Q psy2306 175 AKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD-- 252 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-- 252 (335)
+||+|||.+...... .....+++.|+|||++.+..+++.++||||+||++|+|++|..||.+.+.......+....
T Consensus 160 ~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 160 LKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp EEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence 999999999776543 3456789999999999877766999999999999999999999998877655443332210
Q ss_pred ------------------------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 253 ------------------------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 253 ------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
......++++.+||.+||..||.+|||++|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 01233466889999999999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=367.71 Aligned_cols=245 Identities=24% Similarity=0.450 Sum_probs=204.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+..+++++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 48999999999999999999987 467899999875332 2346889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--c
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--L 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--~ 192 (335)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++........ .
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999999988654 5689999999999999999999999999999999999999999999999999977654332 2
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
....|++.|+|||++.+..+ +.++||||||+++|||+| |.+||...+..++...+..+.. .+...++++.+++.+|
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238 (263)
T ss_dssp -----CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred cceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence 34568899999999998887 899999999999999998 5777888888888887776533 3344577999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q psy2306 270 LNINPSSRADISVICSH 286 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~ 286 (335)
|+.||++|||+++|++|
T Consensus 239 l~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999965
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=371.26 Aligned_cols=245 Identities=24% Similarity=0.409 Sum_probs=208.9
Q ss_pred eeeeccCCeEEEEEEEC--CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEEecCC
Q psy2306 42 RKLGQGNYGKVQLGINK--ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 42 ~~ig~g~~g~Vy~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
++||+|+||+||+|.+. .+++.||+|+++... ......+.+.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 47999999999999864 356789999997543 234456789999999999999999999999865 45789999999
Q ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc----cccc
Q psy2306 120 GGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF----LSTF 195 (335)
Q Consensus 120 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~----~~~~ 195 (335)
+|+|.+++.+..++++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ ....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 999999999989999999999999999999999999999999999999999999999999999977643322 2235
Q ss_pred ccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHhccc
Q psy2306 196 CGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEMLNI 272 (335)
Q Consensus 196 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~ 272 (335)
.|++.|+|||++.+..+ +.++||||||+++|||+| |..||.+.+..++...+..+.. .+...++++.+++.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 67889999999988776 899999999999999997 8999999998888888877643 3445678999999999999
Q ss_pred CCCCCCCHHHHh---cCCCc
Q psy2306 273 NPSSRADISVIC---SHWWI 289 (335)
Q Consensus 273 dp~~Rps~~~ll---~~~~~ 289 (335)
||.+|||+++|+ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 55554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-53 Score=373.40 Aligned_cols=246 Identities=25% Similarity=0.426 Sum_probs=214.2
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||+||+|++..+|..||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 3589999999999999999999999999999999875332 245788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-
Q psy2306 115 MEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~- 191 (335)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999999753 5689999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 192 -LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMP-FDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 192 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p-~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
.....|++.|+|||++.+..+ +.++||||||+++|||++|..| |...+..+....+..+.. .+...++++.+++.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence 233457889999999988777 8999999999999999996554 566677777666665532 33456779999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q psy2306 268 EMLNINPSSRADISVICS 285 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~ 285 (335)
+||+.||.+|||+++|++
T Consensus 251 ~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 251 ACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHH
Confidence 999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=371.20 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=214.9
Q ss_pred cceeEEee-eeccCCeEEEEEEECC--CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRK-LGQGNYGKVQLGINKE--TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~-ig~g~~g~Vy~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 112 (335)
++|.+.+. ||+|+||+||+|.++. ++..||+|++... ......+.+.+|++++++++||||+++++++.+ +..|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 57888884 9999999999998764 4557999998753 345567789999999999999999999999865 4688
Q ss_pred EEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc
Q psy2306 113 LVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF 191 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~ 191 (335)
+||||+++|+|.+++.. +..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999998765 46799999999999999999999999999999999999999999999999999987654322
Q ss_pred ----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHH
Q psy2306 192 ----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASP 264 (335)
Q Consensus 192 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 264 (335)
.....|++.|+|||++.+..+ +.++||||||+++|||+| |..||.+.+..++...+..+.. .++..++++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 223467889999999988776 899999999999999998 9999998888888888877643 34557789999
Q ss_pred HHHHhcccCCCCCCCHHHHh---cCCCc
Q psy2306 265 LIAEMLNINPSSRADISVIC---SHWWI 289 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll---~~~~~ 289 (335)
++.+||+.||++|||+.+|+ +|+|+
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999884 45554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=367.38 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=221.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++++.||+|+||+||+|.+..+|+.||+|+++... ........+.+|+.+++.++||||+++++++.+....++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 58999999999999999999999999999999997644 34456778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc-cccc
Q psy2306 116 EYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR-FLST 194 (335)
Q Consensus 116 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~-~~~~ 194 (335)
+++.++++..++...+.+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||.+....... ....
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 999999999999888899999999999999999999999999999999999999999999999999998765433 3344
Q ss_pred cccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHhcCC---------------------
Q psy2306 195 FCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPF-DGSNFKRLVKQISNGD--------------------- 252 (335)
Q Consensus 195 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~-~~~~~~~~~~~~~~~~--------------------- 252 (335)
..+++.|+|||++......+.++|||||||++|+|++|..|| ...+..+....+....
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 567788999999988776699999999999999999999885 4455554444432200
Q ss_pred ---------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 253 ---------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 253 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
......++.+.+||++||+.||.+|||++|+|+||||++-.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 01123355788999999999999999999999999998643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=365.08 Aligned_cols=245 Identities=21% Similarity=0.433 Sum_probs=216.2
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||+||+|+.+ ++..||+|.++..... .+.+.+|+..+++++||||+++++++.+++.+++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 48899999999999999999985 6788999999864432 346889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc--c
Q psy2306 116 EYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--L 192 (335)
Q Consensus 116 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--~ 192 (335)
||+++|+|.+++.. ...+++..++.++.|+++||+|||++|++||||+|+||+++.++.+||+|||++........ .
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 99999999988654 56799999999999999999999999999999999999999999999999999976544322 2
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
....+++.|+|||++.+..+ +.++||||||+++|||+| |..||...+..++...+..+.. .+...++++.+++++|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred cccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHH
Confidence 34568889999999988777 899999999999999998 8999999999998888887643 3334566899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q psy2306 270 LNINPSSRADISVICSH 286 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~~ 286 (335)
|+.||++|||+++|++|
T Consensus 238 l~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSN 254 (258)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-53 Score=375.51 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=213.0
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe------
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN------ 107 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 107 (335)
-.++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.+++.++|+|++++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 35799999999999999999999999999999999865432 23345567899999999999999999999854
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 108 --REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 108 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
.+..+++||++.++.+.........+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 456899999998777766666677899999999999999999999999999999999999999999999999999976
Q ss_pred ccCC-----ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCC--CCCC--
Q psy2306 186 FTES-----RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGD--YFEP-- 256 (335)
Q Consensus 186 ~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~-- 256 (335)
.... .......||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+.... ....
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 5432 223345789999999999877666999999999999999999999999887766655543311 0000
Q ss_pred -----------------------------CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCC
Q psy2306 257 -----------------------------KNQSTASPLIAEMLNINPSSRADISVICSHWWIDKD 292 (335)
Q Consensus 257 -----------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 292 (335)
..++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 013456789999999999999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=378.22 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=211.8
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe------C
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN------R 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 108 (335)
.-+|+..+.||+|+||+||+|++..+|+.||+|++..... ...+|+.++++++|+||++++++|.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 3389999999999999999999999999999999976432 12369999999999999999999853 3
Q ss_pred CeEEEEEecCCCCCHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-CeEEeeccccc
Q psy2306 109 EKMVLVMEYAAGGELYDF---LDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-NAKIADFGLSN 184 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-~~kL~df~~~~ 184 (335)
.++++||||++++.+..+ ......+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 358999999976543333 23466799999999999999999999999999999999999999775 89999999998
Q ss_pred cccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc--------------
Q psy2306 185 VFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN-------------- 250 (335)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-------------- 250 (335)
............|++.|+|||.+.+...++.++||||+||++|+|++|..||...+..+....+..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 877666666778999999999988766669999999999999999999999988776655544421
Q ss_pred -----CC-----------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 251 -----GD-----------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 251 -----~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.. ...+..++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00 01223466899999999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=370.14 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=203.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||+||+|+.+ ..||+|+++.... .....+.+.+|+.++++++||||+++++++. .+.+++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 458999999999999999999754 3599999976433 3455678999999999999999999999875 4568999
Q ss_pred EecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCC---c
Q psy2306 115 MEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTES---R 190 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~---~ 190 (335)
|||+++|+|.+++.. ..++++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||++...... .
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999999999999965 456999999999999999999999999999999999999999999999999999776432 2
Q ss_pred cccccccCCccCChhhhcCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcCCC------CCCCCCCc
Q psy2306 191 FLSTFCGSPLYASPEIVKGIP--YHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISNGDY------FEPKNQST 261 (335)
Q Consensus 191 ~~~~~~~~~~~~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~------~~~~~~~~ 261 (335)
......||+.|+|||++.+.. .++.++||||||+++|||+||..||.+.+.. .....+..+.. .....+++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 234567899999999986432 2488999999999999999999999876544 44444443322 23345778
Q ss_pred hHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 262 ASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 262 l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+.+++.+||+.||.+|||+++|+++
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999954
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-53 Score=367.54 Aligned_cols=249 Identities=24% Similarity=0.431 Sum_probs=213.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLV 114 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 114 (335)
.++|++.+.||+|+||+||+|.++ ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 469999999999999999999976 567899999975332 23468899999999999999999998754 567899
Q ss_pred EecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc-
Q psy2306 115 MEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF- 191 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~- 191 (335)
|||+++|+|.+++... .++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999999987543 3599999999999999999999999999999999999999999999999999987754332
Q ss_pred -ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHH
Q psy2306 192 -LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIA 267 (335)
Q Consensus 192 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 267 (335)
.....+++.|+|||++.+..+ +.++||||||+++|||+|| .+||...+..+....+..+.. .+...++++.+++.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence 234568889999999987776 8999999999999999995 566677778788887776533 33456779999999
Q ss_pred HhcccCCCCCCCHHHHhc--CCCcC
Q psy2306 268 EMLNINPSSRADISVICS--HWWID 290 (335)
Q Consensus 268 ~~l~~dp~~Rps~~~ll~--~~~~~ 290 (335)
+||+.||++|||+++|++ |+||.
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999997 67764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=377.06 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=207.4
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCc-----EEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCC
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQ-----EVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENRE 109 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 109 (335)
++|++.+.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.++.++ +||||+++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 689999999999999999999875543 68999886532 334455788999999988 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhC-----------------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQK-----------------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLEN 166 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~n 166 (335)
..++||||+++|+|.+++..+ ..+++..++.++.|++.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999999999999754 248999999999999999999999999999999999
Q ss_pred EEEccCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHH
Q psy2306 167 ILLDENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFK 242 (335)
Q Consensus 167 ili~~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~ 242 (335)
|+++.++++||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999977654332 234567999999999988777 899999999999999997 89999876554
Q ss_pred HHHH-HHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 243 RLVK-QISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 243 ~~~~-~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+... .+..+.. .+...++++.+||.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4333 3333322 234567789999999999999999999999965
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=373.95 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=212.7
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE---- 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 109 (335)
+..+|++++.||+|+||+||+|.+..+|+.||||++... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 457999999999999999999999999999999999753 34566678899999999999999999999996543
Q ss_pred -eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 110 -KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 110 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
.++++ +++.+++|.+++..+ ++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 84 KDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 34555 555689999999754 699999999999999999999999999999999999999999999999999976543
Q ss_pred Cc----cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcC-------------
Q psy2306 189 SR----FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNG------------- 251 (335)
Q Consensus 189 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------------- 251 (335)
.. ......|++.|+|||++.....++.++||||+||++|+|++|..||.+.+...........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 22 2345668999999999877666689999999999999999999999887654443332210
Q ss_pred ------------CC-------CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCcc
Q psy2306 252 ------------DY-------FEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHSV 295 (335)
Q Consensus 252 ------------~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 295 (335)
.. ..+..++++.+|+.+||+.||.+|||++|+|+||||++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 00 122345678999999999999999999999999999866444
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=376.02 Aligned_cols=266 Identities=25% Similarity=0.395 Sum_probs=209.1
Q ss_pred Cccchhhhh-h--hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccc
Q psy2306 24 GVRLHNHRR-K--LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIH 100 (335)
Q Consensus 24 ~~~~~~~~~-~--~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 100 (335)
.|+....++ + +.++|++.+.||+|+||+||+|+++.+|+.||+|++.... ........+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~ 80 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIS 80 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeE
Confidence 345555555 3 4589999999999999999999999999999999998644 34556678899999999999999999
Q ss_pred eeEEEEe------CCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCC
Q psy2306 101 IYEVFEN------REKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGN 174 (335)
Q Consensus 101 ~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~ 174 (335)
++++|.. ...+|+||||+.++ +.+.+. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 81 ~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~ 157 (355)
T d2b1pa1 81 LLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_dssp CSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred EEEEEecccccccCceeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc
Confidence 9999953 46899999999664 444443 45899999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc----
Q psy2306 175 AKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISN---- 250 (335)
Q Consensus 175 ~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---- 250 (335)
++++|||.+.............+|+.|+|||++.+..+ +.++||||+||++++|++|..||.+.+.......+..
T Consensus 158 ~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 158 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_dssp EEECCCCC---------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeeechhhhhccccccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence 99999999888777666677789999999999998776 8999999999999999999999988776555444321
Q ss_pred ------------------CCCCCC---------------------CCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCC
Q psy2306 251 ------------------GDYFEP---------------------KNQSTASPLIAEMLNINPSSRADISVICSHWWIDK 291 (335)
Q Consensus 251 ------------------~~~~~~---------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 291 (335)
...... ..++++.+||++||..||++|||++|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000000 01335788999999999999999999999999987
Q ss_pred CCc
Q psy2306 292 DHS 294 (335)
Q Consensus 292 ~~~ 294 (335)
...
T Consensus 317 ~~~ 319 (355)
T d2b1pa1 317 WYD 319 (355)
T ss_dssp GCC
T ss_pred CCC
Confidence 543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-51 Score=368.26 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=210.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEe--CCe
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFEN--REK 110 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~ 110 (335)
..++|++++.||+|+||+||+|++..+|+.||+|+++... .+.+.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3468999999999999999999999999999999987522 346788999999995 9999999999974 456
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCC-CeEEeeccccccccCC
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENG-NAKIADFGLSNVFTES 189 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~-~~kL~df~~~~~~~~~ 189 (335)
.++||||+++++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||.+......
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999987764 4599999999999999999999999999999999999998765 5899999999887776
Q ss_pred ccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhc-------------CC---
Q psy2306 190 RFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFK-RLVKQISN-------------GD--- 252 (335)
Q Consensus 190 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~-------------~~--- 252 (335)
.......+|+.|+|||.+.+...++.++||||+||++|+|++|..||...... .....+.. ..
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 66677789999999999988776699999999999999999999999764321 11111100 00
Q ss_pred ----------------------CCCCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCC
Q psy2306 253 ----------------------YFEPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 253 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
......++++.+||++||..||.+|||++|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 00112355789999999999999999999999999998754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=372.66 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=214.6
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC-----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR----- 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 108 (335)
+.++|++.+.||+|+||+||+|++..+|+.||+|++.... ......+.+.+|+.+++.++|||++++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 4579999999999999999999999999999999998643 3455667888999999999999999999998532
Q ss_pred CeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE 188 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~ 188 (335)
...+++++++.+++|.+++.. +++++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+.....
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred CceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc
Confidence 334556677779999999964 5699999999999999999999999999999999999999999999999999866543
Q ss_pred CccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcCCCC--------------
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQISNGDYF-------------- 254 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------------- 254 (335)
. .....|++.|+|||+..+..+++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 174 ~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp G--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred c--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 2 345668889999999888777789999999999999999999999888766655554321110
Q ss_pred ------------------CCCCCCchHHHHHHhcccCCCCCCCHHHHhcCCCcCCCCc
Q psy2306 255 ------------------EPKNQSTASPLIAEMLNINPSSRADISVICSHWWIDKDHS 294 (335)
Q Consensus 255 ------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 294 (335)
....++++.+||++||..||.+|||++|+|+||||++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 1234668899999999999999999999999999997543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=357.16 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=205.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCC----cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETG----QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.+|++.+.||+|+||.||+|.++.++ ..||+|.+.... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 47999999999999999999877654 469999987532 445566788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+++|||+.++++.+++.. ...+++..+..++.|++.||+|||++|++||||||+||||+.++.+||+|||++.......
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 999999999999988765 4679999999999999999999999999999999999999999999999999998764322
Q ss_pred c----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcCCC--CCCCCCCchH
Q psy2306 191 F----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGSNFKRLVKQISNGDY--FEPKNQSTAS 263 (335)
Q Consensus 191 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 263 (335)
. .....|++.|+|||++.+..+ +.++||||||+++|||++| .+|+...+..++...+..+.. .+...+.++.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred ccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHH
Confidence 1 234567889999999988877 8899999999999999985 555666777777777776543 2334567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q psy2306 264 PLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 264 ~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+++.+||+.||++|||+.+|++
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=360.00 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=205.4
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCC---CcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKET---GQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.++|++.+.||+|+||+||+|.+..+ +..|++|.+.. .......+.+.+|+.++++++||||+++++++. ++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT--TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc--ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 36899999999999999999998654 34688888754 335566778999999999999999999999985 5678
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999999998765 5579999999999999999999999999999999999999999999999999997764332
Q ss_pred --cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHH
Q psy2306 191 --FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPL 265 (335)
Q Consensus 191 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 265 (335)
......+++.|+|||++.+..+ +.++||||||+++|||++ |.+||...+..++...+..+.. .++..++++.++
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241 (273)
T ss_dssp --------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2334567899999999988777 889999999999999997 8999999888888888777653 345577899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q psy2306 266 IAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 266 i~~~l~~dp~~Rps~~~ll~~ 286 (335)
|.+||+.||.+|||+.||+++
T Consensus 242 i~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999855
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=358.23 Aligned_cols=249 Identities=28% Similarity=0.446 Sum_probs=208.1
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeEEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKMVLVM 115 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 115 (335)
++|++.+.||+|+||.||+|.++.+ ..||+|++..... ..+.+.+|+.++++++|+||+++++++.+ +..++||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 5899999999999999999998764 5799999975432 23468899999999999999999999854 5678999
Q ss_pred ecCCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc--c
Q psy2306 116 EYAAGGELYDFLDQ--KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR--F 191 (335)
Q Consensus 116 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~--~ 191 (335)
||+++|+|..++.. .+.+++.++..++.|++.||+|||++|++||||||+||+|+.++.+||+|||++....... .
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999999988864 4569999999999999999999999999999999999999999999999999997764332 2
Q ss_pred ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHH
Q psy2306 192 LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAE 268 (335)
Q Consensus 192 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 268 (335)
.....+++.|+|||++....+ +.++||||||+++|||++| .+|+......+....+..+.. .+...++++.+++.+
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 249 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249 (285)
T ss_dssp -----CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred eccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHH
Confidence 234568899999999988777 8999999999999999995 555666777777777766532 445567799999999
Q ss_pred hcccCCCCCCCHHHHhc--CCCcCC
Q psy2306 269 MLNINPSSRADISVICS--HWWIDK 291 (335)
Q Consensus 269 ~l~~dp~~Rps~~~ll~--~~~~~~ 291 (335)
||+.||++|||+++|++ ++||..
T Consensus 250 cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 250 CWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HcccCHhHCcCHHHHHHHHhhhhcC
Confidence 99999999999999987 788864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=367.04 Aligned_cols=257 Identities=35% Similarity=0.597 Sum_probs=216.8
Q ss_pred cceeEEeeeeccCCeEEEEEEE---CCCCcEEEEEEeecCCc-CCHHHHHHHHHHHHHHHcCCC-CcccceeEEEEeCCe
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGIN---KETGQEVAIKTIKKCKI-ETEADLIRIRREIQIMSSVRH-PNIIHIYEVFENREK 110 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~---~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~ 110 (335)
++|++.+.||+|+||+||+|.+ +.+|+.||+|.+..... ......+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999987 44689999999865322 122234567789999999976 899999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccC--
Q psy2306 111 MVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTE-- 188 (335)
Q Consensus 111 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~-- 188 (335)
.++++||+.+++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 999999999999999999888899999999999999999999999999999999999999999999999999976543
Q ss_pred CccccccccCCccCChhhhcCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhcCC-CCCCCCCCch
Q psy2306 189 SRFLSTFCGSPLYASPEIVKGIP-YHGPEVDCWSLGVLLYTLVYGAMPFDGSN----FKRLVKQISNGD-YFEPKNQSTA 262 (335)
Q Consensus 189 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~tg~~p~~~~~----~~~~~~~~~~~~-~~~~~~~~~l 262 (335)
........|++.|++||.+.+.. .++.++|||||||++|+|++|..||...+ ...+........ ..+...++++
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 263 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHH
Confidence 22334567899999999997654 34789999999999999999999996643 333433333333 3345578899
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCCCcCCC
Q psy2306 263 SPLIAEMLNINPSSRA-----DISVICSHWWIDKD 292 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~ 292 (335)
.+||.+||++||.+|| |++|+++||||++.
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 9999999999999999 58999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=361.86 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=212.5
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcE--EEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeCCeEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQE--VAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENREKMV 112 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~--valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 112 (335)
++|++.+.||+|+||+||+|.++.+|.. |++|.+... ......+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 5899999999999999999999888765 667776542 2334556789999999998 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeE
Q psy2306 113 LVMEYAAGGELYDFLDQK----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAK 176 (335)
Q Consensus 113 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~k 176 (335)
+||||+++|+|.+++..+ ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 999999999999999643 5699999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHHhcCCCC-
Q psy2306 177 IADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGA-MPFDGSNFKRLVKQISNGDYF- 254 (335)
Q Consensus 177 L~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~-~p~~~~~~~~~~~~~~~~~~~- 254 (335)
|+|||++.............++..|+|||.+.+..+ +.++||||||+++|||++|. .||.+.+..++...+..+...
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~ 246 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC
T ss_pred EccccccccccccccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999999977655554556678999999999988777 89999999999999999965 679899999988888765432
Q ss_pred -CCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 255 -EPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 255 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
+...++++.++|.+||+.||++|||+++|+++
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 34467799999999999999999999999965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=354.90 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=202.9
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC-CC--cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE-TG--QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~-~~--~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.++|++.+.||+|+||.||+|+... ++ ..||+|.+...........+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3579999999999999999998643 33 3689999887655555667789999999999999999999999975 467
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
++||||++++++.+.+.. .+++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999987764 4579999999999999999999999999999999999999999999999999998765432
Q ss_pred c----ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCCC---CCCCCCch
Q psy2306 191 F----LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDYF---EPKNQSTA 262 (335)
Q Consensus 191 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~l 262 (335)
. .....++..|+|||++.+..+ +.++||||||+++|||+| |..||.+.+..+....+...... +...++++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 2 223456788999999988776 899999999999999998 89999999999988888766432 34467799
Q ss_pred HHHHHHhcccCCCCCCCHHHHh
Q psy2306 263 SPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 263 ~~li~~~l~~dp~~Rps~~~ll 284 (335)
.+++.+||+.||++|||+++|+
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHH
Confidence 9999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-50 Score=356.28 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=215.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE 109 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 109 (335)
.++|++.+.||+|+||+||+|..+ .++..||+|++... ......+.+.+|+.++++++||||+++++++.+.+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 458999999999999999999875 35678999998753 34555678999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhC------------------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCC
Q psy2306 110 KMVLVMEYAAGGELYDFLDQK------------------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLE 165 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~ 165 (335)
..++++||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 999999999999999999642 24889999999999999999999999999999999
Q ss_pred CEEEccCCCeEEeeccccccccCCc---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCcH
Q psy2306 166 NILLDENGNAKIADFGLSNVFTESR---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGA-MPFDGSNF 241 (335)
Q Consensus 166 nili~~~~~~kL~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~-~p~~~~~~ 241 (335)
||+++.++.+||+|||++....... ......+++.|+|||.+.+..+ +.++||||||+++|||++|. +||...+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999999999999999997654332 2234567889999999998877 89999999999999999985 68999999
Q ss_pred HHHHHHHhcCCCC--CCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 242 KRLVKQISNGDYF--EPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 242 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+....+..+... +...++++.+++.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9988888877653 3356779999999999999999999999963
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=353.35 Aligned_cols=240 Identities=25% Similarity=0.471 Sum_probs=201.9
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-CCeEEEE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN-REKMVLV 114 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 114 (335)
++|++.+.||+|+||.||+|+++ |..||+|+++.. ...+.+.+|+.++++++||||+++++++.+ .+.+++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 47999999999999999999875 778999998652 234578899999999999999999999854 5668999
Q ss_pred EecCCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCccc
Q psy2306 115 MEYAAGGELYDFLDQK--KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRFL 192 (335)
Q Consensus 115 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~~ 192 (335)
|||+++|+|.+++..+ ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999999999999653 358999999999999999999999999999999999999999999999999997654432
Q ss_pred cccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHHHHHHh
Q psy2306 193 STFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASPLIAEM 269 (335)
Q Consensus 193 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 269 (335)
....+++.|+|||++.+..+ +.++||||||+++|||+| |..||...+..++...+.++.. .+...++++.++|++|
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 236 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 236 (262)
T ss_dssp ----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence 34467889999999988776 999999999999999998 7889988888888888876533 3445677999999999
Q ss_pred cccCCCCCCCHHHHhc
Q psy2306 270 LNINPSSRADISVICS 285 (335)
Q Consensus 270 l~~dp~~Rps~~~ll~ 285 (335)
|+.||.+|||+.++++
T Consensus 237 l~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 237 WHLDAAMRPSFLQLRE 252 (262)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cccCHhHCcCHHHHHH
Confidence 9999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=359.56 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=206.3
Q ss_pred cceeEEeeeeccCCeEEEEEEECCCCc----EEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCCeE
Q psy2306 36 QRFDIVRKLGQGNYGKVQLGINKETGQ----EVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENREKM 111 (335)
Q Consensus 36 ~~y~~~~~ig~g~~g~Vy~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 111 (335)
.+|++.+.||+|+||+||+|.+..+|+ +||+|.+.... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 369999999999999999999987776 57888876432 333466789999999999999999999999865 46
Q ss_pred EEEEecCCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCc
Q psy2306 112 VLVMEYAAGGELYDFLDQ-KKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESR 190 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~ 190 (335)
+++++++.+++|.+.+.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++++||+|||++.......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 677888889999887765 5679999999999999999999999999999999999999999999999999998764432
Q ss_pred c---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcCCC--CCCCCCCchHH
Q psy2306 191 F---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVKQISNGDY--FEPKNQSTASP 264 (335)
Q Consensus 191 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 264 (335)
. .....|++.|+|||++.+..+ +.++||||||+++|||+| |..||...+..++...+..+.. .+...++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 2 234467999999999988776 899999999999999998 8999998887777777766543 33456778999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q psy2306 265 LIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 265 li~~~l~~dp~~Rps~~~ll~~ 286 (335)
++.+||+.||.+|||+.+|++|
T Consensus 245 li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=354.44 Aligned_cols=248 Identities=26% Similarity=0.450 Sum_probs=211.0
Q ss_pred ccceeEEeeeeccCCeEEEEEEECCCC-------cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEE
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKETG-------QEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFE 106 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~~~-------~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 106 (335)
.++|++.+.||+|+||.||+|++..++ ..||+|.++... .......+.+|...+.++ +||||+++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 469999999999999999999876543 479999987633 445567788888888888 7999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc
Q psy2306 107 NREKMVLVMEYAAGGELYDFLDQK----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD 170 (335)
Q Consensus 107 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~ 170 (335)
+++..++||||+++|+|.+++..+ ..+++.+++.++.|++.||.|||++|++||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 999999999999999999999754 3589999999999999999999999999999999999999
Q ss_pred cCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q psy2306 171 ENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRLVK 246 (335)
Q Consensus 171 ~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~~~ 246 (335)
.++.+||+|||++........ .....+++.|+|||.+.+..+ +.++||||||+++|||++ |..||.+.+..+...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 999999999999987654322 334668889999999988777 999999999999999998 799999999988888
Q ss_pred HHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 247 QISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 247 ~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
.+..+.. .+...++++.++|.+||+.||.+|||+.||++
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8877643 23345778999999999999999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=351.34 Aligned_cols=249 Identities=23% Similarity=0.392 Sum_probs=217.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeC
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENR 108 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 108 (335)
-.++|++.+.||+|+||+||+|.+.. ++..||+|++... ........+.+|+.++++++||||+++++++...
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 34799999999999999999998752 3578999998753 3455566789999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEe
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQK----------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIA 178 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~ 178 (335)
+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++++||||||+|||++.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999999988642 347899999999999999999999999999999999999999999999
Q ss_pred eccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcCCCC
Q psy2306 179 DFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGSNFKRLVKQISNGDYF 254 (335)
Q Consensus 179 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~~ 254 (335)
|||++........ .....+++.|+|||.+.+..+ +.++||||||+++|||+|| ..||.+.+..+....+..+...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999976644322 234467899999999988877 8899999999999999998 5889999998888888776543
Q ss_pred --CCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 255 --EPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 255 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
+...++.+.+++.+||+.||.+|||+++|++
T Consensus 255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3456779999999999999999999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=351.90 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=197.5
Q ss_pred ccceeEEeeeeccCCeEEEEEEECC-----CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEe-
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINKE-----TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFEN- 107 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~- 107 (335)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... .....+.+.+|...+.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3689999999999999999998754 45689999987532 344456677777777776 68999999998865
Q ss_pred CCeEEEEEecCCCCCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc
Q psy2306 108 REKMVLVMEYAAGGELYDFLDQK----------------KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE 171 (335)
Q Consensus 108 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~ 171 (335)
.+.++++|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 45689999999999999999643 34899999999999999999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCc---cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCcH-HHHHH
Q psy2306 172 NGNAKIADFGLSNVFTESR---FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYG-AMPFDGSNF-KRLVK 246 (335)
Q Consensus 172 ~~~~kL~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg-~~p~~~~~~-~~~~~ 246 (335)
++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|||++| ..||..... +.+..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999997654322 2334578999999999988776 8999999999999999986 567876543 34444
Q ss_pred HHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhcC
Q psy2306 247 QISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICSH 286 (335)
Q Consensus 247 ~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+..+.. .+...++++.+++.+||+.||++|||++||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444332 234467799999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=345.83 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=209.6
Q ss_pred ccceeEEeeeeccCCeEEEEEEEC-----CCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcC-CCCcccceeEEEEeC
Q psy2306 35 KQRFDIVRKLGQGNYGKVQLGINK-----ETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSV-RHPNIIHIYEVFENR 108 (335)
Q Consensus 35 ~~~y~~~~~ig~g~~g~Vy~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 108 (335)
.++|++.+.||+|+||.||+|.+. .+++.||+|.++... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 479999999999999999999853 467889999997633 455566788999999999 699999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhCC------------------CCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEc
Q psy2306 109 EKMVLVMEYAAGGELYDFLDQKK------------------VLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLD 170 (335)
Q Consensus 109 ~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~ 170 (335)
+..+++|||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999997533 589999999999999999999999999999999999999
Q ss_pred cCCCeEEeeccccccccCCcc---ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCcHHHH-H
Q psy2306 171 ENGNAKIADFGLSNVFTESRF---LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVY-GAMPFDGSNFKRL-V 245 (335)
Q Consensus 171 ~~~~~kL~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~t-g~~p~~~~~~~~~-~ 245 (335)
.++.++++|||.+........ .....+++.|+|||++.+..+ +.++||||||+++|||+| |.+||...+..+. .
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987654322 234678999999999988776 899999999999999998 6666666544333 3
Q ss_pred HHHhcCCC--CCCCCCCchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 246 KQISNGDY--FEPKNQSTASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 246 ~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
..+..+.. .+...++++.+||.+||+.||.+|||+++|++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33333322 23446779999999999999999999999984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=341.92 Aligned_cols=244 Identities=22% Similarity=0.328 Sum_probs=201.4
Q ss_pred EEeeeeccCCeEEEEEEECCCC---cEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEe-CCeEEEEE
Q psy2306 40 IVRKLGQGNYGKVQLGINKETG---QEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFEN-REKMVLVM 115 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 115 (335)
..+.||+|+||+||+|.+..++ ..||+|.+.. .......+.+.+|++++++++||||+++++++.+ ++..++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999986643 3589999864 3356667889999999999999999999999865 56899999
Q ss_pred ecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccccccccCCcc---
Q psy2306 116 EYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGLSNVFTESRF--- 191 (335)
Q Consensus 116 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~~~~~~~~~~--- 191 (335)
||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999988754 4578889999999999999999999999999999999999999999999999987643322
Q ss_pred --ccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcCCC--CCCCCCCchHHHH
Q psy2306 192 --LSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDG-SNFKRLVKQISNGDY--FEPKNQSTASPLI 266 (335)
Q Consensus 192 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~l~~li 266 (335)
.....|++.|+|||.+....+ +.++||||||+++|||+||..||.. .+..+....+..+.. .+...++++.+++
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHH
Confidence 223467889999999988776 9999999999999999997777654 344445555554432 2334567999999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q psy2306 267 AEMLNINPSSRADISVICSH 286 (335)
Q Consensus 267 ~~~l~~dp~~Rps~~~ll~~ 286 (335)
.+||+.||++|||+.||++|
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999966
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-47 Score=338.59 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=200.3
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCc-ccceeEEEEeCCeE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPN-IIHIYEVFENREKM 111 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~ 111 (335)
++.++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+..|+++++.++|++ |+.+.+++.+.+..
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 3457899999999999999999999999999999998764322 24678999999998665 55556666888899
Q ss_pred EEEEecCCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc---CCCeEEeecccccccc
Q psy2306 112 VLVMEYAAGGELYDFLD-QKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE---NGNAKIADFGLSNVFT 187 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~---~~~~kL~df~~~~~~~ 187 (335)
++|||+++ +++...+. ....+++..+..++.|++.||+|||++|++||||||+||+++. +..++|+|||++....
T Consensus 79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99999994 56665554 4667999999999999999999999999999999999999853 4579999999998765
Q ss_pred CCc--------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh---c----C-
Q psy2306 188 ESR--------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSNFKRLVKQIS---N----G- 251 (335)
Q Consensus 188 ~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~~~~~~~~~~---~----~- 251 (335)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|..||...........+. . .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 332 1234578999999999998876 899999999999999999999997654433221111 1 1
Q ss_pred -CCCCCCCCCchHHHHHHhcccCCCCCCCHHHH---hcCCCcCCC
Q psy2306 252 -DYFEPKNQSTASPLIAEMLNINPSSRADISVI---CSHWWIDKD 292 (335)
Q Consensus 252 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l---l~~~~~~~~ 292 (335)
.......++++.+++..||+.+|++||+++++ |+++|.+..
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 11234567899999999999999999998754 666665433
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=334.26 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=192.4
Q ss_pred hccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcccceeEEEEeCC----
Q psy2306 34 LKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNIIHIYEVFENRE---- 109 (335)
Q Consensus 34 ~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 109 (335)
+.++|.+.+.||+|+||+||+|+. +|+.||+|++.... ........|+..+..++||||+++++++.+.+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 357899999999999999999976 58899999986522 11122234555556789999999999997654
Q ss_pred eEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHH--------CCcEecCCCCCCEEEccCCCeEEeecc
Q psy2306 110 KMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHK--------HKICHRDLKLENILLDENGNAKIADFG 181 (335)
Q Consensus 110 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~--------~givH~di~p~nili~~~~~~kL~df~ 181 (335)
..|+||||+++++|.+++++. .+++..+..++.|++.||+|||+ +||+||||||+||||+.++.+||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 689999999999999999865 58999999999999999999996 599999999999999999999999999
Q ss_pred ccccccCCcc-----ccccccCCccCChhhhcCCCC-----CCCcchHHHHHHHHHHHHhCCCCCCC-------------
Q psy2306 182 LSNVFTESRF-----LSTFCGSPLYASPEIVKGIPY-----HGPEVDCWSLGVLLYTLVYGAMPFDG------------- 238 (335)
Q Consensus 182 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~-----~~~~~Dv~slG~~l~~l~tg~~p~~~------------- 238 (335)
++........ .....||+.|+|||++.+... ++.++|||||||++|||+||..||..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9977654322 234678999999999876431 25689999999999999999877632
Q ss_pred --CcHHHHHHHHhcCCCCCCCCC---------CchHHHHHHhcccCCCCCCCHHHHhc
Q psy2306 239 --SNFKRLVKQISNGDYFEPKNQ---------STASPLIAEMLNINPSSRADISVICS 285 (335)
Q Consensus 239 --~~~~~~~~~~~~~~~~~~~~~---------~~l~~li~~~l~~dp~~Rps~~~ll~ 285 (335)
................ +..+ ..+.+++.+||+.||.+|||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHTTSCCC-CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHhccccC-CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 2334444444443332 1111 24789999999999999999999984
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-46 Score=328.56 Aligned_cols=245 Identities=20% Similarity=0.277 Sum_probs=203.7
Q ss_pred hhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCC-CcccceeEEEEeCCeE
Q psy2306 33 KLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRH-PNIIHIYEVFENREKM 111 (335)
Q Consensus 33 ~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~ 111 (335)
.+.++|++.+.||+|+||+||+|++..+|+.||+|++...... ..+.+|++.++.++| +|++.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 4568999999999999999999999999999999998653321 246678889999875 8999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEcc-----CCCeEEeecccccc
Q psy2306 112 VLVMEYAAGGELYDFLDQK-KVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDE-----NGNAKIADFGLSNV 185 (335)
Q Consensus 112 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~-----~~~~kL~df~~~~~ 185 (335)
++|||++ +++|.+++... ..++...+..++.|++.||+|||+.|++||||||+||+++. ++.++|+|||++..
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 67999988764 46999999999999999999999999999999999999964 56899999999987
Q ss_pred ccCCc--------cccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhcCC--
Q psy2306 186 FTESR--------FLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGS---NFKRLVKQISNGD-- 252 (335)
Q Consensus 186 ~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~---~~~~~~~~~~~~~-- 252 (335)
..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+. +.......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 64321 2234579999999999998776 89999999999999999999999753 2222222222110
Q ss_pred ----CCCCCCCCchHHHHHHhcccCCCCCCCHHHHh
Q psy2306 253 ----YFEPKNQSTASPLIAEMLNINPSSRADISVIC 284 (335)
Q Consensus 253 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 284 (335)
......++++.+++..|++.+|++||+.+.+.
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 12245678999999999999999999987765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-45 Score=332.00 Aligned_cols=262 Identities=25% Similarity=0.438 Sum_probs=200.3
Q ss_pred ccchhhhhhhc-cceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC---------
Q psy2306 25 VRLHNHRRKLK-QRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR--------- 94 (335)
Q Consensus 25 ~~~~~~~~~~~-~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------- 94 (335)
|++...++.+. +||++++.||+|+||+||+|++..+|+.||||++... ....+.+.+|+.+++.+.
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~ 76 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDS 76 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhh
Confidence 45566778776 4799999999999999999999999999999999752 233456678888887764
Q ss_pred --CCcccceeEEEEe--CCeEEEEEecCCCCC-HHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhHH-CCcEecCCCCCC
Q psy2306 95 --HPNIIHIYEVFEN--REKMVLVMEYAAGGE-LYDFL--DQKKVLTEEEARRIFRQIATAVYYCHK-HKICHRDLKLEN 166 (335)
Q Consensus 95 --~~~i~~~~~~~~~--~~~~~lv~e~~~~~~-L~~~l--~~~~~~~~~~~~~i~~~l~~~l~~LH~-~givH~di~p~n 166 (335)
|+||+++++++.. ....++++.++.... ..... .....+++..++.++.|++.||.|||+ .||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 5789999988754 456666666664443 22222 235679999999999999999999997 899999999999
Q ss_pred EEEccCCC------eEEeeccccccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q psy2306 167 ILLDENGN------AKIADFGLSNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVLLYTLVYGAMPFDGSN 240 (335)
Q Consensus 167 ili~~~~~------~kL~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~tg~~p~~~~~ 240 (335)
||++.++. ++++|||.+...... .....|++.|+|||++....+ +.++|+||+|+++++|++|..||....
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCCc
Confidence 99987653 999999998765433 345678999999999998877 889999999999999999999996532
Q ss_pred HH-------HHHHHHh--c------------------C-----CC-----------------CCCCCCCchHHHHHHhcc
Q psy2306 241 FK-------RLVKQIS--N------------------G-----DY-----------------FEPKNQSTASPLIAEMLN 271 (335)
Q Consensus 241 ~~-------~~~~~~~--~------------------~-----~~-----------------~~~~~~~~l~~li~~~l~ 271 (335)
.. .....+. . . .. .....++++.+||.+||.
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 11 1110000 0 0 00 001123468889999999
Q ss_pred cCCCCCCCHHHHhcCCCcCCCC
Q psy2306 272 INPSSRADISVICSHWWIDKDH 293 (335)
Q Consensus 272 ~dp~~Rps~~~ll~~~~~~~~~ 293 (335)
.||.+|||++|+|+||||++..
T Consensus 314 ~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 314 LDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp SSTTTCBCHHHHHTCGGGTTCT
T ss_pred CChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=8.5e-25 Score=179.27 Aligned_cols=172 Identities=20% Similarity=0.159 Sum_probs=121.1
Q ss_pred eeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcC---------------CHHHHHHHHHHHHHHHcCCCCccccee
Q psy2306 38 FDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIE---------------TEADLIRIRREIQIMSSVRHPNIIHIY 102 (335)
Q Consensus 38 y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 102 (335)
+.++++||+|+||+||+|.+. +|+.||+|+++..... ..........|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999986 6899999987532110 011234456788899999999998887
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHCCcEecCCCCCCEEEccCCCeEEeeccc
Q psy2306 103 EVFENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKHKICHRDLKLENILLDENGNAKIADFGL 182 (335)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~givH~di~p~nili~~~~~~kL~df~~ 182 (335)
++.. .+++||++++..+.+ ++......++.|++.+|.+||++|++||||||+||+++++ .++|+|||.
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 279999998765433 4455577899999999999999999999999999999865 499999999
Q ss_pred cccccCCccccccccCCccCChhhhcCCCCCCCcchHHHHHHH
Q psy2306 183 SNVFTESRFLSTFCGSPLYASPEIVKGIPYHGPEVDCWSLGVL 225 (335)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~ 225 (335)
+.....+........... .-.+.+ ...+ +.++|+||+.--
T Consensus 149 a~~~~~~~~~~~l~rd~~-~~~~~f-~r~y-~~~~d~~s~~~~ 188 (191)
T d1zara2 149 SVEVGEEGWREILERDVR-NIITYF-SRTY-RTEKDINSAIDR 188 (191)
T ss_dssp CEETTSTTHHHHHHHHHH-HHHHHH-HHHH-CCCCCHHHHHHH
T ss_pred cccCCCCCcHHHHHHHHH-HHHHHH-cCCC-CCcccHHHHHHH
Confidence 876654322110000000 001111 1233 778999998643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.91 E-value=4e-09 Score=88.74 Aligned_cols=148 Identities=17% Similarity=0.185 Sum_probs=99.8
Q ss_pred chhhhhhhccceeEEeeeeccCCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEE
Q psy2306 27 LHNHRRKLKQRFDIVRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVF 105 (335)
Q Consensus 27 ~~~~~~~~~~~y~~~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~ 105 (335)
++..-..+-+.|++.+..+.++.+.||+.. .++..+++|......... ...+.+|...++.+. +--+++++.+.
T Consensus 5 ~~~~l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~ 79 (263)
T d1j7la_ 5 ISPELKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp SCHHHHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred cCHHHHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence 333444555688888876666668899884 456778899876532222 224556777777664 33467888888
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhHHC------------------------------
Q psy2306 106 ENREKMVLVMEYAAGGELYDFLDQKKVLTEEEARRIFRQIATAVYYCHKH------------------------------ 155 (335)
Q Consensus 106 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~LH~~------------------------------ 155 (335)
.+.+..++||++++|.++.+..... .....++.++...++.||+.
T Consensus 80 ~~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 80 RHDGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred ecCCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 8899999999999998876544211 11223344444555555531
Q ss_pred -----------------------------CcEecCCCCCCEEEccCCCeEEeeccccc
Q psy2306 156 -----------------------------KICHRDLKLENILLDENGNAKIADFGLSN 184 (335)
Q Consensus 156 -----------------------------givH~di~p~nili~~~~~~kL~df~~~~ 184 (335)
.++|+|++|.||++++++...|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 17999999999999876666799999774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.37 E-value=7.2e-07 Score=79.29 Aligned_cols=80 Identities=19% Similarity=0.147 Sum_probs=49.9
Q ss_pred EeeeeccCCeEEEEEEECCCCcEEEEEEeecCCc----CCHHHHHHHHHHHHHHHcCC--C-CcccceeEEEEeCCeEEE
Q psy2306 41 VRKLGQGNYGKVQLGINKETGQEVAIKTIKKCKI----ETEADLIRIRREIQIMSSVR--H-PNIIHIYEVFENREKMVL 113 (335)
Q Consensus 41 ~~~ig~g~~g~Vy~~~~~~~~~~valK~~~~~~~----~~~~~~~~~~~e~~~l~~l~--~-~~i~~~~~~~~~~~~~~l 113 (335)
.+.||.|....||++.+..+++.+++|...+... .......+...|...|+.+. . ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998887788999997543110 11112334556777777663 2 345555554 4556678
Q ss_pred EEecCCCCC
Q psy2306 114 VMEYAAGGE 122 (335)
Q Consensus 114 v~e~~~~~~ 122 (335)
+||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.33 E-value=1.3e-06 Score=72.39 Aligned_cols=74 Identities=14% Similarity=0.077 Sum_probs=50.1
Q ss_pred eeeccC-CeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC--CCcccceeEEEEeCCeEEEEEecCC
Q psy2306 43 KLGQGN-YGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR--HPNIIHIYEVFENREKMVLVMEYAA 119 (335)
Q Consensus 43 ~ig~g~-~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~ 119 (335)
.+..|. .+.||+.... ++..+++|........ .+..|...++.+. .-.+.+++.+..+.+..+++|++++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344554 3678988643 4667899986543221 3456666666663 2336778888888889999999998
Q ss_pred CCCH
Q psy2306 120 GGEL 123 (335)
Q Consensus 120 ~~~L 123 (335)
|.++
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 8654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.39 E-value=0.00016 Score=62.00 Aligned_cols=131 Identities=13% Similarity=0.113 Sum_probs=74.0
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCCCCcc--ccee-----EEEEeCCeEEEEEecCCC
Q psy2306 48 NYGKVQLGINKETGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVRHPNI--IHIY-----EVFENREKMVLVMEYAAG 120 (335)
Q Consensus 48 ~~g~Vy~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~-----~~~~~~~~~~lv~e~~~~ 120 (335)
..-.||.+... +|..|++|+..+... ..+.+..|...+..+...++ +... ..+...+..+.++++++|
T Consensus 34 ~EN~vy~v~~~-dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 34 YENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ccceeEEEEcC-CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 34589999653 688899999876322 23356677777766642111 1111 223456778899999976
Q ss_pred CCH-----HHH------Hh-------h-----CCCCC-------------------H---HHHHHHHHHHHHHHHHhH--
Q psy2306 121 GEL-----YDF------LD-------Q-----KKVLT-------------------E---EEARRIFRQIATAVYYCH-- 153 (335)
Q Consensus 121 ~~L-----~~~------l~-------~-----~~~~~-------------------~---~~~~~i~~~l~~~l~~LH-- 153 (335)
..+ ..+ +. . +...+ . ......+.++...+...-
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred cCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccc
Confidence 421 111 10 0 01111 1 112223333333333321
Q ss_pred --HCCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 154 --KHKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 154 --~~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
..+++|+|+++.||++++ + ..++||+.++.
T Consensus 189 ~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred cCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 246899999999999964 3 56899997753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.21 E-value=0.00068 Score=59.49 Aligned_cols=74 Identities=18% Similarity=0.167 Sum_probs=49.2
Q ss_pred EEeeeeccCCeEEEEEEECC-------CCcEEEEEEeecCCcCCHHHHHHHHHHHHHHHcCC-CCcccceeEEEEeCCeE
Q psy2306 40 IVRKLGQGNYGKVQLGINKE-------TGQEVAIKTIKKCKIETEADLIRIRREIQIMSSVR-HPNIIHIYEVFENREKM 111 (335)
Q Consensus 40 ~~~~ig~g~~g~Vy~~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 111 (335)
.++.|+.|-.-.+|++.... ..+.|++++.... ... ....+|..+++.+. +.-.+++++++.+
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 34678889999999997653 3467888887631 222 23457888888775 3334567776642
Q ss_pred EEEEecCCCCC
Q psy2306 112 VLVMEYAAGGE 122 (335)
Q Consensus 112 ~lv~e~~~~~~ 122 (335)
++|+||++|.+
T Consensus 117 g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 GRLEEYIPSRP 127 (395)
T ss_dssp EEEECCCCEEE
T ss_pred ceEEEEecccc
Confidence 57899998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.06 E-value=0.0016 Score=55.00 Aligned_cols=31 Identities=19% Similarity=0.274 Sum_probs=27.1
Q ss_pred CCcEecCCCCCCEEEccCCCeEEeecccccc
Q psy2306 155 HKICHRDLKLENILLDENGNAKIADFGLSNV 185 (335)
Q Consensus 155 ~givH~di~p~nili~~~~~~kL~df~~~~~ 185 (335)
.|++|+|+.++||+++.+...-++||+.++.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 5799999999999998877778999998743
|